[
    {
        "id" : "1",
        "url": "https://www.corepeptides.com/peptides/cjc-1295-no-dac-mod-grf-1-29/",
        "name": "CJC-1295 NO DAC (Mod GRF 1-29) (5mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Mod-GRF-1-29-5mg.jpg",
        "display_price": "$41.00",
        "display_specs": [
            "Size: 5mg Contents: CJC-1295 NO DAC (MOD GRF 1-29) Form: Lyophilized powder Purity: >99% SKU: P-MODGRF129",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$38.95"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$36.90"
            }
        ],
        "description": [
            {
                "h2": "CJC-1295 Peptide (No DAC)"
            },
            {
                "p": "CJC-1295 is a synthetic peptide derivative of the naturally occurring GHRH hormone and is composed of 29 amino acids.(2) This peptide is also referred to as Modified GRF (1-29) or CJC 1295 without DAC. It is a modified version of the peptide containing four substituted amino groups that are considered to help prevent the peptide's degradation. CJC without DAC does not have a Drug Affinity Complex that is sometimes added to further extend the half-life of the peptide."
            },
            {
                "p": "Modified growth hormone fragments GRF (1-29) were first discovered in the early 1980s, when it was suggested that the first 29 amino acids of the natural growth hormone-releasing hormone might retain all the properties of the full 44 amino acid peptide.(3) One of the potential drawbacks of synthetically developed growth hormone-releasing peptides is a short half-life. Rigorous research has resulted in a supposedly stabilized, longer-lasting CJC-1295 (No DAC) peptide.(1)"
            },
            {
                "h3": "Overview"
            },
            {
                "p": "CJC-1295 without DAC, alternatively known as the tetra-substituted GRF (1-29), represents a synthetic variant of the naturally occurring hormone responsible for the release of growth hormone (GHRH). Scholars have posited that it facilitates the secretion of growth hormone (GH). This compound is essentially constructed from the minimal sequence of amino acids that might bind to GHRH receptors, specifically the initial 29 amino acids of GHRH. There are notable structural differences between CJC-1295 without DAC and the unmodified fragment, primarily due to the alteration of four amino acids within the original 29 amino acids of GHRH. These changes encompass the 2nd, 8th, 15th, and 27th amino acids, and such adjustments might arguably extend the peptide's lifespan against enzymatic breakdown, particularly by enzymes like dipeptidyl peptidase-4 (DPP-4).(4)"
            },
            {
                "p": "More specifically, these alterations include:"
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C152H252N44O42 Molecular Weight: 3367.9 g/mol Other Known Titles: CJC-1295 Without DAC"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "CJC-1295 (No DAC) Peptide and the Pituitary Gland"
            },
            {
                "p": "CJC-1295 without DAC seems to aim at the GHRH receptor on pituitary cells, potentially engaging with certain binding sites on the receptor molecule. This interaction may induce alterations in the receptor's conformation, possibly sparking a chain of molecular events that might activate signaling pathways within its target cells. The induced structural changes are believed to facilitate the activation of G-proteins, signaling proteins theorized to reside on the cell's interior side of the GHRH receptor.(5) Once activated, these G-proteins might trigger the production of secondary messengers like cAMP or IP3, which are thought to act as intermediary signaling molecules, possibly amplifying the signal inside the cell. Particularly, cAMP may activate protein kinases, which are presumed to be pivotal in phosphorylating specific target proteins.(6) Protein kinases are suggested to have a potential role in managing various cell functions. The stimulation of protein kinases could lead to the phosphorylation of transcription factors, proteins that might influence gene expression regulation. These phosphorylated transcription factors may then enter the nucleus and might alter the transcription of genes linked to the synthesis and secretion of growth hormone. Consequently, the molecular activities seemingly initiated by CJC-1295 no DAC's binding may culminate in the merging of secretory vesicles loaded with growth hormone with the cell membrane. This merger may facilitate the external release of growth hormone from the pituitary cells, potentially enabling it to perform its biological functions."
            },
            {
                "h3": "CJC-1295 (No DAC) Peptide and Growth Hormone Pulsatility"
            },
            {
                "p": "While no studies directly investigate the potential of CJC-1295 no DAC (tetrasubstituted GRF 1-29), some researchers have conducted extensive experimentations with partially modified versions of GRF 1-29. One notable example is research by Khorram et al. This study on CJC-1295 no DAC explored its potential on growth hormone and insulin-like growth factor 1 (IGF-1), skin cell proliferation, muscle tissue hypertrophy, and other potential outcomes.(7) The investigation highlighted the potential of CJC-1295 no DAC to modulate the growth hormone-IGF-1 axis. More specifically, CJC-1295 no DAC appeared to cause a considerable rise, with an approximate increase of 70-107% higher mean 12-hours release of growth hormone by the somatotroph cells in the anterior pituitary. Concurrently, IGF-1 also experienced an increase, approximately 28%, indicating an enhancement in the growth hormone-IGF-1 axis functionality. This increase was also associated with increases in skin tissue thickness, potentially due to the anabolic actions of growth hormone and IGF-1 on collagen-producing skin cells such as fibroblasts. Furthermore, there was a significant increase in muscle tissue hypertrophy, ultimately resulting in a net lean mass gain of 2.77 lbs. These results imply a potential role of CJC-1295 no DAC in promoting skin cell proliferation and muscle tissue hypertrophy that should be investigated in future experiments. However, the specific mechanisms behind these actions remain to be fully elucidated."
            },
            {
                "h3": "CJC-1295 (No DAC) Peptide and Intestinal Studies"
            },
            {
                "p": "Studies(8) were conducted in experimental models, which have suggested a potential interaction between GHRH analog peptides and VPAC(1)-R, found on the smooth muscles of the gastrointestinal system. This interaction was suggested to induce bowel movement, though the potential connection between specific peptides and bowel release are still under investigation."
            },
            {
                "h3": "CJC-1295 (No DAC) Peptide and Heart Rate"
            },
            {
                "p": "Preliminary research(9) in murine models suggested that Modified GRF 1-29 peptide (along with other GHRH derivative analogs) may exhibit some potential to improve heart rate and possibly support the heart's ability to pump blood, particularly following a heart attack. The study(9) commented that GHRH agonist peptides appeared to promote cardiac tissue repair and possibly also improve ejection fraction rates."
            },
            {
                "h3": "CJC-1295 (No DAC) Peptide and Combination"
            },
            {
                "p": "CJC-1295 NO DAC appears to be a relatively short-lasting GHRH analog when not attached to DAC, compared to other synthetic GHRH peptides. Consequently, combined with other short-acting peptides, it may support longer durations for specific properties. Moreover, the peptide may have synergistic actions when combined with growth hormone secretagogues (GHSs). GHSs are considered to be ghrelin mimetics, which interact with the ghrelin receptors within various tissues. These receptors also happen to be found on the somatotroph cells in the anterior pituitary gland - the same cells that also have the GHRH receptors and are associated with growth hormone synthesis. Activating these receptors may lead to an apparent increase in growth hormone synthesis, and some researchers suggest that the simultaneous activation of the GHRH and ghrelin receptors on these pituitary cells may result in synergistically increased growth hormone elevation.(11) One such highly common peptide combination is with Ipamorelin, a synthetic GHRH pentapeptide. Both Ipamorelin and CJC-1295 peptides have been suggested to stimulate the production of growth hormone by the cells of the pituitary gland, albeit via different modes of action, therefore possibly exerting synergism and stimulating even greater growth hormone secretion."
            },
            {
                "p": "CJC-1295 peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "National Center for Biotechnology Information. \"PubChem Compound Summary for CID 91976842, CJC1295 Without DAC\" PubChem, https://pubchem.ncbi.nlm.nih.gov/compound/CJC1295-Without-DAC",
                    "Clark, R G, and I C Robinson. “Growth induced by pulsatile infusion of an amidated fragment of human growth hormone releasing factor in normal and GHRF-deficient rats.” Nature vol. 314,6008 (1985): 281-3. https://pubmed.ncbi.nlm.nih.gov/2858818/",
                    "The Discovery of Growth Hormone-Releasing Hormone: An Update https://onlinelibrary.wiley.com/doi/full/10.1111/j.1365-2826.2008.01740.x",
                    "Martin, B., Lopez de Maturana, R., Brenneman, R., Walent, T., Mattson, M. P., & Maudsley, S. (2005). Class II G protein-coupled receptors and their ligands in neuronal function and protection. Neuromolecular medicine, 7(1-2), 3–36. https://doi.org/10.1385/nmm:7:1-2:003",
                    "Newton, A. C., Bootman, M. D., & Scott, J. D. (2016). Second Messengers. Cold Spring Harbor perspectives in biology, 8(8), a005926. https://doi.org/10.1101/cshperspect.a005926",
                    "Khorram, O., Laughlin, G. A., & Yen, S. S. (1997). Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women. The Journal of clinical endocrinology and metabolism, 82(5), 1472–1479. https://doi.org/10.1210/jcem.82.5.3943",
                    "Ito T, Igarashi H, Pradhan TK, Hou W, Mantey SA, Taylor JE, Murphy WA, Coy DH, Jensen RT. GI side-effects of a possible therapeutic GRF analogue in monkeys are likely due to VIP receptor agonist activity. Peptides. 2001 Jul;22(7):1139-51. https://pubmed.ncbi.nlm.nih.gov/11445245/",
                    "Schally AV, Zhang X, Cai R, Hare JM, Granata R, Bartoli M. Actions and Potential Therapeutic Applications of Growth Hormone-Releasing Hormone Agonists. Endocrinology. 2019 Jul 1;160(7):1600-1612. https://pubmed.ncbi.nlm.nih.gov/31070727/",
                    "Sinha, D. K., Balasubramanian, A., Tatem, A. J., Rivera-Mirabal, J., Yu, J., Kovac, J., Pastuszak, A. W., & Lipshultz, L. I. (2020). Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males. Translational andrology and urology, 9(Suppl 2), S149–S159. https://doi.org/10.21037/tau.2019.11.30"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/01/CJC-1295-coa.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/01/CJC-1295-lc.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/01/CJC-1295-ms.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "CJC-1295 NO DAC (Mod GRF 1-29) for sale online. Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "CJC-1295 NO DAC (Mod GRF 1-29) For Sale (5mg)",
            "og:description": "CJC-1295 NO DAC (Mod GRF 1-29) for sale online. Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/cjc-1295-no-dac-mod-grf-1-29/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T18:26:10+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Mod-GRF-1-29-5mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "CJC-1295 NO DAC (Mod GRF 1-29) For Sale (5mg)",
            "twitter:description": "CJC-1295 NO DAC (Mod GRF 1-29) for sale online. Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Mod-GRF-1-29-5mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$41.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:brand": "Core Peptides",
            "product:price:amount": "41.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-MODGRF129-5",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/ll-37-5mg/",
                "name": "LL-37 (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/LL-37-5mg-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/melanotan-1-10mg/",
                "name": "Melanotan 1 (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Melanotan-1-10MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/bpc-157/",
                "name": "BPC-157 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/BPC-157-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ipamorelin-5mg/",
                "name": "Ipamorelin (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Ipamorelin-5MG-300x300.jpg.webp",
                "price": ""
            }
        ]
    },
    {
        "id": "2",
        "url": "https://www.corepeptides.com/peptides/cjc-1295-dac-5mg/",
        "name": "CJC-1295 DAC (5mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2020/04/CJC-1295-DAC-5MG.jpg",
        "display_price": "$52.00",
        "display_specs": [
            "Size: 5mg Contents: CJC-1295 with DAC (5mg) Form: Lyophilized powder Purity: >99% SKU: P-CJC1295-5",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$49.40"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$46.80"
            }
        ],
        "description": [
            {
                "h2": "CJC-1295 DAC Peptide"
            },
            {
                "p": "CJC-1295 DAC is a peptide that researchers posit may function similarly to growth hormone-releasing hormone (GHRH), potentially increasing the endogenous production of growth hormone (GH) within the organism. The CJC-1295 DAC peptide is a synthetic 29 amino acid analog of GHRH.(1) It is the shortest functional analog of GHRH that still has the potential capacity to trigger GH release from the somatotroph cells in the pituitary gland. Moreover, 4 of the original 29 amino acids in this fragment are substituted in CJC-1295 DAC, to possibly improve the pharmacokinetics of the peptide and prolong its half-life."
            },
            {
                "p": "The DAC component is a biochemical complex that may further increase the half-life of the peptide. This phenomenon might be ascribed to the alleged capability of the DAC to bind to proteins present in plasma. More precisely, the DAC component appears to entail the attachment of a lysine derivative, identified as N-epsilon-3-maleimidopropionamide, to the C terminus of CJC-1295 DAC. Integrating this modified amino acid sequence with the DAC component might conceivably enhance the pharmacokinetics of CJC-1295 DAC, extending its half-life to approximately 8 days. Simultaneously, it appears to maintain a significant affinity for GHRH receptors, similar to the affinity exhibited by CJC-1295 without DAC.(2)"
            },
            {
                "p": "This does not imply that CJC without DAC has no relevance or use in present day research. For example, CJC-1295 without DAC & Ipamorelin blend has been studied for its suggested synergistic potential, as combining GHRH analogs with peptides that appear to activate the ghrelin receptors in the pituitary gland. It is also posited to result in greater GH-synthesis response from the somatotroph cells.(3)"
            },
            {
                "h3": "Overview"
            },
            {
                "p": "CJC-1295 DAC is recognized by many names: CJC-1295, CJC-1295 with DAC, DAC:GRF, long-acting GHRH analog, and synthetic GHRH analog. Theoretically, as the peptide is considered a releasing factor for growth hormone, CJC-1295 DAC has been studied for its potential role in:"
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C152H252N44O42 Molecular Weight: 3367.95 g/mol Other Known Titles: Tetrasubsituted GRF 1-29 with DAC"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "CJC-1295 DAC Peptide Mechanism of Action"
            },
            {
                "p": "Researchers conducted two clinical studies in 2006 to examine the action of CJC-1295 DAC. In the first study, CJC-1295 DAC or a placebo was presented in one of four ascending concentrations. In the second study, CJC-1295 DAC was presented repeatedly at a single concentration. According to the results, after the introduction of CJC-1295 DAC, there appeared to be an increase in GH and insulin-like growth factor-1 (IGF-I) levels among the research models.(5)CJC-1295 DAC is thought to elevate levels of IGF-1 by increasing growth hormone production, which in turn may bind to receptors on liver cells, potentially triggering a cascade of intracellular signaling processes. This binding might activate the Janus kinase-signal transducer and activator of the transcription (JAK-STAT) signaling pathway. Subsequently, the activated STAT proteins might migrate to the nucleus, where they may attach to specific DNA sequences considered to be response elements, potentially resulting in the transcription of the IGF-I gene. It is theorized that the IGF-I produced in liver cells may be transported to various target tissues. Additionally, it is believed that many tissues possess GH receptors, which, upon activation, may lead to the production of IGF-I within the tissues themselves. IGF-I is considered a potent hormone that may play a key role in promoting growth, suggesting it mediates many growth and anabolic effects of growth hormone. It is hypothesized to encourage cell growth and proliferation, as well as the enlargement and strengthening of tissues and organs, possibly aiding in protein synthesis and cellular expansion. Preliminary exposure to CJC-1295 DAC in experimental models has been suggested to significantly affect average growth hormone levels, with studies reporting an apparent increase of 2- to 10-fold for 6 days or possibly longer. Moreover, CJC-1295 DAC has been suggested to lead to dependent increases in average IGF-I levels by 1.5- to 3-fold for about 9–11 days, with suggestions that IGF-I levels may remain high for at least two weeks in experimental models. Following repeated exposure to CJC-1295 DAC, average IGF-I levels appear to remain elevated above baseline for up to 28 days. Notably, data suggests a cumulative effect following repeated exposure of the compound.(5)"
            },
            {
                "p": "In 2006, another group of scientists assessed the GH pulsatility after a single occurrence of CJC-1295 DAC. They found out that there appeared to be an increase of about 50% in mean GH secretion and IGF-I levels after a single presentation of CJC-1295 DAC.(6) Researchers have suggested that the peptide might contribute to an increase in peak growth hormone levels by as much as 7.5 times in the models studied.(6) It seems that CJC-1295 DAC may interact with certain binding sites on the growth hormone-releasing hormone (GHRH) receptor protein. This interaction may lead to changes in the receptor's structure, potentially triggering a series of molecular processes. This interaction is believed to stimulate specific intracellular signaling proteins, often referred to as G-proteins.(7) Upon activation, these proteins may promote the production of secondary messengers, such as cyclic adenosine monophosphate (cAMP) or inositol trisphosphate (IP3), which are considered to play crucial roles in cellular signaling pathways.(8) Secondary messengers, including cAMP, are thought to activate protein kinases, which are enzymes considered capable of modifying specific proteins. These kinases are considered able to regulate cellular functions by phosphorylating transcription regulators, the proteins responsible for controlling gene expression. Once phosphorylated, these transcription regulators are speculated to move into the nucleus of somatotroph cells, where they might influence the genes involved in the production of growth hormone. This intricate cascade of events highlights the potential of CJC-1295 DAC to modulate growth hormone levels through a complex network of molecular interactions."
            },
            {
                "p": "Additional animal studies were conducted to evaluate the potential of CJC-1295 DAC. One study evaluated murine models presented with either the peptide or a placebo. The researchers concluded that exposing the murine models daily CJC-1295 DAC might completely normalize growth. Another finding was that CJC-1295 DAC presented every 2 or 3 days appeared to produce intermediate results, indicating a probable interval-dependent action.(9) Furthermore, this study suggests that CJC-1295 DAC might potentially impact body composition, seemingly by increasing muscle tissue hypertrophy while not impacting, or even possibly reducing, fat tissue levels. The murine models in this study appeared to have a deletion of the GHRH gene (referred to as GHRHKO); observations suggested that CJC-1295 DAC may boost GH synthesis, leading to a beneficial alteration in body composition. Exposure to CJC-1295 DAC in these GHRHKO murine models appeared to preserve normal levels of lean mass, unlike in models that were not exposed and exhibited suboptimal lean mass levels. Furthermore, the amount of subcutaneous fat mass stayed consistent with control levels in all groups associated with the peptide, whereas GHRHKO murine models without CJC-1295 DAC exposure exhibited signs of increased fat levels. This indicates that CJC-1295 DAC might positively affect muscle and bone structure without promoting an increase in fat accumulation. Additionally, the study noted a possible increase in pituitary RNA and GH mRNA levels following CJC-1295 DAC exposure, suggesting an enhanced presence of somatotroph cells—those believed to produce growth hormone in the pituitary gland. The authors commented that \"CJC-1295 caused an increase in total pituitary RNA and GH mRNA, suggesting that proliferation of somatotroph cells had occurred, as confirmed by immunohistochemistry images.” (9)"
            },
            {
                "h3": "CJC-1295 DAC Peptide Half-life"
            },
            {
                "p": "In its original form, CJC-1295 DAC uses a technology referred to as Drug Affinity Complex (DAC).(1) Contrary to GHRH, which is considered to boast a half-life of approximately 7 minutes, researchers report CJC-1295 without DAC to exhibit a longer half-life of 30 minutes due to its truncated 29 amino acid fragment, and 4 of the original amino acids in this fragment are replaced. Alterations to the peptide structure, specifically at the 2nd, 8th, 15th, and 27th amino acid positions, are thought to potentially improve the peptide's stability against breakdown by the enzyme dipeptidyl peptidase-4. These alterations are detailed as follows:"
            },
            {
                "p": "These modifications aim to enhance the peptide's resilience and functional efficacy by mitigating enzymatic degradation and improving stability under physiological conditions. In addition, the half-life of the peptide appears to be additionally extended to 6-8 days due to the DAC technology.(10)"
            },
            {
                "h3": "CJC-1295 DAC Peptide Ancillary Studies"
            },
            {
                "p": "In 2005, a clinical study aimed to evaluate the mechanism of action of CJC-1295 DAC in models of immunodeficiency virus (HIV) associated with visceral obesity. In this study, the models would be presented with CJC-1295 DAC for 3 months, followed by a 6-week follow-up period. However, this study was terminated during recruitment, and no related results were posted.(11)"
            },
            {
                "p": "According to a 2009 Norwegian study, a compound was submitted for analysis to evaluate whether it contained prohibited substances or not. The researchers of the Norwegian Doping Control Laboratory and School of Pharmacy reported that this substance was CJC-1295 DAC. In their published article they concluded that \"CJC-1295 DAC is a releasing factor for growth hormone\".(1)"
            },
            {
                "p": "CJC-1295 DAC peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Henninge J, Pepaj M, Hullstein I, Hemmersbach P. Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation. Drug Testing and Analysis. 2010 Nov-Dec;2(11-12):647-650. DOI: 10.1002/dta.233.",
                    "Jetté L, Léger R, Thibaudeau K, Benquet C, Robitaille M, Pellerin I, Paradis V, van Wyk P, Pham K, Bridon DP. Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog. Endocrinology. 2005 Jul;146(7):3052-8. doi: 10.1210/en.2004-1286. Epub 2005 Apr 7. PMID: 15817669.",
                    "Sinha DK, Balasubramanian A, Tatem AJ, Rivera-Mirabal J, Yu J, Kovac J, Pastuszak AW, Lipshultz LI. Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males. Transl Androl Urol. 2020 Mar;9(Suppl 2):S149-S159. doi: 10.21037/tau.2019.11.30. PMID: 32257855; PMCID: PMC7108996.",
                    "Steiger A, Holsboer F. Neuropeptides and human sleep. Sleep. 1997 Nov;20(11):1038-52. PMID: 9456470.",
                    "Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 2006 Mar;91(3):799-805. doi: 10.1210/jc.2005-1536. Epub 2005 Dec 13. PMID: 16352683.",
                    "Ionescu M, Frohman LA. Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. J Clin Endocrinol Metab. 2006 Dec;91(12):4792-7. doi: 10.1210/jc.2006-1702. Epub 2006 Oct 3. PMID: 17018654.",
                    "Martin, B., Lopez de Maturana, R., Brenneman, R., Walent, T., Mattson, M. P., & Maudsley, S. (2005). Class II G protein-coupled receptors and their ligands in neuronal function and protection. Neuromolecular medicine, 7(1-2), 3–36. https://doi.org/10.1385/nmm:7:1-2:003",
                    "Newton, A. C., Bootman, M. D., & Scott, J. D. (2016). Second Messengers. Cold Spring Harbor perspectives in biology, 8(8), a005926. https://doi.org/10.1101/cshperspect.a005926",
                    "Alba M, Fintini D, Sagazio A, Lawrence B, Castaigne JP, Frohman LA, Salvatori R. Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse. Am J Physiol Endocrinol Metab. 2006 Dec;291(6):E1290-4. doi: 10.1152/ajpendo.00201.2006. Epub 2006 Jul 5. PMID: 16822960.",
                    "Van Hout MC, Hearne E. Netnography of Female Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions. Subst Use Misuse. 2016 Jan 2;51(1):73-84. doi: 10.3109/10826084.2015.1082595. Epub 2016 Jan 15. PMID: 26771670.",
                    "ClinicalTrials.gov, A service of the US National Institutes of Health. Available at: http://clinicaltrials.gov/ct2/show/NCT00267527 (27 June 2010)."
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/12/CJC-1295-DAC-COA.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/12/CJC-1295-DAC-LC.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/12/CJC-1295-DAC-MS.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "CJC-1295 DAC for sale online. Peptides for sale at 99% purity with top customer service. Get CJC-1295 research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "CJC-1295 DAC For Sale (5mg) | Core Peptides",
            "og:description": "CJC-1295 DAC for sale online. Peptides for sale at 99% purity with top customer service. Get CJC-1295 research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/cjc-1295-dac-5mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-05-28T11:02:33+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/CJC-1295-DAC-5MG.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "CJC-1295 DAC For Sale (5mg) | Core Peptides",
            "twitter:description": "CJC-1295 DAC for sale online. Peptides for sale at 99% purity with top customer service. Get CJC-1295 research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/CJC-1295-DAC-5MG.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$52.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "52.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-CJC1295-5",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/ghrp-6/",
                "name": "GHRP-6 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHRP-6-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/cjc-1295-no-dac-mod-grf-1-29/",
                "name": "CJC-1295 NO DAC (Mod GRF 1-29) (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Mod-GRF-1-29-5mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/semax-25mg/",
                "name": "Semax (25mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Semax-25MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/melanotan-2-10mg/",
                "name": "Melanotan 2 (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2023/03/Melanotan-2-10MG-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "id": "3",
        "url": "https://www.corepeptides.com/peptides/cjc-1295-ghrp-2-blend-10mg/",
        "name": "CJC-1295 & GHRP-2 Blend (10mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2023/06/CJC-1295-GHRP-2-5-5MG.jpg",
        "display_price": "$84.00",
        "display_specs": [
            "Size: 10mg Contents: CJC-1295 NO DAC (5mg) & GHRP-2 (5mg) Form: Lyophilized powder Purity: >99% SKU: CJC-1295-GHRP-2",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$79.80"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$75.60"
            }
        ],
        "description": [
            {
                "h2": "CJC-1295 & GHRP-2 Peptide Blend"
            },
            {
                "p": "Research indicates that GHRP-2 and CJC-1295 peptides may act on separate receptors, potentially enhancing the release of growth hormone (GH) from the anterior pituitary."
            },
            {
                "p": "CJC-1295 is a molecular compound that exhibits an apparent binding affinity for the growth hormone-releasing hormone (GHRH) receptors, potentially inducing growth hormone release by pituitary cells. CJC-1295 is derived from GHRH 1-29, which is considered to represent the functional sequence of the initial 29 amino acids of GHRH. The peptide CJC-1295 has undergone tetra substitution and modification through the addition of a drug affinity complex (DAC) component. This DAC component appears to bind to plasma proteins and may enhance the pharmacokinetic profile of CJC-1295.(1)"
            },
            {
                "p": "Growth Hormone Releasing Peptide 2 (GHRP-2) is a synthetic hexapeptide composed of six amino acids. Research teams have observed this peptide to bind to the ghrelin or growth hormone secretagogue 1a receptors (GHS-R1a), which are present in the hypothalamus and the pituitary gland. Consequently, GHRP-2 has been suggested by researchers to stimulate the production of growth hormones in pituitary cells that express the GHS-R1a receptor.(2)"
            },
            {
                "p": "By stimulating different receptors through distinct biochemical pathways, these peptides are believed to synergistically elevate GH release from the anterior pituitary beyond the individual capacities of each peptide."
            },
            {
                "h3": "Chemical Makeup(3)(4)"
            },
            {
                "p": "Molecular Formula"
            },
            {
                "p": "Molecular Weight"
            },
            {
                "p": "Sequence"
            },
            {
                "p": "Other Known Titles"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "CJC-1295 & GHRP-2 Blend and Growth Hormone Secretion"
            },
            {
                "p": "According to research teams exploring the topic, GHRP-2 may possess a strong affinity towards the growth hormone secretagogue 1a receptor (GHS-R1a) in the hypothalamus and pituitary gland, whereas CJC-1295 may possibly interact with the growth hormone-releasing hormone receptor (GHRH-R) in the pituitary gland. Studies suggest that the influence of this peptide blend may increase plasma growth hormone (GH) levels, indicating their potential to enhance GH release. Possible sustained release of this blend also appears to extend the peptide half-life, potentially prolonging GH secretion compared to individual peptide presentation. As per studies, it has been reported that “basal GH levels may increase by 7.5-fold,” which appears to have contributed to “an overall increase GH secretion by 46%” (1)"
            },
            {
                "p": "Though acting on different receptors, research suggests that synergistically, these peptides may promote “pulsatile release of growth hormones that is subject to negative feedback, and may prevent supratherapeutic levels of GH and their sequelae” (5)"
            },
            {
                "p": "It has been hypothesized that GHRH-mimetics such as CJC-1295 and the secretagogue GHRP-2 may potentially exhibit synergistic effects in regard to their apparent stimulation of growth hormone secretion. Interestingly, the combination of both GHRH-mimetic and GHRP-2 was observed to induce a 54-fold increase in pulsatile GH secretion compared to controls. Moreover, GHRP-2 appeared to decrease the time to maximal GH secretion with a median time reduction of 43%. GHRP-2 was reported to lead to a 47-fold increase in pulsatile GH secretion, while GHRH-mimetics appear to lead to only a 20-fold increase.(6)"
            },
            {
                "h3": "CJC-1295 & GHRP-2 Blend and Metabolism of Muscle and Fat"
            },
            {
                "p": "GHRP-2 and CJC-1295 peptides, albeit via different proposed mechanisms, appear to stimulate GH release from the pituitary cells, which may assist with fat loss. Research indicates that CJC-1295 may exhibit a longer half-life compared to endogenous GHRH."
            },
            {
                "p": "Growth hormone is considered to be able to exert anti-obesity effects through several mechanisms, including lipolysis, utilization of fatty acids as an energy source, and increased fat oxidation. The peptide blend has reportedly also exhibited signs of increased glucose synthesis and reduced glucose uptake, which appears to increase fat utilization and storage. Studies indicate that ghrelin-like peptides such as GHRP-2, “because of its dual effects on ... (hGH) and on energy balance,” may “be a critical hormonal signal of nutritional status to the somatotropic axis, playing a role in integrating energy balance with the growth process.” (7)"
            },
            {
                "p": "However, it is important to note that as an apparent ghrelin analog, GHRP-2 may have a similar role, potentially increasing hunger levels. It is hypothesized that the potential appetite-stimulating effects of GHRP-2 are primarily mediated through its interaction with the growth hormone secretagogue receptor (GHSR), specifically GHSR-1a, which is located in various regions such as the hypothalamus, pituitary gland, and stomach. Upon binding to GHSR-1a in the hypothalamus, GHRP-2 is thought to initiate a signal transduction cascade that may lead to the increased production of hunger-inducing neuropeptides, Neuropeptide Y (NPY), and Agouti-related peptide (AgRP). Both NPY and AgRP are suspected to play crucial roles in energy homeostasis and appetite regulation. Concurrently, GHRP-2 could potentially suppress the release of the anorexigenic (appetite-suppressing) hormone, melanocyte-stimulating hormone (α-MSH), thereby tipping the balance towards hunger and stimulating food intake. Additionally, GHRP-2 might influence the mesolimbic reward system, a brain circuitry believed to regulate the desire for palatable food, by activating GHSR-1a. This could hypothetically boost the motivation for food consumption."
            },
            {
                "p": "Moreover, preliminary research suggests that this peptide may induce mild weight gain.(5) Although GHRP-2 seems to predominantly affect appetite through its interaction with GHSR-1a, it is expected to have intricate effects on overall energy homeostasis due to the widespread distribution of GHSRs and the diverse role of ghrelin. Other hormones, neuronal signals, and factors associated with circadian rhythms and physiological states may also modulate its potential appetite-stimulating effects."
            },
            {
                "p": "Ultimately, the peptide may possibly increase energy consumption and negate some of the fat-reducing potential of CJC-1295. Yet, the combination of CJC-1295 & GHRP-2 blend may likely enhance the anabolic potential of each of the compounds. Thus, the blend may have a higher potential for research into weight gain and especially lean muscle gain, rather than fat loss research. This potential is hypothetically mediated by the so-called insulin-like growth factor-1."
            },
            {
                "h3": "CJC-1295 & GHRP-2 Blend and Insulin-like Growth Factor 1 (IGF-1)"
            },
            {
                "p": "CJC-1295 and GHRP-2 may increase growth hormone levels, thereby binding to specific receptors on liver cells, potentially initiating intracellular signaling events that lead to synthesizing a major anabolic mediator called insulin-like growth factor-1 (IGF-1). The binding of growth hormone might trigger the activation of the Janus kinase-signal transducer and activator of the transcription (JAK-STAT) signaling pathway. The activated STAT proteins may then translocate to the nucleus, where they might bind to specific DNA sequences called response elements, possibly leading to the transcription of the IGF-I gene. The newly synthesized IGF-I is then hypothesized to be released into the circulation, where it could act upon various target tissues."
            },
            {
                "p": "It seems that IGF-I could be a potent growth-promoting hormone that hypothetically mediates several of the growth and anabolic actions of growth hormone. It is proposed to stimulate the growth and proliferation of cells, tissues, and organs, potentially fostering protein synthesis and cellular growth."
            },
            {
                "p": "Research studies suggest that even a brief encounter with CJC-1295 may impact mean plasma growth hormone concentrations, potentially leading to a 2- to 10-fold increase for six days or possibly more. It is hypothesized that the peak of growth hormone levels is typically achieved within 1 to 4 hours after introduction. Additionally, CJC-1295 might lead to observable dependent increases in mean plasma IGF-I concentrations by 1.5- to 3-fold for possibly 9 to 11 days.(8) Post introduction, IGF-I levels are suggested to remain elevated for at least two weeks in test models with higher exposure. After multiple introductions of CJC-1295, mean IGF-I levels appear to remain above baseline for up to 28 days. Interestingly, data suggests a cumulative action after 2 or 3 exposures to the compound, with potentially elevated levels of growth hormone and IGF-I above baseline on day 14 in laboratory experimental models."
            },
            {
                "p": "CJC-1295 & GHRP-2 blend is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Ionescu M, Frohman LA. Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. J Clin Endocrinol Metab. 2006 Dec;91(12):4792-7. doi: 10.1210/jc.2006-1702. Epub 2006 Oct 3. PMID: 17018654. https://pubmed.ncbi.nlm.nih.gov/17018654/",
                    "Yamamoto D, Ikeshita N, Matsubara T, Tasaki H, Herningtyas EH, Toda K, Iida K, Takahashi Y, Kaji H, Chihara K, Okimura Y. GHRP-2, a GHS-R agonist, directly acts on myocytes to attenuate the dexamethasone-induced expressions of muscle-specific ubiquitin ligases, Atrogin-1 and MuRF1. Life Sci. 2008 Feb 27;82(9-10):460-6. doi: 10.1016/j.lfs.2007.11.019. Epub 2007 Dec 5. PMID: 18191156. https://pubmed.ncbi.nlm.nih.gov/18191156/",
                    "National Center for Biotechnology Information (2023). PubChem Compound Summary for CID 56841945. https://pubchem.ncbi.nlm.nih.gov/compound/56841945",
                    "National Center for Biotechnology Information (2023). PubChem Compound Summary for CID 6918245, Pralmorelin. https://pubchem.ncbi.nlm.nih.gov/compound/Pralmorelin.",
                    "Sigalos JT, Pastuszak AW. The Safety and Efficacy of Growth Hormone Secretagogues. Sex Med Rev. 2018 Jan;6(1):45-53. doi: 10.1016/j.sxmr.2017.02.004. Epub 2017 Apr 8. PMID: 28400207; PMCID: PMC5632578. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632578/",
                    "Sinha, D. K., Balasubramanian, A., Tatem, A. J., Rivera-Mirabal, J., Yu, J., Kovac, J., Pastuszak, A. W., & Lipshultz, L. I. (2020). Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males. Translational andrology and urology, 9(Suppl 2), S149–S159. https://doi.org/10.21037/tau.2019.11.30",
                    "Laferrère B, Hart AB, Bowers CY. Obese subjects respond to the stimulatory effect of the ghrelin agonist growth hormone-releasing peptide-2 on food intake. Obesity (Silver Spring). 2006 Jun;14(6):1056-63. doi: 10.1038/oby.2006.121. PMID: 16861611; PMCID: PMC2824649. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824649/",
                    "Teichman, S. L., Neale, A., Lawrence, B., Gagnon, C., Castaigne, J. P., & Frohman, L. A. (2006). Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. The Journal of clinical endocrinology and metabolism, 91(3), 799–805. https://doi.org/10.1210/jc.2005-1536"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/12/CJC-1295-GHRP-2-COA-1.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/12/CJC-1295-GHRP-2-LC-1.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/12/CJC-1295-GHRP-2-MS-1.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "CJC-1295 & GHRP-2 Blend for sale (10mg). Purchase peptide blends at 99+% purity with unmatched customer service and free shipping.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "CJC-1295 & GHRP-2 Blend For Sale (10mg) - Core Peptides",
            "og:description": "CJC-1295 & GHRP-2 Blend for sale (10mg). Purchase peptide blends at 99+% purity with unmatched customer service and free shipping.",
            "og:url": "https://www.corepeptides.com/peptides/cjc-1295-ghrp-2-blend-10mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T15:21:19+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2023/06/CJC-1295-GHRP-2-5-5MG.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "CJC-1295 & GHRP-2 Blend For Sale (10mg) - Core Peptides",
            "twitter:description": "CJC-1295 & GHRP-2 Blend for sale (10mg). Purchase peptide blends at 99+% purity with unmatched customer service and free shipping.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2023/06/CJC-1295-GHRP-2-5-5MG.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$84.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "84.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "CJC-1295-GHRP-2",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/ll-37-5mg/",
                "name": "LL-37 (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/LL-37-5mg-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/receptor-grade-igf-1-lr3-100mcg/",
                "name": "Receptor Grade IGF-1 LR3 (100mcg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-100MCG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/semax-25mg/",
                "name": "Semax (25mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Semax-25MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/cjc-1295-no-dac-mod-grf-1-29/",
                "name": "CJC-1295 NO DAC (Mod GRF 1-29) (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Mod-GRF-1-29-5mg-300x300.jpg.webp",
                "price": ""
            }
        ]
    },
    {
        "id": "4",
        "url": "https://www.corepeptides.com/peptides/cjc-1295-ghrp-6-10mg-blend/",
        "name": "CJC-1295 & GHRP-6 Blend (10mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2020/04/CJC-1295-GHRP-6-5-5MG.jpg",
        "display_price": "$75.00 Original price was: $75.00.$69.00Current price is: $69.00.",
        "display_specs": [
            "Size: 10mg Contents: CJC-1295 NO DAC (5mg) & GHRP-6 (5mg) Form: Lyophilized powder Purity: >99% SKU: P-CJCGHR6-10",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$65.55"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$62.10"
            }
        ],
        "description": [
            {
                "h2": "CJC-1295 & GHRP-6 Peptide Blend"
            },
            {
                "p": "Research indicates that peptides CJC-1295 and GHRP-6 may exert potential action on growth hormone release. When presented as a blend, they may possibly induce synergistic action, stimulating an organism’s synthesis and secretion of growth hormones. This peptide blend may possibly help repair mild injuries associated with muscles and surrounding ligaments."
            },
            {
                "p": "GHRP-6 peptide is a synthetic six amino acid peptide analog of ghrelin, a naturally occurring peptide that is considered by scientists to stimulate the secretion of growth hormones and help maintain their concentrations.(1) To do so, researchers hypothesize that it may activate what is known as the growth hormone secretagogue receptor (GHS-R1a). In terms of structure, GHRP-6 does not appear to share any homology with ghrelin despite its affinity to the receptors, but instead it appears to be an opioid analog of the peptide Met-enkephalin. Yet, researchers suggest it lacks the opioid activity which is typically associated with these enkephalins. Thus, GHRP-6 is a synthetic hexapeptide that researchers have classified in the group of growth hormone secretagogues (GHSs)."
            },
            {
                "p": "CJC-1295, also referred to as tetra-substituted GRF (1-29), is a synthetic peptide analog of the naturally occurring growth hormone-releasing hormone (GHRH), which is believed by researchers to trigger the release of growth hormones.(2) It is essentially equivalent to the shortest chain of amino acids that may potentially attach to the GHRH receptors, which are the first 29 amino acids of GHRH. The key structural distinctions between CJC-1295 and GRF (1-29) are found in four altered amino acids of the original 29 amino acids of GHRH. These modifications involve the 2nd, 8th, 15th, and 27th amino acids, and may potentially enhance the peptide's resistance to degradation by the enzyme dipeptidyl peptidase-4. Specifically, the modifications include:"
            },
            {
                "h3": "Chemical Makeup(2)(3)"
            },
            {
                "p": "Molecular Formula: CJC-1295 peptide: C152H252N44O42 GHRP-6 peptide: C46H56N12O6"
            },
            {
                "p": "Molecular Weight: CJC-1295 peptide: 3367.9 g/mol GHRP-6 peptide: 873.0 g/mol"
            },
            {
                "p": "Other Known Titles:"
            },
            {
                "p": "Both forms of the CJC-1295 peptide essentially exert the same action; however, the addition of DAC (known as the drug affinity complex) appears to change the duration of the action of the peptide. CJC-1295 with DAC may have a longer-lasting action than CJC-1295 without DAC. This could be attributed to the proposed ability of the DAC to attach itself to proteins in the plasma. Specifically, the DAC element involves the connection of a lysine derivative, namely N-epsilon-3-maleimidopropionamide, to the C terminus of CJC-1295. The fusion of this altered amino acid sequence with the DAC element may possibly boost the pharmacokinetics of CJC-1295, prolonging its coexistence with plasma proteins to roughly 8 days, while concurrently preserving a noticeable affinity towards GHRH receptors, akin to the affinity demonstrated by CJC-1295 without DAC.  "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "CJC-1295 & GHRP-6 Peptide Blend and Growth Hormone Levels"
            },
            {
                "p": "A clinical trial(4) was conducted in male test subjects aged between 20 and 40. All subjects were divided into two groups; one was presented with a placebo, and the rest received the CJC-1295 peptide. A blood sample was collected from all the subjects before and after peptide presence. Based on these samples, researchers reported that the peptide possibly contributed to a 7.5-fold increase in the subjects’ growth hormone levels compared to the placebo group. The growth hormone levels appeared to increase gradually and remained unchanged one week after the peptide presence."
            },
            {
                "p": "In another clinical study,(5) the peptide was given in ascending concentrations in a group of test subjects aged between 20 and 60. All subjects were divided into two groups – one was presented with the peptide, while the other with a placebo. After the end of the study, when blood samples were examined, it was noted that there appeared to be concentration-dependent action, up to 10-fold, in the levels of the subjects’ growth hormones. As per Madalina Ionescu, et al., “The marked enhancement of trough GH levels by continuous GHRH stimulation implicates the importance of this effect on increasing IGF-I. Long-acting GHRH preparations may benefit patients with intact pituitary GH secretory capability.” IGF-1 stands for insulin-like growth factor-1. It is considered by researchers to be the main anabolic mediator of growth hormone."
            },
            {
                "p": "In a clinical study focusing on the GHRP-6 peptide,(6) younger test subjects between 6 and 11 were presented with the peptide. Some were only given the peptide, while the rest were presented with a blend of peptide and arginine (a growth hormone booster). After the completion of the study, it was reported by the researchers that the growth hormone levels appeared to have increased exponentially and in equal concentrations in all subjects, seemingly regardless of the presence of arginine."
            },
            {
                "h3": "CJC-1295 & GHRP-6 Peptide Blend and Hypothyroidism"
            },
            {
                "p": "Hypothyroidism is characterized by low levels of growth hormones in an organism. In a 1997 clinical study,(7) subjects with hypothyroidism were presented with either GHRP-6 peptide, GHRH peptide, or a blend of peptides (such as CJC-1295) and GHRP-6. Post-study, it was reported that subjects presented with the blend exhibited apparently significantly higher levels of growth hormones than the individual peptides alone. The GHRP-6 peptide is considered to be an antagonist of somatostatin, which may be an inhibitor of growth hormone secretion. Due to this, the peptide blend appeared to yield a higher result. As per F R Pimentel-Filho et al., “When GHRP-6 was associated with GHRH, a significant increase in the GH response was observed in these patients, which could suggest a role for somatostatin in this process. Our data suggest that thyroid hormones modulate GH release induced by GHRH and GHRP-6 through different mechanisms. However, additional studies are necessary to elucidate this hypothesis further.”"
            },
            {
                "h3": "CJC-1295 and GHRP-6 Peptide Blend and Cellular Repair"
            },
            {
                "p": "Experimental animal models were induced with injury and multiple organ failure. They were then presented with either the GHRP-6 peptide or a combination of GHRP-6 and epidermal growth factor (EGF). Based on the laboratory results, it was observed that the peptide might affect the gut epithelial cells of these animal subjects, as well as possibly increasing cellular migration at three times the usual rate. In addition, it appeared to reduce any adverse action of such failure by 50-85%.(8)"
            },
            {
                "p": "GHRP-6 might also show a preference for CD36 receptors, potentially found on the surface of many cell types, such as fat cells, muscle cells, and immune cells. These receptors could have various potential functions, such as participating in fat metabolism, acting as a collector receptor for fats, aiding their absorption, and maybe influencing immune reactions and inflammation. The pathways of CD36 might also have a part in regulating the formation of new blood vessels. By potentially affecting inflammation and angiogenesis, GHRP-6 may further help improve cellular repair in various tissues."
            },
            {
                "h3": "CJC-1295 and GHRP-6 Peptide Blend and Diabetes-Induced Gastrointestinal Activity"
            },
            {
                "p": "Diabetes is considered by scientists to significantly impact the gastrointestinal system and may reduce the gastric emptying rate and colonic and intestinal transit. Research(9) conducted on experimental mouse models induced with diabetes were subjected to growth hormone release-stimulating peptides (such as GHRP-6). The peptide presence appeared to increase the rate of gastric emptying and intestinal transit, suggesting the peptide’s action in reversing the impacts induced by diabetes. No change was seen in the colonic transit. As per Zheng Q et al., peptides such as GHRP-6 “[have…] potential […] [for] delayed upper gastrointestinal transit.”"
            },
            {
                "h3": "CJC-1295 and GHRP-6 Peptide Blend and Heart Rate"
            },
            {
                "p": "Preliminary research(10) was conducted in mice that suggested GHRH derivative analogs (such as the CJC-1295 peptide) may have the potential to stabilize heart rate and improve functionality following a heart attack. Andrew V. Schally et al. reported that the peptide appears to promote cardiac tissue repair and improve the blood pump capacity of the heart. The researchers observed that the results “[suggest] that GHRH agonists promote repair of cardiac tissue, improving ejection fraction and reducing infarct size in rats, reducing infarct scar in swine, and attenuating cardiac hypertrophy in mice.”"
            },
            {
                "h3": "CJC-1295 & GHRP-6 Peptide Blend and Neuroprotection"
            },
            {
                "p": "The GHRP-6 peptide may be linked to the protection and repair of nervous tissue. A study examined its potential on the IGF-1 system in the brains of murine models.(11) GH potential actions are typically thought to be channeled through IGF-1, so the research focused on how the brain's IGF-1 system is influenced. It was found that a one-week exposure to GHRP-6 seemed to boost IGF-1 mRNA levels in the hypothalamus, cerebellum, and hippocampus, but not the cerebral cortex. This hints that GH and GHRP-6 may potentially boost IGF-1 expression in certain brain regions. The study also looked into the expression of the IGF receptor and IGFBP-2, an IGF-binding protein, but no significant variations in activity were found after the peptide was introduced. Nonetheless, the phosphorylation of Akt and Bad might have been triggered in regions where IGF-1 levels rose. This suggests that GH and GHRP-6 might activate intracellular pathways related to cell survival in response to growth factors. Bad is part of the Bcl-2 protein family, which plays a crucial role in cell death. In contrast, Akt is a protein kinase involved in various cellular functions like glucose metabolism, apoptosis, cell growth, transcription, and cell movement. No changes were noted in MAPK, another protein kinase, or glycogen synthase kinase-3beta. Additionally, the antiapoptotic protein Bcl-2 was found to be elevated in regions with increased IGF-1, while the proapoptotic protein Bax remained unchanged. This may imply a move towards cell survival and away from apoptosis. Finally, IGFBP-5, which is considered to be part of neuron survival processes, was mainly elevated in the hypothalamus, indicating a possible neuroendocrine function."
            },
            {
                "p": "CJC-1295 and GHRP-6 blend is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References"
            },
            {
                "references": [
                    "Berlanga-Acosta, Jorge, et al. “Synthetic Growth Hormone-Releasing Peptides (GHRPs): A Historical Appraisal of the Evidences Supporting Their Cytoprotective Effects.” Clinical Medicine Insights. Cardiology vol. 11 1179546817694558. 2 Mar. 2017, doi:10.1177/1179546817694558. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392015/",
                    "National Center for Biotechnology Information (2023). PubChem Compound Summary for CID 91976842, CJC1295 Without DAC. https://pubchem.ncbi.nlm.nih.gov/compound/CJC1295-Without-DAC.",
                    "National Center for Biotechnology Information (2023). PubChem Compound Summary for CID 9919153, Growth hormone releasing hexapeptide. https://pubchem.ncbi.nlm.nih.gov/compound/9919153.",
                    "Ionescu M, Frohman LA. Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. J Clin Endocrinol Metab. 2006 Dec;91(12):4792-7. doi: 10.1210/jc.2006-1702. Epub 2006 Oct 3. PMID: 17018654. https://pubmed.ncbi.nlm.nih.gov/17018654/",
                    "Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 2006 Mar;91(3):799-805. doi: 10.1210/jc.2005-1536. Epub 2005 Dec 13. PMID: 16352683. https://pubmed.ncbi.nlm.nih.gov/16352683/",
                    "Bellone J, Ghizzoni L, Amaretti G, Volta C, Boghen MF, Bernasconi S, Ghigo E. Growth hormone-releasing effect of oral growth hormone-releasing peptide 6 (GHRP-6) administration in children with short stature. Eur J Endocrinol. 1995 Oct;133(4):425-9. https://pubmed.ncbi.nlm.nih.gov/7581965/",
                    "Pimentel-Filho FR, Ramos-Dias JC, Ninno FB, Façanha CF, Liberman B, Lengyel AM. Growth hormone responses to GH-releasing peptide (GHRP-6) in hypothyroidism. Clin Endocrinol (Oxf). 1997 Mar;46(3):295-300. https://pubmed.ncbi.nlm.nih.gov/9156038/",
                    "Cibrián D, Ajamieh H, Berlanga J, León OS, Alba JS, Kim MJ, Marchbank T, Boyle JJ, Freyre F, Garcia Del Barco D, Lopez-Saura P, Guillen G, Ghosh S, Goodlad RA, Playford RJ. Use of growth-hormone-releasing peptide-6 (GHRP-6) for the prevention of multiple organ failure. Clin Sci (Lond). 2006 May;110(5):563-73. https://pubmed.ncbi.nlm.nih.gov/16417467/",
                    "Zheng, Q., Qiu, W. C., Yan, J., Wang, W. G., Yu, S., Wang, Z. G., & Ai, K. X. (2008). Prokinetic effects of a ghrelin receptor agonist GHRP-6 in diabetic mice. World journal of gastroenterology, 14(30), 4795–4799. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2739343/",
                    "Schally AV, Zhang X, Cai R, Hare JM, Granata R, Bartoli M. Actions and Potential Therapeutic Applications of Growth Hormone-Releasing Hormone Agonists. Endocrinology. 2019 Jul 1;160(7):1600-1612. doi: 10.1210/en.2019-00111. PMID: 31070727.",
                    "Frago LM, Pañeda C, Dickson SL, Hewson AK, Argente J, Chowen JA. Growth hormone (GH) and GH-releasing peptide-6 increase brain insulin-like growth factor-I expression and activate intracellular signaling pathways involved in neuroprotection. Endocrinology. 2002 Oct;143(10):4113-22. doi: 10.1210/en.2002-220261. PMID: 12239123."
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/09/CJC-1295-GHRP-6-coa.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/09/CJC-1295-GHRP-6-lc.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/09/CJC-1295-GHRP-6-ms.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "CJC-1295 & GHRP-6 Blend for sale. Purchase peptides for sale at 99+% purity with unmatched customer service and Free shipping.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "CJC-1295 & GHRP-6 blend for sale (10mg) | Core Peptides",
            "og:description": "CJC-1295 & GHRP-6 Blend for sale. Purchase peptides for sale at 99+% purity with unmatched customer service and Free shipping.",
            "og:url": "https://www.corepeptides.com/peptides/cjc-1295-ghrp-6-10mg-blend/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T16:57:08+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/CJC-1295-GHRP-6-5-5MG.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "CJC-1295 & GHRP-6 blend for sale (10mg) | Core Peptides",
            "twitter:description": "CJC-1295 & GHRP-6 Blend for sale. Purchase peptides for sale at 99+% purity with unmatched customer service and Free shipping.",
            "twitter:label1": "Price",
            "twitter:data1": "$69.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:brand": "Core Peptides",
            "product:price:amount": "69.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-CJCGHR6-10",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/cjc-1295-dac-5mg/",
                "name": "CJC-1295 DAC (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/CJC-1295-DAC-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/peg-mgf-5mg/",
                "name": "PEG-MGF (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/PEG-MGF-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/receptor-grade-igf-1-lr3-100mcg/",
                "name": "Receptor Grade IGF-1 LR3 (100mcg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-100MCG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/dsip-5mg/",
                "name": "DSIP (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/DSIP-5MG-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "id": "5",
        "url": "https://www.corepeptides.com/peptides/cjc-1295-ipamorelin-10mg-blend/",
        "name": "CJC-1295 & Ipamorelin Blend (10mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2020/04/CJC-1295-Ipamorelin-5-5mg.jpg",
        "display_price": "$80.00",
        "display_specs": [
            "Size: 10mg Contents: CJC-1295 NO DAC (5mg) & Ipamorelin (5mg) Form: Lyophilized powder Purity: >99% SKU: P-CJCIPAM-10",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$76.00"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$72.00"
            }
        ],
        "description": [
            {
                "h2": "CJC-1295 & Ipamorelin Peptide Blend"
            },
            {
                "p": "Ipamorelin and CJC-1295 are both considered to be growth hormone secretagogues. Ipamorelin is a synthetic pentapeptide,(1) and CJC-1295 peptide consists of 29 amino acids.(2) Ipamorelin appears to fall into a category of peptides classified as growth hormone secretagogues (GHSs). These are peptides that are assumed to stimulate the release of the growth hormones, however are not considered growth hormone releasing peptides themselves. On the other hand, CJC-1295 has also been suggested by researchers to stimulate the release of growth hormone, primarily by mimicking the actions of the naturally occurring growth hormone-releasing hormone (GHRH). Both Ipamorelin and CJC-1295 peptides have been assigned by researchers to this class, studied for similar potential actions and apparently differing only in terms of their half-life and pharmacokinetic profiles."
            },
            {
                "h3": "Overview"
            },
            {
                "p": "CJC-1295 & Ipamorelin peptides both are suggested by researchers to augment the levels of the growth hormones through a possible triggering of the anterior pituitary gland. Scientists consider that once triggered, growth hormones may be naturally secreted, maintaining levels of growth hormones in the organism.(3)"
            },
            {
                "p": "CJC-1295 peptide is a tetrasubstituted version of GHRH 1-29, developed to represent the shortest functional sequence of GHRH. GHRH 1-29 consists of the first 29 amino acids of the native GHRH peptide, and may potentially stimulate growth hormone production in pituitary gland cells, called somatotrophs. The peptide has four amino acid substitutions in its structure, which scientists suggest may enhance its activity and resistance towards proteolytic enzymes. More specifically, the amino acids which are replaced appear to be the 2nd, 8th, 15th, and 27th amino acids. Owing to these substitutions, the peptide might be able to bind covalently to blood albumin, with trace amounts possibly able to bind to fibrinogen and immunoglobulin G (IgG). As a result, the apparent half-life of the peptide may increase from 10 mins to 30 mins.(4) This may lead to elevated levels of plasma growth hormone and insulin-like growth factor 1 (IGF-1)."
            },
            {
                "p": "CJC-1295 might also be linked with the purported drug affinity complex (DAC) element, which may attach to plasma proteins. In particular, the DAC element in CJC-1295 alludes to the connection of N-epsilon-3-maleimidopropionamide derivative of lysine at the C-terminal end. Merging the tetrasubstituted amino acid chain and the DAC element, CJC-1295 appears to display enhanced pharmacokinetics yet retains a comparable attraction to the GHRH receptors in the pituitary gland, similar to natural GHRH.(5) More specifically, researchers comment that when the peptide was “selected for further pharmacokinetic evaluation, where it was found to be present in plasma beyond 72 h.”"
            },
            {
                "p": "Ipamorelin is a man-made pentapeptide, also known as NNC 26-0161, that is believed to associate with a specific receptor in the pituitary gland cells, termed the growth hormone secretagogue receptor (GHS-R1a). These receptors are considered to be located in the hypothalamus. Moreover, GHS-R1a is often referred to as the ghrelin receptors because ghrelin seems to be its primary natural ligand. Ipamorelin appears to stand out from other GHSs as a potentially more selective compound, which may possibly stimulate the release of GH levels by somatotroph cells without also increasing other hormones produced by the anterior pituitary gland, such as prolactin."
            },
            {
                "p": "When the peptide blend, sometimes also called the peptide stack, is presented in combination, research studies typically report that the Ipamorelin exerts initial action, exhibiting some sign of impact within the first two hours of presentation, and as it starts to wean off, the CJC-1295 peptide may gradually supplement action.(6)"
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula:"
            },
            {
                "p": "Molecular Weight:"
            },
            {
                "p": "Other Known Titles"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "CJC-1295 & Ipamorelin Blend and Half Life Determination"
            },
            {
                "p": "Clinical studies have been conducted on test subjects to determine the half life of and individual pharmacokinetic profiles of the two peptides. In one late 1990s study,(6) a clinical trial was conducted on eight male test subjects with a concentration escalation design. The level of growth hormones was monitored after every instance of peptide presentation. At the end of the study, it was suggested by the researchers that there was a single episode of growth hormone release with the highest peak at 0.67 hours, after which there was an exponential decline up to negligible concentrations of the compound. This study concluded that the Ipamorelin peptide appeared to exhibit a short half-life of 2 hours, after which the potential action appears to begin to decline."
            },
            {
                "p": "CJC-1295, by contrast, appears to have a much longer half-life. Researchers comment that a single introduction of the peptide may upregulate growth hormone production by somatotrophs for prolonged periods of time, thus apparently contributing “to an overall increase in [growth hormone] secretion … by 46%” and also potentially upregulating its main anabolic mediator insulin-like growth factor-1 (IGF-1) by 45% on average.(7) Another publication also observes that CJC-1295 may potentially upregulate “[growth hormone] concentrations by 2- to 10-fold,” and estimates that the half-life of the peptide ranges between 5.8 – 8.1 days.(8)"
            },
            {
                "h3": "CJC-1295 & Ipamorelin Blend General Research"
            },
            {
                "p": "In this early 2000s study,(7) a clinical trial was conducted on male test subjects aged between 20 and 40 years old. Test subjects were divided into two groups; one group was presented with the placebo and the other with the peptide. Blood was sampled from the subjects one week before and after the presentation of CJC-1295 peptide (and placebo) to monitor the levels of growth hormone pulsatility. At the end of the study, it was suggested that CJC-1295 contributed to a 7.5-fold increase in the growth hormone pulsatility levels as compared to that of the placebo. Apart from apparently affecting the synthesis of growth hormone, scientists also suggest that CJC-1295 may interact with the survival and proliferation of the cells that synthesize it - the somatotroph cells in the anterior pituitary gland.(9) In one study on murine models, the authors commented that \"CJC-1295 caused an increase in total pituitary RNA and GH mRNA, suggesting that proliferation of somatotroph cells had occurred, as confirmed by immunohistochemistry images.”"
            },
            {
                "p": "To exert these apparent effects, CJC-1295 appears to interact with specific binding sites on the GHRH receptor protein, leading to conformational changes in the receptor structure and potentially initiating a cascade of molecular events. The binding appears to activate intracellular signaling proteins that potentially act as molecular toggles.(10) These proteins are often referred to as G-proteins, which, upon activation, might drive the generation of secondary messengers like cyclic adenosine monophosphate (cAMP) or inositol trisphosphate (IP3.(11) Secondary messengers such as cAMP may set in motion protein kinases, enzymes believed to alter distinct proteins. These kinases possess a modulatory capacity for cellular activities and might phosphorylate transcription regulators, or proteins overseeing gene modulation. Once phosphorylated, these transcription regulators could migrate into the nucleus of somatotroph cells, possibly impacting genes associated with growth hormone formation.(7)"
            },
            {
                "p": "On the other hand, Ipamorelin appears to interact with the anterior pituitary gland cells via the N-terminus of GHS-R1a, which has binding sites that appear to recognize specific sequences in the secretagogue. When Ipamorelin meets this receptor, it may attach in a non-permanent way through forces like hydrogen bonds and forces between molecules called van der Waals forces. This attachment might make the receptor change its shape, which could start cell signals, mainly those involving G-proteins. GHS-R1a might work with a specific part of G-proteins called Gαq/11.(12) A main process started by GHS-R1a involves an enzyme called phospholipase C (PLC). Gαq/11 interacts with PLC, which may split a fat-like molecule, phosphatidylinositol 4,5-bisphosphate (PIP2), into two messaging molecules: IP3 (Inositol trisphosphate) and DAG (Diacylglycerol). IP3 appears to attach to places on a cell part called the endoplasmic reticulum, causing calcium ions (Ca2+) to be released. Also, DAG might turn on an enzyme called protein kinase C (PKC), which may add phosphate groups to other signaling molecules. All these steps might end with the ‘turning on’ of proteins that help release growth hormone from certain cells in the pituitary gland.(13)"
            },
            {
                "h3": "CJC-1295 & Ipamorelin Blend and Nitrogen Balance"
            },
            {
                "p": "The apparent synergistic action of CJC-1295 and Ipamorelin on the production of growth hormone by the somatotroph cells in the anterior pituitary gland appears to result in a positive nitrogen balance and potential increase in lean mass in test models. In a particular study, investigators sought to probe the metabolic capabilities of Ipamorelin within the context of certain hepatic markers related to alpha-amino-nitrogen processing during an artificlaly triggered catabolism. The team evaluated the liver's ability to produce urea-N (CUNS), a potential metric of nitrogen processing within the liver. They examined the observable levels of messenger RNA (mRNA) linked to enzymes of the urea cycle in the liver, gauged the overall nitrogen equilibrium, and postulated the nitrogen quantities in different organs. It was proposed that Ipamorelin might have led to a 20% decline in CUNS, in contrast to the catabolic condition that was artificially prompted by the researchers. Moreover, it could have conceivably decreased the manifestation of urea cycle enzymes, reinstated nitrogen equilibrium, and theoretically adjusted or enhanced the nitrogen values in organs.(14)"
            },
            {
                "p": "CJC-1295 & Ipamorelin peptide blend is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Raun K, Hansen BS, Johansen NL, Thøgersen H, Madsen K, Ankersen M, Andersen PH. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998 Nov;139(5):552-61. doi: 10.1530/eje.0.1390552. PMID: 9849822. https://pubmed.ncbi.nlm.nih.gov/9849822/",
                    "Lucie Jette et al, hGRF1-29-Albumin Bioconjugates Activate the GRF Receptor on the Anterior Pituitary in Rats: Identification of CJC-1295 as a Long Lasting GRF Analog, ResearchGate, January 2005.",
                    "Raun K, Hansen BS, Johansen NL, Thøgersen H, Madsen K, Ankersen M, Andersen PH. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998 Nov;139(5):552-61. doi: 10.1530/eje.0.1390552. PMID: 9849822 https://pubmed.ncbi.nlm.nih.gov/9849822/",
                    "The Discovery of Growth Hormone-Releasing Hormone: An Update https://onlinelibrary.wiley.com/doi/full/10.1111/j.1365-2826.2008.01740.x",
                    "Jetté, L., Léger, R., Thibaudeau, K., Benquet, C., Robitaille, M., Pellerin, I., Paradis, V., van Wyk, P., Pham, K., & Bridon, D. P. (2005). Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog. Endocrinology, 146(7), 3052–3058. https://doi.org/10.1210/en.2004-1286",
                    "Gobburu JV, Agersø H, Jusko WJ, Ynddal L (September 1999). “Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers”. Pharmaceutical Research. 16 (9): 1412–6. doi:10.1023/A:1018955126402",
                    "Ionescu M, Frohman LA. Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. J Clin Endocrinol Metab. 2006 Dec;91(12):4792-7. doi: 10.1210/jc.2006-1702. Epub 2006 Oct 3. PMID: 17018654. https://pubmed.ncbi.nlm.nih.gov/17018654/",
                    "Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 2006 Mar;91(3):799-805. doi: 10.1210/jc.2005-1536. Epub 2005 Dec 13. PMID: 16352683. https://pubmed.ncbi.nlm.nih.gov/16352683/",
                    "Alba, M., Fintini, D., Sagazio, A., Lawrence, B., Castaigne, J. P., Frohman, L. A., & Salvatori, R. (2006). Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse. American journal of physiology. Endocrinology and metabolism, 291(6), E1290–E1294. https://doi.org/10.1152/ajpendo.00201.2006",
                    "Martin, B., Lopez de Maturana, R., Brenneman, R., Walent, T., Mattson, M. P., & Maudsley, S. (2005). Class II G protein-coupled receptors and their ligands in neuronal function and protection. Neuromolecular medicine, 7(1-2), 3–36. https://doi.org/10.1385/nmm:7:1-2:003",
                    "Newton, A. C., Bootman, M. D., & Scott, J. D. (2016). Second Messengers. Cold Spring Harbor perspectives in biology, 8(8), a005926. https://doi.org/10.1101/cshperspect.a005926",
                    "Yin, Y., Li, Y., & Zhang, W. (2014). The growth hormone secretagogue receptor: its intracellular signaling and regulation. International journal of molecular sciences, 15(3), 4837–4855. https://doi.org/10.3390/ijms15034837",
                    "Bill, C. A., & Vines, C. M. (2020). Phospholipase C. Advances in experimental medicine and biology, 1131, 215–242. https://doi.org/10.1007/978-3-030-12457-1_9",
                    "Aagaard, N. K., Grøfte, T., Greisen, J., Malmlöf, K., Johansen, P. B., Grønbaek, H., Ørskov, H., Tygstrup, N., & Vilstrup, H. (2009). Growth hormone and growth hormone secretagogue effects on nitrogen balance and urea synthesis in steroid treated rats. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 19(5), 426–431. https://doi.org/10.1016/j.ghir.2009.01.001"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/12/CJC-1295-Ipamorelin-COA.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/12/CJC-1295-Ipamorelin-LC.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/12/CJC-1295-Ipamorelin-MS.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "CJC-1295 & Ipamorelin blend for sale (10mg). Peptides for sale at 99% purity with top customer service. Get research study results and benefits.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "CJC-1295 & Ipamorelin Blend For Sale (10mg) | Core Peptides",
            "og:description": "CJC-1295 & Ipamorelin blend for sale (10mg). Peptides for sale at 99% purity with top customer service. Get research study results and benefits.",
            "og:url": "https://www.corepeptides.com/peptides/cjc-1295-ipamorelin-10mg-blend/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-05-28T11:02:32+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/CJC-1295-Ipamorelin-5-5mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "CJC-1295 & Ipamorelin Blend For Sale (10mg) | Core Peptides",
            "twitter:description": "CJC-1295 & Ipamorelin blend for sale (10mg). Peptides for sale at 99% purity with top customer service. Get research study results and benefits.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/CJC-1295-Ipamorelin-5-5mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$80.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "80.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-CJCIPAM-10",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/melanotan-1-10mg/",
                "name": "Melanotan 1 (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Melanotan-1-10MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/melanotan-2-10mg/",
                "name": "Melanotan 2 (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2023/03/Melanotan-2-10MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/semax-25mg/",
                "name": "Semax (25mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Semax-25MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/hexarelin-5mg/",
                "name": "Hexarelin (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Hexarelin-5MG-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "id": "6",
        "url": "https://www.corepeptides.com/peptides/decapeptide-12-topical-200mg/",
        "name": "Decapeptide-12 (200mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2023/04/DECAPEPTIDE-12-200mg.jpg",
        "display_price": "$240.00",
        "display_specs": [
            "Size: 200mg Contents: Decapeptide-12 Form: Lyophilized powder Purity: >99% SKU: P-Decapeptide-12",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$228.00"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$216.00"
            }
        ],
        "description": [
            {
                "h2": "Decapeptide-12"
            },
            {
                "p": "Decapeptide-12 is a synthetic peptide that is composed of 10 amino acids. Its developers and subsequent researchers have suggested that Decapeptide-12 may potentially inhibit melanin production in the skin by suppressing the activity of tyrosinase, an enzyme involved in the synthesis of melanin."
            },
            {
                "p": "Decapeptide-12 does not appear to mimic any naturally occurring peptide. Rather, it was designed and synthesized to exhibit specific properties. Decapeptide-12 is primarily researched in reducing melanin production and hyperpigmentation. It has also been studied for its potential impact on cell growth, differentiation, and mitigating cell aging. However, more research is needed to fully understand the potential properties and results of Decapeptide-12 experiments in these contexts."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C65H90N18O17 Molecular Weight: 1311.46 g/mol"
            },
            {
                "p": " "
            },
            {
                "h2": "Overview and Mechanisms of Action"
            },
            {
                "p": "As mentioned, Decapeptide-12 is posited to work primarily by inhibiting melanin synthesis, aka melanogenesis. Melanin synthesis is suggested to be a complex biochemical pathway that may occur within specialized cells in the skin called melanocytes. Tyrosinase is posited to play a pivotal role in this pathway as it appears to catalyze the first two steps in melanin production: the hydroxylation of tyrosine to DOPA (3,4-dihydroxyphenylalanine) and the oxidation of DOPA to DOPAquinone. These reactions are suggested to be essential for the subsequent production of eumelanin and pheomelanin, the two main types of melanin pigments that determine skin, hair, and eye color and may protect against UV radiation. As mentioned, Decapeptide-12 may act by potentially inhibiting tyrosinase activity. While the precise molecular mechanisms are complex and involve multiple pathways, the basic understanding is that Decapeptide-12 may bind to specific sites on the tyrosinase enzyme or its mRNA, thereby blocking the enzyme's ability to catalyze the aforementioned critical reactions in melanin synthesis. This inhibition could occur through direct interaction with the enzyme, leading to a change in its conformation and reducing its catalytic efficiency. Alternatively, Decapeptide-12 might interfere with the enzyme's gene expression, lowering the amount of functional tyrosinase produced in the melanocytes."
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Decapeptide-12 and Melasma"
            },
            {
                "p": "One clinical study aimed to evaluate the potential of Decapeptide-12 in test subjects with moderate to severe melasma, solar lentigines, periocular lines, and wrinkles.(1) This 24-week experiment reported apparent improvements in all of the reported facial conditions among the 25 subjects, with sustained impact."
            },
            {
                "p": "Another clinical trial investigated the potential of Decapeptide-12 on mild-to-moderate melasma in 33 test subjects over 16 weeks.(2) Results suggested a visible reduction in the appearance of melasma."
            },
            {
                "p": "Furthermore, one study reported a complete clearance of melasma in 25% of subjects after six weeks of Decapeptide-12 presentation.(3) Decapeptide-12 also was reported by the researchers to exhibit an apparent impact in test subjects with the Fitzpatrick phototype IV skin type and moderate recalcitrant melasma completed.(4) Subjects with Fitzpatrick skin type IV are reportedly some of the most common melasma sufferers. The researchers concluded that: “All […] demonstrated statistically significant improvement in the appearance of melasma and overall facial aesthetics.”"
            },
            {
                "h3": "Decapeptide-12 and Post-inflammatory Hyperpigmentation"
            },
            {
                "p": "A clinical case study on pigmented skin (Fitzpatrick skin type IV) indicated that Decapeptide-12 may possibly accelerate the clearance of post-inflammatory hyperpigmentation compared to placebo.(5) The researchers suggest this might be due to the tyrosinase-inhibiting potential of Decapeptide-12.(6)"
            },
            {
                "h3": "Decapeptide-12 and Solar Lentigo"
            },
            {
                "p": "One study evaluated the impact of Decapeptide-12 in the form of hyperpigmentation called solar lentigines caused by chronic photodamage.(7) The results reported that 38.5% of the models evaluated appeared to have achieved complete clearance, and all subjects appeared to exhibit some improvement. Furthermore, 30.7% of the models were reported to improve from a moderate degree of photodamage to a milder degree, 15.4% improved from a severe degree to a moderate degree, and another 15.4% improved from a severe degree to a milder degree after 24 weeks."
            },
            {
                "h3": "Decapeptide-12 and Cell Aging"
            },
            {
                "p": "Sirtuins are a family of genes involved in various cellular processes. They are believed to regulate cellular metabolism, DNA repair, inflammation, and stress resistance. One of the most well-known sirtuins is SIRT1, which has been suggested to regulate various biological pathways, such as glucose metabolism, lipid metabolism, and cellular stress responses. Studies have also suggested that SIRT1 may be involved in extending the lifespan in certain model organisms. One of the most promising compounds is resveratrol, found in red wine, and has been suggested to activate SIRT1 in some studies."
            },
            {
                "p": "One study looked at the potential of Decapeptide-12 on sirtuin gene expression levels in keratinocyte progenitors.(8) The researchers used RT-PCR to measure the impact of Decapeptide-12 on seven Sirtuin genes and cellular viability and proliferation after 72-hour incubation with various concentrations of Decapeptide-12. The results suggested that Decapeptide-12 possibly increased the transcription of several Sirtuin genes, including SIRT1, SIRT3, SIRT6, and SIRT7, with reportedly reduced cytotoxicity. The researchers reported that “ decapeptide-12 increased transcription of SIRT1 by 141 ± 11% relative to control cells, whereas levels of SIRT3, SIRT6, and SIRT7 were increased by 121 ± 13%, 147 ± 8% and 95± 14%, respectively.”"
            },
            {
                "p": "SIRT1, with a reported increase in transcription by 141 ± 11% may enhance cellular resilience against oxidative stress and inflammation, possibly delaying aging processes on a cellular level. The apparent increases in SIRT3 (121 ± 13%) and SIRT6 (147 ± 8%) transcription levels further amplify the possible research outcomes. SIRT3's potential involvement in mitochondrial function and energy metabolism suggests that decapeptide-12 might enhance mitochondrial efficiency and antioxidant capacity. Similarly, SIRT6 is possibly associated with DNA repair, telomere maintenance, and inflammation regulation. Its potential upregulation might contribute to improved genomic stability and reduced inflammation, potentially further decelerating the aging process in cells. While the reported increase in SIRT7 transcription (95 ± 14%) appears less pronounced, it may still indicate potential influence on nucleolar functions, including ribosome biogenesis and stress sensing. This subtle modulation might also contribute to the overall cellular homeostasis and longevity.(8)"
            },
            {
                "p": "Decapeptide-12 is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Jiang, L., Hino, P. D., Bhatia, A., Stephens, T. J., & Jimenez, F. (2018). Efficacy of Trifecting® Night Cream, a Novel Triple acting Skin Brightening Product: A Double-blind, Placebo-controlled Clinical Study. The Journal of clinical and aesthetic dermatology, 11(12), 21–25.",
                    "Ramírez, S. P., Carvajal, A. C., Salazar, J. C., Arroyave, G., Flórez, A. M., & Echeverry, H. F. (2013). Open-label evaluation of a novel skin brightening system containing 0.01% decapeptide-12 in combination with 20% buffered glycolic acid for the treatment of mild to moderate facial melasma. Journal of drugs in dermatology : JDD, 12(6), e106–e110.",
                    "Hantash, B. M., & Jimenez, F. (2012). Treatment of mild to moderate facial melasma with the Lumixyl brightening system. Journal of drugs in dermatology : JDD, 11(5), 660–662.",
                    "Hantash, B. M., & Jimenez, F. (2009). A split-face, double-blind, randomized and placebo-controlled pilot evaluation of a novel oligopeptide for the treatment of recalcitrant melasma. Journal of drugs in dermatology : JDD, 8(8), 732–735.",
                    "Bhatia, A., Hsu, J. T.s, & Hantash, B. M. (2014). Combined delivery and dermalinfusion of decapeptide-12 accelerates resolution of post-inflammatory hyperpigmentation in skin of color. Journal of drugs in dermatology : JDD, 13(1), 84–85.",
                    "Chen, J., Bian, J., Hantash, B. M., Albakr, L., Hibbs, D. E., Xiang, X., Xie, P., Wu, C., & Kang, L. (2021). Enhanced skin retention and permeation of a novel peptide via structural modification, chemical enhancement, and microneedles. International journal of pharmaceutics, 606, 120868. https://doi.org/10.1016/j.ijpharm.2021.120868",
                    "Kassim, A. T., Hussain, M., & Goldberg, D. J. (2012). Open-label evaluation of the skin-brightening efficacy of a skin-brightening system using decapeptide-12. Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology, 14(2), 117–121. https://doi.org/10.3109/14764172.2012.672745",
                    "Basil, M. H., & Anan, A. U. (2019). Tyrosinase inhibitors with potent anti-senescence activity in human neonatal keratinocyte progenitors. J Dermatol Surg Res Ther, 2019, 30-39."
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "",
        "high_performance_liquid_chromatography": "",
        "mass_spectrometry": "",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Decapeptide-12 for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Decapeptide-12 For Sale (200mg) - Core Peptides",
            "og:description": "Decapeptide-12 for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:url": "https://www.corepeptides.com/peptides/decapeptide-12-topical-200mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T16:17:32+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2023/04/DECAPEPTIDE-12-200mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Decapeptide-12 For Sale (200mg) - Core Peptides",
            "twitter:description": "Decapeptide-12 for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2023/04/DECAPEPTIDE-12-200mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$240.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "240.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-Decapeptide-12",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/pt-141-10mg-bremelanotide/",
                "name": "PT-141 (Bremelanotide) (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/PT-141-10mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/semax-25mg/",
                "name": "Semax (25mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Semax-25MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ghk-cu-50mg-copper/",
                "name": "GHK-Cu (Copper) (50mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHK-CU-50mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ll-37-5mg/",
                "name": "LL-37 (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/LL-37-5mg-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "id": "7",
        "url": "https://www.corepeptides.com/peptides/cjc-1295-ipamorelin-ghrp-2-blend-9mg/",
        "name": "CJC-1295 (Mod GRF 1-29) & Ipamorelin & GHRP-2 Blend (9mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2020/04/CJC-1295-Ipamorelin-GHRP-2-3-3-3MG.jpg",
        "display_price": "$81.00",
        "display_specs": [
            "Size: 9mg Contents: CJC-1295 NO DAC (Mod GRF 1-29) (3mg), Ipamorelin (3mg), GHRP-2 (3mg) Form: Lyophilized powder Purity: >99% SKU: P-CJCIPAMGHR2-9",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$76.95"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$72.90"
            }
        ],
        "description": [
            {
                "h2": "CJC-1295 (Mod GRF 1-29) & Ipamorelin & GHRP-2 Peptide Blend"
            },
            {
                "p": "CJC-1295 (Mod GRF 1-29), Ipamorelin, and GHRP-2 are all synthetic peptides that are suggested by research teams to potentially stimulate the release of growth hormone. Anecdotal reports suggest that all three peptides appear synergistic when combined as a blend, potentially providing unique peptide action."
            },
            {
                "p": "CJC-1295 (Mod GRF 1-29) is considered to be an agonist to the receptors for the native Growth Hormone-Releasing Hormone (GHRH). It is an analog of its truncated version called GHRH (1-29) which appears to potentially have the same affinity to the receptors. GHRH 1-29 is potentially the shortest functional sequence of GHRH made up of its initial 29 amino acids. CJC-1295 (Mod GRF 1-29) is a variation that has undergone tetrasubstitution and has been further modified with the addition of a drug affinity complex (DAC) element named N-epsilon-3-maleimidopropionamide. This component may, perhaps, bind to plasma proteins, possibly enhancing the pharmacokinetics of CJC-1295 (Mod GRF 1-29)."
            },
            {
                "p": "Ipamorelin is a pentapeptide that apparently mirrors the effects of the natural hunger hormone, ghrelin. This hormone may activate the ghrelin receptors in the pituitary gland, also known as the Growth Hormone Secretagogue receptors (GHS-R1a) which may trigger the release of growth hormone."
            },
            {
                "p": "GHRP-2, also known as Growth Hormone Releasing Peptide 2, is a hexapeptide crafted from six distinct amino acids. It is a synthetic peptide analogous to the receptors of the naturally occurring peptide called ghrelin (aka the GHS-R1a receptors). Thus, GHRP-2 and Ipamorelin peptides appear to trigger GHS-R1a and potentially stimulate the release of growth hormone. However, they may also possibly increase food intake due to their reported effect on ghrelin receptors. This is why they are classified by researchers as Growth Hormone Secretagogues (GHSs)."
            },
            {
                "h3": "Chemical Makeup (3)(4)(5)"
            },
            {
                "p": "Molecular formula:"
            },
            {
                "p": "Molecular weight:"
            },
            {
                "p": "Other known titles:"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "CJC-1295 (Mod GRF 1-29), Ipamorelin, GHRP-2 Blend and Growth Hormone Deficiencies"
            },
            {
                "p": "Numerous clinical studies have been conducted on test subjects exhibiting growth hormone deficiency. These studies are recorded here for educational and research purposes; studies like these are ongoing and do not offer conclusive evidence of the peptide’s potential mechanism of action. In these clinical trials, peptides stimulating growth hormone release appeared to deliver some action in two ways – possibly either via stimulating the pituitary gland to release growth hormones, or possibly acting on the arcuate nucleus of the hypothalamus. While these peptides (including GHRP-2, Ipamorelin, and CJC-1295 (Mod GRF 1-29)) appeared to exhibit high releases of growth hormones, it remains unclear which of the two mechanisms worked. In addition, these studies suggested that these peptides may modulate food intake, cardiac tone, and sleep through apparently specific receptor agonistic action.(4)"
            },
            {
                "p": "In another study,(5) six growth hormone-deficient test subjects facing growth failure were presented with growth hormone-stimulating peptides. All subjects were monitored for episodic growth hormone secretion and toxicity levels during this period. For the duration of the study and short while afterwards, It was observed that there appeared to be a gradual rise in the concentration of growth hormones in all subjects. As per V Mericq et al., the studies suggested that the peptides were “well tolerated and […] stimulate GH secretion.” Studies such as this one are still underway, and these peptides require further research."
            },
            {
                "h3": "CJC-1295 (Mod GRF 1-29) (Mod GRF 1-29), Ipamorelin, GHRP-2 Blend, and Food Intake"
            },
            {
                "p": "In this clinical study,(6) test subjects were presented with GHRP-2 and then presented with unlimited food supply to measure food intake. It was reported that the subjects with peptide presence ate approximately 36% more than the control subjects did. In addition, the growth hormone levels were reportedly increased in these subjects, suggesting the action the peptides had on both food intake and growth hormone levels. As per this study, the growth hormone release-stimulating peptides appeared to be a “valuable tool for investigating the effects on eating behavior.” Research studies are still ongoing to fully explore the potential of peptide blends."
            },
            {
                "p": "Given its potential influence on the ghrelin receptors, Ipamoreline might also potentially enhance appetite and, perhaps, lead to weight gain. One study suggests that Ipamorelin may have possibly contributed to a roughly 15% rise in the body weight of the experimental subjects.(7) Researchers have posited the theory that Ipamorelin might have, to some extent, augmented the fat pad weights in proportion to overall body weight. This may have resulted in a relative increase in body fat as measured by dual energy X-ray absorptiometry (DEXA). Moreover, there is an indication that Ipamorelin might have elevated serum leptin levels, a hormone that is thought to play a role in energy and appetite regulation. Consequently, scientists speculated that the Ipamorelin groups might have experienced an uptick in food consumption leading to an apparent weight gain."
            },
            {
                "p": "Thus, Ipamorelin and GHRP-2 appear may potentially have synergistic effects on increasing hunger levels. On the other hand, CJC-1295 (Mod GRF 1-29) (Mod GRF 1-29) has not been suggested to affect appetite."
            },
            {
                "h3": "CJC-1295 (Mod GRF 1-29) (Mod GRF 1-29), Ipamorelin, GHRP-2 Blend, and Bone Mass"
            },
            {
                "p": "By apparently increasing growth hormone synthesis, all three peptides may potentially upregulate bone mineral density. Yet, Ipamorelin appears to be the most researched of these three peptides for this focus."
            },
            {
                "p": "In a particular study, murine subjects were either exposed to Ipamorelin or a control agent.(8) The potential effects of Ipamorelin on bone mineral density were monitored in real-time using dual X-ray absorptiometry (DXA) at specific locations, including the femur and L6 vertebrae. After the research duration, the murine subjects' femurs underwent analysis with mid-diaphyseal peripheral quantitative computed tomography (pQCT) scans. The findings tentatively indicate that the peptide might have contributed to a potential weight gain and a potential uptick in the overall tibial and vertebral BMC (bone mineral content) as observed via DXA, in contrast to the control set. Yet, when accounting for the weight gain in the total BMC, there seemed to be no notable difference as per the researchers. There might have been a slight increase in the bone mineral density (BMD) of the tibial region, but the overall and vertebral BMDs appeared to stay stable. The pQCT data perhaps suggests that the rise in cortical BMC may be attributed to a growth in the cross-sectional bone area, even though the cortical volumetric BMD seemingly stayed the same. Both the femur and L6 vertebrae volumes might have experienced a growth, but the volumetric BMDs did not appear to shift."
            },
            {
                "p": "These observations hint at the theory that the increase in both cortical and total BMC may potentially stem from improved bone growth leading to expanded bone dimensions, with the volumetric BMD staying consistent. The researchers further suggest that GHRPs may also increase BMC/BMD."
            },
            {
                "h3": "CJC-1295 (Mod GRF 1-29) (Mod GRF 1-29), Ipamorelin, GHRP-2 Blend, and Muscle Mass"
            },
            {
                "p": "The main focus on CJC-1295 (Mod GRF 1-29) (Mod GRF 1-29) & Ipamorelin & GHRP-2 research has been on the peptides’ potential synergy in regards to increasing muscle mass. Studies on murine models with a GHRH gene deletion (referred to as GHRHKO), hinted that CJC-1295 (Mod GRF 1-29) (Mod GRF 1-29) may potentially have favorable action on lean mass.(9)"
            },
            {
                "p": "When influenced by CJC-1295 (Mod GRF 1-29) (Mod GRF 1-29), GHRHKO models appeared to retain typical lean weight and length, unlike the control groups which reportedly struggled to reach standard weight and dimensions. Furthermore, both the comparative lean mass and the underlying fat mass in all groups linked with the peptide seemed to stay consistent with control measurements in normal murine models. This suggests that CJC-1295 (Mod GRF 1-29) (Mod GRF 1-29) might favorably impact muscle and bone structures without necessarily promoting heightened fat accumulation. The researchers also observed a potential uptick in overall pituitary RNA and GH mRNA due to CJC-1295 (Mod GRF 1-29) (Mod GRF 1-29), implying a potential surge in somatotroph cells - the cells in the pituitary gland thought to generate growth hormone. This speculated cell growth was additionally supported by visual evidence from immunohistochemistry."
            },
            {
                "p": "Ipamorelin has also been proposed to increase lean mass, as suggested by the positive nitrogen balance reported in some preliminary studies. In a particular study, researchers sought to explore the potential metabolic effects of Ipamorelin on certain liver markers related to alpha-amino-nitrogen transformation during what might be steroid-induced catabolism. The team attempted to gauge the liver's ability to produce urea-N (CUNS), which could be an indicative measure of nitrogen processing in the liver. They observed potential variations in messenger RNA (mRNA) levels linked with liver urea cycle enzymes, assessed the general nitrogen equilibrium, and speculated on the nitrogen composition of different organs. Researchers suggested that Ipamorelin might have led to an approximate 20% decrease in CUNS in contrast to the catabolic condition potentially brought about by steroids. Moreover, it could have perhaps diminished the activity of urea cycle enzymes, reestablished nitrogen equilibrium, and maybe adjusted or enhanced the nitrogen levels in organs."
            },
            {
                "p": "CJC-1295 (Mod GRF 1-29) (Mod GRF 1-29) & Ipamorelin & GHRP-2 Peptide Blend is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "National Center for Biotechnology Information (2023). PubChem Compound Summary for CID 91976842, CJC1295 Without DAC. https://pubchem.ncbi.nlm.nih.gov/compound/CJC1295-Without-DAC.",
                    "National Center for Biotechnology Information (2023). PubChem Compound Summary for CID 9831659, Ipamorelin. https://pubchem.ncbi.nlm.nih.gov/compound/Ipamorelin.",
                    "National Center for Biotechnology Information (2023). PubChem Compound Summary for CID 6918245, Pralmorelin. https://pubchem.ncbi.nlm.nih.gov/compound/Pralmorelin.",
                    "Rogério G. Gondo et al, Growth Hormone-Releasing Peptide-2 Stimulates GH Secretion in GH-Deficient Patients with Mutated GH-Releasing Hormone Receptor, The Journal of Clinical Endocrinology & Metabolism, Volume 86, Issue 7, 1 July 2001, Pages 3279–3283, https://doi.org/10.1210/jcem.86.7.7694.",
                    "Mericq V, Cassorla F, Salazar T, Avila A, Iñiguez G, Bowers CY, Merriam GR. Effects of eight months treatment with graded doses of a growth hormone (GH)-releasing peptide in GH-deficient children. J Clin Endocrinol Metab. 1998 Jul;83(7):2355-60. https://pubmed.ncbi.nlm.nih.gov/9661608/",
                    "Laferrère, Blandine et al. “Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men.” The Journal of clinical endocrinology and metabolism vol. 90,2 (2005): 611-4. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824650/",
                    "Lall, S., Tung, L. Y., Ohlsson, C., Jansson, J. O., & Dickson, S. L. (2001). Growth hormone (GH)-independent stimulation of adiposity by GH secretagogues. Biochemical and biophysical research communications, 280(1), 132–138. https://doi.org/10.1006/bbrc.2000.4065",
                    "Svensson, J., Lall, S., Dickson, S. L., Bengtsson, B. A., Rømer, J., Ahnfelt-Rønne, I., Ohlsson, C., & Jansson, J. O. (2000). The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats. The Journal of endocrinology, 165(3), 569–577. https://doi.org/10.1677/joe.0.1650569",
                    "Alba M, Fintini D, Sagazio A, Lawrence B, Castaigne JP, Frohman LA, Salvatori R. Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse. Am J Physiol Endocrinol Metab. 2006 Dec;291(6):E1290-4. doi: 10.1152/ajpendo.00201.2006. Epub 2006 Jul 5. PMID: 16822960.",
                    "Aagaard, N. K., Grøfte, T., Greisen, J., Malmlöf, K., Johansen, P. B., Grønbaek, H., Ørskov, H., Tygstrup, N., & Vilstrup, H. (2009). Growth hormone and growth hormone secretagogue effects on nitrogen balance and urea synthesis in steroid treated rats. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 19(5), 426–431. https://doi.org/10.1016/j.ghir.2009.01.001"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/12/CJC-1295-Ipamorelin-GHRP-COA.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/12/CJC-1295-Ipamorelin-GHRP-LC.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/12/CJC-1295-Ipamorelin-GHRP-MS.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "CJC-1295 (Mod GRF 1-29) & Ipamorelin & GHRP-2 Blend For Sale. Purchase peptides for sale at 99+% purity with unmatched customer service and free shipping.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "CJC-1295 (Mod GRF 1-29) & Ipamorelin & GHRP-2 Blend for Sale (9mg)",
            "og:description": "CJC-1295 (Mod GRF 1-29) & Ipamorelin & GHRP-2 Blend For Sale. Purchase peptides for sale at 99+% purity with unmatched customer service and Free shipping.",
            "og:url": "https://www.corepeptides.com/peptides/cjc-1295-ipamorelin-ghrp-2-blend-9mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-05-28T11:02:14+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/CJC-1295-Ipamorelin-GHRP-2-3-3-3MG.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "CJC-1295 (Mod GRF 1-29) & Ipamorelin & GHRP-2 Blend for Sale (9mg)",
            "twitter:description": "CJC-1295 (Mod GRF 1-29) & Ipamorelin & GHRP-2 Blend For Sale. Purchase peptides for sale at 99+% purity with unmatched customer service and Free shipping.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/CJC-1295-Ipamorelin-GHRP-2-3-3-3MG.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$81.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "81.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-CJCIPAMGHR2-9",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/adipotide-10mg/",
                "name": "Adipotide (FTPP) (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Adipotide-FTPP-10MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/bpc-157/",
                "name": "BPC-157 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/BPC-157-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/mgf-5mg/",
                "name": "MGF (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/MGF-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ghrp-2/",
                "name": "GHRP-2 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHRP-2-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "id": "8",
        "url": "https://www.corepeptides.com/peptides/abp-7-10mg/",
        "name": "ABP-7 (10mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2024/05/ABP-7-10mg.jpg",
        "display_price": "$92.00",
        "display_specs": [
            "Size: 10mg Contents: ABP-7 Form: Lyophilized powder Purity: >99% SKU: P-ABP-7",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$87.40"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$82.80"
            }
        ],
        "description": [
            {
                "h2": "ABP-7 Peptide"
            },
            {
                "p": "ABP-7 (actin binding peptide-7) is a heptapeptide made of seven amino acids, which bears the sequence Acetyl-LKKTETQ. This peptide appears to be an N-acylated 17-23 fragment from a bigger molecule, Thymosin Beta 4. Consequently, this fragment is also sometimes termed a TB-500 Fragment."
            },
            {
                "p": "ABP-7 is a synthetic peptide, produced via solid-phase peptide synthesis.(1) Some researchers consider its LKKTETQ sequence to be the central actin-binding domain in Thymosin Beta 4. Therefore, ABP-7 is expected to have similar potential actions regarding actin binding, as its Thymosin Beta 4 counterpart.(2) Thymosin Beta 4 is posited to function as an actin-binding protein, particularly through its domain ABP-7. This domain notably inhibits the polymerization of globular actin (G-actin) into filamentous actin (F-actin), a process termed actin sequestration. This inhibition may result in elevated levels of G-actin within the cell."
            },
            {
                "p": "Actin, a pivotal component of the cellular cytoskeleton, is considered to not only provide structural integrity but may also play an essential role in various cellular activities, including cell motility and shape alteration. The mechanism by which ABP-7 may potentially prevent the polymerization of G-actin into F-actin appears to involve the stabilization of actin in its monomeric form, thereby limiting its availability to form the polymeric filaments necessary for a functional cytoskeleton. This alteration in the cytoskeletal architecture may impact the cell's ability to migrate and adapt its shape, which are considered to be critical functions in numerous biological processes."
            },
            {
                "p": "For instance, studies in wound healing and tissue regeneration suggest that cell motility may enable cells to move into and populate damaged areas to facilitate repair and restoration. Moreover, the possible disruption of actin polymerization by ABP-7 may influence other cellular mechanisms tied to actin dynamics, including intracellular transport and signal transduction pathways that rely on the actin cytoskeleton. The broader implications of these actions suggest that ABP-7's potential role in modulating actin polymerization could be significant in understanding and potentially manipulating cellular behaviors."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C38H81N9O20 Molecular Weight: 889.5 g/mol Other Known Titles: TB-500 Fragment, Ac-LKKTETQ"
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "ABP-7 and Wounds"
            },
            {
                "p": "One study aimed to evaluate the actions of ABP-7, considered the central actin-binding domain of Thymosin Beta 4 (Tb4), focusing on its role in promoting wound repair in aged murine models. The peptide's potential to enhance wound healing was assessed by examining parameters such as keratinocyte migration, collagen deposition, and wound closure.(3) More specifically, the researchers posited that “the actin-binding domain of thymosin beta 4 duplicated in a seven-amino acid synthetic peptide, LKKTETQ, was able to promote repair in the aged animals comparable to that observed with the parent molecule.” The study suggests that the ABP-7 peptide possibly promotes repair in aged murine models in ways that appear comparable to those observed with the parent molecule, Tb4."
            },
            {
                "p": "It is posited that the ABP-7 peptide may encourage epidermal cell migration and increase collagen deposition within the wound site. These activities suggest that the peptide might facilitate the closure and healing of wound models. Moreover, it is mentioned that Thymosin Beta 4 and its derived peptides, including ABP-7, have been studied in various contexts of wound healing and have been evaluated for their general potential in enhancing keratinocyte migration, a crucial aspect of the healing process. The ABP-7 peptide, by mimicking a specific functional domain of Tb4, possibly harnesses similar biological pathways to promote wound repair, although the study suggests that further research is needed to fully understand the peptide's mechanism of action and its potential applicability in this specific field of study."
            },
            {
                "p": "Studies have purported various mechanisms via which ABP-7 may speed up the healing of lesions and skin wounds.(4) One proposed mechanism suggests that ABP-7 may interact with purinergic receptors, which are considered to play pivotal roles in cellular responses to injury. The enhancement of wound healing observed in the presence of ABP-7 may be mediated by these receptors. The interaction may increase intracellular calcium levels, which is believed to be a critical factor in activating cellular pathways that facilitate wound closure. This rise in calcium levels might stimulate processes such as cell migration and extracellular matrix remodeling, which are essential for wound model repair."
            },
            {
                "p": "Additionally, the peptide’s interaction with actin—a fundamental component of the cellular cytoskeleton—suggests a mechanism where ABP-7 might influence actin dynamics. By binding to actin, ABP-7 might potentially stabilize or alter the structure of the cytoskeleton, thereby affecting the cell’s ability to migrate and cover the wound models. Furthermore, the possibility that ABP-7 enhances the activation of downstream signaling pathways, such as those mediated by MAP kinases, cannot be ruled out. These pathways are considered to often regulate gene expression related to cell proliferation and migration. The modulation of these pathways by ABP-7 might enhance the cellular responses necessary for wound healing."
            },
            {
                "h3": "ABP-7 and Tissue Scarring (Fibrosis)"
            },
            {
                "p": "Research has been undertaken to investigate the potential anti-fibrotic properties of ABP-7 and its actions on hepatic stellate cells (HSC) within the context of liver fibrosis. One study posits that ABP-7 might influence the behavior of these cells. Preliminary data tentatively suggests that ABP-7 might potentially inhibit the PDGF-BB-dependent up-regulation of critical biomarkers such as PDGFβ receptor, α-smooth muscle actin (α-SMA), and collagen type I. Furthermore, it appears that ABP-7 may obstruct the phosphorylation of Akt at both T308 and S473 sites, which might consequently impede the phosphorylation of PRAS40. In elaborating on these pathways, the PDGF-BB-dependent up-regulation is believed to involve an enhancement of specific cellular signals initiated by PDGF-BB, a platelet-derived growth factor that engages and activates the PDGFβ receptor. The scientists commented that the fragment may have “prevented the PDGF-BB induced reappearance of the receptor protein once it is already degraded.”(5)"
            },
            {
                "p": "This receptor is considered crucial for cellular growth and division. α-Smooth muscle actin (α-SMA), serves as a marker for the transition of quiescent stellate cells into their contractile phenotype, considered a critical event in the development of fibrosis. Collagen type I is a principal component of the extracellular matrix that tends to accumulate during liver fibrosis. Regarding the signaling aspect, the phosphorylation of Akt at the T308 and S473 sites is hypothesized to activate Akt, potentially leading to the activation of several downstream proteins, including PRAS40, lauded as an essential regulator of cell survival and metabolism. The inhibition of these phosphorylation events may, theoretically, disrupt these signaling pathways, which are believed to be vital for the integral processes of cell proliferation and migration in fibrogenesis. This inhibition sequence is conjectured to correlate with a reduction in the proliferation and migration of activated HSCs. These observations suggest that ABP-7 may possibly play an influential role in mitigating the activation of HSC and the subsequent fibrotic response.(5)"
            },
            {
                "h3": "ABP-7 and Angiogenesis"
            },
            {
                "p": "The peptide ABP-7 may have a role in promoting angiogenesis, or the development of new blood vessels. It is thought that ABP-7 might facilitate endothelial cell behaviors crucial for new blood vessel formation, such as migration and tube formation in vitro. These processes are considered essential for angiogenesis, where endothelial cells may migrate, align, and form tubular structures to establish new blood vessels. Ex vivo assays, such as sprouting from aortic rings, have suggested that ABP-7 may possibly support the initial steps of vessel sprouting.(2) Researchers consider vessel sprouting as a potential step in angiogenesis. The addition of ABP-7 to these systems might indicate reduced interaction of actin with other cellular components by its actin-binding activity, thus potentially freeing up actin to participate more actively in the dynamic structural changes that endothelial cells undergo during angiogenesis. It is posited that by modifying actin's availability or organization within endothelial cells, ABP-7 might be influencing the cellular architecture in a way that favors angiogenic processes. This may involve cell shape and motility alterations, which are critical for forming new vascular structures. Given the complexity of angiogenic signaling and the multiple steps involved, it is also possible that ABP-7 may interact indirectly with other cellular pathways or signaling molecules that contribute to angiogenesis. These potential interactions and their actions on angiogenesis are still under investigation and hold the promise for further elucidation in future studies."
            },
            {
                "p": "ABP-7 peptide is available for research and laboratory purposes only. Please review our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Esposito, S., Deventer, K., Goeman, J., Van der Eycken, J., & Van Eenoo, P. (2012). Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500, a product suspected to possess doping potential. Drug testing and analysis, 4(9), 733–738. https://doi.org/10.1002/dta.1402",
                    "Sosne, G., Qiu, P., Goldstein, A. L., & Wheater, M. (2010). Biological activities of thymosin beta4 defined by active sites in short peptide sequences. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 24(7), 2144–2151. https://doi.org/10.1096/fj.09-142307",
                    "Philp, D., Badamchian, M., Scheremeta, B., Nguyen, M., Goldstein, A. L., & Kleinman, H. K. (2003). Thymosin beta 4 and a synthetic peptide containing its actin-binding domain promote dermal wound repair in db/db diabetic mice and in aged mice. Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society, 11(1), 19–24. https://doi.org/10.1046/j.1524-475x.2003.11105.x",
                    "Huang, C. M., Wang, C. C., Barnes, S., & Elmets, C. A. (2006). In vivo detection of secreted proteins from wounded skin using capillary ultrafiltration probes and mass spectrometric proteomics. Proteomics, 6(21), 5805–5814. https://doi.org/10.1002/pmic.200600163",
                    "Shah, R., Reyes-Gordillo, K., & Rojkind, M. (2018). Thymosin β4 inhibits PDGF-BB induced activation, proliferation, and migration of human hepatic stellate cells via its actin-binding domain. Expert opinion on biological therapy, 18(sup1), 177–184. https://doi.org/10.1080/14712598.2018.1478961"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "",
        "high_performance_liquid_chromatography": "",
        "mass_spectrometry": "",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "ABP-7 for sale online (10mg). Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "ABP-7 for Sale (10mg) - Core Peptides",
            "og:description": "ABP-7 for sale online (10mg). Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/abp-7-10mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-05-22T16:20:51+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2024/05/ABP-7-10mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "ABP-7 For Sale (10mg) - Core Peptides",
            "twitter:description": "ABP-7 for sale online (10mg). Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2024/05/ABP-7-10mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$92.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:brand": "Core Peptides",
            "product:price:amount": "92.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-ABP-7",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/epitalon-25mg/",
                "name": "Epithalon (25mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Epithalon-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ghrp-2/",
                "name": "GHRP-2 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHRP-2-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/mgf-5mg/",
                "name": "MGF (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/MGF-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/receptor-grade-igf-1-lr3-100mcg/",
                "name": "Receptor Grade IGF-1 LR3 (100mcg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-100MCG-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "id": "9",
        "url": "https://www.corepeptides.com/peptides/chonluten-20mg/",
        "name": "Chonluten (20mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2022/11/Chonluten-20mg.jpg",
        "display_price": "$51.00",
        "display_specs": [
            "Size: 20mg Contents: Chonluten (20mg) Form: Lyophilized powder Purity: >99% SKU: P-Chonluten",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$48.45"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$45.90"
            }
        ],
        "description": [
            {
                "h2": "Chonluten Peptide"
            },
            {
                "p": "Chonluten, also known as EDG tripeptide or T-34, is a tripeptide that may potentially regulate the physiological processes of the respiratory system by influencing inflammation and proliferation. It may potentially restore mechanisms of anabolism and catabolism, critical to functional tissues. Chonluten is a peptide complex containing glycine, glutamine, and asparagine, which is considered to normalize the performance of bronchial mucous membrane cells.(1)"
            },
            {
                "p": "Chonluten has been primarily researched for its potential to normalize the impact on target organs by replacing or supporting the activity of substances secreted by these morphological structures through immunomodulation. It may possibly increase the lifespan of mesenchymal stem cells (MCS) and possibly induce molecular mechanisms that contrast senescence."
            },
            {
                "p": "Chonluten appears to be organ-specific, with its primary potential exhibited in lung tissues, possibly extending action in the gastrointestinal tract.(2) Chonluten may revitalize, regulate, and otherwise provide favorable actions on the airway and bronchial mucosa."
            },
            {
                "h3": "Chemical Makeup(3)"
            },
            {
                "p": "Molecular Formula: C11H17N3O8 Molecular Weight: 319.27 g/mol Structure: 4S)-4-amino-5-[[(2S)-3-carboxy-1-(carboxymethyl amino)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid Other Known Titles: Glu-asp-gly, Glutamyl-aspartyl-glycine, H-Glu-asp-gly-OH, T-34 tripeptide"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Chonluten Peptide and Inflammation Reduction"
            },
            {
                "p": "As lung capacity reduces, researchers suggest Chonluten may decrease the rate of cell death while encouraging proliferative activity via protection of the bronchial lining. (1) The bronchial inner lining is a barrier between the external environment and internal structures. Different inflammatory conditions may affect this inner lining and change mucus production and the structure of the cells’ extracellular matrix. Chonluten's proposed mechanisms of action may help reduce levels of inflammation within the lungs."
            },
            {
                "p": "One such potential mechanism of action may be the initiation of phosphorylation in STAT molecules, especially STAT1, within immune cells called macrophage cells. STAT stands for \"Signal Transducer and Activator of Transcription.” These molecules appear to be messengers inside the cells, mediating signals and passing them to the cellular nucleus. Thus, STAT1 works like a switch that turns on genes, and it might work together with other proteins to send immune signal messages into the macrophage cell's nucleus, ultimately regulating this type of immune cell and reducing inflammation. The researchers also theorized that Chonluten may potentially decrease the activation of STAT3, another important protein that may act like a gene switch. STAT3 is involved in quick immune responses and might help control the gene for IL-6 (interleukin-6), an important immune system protein during inflammation. By affecting STAT3, Chonluten might change how IL-6 works, which could help reduce inflammation. Further, the researchers suggest Chonluten might exhibit some capacity to reduce levels of IL-6, TNF (tumor necrosis factor), and IL-17 in immune cells triggered by bacterial and other foreign substances. IL-6, TNF, and IL-17 are all proteins that scientists consider to cause inflammation and help regulate the immune system. Lowering the levels of these proteins may help calm inflammation in these activated immune cells. The scientists commented that the peptide apparently “inhibited in vitro tumor necrosis factor (TNF) production of monocytes exposed to pro-inflammatory bacterial lipopolysaccharide (LPS). The low TNF release by monocytes is linked to a documented mechanism of TNF tolerance, promoting attenuation of inflammatory action.\" Chonluten might also reduce the sticking process between the inner lining of blood vessels and immune cells. This was first posited by researchers who observed Chonluten mixed with endothelial cells (cells lining blood vessels) in experiments. By changing how these cells stick to each other, Chonluten may potentially affect how immune cells move and travel around the organism, which may be important in controlling inflammation and immune reactions.(1)"
            },
            {
                "h3": "Chonluten Peptide and Gastrointestinal Tract Tissues"
            },
            {
                "p": "Chonluten's suggested impact on the gastrointestinal tract is reportedly similar to that in the lungs, with studies positing its potential to reduce inflammation and prevent the prevalence of vascular changes that induce inflammatory diseases. For example, Chonluten might help repair cells in the stomach and intestinal tissues. It is posited to do this by controlling the activity of genes linked to antioxidant enzymes like superoxide dismutase (SOD). Research on Chonluten suggests that it might normalize these genes, helping to balance antioxidant defenses in the stomach lining. This might reduce oxidative stress, which harms cells, and encourage cell repair. It is also believed that Chonluten may reduce inflammation by affecting inflammation-related genes, such as TNF-α and cyclooxygenase-2 (Cox-2). By lowering the activity of these inflammation-causing substances, Chonluten might help control stomach tissue inflammation, aiding in cell repair. Additionally, Chonluten may promote new tissue growth, important for healing damaged areas. It might encourage the multiplication of fibroblasts, which are cells that help in tissue repair and the growth of new blood vessels in the healing tissue. It may also help repair damaged stomach lining by stimulating the growth of epithelial cells, which could lead to the recovery of damaged and ulcerated tissues. Furthermore, Chonluten may reduce excessive cell death (apoptosis) in the stomach lining. It is thought to possibly regulate the expression of heat shock protein 70 (HSP70), which protects cells from triggers that cause apoptosis. By controlling HSP70, Chonluten may possibly prevent excess cell death and promote the survival and repair of gastrointestinal tract tissues.(2)"
            },
            {
                "h3": "Chonluten Peptide and Gene Expression"
            },
            {
                "p": "Short peptides, such as Chonluten, have been researched in the context of certain modes of DNA expression, such as DNA methylation.(4)(5) Research suggests that “Short peptides, consisting of 2-7 amino acid residues, can penetrate into the nuclei and nucleoli of cells and interact with the nucleosome, the histone proteins, and both single- and double-stranded DNA. DNA-peptide interactions, including sequence recognition in gene promoters, are important for template-directed synthetic reactions, replication, transcription, and reparation. Peptides can regulate the status of DNA methylation, which is an epigenetic mechanism for the activation or repression of genes in both the normal condition, as well as in cases of pathology and senescence.”(4)"
            },
            {
                "h3": "Chonluten Peptide and the Immune System"
            },
            {
                "p": "Research studies suggest that Chonluten may regulate the immune system, stimulating or suppressing it to respond to advancing conditions. Chonluten's possible mechanisms of action have been suggested to be mediated by many genes, including heat shock protein, gene HSP70, SOD, c-Fos, antioxidative system genes, and TNF-alpha. The regulation of such genes may result in anti-inflammatory impacts, particularly c-Fos—a protein bioregulator of cell differentiation, survival, and proliferation that is activated in response to hypoxia and cellular damage. Although c-Fos may induce the growth of new blood vessels and cell proliferation locally in response to an injury, progressive expression might result in thickened bronchial mucosa or cancer.(2)"
            },
            {
                "h3": "Chonluten Peptide and Aerobic Activity"
            },
            {
                "p": "Research studies have grappled with the role of Chonluten peptide in various aerobic studies:"
            },
            {
                "p": "“Studies have [suggested] that several bioactive peptides elicit strongly upregulating effects on muscle protein synthesis or increase muscular strength and recovery [...] Besides positive effects on [contractile] strength and recovery, recent investigations found that hydrolyzed proteins might also influence endurance performance and metabolism.”(6)"
            },
            {
                "p": "Further research indicates that the Chonluten tripeptide might reduce stress hormone secretion and potentially improve the organism’s tolerance to low oxygen conditions. This suggests that the Chonluten tripeptide could help the lung and muscle tissues work better when insufficient oxygen exists. For example, researchers share that the Chonluten tripeptide may possibly exert a protective effect against low oxygen stress, which might stem from the peptide’s potential to control the activity of certain genes. These genes may include the c-Fos gene, which is involved in cell growth and survival; the heat shock protein gene HSP70, which might protect cells from low oxygen stress; genes that make enzymes in internal antioxidant systems, like SOD and COX-2, which are considered to help protect against oxidative damage; and the tumor necrosis factor gene TNF-α, which is believed to be important in inflammation and immune response. These findings suggest that the Chonluten tripeptide might potentially influence various biological processes, contributing to what seems to be its effect in protecting against low oxygen stress. (7)"
            },
            {
                "p": "Chonluten peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References"
            },
            {
                "references": [
                    "Avolio F, Martinotti S, Khavinson VK, Esposito JE, Giambuzzi G, Marino A, Mironova E, Pulcini R, Robuffo I, Bologna G, Simeone P, Lanuti P, Guarnieri S, Trofimova S, Procopio AD, Toniato E. Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line. Int J Mol Sci. 2022 Mar 25;23(7):3607",
                    "V. K. Khavinson, N. S. Lin’kova, A. V. Dudkov, V. O. Polyakova, and I. M. Kvetnoi, “Peptidergic regulation of expression of genes encoding antioxidant and anti-inflammatory proteins,” Bull. Exp. Biol. Med., vol. 152, no. 5, pp. 615–618, Mar. 2012, DOI: 10.1007/s10517-012-1590-2",
                    "PubChem [Internet]. Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information; 2004-. PubChem Compound Summary for CID 194641, Glutamyl-aspartyl-glycine; [cited 2024 Feb. 20]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Glutamyl-aspartyl-glycine",
                    "Khavinson VK, Popovich IG, Linkova NS, Mironova ES, Ilina AR. Peptide Regulation of Gene Expression: A Systematic Review. Molecules. 2021 Nov 22;26(22):7053",
                    "Khavinson VK, Lin'kova NS, Tarnovskaya SI. Short Peptides Regulate Gene Expression. Bull Exp Biol Med. 2016 Dec;162(2):288-292",
                    "König D, Kohl J, Jerger S, Centner C. Potential Relevance of Bioactive Peptides in Sports Nutrition. Nutrients. 2021 Nov 10;13(11):3997. DOI: 10.3390/nu13113997",
                    "Khavinson, V., Linkova, N., Dyatlova, A., Kuznik, B., & Umnov, R. (2020). Peptides: Prospects for Use in the Treatment of COVID-19. Molecules (Basel, Switzerland), 25(19), 4389. https://doi.org/10.3390/molecules25194389"
                ]
            },
            {
                "p": " "
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/12/Chonluten-COA-1.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/12/Chonluten-LC-1.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/12/Chonluten-MS-1.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Chonluten peptide for sale online (20mg). Peptides for sale at 99% purity with top customer service. Get Chonluten research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Chonluten For Sale (20mg) - Core Peptides",
            "og:description": "Chonluten peptide for sale online (20mg). Peptides for sale at 99% purity with top customer service. Get Chonluten research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/chonluten-20mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-06-17T14:45:28+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2022/11/Chonluten-20mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Chonluten For Sale (20mg) - Core Peptides",
            "twitter:description": "Chonluten peptide for sale online (20mg). Peptides for sale at 99% purity with top customer service. Get Chonluten research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2022/11/Chonluten-20mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$51.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:brand": "Core Peptides",
            "product:price:amount": "51.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-Chonluten",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/ghrp-6/",
                "name": "GHRP-6 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHRP-6-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/melanotan-2-10mg/",
                "name": "Melanotan 2 (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2023/03/Melanotan-2-10MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ipamorelin-5mg/",
                "name": "Ipamorelin (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Ipamorelin-5MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ll-37-5mg/",
                "name": "LL-37 (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/LL-37-5mg-300x300.jpg.webp",
                "price": ""
            }
        ]
    },
    {
        "id": "10",
        "url": "https://www.corepeptides.com/peptides/cartalax-20mg/",
        "name": "Cartalax (20mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2023/11/Cartalax-Ala-Glu-Asp-20MG.jpg",
        "display_price": "$63.00",
        "display_specs": [
            "Size: 20mg Contents: Cartalax Form: Lyophilized powder Purity: >99% SKU: P-CARLATAX-20",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$59.85"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$56.70"
            }
        ],
        "description": [
            {
                "h2": "Cartalax Peptide"
            },
            {
                "p": "Cartalax, or AED or T-31 peptide, is a synthetic peptide designed to target specific biological pathways that may have implications in cellular aging. The peptide is based on the sequence of amino acids derived from the alpha-1 chain of type XI collagen (hence AED, standing for the amino acid sequence Alanine-Glutamate-Aspartate). It has also been isolated from kidney extracts containing polypeptides. Peptides like Cartalax are often investigated for their potential to modulate biological processes, including inflammation and cartilage repair, which are significant factors in osteoarthritis. More specifically, it is classified among the Khavinson peptides and has been suggested by researchers to act as a bioregulator."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular formula: C12H19N3O8 Molecular weight: 333.29 g/mol Sequence: Ala-Glu-Asp Other known titles: AED, T-31, SCHEMBL5324601"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "p": "The data presented here distills the most recent findings from preclinical studies on the potential of Cartalax, as evidenced across a spectrum of experimental frameworks."
            },
            {
                "h3": "Cartalax and Fibroblasts"
            },
            {
                "p": "The peptide Cartalax, when explored for its impacts on skin fibroblasts, appears to hold properties that may potentially influence the aging process of these cells in culture.(1) Cartalax has been suggested to potentially play a role in several critical cellular processes that are pivotal for fibroblast function and longevity. Firstly, Cartalax may contribute to the proliferation of fibroblasts, as suggested by its potential enhancement of Ki-67 expression. Ki-67 is a well-known marker associated with cell proliferation. The expression of Ki-67 typically decreases during the aging of fibroblasts in culture. The fact that Cartalax seemingly promotes the levels of Ki-67 implies that this peptide may encourage fibroblast growth or increase their replicative lifespan, potentially combating the natural decline in cell division over time."
            },
            {
                "p": "Additionally, the apparent action of Cartalax on the expression of CD98hc is noteworthy. CD98hc is implicated in the regeneration and aging processes of cells. The increased expression of CD98hc in the presence of Cartalax may suggest a role in enhancing the regenerative capacity or possibly sustaining the vitality of aging fibroblasts. By promoting the expression of CD98hc, Cartalax may help maintain cellular functions that usually wane as cells age. The study also indicates that Cartalax potentially suppresses caspase-3 activity, which indicates its potential to inhibit apoptosis (cell death)."
            },
            {
                "p": "Apoptosis, the programmed cell death that is a natural part of an organ's renewal and homeostasis, may be detrimental when excessive or dysregulated. During the aging of cell cultures, an increase in apoptosis, or programmed cell death, is common. Cartalax's apparent suppression of caspase-dependent apoptosis could suggest that this peptide may allow fibroblasts to avert the increased incidence of cell death associated with aging, potentially contributing to an extended cellular lifespan. Moreover, the researchers commented that the peptide “reduced the level of apoptosis in young and aged cultures.”"
            },
            {
                "p": "Cartalax was also observed to inhibit the synthesis of MMP-9. MMP-9 is an enzyme involved in the remodeling of the extracellular matrix, and its increased activity is often associated with aging in fibroblasts. By inhibiting MMP-9 synthesis, Cartalax might help preserve the integrity of the extracellular matrix, possibly preventing or mitigating the degenerative changes that typically occur with aging.(1)"
            },
            {
                "p": "Ultimately, Cartalax has been suggested to regulate several markers in this replicative aging murine model of skin fibroblasts, such as Ki67 (a protein associated with proliferation), CD98hc (a glycoprotein), Caspase-3 (an apoptosis marker), and MMP9 (an enzyme involved in the degradation of extracellular matrix). Since chondrocytes (cartilage cells) share structural and functional characteristics with fibroblasts, these findings might suggest that Cartalax could have reparative properties in cartilage tissues as well.(2)"
            },
            {
                "h3": "Cartalax and Kidney Cells"
            },
            {
                "p": "The peptide Cartalax may carry the potential to influence kidney cell regeneration favorably. This influence is posited upon observations in organotypic kidney tissue cultures taken from both young and older murine models, where the presence of Cartalax was associated with a promotion of cellular proliferation. This proliferative action was apparently indicated by an increased expression of the marker Ki-67, which is commonly used to gauge cell proliferation. Furthermore, Cartalax may also contribute to a decrease in apoptotic processes within the kidney cells. The peptide Cartalax appears to potentially mitigate this by reducing the expression of the proapoptotic peptide p53. This protein, when expressed in high levels, is suggested to facilitate the process of apoptosis, and its down-regulation by Cartalax suggests that the peptide might help maintain cellular integrity and prolong cell survival. Thus, the presented information in this study also suggests Cartalax as a molecule of interest for its potential in the aging process of kidney cells.(3)"
            },
            {
                "p": "Other studies, such as another trial in aging renal cell cultures, further elaborated this suggestion. The study in question suggested that Cartalax may have an impact by promoting cell proliferation and possibly modifying the expression of several critical markers associated with aging. Specifically, the peptide is suggested to potentially decrease the expression of aging markers such as p16, p21, and p53, which are proteins frequently linked to the advancement of cellular senescence—the state in which cells stop dividing and growing."
            },
            {
                "p": "Beyond the suppression of these markers, Cartalax is also suggested to potentially increase the expression of SIRT-6, a protein that plays a significant role in DNA repair and in maintaining genomic stability, known to wane with age. The promotion of SIRT-6 by Cartalax might contribute to slowing down the aging process in renal cells, as a reduction in SIRT-6 is implicated in the acceleration of cellular aging. The study further suggests that the protective actions of Cartalax on kidney cells may be attributable to the peptide's interactions with DNA. It appears that Cartalax may form energetically favorable complexes with specific sequences of DNA, particularly d(ATATATATAT)2 in the minor groove. This interaction is hypothesized to be a catalyst for the changes observed in gene expression, including those genes that code for aging markers in renal cells. By potentially affecting gene expression, Cartalax might aid in preserving the health and function of kidney cells, possibly delaying aging. The development of experimental data models to understand the interaction between Cartalax and DNA sequences emphasizes the intricacies of the underlying mechanisms. The proposition that this interaction may cause gene expression changes offers a novel insight into how particular peptides might influence the aging process at the molecular level.(4)"
            },
            {
                "h3": "Cartalax and Cellular Aging"
            },
            {
                "p": "Apart from its potential on fibroblasts and kidney cell cultures, Cartalax has also been researched on its potential impact on bone marrow mesenchymal stem cells. More specifically, the peptide Cartalax could potentially exert a notable influence on the cellular mechanisms related to aging in bone marrow mesenchymal stem cells, based on observations from a study examining gene expression levels in cells that are undergoing an aging process in two distinct environments: \"passages\" or during their proliferation phase, and \"stationary\" or non-proliferating conditions. As cells age, they go through various stages, often described as \"passages\" in cell culture, which denote the number of times the cells have been divided and subcultured. Eventually, cells enter a \"stationary\" phase of growth, commonly associated with cellular senescence, where they no longer divide but are still metabolically active. This phase may reflect the aging process of cells."
            },
            {
                "p": "Cartalax might play a role in the upregulation of the insulin-like growth factor 1 (IGF1) gene in both aging models, potentially enhancing its expression by approximately 3.5 to 5.6 fold. The IGF1 protein is known for its involvement in cellular growth and development, and its increased expression might suggest a role for Cartalax in promoting growth-related cellular functions, which could possibly counteract certain aspects of the cellular aging process. The study also noted an eightfold increase in the expression of the TERT gene, which encodes the catalytic subunit of the enzyme telomerase, in \"stationary\" aging conditions. However, the text provided does not specify the action of Cartalax on TERT expression. Since telomerase plays a crucial role in maintaining telomere length and thus cellular longevity, any potential modulation by Cartalax might have significant implications for cellular aging. Further, Cartalax appeared to stimulate the expression of the NFκB gene in both aging models. NFκB is a protein complex that functions in various cellular processes, including inflammation, immunity, and cellular survival. The stimulation of NFκB by Cartalax could imply a potential influence on the cellular stress response pathways, which are intimately linked to the aging process. Further, the authors commented that the “peptide does not affect TNKS2 in “passages,” but inhibits it in “stationary”aging culture.” TNKS2 refers to \"Tankyrase 2,\" which is a member of the poly(ADP-ribose) polymerase (PARP) family of enzymes. Tankyrases, including TNKS2, play a crucial role in various cellular processes, such as regulation of Wnt signaling, telomere maintenance, and regulation of vesicle trafficking. Particularly, the role of maintaining telomeres is thought to mediate the potential anti-aging impact of the interaction between Cartalax and TNKS2.(5)"
            },
            {
                "p": "Cartalax peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Lin'kova, N. S., Drobintseva, A. O., Orlova, O. A., Kuznetsova, E. P., Polyakova, V. O., Kvetnoy, I. M., & Khavinson, V. K.h (2016). Peptide Regulation of Skin Fibroblast Functions during Their Aging In Vitro. Bulletin of experimental biology and medicine, 161(1), 175–178. https://doi.org/10.1007/s10517-016-3370-x",
                    "Linkova, N., Khavinson, V., Diatlova, A., Myakisheva, S., & Ryzhak, G. (2023). Peptide Regulation of Chondrogenic Stem Cell Differentiation. International Journal of Molecular Sciences, 24(9), 8415.",
                    "Chalisova, N. I., Lin'kova, N. S., Nichik, T. E., Ryzhak, A. P., Dudkov, A. V., & Ryzhak, G. A. (2015). Peptide Regulation of Cells Renewal Processes in Kidney Tissue Cultures from Young and Old Animals. Bulletin of experimental biology and medicine, 159(1), 124–127. https://doi.org/10.1007/s10517-015-2906-9",
                    "Khavinson, V. K.h, Tarnovskaia, S. I., Lin'kova, N. S., Poliakova, V. O., Durnova, A. O., Nichik, T. E., Kvetnoĭ, I. M., D'iakonov, M. M., & Iakutseni, P. P. (2014). Advances in gerontology = Uspekhi gerontologii, 27(4), 651–656.",
                    "Ashapkin, V., Khavinson, V., Shilovsky, G., Linkova, N., & Vanuyshin, B. (2020). Gene expression in human mesenchymal stem cell aging cultures: modulation by short peptides. Molecular biology reports, 47(6), 4323–4329. https://doi.org/10.1007/s11033-020-05506-3"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/12/Cartalax-COA-1.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/12/Cartalax-LC-1.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/12/Cartalax-MS-1.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Cartalax for sale online (20mg). Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Cartalax for Sale (20mg) - Core Peptides",
            "og:description": "Cartalax for sale online (20mg). Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/cartalax-20mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T15:27:35+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2023/11/Cartalax-Ala-Glu-Asp-20MG.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Cartalax For Sale (20mg) - Core Peptides",
            "twitter:description": "Cartalax for sale online (20mg). Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2023/11/Cartalax-Ala-Glu-Asp-20MG.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$63.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:brand": "Core Peptides",
            "product:price:amount": "63.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-CARLATAX-20",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/ghrp-6/",
                "name": "GHRP-6 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHRP-6-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/aod-9604-5mg/",
                "name": "AOD 9604 (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/AOD-9604-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ll-37-5mg/",
                "name": "LL-37 (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/LL-37-5mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/oxytocin-10mg/",
                "name": "Oxytocin (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Oxytocin-10mg-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "id": "11",
        "url": "https://www.corepeptides.com/peptides/cardiogen-20mg/",
        "name": "Cardiogen (20mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2022/11/Cardiogen-20MG.jpg",
        "display_price": "$75.00",
        "display_specs": [
            "Size: 20mg Contents: Cardiogen (20mg) Form: Lyophilized powder Purity: >99% SKU: P-cardiogen",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$71.25"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$67.50"
            }
        ],
        "description": [
            {
                "h2": "Cardiogen Peptide"
            },
            {
                "p": "Cardiogen is considered a peptide bioregulator that possibly regulates fibroblasts, which are cells that play a role in scar formation and tissue repair. The peptide has been widely researched for its potential to interact with the tissues in the cardiovascular system. Still, recent research has suggested that it may also be functional in other tissues via influencing fibroblast activities. Furthermore, scientists believe Cardiogen may increase tumor cell apoptosis (programmed cell death)."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C18H31N7O9 Molecular Weight: 489.5 g/mol Structure: H-Ala-Glu-Asp-Arg-OH Other Known Titles: SCHEMBL3194515"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Cardiogen Peptide and Cancer Research"
            },
            {
                "p": "Researchers consider the peptide to be an apoptotic reductant in cardiac cells via possibly decreasing p53 expression and may exhibit opposite impacts on tumor cells. The p53 gene produces a protein found inside the nucleus of cells and is considered essential in controlling cell division and cell death. An experiment was conducted on murine models with M-1 sarcoma (indicating it has metastasized to other distant tissues and organs) to determine the tumor-modulating potential of Cardiogen, with apoptosis on tumor cells exceeding normal levels and considered uncontrollable.(1) The results indicated a consequence of necrotic and hemorrhagic development and the improvement of tumor cell apoptosis. The results of the experiment suggested that:"
            },
            {
                "p": "“The [concentration-dependent] inhibition of M-1 sarcoma growth after [...] cardiogen was caused by the development of hemorrhagic necrosis and stimulation of tumor cell apoptosis. The parameters of proliferative activity indicate that inhibition of tumor growth was not caused by the direct cytostatic effect of the [peptide] on the tumor. Morphological signs indicate a specific mechanism of cardiogen action, realized through the vascular network of the tumor.” (1)"
            },
            {
                "p": "The supposed anti-proliferative action of the peptide suggests that tumor growth inhibition may not result from a cytostatic compound on the tumor. According to morphology, tumor growth inhibition may be mediated by a specific mechanism of action related to blood cell supply. This event may be particular to some tumor cells due to their atypical and increased vascular supply."
            },
            {
                "h3": "Cardiogen Peptide and Prostate Cell Aging"
            },
            {
                "p": "According to researchers, Cardiogen may significantly increase the expression of signaling factors involved in the differentiation of prostate fibroblasts that typically decrease in senescent cultures.(2) Because these signaling factors are considered to decline in aging and senescent fibroblasts, and Cardiogen appears to restore the levels of these factors, especially in senescent cell cultures, it is posited that the peptide may be a relevant candidate for further research in developing methods to address age-related dysfunctions of prostate cells."
            },
            {
                "h3": "Cardiogen Peptide and Cardiomyocytes Proliferation"
            },
            {
                "p": "Cardiogen may potentially be able to enter different parts of cells, specifically the cytoplasm, nucleus, and nucleolus. Additionally, researchers have hypothesized that Cardiogen might be able to hinder the breakdown of DNA fragments by endonucleases, which are enzymes involved in DNA processing. To explore this, a study was performed using murine embryonic fibroblast cells.(3) These cells were grown in a laboratory setting, in a culture medium known as DMEM, enriched with approximately 10% embryonic calf serum, and kept in a humid environment. After about five days of growth, the cells were separated into two groups. The first group was left as is, serving as a control, while the second group was exposed to Cardiogen for approximately 30 minutes. It appears that in the cells cultivated with Cardiogen, there was a notable increase in the levels of certain proteins within the cytoplasm (such as actin, vimentin, and tubulin) and in the nucleus (specifically nuclear matrix proteins lamin A and C). Actin, vimentin, and tubulin are integral components of the cytoskeleton, the complex network of protein fibers that provide structure and shape to the cells. Actin forms microfilaments, which are thin, flexible fibers crucial for cellular movement and shape. Vimentin, a type of intermediate filament, offers mechanical support and resilience, particularly vital in cells like fibroblasts that endure stress. Tubulin, on the other hand, is the building block of microtubules, which are thicker, hollow tubes essential for maintaining cell shape, enabling intracellular transport, and facilitating chromosome segregation during cell division. Further, lamin A and C are types of nuclear lamins, which are fibrous proteins providing structural support to the nucleus. They form a mesh-like layer called the nuclear lamina on the inner surface of the nuclear envelope. Lamins are involved in organizing the chromatin (DNA and proteins) within the nucleus, and they also play roles in DNA replication, cell division, and regulating gene expression. The protein increases were roughly 2x - 5x higher with Cardiogen than in the control group. These findings suggest that Cardiogen might be activating the expression of these cytoskeletal and nuclear matrix proteins. A possible explanation might be that Cardiogen may potentially influence the proteins associated with DNA, such as enzymes and transcription factors. This influence may improve the way genes related to these cytoskeletal proteins are accessed for transcription, potentially leading to increased cellular metabolism and the stimulation of cell growth and differentiation.(3)"
            },
            {
                "h3": "Cardiogen Peptide and Cardiomyocytes Apoptosis"
            },
            {
                "p": "Researchers have suggested Cardiogen to increase cardiomyocyte proliferation while possibly decreasing fibroblast growth and development and scar formation, resulting in potential long-term and improved cardiac remodeling. Studies suggest that Cardiogen may reduce the expression of the p53 gene, resulting in a lower apoptosis rate of cardiomyocytes after injury.(4,5) Researchers propose Cardiogen's potential in cardiac tissue:"
            },
            {
                "p": "“The tetrapeptide cardiogen demonstrated the great stimulating effect on the proliferation both in tissues from young and old rats. The immunohistochemical study demonstrated a decrease of the p53 protein expression by cardiogen action. This fact can testify that cardiogen inhibits the apoptosis process in the myocardial tissue.”(5)"
            },
            {
                "p": "More specifically, the synthetic tetrapeptide Cardiogen appears, based on the study's observations, to potentially play a role in enhancing cell proliferation in murine models of both young and aged specimens. This intriguing finding leads to the tentative hypothesis that Cardiogen might have the capacity to stimulate cell growth in heart muscle tissue. As mentioned, Cardiogen might possibly lead to a reduction in the expression of the p53 protein. This protein, often referred to as the \"guardian of the genome,\" is believed to have crucial roles in controlling the cell cycle and may act as a tumor suppressor, thereby making this a significant point of interest for future cancer research. When active, p53 is considered to have the ability to initiate apoptosis, or programmed cell death. Therefore, a potential decrease in p53 expression as a result of Cardiogen might imply that this compound could inhibit apoptosis in the heart's myocardial tissue. This aspect of the study's findings seems to add an extra layer of complexity and potential significance, warranting further investigation.(5)"
            },
            {
                "p": "Another experiment investigating the potential of Cardiogen on cardiomyocyte cell apoptosis was conducted in an experimental murine model of myocardial damage, achieved through the deliberate ligation of the coronary artery.(6) There appears to be research data suggesting that the Cardiogen peptide might significantly reduce mortality following this experimentally induced heart damage. Observations point to a threefold decrease in mortality compared to the control group. Additionally, this peptide may play a role in diminishing necrotic zones within the myocardial tissue, which are considered to be areas of cell death due to a suspected lack of blood flow (ischaemia). It is also proposed that the Cardiogen peptide might assist in preserving the glycogen content in the myocardial tissue. Glycogen, considered to be a vital form of energy storage in cells, when preserved, indicates that the cells might have been better able to maintain their energy reserves in the presence of the Cardiogen peptide. This preservation may potentially enhance the survival and function of cells post-ischaemia. The study further suggests that the Cardiogen peptide may exert a protective effect on mitochondria, which are the structures within cells responsible for energy production. Finally, there is a hypothesis that the Cardiogen peptide might stimulate reparative processes, which may theoretically contribute to repairing the damage caused by ischaemia. Such processes might also potentially improve the metabolism of cardiomyocytes, and reduce cell apoptosis.(6)"
            },
            {
                "p": "Cardiogen peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References"
            },
            {
                "references": [
                    "Levdik NV, Knyazkin IV. Tumor-modifying effect of cardiogen peptide on M-1 sarcoma in senescent rats. Bull Exp Biol Med. 2009 Sep;148(3):433-6. English, Russian",
                    "Kheĭfets OV, Poliakova VO, Kvetnoĭ IM. [Peptidergic regulation of the expression of signal factors of fibroblast differentiation in the human prostate gland in cell aging]. Adv Gerontol. 2010;23(1):68-70",
                    "Khavinson, V. K.h, Lin'kova, N. S., Polyakova, V. O., Kvetnoy, I. M., Benberin, V. V., D'yakonov, M. M., & Titkov, Y. S. (2012). Tetrapeptide H-Ala-Glu-Asp-Arg-OH stimulates expression of cytoskeletal and nuclear matrix proteins. Bulletin of experimental biology and medicine, 153(4), 559–562. https://doi.org/10.1007/s10517-012-1766-9",
                    "Grieco P, Gomez-Monterrey I. Natural and synthetic peptides in the cardiovascular diseases: An update on diagnostic and therapeutic potentials. Arch Biochem Biophys. 2019 Feb 15;662:15-32. doi: 10.1016/j.abb.2018.11.021",
                    "N. I. Chalisova et al., “[The effect of the amino acids and cardiogen on the development of myocard tissue culture from young and old rats],” Adv. Gerontol. Uspekhi Gerontol., vol. 22, no. 3, pp. 409–413, 2009",
                    "Khavinson, V., Linkova, N., Dyatlova, A., Kantemirova, R., & Kozlov, K. (2022). Senescence-Associated Secretory Phenotype of Cardiovascular System Cells and Inflammaging: Perspectives of Peptide Regulation. Cells, 12(1), 106."
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/12/Cardiogen-COA-1.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/12/Cardiogen-LC-1.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/12/Cardiogen-MS-1.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Cardiogen peptide for sale online (20mg). Peptides for sale at 99% purity with top customer service. Get Cardiogen research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Cardiogen For Sale (20mg) - Core Peptides",
            "og:description": "Cardiogen peptide for sale online (20mg). Peptides for sale at 99% purity with top customer service. Get Cardiogen research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/cardiogen-20mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T16:31:37+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2022/11/Cardiogen-20MG.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Cardiogen For Sale (20mg) - Core Peptides",
            "twitter:description": "Cardiogen peptide for sale online (20mg). Peptides for sale at 99% purity with top customer service. Get Cardiogen research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2022/11/Cardiogen-20MG.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$75.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:brand": "Core Peptides",
            "product:price:amount": "75.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-cardiogen",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/semax-25mg/",
                "name": "Semax (25mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Semax-25MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/melanotan-1-10mg/",
                "name": "Melanotan 1 (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Melanotan-1-10MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/epitalon-25mg/",
                "name": "Epithalon (25mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Epithalon-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/cjc-1295-dac-5mg/",
                "name": "CJC-1295 DAC (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/CJC-1295-DAC-5MG-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "id": "12",
        "url": "https://www.corepeptides.com/peptides/bronchogen-20mg/",
        "name": "Bronchogen (20mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2023/10/Bronchogen-Ala-Glu-Asp-Leu-20mg.jpg",
        "display_price": "$68.00",
        "display_specs": [
            "Size: 20mg Contents: Bronchogen Form: Lyophilized powder Purity: >99% SKU: P-BRONCHOGEN-20",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$64.60"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$61.20"
            }
        ],
        "description": [
            {
                "h2": "Bronchogen Peptide"
            },
            {
                "p": "Bronchogen, also known as AEDL, is classified among the Khavinson peptides and is has been suggested by researchers to act as a bioregulator. These are short signaling peptides which may cross through cellular and nuclear membranes to directly interact with the DNA. Bronchogen may have specific affinity for lung cells by regulating the expression of the NKX2-1, SCGB1A1, SCGB3A2, FOXA1, and FOXA2 genes.(1) Furthermore, authors comment that it may “bind preferentially with deoxyribooligonucleotides containing CNG sequence (CNG sites are targets for cytosine DNA methylation in eukaryotes).”(2) Indeed, the peptide has been suggested to potentially attenuate inflammatory reactions in the lungs of murine models with bleomycin-induced fibrosis(3)"
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular formula: C18H30N4O9 Molecular weight: 446.45 g/mol Sequence: Ala-Glu-Asp-Leu Other known titles: AEDL"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "p": "Below we have delved deep into the latest clinical and preclinical data on the potential actions of Bronchogen as seen in various research models."
            },
            {
                "h3": "Bronchogen and DNA"
            },
            {
                "p": "Studies have suggested that the peptide may interact with “lung cells by regulating the expression of the NKX2-1, SCGB1A1, SCGB3A2, FOXA1, and FOXA2 genes” to exert its potential actions on DNA. These actions may include reducing inflammation, promoting differentiation and preventing remodeling. (1) (4)"
            },
            {
                "p": "Further, Bronchogen’s interaction with DNA may affect genetic expression. The interaction between Bronchogen and deoxyribooligonucleotides (short DNA segments) containing a CNG sequence may potentially influence gene regulation and expression due to its association with cytosine DNA methylation sites. In eukaryotes, CNG sites (where \"C\" denotes cytosine, \"N\" stands for any nucleotide including A, T, G, or C, and \"G\" signifies guanine) are common targets for DNA methylation, which is considered to play a pivotal role in epigenetic modulation. Methylation at cytosine residues, particularly at CpG dinucleotides, is associated with gene silencing. If Bronchogen preferentially binds to these CNG sites, it may interfere with or modulate the methylation process, thereby impacting gene expression. This interaction may influence cellular differentiation and development or alter normal cellular functions.(2)"
            },
            {
                "p": "Bronchogen has been suggested to potentially increase DNA thermal stability as well. One study explored the impact of Bronchogen on the thermal stability of DNA derived from calf thymus and mouse liver, employing differential scanning microcalorimetry to analyze thermodynamic parameters during DNA melting. Bronchogen apparently elevated the melting temperature of DNA by 3.1 °C, acting as a DNA-stabilizing agent. The researchers also suggested that Bronchogen may not exhibit base specificity in its binding (non-selective for adenine-thymine or guanine-cytosine pairs), and apparently engages strongly yet sporadically with both DNA strands, primarily interacting with nitrogen bases, which is in contrast with previous suggestions that it targets CNG sites. Potential mechanisms might involve non-covalent interactions, such as hydrogen bonding or van der Waals forces, between Bronchogen and nitrogen bases. The implications of Bronchogen’s potential stabilizing effect on DNA may have relevance in the study and stabilization of DNA structures, possibly aiding in the development of strategies involving nucleic acids, or in biotechnological advancements where enhanced DNA stability is crucial. Further investigations into the structural and molecular aspects of this interaction may unveil more detailed mechanisms.(5)"
            },
            {
                "h3": "Bronchogen and Cell Renewal"
            },
            {
                "p": "Studies suggest that the Bronchogen peptide may impact cell renewal processes and augment the functionality of bronchial epithelial cells, which opens up new potential avenues in cell regeneration research, especially related to bronchial epithelial cells. The specific binding of the peptide to DNA, notably at the guanine N7 site without visibly altering the double-helix structure, indicates a targeted interaction that might be explored further. This suggests that Bronchogen may potentially modulate cellular activities at the genetic level. However, the molecular mechanism through which Bronchogen enhances cell functionality and renewal is not fully detailed yet, making an in-depth investigation into its pharmacodynamics essential to ascertain its potential and to verify that it will not provoke unwanted mutagenic or cytotoxic effects. Furthermore, Bronchogen's potential capability to bind with DNA suggests that it may be utilized in research dedicated to developing targeted delivery systems, where the peptide might be employed to direct other compounds or agents to specific DNA sequences. This interaction and the resulting biological actions need to be extensively studied to establish the potential of Bronchogen in scientific research, considering factors like potential off-target effects, stability, and delivery mechanisms. Ultimately, the researchers commented that the “peptide proved to be an efficient agent stimulating the cell renewal processes and the enhancement of the functional activity of bronchial epithelial cells.”(6)"
            },
            {
                "h3": "Bronchogen and Inflammation"
            },
            {
                "p": "Studies have examined the potential impact of Bronchogen, on the structural and functional aspects of bronchial epithelium, as well as the inflammatory activity within murine models. This model was generated in murine subjects through intermittent exposure to nitrogen dioxide for 60 days which is considered to damage the bronchial epithelium. The bronchial epithelium plays an essential role in guarding against inhaled noxious substances. Bronchogen, by hypothetically modulating inflammatory activity and the bronchial epithelium state in this model, may have led to a reduction in neutrophilic inflammation and normalization of the cellular composition and profile of pro-inflammatory cytokines and enzymes in the bronchoalveolar space. The researchers suggested an apparent structural and functional rejuvenation of the bronchial epithelium, indicated by increased levels of secretory immunoglobulin A, a marker for local immunity, and surfactant protein B, which modulates alveolar surface tension. Possible mechanisms related to these observations may involve Bronchogen intervening in the inflammatory cascade, possibly inhibiting pro-inflammatory cytokines and enzymes, thus alleviating inflammation. Additionally, the peptide might promote regenerative processes in the bronchial epithelium, enhancing its barrier function, and contributing to the balance of surfactant proteins essential for lung function and defenses. This research hints at novel peptide-based strategies for addressing the inflammatory and structural challenges posed by specific respiratory conditions. Further studies, particularly in broader models, are ongoing.(7) Further research suggest that these antiinflammatory actions may be exerted on the bronchial epithelium state to prevent fibrotic changes in the lungs but that the peptide may have potentially beneficial actions in other areas such as minimizing hemodynamic disturbances and possibly reducing myocardial hypertrophy in experimental models.(3)"
            },
            {
                "h3": "Bronchogen and Tissue Remodeling"
            },
            {
                "p": "Trials have investigated the potential of Bronchogen for preventing tissue remodeling in murine models which went through 60-day intermittent exposure to NO2. Bronchogen appeared to abate typical symptoms of bronchial epithelium and lung tissue remodeling, such as goblet cell hyperplasia, squamous metaplasia, lymphocytic infiltration, and emphysema, while also potentially restoring ciliated cells. The researchers commented that there may be an increase in secretory IgA production, indicative of normalized functional activity of bronchial epithelium, and stabilization of cell composition and proinflammatory cytokine profile in the bronchoalveolar space, hinting at reduced neutrophilic inflammation. These outcomes suggest that Bronchogen might alleviate the physical restructuring and dysfunction of lung tissues but also potentially reverse these alterations. The enhanced production of secretory IgA and the modulation of inflammatory markers suggest a mechanism involving immune enhancement and inflammation control.(8)"
            },
            {
                "p": "NOTE: These products are intended for laboratory research use only. This peptide is not intended for personal use. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Khavinson, V. K., Popovich, I. G., Linkova, N. S., Mironova, E. S., & Ilina, A. R. (2021). Peptide Regulation of Gene Expression: A Systematic Review. Molecules (Basel, Switzerland), 26(22), 7053. https://doi.org/10.3390/molecules26227053",
                    "Fedoreyeva, L. I., Kireev, I. I., Khavinson, V. K.h, & Vanyushin, B. F. (2011). Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNA. Biochemistry. Biokhimiia, 76(11), 1210–1219. https://doi.org/10.1134/S0006297911110022",
                    "Khavinson, V. K.h, Linkova, N. S., Polyakova, V. O., Kheifets, O. V., Tarnovskaya, S. I., & Kvetnoy, I. M. (2012). Peptides tissue-specifically stimulate cell differentiation during their aging. Bulletin of experimental biology and medicine, 153(1), 148–151. https://doi.org/10.1007/s10517-012-1664-1",
                    "Caputi, S., Trubiani, O., Sinjari, B., Trofimova, S., Diomede, F., Linkova, N., Diatlova, A., & Khavinson, V. (2019). Effect of short peptides on neuronal differentiation of stem cells. International journal of immunopathology and pharmacology, 33, 2058738419828613. https://doi.org/10.1177/2058738419828613",
                    "Monaselidze, J. R., Khavinson, V. K.h, Gorgoshidze, M. Z., Khachidze, D. G., Lomidze, E. M., Jokhadze, T. A., & Lezhava, T. A. (2011). Effect of the peptide bronchogen (Ala-Asp-Glu-Leu) on DNA thermostability. Bulletin of experimental biology and medicine, 150(3), 375–377. https://doi.org/10.1007/s10517-011-1146-x",
                    "Morozova, E. A., Lin’kova, N. S., Khavinson, V. K., Soloviev, A. Y., & Kasyanenko, N. A. (2017). In vitro interaction of the AEDL peptide with DNA. Journal of Structural Chemistry, 58, 420-424.",
                    "Titova, O. N., Kuzubova, N. A., Lebedeva, E. S., Preobrazhenskaya, T. N., Surkova, E. A., & Dvorakovskaya, I. V. (2017). Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova, 103(2), 201–208.",
                    "Kuzubova, N. A., Lebedeva, E. S., Dvorakovskaya, I. V., Surkova, E. A., Platonova, I. S., & Titova, O. N. (2015). Modulating Effect of Peptide Therapy on the Morphofunctional State of Bronchial Epithelium in Rats with Obstructive Lung Pathology. Bulletin of experimental biology and medicine, 159(5), 685–688. https://doi.org/10.1007/s10517-015-3047-x"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/12/Bronchogen-COA-1.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/12/Bronchogen-LC-1.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/12/Bronchogen-MS-1.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Bronchogen for sale online (20mg). Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Bronchogen for Sale (20mg) - Core Peptides",
            "og:description": "Bronchogen for sale online (20mg). Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/bronchogen-20mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T15:24:58+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2023/10/Bronchogen-Ala-Glu-Asp-Leu-20mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Bronchogen For Sale (20mg) - Core Peptides",
            "twitter:description": "Bronchogen for sale online (20mg). Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2023/10/Bronchogen-Ala-Glu-Asp-Leu-20mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$68.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:brand": "Core Peptides",
            "product:price:amount": "68.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-BRONCHOGEN-20-1",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/dsip-5mg/",
                "name": "DSIP (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/DSIP-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/cjc-1295-no-dac-mod-grf-1-29/",
                "name": "CJC-1295 NO DAC (Mod GRF 1-29) (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Mod-GRF-1-29-5mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/peg-mgf-5mg/",
                "name": "PEG-MGF (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/PEG-MGF-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ghk-cu-50mg-copper/",
                "name": "GHK-Cu (Copper) (50mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHK-CU-50mg-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "id": "13",
        "url": "https://www.corepeptides.com/peptides/bpc-157-tb-500-10mg-blend/",
        "name": "BPC-157 & TB-500 Blend (10mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2020/04/BPC-157-TB-500-5-5MG.jpg",
        "display_price": "$112.00 Original price was: $112.00.$105.00Current price is: $105.00.",
        "display_specs": [
            "Size: 10mg Contents: BPC-157 5mg, TB-500 (thymosin beta 4) 5mg Form: Lyophilized powder Purity: >99% SKU: P-BPC157TB500-10",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$99.75"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$94.50"
            }
        ],
        "description": [
            {
                "h2": "BPC-157 & TB-500 Peptide Blend"
            },
            {
                "p": "BPC-157 Peptide, also known as Pentadecapeptide BPC-157, or Body Protection Compound 157, is a wholly synthetic peptide that is potentially linked to multiple cellular functions and is perceived to have significance in healing of experimental models of injury. It is speculated to engage with cellular communication routes, possibly affecting elements associated with rejuvenation and recuperation. A few research studies hint that BPC-157 might also possess capabilities to encourage blood vessel formation and regulate inflammation-related activities.(1) Moreover, experimental findings have posited that BPC-157 may aid in safeguarding and regenerating various cells and tissues. Overall, BPC-157 has been suggested in various studies to potentially help with healing joint, tendon, and muscle tissue, as well as nerve tissue."
            },
            {
                "p": "TB-500 Peptide, also known as Synthetic thymosin beta-4, or TB-4, has been suggested by researchers to possibly assist in the healing process after injury, especially brain and neurological injury. Other TB-500 research has suggested it helps with wound healing and with hair growth. The peptide is a man-made variant of the thymosin beta-4 (Tβ4) peptide found naturally within the cells of the thymus organ, and encoded by the TMSB4X gene. From research on thymosin beta-4, TB-500 appears to modulate cell movement, differentiation, and tissue healing. It is believed to engage with various cellular signaling routes to manifest its actions. Investigations further imply that TB-500 might encourage angiogenesis, as well as cellular and tissue renewal.(2)"
            },
            {
                "p": "Both BPC-157 and TB-500 are synthetic polypeptides, where TB-500 is composed of 43 amino acids, and BPC-157 is composed of 15 amino acids.(3)(4)"
            },
            {
                "h3": "Overview"
            },
            {
                "p": "Based on Tβ4 research, TB-500 has been suggested to exert potential action on cellular motility via elevating the levels of actin proteins. More specifically it has been posited to regulate the cellular actin-cytoskeleton and cellular migration by sequestering G-actin. TB-500 has a distinct amino acid segment [(17)LKKTETQ(23)] which is hypothesized to be responsible for actin binding and potentially enhancing cellular motility. This in turn may exhibit positive action on wound healing processes.(5) TB-500 also seems to amplify the presence of microRNA-146a (miR-146a), which may act as a repressive regulator for certain cellular signaling routes such as those related to the activity of two inflammation-related cytokines called L-1 receptor-linked kinase 1 (IRAK1) and tumor necrosis factor receptor-linked factor 6 (TRAF6). This suggestion was further insisted as a potential mechanism of TB-500 by the authors of the research study, who also commented that \"transfection of anti-miR-146a nucleotides reversed the inhibitory effect of Tβ4 on IRAK1 and TRAF6.\" Thus, TB-500 also appears to potentially work for healing by exerting anti-inflammatory action.(6)"
            },
            {
                "p": "BPC-157 peptide has been suggested to exert some action via various processes encompassing nitric oxide production, control of cells pertinent to tissue restoration, growth elements, and inflammatory responses. It is conceivable that BPC-157 may exhibit some engagement with the NO mechanism, possibly providing a safeguard for the endothelium and perhaps encouraging angiogenic behaviors by fostering the development of new circulatory routes. Researchers suggest there is a chance it may boost the expression of the early growth response 1 gene, which may play a role in producing cytokines and growth stimuli, and possibly aid in the initial assembly of the extracellular framework, inclusive of collagen. It is worth highlighting that BPC-157's relation with nerve growth factor 1-A binding protein-2 may exert inhibitory action on specific elements.(7) As a result, new tissues composed of collagen may be formed, thereby possibly enhancing the healing of wounds more rapidly.(8)"
            },
            {
                "p": "As both TB-500 and BPC-157 peptides appear to exhibit similar pharmacological potential, when blended together, the potential action of both may be maximized – what would otherwise occur with one peptide, might occur at a better, faster rate when combined."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula:"
            },
            {
                "p": "Molecular Weight:"
            },
            {
                "p": "Other Known Titles"
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/12/BPC-157-TB-500-COA.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/12/BPC-157-TB-500-LC.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/12/BPC-157-TB-500-MS.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "BPC-157 & TB-500 blend for sale online (10mg). Peptides for sale at 99% purity with top customer service. Read about research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "BPC-157 & TB-500 Blend For Sale (10mg) | Core Peptides",
            "og:description": "BPC-157 & TB-500 for sale online (10mg). Peptides for sale at 99% purity with top customer service. Read about research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/bpc-157-tb-500-10mg-blend/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-05-28T11:02:31+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/BPC-157-TB-500-5-5MG.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "BPC-157 & TB-500 Blend For Sale (10mg) | Core Peptides",
            "twitter:description": "BPC-157 & TB-500 for sale online (10mg). Peptides for sale at 99% purity with top customer service. Read about research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/BPC-157-TB-500-5-5MG.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$105.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "105.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-BPC157TB500-10",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/ghrp-2/",
                "name": "GHRP-2 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHRP-2-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/cjc-1295-no-dac-mod-grf-1-29/",
                "name": "CJC-1295 NO DAC (Mod GRF 1-29) (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Mod-GRF-1-29-5mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/peg-mgf-5mg/",
                "name": "PEG-MGF (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/PEG-MGF-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/receptor-grade-igf-1-lr3-1mg/",
                "name": "Receptor Grade IGF-1 LR3 (1mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-1MG-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "id": "14",
        "url": "https://www.corepeptides.com/peptides/bpc-157/",
        "name": "BPC-157 (5mg / 10mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2020/04/BPC-157.jpg",
        "display_price": "$52.00 – $97.00",
        "display_specs": [
            "Size: 5mg / 10mg Contents: BPC-157 Form: Lyophilized powder Purity: >99% SKU: P-BPC157",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$49.40 – $92.15"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$46.80 – $87.30"
            },
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$92.15"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$87.30"
            },
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$49.40"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$46.80"
            }
        ],
        "description": [
            {
                "h2": "BPC-157 Peptide"
            },
            {
                "p": "The BPC-157 peptide, also known as Pentadecapeptide BPC 157 or Body Protection Compound 157, is a synthetic compound that has been suggested in various studies to assist with healing joint, tendon, and muscle tissue, as well as nerve tissue."
            },
            {
                "p": "BPC-157 is a peptide composed of 15 amino acids with potential protective properties. As the name suggests, Body Protection Compound (BPC) is an amino acid fragment isolated from gastric juice.(1) BPC-157 is also commonly known as pentadecapeptide due to the 15 amino acids it is comprised of.(1)"
            },
            {
                "h3": "Overview"
            },
            {
                "p": "BPC-157 has been steadily researched for its potential in wound healing. Presentation of BPC-157 may stimulate the growth hormone (GH) receptors, thereby inducing similar GH potential. BPC-157 peptide appears to bind with growth hormone receptors, possibly stimulating cell proliferation. This may lead to the development of new tissue composed of collagen and the development of a network of blood vessels in a process also called ‘angiogenesis.’ Consequently, the wound is ‘rebuilt’ and healed faster than the usual rate.(1)"
            },
            {
                "p": "BPC-157 has also been studied in correlation to gastrointestinal function. Serotonin, an enteric neurotransmitter, is localized in the GI tract and GI mucosa. Altered serotonin levels may inhibit gastric acid secretion, affecting gut mucosal function and influencing gastric blood flow.(2) BPC-157 appears to have a particular antidepressant activity, which may counteract serotonin-induced action. The peptide may counteract the 5-HT2A receptors, restricting the serotonin binding with these receptors and thereby inhibiting its action.(3) The peptide has been researched for its potential action across diverse functions, including tissue repair, pain perception, gastrointestinal regulation, and tendon, ligament, muscle, and bone cell reparations."
            },
            {
                "p": "Multiple studies have since been conducted to understand the full action of the peptide, especially in the area of healing gastrointestinal ulceration, which is elaborated on below. Studies have suggested the peptide may increase the build-up of the blood vessels and induce anti-inflammation potential via improving functional recovery.(4)"
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C62H98N16O22 Molecular Weight: 1419.55 g/mol Other Known Titles: Body Protection Compound-157"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "BPC-157 Peptide and Wound Healing"
            },
            {
                "p": "In a study, three experimental murine models were used – first with skin tissue wounds, second with colon tissue anastomosis, and third with synthetic sponge implantation. A portion of the murine models were presented with a placebo, whereas others were presented with the BPC 157 peptide. After the study, all models were histologically examined. The researchers reported that the BPC-157 murine models appeared to exhibit higher numbers of collagen, reticulin, and blood vessel development than the ones in the control group.(5)"
            },
            {
                "p": "In a particular study, researchers explored the theory that the peptide BPC-157 might potentially hasten wound healing compared to a control group. This hypothesis was rooted in observing possible improvements in several key areas of wound healing. These included the formation of new granulation tissue, which is critical in the healing process, along with reepithelialization. In this process, new epithelial cells form to replace those damaged by the wound. Additionally, there was an observation of potential improvements in dermal remodeling, a phase where the skin regains strength and elasticity, and collagen deposition, crucial for tissue repair.(6)"
            },
            {
                "p": "The study also suggested that BPC-157 might have enhanced the expression of vascular endothelial growth factor (VEGF) in the injured skin tissues. VEGF is a significant protein that promotes blood vessel growth, vital to healing damaged tissues. The researchers further speculated that the peptide could have influenced umbilical vein endothelial cell proliferation (HUVECs). These cells line the blood vessels and are considered to be integral to forming new blood vessels during wound healing.(6)"
            },
            {
                "p": "Additionally, there was a conjecture about a noticeable increase in the migration of HUVECs. This observation was based on results from wound healing assays, tests designed to measure various aspects of wound healing. The presence of BPC-157 might have led to an increased expression of VEGF-a, a variant of VEGF, and consequently accelerated the formation of vascular tubes in a laboratory setting. Moreover, the study hinted at the possibility that BPC-157 might influence the activity of specific proteins and enzymes involved in cellular signaling pathways. Specifically, it seemed that BPC-157 could regulate the phosphorylation level of extracellular signal-regulated kinases 1 and 2 (ERK1/2). Phosphorylation is a process that activates or deactivates many protein enzymes and is a crucial step in sending signals within cells. The affected enzymes, ERK1/2, along with their downstream targets, including c-Fos, c-Jun, and Egr-1, are believed to play significant roles in cell growth, migration, and angiogenesis, which is the development of new blood vessels.(6)"
            },
            {
                "h3": "BPC-157 Peptide and Tendon Healing"
            },
            {
                "p": "An experiment was conducted in the cultured tendon fibroblasts derived from the tendons of murine models. The cultures were divided into two groups; one was the control, whereas the other was presented with the peptide. Following the study, the following was reported:(1)"
            },
            {
                "p": "Upon analysis, it was suggested that the peptide may impact tendon healing, tendon outgrowth, and cell survival via the F-actin formation and activation of the FAK and paxillin pathways.(1) F-actin formation is considered a key component in the cell's cytoskeleton, providing structure and aiding in cell movement. If BPC-157 enhances F-actin formation, this might indicate an improvement in the cytoskeletal organization and cell motility of tendon fibroblasts, which are essential for the repair and regeneration of tendon tissues. Further into the study, researchers utilized Western blotting, a laboratory method to detect specific proteins in a sample. Through this analysis, they suggested that BPC-157 might activate focal adhesion kinase (FAK) and paxillin, two proteins that play a significant role in cellular processes. The tentative finding was that the phosphorylation levels of FAK and paxillin appeared to increase in the presence of BPC-157. Interestingly, the total amounts of these proteins appeared to have remained unchanged, leading to the speculation that BPC-157's role might be more about activating existing molecules rather than increasing their production. This led to a further hypothesis that BPC-157 might activate the FAK-paxillin pathway. This pathway is considered to promote cell migration and adhesion, especially in tendon fibroblasts. The activation of this pathway could imply that BPC-157 plays a role in enhancing the movement and adherence of these cells, which are key processes in tendon healing and regeneration."
            },
            {
                "h3": "BPC-157 Peptide and Gastrointestinal Healing"
            },
            {
                "p": "A study was conducted to scrutinize the action of BPC-157 peptide against similar angiogenic growth factors such as EGF, FGF, and VEGF. The primary assumptions were that BPC-157 is highly stable, biocompatible, and sufficient to exert action when presented by itself. While the study reported improved healing, only BPC-157 appeared to have exhibited consistent results in all wound types (i.e., chronic and acute) on the esophagus, stomach, duodenum, and lower GI tract. This study suggested the extent of the angiogenic potential of the peptide is apparently very high as it appeared to extend not only on local wounds and ligaments but also on GI wounds and bone healing.(7)"
            },
            {
                "h3": "BPC-157 Peptide and Tissue Damage"
            },
            {
                "p": "A study was conducted to understand the extent of the angiogenic potential of the peptide beyond local wounds, ligaments, and GI tract wounds and to study its action on multiple gastrointestinal lesions on the pancreas, liver injuries, heart damage, endothelium damage, and blood pressure. Following the results, scientists suggested that the BPC-157 peptide may induce a network of activities via peptidergic defense systems. There is also a possibility that BPC-157 may play a role in addressing both acute and chronic inflammation, aiding in wound healing, and assisting in the healing of fractures, including cases of pseudoarthrosis. This broad spectrum of potential suggests that BPC-157 could be part of the organism's unique peptidergic defense system.(8)"
            },
            {
                "p": "There are several neurotransmitters and functions considered by scientists to be important, such as dopamine, nitrous oxide, prostaglandin, and other neuron systems. Any over-activity or inhibition of these systems may lead to lesions in different organs. BPC-157, through its defense system, appears to counteract these systems and possibly reverse their over-activation and inhibition. The researchers commented that these might include important systems, ”namely, dopamine-, NO-, prostaglandin-, somatosensory neuron-system,” and more.(8)"
            },
            {
                "h3": "BPC-157 Peptide and Muscle Healing"
            },
            {
                "p": "A study was conducted on murine models with injured gastrocnemius muscle complex. These murine models were then presented with methylprednisolone (corticosteroid). These corticosteroid murine models were then divided into two groups: one was presented with BPC-157, and the other was presented with a placebo. Both compounds were presented once in 24 hours and examined on days 1, 2, 4, 7, and 14. Upon examination, it was reported that the corticosteroid appeared to significantly worsen the muscle damage in the murine models. However, BPC-157 appeared to exhibit apparent signs of healing and restoration of the damaged gastrocnemius muscle and restoring functioning ability.(9)"
            },
            {
                "h3": "Amphetamine-Induced Hypersensitivity"
            },
            {
                "p": "Laboratory experiments have suggested that the BPC-157 peptide may have the ability to heal multiple different lesions – in the GI tract, liver, pancreas, and others. This trend in lab findings indicated that the peptide had some interaction with the dopamine system. To investigate further, this study presented the BPC-157 peptide in amphetamine (dopamine agonist) murine models. It was observed that BPC-157 appeared to be able to reverse the amphetamine-induced excitability in the murine models. Furthermore, murine models were presented with another dopamine agonist, haloperidol, and then presented with amphetamine on days 1, 2, 4, and 10. These murine models were then presented with BPC-157 to illustrate its action. Upon examination, it was suggested by the researchers that the peptide appeared to cause an almost complete reversal of the haloperidol action.(10)"
            },
            {
                "h3": "BPC-157 Peptide and Central Nervous System"
            },
            {
                "p": "In a particular study using a murine model, researchers explored the potential of BPC-157 in the context of traumatic brain injury (TBI). BPC-157 might have played a role in significantly reducing the damage caused by TBI in experimental models, as indicated by improved early outcomes in the experiments conducted. During the critical 24-hour period following the injury, the observations hinted a minimal mortality rate in the BPC-157 group. Furthermore, the severity of traumatic lesions typically associated with TBI, such as subarachnoid hemorrhage (bleeding in the space between the brain and the tissues that cover it), intraventricular hemorrhage (bleeding inside the brain's ventricular system), brain laceration, and hemorrhagic laceration, appeared to be less pronounced in the murine models of the BPC-157 group. This suggested a protective potential of the peptide against such injuries.(11)"
            },
            {
                "p": "Another interesting observation was the considerable improvement in brain edema, swelling in the brain tissue often caused by traumatic injuries. The hypothesis extended to the possibility that if BPC-157 were introduced before the occurrence of TBI, it might show an improved ratio of conscious/unconscious/death states in the test subjects. In other words, the peptide might potentially prevent or reduce the severity of unconsciousness and lower mortality rates associated with TBI in experimental models. Moreover, there was a suggestion that the immediate exposure of BPC-157 immediately before the injury may have mitigated the damage in the murine models subjected to a force impulse, typically used to simulate TBI in research. This hinted at the possibility of the peptide having preventive or protective potential against the immediate consequences of traumatic brain injury in experimental models.(11)"
            },
            {
                "p": "BPC 157 peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Chang, Chung-Hsun et al. “The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration.” Journal of applied physiology (Bethesda, Md. : 1985) vol. 110,3 (2011): 774-80. doi:10.1152/japplphysiol.00945.2010. https://pubmed.ncbi.nlm.nih.gov/21030672/",
                    "Ormsbee, H S 3rd, and J D Fondacaro. “Action of serotonin on the gastrointestinal tract.” Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) vol. 178,3 (1985): 333-8. doi:10.3181/00379727-178-42016. https://pubmed.ncbi.nlm.nih.gov/3919396/",
                    "Sikiric, Predrag et al. “Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications.” Current neuropharmacology vol. 14,8 (2016): 857-865. doi:10.2174/1570159x13666160502153022. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333585/#r1",
                    "Krivic, A., Majerovic, M., Jelic, I. et al. Modulation of early functional recovery of Achilles tendon to bone unit after transection by BPC 157 and methylprednisolone. Inflamm. res. 57, 205–210 (2008). https://doi.org/10.1007/s00011-007-7056-8",
                    "S Seiwerth, et al. “BPC 157's effect on healing.” Journal of physiology, Paris vol. 91,3-5 (1997): 173-8. doi:10.1016/s0928-4257(97)89480-6. https://pubmed.ncbi.nlm.nih.gov/9403790/",
                    "Huang, T., Zhang, K., Sun, L., Xue, X., Zhang, C., Shu, Z., Mu, N., Gu, J., Zhang, W., Wang, Y., Zhang, Y., & Zhang, W. (2015). Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro. Drug design, development and therapy, 9, 2485–2499. https://doi.org/10.2147/DDDT.S82030",
                    "Seiwerth, Sven et al. “BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing.” Current pharmaceutical design vol. 24,18 (2018): 1972-1989. doi:10.2174/1381612824666180712110447. https://pubmed.ncbi.nlm.nih.gov/29998800/",
                    "Sikiric P. (1999). The pharmacological properties of the novel peptide BPC 157 (PL-10). Inflammopharmacology, 7(1), 1–14. https://doi.org/10.1007/s10787-999-0022-z https://pubmed.ncbi.nlm.nih.gov/17657443/",
                    "Pevec D, Novinscak T, Brcic L, Sipos K, Jukic I, Staresinic M, Mise S, Brcic I, Kolenc D, Klicek R, Banic T, Sever M, Kocijan A, Berkopic L, Radic B, Buljat G, Anic T, Zoricic I, Bojanic I, Seiwerth S, Sikiric P. Impact of pentadecapeptide BPC 157 on muscle healing impaired by systemic corticosteroid application. Med Sci Monit. 2010 Mar;16(3):BR81-88. PMID: 20190676. https://pubmed.ncbi.nlm.nih.gov/20190676/",
                    "Jelovac, N et al. “A novel pentadecapeptide, BPC 157, blocks the stereotypy produced acutely by amphetamine and the development of haloperidol-induced supersensitivity to amphetamine.” Biological psychiatry vol. 43,7 (1998): 511-9. doi:10.1016/s0006-3223(97)00277-1. https://pubmed.ncbi.nlm.nih.gov/9547930/",
                    "Tudor, M., Jandric, I., Marovic, A., Gjurasin, M., Perovic, D., Radic, B., Blagaic, A. B., Kolenc, D., Brcic, L., Zarkovic, K., Seiwerth, S., & Sikiric, P. (2010). Traumatic brain injury in mice and pentadecapeptide BPC 157 effect. Regulatory peptides, 160(1-3), 26–32. https://doi.org/10.1016/j.regpep.2009.11.012",
                    "Gwyer, D., Wragg, N.M. & Wilson, S.L. Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell Tissue Res 377, 153–159 (2019). https://doi.org/10.1007/s00441-019-03016-8",
                    "Veljaca, Marija et al, The development of PL 14736 for treatment of inflammatory bowel disease, Advanced in GI pharmacology, 2002 O-32. https://www.bib.irb.hr/192824",
                    "Phase I clinical trial in healthy volunteers to study safety and pharmacokinetics of BPC-157, a pentadecapeptide from gastric source. https://clinicaltrials.gov/ct2/show/NCT02637284?"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/12/BPC-157-5MG-COA.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/12/BPC-157-5MG-LC.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/12/BPC-157-5MG-MS.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "BPC-157 for sale online (5mg / 10mg). Offering peptides at 99% purity with top customer service. Discover BPC 157 research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "BPC-157 For Sale (5mg / 10mg) | Core Peptides",
            "og:description": "BPC-157 for sale online (5mg / 10mg). Offering peptides at 99% purity with top customer service. Discover BPC 157 research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/bpc-157/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-05-28T11:02:34+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/BPC-157.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "BPC-157 For Sale (5mg / 10mg) | Core Peptides",
            "twitter:description": "BPC-157 for sale online (5mg / 10mg). Offering peptides at 99% purity with top customer service. Discover BPC 157 research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/BPC-157.jpg",
            "twitter:label1": "Availability",
            "twitter:data1": "In stock",
            "product:brand": "Core Peptides",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-BPC157",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/melanotan-1-10mg/",
                "name": "Melanotan 1 (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Melanotan-1-10MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/receptor-grade-igf-1-lr3-100mcg/",
                "name": "Receptor Grade IGF-1 LR3 (100mcg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-100MCG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/pt-141-10mg-bremelanotide/",
                "name": "PT-141 (Bremelanotide) (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/PT-141-10mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/melanotan-2-10mg/",
                "name": "Melanotan 2 (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2023/03/Melanotan-2-10MG-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "id": "15",
        "url": "https://www.corepeptides.com/peptides/b7-33-6mg/",
        "name": "B7-33 (6mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2022/01/B7-33.jpg",
        "display_price": "$60.00",
        "display_specs": [
            "Size: 6mg Contents: B7-33 (6mg) Form: Lyophilized powder Purity: >99% SKU: P-B733-6",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$57.00"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$54.00"
            }
        ],
        "description": [
            {
                "h2": "B7-33 Peptide"
            },
            {
                "p": "H2-relaxin is a naturally occurring, endogenous protein compound, which was synthetically mimicked and named the “B7-33” peptide. The H2-relaxin protein class comprises relaxin, H3-relaxin, insulin-like peptide-3, and insulin-like peptide-5. All these proteins have been suggested to exhibit a variety of biological actions, including possibly affecting genetic functions and the reproductive, musculoskeletal, and cardiovascular systems.(2) Considered structurally similar to H2-relaxin, the synthetic equivalent B7-33 may possess anti-fibrotic potential."
            },
            {
                "p": "There are four different receptors that these naturally produced relaxin proteins are speculated to bind with, namely RXFP-1, RXFP-2, RXFP-3, and RXFP-4. Each receptor has a different action, as outlined below:(2)"
            },
            {
                "p": "Due to the variety of receptors involved and a wide range of biological impact, extensive research has been conducted on the relaxin protein and its analogs, such as the B7-33 peptide, to fully understand their potential."
            },
            {
                "h3": "Overview"
            },
            {
                "p": "B7-33 is a singular chain peptide, a smaller analogous derivative of the endogenous relaxin protein.(3) Typically, the relaxin peptide comprises four components - a signal peptide, B chain, C chain, and COOH terminal. Several studies were conducted initially to replicate these peptide structures, however the researchers reported that results indicated it being highly insoluble and inactive. After extensive subsequent research, scientists modified the structure by producing a B chain and elongating the COOH terminal, thereby forming the first-ever soluble analog - B7-33 peptide - in 2016.(3)"
            },
            {
                "p": "Besides the structural difference, the peptide has other variations from the endogenous protein. B7-33 peptide has been suggested to act via the pERK pathway instead of the cAMP pathway. The pERK pathway is a signaling route within cells that may affect cell function, often related to cell growth and survival. In contrast, the cAMP pathway involves different cellular activities primarily related to energy balance and metabolism. H2-relaxin has been suggested to produce antifibrotic potential via the cAMP pathway, which may stimulate tumor formation.(1) Furthermore, the peptide may have a strong affinity towards the RXFP-1 receptors. The peptide appears to bind with these RXFP-1 receptors, stimulating the pERK pathway, which then may lead to increased synthesis of MMP-2 matrix metalloproteinase chemicals. MMP-2 is an enzyme that breaks down proteins and plays a crucial role in tissue remodeling and repair. These chemicals then possibly inhibit the scarring of tissues, thereby preventing fibrosis.(1) Fibrosis is considered the formation of excess fibrous connective tissue in an organ or tissue in a reparative or reactive process, which is associated with a loss of function."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C131H228N40O37S Molecular Weight:2987,75 g/mol Other Known Titles: (B7-33)H2, GTPL9321"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "B7-33 Peptide and Vasoprotection"
            },
            {
                "p": "This 2017 study(4) was conducted on male Wistar murine models where their tails were presented with a control compound (which was sodium acetate), H2 relaxin, or B7-33 peptide. After three hours, these mice were examined for their vascular functions, mainly in the mesenteric artery, renal artery, and abdominal aorta. While the results were not as promising in the renal artery and abdominal aorta, B7-33 and H2 relaxin exhibited potential vasodilatory properties in the mesenteric artery. Thus, the results suggest that both B7-33 and serelaxin may preferentially augment bradykinin-induced endothelium-dependent relaxation, particularly emphasizing the mesenteric artery in rats. This augmentation appears to be linked to enhanced endothelium-derived hyperpolarization."
            },
            {
                "p": "To understand better, the researchers reported an additional study(4) carried out in female murine models experimentally induced with endothelial dysfunction. These mice were then either given B7-33 or H2 relaxin. Following the study, the researchers suggested that both compounds may have helped combat and prevent the further spread of endothelial dysfunction in mice. These results suggest that B7-33 has the potential to replicate the vasoprotective action of H2 relaxin and thereby protect blood vessels from further damage."
            },
            {
                "h3": "B7-33 Peptide and Preeclampsia"
            },
            {
                "p": "Preeclampsia is a pregnancy ailment characterized by increased hypertension in mothers and decreased fetal weight. This clinical study(5) was conducted to understand the potential of B7-33 peptide in pregnant females with preeclampsia. A cell culture of cytotrophoblasts (CTBs) was used. Cytotrophoblasts are the cells found in the inner cellular layer of the embryo. These cells were given either control compound, a marinobufagenin steroid, or glucose for two days. Following this preparation, some of these cells were given either a relaxin antagonist, or the B7-33 compound. Upon examination, the cells given B7-33 peptide appeared to exhibit an upregulation of the vascular endothelial growth factor, VEGF. Cells that were given relaxin antagonists exhibited apparent reduced VEGF concentration. VEGF is thought to stimulate the proliferation and migration of endothelial cells, which line the interior surfaces of blood vessels. By potentially enhancing these processes, VEGF may play a vital role in forming new vascular structures, essential for supplying tissues with oxygen and nutrients, especially during rapid growth or healing periods. VEGF's actions are primarily mediated through two tyrosine kinase receptors, VEGFR-1 and VEGFR-2, located on the surface of endothelial cells. The binding of VEGF to these receptors is thought to trigger a cascade of signaling pathways that could lead to endothelial cell proliferation, migration, and survival."
            },
            {
                "h3": "B7-33 Peptide and Anti-Fibrosis"
            },
            {
                "p": "Studies(6)(7) have suggested that when presented with a fully extended strain of H2 relaxin protein, it may induce an increased heart rate and possibly stimulate the spread of carcinogenic cells. This is mainly attributed to its mechanism as it appears to activate the cAMP pathway. Hence, researchers are looking for a derivative that might produce the exact biological action of anti-fibrosis without cAMP activation. When the peptide was exposed in mice with myocardial infarction, it was reported to result in almost 50% reduction in cardiac tissue fibrosis."
            },
            {
                "p": "Furthermore, a study(1) was also conducted in mice with prostate diseases. These mice were presented with two different concentrations of B7-33 peptide. At both concentrations, the results were the same, and researchers suggested that the compound might contribute to the development of fibrosis without promoting the spread of prostate tumors. This suggested that the peptide may have the potential to act via the pERK pathway and not via cAMP activation. The designation \"pERK\" refers to the phosphorylated state of extracellular signal-regulated kinase (ERK), indicating its activated status. It is hypothesized that the activation pathway initiates when a growth factor interacts with its corresponding receptor on the cellular surface, potentially activating the receptor's intrinsic kinase capabilities. This interaction is believed to initiate a sequence of phosphorylation events, transmitting the signal through a network of intermediary proteins, such as RAF and MEK (MAPK/ERK kinase). This sequence is thought to ultimately result in the phosphorylation and subsequent activation of ERK. Following activation, it is suggested that ERK translocates to the nucleus where it may phosphorylate various transcription factors, potentially leading to changes in gene expression that might influence cellular processes, including division and differentiation."
            },
            {
                "h3": "B7-33 Peptide as a Coating Material"
            },
            {
                "p": "In one animal study(8), a peptide-coated device was implanted in murine models. The researchers were curious to see if the peptide might counteract possible fibrotic actions in the mice. As a result of this peptide release from the device coating, the reduction in device thickness (by fibrosis) was reported to be decreased by 49.2% over the 6-week duration of the study."
            },
            {
                "p": "B7-33 peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Mohammed Akhter Hossain et al, A single-chain derivative of the relaxin hormone is a functionally selective agonist of the G protein-coupled receptor, RXFP1, Drug Discovery Biology Pharmacology Monash Biomedicine Discovery Institute, Vol 7, 2016.",
                    "R J Summers, Recent progress in the understanding of relaxin family peptides and their receptors, British Journal of Pharmacology, Vol 174, issue 10, pg 915-920. https://doi.org/10.1111/bph.13778",
                    "Nitin A Patil et al, Relaxin family peptides: structure–activity relationship studies, British Pharmacological Society, vol 174 issue 10, published 06 December 2016. https://doi.org/10.1111/bph.13684",
                    "Marshall SA, O'Sullivan K, Ng HH, Bathgate RAD, Parry LJ, Hossain MA, Leo CH. B7-33 replicates the vasoprotective functions of human relaxin-2 (serelaxin). Eur J Pharmacol. 2017 Jul 15;807:190-197. doi: 10.1016/j.ejphar.2017.05.005. Epub 2017 May 3. PMID: 28478069. https://pubmed.ncbi.nlm.nih.gov/28478069/",
                    "S.H Afroze et al, Abstract P3042: Novel Peptide B7-33 and It's Lipidated Derivative Protect Cytotrophoblasts From Preeclampsia Phenotype in a Cellular Model of the Syndrome, 4 Sep 2019. https://doi.org/10.1161/hyp.74.suppl_1.P3042",
                    "Silvertown JD, Ng J, Sato T, Summerlee AJ, Medin JA. H2 relaxin overexpression increases in vivo prostate xenograft tumor growth and angiogenesis. Int J Cancer. 2006 Jan 1;118(1):62-73. https://pubmed.ncbi.nlm.nih.gov/16049981",
                    "Shu Feng, Irina U. Agoulnik, Natalia V. Bogatcheva, Aparna A. Kamat, Bernard Kwabi-Addo, Rile Li, Gustavo Ayala, Michael M. Ittmann and Alexander I. Agoulnik, Relaxin Promotes Prostate Cancer Progression, March 2007. https://clincancerres.aacrjournals.org/content/13/6/1695",
                    "N.Welch et al, Coatings Releasing the Relaxin Peptide Analogue B7-33 Reduce Fibrotic Encapsulation, ACS Applied Materials and Interfaces, Nov 2019. www.researchgate.net/publication/337205944_Coatings_Releasing_the_Relaxin_Peptide_Analogue_B7-33_Reduce_Fibrotic_Encapsulation"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/12/B7-33-COA-1.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/12/B7-33-LC-1.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/12/B7-33-MS-1.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "B7-33 peptide for sale online (6mg). Peptides for sale at 99% purity with top customer service. Get B7-33 research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "B7-33 For Sale (6mg) - Core Peptides",
            "og:description": "B7-33 peptide for sale online (6mg). Peptides for sale at 99% purity with top customer service. Get B7-33 peptide research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/b7-33-6mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-04-25T14:57:37+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2022/01/B7-33.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "B7-33 For Sale (6mg) - Core Peptides",
            "twitter:description": "B7-33 peptide for sale online (6mg). Peptides for sale at 99% purity with top customer service. Get B7-33 research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2022/01/B7-33.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$60.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:brand": "Core Peptides",
            "product:price:amount": "60.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-B733-6",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/mgf-5mg/",
                "name": "MGF (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/MGF-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/adipotide-10mg/",
                "name": "Adipotide (FTPP) (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Adipotide-FTPP-10MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/pt-141-10mg-bremelanotide/",
                "name": "PT-141 (Bremelanotide) (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/PT-141-10mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/peg-mgf-5mg/",
                "name": "PEG-MGF (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/PEG-MGF-5MG-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "id": "16",
        "url": "https://www.corepeptides.com/peptides/ara-290-16mg/",
        "name": "ARA-290 (16mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2021/12/ARA-290-16mg.jpg",
        "display_price": "$92.00",
        "display_specs": [
            "Size: 16mg Contents: ARA-290 (16mg) Form: Lyophilized powder Purity: >99% SKU: P-ARA290-16",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$87.40"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$82.80"
            }
        ],
        "description": [
            {
                "h2": "ARA-290 Peptide"
            },
            {
                "p": "ARA-290 peptide, also known as cibinetide and helix B surface peptide (HBSP) in scientific literature, is an 11 amino acid chain derived from the beta domain of the naturally-occurring protein erythropoietin (EPO). This part of the EPO sequence is considered to assist in tissue regeneration and repair without exerting stimulus on the production of red blood cells.(1) Scientists consider the primary function of the EPO is to stimulate tissues to produce red blood cells. Still, the beta domain of the protein, and consequently ARA-290, do not appear to possess this property. Instead, they may possess certain potential regenerative, anti-inflammatory, anti-nociceptive, and other lesser-known properties of the original naturally occurring EPO protein."
            },
            {
                "h3": "Overview"
            },
            {
                "p": "Scientific findings(2) thus far suggest that once a tissue undergoes an injury, a tissue-protective receptor (TPR) pathway may be activated. This TPR receptor mainly consists of a beta receptor unit (CD131) and a subunit from the EPO receptor, jointly called the innate repair receptor. Researchers have suggested that the ARA-290 peptide molecule may bind to this innate repair receptor and possibly attenuate nerve and allodynia-led pain (nociception).(3) It is also suggested that the ARA-290 peptide may act primarily via this IRR-mediated pathway."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C51H54N16O21 Molecular Weight: 1257.3 g/mol Other Known Titles: PH-BSP"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "ARA-290 Peptide and Nociception"
            },
            {
                "p": "Scientists consider that Transient Receptor Potential (TRP) channels may be the primary nociceptive stimulating channels, including possible thermal, chemical, and mechanical stimuli. In the presence of such a causative agent, one of the TRP channels, namely TRPV1, may be triggered. Upon activation, it might induce the ejection of neuropeptides, which then are considered to generate action potential in the nervous systems. This action potential is referred to as \"nociception.\"(4) A 2016 study(5) suggested that ARA-290 peptide may have the potential to increase the threshold of this TRPV1 channel, with researchers further implying that the peptide might inhibit the TRPV1 actions and thereby no neuropeptides will be released to spark a nociceptive response. The researchers conducted a study with a C57/BL6 strain of murine models to investigate this hypothesis. They took neurons from two areas of the murine nervous system, the dorsal root ganglion, and the trigeminal ganglion, and studied them using calcium imaging. This involved the introduction of a special dye to the cells that lights up when calcium is present and then examining them under a special microscope. The experiment measured how these neurons potentially reacted to three substances: ARA-290, capsaicin (the compound that makes chili peppers hot), and KCl (a common chemical compound that can be used as a control). The researchers were particularly interested in whether ARA-290 could reduce the reaction of the neurons to capsaicin. They also did some direct tests on the murine models. One test measured how potentially sensitive the murine models' appendages were to nociception. They used different concentrations of ARA-290 or a control solution on the murine models' hind appendages. Then, they exposed them to capsaicin to see if it made them potentially more sensitive to nociception. They used a tool to apply pressure to the appendages and measured the point at which the murine models pulled their appendages away. Another test checked how often the murine models withdrew their appendages over 24 hours after exposure to capsaicin. Here, the researchers were evaluating whether giving the murine models ARA-290 after the capsaicin may have affected their sensitivity to nociception. Thus, the findings suggested that ARA-290 might specifically block the reaction of neurons to capsaicin without affecting other types of heat sensors. This may suggest that ARA-290 targets specifically the TRPV1 channels and might potentially increase the amount of capsaicin needed to activate these channels. ARA-290 is still being actively studied for its possible role in nociception \"mitigation\". However, researchers have also developed hypotheses about its other potential mechanisms of action, such as potential anti-inflammatory and possible immunomodulatory impact."
            },
            {
                "h3": "ARA-290 Peptide and Retinal Ischemia"
            },
            {
                "p": "A recent study(6) has suggested that ARA-290 may have the potential to protect the endothelial blood vessels and possibly thereby combat retinal ischemia in models of ischemic retinopathies. A possible mitigation method for retinal ischemia is the restoration of endothelial colony-forming cells (ECFC) in the retinal tissue. This study explored the potential of ARA-290 in reducing the current pro-inflammatory conditions in the ischemic retina and its potential effects on vascular regeneration aided by ECFCs. Experimental murine models induced with retinal ischemia underwent ECFC cell transplantation for this study. To determine the potential of the peptide, transplantation in some murine models occurred in the presence of ARA-290 while the rest was in the absence of peptides. Experimental investigations were conducted to assess the impact of ARA-290 on the survival mechanisms and functionality within ECFC (Endothelial Colony-Forming Cell) cultures. The research suggested that ARA-290 might potentially initiate survival pathways and improve cell survival in ECFCs under oxidative stress caused by H2O2. The study aimed to determine the effectiveness of ECFC transplantation in promoting vascular repair in the retinal area of mice, utilizing the oxygen-induced retinopathy (OIR) model for this purpose. The research compared the effects of transplanting ECFCs with and without ARA-290. Additionally, the study examined the inflammatory cytokine profile and microglia activation, which may act as markers of inflammation. Preliminary results indicated that introducing ECFCs with EPO or ARA-290 before transplantation did not appear to significantly enhance their ability to repair blood vessels in the ischemic retina. However, the systemic introduction of ARA-290 in OIR mice seemed to lower the levels of pro-inflammatory cytokines like IL-1β and TNF-α in the retinal tissue, hinting at its possible anti-inflammatory properties. The introduction of ECFCs into the vitreous humor of the eye led to their integration into the impaired retinal blood vessels and seemed to notably reduce the area without blood vessels. Notably, ARA-290 appeared to enhance the vaso-reparative capacity of the ECFCs, a result not observed with EPO. After the study, it was suggested by the researchers that the peptide exhibited a reduction in the inflammatory expression of interleukin cells in the retina. The scientists commented that: “regulation of the pro-inflammatory milieu of the ischemic retina can be enhanced by ARA290 and may be a useful [research agent] to ECFC-based cell [procedures] for ischemic retinopathies.”"
            },
            {
                "h3": "ARA-290 Peptide and Inflammatory Cytokine Cells"
            },
            {
                "p": "One study(7) was conducted to determine whether the erythropoietin analog, ARA-290 peptide, may possess anti-inflammatory and cell protective potential. More specifically, the researchers investigated the potential of the peptide in pancreatic islet transplantation (PITx) models, which typically demonstrates limited success due to islet damage that occurs during isolation and from the severe inflammatory reactions caused by the transplantation procedure. In this study,(7) experimental murine models, which underwent transplantation intervention for 180+ pancreatic islet cells, were used. The murine models were introduced to the ARA-290 peptide right before, at 0, 6, and 24 hours after intervention. After 12 hours of peptide presence, the liver samples from the murine models were collected and analyzed. Peptide cells appeared to exhibit minimal damage to the islets. The researchers indicated that the peptide may have protected the islet cells from cytokines and subsequent apoptosis. More precisely, the scientists commented that “ARA-290 protected islets from cytokine-induced damage and apoptosis. Secretion of pro-inflammatory cytokines (IL-6, IL-12, and TNF-α) from macrophages was significantly inhibited by ARA-290.” The findings indicated that ARA-290 might potentially maintain the functionality of cultured islets under the stress of proinflammatory cytokines. This hypothesis is supported by observed reductions in caspase 3/7 activity, suggesting a protective effect against apoptosis triggered by cytokines. Additionally, ARA-290 appeared to diminish the production of proinflammatory cytokines in the liver following pancreatic islet transplantation, hinting at its possible role in mitigating inflammatory responses within the liver. Further delving into ARA-290's potential mode of action, it is believed to engage the EPOR-βcR complex, apparently initiating a cascade of signaling events. EPOR-βcR is a complex formed by the erythropoietin receptor (EPOR) and the beta-common receptor (βcR). It plays a key role in cellular signaling, particularly in response to certain growth factors and cytokines. These events might inhibit the transcription of proinflammatory genes and promote cellular survival. It is theorized that this process could involve the activation of the PI3K-Akt and JAK2-STAT5 pathways (pathways with essential roles in cell growth, survival, and metabolism), along with a reduction in NF-κB-mediated gene transcription (proinflammatory pathways that can lead to cell damage and death). ARA-290's interaction with the heightened EPOR-βcR complex typically upregulated in response to cell or tissue damage, is also of interest. Ultimately, the scientists commented that “ARA 290 protected pancreatic islets from cytokine-induced damage and apoptosis and ameliorated the inflammatory response” in these experimental models. Thus, the researchers concluded that this interaction may potentially shield islets against the detrimental effects of proinflammatory cytokines, which might be released by activated macrophages or as a result of the transplantation procedure itself."
            },
            {
                "h3": "ARA-290 Peptide and Tissue Protection"
            },
            {
                "p": "Based on the available research(8), the ARA-290 peptide is considered to have potential binding capacity to TPRs, which may assist in maintaining the function of the tissues protecting against harmful inflammation and subsequent cellular and tissue death. Researchers have posited the main potential of ARA-290 peptide over the endogenous erythropoietin cells to bind TPR receptor cells without further cardiovascular or muscular impact.(8) This potential of the peptide may help improve tissue regeneration and reduce tissue damage, possibly promoting better wound recovery and healing and decreasing the formation of scars in experimental murine models."
            },
            {
                "h3": "ARA-290 Peptide and Immunomodulation via TPR Pathway"
            },
            {
                "p": "Scientists posit that the TPR pathway, once stimulated, may express on various immunological cells, including macrophages. With the potential of ARA-290 peptide to bind with the TPR receptor cells, it may restrict the release of certain inflammatory molecules such as interleukin-6 (IL-6). Owing to a reduced secretion, it may lead to reduced severity of immuno-compromising conditions. (8)"
            },
            {
                "h3": "ARA-290 Peptide and Immunomodulation via Adaptive Immunity"
            },
            {
                "p": "Research(8) has suggested that ARA-290 peptide may potentially alter the presentation of antigens by the dendritic cells, thereby possibly altering adaptive immunity in test models. Owing to the peptide's potential to \"fine tune\" the immune cells, they may not reject transplanted bodies, potentially leading to successful transplantation experiments in laboratory models."
            },
            {
                "p": "ARA-290 peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "What is Erythropoietin? Home Health Network. https://www.hormone.org/your-health-and-hormones/glands-and-hormones-a-to-z/hormones/erythropoietin",
                    "Brines M, Cerami A. The receptor that tames the innate immune response. Mol Med. 2012 May 9;18(1):486-96. https://pubmed.ncbi.nlm.nih.gov/22183892/",
                    "Dahan, A., Dunne, A., Swartjes, M., Proto, P. L., Heij, L., Vogels, O., van Velzen, M., Sarton, E., Niesters, M., Tannemaat, M. R., Cerami, A., & Brines, M. (2013). ARA 290 improves symptoms in patients with sarcoidosis-associated small nerve fiber loss and increases corneal nerve fiber density. Molecular medicine (Cambridge, Mass.), 19(1), 334–345. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883966/",
                    "Jara-Oseguera, A., Simon, S. A., & Rosenbaum, T. (2008). TRPV1: on the road to pain relief. Current molecular pharmacology, 1(3), 255–269. https://doi.org/10.2174/1874467210801030255",
                    "Zhang W, Yu G, Zhang M. ARA 290 relieves pathophysiological pain by targeting TRPV1 channel: Integration between immune system and nociception. Peptides. 2016 Feb;76:73-9. https://pubmed.ncbi.nlm.nih.gov/26774587/",
                    "O'Leary OE, Canning P, Reid E, Bertelli PM, McKeown S, Brines M, Cerami A, Du X, Xu H, Chen M, Dutton L, Brazil DP, Medina RJ, Stitt AW. The vasoreparative potential of endothelial colony-forming cells in the ischemic retina is enhanced by cibinetide, a non-hematopoietic erythropoietin mimetic. Exp Eye Res. 2019 May;182:144-155. https://pubmed.ncbi.nlm.nih.gov/30876881/",
                    "Watanabe M, Lundgren T, Saito Y, Cerami A, Brines M, Östenson CG, Kumagai-Braesch M. A Nonhematopoietic Erythropoietin Analogue, ARA 290, Inhibits Macrophage Activation and Prevents Damage to Transplanted Islets. Transplantation. 2016 Mar;100(3):554-62. https://pubmed.ncbi.nlm.nih.gov/26683514/",
                    "Peng, B., Kong, G., Yang, C. et al. Erythropoietin and its derivatives: from tissue protection to immune regulation. Cell Death Dis 11, 79 (2020). https://doi.org/10.1038/s41419-020-2276-8"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/09/ARA-290-coa.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/09/ARA-290-lc.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/09/ARA-290-ms.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "ARA-290 peptide for sale. Offering peptides for sale at 99+% purity with unmatched service, bulk purchase discounts & Free shipping",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "ARA-290 For Sale (16mg) - Core Peptides",
            "og:description": "ARA-290 peptide for sale. Offering peptides for sale at 99+% purity with unmatched service, bulk purchase discounts & Free shipping",
            "og:url": "https://www.corepeptides.com/peptides/ara-290-16mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-05-22T21:34:04+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2021/12/ARA-290-16mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "ARA-290 For Sale (16mg) - Core Peptides",
            "twitter:description": "ARA-290 peptide for sale. Offering peptides for sale at 99+% purity with unmatched service, bulk purchase discounts & Free shipping",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2021/12/ARA-290-16mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$92.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:brand": "Core Peptides",
            "product:price:amount": "92.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-ARA290-16",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/receptor-grade-igf-1-lr3-100mcg/",
                "name": "Receptor Grade IGF-1 LR3 (100mcg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-100MCG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/adipotide-10mg/",
                "name": "Adipotide (FTPP) (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Adipotide-FTPP-10MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/dsip-5mg/",
                "name": "DSIP (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/DSIP-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ipamorelin-5mg/",
                "name": "Ipamorelin (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Ipamorelin-5MG-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "id": "17",
        "url": "https://www.corepeptides.com/peptides/vip-6mg/",
        "name": "VIP (6mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2022/01/VIP-6mg.jpg",
        "display_price": "$64.00",
        "display_specs": [
            "Size: 6mg Contents: VIP (6mg) Form: Lyophilized powder Purity: >99% SKU: P-VIP-6",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$60.80"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$57.60"
            }
        ],
        "description": [
            {
                "h2": "VIP Peptide"
            },
            {
                "p": "Vasoactive Intestinal Peptide, or VIP, is a short peptide hormone composed of 28 amino acid residues found naturally in both peripheral and central nervous systems.(1) Researchers speculate that the apparently wide distribution of the peptide indicates its pleiotropic potential as a neurotransmitter, vasodilator, and possibly as an immune regulator and secretagogue.(1)"
            },
            {
                "p": "VIP has a vast spectrum of potential, including but not limited to neuromodulation and neurotransmission functions. Given the wide range of its possible relevance in various research contexts, VIP has been of immense interest among researchers for further exploration.(2)(3)"
            },
            {
                "h3": "Overview"
            },
            {
                "p": "Scientists posit that the VIP peptide binds with three types of G protein-coupled receptors, namely VPAC1, VPAC2, and PAC1. Upon binding with these receptors, the pathway associated with adenylate cyclase (key regulatory enzyme) may be activated, possibly resulting in biological activity.(4) The primary difference between the three receptors is their localization. Research indicates that VPAC1 is mainly expressed in the brain and peripheral areas, such as the liver, lungs, intestine, and immune cells, whereas VPAC2 is expressed in the central nervous system and other peripheral areas such as the pancreas, heart, kidney, skeletal muscles, gastrointestinal and reproductive tract, and PAC1 is predominant in the brain and adrenal region.(4) Owing to the wide distribution of the receptors, researchers suggest that VIP and receptor binding might affect different targets in the central and peripheral system (depending on receptor location)."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C147H237N43O43S Molecular Weight: 3326.8 g/mol Other Known Titles: PHM27, Vasoactive intestinal polypeptide"
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "VIP Peptide and Inflammation"
            },
            {
                "p": "Research(5) has suggested that VIP, which appears to be produced directly by immune cells themselves, exhibits various potential immunological actions to maintain an equilibrium of the immune system. Several studies have suggested that VIP possesses anti-inflammatory potential in both innate (hereditary) immunity and adaptive (acquired) immunity. In innate immunity, VIP has been posited to inhibit the synthesis of inflammatory chemicals such as cytokines and chemokines, while in adaptive immunity, VIP may inhibit responses of the inflammatory Th1-type cells and may promote Th2-type cell responses. Due to its potential to reduce Th1-type inflammatory cell actions, VIP may improve intestinal immunity and decrease inflammation.(6)"
            },
            {
                "p": "One study explored the potential interactions between VIP and inflammation within the context of necrotizing enterocolitis (NEC), primarily using murine models. VIP, lauded for its potential anti-inflammatory characteristics, might regulate intestinal epithelial barrier integrity and homeostasis. The research posits that the decreased expression of VIP-ergic neurons in the NEC-affected ileum may be linked to heightened inflammation and compromised barrier function. In this experimental setup, NEC was induced in neonatal C57BL/6 murine models between postnatal days 5 and 9. The study measured NEC severity, intestinal inflammation markers like IL-6 and TNFα, and the expression of tight junction proteins such as Claudin-3. The results indicated that VIP mRNA expression and immunoactivity appeared substantially reduced in NEC models compared to controls. Exogenous VIP apparently reduced NEC severity and decreased the levels of proinflammatory cytokines IL-6 and TNFα in the NEC + VIP group compared to the NEC group alone. This suggests that VIP might have a role in moderating inflammatory responses. Furthermore, the research suggested that VIP might help preserve tight junction integrity. Specifically, Claudin-3 expression, considered crucial for tight junction function and intestinal barrier integrity, was enhanced in the NEC + VIP group relative to the NEC group alone. This finding implies a potential mechanism by which VIP might maintain barrier function amidst inflammatory conditions."
            },
            {
                "h3": "VIP Peptide and the Blood Brain Barrier"
            },
            {
                "p": "The blood-brain barrier (BBB) and blood-spinal barrier (BSB) are considered a crucial part of the nervous system, providing cellular protection to the tissues and blood vessels of the central nervous system. The blood-brain barrier appears to filter everything from oxygen to nutrition factors, which may potentially enter these neurological vessels and affect immune function. Compromise of the blood-brain barrier may lead to severe physiological impacts. Research has suggested that VIP may exhibit some neuroprotective potential, which might support proper maintenance of the blood-brain barrier.(9) VIP is possibly involved in several functions, such as neurotransmission, vasodilation, and immune modulation. By activating adenylate cyclase (AC), VIP may play a pivotal role in the production of cyclic adenosine monophosphate (cAMP), a regulator of immune responses, including those involving regulatory T cells (Tregs). The disruption of these functions due to autoimmune reactions against VIP or its receptors might potentially lead to increased permeability of the BBB and BSB, commonly referred to as \"leakiness,\" which may facilitate further autoimmune events. This may result in exacerbated neuroinflammatory and neurodegenerative processes. The Virchow-Robin spaces (VRS), perivascular areas surrounding small vessels in the central nervous system, are particularly noted for their contributions to the integrity of the BBB and BSB. These spaces may contain receptors for VIP and are involved in modulating immune responses. Autoimmune responses targeting these receptors may impair the function of the BBB and BSB, hence the potential role of VIP in their preservation. This is currently under investigation in several experimental models of neurodegeneration.(10)(11)"
            },
            {
                "h3": "VIP Peptide and Cardiac Fibrosis"
            },
            {
                "p": "The pathophysiology of cardiac fibrosis is considered to have a high association with angiotensinogen receptors and angiotensinogen converting enzymes (ACE), both of which may lead to vascular inflammation. Research(12) has suggested that VIP peptide may promote some reduction in these angiotensinogen expressions – possibly similar in action to ACE inhibitor compounds. As a result, VIP may mitigate cardiac fibrosis and possibly reverse heart muscle scarring. This is also posited based on observations that lower VIP concentrations correspond with increased fibrosis and are nearly undetectable in end-stage cardiomyopathy. To probe this association further, the study experimented with VIP introduced to murine models on a high-salt diet and assessed changes in myocardial VIP levels, fibrosis quantification via histomorphometry, and the expression of pro-fibrotic mediators through quantitative rt-PCR. Findings suggested that VIP-exposed murine models may have exhibited significantly higher myocardial VIP levels than controls, alongside notably lower fibrosis metrics. Not all pro-fibrotic mediators were impacted by VIP infusion; that stated, significant reductions in angiotensinogen (Agt) and angiotensin receptor type 1a (AT1a) mRNA expression were noted, indicating a potential downregulation of the renin-angiotensin system—a key pathway implicated in fibrotic processes. The study cautiously infers that the observed decrease in myocardial fibrosis may be attributed, at least in part, to the downregulation of key components of the renin-angiotensin system, moderated by elevated VIP levels. This hypothesis aligns with the noted decreases in Agt and AT1a mRNA expression post-VIP exposure. However, the mechanisms through which VIP may exert these actions remain uncertain and warrant further investigation. Moreover, while VIP appeared to influence some pro-fibrotic mediators, it did not appear to alter others, such as TGFβ, TNFα, CTGF, and NFκB, suggesting that the anti-fibrotic actions of VIP might be selective or mediated through alternative pathways not examined in this study."
            },
            {
                "h3": "VIP and Behavioral Responses in Animals"
            },
            {
                "p": "Studies(13) have suggested that VIP neurons may be activated when animals process behavioral responses. Activating the VIP neurons in the hypothalamus region may also trigger the secretion of prolactin hormones, which is considered the primary trigger of behaviors such as affiliation, gregariousness, pair bonding, and aggression. More specifically, it appears that VIP and its associated VPAC receptors, which are distributed across both hypothalamic and extrahypothalamic regions, may ultimately result in its potential on various behavioral and reproductive functions. Further, VIP's influence on prolactin (PRL) secretion is linked to various reproductive behaviors across different experimental models, as changes in VIP levels within the hypothalamus closely mirror fluctuations in plasma PRL levels corresponding to different reproductive stages. This suggests that VIP might have a role in modulating behaviors preparatory to offspring care. Moreover, VIP's role in circadian rhythm regulation, particularly through its interactions in the suprachiasmatic nucleus (SCN), where it modulates the activity of GABAergic cells, highlights its importance in the synchronization of biological rhythms. These include the potential timing of ovulation and responses to photoperiod changes, which might be crucial for understanding seasonal reproduction patterns in both mammals and birds. The study also delves into VIP’s roles in social behavior networks, indicating that VIP might influence behaviors such as aggression and pair bonding through itsinteractions with other neuropeptides, including oxytocin and vasopressin, in these networks. Intriguingly, the study posits that VIP’s interaction with these neuropeptides might modulate responses to social and environmental stressors, potentially affecting an animal’s social dynamics and behaviors. In terms of aggression, VIP is thought to potentially alter aggressive behaviors, as indicated in studies where manipulation of VIP levels in the hypothalamic regions appeared to have influenced aggressive responses in certain avian species. This action may also be mediated through the interactions of VIP with other signaling molecules within key areas of the brain known to regulate aggression. The full role of VIP in behavioral responses is still under exploration."
            },
            {
                "p": "VIP peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Delgado, M., & Ganea, D. (2013). Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions. Amino acids, 45(1), 25–39. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883350/",
                    "Iwasaki, M., Akiba, Y., & Kaunitz, J. D. (2019). Recent advances in vasoactive intestinal peptide physiology and pathophysiology: focus on the gastrointestinal system. F1000Research, 8, F1000 Faculty Rev-1629. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743256/",
                    "Welsh, D. K., Takahashi, J. S., & Kay, S. A. (2010). Suprachiasmatic nucleus: cell autonomy and network properties. Annual review of physiology, 72, 551–577. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758475/",
                    "Vosko, A. M., Schroeder, A., Loh, D. H., & Colwell, C. S. (2007). Vasoactive intestinal peptide and the mammalian circadian system. General and comparative endocrinology, 152(2-3), 165–175. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1994114/",
                    "Gonzalez-Rey E, Delgado M. Role of vasoactive intestinal peptide in inflammation and autoimmunity. Curr Opin Investig Drugs. 2005 Nov;6(11):1116-23. https://pubmed.ncbi.nlm.nih.gov/16312132/",
                    "Seo S, Miyake H, Alganabi M, Janssen Lok M, O'Connell JS, Lee C, Li B, Pierro A. Vasoactive intestinal peptide decreases inflammation and tight junction disruption in experimental necrotizing enterocolitis. https://pubmed.ncbi.nlm.nih.gov/31668399/",
                    "Chorny A, Gonzalez-Rey E, Delgado M. Regulation of dendritic cell differentiation by vasoactive intestinal peptide: therapeutic applications on autoimmunity and transplantation. Ann N Y Acad Sci. 2006 Nov;1088:187-94. https://pubmed.ncbi.nlm.nih.gov/17192565/",
                    "Chorny, A., Gonzalez-Rey, E., Fernandez-Martin, A., Pozo, D., Ganea, D., & Delgado, M. (2005). Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders. Proceedings of the National Academy of Sciences of the United States of America, 102(38), 13562–13567. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1224633/",
                    "Staines DR, Brenu EW, Marshall-Gradisnik S. Postulated vasoactive neuropeptide immunopathology affecting the blood-brain/blood-spinal barrier in certain neuropsychiatric fatigue-related conditions: A role for phosphodiesterase inhibitors in treatment? Neuropsychiatr Dis Treat. 2009;5:81-9. Epub 2009 Apr 8. PMID: 19557103; PMCID: PMC2695238. https://pubmed.ncbi.nlm.nih.gov/19557103/",
                    "Mosley RL, Lu Y, Olson KE, Machhi J, Yan W, Namminga KL, Smith JR, Shandler SJ, Gendelman HE. A Synthetic Agonist to Vasoactive Intestinal Peptide Receptor-2 Induces Regulatory T Cell Neuroprotective Activities in Models of Parkinson's Disease. Front Cell Neurosci. 2019 Sep 18;13:421. https://pubmed.ncbi.nlm.nih.gov/31619964/",
                    "Solés-Tarrés, I., Cabezas-Llobet, N., Vaudry, D., & Xifró, X. (2020). Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide Against Cognitive Decline in Neurodegenerative Diseases. Frontiers in cellular neuroscience, 14, 221. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380167/",
                    "Karen A. Duggan, George Hodge, Juchuan Chen, Tegan Hunter, Vasoactive intestinal peptide infusion reverses existing myocardial fibrosis in the rat, European Journal of Pharmacology, Volume 862, 2019, 172629, ISSN 0014-2999. https://www.sciencedirect.com/science/article/pii/S0014299919305813",
                    "Kingsbury MA. New perspectives on vasoactive intestinal polypeptide as a widespread modulator of social behavior. Curr Opin Behav Sci. 2015 Dec 1;6:139-147. https://pubmed.ncbi.nlm.nih.gov/26858968/",
                    "Domschke, S., Domschke, W., Bloom, S. R., Mitznegg, P., Mitchell, S. J., Lux, G., & Strunz, U. (1978). Vasoactive intestinal peptide in man: pharmacokinetics, metabolic and circulatory effects. Gut, 19(11), 1049–1053. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1412244/"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/09/VIP-6MG-coa.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/09/VIP-6MG-lc.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/09/VIP-6MG-ms.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "VIP peptide for sale online (6mg). Peptides for sale at 99+% purity with unmatched service, Bulk purchase discounts & Free shipping from Core.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "VIP Peptide For Sale (6mg) - Core Peptides",
            "og:description": "VIP peptide for sale online (6mg). Peptides for sale at 99+% purity with unmatched service, Bulk purchase discounts & Free shipping from Core.",
            "og:url": "https://www.corepeptides.com/peptides/vip-6mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T16:27:05+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2022/01/VIP-6mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "VIP Peptide For Sale (6mg) - Core Peptides",
            "twitter:description": "VIP peptide for sale online (6mg). Peptides for sale at 99+% purity with unmatched service, Bulk purchase discounts & Free shipping from Core.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2022/01/VIP-6mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$64.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:brand": "Core Peptides",
            "product:price:amount": "64.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-VIP-6",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/melanotan-2-10mg/",
                "name": "Melanotan 2 (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2023/03/Melanotan-2-10MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/epitalon-25mg/",
                "name": "Epithalon (25mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Epithalon-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/receptor-grade-igf-1-lr3-100mcg/",
                "name": "Receptor Grade IGF-1 LR3 (100mcg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-100MCG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ghk-cu-50mg-copper/",
                "name": "GHK-Cu (Copper) (50mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHK-CU-50mg-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "id": "18",
        "url": "https://www.corepeptides.com/peptides/vilon-20mg/",
        "name": "Vilon (20mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2022/11/Vilon-20MG.jpg",
        "display_price": "$74.00",
        "display_specs": [
            "Size: 20mg Contents: Vilon (20mg) Form: Lyophilized powder Purity: >99% SKU: P-Vilon",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$70.30"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$66.60"
            }
        ],
        "description": [
            {
                "h2": "Vilon Peptide"
            },
            {
                "p": "Vilon is a dipeptide composed of amino acids lysine and glutamic acid. It also goes by the name 'Lysylglutamic Acid or Lysylglutamate.'(1) It is the shortest peptide suggested to possess potential action in the immune system, possibly mitigate cancer cell proliferation, and potentially induce anti-aging action within cells, possibly working on tissues within the liver, heart, and kidney. Vilon appears to exert its potential by possible interaction with the chromatin structure."
            },
            {
                "p": "Vilon peptide research has also led to the postulating of several research hypotheses, including that the peptide may act to unroll chromatin structures, that it may activate ribosomal genes stimulating the synthetic process, that it may release inactive genes, and that it may not decondense the chromatin situated on each side of the centromere of the chromosome. Through its potential action on the chromatin, Vilon may possibly alter DNA structure to reactivate the genes and cells that have gone 'silent.'"
            },
            {
                "h3": "Overview"
            },
            {
                "p": "Considered a bioregulator peptide, researchers speculate that Vilon may potentially support functions within the immune system, including in immunocompromised animal models. Researchers suggest Vilon may activate the interleukin-2 protein in spleen cells, which is considered critical in maintaining immune function.(3) It may stimulate the organism to fight against microbial infection and foreign bodies and prevent harmful autoimmune responses. Vilon has been suggested to activate white blood and spleen cells and potentially naturally boost the organism to protect against autoimmune elements."
            },
            {
                "p": "A study was conducted in 2002 with three bioregulatory peptides to study their potential on interleukin-2 mRNA synthesis in spleen cells. According to this study, “The intensity of interleukin-2 mRNA synthesis in splenocytes depended on the type, concentration, and duration of [exposure] with the peptides. Vilon and Epithalon were most potent, while Cortagen produced a less pronounced effect on interleukin-2 mRNA synthesis.”(3)"
            },
            {
                "p": "Furthermore, research suggests that Vilon peptides may possibly mitigate autoimmune action by interacting with the thymus gland. The thymus gland is considered responsible for the proliferation of T-helper cells, and with the help of the Vilon peptide, this proliferation may be further enhanced. As per N N Sevostianiva et al., the Vilon peptide is “considered as a bioactive substance possessing immunomodulator and antiallergic activity.” (4) The research indicates that there is a potential for Vilon to enhance the expression of the CD5 molecule in embryonic thymic cells. Specifically, the data revealed a tentative increase of 78% in the expression levels of CD5 in rat thymic cells and a 45% increase in embryonic thymic cells compared with the baseline levels in the control group. CD5 is a marker important in the development and maturation of T-cells in the thymus, an organ considered pivotal for the generation of immune cells. The study further hypothesizes that Vilon may influence the maturation process of thymic cells, potentially steering the development of T-cell precursors more toward becoming CD4+ T-helper cells. T-helper cells are deemed critical components of the adaptive immune system, aiding in the activation and direction of other immune cells."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular formula: C11H21N3O5 Molecular weight: 257.30g/mol Other known titles: Lysylglutamate, normophthal, Lysylglutamic acid"
            },
            {
                "p": " "
            },
            {
                "h2": "Vilon Research and Clinical Studies"
            },
            {
                "p": "Extended research has produced a wide variety of hypotheses speculating on the action of the Vilon peptide, some detailed below:"
            },
            {
                "h3": "Vilon Peptide and Cellular Lifespan"
            },
            {
                "p": "Vilon may potentially extend the average lifespan of certain animal models under laboratory conditions through an extension and mitigation of cell death. As stated above, Vilon has been suggested to exhibit potential in enhancing the immune system, improving physical endurance and energy levels, thereby possibly increasing average lifespan of animal test models.(5) Vilon is advised to study earlier in the test model lifespan rather than later for clearest possible action. Researchers hypothesize when a bioregulator like Vilon is exposed in vivo in lab models, it may only reverse 'silent' cells, exerting no apparent action on cells killed via apoptosis."
            },
            {
                "p": "In another experiment, researchers explored the potential of Vilon on spleen organotypic tissue cultures derived from murine models of differing ages. The findings from this investigation suggest that Vilon potentially influences the development of the explants.(6) Further research investigated research models where the peptide was introduced into the cultural medium of tissue explants derived from murine models at varying stages of development: 3 days, 3 weeks, and 2 years old. It was posited that Vilon induces morphological stability in the tissues while potentially activating both regeneration and functional activity of the cells involved. Interestingly, the results suggest that the impact of Vilon appeared to be more pronounced in explants from older murine models. This observation leads to the hypothesis that Vilon may have potential relevance in geriatric research, focusing on the mechanisms of cell aging and regeneration. The possibility that Vilon preferentially supports older tissues might be indicative of its role in modulating age-related cellular mechanisms or promoting stability in more senescent cells.(7)"
            },
            {
                "p": "Another study examined the actions of low amounts of ionizing radiation, which apparently leads to accelerated cell aging of the thymus and spleen in murine models. Vilon was tested for its potential to mitigate this accelerated cellular aging process. The researchers tentatively suggest that Vilon partially inhibited the pro-aging action induced by the radiation. This research posits that Vilon might be of interest in the field of geriatric research, potentially as an agent to manage or reduce the impacts of cell aging in critical immune organs post-radiation exposure. The study highlights Vilon’s potential role in preserving organ function in an irradiated environment, which may be crucial for developing strategies against radiation-induced degeneration in murine models.(8)"
            },
            {
                "h3": "Vilon Peptide and Carcinogenic Cells"
            },
            {
                "p": "Several studies suggest that peptide exhibits the potential to prevent some spread of carcinogenic cells by preventing the formation of new tumors, and potentially inhibiting existing tumors' growth.(9) Another study examined the potential of Vilon on the development of urinary bladder carcinogenesis in murine models exposed to N-butyl-N-(4-hydroxybutyl)nitrosamine (BBNA).(10) The experiment included a control group and a Vilon-exposed group. Each group began with 50 rats, all of which received BBNA. The primary observation was that the incidence of urinary bladder cancer cells was lower in the Vilon-exposed group compared to the control group. Specifically, cancer cells developed in 56% of the Vilon-exposed murine models versus 75.5% of the controls. This data possibly indicates that Vilon may have a moderating action on cancer cell development when exposed to BBNA. Further, the study noted a reduction in both the prevalence and severity of preneoplastic and early neoplastic changes in the urinary bladder mucosa in the Vilon-exposed murine models. In terms of morphological changes, the study reported fewer hyperplastic changes and lower malignancy rates in the Vilon group. There was a noticeable delay in the malignization of epithelial tissues in the Vilon group, suggesting a potential role of Vilon in modulating the rate or extent of tumor malignancy. Additionally, the average number of tumors per animal was lower in the Vilon group (1.5 tumors per rat) compared to the control group (2.6 tumors per rat), and the tumor cells in the Vilon-exposed rats appeared to manifest with a less aggressive growth pattern. The reduction in tumor aggressiveness and prevalence might indicate that Vilon has the potential to modulate the carcinogenic actions of BBNA. The findings suggest that Vilon, potentially acting as an immunomodulator, might inhibit the early stages of carcinogenesis as well as tumor progression in experimental models."
            },
            {
                "p": "One study contradicts this potential property of Vilon. According to this study, when used with chemotherapeutic agents derived from platinum ions, this peptide–platinum combination may be more harmful than helpful.(11) Unfortunately, since this study only considers one specific type of chemotherapeutic action, the results reported by researchers may be inconclusive."
            },
            {
                "h3": "Vilon Peptide and the Gastrointestinal Tract"
            },
            {
                "p": "Vilon peptide may act on gastrointestinal functionality by possibly enhancing the working mechanisms of certain enzymes in the gastrointestinal tract. By doing so, the peptide exhibits potential resistance towards GI-specific ailments, and may reduce leaky bowels in animal models.(12) Acting on the small intestinal muscles, Vilon peptide may ameliorate glucose accumulation and glycine absorption.(13)"
            },
            {
                "h3": "Vilon Peptide and Gene Expression"
            },
            {
                "p": "Upon presenting the Vilon peptide, researchers have suggested it exhibits potential to alter the gene expression of 36 genes in the heart. When presented with Epitalon, this number was reported as 144 genes. This suggests the peptide's possible action on genetic expression in the cardiac system, possibly impacting hemodynamic actions.(14)"
            },
            {
                "h3": "Vilon Peptide and Fibrinolysis"
            },
            {
                "p": "Researchers suggested in one study that Vilon exhibits the potential to stimulate fibrinolysis and increase the concentration of natural anticoagulants in the organsim, namely antithrombin III and protein C. It was also suggested to reduce insulin levels and possibly regulate the metabolism of carbohydrates.(15) This suggests a possible interplay between Vilon's actions on coagulation and glucose regulation, although the mechanisms behind this interaction are not fully elucidated in the study. Furthermore, the study posits that Vilon may have a stabilizing impact on the immune system. This is inferred from changes in various immune cell types and immunoglobulins; notably, a reduction in T-helpers, T-dependent and non-T-dependent NK cells, and a normalization in the levels of active T-lymphocytes, B-lymphocytes, and IgA. Such findings suggest that Vilon may modulate both innate and adaptive immune responses, which may be crucial for overall immune homeostasis."
            },
            {
                "p": "Further, Vilon is suggested to increase the permeability of mesenteric microvessels in the vascular system. As per N. Gavrisheva et al., these results indicate that “the preparation produces a potent homeostatic effect in the early period of chronic renal failure.”(16)"
            },
            {
                "p": "Vilon peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "National Center for Biotechnology Information (2022). PubChem Compound Summary for CID 7010502, Lysylglutamic acid. Retrieved November 21, 2022 from https://pubchem.ncbi.nlm.nih.gov/compound/Lysylglutamic-acid",
                    "Lezhava T, Khavison V, Monaselidze J, Jokhadze T, Dvalishvili N, Bablishvili N, Barbakadze S. Bioregulator Vilon-induced reactivation of chromatin in cultured lymphocytes from old people. Biogerontology. 2004;5(2):73-9. https://pubmed.ncbi.nlm.nih.gov/15105581/",
                    "Kazakova TB, Barabanova SV, Khavinson VKh, Glushikhina MS, Parkhomenko EP, Malinin VV, Korneva EA. In vitro effect of short peptides on expression of interleukin-2 gene in splenocytes. Bull Exp Biol Med. 2002 Jun;133(6):614-6. https://pubmed.ncbi.nlm.nih.gov/12447482/",
                    "Sevostianova NN, Linkova NS, Polyakova VO, Chervyakova NA, Kostylev AV, Durnova AO, Kvetnoy IM, Abdulragimov RI, Khavinson VH. Immunomodulating effects of Vilon and its analogue in the culture of human and animal thymus cells. Bull Exp Biol Med. 2013 Feb;154(4):562-5. English, Russian. https://pubmed.ncbi.nlm.nih.gov/23486604/",
                    "Khavinson VK, Anisimov VN, Zavarzina NY, Zabezhinskii MA, Zimina OA, Popovich IG, Shtylik AV, Malinin VV, Morozov VG. Effect of vilon on biological age and lifespan in mice. Bull Exp Biol Med. 2000 Jul;130(7):687-90. DOI: 10.1007/BF02682106. PMID: 11140587. https://pubmed.ncbi.nlm.nih.gov/11140587/",
                    "Bykov NM, Chalisova NI. Osobennosti deĭstviia ul'tramalykh doz vilona v organotipicheskoĭ kul'ture selezenki krys raznogo vozrasta [Characteristics of effect of ultralow doses of vilon in organotypic culture of spleens from rats of various ages]. Adv Gerontol. 2002;10:85-7. Russian. PMID: 12577696.",
                    "Kniaz'kin IV, Iuzhakov VV, Chalisova NI, Grigor'ev EI. Funktsional'naia morfologiia organotipicheskoĭ kul'tury selezenkoi krys razlichnogo vozrasta pri deĭstvii vilona [Functional morphology of organotypic culture of spleens from rats of various ages exposed to vilon]. Adv Gerontol. 2002;9:110-5. Russian. PMID: 12096432.",
                    "Kniaz'kin IV, Poliakova VO. Deĭstvie vilona na timus i selezenku v radiatsionnoĭ modeli prezhdevremennogo stareniia [The effect of vilon on the thymus and spleen in a radiation model of premature aging]. Adv Gerontol. 2002;9:105-9. Russian. PMID: 12096431.",
                    "Khavinson VKh, Anisimov VN. A synthetic dipeptide vilon (L-Lys-L-Glu) inhibits the growth of spontaneous tumors and increases the life span of mice. Dokl Biol Sci. 2000 May-Jun;372:261-3. PMID: 10944717. https://pubmed.ncbi.nlm.nih.gov/10944717/",
                    "Pliss GB, Mel'nikov AS, Malinin VV, Khavinson VK. Inhibitory effect of peptide vilon on the development of induced rat urinary bladder tumors in rats. Bull Exp Biol Med. 2001 Jun;131(6):558-60. doi: 10.1023/a:1012354603132. PMID: 11586406.",
                    "Barykina OP, Iuzhakov VV, Chalisova NI, Kvetnoĭ IM, Konovalov SS. Sochetannoe vliianie vilona i tsiklofosfana na transplanty opukholeĭ i éksplantaty limfoidnoĭ tkani mysheĭ i krys raznogo vozrasta [Combined effect of vilon and cyclophosphane on tumor transplants and lymphoid tissue explants in mice and rats of various age]. Adv Gerontol. 2003;12:128-31. Russian. PMID: 14743610. https://pubmed.ncbi.nlm.nih.gov/14743610/",
                    "Khavinson VKh, Timofeeva NM, Malinin VV, Cordova LA, Nikitina AA. Effect of vilon and epithalon on activity of enzymes in epithelial and subepithelial layers in small intestine of old rats. Bull Exp Biol Med. 2002 Dec;134(6):562-4. https://pubmed.ncbi.nlm.nih.gov/12660839/",
                    "Khavinson VKh, Egorova VV, Timofeeva NM, Malinin VV, Cordova LA, Gromova LV. Effect of Vilon and Epithalon on glucose and glycine absorption in various regions of small intestine in aged rats. Bull Exp Biol Med. 2002 May;133(5):494-6. https://pubmed.ncbi.nlm.nih.gov/12420071/",
                    "Anisimov SV, Bokheler KR, Khavinson VKh, Anisimov VN. Studies of the effects of Vilon and Epithalon on gene expression in mouse heart using DNA-microarray technology. Bull Exp Biol Med. 2002 Mar;133(3):293-9. https://pubmed.ncbi.nlm.nih.gov/12360356/",
                    "Kuznik BI, Isakova NV, Kliuchereva NN, Maleeva NV, Pinelis IS. [Effect of vilon on the immunity status and coagulation hemostasis in patients of different age with diabetes mellitus]. Adv Gerontol. 2007;20(2):106-15. Russian. PMID: 18306698. https://pubmed.ncbi.nlm.nih.gov/18306698/",
                    "Gavrisheva NA, Malinin VV, Ses TP, Kozlov KL, Panchenko AV, Titkov AY. Effect of peptide Vilon on the content of transforming growth factor-beta and permeability of microvessels during experimental chronic renal failure. Bull Exp Biol Med. 2005 Jan;139(1):24-6. DOI: 10.1007/s10517-005-0202-9. PMID: 16142267. https://pubmed.ncbi.nlm.nih.gov/16142267/"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/12/Vilon-COA.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/12/Vilon-LC.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/12/Vilon-MS.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Vilon peptide for sale online (20mg). Peptides for sale at 99+% purity with unmatched service, Bulk purchase discounts and free shipping from Core.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Vilon For Sale (20mg) - Core Peptides",
            "og:description": "Vilon peptide for sale online (20mg). Peptides for sale at 99+% purity with unmatched service, Bulk purchase discounts and free shipping from Core.",
            "og:url": "https://www.corepeptides.com/peptides/vilon-20mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T16:35:23+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2022/11/Vilon-20MG.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Vilon For Sale (20mg) - Core Peptides",
            "twitter:description": "Vilon peptide for sale online (20mg). Peptides for sale at 99+% purity with unmatched service, Bulk purchase discounts and free shipping from Core.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2022/11/Vilon-20MG.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$74.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "74.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-Vilon",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/adipotide-10mg/",
                "name": "Adipotide (FTPP) (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Adipotide-FTPP-10MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/oxytocin-10mg/",
                "name": "Oxytocin (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Oxytocin-10mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/pt-141-10mg-bremelanotide/",
                "name": "PT-141 (Bremelanotide) (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/PT-141-10mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/bpc-157/",
                "name": "BPC-157 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/BPC-157-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "id": "19",
        "url": "https://www.corepeptides.com/peptides/vialox-pentapeptide-3v-topical-200mg/",
        "name": "Vialox (Pentapeptide-3V) (200mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2023/04/VIALOX-200mg.jpg",
        "display_price": "$176.00",
        "display_specs": [
            "Size: 200mg Contents: Vialox (Pentapeptide-3V) Form: Lyophilized powder Purity: >99% SKU: P-Vialox",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$167.20"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$158.40"
            }
        ],
        "description": [
            {
                "h2": "Vialox Peptide"
            },
            {
                "p": "Vialox, or pentapeptide-3, is a synthetic peptide molecule with the amino acid sequence GPRPA. It is believed to work by blocking neuronal nicotinic acetylcholine receptors located in the postsynaptic membrane of muscle cells. These receptors transmit signals from nerve cells to muscle cells, resulting in muscle contraction. By potentially reducing the release of acetylcholine, Vialox may relax muscles, reducing wrinkle depth and development along the skin barrier. The mechanism of action of Vialox may be similar to that of tubocurarine, a natural alkaloid compound considered to have muscle-relaxing activity."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C21H37N9O5 Molecular Weight: 495.58 g/mol Other Known Titles: Pentapeptide-3V, SCHEMBL1552457, HY-P0099, ZINC35922739"
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Vialox Peptide Mechanism of Action"
            },
            {
                "p": "Vialox is a synthetic peptide molecule suggested by researchers to be an inhibitor of neurotransmitter activity.(1) Vialox may act in a manner that is similar to that of tubocurarine, specifically through its interaction with acetylcholine receptors located on the postsynaptic membrane of muscle cells.(2) Tubocurarine is a naturally occurring alkaloid compound found in the bark of certain plants, particularly in the species Chondrodendron tomentosum, commonly known as \"curare.\" It is considered to be a potent neurotoxin that appears to act as a non-depolarizing neuromuscular blocker by blocking the action of acetylcholine at the neuromuscular junction, thereby preventing muscle contraction."
            },
            {
                "p": "Researchers also classify Vialox as a non-depolarizing neuromuscular blocker. The peptide appears to bind to the acetylcholine receptors on the postsynaptic membrane of muscle cells. By doing so, studies report that it acts as \"a competitive antagonist at the acetylcholine postsynaptic membrane receptor.\"(3)"
            },
            {
                "p": "The peptide may possibly interact with the neuronal nicotinic acetylcholine receptors. Nicotinic acetylcholine receptors reportedly play a crucial role in regulating muscle contraction by serving as the primary receptor in muscles for the communication between motor nerves and muscles at the neuromuscular junction."
            },
            {
                "p": "As an antagonist, Vialox appears to block the binding of acetylcholine to these receptor sites, thereby preventing the opening of the sodium ion channels responsible for depolarizing the cell and normally leading to muscle contraction.(4) By inhibiting the activity of the acetylcholine receptors, Vialox may cause the smooth muscles to stay relaxed, reducing wrinkles and fine lines in the skin."
            },
            {
                "h3": "Vialox Peptide and Wrinkle Development, Skin Texture"
            },
            {
                "p": "Vialox has been researched for its potential to reduce wrinkles upon the skin surface, and decrease texture variations along the skin barrier. There are some risks associated with using compounds to induce wrinkle reduction, particularly when used in higher concentrations or for extended periods. Furthermore, there is some concern that long-term exposure may have unknown or unanticipated impact. However, Vialox appears to have a short half-life and may be introduced less invasively. Nevertheless, it may be impactful, as researchers report that \"studies [...] showed that this [compound] softened wrinkles and reduced skin roughness(4)."
            },
            {
                "p": "These researchers reported that the tests appeared to result in reduced muscle contractions by 71% within one minute after Vialox presentation, leading to a 58% reduction two hours later. Ultimately, the scientists suggested that the reduced frequency of muscle contractions has the potential to result in shallower lines along the surface of the skin barrier."
            },
            {
                "p": "According to research, the peptide may also potentially mitigate the impact of skin wrinkles.(9) The results of the study indicate a noticeable decrease of 49% in the size of wrinkles, accompanied by a 47% decrease in the roughness of the skin within a time frame of 28 days of consistent presentation."
            },
            {
                "p": "Vialox peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Husein el Hadmed, H., & Castillo, R. F. (2016). Cosmeceuticals: peptides, proteins, and growth factors. Journal of cosmetic dermatology, 15(4), 514-519.",
                    "Lupo, M. P., & Cole, A. L. (2007). Cosmeceutical peptides. Dermatologic therapy, 20(5), 343-349.",
                    "Gorouhi, F., & Maibach, H. I. (2009). Role of peptides in preventing or treating aged skin. International journal of cosmetic science, 31(5), 327-345.",
                    "Satriyasa B. K. (2019). Botulinum toxin (Botox) A for reducing the appearance of facial wrinkles: a literature review of clinical use and pharmacological aspect. Clinical, cosmetic and investigational dermatology, 12, 223–228. https://doi.org/10.2147/CCID.S202919",
                    "Kalandakanond, S., & Coffield, J. A. (2001). Cleavage of SNAP-25 by botulinum toxin type A requires receptor-mediated endocytosis, pH-dependent translocation, and zinc. The Journal of pharmacology and experimental therapeutics, 296(3), 980–986.",
                    "Bakheit A. M. (2006). The possible adverse effects of intramuscular botulinum toxin injections and their management. Current drug safety, 1(3), 271–279. https://doi.org/10.2174/157488606777934431",
                    "Witmanowski, H., & Błochowiak, K. (2020). The whole truth about botulinum toxin - a review. Postepy dermatologii i alergologii, 37(6), 853–861. https://doi.org/10.5114/ada.2019.82795",
                    "Reddy, B. Y., Jow, T., & Hantash, B. M. (2012). Bioactive oligopeptides in dermatology: Part II. Experimental dermatology, 21(8), 569-575."
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "",
        "high_performance_liquid_chromatography": "",
        "mass_spectrometry": "",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Vialox (Pentapeptide-3V) for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Vialox (Pentapeptide-3V) For Sale (200mg) - Core Peptides",
            "og:description": "Vialox (Pentapeptide-3V) for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:url": "https://www.corepeptides.com/peptides/vialox-pentapeptide-3v-topical-200mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T16:18:30+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2023/04/VIALOX-200mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Vialox (Pentapeptide-3V) For Sale (200mg) - Core Peptides",
            "twitter:description": "Vialox (Pentapeptide-3V) for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2023/04/VIALOX-200mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$176.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "176.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-Vialox",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/selank-10mg/",
                "name": "Selank (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Selank-10MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/pt-141-10mg-bremelanotide/",
                "name": "PT-141 (Bremelanotide) (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/PT-141-10mg-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/hexarelin-5mg/",
                "name": "Hexarelin (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Hexarelin-5MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/receptor-grade-igf-1-lr3-1mg/",
                "name": "Receptor Grade IGF-1 LR3 (1mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-1MG-300x300.jpg.webp",
                "price": ""
            }
        ]
    },
    {
        "id": "20",
        "url": "https://www.corepeptides.com/peptides/vesugen-20mg/",
        "name": "Vesugen (20mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2023/11/Vesugen-Lys-Glu-Asp-20mg.jpg",
        "display_price": "$63.00",
        "display_specs": [
            "Size: 20mg Contents: Vesugen Form: Lyophilized powder Purity: >99% SKU: P-VESUGEN-20",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$59.85"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$56.70"
            }
        ],
        "description": [
            {
                "h2": "Vesugen Peptide"
            },
            {
                "p": "Vesugen, aka KED, is a bioregulator peptide and identified within the group of peptides isolated and synthesized by Russian scientist, Vladimir Khavinson. It is a tripeptide derived from a sequence of amino acids related to vascular wall proteins, encapsulating the amino acids lysine, glutamic acid, and aspartic acid. Vesugen is primarily known for its potential influence on vascular endothelial cells. Further, its potential extends to a wide array of biological processes, making it a viable research compound within the context of anti-aging and neuroprotection research. Primarily, Vesugen is recognized for its potential vasoprotective impacts, with a particular emphasis on its role in the maintenance and repair of vascular endothelial cells. These cells form the lining of blood vessels. In addition to its vascular implications, Vesugen has also been explored for its neuroprotective and geroprotective consequences. Studies have examined its effects on neuron survival and morphology, suggesting its possible role in combating neurodegenerative diseases and enhancing neuroplasticity."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular formula: C15H26N4O8 Molecular weight: 390.39 g/mol Sequence: Lys-Glu-Asp Other known titles: KED, lysyl glutamyl aspartic acid, SCHEMBL3767701"
            },
            {
                "p": " "
            },
            {
                "h2": "Vesugen Research and Clinical Studies"
            },
            {
                "p": "The information provided below synthesizes the latest insights from early-stage research regarding the capabilities of Vesugen, as demonstrated through a variety of experimental approaches."
            },
            {
                "h3": "Vesugen and Vasoprotective Potential"
            },
            {
                "p": "Vasugen may have vasoprotective potential, particularly relevant in the context of aging and vascular function. This potential is primarily attributed to its proposed ability to influence the behavior of vascular endothelial cells. The available research posits that Vesugen may exert vasoprotective action through the modulation of cell proliferation.(1) It is thought to do this by potentially regulating the expression of the Ki-67 protein, a marker that is closely associated with cellular proliferation. This protein's expression seemingly decreases as part of the natural aging process, affecting the vascular endothelium's ability to renew itself."
            },
            {
                "p": "Vesugen is hypothesized to interact with the promoter regions of the Ki-67 gene, potentially leading to increased expression of this protein. The possible impact of Vesugen on vascular endothelial cells includes the stimulation of cell proliferation. By potentially enhancing the expression of Ki-67, Vesugen might contribute to the maintenance or restoration of the integrity and function of the vascular endothelium. This may be particularly relevant in addressing age-related vascular function problems, including issues such as reduced proliferative capacity and the increasing prevalence of polyploid cells, which may contribute to vascular lesions and atherosclerosis. Moreover, the study suggests that Vesugen might interact with DNA at specific sites, influencing gene expression in a way that may favor vascular function. This interaction is thought to occur mainly in the minor groove of DNA, with Vesugen forming hydrogen bonds with specific DNA base pairs. Ultimately, the researchers concluded that the “vasoprotective effect of peptide vesugen ... could be realized through epigenetic regulation of Ki-67 gene expression.”"
            },
            {
                "p": "The presumed mechanism underlying its potential effects of Vesugen may involve the epigenetic regulation of genes thought to code for proteins that serve as markers of endothelial functional activity, crucial in cardiovascular function. In vitro investigations into Vesugen's impact on endothelial cells, particularly those impacted by atherosclerosis and restenosis, suggest that it may help normalize the expression of endothelin-1.(2) This molecule's expression typically rises in atherosclerotic and restenotic conditions, suggesting that Vesugen could possibly play a role in addressing these pathologies. Moreover, Vesugen appears to potentially aid in restoring cellular interactions, possibly through its influence on connexin expression. Connexins are vital for cell-to-cell communication, which is essential for maintaining endothelial integrity and function. An additional aspect of Vesugen's potential action is its apparent geroprotective effect, potentially achieved by increasing the expression of sirtuin1, a protein involved in DNA repair. This increase in sirtuin1 expression might be significant for cardiovascular function, as it may contribute to the mitigation of damage at the genetic level."
            },
            {
                "h3": "Vesugen and Neuroprotective Potential"
            },
            {
                "p": "Investigation into Vesugen’s neuroprotective potential within the context of neurodegeneration has elaborated on the apparent impact of the peptide on neuroplasticity and neuron morphology in murine models simulating certain neurodegeneration conditions.(3) A key aspect of this research was the examination of long-term potentiation (LTP) in the hippocampus, a crucial area for memory and learning. The neurodegenerated murine models showed a trend toward impaired neuroplasticity compared to wild-type murine models, particularly after high-frequency stimulation of Schaffer’s collaterals. However, this observed impairment in neuroplasticity was not statistically significant, suggesting only a subtle action."
            },
            {
                "p": "The exposure to the Vesugen peptide in these murine models suggested a potential to restore LTP, suggesting a role in enhancing neuroplasticity. Despite this positive suggestion, the action of the Vesugen peptide on restoring LTP also did not reach statistical significance, leaving its impact as a promising yet unconfirmed hypothesis. Furthermore, the study delved into the action of Vesugen peptide on neuron morphology, specifically focusing on the dendritic spine density in the CA1 region of the hippocampus. This area is vital for synaptic connections and is notably affected in neurodegeneration. The research found that the introduction of the Vesugen peptide helped prevent the elimination of postsynaptic structures in CA1 neurons of the neurodegeneration murine models. Interestingly, the most pronounced action of Vesugen was observed in the restoration of mushroom and thin spines, which are critical for synaptic strength and memory. This finding aligns with literature data on spine balancing in neurodegeneration progression, suggesting a modulatory action of Vesugen on spine morphology. Moreover, the study noted sex-related differences in the neuroprotective action of Vesugen peptide in neurodegeneration murine models. In male models, Vesugen peptide significantly increased dendritic spine density and restored mushroom spine numbers, suggesting a gender-specific response in neuroprotective action. The authors commented that the neuroprotective potential of Vesugen and similar peptides is “defined by their ability to prevent dendritic spine elimination and neuroplasticity impairments at the molecular epigenetic level.”"
            },
            {
                "p": "Another trial aimed to investigate the mechanisms behind the potential of Vesugen in addressing neurodegenerative conditions.(4) The primary focus was on its influence on gene expression and protein synthesis, which are crucial in processes like apoptosis, aging, neurogenesis, and, more specifically, neurodegeneration. Experimental findings, coupled with published reports, suggest that Vesugen may play a role in regulating the expression of genes associated with cell aging and apoptosis, such as р16 and р21. These genes are pivotal in determining the lifespan of cells and their programmed death, which are critical factors in neurodegenerative diseases. Moreover, Vesugen appears to affect genes and proteins that are involved in neuronal differentiation, such as NES (Nestin) and GAP43. Nestin is a type of intermediate filament protein potentially involved in the structural support of cells, particularly in the early stages of development in the nervous system. GAP43, on the other hand, is a protein that may play a key role in axonal growth during neural development and in the regeneration of neurons. The modulation of these genes and proteins by Vesugen might be integral in fostering neurogenesis, a process that may be beneficial in countering neurodegenerative processes. Furthermore, the peptide seems to interact with genes implicated in the pathogenesis of neurodegeneration. These include SUMO, APOE, and IGF1. SUMOylation, a post-translational modification involving the SUMO protein, is known to be involved in a variety of cellular processes, including transcriptional regulation, DNA repair, and protein stability – all of which are critical in the context of neurodegeneration. APOE, or apolipoprotein E, has been extensively studied for its role in lipid metabolism and its significant association with neurodegenerative diseases. Lastly, IGF1, or Insulin-like Growth Factor 1, is a hormone crucial for brain development and is thought to have neuroprotective properties."
            },
            {
                "h3": "Vesugen and Geroprotective Potential"
            },
            {
                "p": "Vesugen may potentially influence the behavior of prostatic fibroblasts, particularly concerning the expression of certain differentiation factors. This potential was observed in contexts where these cells exhibited signs of aging, suggested by reduced expression of differentiation markers in late-passage cultures.(5) Specifically, Vesugen is posited to stimulate the expression of CXCL12 and WEGC1 in these prostatic fibroblasts. CXCL12, also known as stromal cell-derived factor 1 (SDF-1), is a chemokine, a type of signaling protein. It is primarily indentified for its potential in the immune system, where it may aid in the regulation of immune cell movement. CXCL12 may also be involved in other biological processes, such as hematopoiesis (the formation of blood cellular components) and angiogenesis (the formation of new blood vessels). Its significance in cellular signaling may extend to influencing cell migration and activation, although the full scope of its actions and interactions in various tissues is still a subject of ongoing research. WEGC1, on the other hand, is less extensively studied, and its role is not as clearly defined in the literature. It might be involved in cellular differentiation processes, particularly in specific types of cells like fibroblasts. The exact functions of WEGC1, including how it influences cell behavior and interacts with other cellular components, are areas that require more detailed exploration. Its identification in studies concerning cellular aging and differentiation, such as those involving Vesugen, suggests that it could have a role in these processes, but the extent and nature of this role are yet to be fully elucidated. Most notably, the potential of Vesugen seemed to be more pronounced in aged cultures. This suggests, albeit with a degree of uncertainty, that Vesugen might exhibit geroprotective action, potentially supporting the maintenance or rejuvenation of cellular functions that decline with age."
            },
            {
                "p": "Clinical research has also aimed to explore Vesugen's potential in modifying biological age markers, a key aspect of aging, and thus its geroprotective potential.(6) Vesugen reportedly exhibited a notable anabolic effect, which is linked to improved activity in the central nervous system and other vital organs. This action was associated with a potential slowing of the aging process according to biological age indicators. An interesting aspect of the study was the observation of prooxidant activity through chemiluminescence. This suggests that Vesugen may induce some oxidative processes. Additionally, there was a reported decrease in CD34+ positive hematopoietic polypotent cells in the blood, suggesting a potential inhibition of hemopoiesis. This finding suggests these cells might not be actively involved in adaptive reactions during the appreciation of Vesugen."
            },
            {
                "p": "Vesugen peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Khavinson, V. K.h, Tarnovskaia, S. I., Lin'kova, N. S., Guton, E. O., & Elashkina, E. V. (2014). Advances in gerontology = Uspekhi gerontologii, 27(1), 108–114.",
                    "Kozlov KL, Bolotov II, Linkova NS, Drobintseva AO, Khavinson VK, Dyakonov MM, Kozina LS. [Molecular aspects of vasoprotective peptide KED activity during atherosclerosis and restenosis]. Adv Gerontol. 2016;29(4):646-650. Russian. PMID: 28539025.",
                    "Khavinson V, Ilina A, Kraskovskaya N, Linkova N, Kolchina N, Mironova E, Erofeev A, Petukhov M. Neuroprotective Effects of Tripeptides-Epigenetic Regulators in Mouse Model of Alzheimer's Disease. Pharmaceuticals (Basel). 2021 May 27;14(6):515. doi: 10.3390/ph14060515. PMID: 34071923; PMCID: PMC8227791.",
                    "Khavinson VK, Lin'kova NS, Umnov RS. Peptide KED: Molecular-Genetic Aspects of Neurogenesis Regulation in Alzheimer's Disease. Bull Exp Biol Med. 2021 May;171(2):190-193. doi: 10.1007/s10517-021-05192-6. Epub 2021 Jun 26. PMID: 34173097.",
                    "Khavinson VKh, Linkova NS, Polyakova VO, Kheifets OV, Tarnovskaya SI, Kvetnoy IM. Peptides tissue-specifically stimulate cell differentiation during their aging. Bull Exp Biol Med. 2012 May;153(1):148-51. doi: 10.1007/s10517-012-1664-1. PMID: 22808515.",
                    "Meshchaninov VN, Tkachenko EL, Zharkov SV, Gavrilov IV, Katyreva IuE. [EFFECT OF SYNTHETIC PEPTIDES ON AGING OF PATIENTS WITH CHRONIC POLYMORBIDITY AND ORGANIC BRAIN SYNDROME OF THE CENTRAL NERVOUS SYSTEM IN REMISSION]. Adv Gerontol. 2015;28(1):62-7. Russian. PMID: 26390612."
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "",
        "high_performance_liquid_chromatography": "",
        "mass_spectrometry": "",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Vesugen for sale online (20mg). Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Vesugen for Sale (20mg) - Core Peptides",
            "og:description": "Vesugen for sale online (20mg). Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/vesugen-20mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T15:29:16+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2023/11/Vesugen-Lys-Glu-Asp-20mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Vesugen For Sale (20mg) - Core Peptides",
            "twitter:description": "Vesugen for sale online (20mg). Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2023/11/Vesugen-Lys-Glu-Asp-20mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$63.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:brand": "Core Peptides",
            "product:price:amount": "63.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-VESUGEN-20",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/melanotan-1-10mg/",
                "name": "Melanotan 1 (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Melanotan-1-10MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/pt-141-10mg-bremelanotide/",
                "name": "PT-141 (Bremelanotide) (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/PT-141-10mg-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/semax-25mg/",
                "name": "Semax (25mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Semax-25MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/cjc-1295-dac-5mg/",
                "name": "CJC-1295 DAC (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/CJC-1295-DAC-5MG-300x300.jpg.webp",
                "price": ""
            }
        ]
    },
    {
        "id": "21",
        "url": "https://www.corepeptides.com/peptides/vesilut-20mg/",
        "name": "Vesilut (20mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2023/11/Vesilut-Glu-Asp-20mg.jpg",
        "display_price": "$64.00",
        "display_specs": [
            "Size: 20mg Contents: Vesilut Form: Lyophilized powder Purity: >99% SKU: P-VESILUT-20",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$60.80"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$57.60"
            }
        ],
        "description": [
            {
                "h2": "Vesilut Peptide"
            },
            {
                "p": "Vesilut, aka ED (Glu-Asp) is a synthetic bioregulator peptide, classified amongst the Khavinson peptides. It contains the Glu-Asp sequence which is also found in another Khavinson peptide called Prostamax (Lys-Glu-Asp-Pro). There is a general lack of research on Vesilut, but due to its similarity with Prostamax, it is expected to exhibit similar potential action on tissues such as prostate gland cells and bladder cells. As a bioregulator, aka citomedine, Vasilut is posited to exert these actions via direct interaction with the expression of genes on a cellular level."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular formula: C9H14N2O7 Molecular weight: 262.2 g/mol Sequence: Glu-Asp Other known titles: alpha-glutamylaspartic acid, ED, SCHEMBL1674753, Vesilute"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "p": "Due to the lack of any published research that addresses Vesilut’s research potential, we have extracted and presented data from related bioregulators that share the same Glu-Asp sequence."
            },
            {
                "h3": "Vesilut and Urinary Bladder Function"
            },
            {
                "p": "Urinary bladder function is tightly related to that of surrounding tissues and especially the prostate gland tissues. Swelling of prostate tissues may significantly impede the function of urinary bladder tissues. In the realm of bioregulatory peptides, citomedines with a sequence akin to Vesilut (Glu-Asp), have been suggested to induce intriguing mechanisms of action. This is particularly noted within the context of experimental models of chronic aseptic inflammation in prostate tissues, which commonly translates to swelling and impeded urinary bladder tissue function.(1) Thus, researchers have posited that Vesilut's mechanism may potentially be similar to that of related bioregulators, and may center on modulating key signs of chronic inflammation at the cellular level."
            },
            {
                "p": "One primary action observed in the trials was the reduction in swelling in the experimental prostate tissues.(1) This appeared to have been achieved by influencing the fluid dynamics and cellular responses in the inflamed tissue, leading to a decrease in edema or swelling. Another potential aspect of Vesilut's mechanism, based on the data from related bioregulators, is the attenuation of hyperemia, which refers to an excess of blood in the vessels supplying the prostate gland tissues. This regulation of blood flow may be linked to bioregulator influence on the vascular endothelium and smooth muscle cells, leading to a normalization of blood supply and thus reducing the hyperemic state. Furthermore, bioregulators related to Vesilut appear to exert a potential role in modulating cellular infiltration, an indicator of immune response and inflammation. By potentially regulating the migration and activity of immune cells, these citomedines may potentially support a balance in the inflammatory response, preventing excessive cellular infiltration. A crucial aspect of the aforementioned peptides related to Vesilut is their potential to block the development of sclerotic processes. Sclerosis, the hardening of tissues, is considered to often result from prolonged inflammation, and may lead to the thickening and stiffening of the affected tissue. Thickening and stiffening of prostate tissues may also significantly impact the normal functionality of urinary bladder tissues. Citomedines may intervene in the pathways that lead to the accumulation of fibrous tissues, thereby mitigating the progression of chronic inflammation towards sclerosis. Ultimately, the authors concluded that the exposure of related bioregulator peptides apparently led to “reduced swelling intensity, hyperaemia, and cellular infiltration, blocked the development of sclerosal processes.” (1)"
            },
            {
                "h3": "Vesilut and Gene Bioregulation"
            },
            {
                "p": "The aforementioned potential actions of Vesilut may be related to its hypothetical action on gene expression in tissues. Related peptides that contain the Glu-Asp sequence have been posited to interact with chromosomes and chromatin, possibly leading to the release of genes previously repressed by heterochromatinization."
            },
            {
                "p": "Chromatin is a complex of DNA and proteins found in the nucleus of eukaryotic cells. Its primary function is to package DNA into a smaller volume to fit in the cell, control gene expression, and facilitate DNA replication. Chromosomes are long, thread-like structures made of protein and a single molecule of DNA. They carry genetic information in the form of genes. Ribosomal RNA (rRNA), a key component of ribosomes (the cell's protein factories), is considered to be crucial for translating this genetic code into proteins. The mechanism of peptides with homology to Vesilut may involve alterations in chromatin structure, specifically in aging cells.(2) This alteration might lead to the decondensation of chromatin, as opposed to condensed chromatin which is generally considered to have lower levels of gene activity. By potentially causing decondensation, bioregulator peptides might reactivate certain genes that have been silenced over time due to the natural cell aging process. This reactivation might, in theory, lead to increased protein synthesis and potentially counteract some aspects of cellular aging in various tissues, including prostate gland cells and urinary bladder cells. Thus, the authors posited that “short peptides activate heterochromatin and heterochromatinized regions of cell chromosomes in senile subjects.”"
            },
            {
                "p": "Furthermore, bioregulator peptides similar to Vesilut might influence the dynamics of chromosomes by increasing the frequency of sister chromatid exchanges (SCE).(3) SCEs are a natural process where identical sister chromatids exchange genetic material during cell division. An increase in SCE frequency may suggest a role for Vesilut in enhancing chromosomal repair and maintenance mechanisms, potentially contributing to genomic stability in aging cells. Additionally, bioregulator peptides could potentially impact the activity of ribosomal RNA genes, as suggested by an increase in Ag-positive nucleolus organizer regions (NORs). NORs are chromosomal regions that are involved in the formation of ribosomes. An increase in Ag-positive NORs might indicate enhanced production of rRNA, leading to more ribosomes and thus higher protein synthesis capacity. This change may be particularly significant in aging cells, where protein synthesis often decreases. Lastly, the apparent action of bioregulators like Vesilut might involve the reduction of large segments of C-pericentromeric heterochromatin, particularly in specific chromosomes. Heterochromatin is a tightly packed form of DNA, and its decondensation may imply a release of genes previously repressed by such compact structures, leading to potential changes in gene expression profiles in aging cells."
            },
            {
                "p": "Vesilut peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Borovskaya, T. G., Pakhomova, A. V., Vychuzhanina, A. V., Poluektova, M. E., Fomina, T. I., Ermolaeva, L. A., ... & Neplochov, E. A. (2013). Experimental studying of the drug efficiency Prostamax in the therapy of chronic aseptic prostatitis and its complications. Modern Research in Inflammation, 2013.",
                    "Khavinson VKh, Lezhava TA, Malinin VV. Effects of short peptides on lymphocyte chromatin in senile subjects. Bull Exp Biol Med. 2004 Jan;137(1):78-81. doi: 10.1023/b:bebm.0000024393.40560.05. PMID: 15085253.",
                    "Dzhokhadze TA, Buadze TZh, Gaĭozishvili MN, Baratashvili NA, Lezhava TA. [Deheterochromatinization of the chromatin in old age induced by oligopeptide bioregulator (Lys-Glu-Asp-Pro)]. Georgian Med News. 2012 Nov;(212):76-82. Russian. PMID: 23221144."
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "",
        "high_performance_liquid_chromatography": "",
        "mass_spectrometry": "",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Vesilut for sale online (20mg). Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Vesilut for Sale (20mg) - Core Peptides",
            "og:description": "Vesilut for sale online (20mg). Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/vesilut-20mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-05-22T16:40:31+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2023/11/Vesilut-Glu-Asp-20mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Vesilut For Sale (20mg) - Core Peptides",
            "twitter:description": "Vesilut for sale online (20mg). Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2023/11/Vesilut-Glu-Asp-20mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$64.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:brand": "Core Peptides",
            "product:price:amount": "64.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-VESILUT-20",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/adipotide-10mg/",
                "name": "Adipotide (FTPP) (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Adipotide-FTPP-10MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ghrp-6/",
                "name": "GHRP-6 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHRP-6-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ll-37-5mg/",
                "name": "LL-37 (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/LL-37-5mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ipamorelin-5mg/",
                "name": "Ipamorelin (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Ipamorelin-5MG-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "id": "22",
        "url": "https://www.corepeptides.com/peptides/triptorelin-2mg/",
        "name": "Triptorelin (2mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2021/10/Triptorelin-2MG.jpg",
        "display_price": "$54.00",
        "display_specs": [
            "Size: 2mg Contents: Triptorelin (2mg) Form: Lyophilized powder Purity: >99% SKU: P-TRIPTORL-2",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$51.30"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$48.60"
            }
        ],
        "description": [
            {
                "h2": "Triptorelin Peptide"
            },
            {
                "p": "Triptorelin is a synthetic peptide composed of ten amino acids, similar to gonadotropin-releasing hormones (GnRH).(1) GnRH, secreted by the hypothalamus, is considered by scientists to be responsible for the synthesis and secretion of the follicle-stimulating hormone (FSH) and luteinizing hormone (LH).(2) Triptorelin may act similarly on the pituitary gland to stimulate the synthesis and release of the LH and FSH hormones, both apparently vital for testosterone production in male species and estrogen synthesis in female species.(3)"
            },
            {
                "h3": "Overview"
            },
            {
                "p": "As an agonist analog of GnRH, researchers have suggested that Triptorelin binds to the receptors in the pituitary gland, which may then stimulate the secretion of LH and FSH. This, at first, may cause an upsurge in the initial phase of LH and FSH stimulation. However, it is important to note that Triptorelin is an analog that appears to have upregulated stability and affinity to the receptors than endogenous GnRH. Thus, the receptors eventually may become less sensitive to the compound (i.e., downregulation of the receptors), and Triptorelin may lead to reduced release of LH and FSH."
            },
            {
                "p": "Scientists consider that a reduction in the levels of LH and FSH hormones eventually leads to a decrease in testosterone and estrogen levels. This event may lead to the suppression of steroidogenesis by ovaries and testicles.(4) Researchers suggest that Triptorelin exhibits some potential in sustaining the decline in LH and FSH secretion. Therefore, intermittent exposure to Triptorelin may upregulate hormonal levels, while prolonged exposure may lead to dramatic suppression."
            },
            {
                "h2": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C64H82N18O13 Molecular Weight: 1311.4 g/mol Other Known Titles: 57773-63-4"
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Triptorelin Peptide and Hormonal Upregulation"
            },
            {
                "p": "It is posited that a single exposure to Triptorelin may, under certain experimental conditions, potentially induce a surge in hormone release from cells by interacting with receptors that control gonadotropin secretion.(5) This single interaction may temporarily reset or stimulate the hypothalamic-pituitary axis, thereby possibly enhancing the secretion of endogenous gonadotropins and subsequent hormonal synthesis. It is hypothesized that Triptorelin might activate signaling pathways that had been previously suppressed or downregulated, possibly leading to an increase in luteinizing hormone release and ultimately fostering the synthesis of androgens. The signaling pathways may be suppressed due to previous exposure to androgenic anabolic agents, which may"
            },
            {
                "p": "“have pronounced effects on the male pituitary-gonadal axis, affecting the regulation of production of serum luteinizing hormone (LH) and follicle-stimulating hormone and inducing a state of hypogonadotropic hypogonadism characterized by decreased serum endogenous testosterone production and impaired spermatogenesis”."
            },
            {
                "p": "Studies employing controlled conditions have suggested that even a one-time exposure could serve as a catalyst for restoring or augmenting endogenous hormone production. The underlying biological processes, however, remain complex and may depend on multiple variables that have yet to be fully elucidated."
            },
            {
                "h3": "Triptorelin Peptide and Hormonal Suppression"
            },
            {
                "p": "Prolonged exposure to triptorelin may, according to various mechanistic hypotheses, alter the normal function of GnRH receptors.(6) Instead of the typical pulsatile pattern that is possibly required to maintain receptor sensitivity, the continuous presence of a GnRH analog might potentially lead to a state of receptor desensitization. This desensitization, as posited by some researchers, may potentially be tied to alterations in receptor trafficking, where receptors may become internalized and apparently not recycled to the cell surface as efficiently. Such a process may diminish their ability to respond to further stimulation, thereby reducing the secretion of upstream hormones, and ultimately lowering the synthesis of downstream hormones."
            },
            {
                "p": "Studies employing controlled research approaches have hinted that this continuous stimulation may induce conformational changes in the receptor or associated signaling proteins. These changes may disrupt the receptor’s normal feedback and resensitization mechanisms. Over time, this condition could result in persistently dampened signaling cascades, potentially leading to less hormonal release and reduced hormone production at later stages in the endocrine pathway."
            },
            {
                "h3": "Triptorelin Peptide and Thymus Cells"
            },
            {
                "p": "In murine models, GnRH-analog peptides structurally related to Triptorelin have been posited to interact with specific binding sites within thymic compartments, potentially influencing immune-related processes.(7) It is possible that age-related reductions in LHRH-binding sites, coupled with complex endocrine-immune signaling pathways, obscure the precise manner in which Triptorelin might modulate thymic function. The researchers have commented that the peptide may “exert a powerful modulation of immune system function during the physiological decline of immunological capacities.” However, the limited data currently available may stem from the difficulty in separating local thymic actions from broader neuroendocrine influences, as well as from the challenges of elucidating how these peptides apparently alter receptor densities, cellular organization, and the proliferative capacity of T-lymphocyte precursors. Therefore, it remains uncertain how Triptorelin could potentially modulate immunity at the molecular and cellular level."
            },
            {
                "p": "Triptorelin peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "National Center for Biotechnology Information. PubChem Compound Summary for CID 25074470, Triptorelin.",
                    "Tsutsumi, Rie, and Nicholas J G Webster. “GnRH pulsatility, the pituitary response and reproductive dysfunction.” Endocrine journal vol. 56,6 (2009): 729-37. doi:10.1507/endocrj.k09e-185. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307809/",
                    "LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. Triptorelin. https://www.ncbi.nlm.nih.gov/books/NBK548756/",
                    "Lepor, Herbert. “Comparison of single-agent androgen suppression for advanced prostate cancer.” Reviews in urology vol. 7 Suppl 5 (2005): S3-S12. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1477619/",
                    "Pirola I, Cappelli C, Delbarba A, Scalvini T, Agosti B, Assanelli D, Bonetti A, Castellano M. Anabolic steroids purchased on the Internet as a cause of prolonged hypogonadotropic hypogonadism. Fertil Steril. 2010 Nov;94(6):2331.e1-3. doi: 10.1016/j.fertnstert.2010.03.042. Epub 2010 Apr 22. PMID: 20416868.",
                    "Chung LY, Kang E, Nam HK, Rhie YJ, Lee KH. Efficacy of Triptorelin 3-Month Depot Compared to 1-Month Depot for the Treatment of Korean Girls with Central Precocious Puberty in Single Tertiary Center. J Korean Med Sci. 2021 Aug 30;36(34):e219. doi: 10.3346/jkms.2021.36.e219. PMID: 34463062; PMCID: PMC8405405.",
                    "Marchetti B, Guarcello V, Morale MC, Bartoloni G, Raiti F, Palumbo G Jr, Farinella Z, Cordaro S, Scapagnini U. Luteinizing hormone-releasing hormone (LHRH) agonist restoration of age-associated decline of thymus weight, thymic LHRH receptors, and thymocyte proliferative capacity. Endocrinology. 1989 Aug;125(2):1037-45. doi: 10.1210/endo-125-2-1037. PMID: 2546733."
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "",
        "high_performance_liquid_chromatography": "",
        "mass_spectrometry": "",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Triptorelin peptide for sale 2mg. Offering peptides for sale at 99+% purity with unmatched service, bulk purchase discounts & Free shipping",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Triptorelin For Sale (2mg) - Core Peptides",
            "og:description": "Triptorelin peptide for sale 2mg. Offering peptides for sale at 99+% purity with unmatched service, bulk purchase discounts & Free shipping",
            "og:url": "https://www.corepeptides.com/peptides/triptorelin-2mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T16:23:16+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2021/10/Triptorelin-2MG.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Triptorelin For Sale (2mg) - Core Peptides",
            "twitter:description": "Triptorelin peptide for sale 2mg. Offering peptides for sale at 99+% purity with unmatched service, bulk purchase discounts & Free shipping",
            "twitter:label1": "Price",
            "twitter:data1": "$54.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:brand": "Core Peptides",
            "product:price:amount": "54.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-TRIPTORL-2",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/ll-37-5mg/",
                "name": "LL-37 (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/LL-37-5mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/adipotide-10mg/",
                "name": "Adipotide (FTPP) (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Adipotide-FTPP-10MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/bpc-157/",
                "name": "BPC-157 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/BPC-157-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/receptor-grade-igf-1-lr3-100mcg/",
                "name": "Receptor Grade IGF-1 LR3 (100mcg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-100MCG-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "id": "23",
        "url": "https://www.corepeptides.com/peptides/tripeptide-29-topical-200mg/",
        "name": "Tripeptide-29 (200mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2023/04/Tripeptide-29.jpg",
        "display_price": "$176.00",
        "display_specs": [
            "Size: 200mg Contents: Tripeptide-29 Form: Lyophilized powder Purity: >99% SKU: P-Tripeptide-29",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$167.20"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$158.40"
            }
        ],
        "description": [
            {
                "h2": "Tripeptide-29"
            },
            {
                "p": "Tripeptide-29 is a small, naturally occurring amino-acid peptide, one of the primary building blocks for collagen protein.(1) Collagen is a major component of the extracellular matrix, the network of proteins and fibers comprising connective tissues. It is considered responsible for providing structure and support to cellular complexes."
            },
            {
                "p": "Researchers suggest Tripeptide-29 may have the potential to stimulate collagen synthesis and promote the formation of collagen fibers. In addition to its possible role in collagen synthesis, Tripeptide-29 may have other biological functions. For example, research studies have hypothesized its potential as an antioxidant, which might help protect cells from oxidative stress and damage. It may also exhibit anti-inflammatory, anti-fibrotic, and anti-melanogenic characteristics."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C12H19N3O5 Molecular Weight: 285.3 g/mol Other Known Titles: Glycylprolylhydroxyproline"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Tripeptide-29 and Collagen Integrity"
            },
            {
                "p": "Tripeptide-29 may be a major contributor to the stability of type 1 collagen molecules. Studies suggest that the OH group of Hyp in Tripeptide-29 may contribute to the formation of favorable interatomic interactions.(2) The researchers propose that Tripeptide-29 as a monomer may enhance the stability of collagen and collagen microfibrils. Studies also suggest that the presence of Tripeptide-29 as a part of the sequence in collagen may significantly reduce UV-related damage and lower the degradation rate when exposed to intensive radiation.(3)"
            },
            {
                "p": "A study conducted on dermal fibroblasts reported that hydrolyzed type 1 collagen tripeptides exhibited promising potential in reducing oxidative stress and damage.(4) As previously noted, Tripeptide-29 appears to be the primary tripeptide that forms when hydrolyzing type 1 collagen. The hydrolysate showed potential in reducing the build-up of advanced glycation end products (AGEs), reportedly preventing the production of denatured collagen and lowering levels of reactive oxygen species. The glycation process refers to sugar molecules bonding with proteins, potentially speeding up skin cell aging by altering its mechanical properties and stability. Ultimately, the scientists suggested that tripeptide-29 “might improve [cell aging] phenotypes via the inhibition of glycation and oxidative stress, leading to a delay in cellular aging.” From an in vitro perspective, the study explored the mechanisms underpinning the observed action. It was suggested that Tripeptide-29 may reduce the production of AGEs and denatured collagen while inhibiting the activity of matrix metalloproteinases (MMPs) and enhancing collagen 1 levels in dermal fibroblasts. These results suggest that Tripeptide-29 may mitigate cell aging by preserving collagen integrity and inhibiting processes that degrade the skin matrix. Furthermore, it is indicated that Tripeptide-29 might be linked to its smaller peptide size, which is believed to support its skin penetration and bioavailability."
            },
            {
                "h3": "Tripeptide-29 and Glucose Control"
            },
            {
                "p": "According to researchers, Tripeptide-29 may act as a peptidic inhibitor of dipeptidyl peptidase-IV (DPP-IV) due to its potential to inhibit the hydrolysis of the Pro-Hyp bond.(5) It was considered a moderately competitive inhibitor. The scientists reported that “Gly-Pro-Hyp in the collagen hydrolysates is suggested to be mainly responsible for the DPP-IV inhibition in vitro,” inferring that Tripeptide-29 may contribute to the overall inhibitory action of collagen peptides on DPP-IV. Interestingly, Tripeptide-29 was reportedly not hydrolyzed by DPP-IV, indicating resistance to this specific enzyme. This observation might point to the peptide's stability and efficacy in the presence of this enzyme."
            },
            {
                "p": "Dipeptidyl peptidase-IV (DPP-IV) is a serine peptidase involved in several biological processes.(6) The enzyme is expressed on the surface of various cell types, including immune cells, epithelial cells, and endothelial cells. It is also apparently found in circulation in the liver, kidney, and intestine tissues. DPP-IV cleaves peptide bonds at the N-terminus of dipeptides, tripeptides, and smaller peptides, but not larger peptides or proteins. This specificity means it may act on various substrates, including hormones, neuropeptides, and chemokines. Some of the substrates of DPP-IV include glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and peptide YY (PYY), all of which are suggested to be involved in the regulation of glucose homeostasis and energy metabolism.(7) The cleavage of GLP-1 and GIP by DPP-IV may result in rapid inactivation and clearance from circulation. Inhibiting DPP-IV may upregulate the levels of GLP-1 and GIP, which may lead to an increase in insulin secretion, reduction in glucagon levels, lower blood glucose, and decreased appetite.(8)"
            },
            {
                "h3": "Tripeptide-29 and Platelet Aggregation"
            },
            {
                "p": "Collagen-related peptides that contain a glycine-proline-hydroxyproline repeat motif are considered to be cross-linked through cysteine residues, which may stimulate platelet aggregation and secretion through glycoprotein VI (GPVI) receptors. GPVI is a platelet receptor that scientists believe to be crucial in blood clotting or hemostasis. It is a transmembrane glycoprotein that appears to be primarily expressed on the surface of platelets, which are blood cells involved in blood clotting. GPVI is a member of the immunoglobulin (Ig) superfamily of proteins, comprised of two subunits called alpha and beta. The alpha subunit is considered to contain the collagen-binding site, while the beta subunit is deemed responsible for signaling within the platelet. When the GPVI receptor binds to collagen, it may trigger a series of events that lead to the activation of platelets and the formation of a blood clot."
            },
            {
                "p": "Studies suggest that the non-cross-linked form of glycine-proline-hydroxyproline, or Tripeptide-29, may induce tyrosine phosphorylation of the tyrosine kinase Syk and phospholipase C gamma2 (PLCgamma2) in platelets.(9) This may ultimately stimulate platelet aggregation to stop or prevent bleeding. Overall, the researchers report that Tripeptide-29, “present as a repeat motif, is sufficient to activate the platelet collagen receptor GPVI,” and may stimulate the formation of thrombi to prevent excessive bleeding."
            },
            {
                "p": "Tripeptide-29 peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Wiśniewski, K., Artemowicz, B., Lutostańska, A., Maćkowiak, J., & Koziołkiewicz, W. (1994). Central activity of peptide Gly-Pro-Hyp--the main component of collagen degradation products mixture. Acta neurobiologiae experimentalis, 54(1), 33–38.",
                    "Némethy, G., & Scheraga, H. A. (1986). Stabilization of collagen fibrils by hydroxyproline. Biochemistry, 25(11), 3184–3188. target=\"_blank\" rel=\"noopener\"https://doi.org/10.1021/bi00359a016",
                    "Jariashvili, K., Madhan, B., Brodsky, B., Kuchava, A., Namicheishvili, L., & Metreveli, N. (2012). UV damage of collagen: insights from model collagen peptides. Biopolymers, 97(3), 189–198. https://doi.org/10.1002/bip.21725",
                    "Lee, Y. I., Lee, S. G., Jung, I., Suk, J., Lee, M. H., Kim, D. U., & Lee, J. H. (2022). Effect of a Collagen Tripeptide on Antiaging and Inhibition of Glycation of the Skin: A Pilot Study. International journal of molecular sciences, 23(3), 1101. https://doi.org/10.3390/ijms23031101",
                    "Hatanaka, T., Kawakami, K., & Uraji, M. (2014). Inhibitory effect of collagen-derived tripeptides on dipeptidylpeptidase-IV activity. Journal of enzyme inhibition and medicinal chemistry, 29(6), 823–828. https://doi.org/10.3109/14756366.2013.858143",
                    "Trzaskalski, N. A., Fadzeyeva, E., & Mulvihill, E. E. (2020). Dipeptidyl Peptidase-4 at the Interface Between Inflammation and Metabolism. Clinical medicine insights. Endocrinology and diabetes, 13, 1179551420912972. https://doi.org/10.1177/1179551420912972",
                    "Kieffer, T. J., McIntosh, C. H., & Pederson, R. A. (1995). Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. Endocrinology, 136(8), 3585–3596. https://doi.org/10.1210/endo.136.8.7628397",
                    "Kasina, S. V. S. K., & Baradhi, K. M. (2022). Dipeptidyl Peptidase IV (DPP IV) Inhibitors. In StatPearls. StatPearls Publishing.",
                    "Asselin, J., Knight, C. G., Farndale, R. W., Barnes, M. J., & Watson, S. P. (1999). Monomeric (glycine-proline-hydroxyproline)10 repeat sequence is a partial agonist of the platelet collagen receptor glycoprotein VI. The Biochemical journal, 339 ( Pt 2)(Pt 2), 413–418."
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "",
        "high_performance_liquid_chromatography": "",
        "mass_spectrometry": "",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Tripeptide-29 for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Tripeptide-29 For Sale (200mg) - Core Peptides",
            "og:description": "Tripeptide-29 for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:url": "https://www.corepeptides.com/peptides/tripeptide-29-topical-200mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T16:20:01+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2023/04/Tripeptide-29.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Tripeptide-29 For Sale (200mg) - Core Peptides",
            "twitter:description": "Tripeptide-29 for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2023/04/Tripeptide-29.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$176.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "176.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-Tripeptide-29",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/semax-25mg/",
                "name": "Semax (25mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Semax-25MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ipamorelin-5mg/",
                "name": "Ipamorelin (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Ipamorelin-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/cjc-1295-dac-5mg/",
                "name": "CJC-1295 DAC (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/CJC-1295-DAC-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/bpc-157/",
                "name": "BPC-157 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/BPC-157-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "id": "24",
        "url": "https://www.corepeptides.com/peptides/thyrotropin-25mg/",
        "name": "Thyrotropin TRH (25mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2021/10/Thyrotropin-TRH-25mg.jpg",
        "display_price": "$73.00",
        "display_specs": [
            "Size: 25mg Contents: Thyrotropin (25mg) Form: Lyophilized powder Purity: >99% SKU: P-THYROTRP-25",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$69.35"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$65.70"
            }
        ],
        "description": [
            {
                "h2": "Thyrotropin Peptide"
            },
            {
                "p": "Thyroid hormones are considered to be growth and metabolism regulators. In order to maintain the synchrony of these regulating mechanisms and hemostasis, hormones released by the hypothalamus are called Thyrotropin-releasing hormone (TRH).(1) This hypothalamic hormone is posited to play a crucial role in the feedback loop that regulates thyroid function. Scientists consider the main function of Thyrotropin-releasing hormone (TRH) to be the stimulation of the pituitary gland to release Thyroid-Stimulating Hormone (TSH) which in turn plays a role in the maintenance of the levels of thyroid hormones.(2) More specifically, TSH acts directly on the thyroid gland to promote the synthesis and release of thyroid hormones, primarily thyroxine (T4) and triiodothyronine (T3). While TRH is an endogenous compound, a synthetic peptide was developed with the hopes of simulating TRH characteristics and is known as Thyrotropin, or Protirelin.(3)"
            },
            {
                "h3": "Overview"
            },
            {
                "p": "Thyrotropin is the synthetic analogue of the endogenous peptide hormone Thyrotropin-releasing hormone.(3) Structurally analogous to TRH, Thyrotropin is a tripeptide composed of three amino acid residues connected in a sequential form.(3) Researchers consider Thyrotropin to potentially function via binding to the thyrotropin-releasing hormone (TRH) receptors TRH-1 and TRH-2.(4)(5)(6) This interaction stimulates a cascade of biochemical events within the cell, highlighting the significant impact of these hormonal interactions on overall endocrine system function."
            },
            {
                "p": "On binding with these receptors, which are mediated by G proteins, a possible cascade of signals may be generated. First, a hydrolase enzyme may be activated, which in turn may cause a breakdown of an existing compound, producing inositol. Research indicates that Inositol may bind with another receptor, a calcium channel, thereby resulting in possible increased cellular levels of calcium which may activate protein kinase C, potentially leading to elevated phosphorylation of secondary messenger enzymes."
            },
            {
                "p": "All these signals carry the collective potential to modify gene expression in the nucleus of a cell, which may transduce the TRH binding signal to stimulate the pituitary gland to release TSH, thus regulating thyroid hormone production in the thyroid gland. This detailed mechanism is essential for maintaining metabolic balance and responding to physiological demands."
            },
            {
                "h3": "Specifications:"
            },
            {
                "p": "Molecular Formula: C16H22N6O4 Molecular Weight: 362.39 g/mol Other Known Titles: Protirelin"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Thyrotropin Releasing Peptide and The Central Nervous System"
            },
            {
                "p": "Studies have investigated the potential of Thyrotropin-releasing hormone within the central nervous system, particularly its potential to modulate neurotransmitter systems, focusing on its actions in superfused rat hippocampal slices subjected to potassium-induced depolarization.(7) Although specific mechanisms are not fully delineated, Thyrotropin-releasing hormone seems to exert notable actions under certain conditions. The experiments demonstrated that while Thyrotropin-releasing hormone did not modify basal levels of glutamate or aspartate, it significantly inhibited their release during neuronal activation triggered by potassium. This suggests that Thyrotropin-releasing hormone may play a role in controlling the release of excitatory neurotransmitters during heightened neuronal activity, indicative of a modulatory capacity that could be relevant in conditions of neural excitability such as seizures or neurodegenerative states. The observed actions of Thyrotropin-releasing hormone might be mediated through its interaction with high-affinity receptors associated with G-protein coupled receptor pathways, which involve complex intracellular signaling cascades including calcium mobilization. The inhibition of glutamate and aspartate release appears to be calcium-dependent, raising the possibility that Thyrotropin-releasing hormone might influence calcium channels or the associated release machinery. Interestingly, the inhibitory action on neurotransmitter release did not follow a straightforward response curve, suggesting intricate receptor interactions or the influence of additional regulatory mechanisms"
            },
            {
                "h3": "Thyrotropin Releasing Peptide and Amyotrophic Lateral Sclerosis"
            },
            {
                "p": "Researchers are considering the potential function of Thyrotropin in Amyotrophic Lateral Sclerosis (ALS).(8) Researchers suggest that Thyrotropin may act as a neuromodulator during the hyperactivity of the hypothalamic nervous system, which may assert some mitigation of Amyotrophic Lateral Sclerosis (ALS) symptoms.(9)"
            },
            {
                "h3": "Thyrotropin Releasing Peptide and Behavioral Research"
            },
            {
                "p": "Initial clinical studies conducted to assess the potential of the peptide were somewhat hindered as researchers considered the peptide might not be able to cross the blood brain barrier.(10) Scientists consider the blood brain barrier to be one of the most difficult membranes to cross as it is composed of closely spaced cells in order to prevent toxic substances from crossing over and reaching the brain.(11)"
            },
            {
                "p": "In this study,(10) the peptide was presented into the spinal theca (or cerebrospinal fluid). Eight test subjects with depressive symptoms were enrolled in a double-blind clinical trial study. Upon analysis, it was observed by the researchers that five out of the eight subjects exhibited an apparent 50% or more reduction in depressive behavior. It is suggested that the peptide's modes of action could potentially be linked to its interactions with certain neurotransmitter systems. Thyrotropin-releasing peptide is hypothesized to affect the pathways of serotonin and dopamine, both of which play significant roles in regulating mood. These actions might be facilitated through TRH receptors, which are prominently found in areas of the brain such as the amygdala and hippocampus, key sites for behavioral regulation. Additionally, it is conceivable that Thyrotropin-releasing peptide could influence these neurotransmitter systems by modifying their synthesis, the release of neurotransmitters, or their reuptake at the points where neurons communicate, known as synapses. Furthermore, Thyrotropin-releasing peptide is reported to exhibit actions on behavior that are contingent upon the existing neural or physiological conditions of the individual. For example, Thyrotropin-releasing peptide may have the capacity to restore balance to both overactive and underactive neural conditions by altering neurotransmitter levels appropriately. This hypothesis is supported by the observations of behavioral enhancements noted in clinical studies like this one, where changes in mood are described as quick yet short-lived, indicating a temporary recalibration of neural processes rather than a permanent alteration. This dynamic response could be indicative of Thyrotropin-releasing peptide’s capacity to adjust to and moderate varying neurological states."
            },
            {
                "p": "In another study,(12) 44 subjects were presented with the \"Thyrotropin test\". Out of the 44 test subjects, 19 exhibited an apparently blunted response to the test, indicating possible hypothyroidism, whereas 6 exhibited an apparently higher response to the test. Five of these subjects with a high augmented response were reported to naturally produce antithyroid antibodies. Through this study, researchers posited that the peptide may serve to indicate improper functioning of the thyroid gland, or determine any possible behavioral depressors."
            },
            {
                "h3": "Thyrotropin Releasing Peptide and Blood Pressure"
            },
            {
                "p": "In one clinical study which sought to conduct diagnostic tests on test subjects, it was suggested by the researchers that the peptide might contribute to an elevation in blood pressure rate. In this study,(13) eight subjects were examined one day before, the day after, and four weeks after heart surgery. All these subjects were given Thyrotropin. While the peptide did not appear to induce any significant changes in the levels of heart rate and thyroid hormones, the blood pressure rates reportedly increased on all three days. These results indicate that Thyrotropin may lead to increased blood pressure rates, and hence it is important for the clinical researcher to be aware of the subjects' pre-existing heart conditions when it comes to peptide experimentation."
            },
            {
                "p": "Researchers have further experimented with the peptide to investigate its specific mechanisms.(14) When the preoptic suprachiasmatic nucleus (POS) and the medial preoptic nucleus (pom) in test models were exposed to Thyrotropin, there was a 7% increase in blood pressure and a 19% increase in heart rate observed. The response in these areas was noted to be more pronounced compared to other regions, suggesting a possible localized action of Thyrotropin within these nuclei. Interestingly, different responses were recorded in other areas of the hypothalamus, such as the posterior hypothalamic nucleus (NHP), where Thyrotropin not only increased heart rate but also blood pressure, whereas only heart rate increases were observed in the anterior (NHA) and dorsomedial (NDM) hypothalamic nuclei. Preliminary exploration into the underlying mechanisms suggests that these cardiovascular changes could potentially be mediated by a mix of autonomic nervous system regulations. It is posited that inhibition of the parasympathetic nerves could contribute to the heart rate increases in the POSregion. Conversely, in the NHP area, the response to Thyrotropin is thought to be mediated by adrenal catecholamine release, indicating a role of adrenal hormones in these actions. Further, the study indicates that activation of the cardiac sympathetic nerves may play a role in the NHA region, as responses to Thyrotropin were not prevented by either methylatropine preexposure or adrenalectomy. This observation suggests a potential mechanism whereby Thyrotropin acts through pathways independent of adrenal involvement or parasympathetic inhibition. It is also notable that Thyrotropin’s impact was not uniform across all tested areas, with a decrease in both blood pressure and heart rate observed in a specific pom region (A7050–7400)."
            },
            {
                "p": "Thyrotropin peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Shahid MA, Ashraf MA, Sharma S. Physiology, Thyroid Hormone. [Updated 2021 May 12]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021. https://www.ncbi.nlm.nih.gov/books/NBK500006/",
                    "Michigan Medicine, University of Michigan Health. March 31, 2020. https://www.uofmhealth.org/health-library/ug1836",
                    "National Center for Biotechnology Information. \"PubChem Compound Summary for CID 638678, Protirelin\" PubChem, https://pubchem.ncbi.nlm.nih.gov/compound/Protirelin.",
                    "Boler J, Enzmann F, Folkers K, Bowers CY, Schally AV. The identity of chemical and hormonal properties of the thyrotropin releasing hormone and pyroglutamyl-histidyl-proline amide. Biochem Biophys Res Commun. 1969 Nov 6;37(4):705-10. https://pubmed.ncbi.nlm.nih.gov/4982117/",
                    "Kobayashi, Naotake et al. “Discovery of the Orally Effective Thyrotropin-Releasing Hormone Mimetic: 1-{N-[(4S,5S)-(5-Methyl-2-oxooxazolidine-4-yl)carbonyl]-3-(thiazol-4-yl)-l-alanyl}-(2R)-2-methylpyrrolidine Trihydrate (Rovatirelin Hydrate).” ACS omega vol. 3,10 (2018): 13647-13666. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6217654/",
                    "A. Eugene Pekary, Protirelin should be used with care in patients with ischemic heart disease, obstructive airway disease, or severe hypopituitarism (Parfitt, 1999). https://www.sciencedirect.com/topics/medicine-and-dentistry/protirelin",
                    "Nie Y, Schoepp DD, Klaunig JE, Yard M, Lahiri DK, Kubek MJ. Thyrotropin-releasing hormone (protirelin) inhibits potassium-stimulated glutamate and aspartate release from hippocampal slices in vitro. Brain Res. 2005 Aug 23;1054(1):45-54. doi: 10.1016/j.brainres.2005.06.077. PMID: 16055093.",
                    "Amyotrophic Lateral Sclerosis (ALS) Fact Sheet. National Institute of Neurological Disorders and Stroke.",
                    "Miller SC, Warnick JE. Protirelin (thyrotropin-releasing hormone) in amyotrophic lateral sclerosis. The role of androgens. Arch Neurol. 1989 Mar;46(3):330-5. https://pubmed.ncbi.nlm.nih.gov/2563937/",
                    "Marangell LB, George MS, Callahan AM, Ketter TA, Pazzaglia PJ, L'Herrou TA, Leverich GS, Post RM. Effects of intrathecal thyrotropin-releasing hormone (protirelin) in refractory depressed patients. Arch Gen Psychiatry. 1997 Mar;54(3):214-22. https://pubmed.ncbi.nlm.nih.gov/9075462/",
                    "Blood-brain barrier. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/blood-brain-barrier",
                    "Sternbach HA, Gold MS, Pottash AC, Extein I. Thyroid failure and protirelin(thyrotropin-releasing hormone) test abnormalities in depressed outpatients. JAMA. 1983 Mar 25. https://pubmed.ncbi.nlm.nih.gov/6402617/",
                    "Zaloga GP, Chernow B, Zajtchuk R, Chin R, Rainey TG, Lake CR. Diagnostic dosages of protirelin (TRH) elevate BP by noncatecholamine mechanisms. Arch Intern. https://pubmed.ncbi.nlm.nih.gov/6428340/",
                    "Diz DI, Jacobowitz DM. Cardiovascular effects produced by injections of thyrotropin-releasing hormone in specific preoptic and hypothalamic nuclei in the rat. Peptides. 1984 Jul-Aug;5(4):801-8. doi: 10.1016/0196-9781(84)90025-1. PMID: 6436799."
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "",
        "high_performance_liquid_chromatography": "",
        "mass_spectrometry": "",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Thyrotropin TRH peptide for sale online (25mg). Offering peptides for sale at 99+% purity with unmatched service, bulk purchase discounts & Free shipping",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Thyrotropin TRH For Sale (25mg) - Core Peptides",
            "og:description": "Thyrotropin TRH peptide for sale online (25mg). Offering peptides for sale at 99+% purity with unmatched service, bulk purchase discounts & Free shipping",
            "og:url": "https://www.corepeptides.com/peptides/thyrotropin-25mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-02-18T15:24:29+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2021/10/Thyrotropin-TRH-25mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Thyrotropin TRH For Sale (25mg) - Core Peptides",
            "twitter:description": "Thyrotropin TRH peptide for sale online (25mg). Offering peptides for sale at 99+% purity with unmatched service, bulk purchase discounts & Free shipping",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2021/10/Thyrotropin-TRH-25mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$73.00",
            "twitter:label2": "Availability",
            "twitter:data2": "Out of stock",
            "product:brand": "Core Peptides",
            "product:price:amount": "73.00",
            "product:price:currency": "USD",
            "og:availability": "out of stock",
            "product:availability": "out of stock",
            "product:retailer_item_id": "P-THYROTRP-25",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/cjc-1295-dac-5mg/",
                "name": "CJC-1295 DAC (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/CJC-1295-DAC-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/oxytocin-10mg/",
                "name": "Oxytocin (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Oxytocin-10mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/adipotide-10mg/",
                "name": "Adipotide (FTPP) (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Adipotide-FTPP-10MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/bpc-157/",
                "name": "BPC-157 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/BPC-157-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "id": "25",
        "url": "https://www.corepeptides.com/peptides/thymosin-alpha-1/",
        "name": "Thymosin Alpha-1 (5mg / 10mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Thymosin-Alpha-1.jpg",
        "display_price": "$81.00 – $149.00",
        "display_specs": [
            "Size: 5mg / 10mg Contents: Thymosin Alpha-1 Form: Lyophilized powder Purity: >99% SKU: P-THYMOSA1-5-10",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$76.95 – $141.55"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$72.90 – $134.10"
            },
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$141.55"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$134.10"
            },
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$76.95"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$72.90"
            }
        ],
        "description": [
            {
                "h2": "Thymosin Alpha-1 Peptide"
            },
            {
                "p": "Thymosin Alpha-1 peptide, also known as Thymosin Alpha, TA1, or T α 1, is a fragment of a protein molecule that has been widely studied for its potential implications with the immune system. Researchers have hypothesized that it contributes to the production of T-cells to mitigate and alleviate infection and bacterial spread.(1)"
            },
            {
                "p": "Thymosin Alpha-1 is a naturally occurring polypeptide that is considered by researchers to potentially restore and enhance immune functions.(2) Thymosin Alpha-1 is considered to be one of the polypeptides found in Thymosin Fraction 5, which is a crude extract of the thymus gland.(3)"
            },
            {
                "p": "Since its discovery, a synthetically developed form of Thymosin Alpha-1 has also been studied, researchers refer to the peptide as Thymalfasin.(2) Thymalfasin is composed of 28 amino acids, similar to the naturally occurring Tα 1, and is derived from a longer polypeptide precursor composed of 113 amino acids, known as Prothymosin Alpha.(3)"
            },
            {
                "h3": "Overview"
            },
            {
                "p": "The main aim of initial research into Thymosin Alpha-1(4) was to understand and examine the immunomodulating potential of the peptide. Studies have suggested that the peptide may increase the concentration of the major histocompatibility complex (MHC) class I and cytokine production, which may possibly lead to increased immune responses. The peptide may also enhance the activity of natural killer cells and foster the expression of phenotypic markers on T cells, suggesting a multi-faceted role in modulating the immune response. The researchers posited that the peptide may also increase the expression of high-affinity receptors for interleukin-2. This could potentially lead to a more vigorous activation and proliferation of T lymphocytes."
            },
            {
                "p": "Researchers speculate that Thymosin Alpha-1 may stimulate possible action by targeting the T-helper cells and cytotoxic T-cell populations.(3) Tα 1 may possibly induce differentiation of the T-cells (thymocytes) and the terminal differentiation of the blood lymphocytes. Scientists posit that it may elevate the production of the natural killer cells and potentially stimulate cytokine mediated inflammation.(2)(3) Furthermore, the peptide has been studied for its potential to enhance efficiency of macrophages and functions as the modulator of the alpha thrombin activity.(3)"
            },
            {
                "h3": "Specifications"
            },
            {
                "p": "Molecular Formula: C129H215N33O55 Molecular Weight: 3108.31 g/mol Other Known Titles: TA1, Tα1, Thymalfasin"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Thymosin Alpha-1 Peptide and Immune System"
            },
            {
                "p": "In a clinical study,(5) 11 test subjects with different immune system dysfunctions were evaluated for the levels of their natural killer (NK) and lymphokine activated killer cells (LAK) present in their system. It was noted that the immunodeficient subjects demonstrated the mean LAK-cell activity of approximately 65% as compared to the control subjects. Upon presenting Thymosin Alpha-1 to the test subjects, researchers observed that it did not significantly improve the levels of NK or LAK cells. Only 3 test subjects were reported to exhibit improved LAK-cell activity by up to 30% whereas others were not significantly impacted."
            },
            {
                "h3": "Thymosin Alpha-1 Peptide and Hepatitis"
            },
            {
                "p": "Clinical trials were conducted in test subjects with liver complications, with some exhibiting Hepatitis B & C. Tα 1 was presented to the subjects to explore its potential mechanism of action on these complications.(2) For subjects exhibiting Hepatitis B, it was reported by the research team that when these subjects were presented with Thymosin Alpha-1 twice a week for the duration of the study, the reported virological response rate of the subjects appeared increased by 40.6%. For Hepatitis C, subjects reportedly exhibited improved results when Tα 1 was present in combination with interferon alpha compounds. Thymosin alpha-1's apparent role in modulating the immune system was further explored through its potential engagement with toll-like receptors (TLR)-2 and TLR-9 on dendritic cells and other antigen-presenting cells. This interaction potentially initiates a cascade of immune responses, including the stimulation of cytokines such as interleukin-2 (IL-2), IL-10, and interferon-gamma (IFN-γ), which in turn may support the adaptive immune system. Such modulation is crucial not just for combating infections but also for controlling inflammatory responses, potentially benefiting chronic hepatitis and acute pancreatitis due to its apparent actions on cytokine profiles. In murine models and in vitro studies, Thymosin alpha-1 has been shown to possibly stimulate T-cell maturation and enhance the efficacy of natural killer cells. It might also play a role in reducing inflammatory cytokines such as tumor necrosis factor-alpha, which could be particularly beneficial in chronic inflammatory models."
            },
            {
                "h3": "Thymosin Alpha-1 Peptide and Sepsis"
            },
            {
                "p": "In a 2015 study,(6) a meta-analysis was conducted where all the relevant clinical trials prior to 2014 were analyzed to understand the possible mechanism of Thymosin Alpha-1 in relation to the sepsis reaction. In this study, 12 controlled trials were evaluated in total. Based on the extracted data and assessment, it was observed by the research analysts that there was a reported significant decline in mortality rate amongst test subjects following introduction to Thymosin Alpha-1. Subsequent studies and systematic reviews, such as those conducted by Yu et al., have supported the hypothesis that Tα1 could alleviate the immunosuppression associated with severe sepsis. However, all these studies were conducted on an exceedingly small pool of test subjects. Given the complex immune dynamics during sepsis, characterized by an initial hyperinflammatory response followed by a phase of immunosuppression, it is plausible that Tα1's potential could be highly dependent on the timing of exposure. Addressing this aspect, further investigations are required to establish a more detailed understanding of how Tα1 influences immune pathways during different stages of sepsis."
            },
            {
                "h3": "Thymosin Alpha-1 Research with HIV"
            },
            {
                "p": "A study(7) consisted of a randomized phase II open-label clinical trial on 20 clinically stable test subjects. These patients were already undergoing highly active antiretroviral (HAART), alongside which Thymosin Alpha-1 peptide was presented to monitor the impact of the combination. Thymosin Alpha-1 was presented two times in a week in 13 subjects. The remaining 7 subjects were given placebo. Every 2 weeks, the cell counts of CD4/CD8 cells, CD45 cells and signal joint T-cell receptor circles (sjTREC) levels were monitored. After 12 weeks, it was reported by the researchers that there were no apparent significant changes in the levels of CD4, CD and CD45 levels in both the peptide or the placebo group. However, the sjTREC levels reportedly increased in the subjects presented with the peptide. These elevated levels of sjTREC might potentially stimulate immune responses. This increase in sjTREC levels hints at the possibility that Thymosin Alpha-1 may contribute to immune reconstitution by enhancing thymic output. However, this change did not correspond with an increase in total T-cell numbers or significant changes in the proportions of naive and memory T-cell phenotypes. Researchers posited that while the rise in sjTREC levels might indicate a modest improvement in thymopoiesis, the overall recovery and functionality of the T-cell compartment appeared largely unchanged within the duration of this study."
            },
            {
                "h3": "Thymosin Alpha-1 and Cancer Cells"
            },
            {
                "p": "In a study,(8) the levels of the reactive oxygen species (ROS) were monitored in test models after the presentation of Tα 1. During this study, Thymosin Alpha-1 was presented in mice with liver carcinoma. Both the leukomonocytes and HepG2 cells, given the peptide, were isolated from the mouse spleens, for the purpose of this study. Upon analysis, it was observed by the researchers that the ROS level appeared to be significantly higher in the isolated leuko-monocytes, whereas it was apparently lower in the HepG2 cells. Also, the peptide appeared to possibly increase the levels of the leuko-monocytes, whereas it may have delayed the cell cycle for HepG2 cells and thereby reduced their levels in the system. The study also delved into the possible molecular pathways affected by these changes in the redox state. Particularly, the Akt signaling pathway, known to be influenced by ROS, was examined. It was found that in HepG2 cells, there was a dephosphorylation of Akt at Ser473 following Tα1 exposure, suggesting a decrease in Akt activity associated with lowered oxidative stress. This dephosphorylation of Akt might underpin the reduced proliferation seen in these cancer cells."
            },
            {
                "p": "Another laboratory study focused on lung cancer cells (A549), in order to investigate the potential of Thymosin Alpha-1 on cell proliferation, antioxidant enzyme activities, and cell migration.(9) The study's findings suggest that Thymosin Alpha-1 potentially exhibits an anti-proliferative action on A549 cells, particularly at concentrations of 24 and 48 μg/mL, which apparently led to a reduction in cell viability after 24 hours of exposure. Additionally, Thymosin Alpha-1 is posited to enhance the activity of several key antioxidant enzymes. For instance, increases in the activity levels of catalase were observed at concentrations of 12 μg/mL, suggesting a possible strengthening of the cells' oxidative stress response. The activities of superoxide dismutase (SOD) and glutathione peroxidase (GPx) also showed possible enhancements at concentrations of 6 and 12 μg/mL. These findings indicate that Thymosin Alpha-1 might contribute to the cellular antioxidant defense by mitigating the adverse actions of reactive oxygen species (ROS). Regarding cell migration, Thymosin Alpha-1 potentially inhibits the migration of A549 cells in a concentration-dependent manner, as indicated by scratch assays. In terms of ROS production, the study suggests that Thymosin Alpha-1 might lead to a reduction in cellular ROS levels, and this outcome further supports the notion that Thymosin Alpha-1 could play a role in moderating oxidative stress within cancer cells."
            },
            {
                "p": "Thymosin Alpha-1 peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Immunodeficiency, British Society for Immunology. Published March 2017. https://www.immunology.org/policy-and-public-affairs/briefings-and-position-statements/immunodeficiency",
                    "Dominari A, Hathaway Iii D, Pandav K, Matos W, Biswas S, Reddy G, Thevuthasan S, Khan MA, Mathew A, Makkar SS, Zaidi M, Fahem MMM, Beas R, Castaneda V, Paul T, Halpern J, Baralt D. Thymosin alpha 1: A comprehensive review of the literature. World J Virol. 2020 Dec 15;9(5):67-78. doi: 10.5501/wjv.v9.i5.67. PMID: 33362999; PMCID: PMC7747025. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747025/",
                    "National Center for Biotechnology Information. \"PubChem Compound Summary for CID 16130571, Thymalfasin\" PubChem, https://pubchem.ncbi.nlm.nih.gov/compound/Thymalfasin",
                    "Garaci E. Thymosin alpha1: a historical overview. Ann N Y Acad Sci. 2007 Sep;1112:14-20. doi: 10.1196/annals.1415.039. Epub 2007 Jun 13. PMID: 17567941. https://pubmed.ncbi.nlm.nih.gov/17567941/",
                    "Eckert K, Schmitt M, Garbin F, Wahn U, Maurer HR. Thymosin alpha 1 effects, in vitro, on lymphokine-activated killer cells from patients with primary immunodeficiencies: preliminary results. Int J Immunopharmacol. 1994 Dec;16(12):1019-25. doi: 10.1016/0192-0561(94)90081-7. PMID: 7705963. https://pubmed.ncbi.nlm.nih.gov/7705963/",
                    "Li C, Bo L, Liu Q, Jin F. Thymosin alpha1 based immunomodulatory therapy for sepsis: a systematic review and meta-analysis. Int J Infect Dis. 2015 Apr;33:90-6. doi: 10.1016/j.ijid.2014.12.032. Epub 2014 Dec 19. PMID: 25532482. https://pubmed.ncbi.nlm.nih.gov/25532482/",
                    "Chadwick D, Pido-Lopez J, Pires A, Imami N, Gotch F, Villacian JS, Ravindran S, Paton NI. A pilot study of the safety and efficacy of thymosin alpha 1 in augmenting immune reconstitution in HIV-infected patients with low CD4 counts taking highly active antiretroviral therapy. Clin Exp Immunol. 2003 Dec;134(3):477-81. doi: 10.1111/j.1365-2249.2003.02331.x. PMID: 14632754; PMCID: PMC1808897. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1808897/",
                    "Qin Y, Chen FD, Zhou L, Gong XG, Han QF. Proliferative and anti-proliferative effects of thymosin alpha1 on cells are associated with manipulation of cellular ROS levels. Chem Biol Interact. 2009 Aug 14;180(3):383-8. doi: 10.1016/j.cbi.2009.05.006. Epub 2009 May 12. PMID: 19442654. https://pubmed.ncbi.nlm.nih.gov/19442654/",
                    "Kharazmi-Khorassani J, Asoodeh A. Thymosin alpha-1; a natural peptide inhibits cellular proliferation, cell migration, the level of reactive oxygen species and promotes the activity of antioxidant enzymes in human lung epithelial adenocarcinoma cell line (A549). Environ Toxicol. 2019 Aug;34(8):941-949. doi: 10.1002/tox.22765. Epub 2019 May 8. PMID: 31067016."
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/09/Thymosin-Alpha-1-5MG-coa.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/09/Thymosin-Alpha-1-5MG-lc.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/09/Thymosin-Alpha-1-5MG-ms.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Thymosin Alpha-1 for sale online. Peptides for sale at 99% purity with top customer service. Get Thymosin Alpha-1 research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Thymosin Alpha-1 For Sale (5mg / 10mg) | Core Peptides",
            "og:description": "Thymosin Alpha-1 for sale online. Peptides for sale at 99% purity with top customer service. Get Thymosin Alpha-1 research study results & information.",
            "og:url": "https://www.corepeptides.com/peptides/thymosin-alpha-1/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-02-18T15:23:01+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Thymosin-Alpha-1.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Thymosin Alpha-1 For Sale (5mg / 10mg) | Core Peptides",
            "twitter:description": "Thymosin Alpha-1 for sale online. Peptides for sale at 99% purity with top customer service. Get Thymosin Alpha-1 research study results & information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Thymosin-Alpha-1.jpg",
            "twitter:label1": "Availability",
            "twitter:data1": "In stock",
            "product:brand": "Core Peptides",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-THYMOSA1-5-10",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/mgf-5mg/",
                "name": "MGF (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/MGF-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/aod-9604-5mg/",
                "name": "AOD 9604 (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/AOD-9604-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ghk-cu-50mg-copper/",
                "name": "GHK-Cu (Copper) (50mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHK-CU-50mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/peg-mgf-5mg/",
                "name": "PEG-MGF (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/PEG-MGF-5MG-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "id": "26",
        "url": "https://www.corepeptides.com/peptides/thymalin-25mg/",
        "name": "Thymalin (25mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Thymalin-25MG.jpg",
        "display_price": "$138.00",
        "display_specs": [
            "Size: 25mg Contents: Thymalin (25mg) Form: Lyophilized powder Purity: >99% SKU: P-THYMALIN-25",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$131.10"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$124.20"
            }
        ],
        "description": [
            {
                "h2": "Thymalin Peptide"
            },
            {
                "p": "Thymalin is a polypeptide isolated from the thymus gland, believed by researchers to help regulate immune functions.(2) Studies have suggested that Thymalin, a naturally occurring polypeptide, is primarily found in the young epidermal cells of the thymus gland. With increasing age, the levels of Thymalin decrease, eventually becoming thinned out and non-uniform in nature.(5)"
            },
            {
                "p": "Natural thymic peptides such as Thymalin were first isolated from the thymus gland via a mild acid extraction process. Upon further isolation studies, the proposed immunomodulatory molecule composed by Thymalin (L-Glu-L-Trp) was discovered and researched. This dipeptide molecule in Thymalin may possibly play a role in the peptide mechanism.(4)"
            },
            {
                "p": "While both Thymalin and Thymulin are naturally occurring thymic factors, their mode of action is hypothesized by researchers to different, where Thymalin is a polypeptide that may regulate thymic functions at optimal levels, the Thymulin appears to be a zinc-dependent nonapeptide hormone that may possibly enhance the thymic functions in fighting T-cell suppression."
            },
            {
                "h3": "Overview"
            },
            {
                "p": "Studies have been conducted to understand the functioning of both natural and synthetic thymic peptides.(6) The main compounds that have been studied areThymalin (natural polypeptide), Thymogen (synthetic peptide) and Vilon (its derived dipeptide)."
            },
            {
                "p": "The study suggested that all the peptides within this thymic family appear to function via possibly stimulating thymic functions i.e., differentiation of T-cells, induced changes in the nucleotides and cytokine cells and secretion of lymphocytes. The other significant hypothesis made during this study was that the naturally occurring peptide, Thymalin, may potentially stimulate the antioxidant responses, whereas the two synthetic analogues did not appear to the researchers to alter these responses. Thymalin, being a natural extract, possibly exhibits a broader range of biological activities compared to its synthetic counterparts, Thymogen and Vilon. For instance, by potentially aiding in the reduction of oxidative stress, Thymalin might contribute indirectly to controlling inflammatory responses, which are typically exacerbated by oxidative damage."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C33H54N12O15 Molecular Weight: 858.864 g/mol Other Known Titles: Thymulin, Thymic Factor"
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Thymalin and Carcinogenesis"
            },
            {
                "p": "In this study,(7) 76 female rats of 5 months of age were selected. The main aim of this study was to determine the potential of Thymalin on the tumor development and thereby survival rates of the test models. The rats were divided into two groups, where 32 rats were presented with saline, and the remaining rats were presented with Thymalin. The compounds were introduced to the test subjects 5x a week for one year. All rats were monitored for mortality rates and development of tumors throughout the one-year period. The study results reported that the average lifespan in the control group was 949 days whereas in the peptide group was 1048 days. The \"aging rate\" was reported as 0.0071 days in the control group and 0.0041 in the peptide group. What's more, the tumor incidence reportedly decreased by 1.5x in the peptide group as compared to the control group. It is plausible that the reduction in tumor occurrence was even more significant for hematopoietic cancer cells, with incidences appearing to be approximately 3.4 times lower in murine models exposed to the peptide. This observation might indicate that the peptide could influence key elements of the immune system essential for inhibiting cancer cell development and its progression. Subsequent inquiries into the mechanisms underlying these observations might show that the L-Glu-L-Trp in Thymalin is linked with improved differentiation of T-cumin, which are critical components of the adaptive immune system. This process may enhance the ability of these cells to identify complexes of peptides and major histocompatibility complex (MHC) molecules. Furthermore, noticeable alterations were observed in the levels of cyclic nucleotides within the cells, which play roles in cellular signaling processes. Additionally, there was an activation of neutrophil chemotaxis and phagocytosis, processes involved in the first-line defense against pathogens and potentially malignant cells. Furthermore, analysis of the study's data demonstrated that L-Glu-L-Trp was quickly absorbed, attaining notable concentrations in tissues such as the liver and lymph nodes. The presence of the peptide in these pivotal locations might enable a more efficient immune response, which could be a factor in the observed scientific findings."
            },
            {
                "h3": "Thymalin and Viral Infection"
            },
            {
                "p": "In this clinical study,(8) 50 female test subjects with HHV 1 and a group of control subjects were examined. All the subjects were presented with thymic peptides similar to Thymalin for a period of 2 months. Before and after the study, peripheral blood cell tissues were collected from the subjects and examined to monitor the cytokine levels upon peptide presentation. Upon analysis, it was determined that compared to the control group, the cytokine levels were elevated in a higher proportion in the HHV 1 group. The levels of cytokines CD4+ and CD8+ were reportedly elevated in the HHV 1 group as compared to the control. Additionally, researchers reported that after a two-month period, no reactivation of the HHV 1 virus was reported in the test group. Further analysis was conducted to understand the potential mechanisms through which thymic peptides may influence immune exhaustion markers and cytokine levels. The study reported changes in the expression of the exhaustion markers PD-1 and PD-L1 on both T and B lymphocytes. Post-exposure measurements indicated a notable decrease in the co-expression of these markers, suggesting a potential revitalization of immune response capabilities in the subjects. Moreover, the specific increase in the levels of IFN-γ and IL-2 related to thymic peptides suggests a targeted enhancement of Th1 immune responses, which are crucial for antiviral defense. This action was observed without significant changes in the levels of IL-4 and IL-10, indicating that thymic peptides might selectively promote a type of immune response that is more effective against viral infections, without broadly elevating all aspects of immune activation."
            },
            {
                "h3": "Thymalin and Toxic Goiter Models"
            },
            {
                "p": "In this clinical study,(9) 104 test subjects with mild Diffuse Toxic Goiter (DTG) were enrolled, and their levels of medium weight molecular peptides and lipid oxidation rates were monitored. The main aim of this study was to establish the potential of Thymalin in interacting with DTG. The test subjects were divided into five groups where each group was presented with an external compound, a combination of Thymalin and an external compound, or the peptide alone. Following the study, it was reported that a combination of compounds and Thymalin exhibited mitigation of DTG symptoms in the test subjects."
            },
            {
                "h3": "Thymalin and Lympholeukemia Models"
            },
            {
                "p": "In this clinical study,(12) test subjects with chronic lymphoid leukemia were enrolled in the inclusion study composed of specific and nonspecific immune correction action, namely Thymalin presentation and plasmapheresis, respectively. Compared to the sole impact of chemotherapeutic agents, this combined presentation apparently resulted in a reported increase in physiological functioning within a short period."
            },
            {
                "h3": "Thymalin and Geroprotection"
            },
            {
                "p": "In this test study,(13) the geroprotective potential of Thymalin (thymic peptide) and Epithalamin (pineal peptide) were studied on 266 mature test subjects for a period of 6 to 8 years. The subjects were presented with the peptides for the first 2 to 3 years and were then monitored on a regular basis. The subjects were divided into several groups: Group I was presented with Thymalin, Group II with Epithalamin, Group III with both peptides and a separate group where test subjects were presented with both peptides at a different concentration rate. The peptides were presented to the test models annually for 6 years. The studies suggested that basic functions improved significantly upon study under both the peptides, including cardiovascular, neurological, immunological functions and that the peptide possibly improved rates of metabolism and hemostasis. It is posited that Thymalin may contribute to the maintenance or possibly the rejuvenation of thymic function, which typically declines gradually. This action on thymic function might explain the observed improvements in T-cell mediated immunity. Researchers noted a potential restoration of both the quantity and functionality of T-cells, which are critical for adaptive immunity. Additionally, Thymalin may exert actions on systemic inflammation, a common feature in aging models. The study hinted at a possible reduction in markers of systemic inflammation in subjects exposed to Thymalin. This observation aligns with the hypothesized role of Thymalin in modulating cytokine production and immune cell regulation, which may collectively contribute to a reduction in chronic inflammation. The potential influence of Thymalin on stress hormones, particularly cortisol, was another focal point of the study. Thymalin might potentially modulate the hypothalamic-pituitary-adrenal (HPA) axis to stabilize cortisol levels, thereby mitigating some of the adverse actions of stress. In terms of metabolic actions, subjects exposed to Thymalin showed potential improvements in metabolic stability. Researchers observed a possible normalization of metabolic parameters such as glucose and lipid profiles. These changes could be indicative of Thymalin's influence on metabolic processes, possibly through enhancement of cellular metabolism or through direct actions on metabolic enzymes."
            },
            {
                "p": "Thymalin peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Disorders of the Immune system. https://www.hopkinsmedicine.org/health/conditions-and-diseases/disorders-of-the-immune-system",
                    "Khavinson VK, Linkova NS, Kvetnoy IM, Polyakova VO, Drobintseva AO, Kvetnaia TV, Ivko OM. Thymalin: Activation of Differentiation of Human Hematopoietic Stem Cells. Bull Exp Biol Med. 2020 Nov;170(1):118-122. doi: 10.1007/s10517-020-05016-z. Epub 2020 Nov 25. https://pubmed.ncbi.nlm.nih.gov/33237528/",
                    "Remien K, Jan A. Anatomy, Head and Neck, Thymus. [Updated 2021 Feb 9]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK539748/",
                    "Morozov VG, Khavinson VK. Natural and synthetic thymic peptides as therapeutics for immune dysfunction. Int J Immunopharmacol. 1997 Sep-Oct;19(9-10):501-5. doi: 10.1016/s0192-0561(97)00058-1. https://pubmed.ncbi.nlm.nih.gov/9637345/",
                    "Khlystova, Z.S., Kalinina, I.I., Shmeleva, S.P. et al. Age-Related Changes of Thymalin Content in Human Epidermis. Bulletin of Experimental Biology and Medicine 133, 620–622 (2002). https://doi.org/10.1023/A:1020214816056",
                    "V.G. Morozov, V.Kh. Khavinson, Natural and synthetic thymic peptides as therapeutics for immune dysfunction, International Journal of Immunopharmacology, Volume 19, Issues 9–10, 1997, Pages 501-505. https://www.sciencedirect.com/science/article/abs/pii/S0192056197000581",
                    "Anisimov VN, Khavinson VK, Morozov VG. Immunomodulatory synthetic dipeptide L-Glu-L-Trp slows down aging and inhibits spontaneous carcinogenesis in rats. Biogerontology. 2000;1(1):55-9. https://pubmed.ncbi.nlm.nih.gov/11707921/",
                    "Hymos A, Grywalska E, Klatka J, Klatka M, Korona-Głowniak I, Roliński J. ThymicPeptides Reverse Immune Exhaustion in Patients with Reactivated Human Alphaherpesvirus1 Infections. Int J Mol Sci. 2020 Mar 30;21(7):2379. https://pubmed.ncbi.nlm.nih.gov/32235584/",
                    "Iangolenko VV. The effect of combined therapy with the use of thymalin and piracetam on the level of middle-molecule peptides in the blood and on the lipid peroxidation activity in patients with diffuse toxic goiter. Ter Arkh. 1991;63(10):60-3. Russian. https://pubmed.ncbi.nlm.nih.gov/1725225/",
                    "Khavinson, V., Linkova, N., Dyatlova, A., Kuznik, B., & Umnov, R. (2020). Peptides: Prospects for Use in the Treatment of COVID-19. Molecules (Basel, Switzerland), 25(19), 4389. https://doi.org/10.3390/molecules25194389",
                    "Khavinson, V. K., Linkova, N. S., Kvetnoy, I. M., Polyakova, V. O., Drobintseva, A. O., Kvetnaia, T. V., & Ivko, O. M. (2020). Thymalin: Activation of Differentiation of Human Hematopoietic Stem Cells. Bulletin of experimental biology and medicine, 170(1), 118–122. https://doi.org/10.1007/s10517-020-05016-z",
                    "Tretiak NN, Babenko TF, Gaĭdukova SN, Zverkova AS, The efficacy of using thymalin and plasmapheresis in the combined treatment of patients with chronic lympholeukemia. Lik Sprava. 1998 Mar-Apr;(2):93-6. Russian. https://pubmed.ncbi.nlm.nih.gov/9670669/",
                    "Khavinson VKh, Morozov VG. Peptides of pineal gland and thymus prolong human life. Neuro Endocrinol Lett. 2003 Jun-Aug;24(3-4):233-40. PMID: 14523363. https://pubmed.ncbi.nlm.nih.gov/14523363/",
                    "Hermánek J, Prokopic J. Influence of thymic preparations on the result of experimental infection with Taenia crassiceps (Zeder, 1800) in ICR mice. Folia Parasitol (Praha). 1989;36(4):331-40. https://pubmed.ncbi.nlm.nih.gov/2488049/",
                    "Bach JF, Dardenne M. Thymulin, a zinc-dependent hormone. Med Oncol Tumor Pharmacother. 1989;6(1):25-9. doi: 10.1007/BF02985220. PMID: 2657247. https://pubmed.ncbi.nlm.nih.gov/2657247/",
                    "National Center for Biotechnology Information. \"PubChem Compound Summary for CID 3085284, Nonathymulin\" PubChem, https://pubchem.ncbi.nlm.nih.gov/compound/Nonathymulin"
                ]
            },
            {
                "p": " "
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/09/Thymalin-25MG-coa.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/09/Thymalin-25MG-lc.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/09/Thymalin-25MG-ms.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Thymalin for sale online (25mg). Peptides for sale at 99% purity with top customer service. Get Thymalin research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Thymalin For Sale (25mg) | Core Peptides",
            "og:description": "Thymalin for sale online (25mg). Peptides for sale at 99% purity with top customer service. Get Thymalin research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/thymalin-25mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T16:53:22+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Thymalin-25MG.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Thymalin For Sale (25mg) | Core Peptides",
            "twitter:description": "Thymalin for sale online (25mg). Peptides for sale at 99% purity with top customer service. Get Thymalin research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Thymalin-25MG.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$138.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:brand": "Core Peptides",
            "product:price:amount": "138.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-THYMALIN-25",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/bpc-157/",
                "name": "BPC-157 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/BPC-157-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ghrp-6/",
                "name": "GHRP-6 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHRP-6-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/cjc-1295-dac-5mg/",
                "name": "CJC-1295 DAC (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/CJC-1295-DAC-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ghrp-2/",
                "name": "GHRP-2 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHRP-2-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "id": "27",
        "url": "https://www.corepeptides.com/peptides/thymagen-20mg/",
        "name": "Thymagen (20mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2023/12/Thymagen-Glu-Trp-20mg.jpg",
        "display_price": "$78.00",
        "display_specs": [
            "Size: 20mg Contents: Thymagen Form: Lyophilized powder Purity: >99% SKU: P-THYMAGEN-20",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$74.10"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$70.20"
            }
        ],
        "description": [
            {
                "h2": "Thymagen Peptide"
            },
            {
                "p": "Thymagen, also known as EW (Glu-Trp), is a synthetically formulated bioregulator peptide, classified within the group of Khavinson peptides. It is an artificial peptide analog of the thymus-derived polypeptide, thymalin, and is noted for its potential immunomodulating characteristics. Thymagen’s role in immune system modulation is becoming increasingly recognized. It seems to interact with key immune processes, potentially modifying immune responses and defense mechanisms. This includes the possibility of altering immune cell activities and influencing the production of various cytokines. In cellular studies, Thymagen research has suggested its potential action on immune regulation, positing its involvement in reinforcing the natural defense mechanisms."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular formula: C16H19N3O5 Molecular weight: 333.3 g/mol Sequence: Glu-Trp Other known titles:Oglufanide, Thymogen"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Thymagen and Immune Cells"
            },
            {
                "p": "The research on Thymagen may indicate a potential influence on cyclic nucleotide systems in murine models, which is particularly noted in the context of anaphylaxis and sensitization. In such models, Thymagen, along with other peptide substances with similar potential like thymalin and vilosen, possibly affects the catabolic processes of cyclic nucleotides. In sensitized animals, researchers have noted an apparent decrease in the ratio of cyclic adenosine monophosphate (cAMP) to cyclic guanosine monophosphate (cGMP). Thymagen's potential role in this process appears to be connected to a modulation of this ratio. When anaphylaxis occurs, the cAMP/cGMP ratio apparently returns to a reference level, implying a balancing action. Further, Thymagen may potentially contribute to the increased activity of enzymes responsible for cyclic nucleotide catabolism in lymphocytes of sensitized murine models. This tendency towards an increase is also posited in lymphocytes of murine models of anaphylaxis.(1)"
            },
            {
                "p": "Apart from anaphylaxis and hypersensitivity models, Thymagen has also been researched regarding its potential action in models of bacterial infections. According to one trial, Thymagen may have a potential immunoregulatory action in murine models of Yersinia enterocolitica infection. This potential might include a reduction in the polyclonal immune response and the development of autoimmune reactions. Notably, Thymagen appeared to have promoted the intensive development of delayed hypersensitivity in a model of enteral infection with Yersinia enterocolitica. However, it is important to note that this action did not appear to manifest in all cases. Furthermore, Thymagen appeared to have enhanced the nonspecific resistance of the murine models. This enhancement may have potentially contributed to a decrease in the spread of the infective agents across various organs and tissues and facilitated their subsequent elimination from the murine models.(2)"
            },
            {
                "p": "Thymagen may also have potential to regulate immunological processes, particularly in the context of T-lymphocyte differentiation and secondary immunodeficiency in experimental models of autoimmune conditions. It is posited that Thymogen may act to modulate certain immune responses, thereby reducing potential secondary immune deficit in these models. The researchers commented that “clinical effect […] was registered in 94.4%, laboratory effect in 83.3%” in tested models.(3)"
            },
            {
                "p": "Other experiments have also investigated scenarios involving secondary immunodeficiency, particularly in models of fungal infections like candidiasis. The underlying hypothesis of one such study posits that Thymogen might possibly activate the immunocompetent system, including the thymus. This activation is thought to potentially contribute to the mitigation of the severity of candidiasis. In murine models, where secondary immunodeficiency is induced and followed by the development of candidiasis, Thymogen has been suggested to affect the course of the infection. The observations suggest that after exposure to Thymogen, the severity of candidiasis in these models might be reduced. This outcome implies that Thymogen may have a role in bolstering the immune response, particularly in fungal infection models.(4)"
            },
            {
                "h3": "Thymagen and Cardiac Cells"
            },
            {
                "p": "Thymagen may have shown potential in addressing various types of arrhythmias in murine models. This potential has been posited through its examination in six distinct arrhythmia models. These models include those apparently induced by agents like aconitine, calcium chloride, strophanthin, scenarios of low sodium levels, reperfusion, and epinephrine administration. These agents are also known to induce ischaemia and therefore used to model arrhythmia. Yet, more trials are needed to evaluate and access these findings. The scientists specifically noted that “The mechanism of the Thymogen anti-ischemic action is realized without the participation of the opiate receptors and blockade of calcium entrance into the cardiomyocytes.”(5)"
            },
            {
                "h3": "Thymagen and Tumor Cells"
            },
            {
                "p": "A study in murine models which underwent exposure of N-nitrososarcosine ethyl ester (NSEE) reported an apparent induction of the formation of papilloma cells and carcinoma cells in cultures from esophagus cell lines. The researchers reported that Thymagen apparently decreased the occurrence of such tumor cells by roughly 12% and seemingly reduced the tumor multiplicity by 1.7 times.(6)"
            },
            {
                "p": "In another study involving murine models and Thymagen, the models were exposed to high levels of radiation exposure from radionuclide over 12 months, ultimately inducing the formation of cancer cells. Some of these models were also apparently introduced with Thymagen for five consecutive days each month, alongside the radionuclide exposure. The results from this study suggested that the murine models exposed to radionuclides alone exhibited a higher occurrence of tumor cells generally, and especially in cell lines from breast tissue. Conversely, in the rats that were also exposed to Thymagen alongside the radionuclides, there appeared to be a reduction in both the total number of tumor cells and their incidence. Furthermore, the study posited that murine models exposed only to Thymagen (without radionuclide exposure) appeared to exhibit an apparently longer lifespan, a slower aging rate, and a lower overall occurrence of tumor cells, both malignant and benignant. This finding may highlight Thymagen's potentially broader role in influencing aging and tumor development, beyond its apparent interaction with radiation-induced carcinogenesis.(7)"
            },
            {
                "p": "A third study explored the potential of Thymagen, particularly focusing on its action on cellular immunity in the context of subjects with solid tumors in the abdominal cavity and retroperitoneal space, specifically before manual excision. Study findings following Thymagen exposure for seven days suggest that it may potentially aid in restoring the structural and functional parameters of cellular immunity, when compared to a placebo group. This potential is indicated by a reduction in the number and severity of complications observed in the study, as well as a possible shortening of the recovery period following an excision.(8)"
            },
            {
                "p": "Thymagen peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Demidov, S. V., Kostromin, A. N., Kuĭbeda, V. V., Chernaia, I. V., & Borovok, M. I. (1991). Vliianie timagena, timalina i vilozena na soderzhanie cAMP, cGMP i aktivnost' fosfodiésteraz v limfotsitakh selezenki pri sensibilizatsii i anafilakticheskom shoke [Effect of thymagen, thymalin and vilosen on the cAMP and cGMP levels and phosphodiesterase activity in spleen lymphocytes during sensitization and anaphylactic shock]. Ukrainskii biokhimicheskii zhurnal (1978), 63(4), 104–106. https://pubmed.ncbi.nlm.nih.gov/1659006/",
                    "Iushchuk, N. D., Tseneva, G. I.a, Alenushkina, T. V., & Kuliashova, L. B. (1995). Effektivnost' primeneniia timogena pri éksperimental'noĭ infektsii, vyzvannoĭ Yersinia enterocolitica [The efficacy of using thymogen in an experimental infection caused by Yersinia enterocolitica]. Zhurnal mikrobiologii, epidemiologii i immunobiologii, (3), 106–108. https://pubmed.ncbi.nlm.nih.gov/7660690/",
                    "Zhuk, E. A., & Galenok, V. A. (1996). Timogen v lechenii sakharnogo diabeta I tipa [Thymogen in the treatment of type-1 diabetes mellitus]. Terapevticheskii arkhiv, 68(10), 12–14. https://pubmed.ncbi.nlm.nih.gov/9026934/",
                    "Khmel'nitskiĭ, O. K., Iakovlev, G. M., Belianin, V. L., Khavinson, V. K.h, Morozov, V. G., & Deĭgin, V. I. (1990). Vliianie sinteticheskogo peptida timusa (timogena) na immunnuiu sistemu pri kandidoze v usloviiakh immunodepressii [The effect of a synthetic thymus peptide (thymogen) on the immune system in candidiasis under immunodepression]. Arkhiv patologii, 52(1), 20–25. https://pubmed.ncbi.nlm.nih.gov/2337388/",
                    "Filippova, O. V., Reznikov, K. M., Alabovskił, V. V., Khamburov, V. V., & Vinokurov, A. A. (1997). Vliianie timogena na sostoianie serdtsa pri ishemii i reperfuzii [The effect of thymogen on the heart in ischemia and reperfusion]. Eksperimental'naia i klinicheskaia farmakologiia, 60(3), 27–29. https://pubmed.ncbi.nlm.nih.gov/9324392/",
                    "Bespalov, V. G., Troian, D. N., Petrov, A. S., Morozov, V. G., & Khavinson, V. K.h (1989). Ingibiruiushchiĭ éffekt timogena na razvitie opukholeĭ pishchevoda i predzheludka, indutsirovannykh étilovym éfirom N-nitrozosarkozina u krys [Inhibiting effect of thymogen on the development of tumors of the esophagus and forestomach induced by N-nitrososarcosine ethyl ester in rats]. Eksperimental'naia onkologiia, 11(4), 23–26. https://pubmed.ncbi.nlm.nih.gov/2759010/",
                    "Anisimov, V. N., Miretskiĭ, G. I., Morozov, V. G., Pavel'eva, I. A., & Khavinson, V. K.h (1992). Vliianie sinteticheskogo immunomoduliatora timogena na radiatsionnyĭ kantserogenez u krys [The effect of the synthetic immunomodulator thymogen on radiation-induced carcinogenesis in rats]. Voprosy onkologii, 38(4), 451–458. https://pubmed.ncbi.nlm.nih.gov/1300740/",
                    "Smirnov, V. S., Petlenko, S. V., & El'tsin, S. S. (2011). Advances in gerontology = Uspekhi gerontologii, 24(2), 278–284. https://pubmed.ncbi.nlm.nih.gov/21957588/"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "",
        "high_performance_liquid_chromatography": "",
        "mass_spectrometry": "",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Thymagen for sale online (20mg). Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Thymagen for Sale (20mg) - Core Peptides",
            "og:description": "Thymagen for sale online (20mg). Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/thymagen-20mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-05-12T13:56:24+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2023/12/Thymagen-Glu-Trp-20mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Thymagen For Sale (20mg) - Core Peptides",
            "twitter:description": "Thymagen for sale online (20mg). Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2023/12/Thymagen-Glu-Trp-20mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$78.00",
            "twitter:label2": "Availability",
            "twitter:data2": "Out of stock",
            "product:brand": "Core Peptides",
            "product:price:amount": "78.00",
            "product:price:currency": "USD",
            "og:availability": "out of stock",
            "product:availability": "out of stock",
            "product:retailer_item_id": "P-THYMAGEN-20",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/cjc-1295-dac-5mg/",
                "name": "CJC-1295 DAC (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/CJC-1295-DAC-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/semax-25mg/",
                "name": "Semax (25mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Semax-25MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/dsip-5mg/",
                "name": "DSIP (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/DSIP-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/epitalon-25mg/",
                "name": "Epithalon (25mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Epithalon-5MG-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "id": "28",
        "url": "https://www.corepeptides.com/peptides/testagen-20mg/",
        "name": "Testagen (20mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2023/10/Testagen-20mg.jpg",
        "display_price": "$63.00",
        "display_specs": [
            "Size: 20mg Contents: Testagen Form: Lyophilized powder Purity: >99% SKU: P-TESTAGEN-20",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$59.85"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$56.70"
            }
        ],
        "description": [
            {
                "h2": "Testagen Peptide"
            },
            {
                "p": "Testagen, alternatively known as KEDG, is classified among the Khavinson peptides and functions as a short signaling peptide. Short peptides such as Testagen are also suggested to serve as bioregulators which means that they may potentially cross both the cell and nuclear membranes to interact directly with DNA of target tissues.(1) Potentially, it may interact with the function of the anterior pituitary gland cells and interact with endocrine pathways that play a role in the synthesis of testosterone and thyroid-stimulating hormone (TSH).(2) This is likely due to the synthesis of Testagen, which is based on the amino acid composition of extracts from the anterior lobe of the pituitary gland.(3) As a result, it is made of the amino acids lysine, glutamine, asparagine and glycine, forming a tetrapeptide."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular formula: C17H29N5O9 Molecular weight: 447.2 g/mol Sequence: Lys-Glu-Asp-Gly Reconstitution: Required Other known titles: KEDG, Anterior pituitary peptide (APP)"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Testagen and the Hypothalamic-Pituitary-Gonadal Axis"
            },
            {
                "p": "Testagen appears to be a bioregulator that may interact with the pituitary gland to upregulate testosterone production. Some trials suggest that the peptide may enhance testosterone production in research models of chronic inflammation and low testosterone as a result. Testagen was suggested to potentially improve uroflowmetry indicators, reduce markers of inflammation, and potentially cause an elevation in the total levels of testosterone. The researchers commented about “a decrease in the level of inflammation in the prostate, an increase in the level of total testosterone.”(4)"
            },
            {
                "p": "While the exact mechanisms behind the potential of testagen remain unknown, some researchers have posited that the peptide may potentially have interactions with histones, which might influence epigenetic mechanisms, affecting cellular activities and differentiation. This interaction between short peptides and histones, particularly in the N-terminal histone regions containing seemingly homologous peptide-binding motifs, suggests an intriguing role in the regulation of chromatin structure and gene expression."
            },
            {
                "p": "Testagen has been observed to bind to certain histone regions with a specific conformational structure, this implies a potential impact on the structural dynamics of chromatin. Although core histones did not reveal homologous amino acid sequences, the specific binding indicates that peptides might interact with them through unique spatial conformation rather than sequence homology. This complexation with histones, as well as histone-deoxyribooligonucleotide complexes, suggests a site-specific nature, being influenced by the primary structures of peptides and oligonucleotides involved. Testagen appears to be interacting with histones, and may play a role in the conformation and functional state of chromatin, consequently influencing gene activity and cellular differentiation through epigenetic mechanisms. Understanding the exact pathways and impacts of these interactions would require further exploration and detailed studies into how such peptide-histone complexes influence gene transcription, DNA repair, replication, and other cellular processes influenced by chromatin structure.(5)"
            },
            {
                "h3": "Testagen and the Hypothalamic–Pituitary–Thyroid Axis"
            },
            {
                "p": "In a thorough exploration of Testagen, its impact was conducted on hypophysectomized avian models. The models were apparently used to analyze the synthetic peptide's potential on the functional activity and morphological structure of the thyroid gland. Hypophysectomization, a procedure involving the removal or disabling of the pituitary gland, apparently induced a series of physiological alterations in the avian models, such as growth retardation, reduced excitability, and anorexia, along with changes including decreased body and thyroid gland weight, increased thyroid follicle size, and flattened thyrocytes. Furthermore, a notable decrease was reported in thyroid hormone concentrations, including thyroid-stimulating hormone (TSH), T3 (Triiodothyronine), T4 (Thyroxine), and free thyroxine.(3)"
            },
            {
                "p": "After introducing Testagen there appeared to be distinct outcomes noticed among the avian models. An apparent 23% increase in body weight was suggested, complemented by a slight apparent augmentation in the thyroid gland's weight. Morphological adaptations also appeared to take place, such as an apparent reduction in the mean sectional area of follicles and a potential prevention of follicular epithelium flattening and colloid accumulation within the follicular cavity. Noteworthy appeared to be a well-defined interfollicular epithelium, coupled with variations in the nuclear-cytoplasmic ratio and a decrease in the height of thyrocytes, though these were considered less significant than in the control group. Additionally, Testagen exhibited an apparent stimulating impact on the growth of the thyroid capsule, despite the width of the thyroid capsule in these models still appearing to be inferior to that of control models.(3)"
            },
            {
                "p": "Diving into the realm of aged avian models a normalization of the thyroid gland weight post-Testagen introduction was apparently observed. The synthetic peptide appeared to exert a moderate stimulating impact on the proliferation of epithelial cells. Consequently, the follicle size in these older avian models may have exceeded that of their younger counterparts. While the epithelium shape may have remained almost constant, a minor elevation was apparently seen in the nuclear-cytoplasmic ratio. Overall, the researchers suggested that the peptide may have better action in younger models and commented that “Restoration of the thyroid functions and morphology was registered to be greater in one-year-old chicken as compared to five-year-old ones.”(3)"
            },
            {
                "p": "Testagen peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Fedoreyeva, L. I., Kireev, I. I., Khavinson, V. K.h, & Vanyushin, B. F. (2011). Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNA. Biochemistry. Biokhimiia, 76(11), 1210–1219. https://doi.org/10.1134/S0006297911110022",
                    "Khavinson, V. K., Popovich, I. G., Linkova, N. S., Mironova, E. S., & Ilina, A. R. (2021). Peptide Regulation of Gene Expression: A Systematic Review. Molecules (Basel, Switzerland), 26(22), 7053. https://doi.org/10.3390/molecules26227053",
                    "Kuznik, B. I., Pateiuk, A. V., Rusaeva, N. S., Baranchugova, L. M., & Obydenko, V. I. (2011). Advances in gerontology = Uspekhi gerontologii, 24(1), 93–98. https://pubmed.ncbi.nlm.nih.gov/21809626/",
                    "Rossikhin, V. V., Hoshchenko, Y. O., & Osipov, P. G. (2011). EFFICACY OF TESTOSTERONE SYNTHESIS INDUCTOR APPLICATION\" TESTAGEN\" IN ANDROGENIC DEFICIENCY IN PATIENTS WITH CHRONIC ABACTERIAL PROSTATITIS. Problems of Endocrine Pathology, 36(2), 17-22. DOI: 10.21856/j-PEP.2011.2.03",
                    "Fedoreyeva, L. I., Smirnova, T. A., Kolomijtseva, G. Y., Khavinson, V. K., & Vanyushin, B. F. (2013). Interaction of short peptides with FITC-labeled wheat histones and their complexes with deoxyribooligonucleotides. Biochemistry (Moscow), 78, 166-175. https://doi.org/10.1134/S0006297913020053"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/12/Testagen-COA.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/12/Testagen-LC.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/12/Testagen-MS.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Testagen for sale online (20mg). Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Testagen For Sale (20mg) - Core Peptides",
            "og:description": "Testagen for sale online (20mg). Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/testagen-20mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-05-22T17:26:15+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2023/10/Testagen-20mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Testagen For Sale (20mg) - Core Peptides",
            "twitter:description": "Testagen for sale online (20mg). Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2023/10/Testagen-20mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$63.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:brand": "Core Peptides",
            "product:price:amount": "63.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-TESTAGEN-20",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/adipotide-10mg/",
                "name": "Adipotide (FTPP) (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Adipotide-FTPP-10MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/aod-9604-5mg/",
                "name": "AOD 9604 (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/AOD-9604-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/mgf-5mg/",
                "name": "MGF (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/MGF-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/selank-10mg/",
                "name": "Selank (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Selank-10MG-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "id": "29",
        "url": "https://www.corepeptides.com/peptides/tesamorelin-ipamorelin-blend-8mg/",
        "name": "Tesamorelin & Ipamorelin Blend (8mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2023/06/Tesamorelin-Ipamorelin-6-2-MG.jpg",
        "display_price": "$90.00",
        "display_specs": [
            "Size: 8mg Contents: Tesamorelin (6mg) & Ipamorelin (2mg) Form: Lyophilized powder Purity: >99% SKU: TESA-IPA-8MG",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$85.50"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$81.00"
            }
        ],
        "description": [
            {
                "h2": "Tesamorelin & Ipamorelin Peptide Blend"
            },
            {
                "p": "The Tesamorelin and Ipamorelin blend consists of two peptides that appear to share the potential to stimulate the growth hormone axis, albeit through differing mechanisms. This combination may synergistically activate the pituitary gland, which research suggests results in the release of endogenous growth hormone. The blend seems to offer a potential means to optimize growth hormone levels and may elicit effects on sleep, metabolic function, cognition, muscle tissue, lean mass, and lipid profiles.(1)(2)"
            },
            {
                "p": "It is possible that the combination of Tesamorelin and Ipamorelin may yield a range of impacts, which may include improved deep sleep, reduced levels of triglycerides, visceral adipose tissue (VAT), and carotid intima-media thickness (cIMT), enhanced cognition, and possible overall optimization of metabolic function. This blend appears to present an opportunity to harness the synergistic actions of both to potentially augment natural growth hormone levels."
            },
            {
                "h3": "Chemical Makeup(3)(4)"
            },
            {
                "p": "Molecular Formula"
            },
            {
                "p": "Molecular Weight"
            },
            {
                "p": "Sequence"
            },
            {
                "p": "Other Known Titles"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Tesamorelin & Ipamorelin Blend and Growth Hormone Deficiency"
            },
            {
                "p": "The Tesamorelin and Ipamorelin blend appears to exert its potential through distinct yet complementary proposed mechanisms of action. Tesamorelin, a growth hormone-releasing hormone (GHRH) analog, appears to act by binding to and activating the GHRH receptor on somatotrophs in the pituitary gland. This stimulation potentially triggers the synthesis and secretion of endogenous growth hormone (GH) in a pulsatile manner. By promoting GH release, Tesamorelin may possibly enhance lipolysis, reduce visceral adipose tissue, and also potentially improve glucose metabolism."
            },
            {
                "p": "Ipamorelin, a growth hormone secretagogue receptor (GHSR) agonist, by contrast, appears to activate GHSR in the hypothalamus and peripheral tissues, potentially leading to the release of GH. This peptide appears to exhibit a high selectivity for GHSR, potentially without interfering with other hormones. This GHSR activation by Ipamorelin may result in increased GH secretion, which, in turn, might promote protein synthesis, lipolysis, and insulin-like growth factor-1 (IGF-1) production, as suggested by researchers."
            },
            {
                "p": "When combined, the Tesamorelin and Ipamorelin blend may provide a synergistic impact by targeting different components of the growth hormone axis. Tesamorelin has been suggested to enhance GHRH-mediated GH release, while Ipamorelin has been suggested to directly stimulate GHSR to increase GH secretion. This dual action appears to amplify the overall GH, such as improved body composition, lipid profile, insulin sensitivity, and overall metabolic function in laboratory test models. By seemingly targeting the growth hormone axis through their supposed distinct mechanisms of action, Tesamorelin and Ipamorelin may collectively stimulate the pituitary gland, thereby potentially enhancing the release of endogenous growth hormone.(5)"
            },
            {
                "h3": "Tesamorelin & Ipamorelin Blend and the Pituitary Gland"
            },
            {
                "p": "The Tesamorelin and Ipamorelin blend appears to exhibit some impact on the pituitary gland, a critical endocrine organ considered responsible for the regulation of growth hormone secretion."
            },
            {
                "p": "Studies suggest that Tesamorelin may specifically target the growth hormone-releasing hormone receptor (GHRHR), potentially activating the signaling cascade that leads to growth hormone synthesis and subsequent release. As per the researchers, “Tesamorelin is a synthetic growth hormone-releasing hormone that acts on the anterior pituitary gland to stimulate the endogenous growth hormone secretion.”(6)"
            },
            {
                "p": "Studies suggest that the peptide may potentially cause a 69% increase in total growth hormone levels (apparently assessed via area under the curve - AUC) and a purported 55% increase in the mean pulse area of the growth hormone. The peptide was not reported to affect growth hormone pulse frequency or peak growth hormone levels.(7)"
            },
            {
                "p": "Ipamorelin, on the other hand, studies suggest may act as a potent agonist for the growth hormone secretagogue receptor (GHSR), seemingly promoting growth hormone secretion.(8) As stated in the studies, “Ipamorelin is the first GHRP-receptor agonist with a selectivity for GH release similar to that displayed by GHRH. The specificity of ipamorelin makes this compound a very interesting candidate for future clinical development.”(8)"
            },
            {
                "p": "Ipamorelin may have exhibited a propensity to elevate growth hormone levels, potentially reaching heights of up to 80mIU/l (equivalent to an approximate concentration of 26.6ng/ml). When expressed as a percentage increase in comparison to a placebo (1.31mIU/l or 0.4ng/ml), this augmentation appears to surpass 60-fold.(9)"
            },
            {
                "p": "When combined, these peptides appear to exert a synergistic action on the pituitary gland, which might result in enhanced growth hormone production. This proposed synergistic interaction between Tesamorelin and Ipamorelin may offer a promising avenue for research in optimizing growth hormone levels."
            },
            {
                "h3": "Tesamorelin & Ipamorelin Blend and Lipodystrophy"
            },
            {
                "p": "Research studies frequently indicate that lipodystrophy is often accompanied by insulin resistance, dyslipidemia, and an increased risk of cardiovascular complications. Clinical studies have suggested that Tesamorelin presentation in lipodystrophic test subjects might lead to a reduction in visceral adipose tissue (VAT) and improvements in insulin sensitivity and lipid profiles. Tesamorelin appears to act through the activation of the growth hormone-releasing hormone receptor (GHRHR), potentially stimulating endogenous growth hormone secretion and promoting lipolysis; and potentially preserving “abdominal subcutaneous adipose tissue, improving body image and lipids”.(10)"
            },
            {
                "p": "Similarly, Ipamorelin has been reported to exhibit some promise in influencing adipose tissue metabolism. By combining Tesamorelin and Ipamorelin, it is hypothesized by researchers that the synergistic potential of these peptides may enhance the reduction of VAT and improve metabolic parameters in lipodystrophy test models.(10)"
            },
            {
                "h3": "Tesamorelin & Ipamorelin Blend and Type 2 Diabetes"
            },
            {
                "p": "Preclinical and clinical studies have suggested that both Tesamorelin and Ipamorelin hold promise in improving glycemic control and mitigating the metabolic abnormalities associated with T2DM. Tesamorelin appears to stimulate endogenous growth hormone secretion, which has been long considered by scientists to enhance insulin sensitivity and glucose utilization. Ipamorelin studies also indicate that the peptide may influence glucose metabolism and insulin sensitivity. Combining Tesamorelin and Ipamorelin may provide complementary effects, which could also include reductions in hemoglobin A1c (HbA1c) levels, possible improvements in insulin sensitivity, and possible reductions in visceral adiposity in individuals with Type II Diabetes Mellitus.(11)"
            },
            {
                "h3": "Tesamorelin & Ipamorelin and Cognitive Improvement"
            },
            {
                "p": "Studies have indicated that growth hormone and its secretagogues, such as Tesamorelin and Ipamorelin, might play a role in neuroplasticity, neuronal survival, and synaptic plasticity, all of which are considered critical for optimal cognitive performance."
            },
            {
                "p": "Preclinical research has further suggested that Tesamorelin introduction may improve memory and learning abilities, possibly through its proposed impact on neurogenesis and synaptic plasticity. Furthermore, Ipamorelin has been suggested to enhance spatial memory and cognitive function in animal models. The combined influence of Tesamorelin and Ipamorelin may potentially amplify these cognitive benefits through their complementary mechanisms of action. By stimulating the growth hormone axis and modulating neurotrophic factors, this blend holds promise in cognitive improvement research."
            },
            {
                "h3": "Tesamorelin & Ipamorelin Blend and Muscle Density"
            },
            {
                "p": "In one of the aforementioned scientific examinations, the potential effects of Tesamorelin on muscle tissue integrity were assessed utilizing computed tomography (CT) scans. The results posited that there might be a relationship between Tesamorelin and enhancements in muscle density and size. Interestingly, certain muscle groups, notably the rectus abdominis, psoas major, and paraspinal muscles, appeared to display more pronounced changes, which were typified by either an augmentation in muscle density and size or a diminution in fat content. Statistically, these changes were distinct when compared with placebo. Yet, while it is believed that Tesamorelin's mechanism might be interconnected with molecules such as IGF-1, the study found no significant linkage between IGF-1 level shifts and modifications in muscle dimensions or density.(6)"
            },
            {
                "p": "In parallel, early explorations employing experimental frameworks have posited that Ipamorelin may potentially manifest actions akin to those observed with Tesamorelin in relation to skeletal muscle and bone structures. Yet, these observations are yet to be definitively corroborated. Delving deeper, it was suggested that Ipamorelin might interface with, and perhaps elevate, IGF-I concentrations. Such interactions seemed to correlate with a surge in muscle fiber dimensions, overall muscle volume, and consequently, a potential amplification in skeletal muscle robustness during this murine investigation.(12)"
            },
            {
                "h3": "Tesamorelin & Ipamorelin Blend and Bone Density"
            },
            {
                "p": "Ipamorelin seems to have a positive impact on bone health, potentially stimulating bone formation and fostering an enhancement in bone mass. The research posited a possible augmentation in bone mineral content that could be related to Ipamorelin. Various murine trials have alluded to the favorable effects of Ipamorelin on bone tissue.(13) (14) One specific murine study delved into the effects of Ipamorelin on bone mineral content (BMC). The findings proposed that there might be a surge in the test animals’ body weight and BMC, possibly discerned through dual X-ray absorptiometry. Yet, when standardized for body weight variations, the BMC to body weight ratio appeared consistent. An in vitro examination also indicated that the rise in cortical BMC could be attributed to an enlarged bone area, while the volumetric BMD seems to be stable."
            },
            {
                "h3": "Tesamorelin & Ipamorelin Blend on Appetite and Digestion"
            },
            {
                "p": "The interaction of Ipamorelin with ghrelin receptors appears to have implications for appetite modulation, potentially leading to augmented weight gain. One investigation posited that subjects exposed to Ipamorelin observed a roughly 15% ascent in body weight. It is suggested that this compound might have selectively amplified fat pad weights in relation to total body mass. Consequently, dual-energy X-ray absorptiometry assessments could reveal a nuanced increase in body fat composition. Emerging data also hints that Ipamorelin might elevate serum leptin levels, a hormone integral to energy and appetite regulation. This prompts the scientific community to consider the possibility that heightened food consumption may play a role in the documented weight augmentation within the Ipamorelin cohorts.(15)"
            },
            {
                "p": "In addition, activating the ghrelin receptor also appears to affect digestion. Thus, researchers delved into the possible effects of Ipamorelin on gastric functions compared to placebo, with a spotlight on its purported ability to expedite gastric emptying. To gauge this, they employed an intricate technique that tracked the residual radioactivity in the stomach 15 minutes after the introduction of a specific substance through intragastric gavage. It was posited that abdominal surgical interventions might have played a role in decelerating gastric emptying, a phenomenon seemingly prominent in the placebo control cohort. In contrast, Ipamorelin appeared to expedite this emptying process relative to the control group. These observations suggested the potential of Ipamorelin in augmenting the rate of gastric emptying.(16)"
            },
            {
                "p": "Diving deeper, the team sought to unravel the effects of this compound on the contractile dynamics of gastric smooth muscles when exposed to acetylcholine and electrical field stimulation. Data hinted that surgical manipulations of the intestines might markedly dampen the contractile responses to both inducements. Yet, intriguingly, this inhibitory effect seemed to be mitigated when Ipamorelin was co-presented with ghrelin. This introduces the tentative proposition that Ipamorelin might not just enhance gastric muscle contractility, but also possibly counterbalance the repressive outcomes instigated by specific surgical measures. (16)"
            },
            {
                "p": "Tesamorelin & Ipamorelin blend is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Adrian S, Scherzinger A, Sanyal A, Lake JE, Falutz J, Dubé MP, Stanley T, Grinspoon S, Mamputu JC, Marsolais C, Brown TT, Erlandson KM. The Growth Hormone Releasing Hormone Analogue, Tesamorelin, Decreases Muscle Fat and Increases Muscle Area in Adults with HIV. J Frailty Aging. 2019;8(3):154-159. doi: 10.14283/jfa.2018.45. PMID: 31237318; PMCID: PMC6766405. https://pubmed.ncbi.nlm.nih.gov/31237318/",
                    "Clemmons DR, Miller S, Mamputu JC. Safety and metabolic effects of tesamorelin, a growth hormone-releasing factor analogue, in patients with type 2 diabetes: A randomized, placebo-controlled trial. PLoS One. 2017 Jun 15;12(6):e0179538. doi: 10.1371/journal.pone.0179538. PMID: 28617838; PMCID: PMC5472315. https://pubmed.ncbi.nlm.nih.gov/28617838/",
                    "National Center for Biotechnology Information (2023). PubChem Compound Summary for CID 16137828, Tesamorelin. https://pubchem.ncbi.nlm.nih.gov/compound/Tesamorelin",
                    "National Center for Biotechnology Information (2023). PubChem Compound Summary for CID 9831659, Ipamorelin. https://pubchem.ncbi.nlm.nih.gov/compound/Ipamorelin",
                    "Rogério G. Gondo et al, Growth Hormone-Releasing Peptide-2 Stimulates GH Secretion in GH-Deficient Patients with Mutated GH-Releasing Hormone Receptor, The Journal of Clinical Endocrinology & Metabolism, Volume 86, Issue 7, 1 July 2001, Pages 3279–3283, https://doi.org/10.1210/jcem.86.7.7694",
                    "Adrian S, Scherzinger A, Sanyal A, Lake JE, Falutz J, Dubé MP, Stanley T, Grinspoon S, Mamputu JC, Marsolais C, Brown TT, Erlandson KM. The Growth Hormone Releasing Hormone Analogue, Tesamorelin, Decreases Muscle Fat and Increases Muscle Area in Adults with HIV. J Frailty Aging. 2019;8(3):154-159. doi: 10.14283/jfa.2018.45. PMID: 31237318; PMCID: PMC6766405. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6766405/",
                    "Stanley TL, Chen CY, Branch KL, Makimura H, Grinspoon SK. Effects of a growth hormone-releasing hormone analog on endogenous GH pulsatility and insulin sensitivity in healthy men. J Clin Endocrinol Metab. 2011 Jan;96(1):150-8. doi: 10.1210/jc.2010-1587. Epub 2010 Oct 13. PMID: 20943777; PMCID: PMC3038486. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038486/",
                    "Raun K, Hansen BS, Johansen NL, Thøgersen H, Madsen K, Ankersen M, Andersen PH. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998 Nov;139(5):552-61. doi: 10.1530/eje.0.1390552. PMID: 9849822. https://pubmed.ncbi.nlm.nih.gov/9849822/",
                    "Gobburu, J. V., Agersø, H., Jusko, W. J., & Ynddal, L. (1999). Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers. Pharmaceutical research, 16(9), 1412–1416. https://doi.org/10.1023/a:1018955126402",
                    "Falutz J, Mamputu JC, Potvin D, Moyle G, Soulban G, Loughrey H, Marsolais C, Turner R, Grinspoon S. Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data. J Clin Endocrinol Metab. 2010 Sep;95(9):4291-304. doi: 10.1210/jc.2010-0490. Epub 2010 Jun 16. PMID: 20554713. https://pubmed.ncbi.nlm.nih.gov/20554713",
                    "Clemmons DR, Miller S, Mamputu JC. Safety and metabolic effects of tesamorelin, a growth hormone-releasing factor analogue, in patients with type 2 diabetes: A randomized, placebo-controlled trial. PLoS One. 2017 Jun 15;12(6):e0179538. doi: 10.1371/journal.pone.0179538. PMID: 28617838; PMCID: PMC5472315. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472315/",
                    "Andersen, N. B., Malmlöf, K., Johansen, P. B., Andreassen, T. T., Ørtoft, G., & Oxlund, H. (2001). The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation of adult rats. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 11(5), 266–272. https://doi.org/10.1054/ghir.2001.0239",
                    "Johansen, P. B., Nowak, J., Skjaerbaek, C., Flyvbjerg, A., Andreassen, T. T., Wilken, M., & Orskov, H. (1999). Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 9(2), 106–113. https://doi.org/10.1054/ghir.1999.9998",
                    "Svensson, J., Lall, S., Dickson, S. L., Bengtsson, B. A., Rømer, J., Ahnfelt-Rønne, I., Ohlsson, C., & Jansson, J. O. (2000). The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats. The Journal of endocrinology, 165(3), 569–577. https://doi.org/10.1677/joe.0.1650569",
                    "Lall, S., Tung, L. Y., Ohlsson, C., Jansson, J. O., & Dickson, S. L. (2001). Growth hormone (GH)-independent stimulation of adiposity by GH secretagogues. Biochemical and biophysical research communications, 280(1), 132–138. https://doi.org/10.1006/bbrc.2000.4065",
                    "Greenwood-Van Meerveld, B., Tyler, K., Mohammadi, E., & Pietra, C. (2012). Efficacy of ipamorelin, a ghrelin mimetic, on gastric dysmotility in a rodent model of postoperative ileus. Journal of experimental pharmacology, 4, 149–155. https://doi.org/10.2147/JEP.S35396"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/12/Tesamorelin-Ipamorelin-COA-1.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/12/Tesamorelin-Ipamorelin-LC-1.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/12/Tesamorelin-Ipamorelin-MS-1.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Tesamorelin & Ipamorelin blend for sale (8mg). Purchase peptide blends at 99+% purity with unmatched customer service and free shipping.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Tesamorelin & Ipamorelin Blend For Sale (8mg) - Core Peptides",
            "og:description": "Tesamorelin & Ipamorelin blend for sale (8mg). Purchase peptide blends at 99+% purity with unmatched customer service and free shipping.",
            "og:url": "https://www.corepeptides.com/peptides/tesamorelin-ipamorelin-blend-8mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-05-22T17:28:05+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2023/06/Tesamorelin-Ipamorelin-6-2-MG.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Tesamorelin & Ipamorelin Blend For Sale (8mg) - Core Peptides",
            "twitter:description": "Tesamorelin & Ipamorelin blend for sale (8mg). Purchase peptide blends at 99+% purity with unmatched customer service and free shipping.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2023/06/Tesamorelin-Ipamorelin-6-2-MG.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$90.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "90.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "TESA-IPA-8MG",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/dsip-5mg/",
                "name": "DSIP (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/DSIP-5MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ipamorelin-5mg/",
                "name": "Ipamorelin (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Ipamorelin-5MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/peg-mgf-5mg/",
                "name": "PEG-MGF (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/PEG-MGF-5MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ll-37-5mg/",
                "name": "LL-37 (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/LL-37-5mg-300x300.jpg.webp",
                "price": ""
            }
        ]
    },
    {
        "id": "30",
        "url": "https://www.corepeptides.com/peptides/tesamorelin-mod-grf-ipamorelin-12mg/",
        "name": "Tesamorelin & CJC-1295 (Mod GRF 1-29) & Ipamorelin Blend (12mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2023/06/Tesamorelin-Mod-GRF-Ipamorelin-6-3-3-MG.jpg",
        "display_price": "$117.00",
        "display_specs": [
            "Size: 12mg Contents: Tesamorelin (6mg) & CJC-1295 (Mod GRF 1-29) (3mg) & Ipamorelin (3mg) Form: Lyophilized powder Purity: >99% SKU: TESA-MOD-GRF-IPA-12MG",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$111.15"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$105.30"
            }
        ],
        "description": [
            {
                "h2": "Tesamorelin & CJC-1295 (Mod GRF 1-29) & Ipamorelin Peptide Blend"
            },
            {
                "p": "Tesamorelin & CJC-1295 (Mod GRF 1-29) & Ipamorelin are all synthetic peptides which, albeit via different proposed mechanisms, have exhibited potential to stimulate growth hormone (GH) synthesis and secretion."
            },
            {
                "p": "Tesamorelin, a synthetic analogue of the growth hormone-releasing hormone (GHRH), appears to act by specifically stimulating the production and release of endogenous growth hormone (GH) due to its potential binding affinity for GHRH receptors. Structurally, Tesamorelin is a chain of 44 amino acids, containing a sequence that bears resemblance to GHRH. Intriguingly, modifications have been introduced to Tesamorelin to possibly fortify its defense against enzymatic breakdown. For instance, its C-terminus showcases a trans-3-hexenoic acid group alteration, a change sometimes referred to as an omega-amino acid modification, which is suggested to bolster the peptide's resilience to enzymatic degradation. Further, Tesamorelin's N-terminus is adorned with an acetyl group (CH₃CO-), a modification that might further amplify the molecule's stability and biological efficacy. Consequently, this peptide garners the designation N-(trans-3-hexenoyl)-[Tyr1]hGRF(1–44)NH2 acetate. When engaging with GHRH receptors located in regions like the pituitary and hypothalamus, it is theorized that Tesamorelin may stimulate the secretion of HGH from the resident pituitary cells."
            },
            {
                "p": "CJC-1295 (Mod GRF 1-29) is a synthetic peptide that appears to exhibit prolonged half-life as it is likely to resist enzymatic degradation. It is also known as CJC-1295 without DAC (Drug Affinity Complex). References suggest it as a tetrasubstituted variant of the shortest functional GHRH sequence, denoted GRF (1-29). Consequently, it is posited that this molecule may potentially engage with GHRH receptors on pituitary cells, possibly influencing the release of hGH. Research indicates that the peptide appears to act as a potent stimulator of GH secretion, similar to GHRH, which may show promise in promoting protein synthesis, muscle growth, and enhanced metabolic processes."
            },
            {
                "p": "Ipamorelin, a synthetic pentapeptide, appears to act as a selective agonist for the ghrelin receptor and may stimulate the release of GH. This is because ghrelin receptors are found in the pituitary gland, where they are called growth hormone secretagogue (GHS) receptors. It appears to display high specificity and minimal action on other hormonal systems, making it a target for research in GH stimulation."
            },
            {
                "h3": "Chemical Makeup (1)(2)(3)"
            },
            {
                "p": "Molecular Formula:"
            },
            {
                "p": "Molecular Weight:"
            },
            {
                "p": "Sequence"
            },
            {
                "p": "Other Known Titles"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Tesamorelin & CJC-1295 (Mod GRF 1-29) & Ipamorelin Blend and the Pituitary Gland"
            },
            {
                "p": "The Tesamorelin & CJC-1295 (Mod GRF 1-29) & Ipamorelin peptide blend appear to exhibit significant interactions with the pituitary gland, seemingly exerting potential impact through specific receptor binding and subsequent modulation of growth hormone (GH) release."
            },
            {
                "p": "Tesamorelin & CJC-1295 (Mod GRF 1-29) appear to engage with GHRH receptors through intricate molecular processes, potentially initiating various signaling pathways. Upon interaction with the GHRH receptor, it is posited that Tesamorelin & CJC-1295 (Mod GRF 1-29) may cause shifts in receptor configuration, possibly instigating intracellular communication channels.(4) There is suggestion amongst researchers that Tesamorelin & CJC-1295 (Mod GRF 1-29) might promote the generation of cyclic adenosine monophosphate (cAMP) within specific target cells. This may potentially be facilitated by the activation of adenylate cyclase, which might transform ATP to cAMP. Elevated cAMP levels are believed to possibly activate protein kinase A (PKA), a molecule that appears integral to intracellular signaling. PKA might then phosphorylate a range of target proteins, setting off subsequent cellular reactions. The hypothetical activation of the GHRH receptor by Tesamorelin & CJC-1295 (Mod GRF 1-29), coupled with the proposed cAMP-PKA signaling sequence, may stimulate hGH production and dispersal from somatotrophs located in the pituitary gland. The HGH secreted from these cells may also play a role in the formation of insulin-like growth factor-1 (IGF-1).(5)"
            },
            {
                "p": "CJC-1295 (Mod GRF 1-29) peptide has four amino acid substitutions in its structure, which appears to enhance its GH-related activity as well as its potential resistance towards the proteolytic enzymes. These modifications are also believed to assist “at least 90% of the peptide” to bind covalently to blood albumin, with trace amounts potentially binding to fibrinogen and immunoglobulin G (IgG).(5)"
            },
            {
                "p": "As per the researchers, “No other chemical species have been found bound to DAC-GRF after administration This binding extends the half-life of the active pharmacophore, resulting in a markedly prolonged duration of action in several animal species.”(5)"
            },
            {
                "p": "Ipamorelin, on the other hand, appears to act as a selective agonist for the GHS (ghrelin) receptor, which is also present on somatotrophs within the pituitary gland. Its binding to GHS (ghrelin) receptors is believed to induce GH release with high specificity and minimal impact on other hormonal systems. Research-based outcomes have indicated that Ipamorelin influence in certain test models may lead to increased GH secretion, without significantly affecting prolactin, or ACTH levels.(6) In vitro analyses indicate that Ipamorelin's interaction with GHS receptors possibly influences somatotroph cells within the anterior pituitary gland. This interaction appears to initiate a series of intracellular signaling cascades. One posited mechanism is the activation of phospholipase C (PLC), which, according to some researchers, might subsequently facilitate the release of inositol triphosphate (IP3) and diacylglycerol (DAG). IP3 might then prompt the release of calcium ions (Ca2+) from intracellular reserves, whereas DAG potentially activates protein kinase C (PKC). Such elevation in intracellular calcium and the probable activation of PKC are suggested to culminate in the observed exocytosis of vesicles containing growth hormone from pituitary cells.(7)"
            },
            {
                "h3": "Tesamorelin & CJC-1295 (Mod GRF 1-29) & Ipamorelin Blend and the GI Tract"
            },
            {
                "p": "Ipamorelin is believed to primarily interact with the ghrelin receptor within the GI tract. Upon binding to the ghrelin receptors, Ipamorelin may elicit a variety of responses including promoting gut motility and improving intestinal absorption. Moreover, Ipamorelin has shown promise in attenuating inflammation and promoting tissue repair in various models of GI injury. As per researchers, Ipamorelin may “increase total body fat percentages” , identifying the peptide as a “potent and selective stimulator of GH that can significantly influence the GI system, body composition, and adiposity.”(6) Investigators explored the potential impacts of Ipamorelin on gastric functions, contrasting its effects with a placebo. They were particularly interested in its suggested ability to hasten gastric emptying. To assess this, they utilized a method that monitored leftover radioactivity in the stomach a quarter-hour after introducing a particular substance via intragastric gavage. It appears that abdominal surgeries might potentially slow down gastric emptying, an effect that was notably evident in the placebo group. In comparison, Ipamorelin seemed to accelerate this process. Such findings hint at Ipamorelin's potential to boost the pace of gastric emptying. Further, the group aimed to understand how this compound influenced the contractile behavior of gastric smooth muscles when exposed to acetylcholine and electrical field stimulation. Information gathered indicated that intestinal surgeries might notably reduce the contractile reactions to these simulations. However, this suppression appeared to be lessened when Ipamorelin was combined with ghrelin. This raises the possibility that Ipamorelin may not only promote gastric muscle contractility but also possibly offset the inhibitory effects resulting from certain surgical procedures. (8)"
            },
            {
                "h3": "Synergistic Action of Tesamorelin & CJC-1295 (Mod GRF 1-29) & Ipamorelin Blend"
            },
            {
                "p": "The rationale for combining these peptides lies in their supposed distinct mechanisms of action and potential to enhance growth hormone (GH) secretion synergistically. The apparent synergy of all these peptides lies in their individual potential to increase lean mass and muscle growth."
            },
            {
                "p": "For example, a recent scientific investigation proposed that the potential impacts of Tesamorelin on muscle tissue integrity may be examined using CT scans. Following a placebo-controlled experiment, the CT-scan findings suggest a possible association between Tesamorelin and improvements in muscle density and size. Notably, some muscle groups, especially the rectus abdominis, psoas major, and paraspinal muscles, reportedly showed more evident changes. These changes were characterized by either an increase in muscle size and density or a reduction in fat content. Statistically, these alterations were different compared to the placebo group. Although some theorize that Tesamorelin's effects might be related to molecules like IGF-1, the study did not find a notable connection between changes in IGF-1 levels and shifts in muscle size or density.(9)"
            },
            {
                "p": "Further, preliminary research involving CJC-1295 (Mod GRF 1-29) 1-29 indicates a potential rise in nocturnal growth hormone levels, as well as serum levels of IGF-I and IGFBP-3, and GHBP concentrations.(10) Consequently, male research models exposed to the peptide over a span of four months seemingly gained an average of 1.26 kg in lean body mass. Additionally, research suggests that the peptide might influence an increase in skin thickness among males and may possibly enhance insulin sensitivity."
            },
            {
                "p": "Similarly, preliminary studies have suggested that Ipamorelin might exhibit effects similar to those seen with Tesamorelin concerning skeletal muscle and bone structures. However, these findings are still awaiting further confirmation. Going further, there is a working hypothesis amongst researchers that Ipamorelin may interact with, and possibly increase, IGF-I levels. These interactions appeared to align with an increase in muscle fiber size, overall muscle mass, and hence, a potential boost in skeletal muscle strength during this mouse-based study.(11)"
            },
            {
                "p": "Tesamorelin & CJC-1295 (Mod GRF 1-29) & Ipamorelin blend is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "National Center for Biotechnology Information (2023). PubChem Compound Summary for CID 9831659, Ipamorelin. https://pubchem.ncbi.nlm.nih.gov/compound/Ipamorelin.",
                    "National Center for Biotechnology Information (2023). PubChem Compound Summary for CID 56841945. https://pubchem.ncbi.nlm.nih.gov/compound/56841945.",
                    "National Center for Biotechnology Information (2023). PubChem Compound Summary for CID 16137828, Tesamorelin. https://pubchem.ncbi.nlm.nih.gov/compound/Tesamorelin.",
                    "Spooner, L. M., & Olin, J. L. (2012). Tesamorelin: a growth hormone-releasing factor analogue for HIV-associated lipodystrophy. The Annals of pharmacotherapy, 46(2), 240–247. https://doi.org/10.1345/aph.1Q629",
                    "Zhou, F., Zhang, H., Cong, Z., Zhao, L. H., Zhou, Q., Mao, C., Cheng, X., Shen, D. D., Cai, X., Ma, C., Wang, Y., Dai, A., Zhou, Y., Sun, W., Zhao, F., Zhao, S., Jiang, H., Jiang, Y., Yang, D., Eric Xu, H., ... Wang, M. W. (2020). Structural basis for activation of the growth hormone-releasing hormone receptor. Nature communications, 11(1), 5205. https://doi.org/10.1038/s41467-020-18945-0",
                    "Sinha DK, Balasubramanian A, Tatem AJ, Rivera-Mirabal J, Yu J, Kovac J, Pastuszak AW, Lipshultz LI. Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males. Transl Androl Urol. 2020 Mar;9(Suppl 2):S149-S159. doi: 10.21037/tau.2019.11.30. PMID: 32257855; PMCID: PMC7108996 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108996/",
                    "Jiménez-Reina, L., Cañete, R., de la Torre, M. J., & Bernal, G. (2002). Influence of chronic treatment with the growth hormone secretagogue Ipamorelin, in young female rats: somatotroph response in vitro. Histology and histopathology, 17(3), 707–714. https://doi.org/10.14670/HH-17.707",
                    "Greenwood-Van Meerveld, B., Tyler, K., Mohammadi, E., & Pietra, C. (2012). Efficacy of ipamorelin, a ghrelin mimetic, on gastric dysmotility in a rodent model of postoperative ileus. Journal of experimental pharmacology, 4, 149–155. https://doi.org/10.2147/JEP.S35396",
                    "Adrian S, Scherzinger A, Sanyal A, Lake JE, Falutz J, Dubé MP, Stanley T, Grinspoon S, Mamputu JC, Marsolais C, Brown TT, Erlandson KM. The Growth Hormone Releasing Hormone Analogue, Tesamorelin, Decreases Muscle Fat and Increases Muscle Area in Adults with HIV. J Frailty Aging. 2019;8(3):154-159. doi: 10.14283/jfa.2018.45. PMID: 31237318; PMCID: PMC6766405. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6766405/",
                    "Khorram, O., Laughlin, G. A., & Yen, S. S. (1997). Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women. The Journal of clinical endocrinology and metabolism, 82(5), 1472–1479. https://doi.org/10.1210/jcem.82.5.3943",
                    "Andersen, N. B., Malmlöf, K., Johansen, P. B., Andreassen, T. T., Ørtoft, G., & Oxlund, H. (2001). The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation of adult rats. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 11(5), 266–272. https://doi.org/10.1054/ghir.2001.0239"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/12/Tesamorelin-Mod-GRF-Ipamorelin-COA.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/12/Tesamorelin-Mod-GRF-Ipamorelin-LC.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/12/Tesamorelin-Mod-GRF-Ipamorelin-MS.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Tesamorelin & CJC-1295 (Mod GRF 1-29) & Ipamorelin Blend for Sale (12mg). Purchase peptide blends at 99+% purity with unmatched customer service...",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Tesamorelin & CJC-1295 (Mod GRF 1-29) & Ipamorelin Blend For Sale (12mg)",
            "og:description": "Tesamorelin & CJC-1295 (Mod GRF 1-29) & Ipamorelin Blend for sale (12mg). Purchase peptide blends at 99+% purity with unmatched customer service and free shipping.",
            "og:url": "https://www.corepeptides.com/peptides/tesamorelin-mod-grf-ipamorelin-12mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-02-18T14:57:31+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2023/06/Tesamorelin-Mod-GRF-Ipamorelin-6-3-3-MG.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Tesamorelin & CJC-1295 (Mod GRF 1-29) & Ipamorelin Blend For Sale (12mg)",
            "twitter:description": "Tesamorelin & CJC-1295 (Mod GRF 1-29) & Ipamorelin Blend for sale (12mg). Purchase peptide blends at 99+% purity with unmatched customer service and free shipping.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2023/06/Tesamorelin-Mod-GRF-Ipamorelin-6-3-3-MG.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$117.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "117.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "TESA-MOD-GRF-IPA-12MG",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/receptor-grade-igf-1-lr3-1mg/",
                "name": "Receptor Grade IGF-1 LR3 (1mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-1MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/receptor-grade-igf-1-lr3-100mcg/",
                "name": "Receptor Grade IGF-1 LR3 (100mcg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-100MCG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/cjc-1295-no-dac-mod-grf-1-29/",
                "name": "CJC-1295 NO DAC (Mod GRF 1-29) (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Mod-GRF-1-29-5mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/hexarelin-5mg/",
                "name": "Hexarelin (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Hexarelin-5MG-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "id": "31",
        "url": "https://www.corepeptides.com/peptides/tesamorelin-10mg/",
        "name": "Tesamorelin (5mg / 10mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Tesamoerlin.jpg",
        "display_price": "$43.00 – $79.00",
        "display_specs": [
            "Size: 5mg & 10mg Contents: Tesamorelin Form: Lyophilized powder Purity: >99% SKU: P-TESAMRLN-5-10",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$40.85 – $75.05"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$38.70 – $71.10"
            },
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$75.05"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$71.10"
            },
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$40.85"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$38.70"
            }
        ],
        "description": [
            {
                "h2": "Tesamorelin Peptide"
            },
            {
                "p": "Tesamorelin is a synthetic polypeptide composed of 44 amino acids analogous to growth hormone-releasing hormone. The N-terminus of the compound has been modified compared to growth hormone-releasing hormone, the modification of which researchers suggest may lead to improved stability.(1)"
            },
            {
                "p": "Tesamorelin has been studied for its potential mechanism of action, posited to be similar to growth hormone-releasing hormones (GHRH) receptors located at the anterior pituitary gland, possibly leading to increased production and secretion of growth hormones. Growth hormones may act on several cells, including hepatocytes, stimulating the systemic synthesis of insulin-like growth factor-1 (IGF-1). In addition, growth hormone may also stimulate IGF-1 production locally, inside various tissues.(1)"
            },
            {
                "h3": "Overview"
            },
            {
                "p": "IGF-1 has been posited to be the main anabolic mediator of growth hormone, potentially working to stimulate growth and inhibit programmed cell death.(1) On the other hand, growth hormone itself is suggested to be lipolytic, inducing fat breakdown at specific adipose depots, such as abdominal and visceral fat depositions. Tesamorelin appears to stimulate the release of growth hormone, and consequently IGF-1, by potentially interacting with the GHRH receptors in the anterior pituitary gland cells. When Tesamorelin interacts with the GHRH receptor, it is hypothesized that this interaction might alter the receptor's structure, potentially initiating communication pathways within the cell. It is also theorized that Tesamorelin might enhance the production of cyclic adenosine monophosphate (cAMP) in certain cells. This process may occur through the stimulation of adenylate cyclase, an enzyme that converts adenosine triphosphate (ATP) into cAMP. Increased cAMP levels may lead to the activation of protein kinase A (PKA), an enzyme deemed critical for transmitting signals within cells. Activated PKA may phosphorylate various target proteins, triggering a cascade of cellular responses. The conjectural stimulation of the GHRH receptor by Tesamorelin and the cAMP-PKA signaling pathway might promote the secretion and distribution of growth hormone (hGH) from somatotroph cells in the pituitary gland. Research indicates that this peptide may lead to an estimated 69% increase in overall growth hormone levels, measured by the area under the curve (AUC), and a reported 55% increase in the mean pulse area of the growth hormone. However, it does not seem to influence the frequency or peak levels of growth hormone pulses. Additionally, IGF-1 levels apparently surged by 122%.(3)"
            },
            {
                "p": "The N-terminus and C-terminus of the GHRH molecule are altered in Tesamorelin, potentially lending stability to the peptide and possibly increasing the compound's resistance to enzyme deactivation compared to natural GHRH.(4) Focusing on the specific alterations, the C-terminus of Tesamorelin is modified by the addition of a trans-3-hexenoic acid group. This particular change, often referred to as an omega-amino acid modification, is believed to potentially reinforce the peptide's defense against enzymatic breakdown. On the other end, the N-terminus is modified by the attachment of an acetyl group, represented by the chemical notation CH₃CO-. This acetylation might enhance not only the molecule's stability but also its biological activity. As a result of these specific modifications, Tesamorelin is designated chemically as N-(trans-3-hexenoyl)-[Tyr1]hGRF(1–44)NH2 acetate, highlighting the specific alterations made to the peptide."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C221H366N72O67S Molecular Weight: 5136 g/mol Other Known Titles: (3E)-hex-3-enoylsomatoliberin"
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Tesamorelin Peptide and Lipodystrophy"
            },
            {
                "p": "Lipodystrophy models refer to abnormal or pathological fat distribution and metabolism. The primary feature of lipodystrophy is the irregular distribution of fat into depots, leading to loss of fat (lipoatrophy) from specefic areas, and accumulation of excess fat (lipohypertrophy) in other regions. This abnormal fat distribution is often associated with serious negative metabolic changes, including insulin resistance, elevated cholesterol and triglyceride levels. Test models exhibiting lipodystrophy report low levels of GH and IGF-1. Researchers studying Tesamorelin's action and potential impact, suggest that the peptide may positively influence lipid metabolism, especially in lipodystrophy models."
            },
            {
                "p": "For example, two phase III studies(6) were conducted with 806 test subjects over 26 weeks, followed by another 26-week extension. Each of the 806 test subjects had immunodeficiencies and lipodystrophy. The subjects were divided into two groups; one group with 543 subjects was presented with Tesamorelin, and the remaining 263 subjects were presented with a placebo for 26 weeks. After this duration, the Tesamorelin subjects were again randomly divided into 2 groups, in which one group continued Tesamorelin influence, and the other half was presented with a placebo for another 26 weeks. At week 26, the researchers observed a significant decrease in visceral adipose tissue level amongst the Tesamorelin subjects, at least 15.4%. Additionally, the levels of triglyceride and cholesterol were reported significantly decreased compared to the placebo group."
            },
            {
                "h3": "Tesamorelin Peptide and Immunodeficient Fat Fractions"
            },
            {
                "p": "Researchers posit that serious immunodeficiencies may induce non-alcoholic fatty liver disease (NAFLD), which in clinical cases is reported in nearly 40% of HIV-positive test models.(7) In this study,(5) 61 test subjects with HIV and a high hepatic fat fraction (HFF) were selected as test models. These subjects were influenced with Tesamorelin or a placebo for 12 months. The rate of HFF was monitored at the end of the study. After 12 months, it was reported by the researchers that 35% of subjects presented with Tesamorelin exhibited an apparent reduction in HFF rate by less than 5% vs. only 4% of subjects receiving placebo exhibited any HFF reduction. There was no reported alteration in the glucose levels."
            },
            {
                "h3": "Tesamorelin Peptide and Cognition"
            },
            {
                "p": "In this clinical study,(8) immunodeficient models with mild cognitive impairment were observed. The main intent of this study was to determine Tesamorelin's potential effect on neurological functioning. 100 subjects, aged more than 40 years, participated in this trial and underwent Tesamorelin presentation daily for 6 months, followed by all absence of Tesamorelin influence for the next 6 months. Then Tesamorelin was re-introduced once a day for another 6 months. The primary outcome of this study was reported in changes in neurocognitive performance measured by the Global Deficit Score (GDS) after 6 and 12 months. This study is underway, and the final results have not been published."
            },
            {
                "h3": "Tesamorelin Peptide and Insulin"
            },
            {
                "p": "The main aim of this study(9) was to determine any potential Tesamorelin might exhibit in altering insulin sensitivity. In this clinical trial setting, 53 test subjects with Type II diabetes were observed in this 12-week randomized trial. The subjects were divided into three groups, each receiving a lower or higher concentration of Tesamorelin or a placebo. Following the study period of 12 weeks, the concentration of fasting glucose, glycosylated hemoglobin, and diabetes control was measured. There was no reported significant reduction in either of these parameters. The results of all three groups appeared to be indifferent."
            },
            {
                "h3": "Tesamorelin Peptide and Muscle Tissue"
            },
            {
                "p": "In a research investigation, the possible impacts of Tesamorelin on the structural quality of muscle tissues were evaluated using computed tomography (CT) scans.(10) Computed tomography (CT) is an imaging tool that combines X-rays and computer technology to produce detailed pictures of internal structures. The findings from this study tentatively suggested a potential association between Tesamorelin and improvements in the density and overall volume of muscle tissues. It was observed that specific muscle groups, particularly the rectus abdominis, psoas major, and paraspinal muscles, exhibited more noticeable variations. These variations consisted of either increased muscle density and volume or decreased fat within the muscle tissue. From a statistical perspective, the alterations in muscle density and size or the reduction in fat content in these specific muscles were significantly different when compared to results from a control group receiving a placebo."
            },
            {
                "h3": "Tesamorelin Peptide and Visceral Fat"
            },
            {
                "p": "Visceral obesity involves the accumulation of excess fat around and within internal organs, a condition often observed in models of lipodystrophy—a disorder characterized by abnormal distribution of fat cells. This form of excessive fat accumulation is potentially linked to several metabolic issues. These issues include insulin resistance, a diminished ability to respond to insulin leading to elevated blood glucose levels. Additionally, visceral obesity is associated with the development of atherosclerosis, a condition where plaque builds up in the arteries, elevated levels of low-density lipoprotein (LDL) cholesterol, and hyperuricemia, an excess of uric acid. The significance of these models extends beyond aesthetic concerns, indicating that lipodystrophy may precipitate profound metabolic disturbances. In addressing these challenges, Tesamorelin, a synthetic form of the growth-hormone-releasing factor, has been proposed as a possibly positive avenue for further development. Research into Tesamorelin has suggested it may lead to a reduction of up to 25% in visceral fat among lipodystrophy models.(11)"
            },
            {
                "p": "Tesamorelin peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. Tesamorelin. [Updated 2018 Oct 20]. https://www.ncbi.nlm.nih.gov/books/NBK548730/",
                    "Spooner, L. M., & Olin, J. L. (2012). Tesamorelin: a growth hormone-releasing factor analogue for HIV-associated lipodystrophy. The Annals of pharmacotherapy, 46(2), 240–247. https://doi.org/10.1345/aph.1Q629",
                    "Stanley TL, Chen CY, Branch KL, Makimura H, Grinspoon SK. Effects of a growth hormone-releasing hormone analog on endogenous GH pulsatility and insulin sensitivity in healthy men. J Clin Endocrinol Metab. 2011 Jan;96(1):150-8. doi: 10.1210/jc.2010-1587. Epub 2010 Oct 13. PMID: 20943777; PMCID: PMC3038486. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038486/",
                    "Ferdinandi ES, Brazeau P, High K, Procter B, Fennell S, Dubreuil P. Non-clinical pharmacology and safety evaluation of TH9507, a human growth hormone-releasing factor analogue. Basic Clin Pharmacol Toxicol. 2007 Jan;100(1):49-58. doi: 10.1111/j.1742-7843.2007.00008.x. PMID: 17214611. https://pubmed.ncbi.nlm.nih.gov/17214611/",
                    "Stanley, T. L., Fourman, L. T., Feldpausch, M. N., Purdy, J., Zheng, I., Pan, C. S., Aepfelbacher, J., Buckless, C., Tsao, A., Kellogg, A., Branch, K., Lee, H., Liu, C. Y., Corey, K. E., Chung, R. T., Torriani, M., Kleiner, D. E., Hadigan, C. M., & Grinspoon, S. K. (2019). Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial. The lancet. HIV, 6(12), e821–e830. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6981288/",
                    "Falutz J, Mamputu JC, Potvin D, Moyle G, Soulban G, Loughrey H, Marsolais C, Turner R, Grinspoon S. Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data. J Clin Endocrinol Metab. 2010 Sep;95(9):4291-304. doi: 10.1210/jc.2010-0490. Epub 2010 Jun 16. PMID: 20554713. https://pubmed.ncbi.nlm.nih.gov/20554713/",
                    "Tesamorelin Effects on Liver Fat and Histology in HIV. https://clinicaltrials.gov/ct2/show/NCT02196831",
                    "Phase II Trial of Tesamorelin for Cognition in Aging HIV-Infected Persons. https://clinicaltrials.gov/ct2/show/record/NCT02572323",
                    "Clemmons, D. R., Miller, S., & Mamputu, J. C. (2017). Safety and metabolic effects of tesamorelin, a growth hormone-releasing factor analogue, in patients with type 2 diabetes: A randomized, placebo-controlled trial. PloS one, 12(6), e0179538. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472315/",
                    "Adrian S, Scherzinger A, Sanyal A, Lake JE, Falutz J, Dubé MP, Stanley T, Grinspoon S, Mamputu JC, Marsolais C, Brown TT, Erlandson KM. The Growth Hormone Releasing Hormone Analogue, Tesamorelin, Decreases Muscle Fat and Increases Muscle Area in Adults with HIV. J Frailty Aging. 2019;8(3):154-159. doi: 10.14283/jfa.2018.45. PMID: 31237318; PMCID: PMC6766405. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6766405/",
                    "Sivakumar T, Mechanic O, Fehmie DA, Paul B. Growth hormone axis treatments for HIV-associated lipodystrophy: a systematic review of placebo-controlled trials. HIV Med. 2011 Sep;12(8):453-62. doi: 10.1111/j.1468-1293.2010.00906.x. Epub 2011 Jan 25. PMID: 21265979."
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/12/Tesamorelin-10MG-COA-1.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/12/Tesamorelin-10MG-LC-1.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/12/Tesamorelin-10MG-MS-1.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Tesamorelin peptide for sale online (5mg & 10mg). Peptides for sale at 99% purity with top customer service. Get Tesamorelin research study results...",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Tesamorelin For Sale (5mg & 10mg) | Core Peptides",
            "og:description": "Tesamorelin peptide for sale online (5mg & 10mg). Peptides for sale at 99% purity with top customer service. Get Tesamorelin research study results and info.",
            "og:url": "https://www.corepeptides.com/peptides/tesamorelin-10mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-05-28T11:02:33+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Tesamoerlin.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Tesamorelin For Sale (5mg & 10mg) | Core Peptides",
            "twitter:description": "Tesamorelin peptide for sale online (5mg & 10mg). Peptides for sale at 99% purity with top customer service. Get Tesamorelin research study results and info.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Tesamoerlin.jpg",
            "twitter:label1": "Availability",
            "twitter:data1": "In stock",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-TESAMRLN-5-10",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/epitalon-25mg/",
                "name": "Epithalon (25mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Epithalon-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ghk-cu-50mg-copper/",
                "name": "GHK-Cu (Copper) (50mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHK-CU-50mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/cjc-1295-no-dac-mod-grf-1-29/",
                "name": "CJC-1295 NO DAC (Mod GRF 1-29) (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Mod-GRF-1-29-5mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/selank-10mg/",
                "name": "Selank (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Selank-10MG-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "id": "32",
        "url": "https://www.corepeptides.com/peptides/tb-500/",
        "name": "TB-500 (Thymosin Beta 4) (5mg / 10mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2020/04/TB-500.jpg",
        "display_price": "$57.00 – $99.00",
        "display_specs": [
            "Size: 5mg / 10mg Contents: TB-500 Form: Lyophilized powder Purity: >99% SKU: P-TB500",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$54.15 – $94.05"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$51.30 – $89.10"
            },
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$54.15"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$51.30"
            },
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$94.05"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$89.10"
            }
        ],
        "description": [
            {
                "h2": "TB-500 Peptide"
            },
            {
                "p": "TB-500 peptide, also known as synthetic Thymosin Beta 4 or Tβ4 is the synthetic version of the naturally occurring protein Thymosin beta 4. The latter is found naturally within the cells of the thymus organ and encoded by the TMSB4X gene. Researchers have suggested TB-500 peptide hosts similar potential as Thymosin beta 4. These potential mechanisms of action may include inducing angiogenesis, elevating wound healing, or possibly elevated metastatic potential of tumor cells and hair growth."
            },
            {
                "p": "Besides being highly soluble in water and light in weight, TB-500 is a 43 amino acid-containing peptide found in abundance in the wound fluid comprising multiple blood platelets. This peptide may exhibit possible anti-inflammatory potential and may support neurological healing, as well as potentially supporting healing processes in the spinal cord, heart, and epidermis.(1)"
            },
            {
                "h3": "Overview"
            },
            {
                "p": "TB-500 peptide, also known as thymosin β(4), includes a distinct peptide segment (17)LKKTETQ(23), which acts as the active site and which researchers consider potentially impactful in actin binding, cell migration, and wound healing.(2) The amino acid sequence of TB-500 is: Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser-OH."
            },
            {
                "p": "Actins are essential proteins that form a key component of the cytoskeleton within cells, serving not only to maintain cellular structure but also to facilitate various cellular functions, including movement. Actin is suggested to be critical in supporting these cellular structures and processes. Thymosin beta-4 and, thus, TB-500 are believed to interact with actin, potentially by binding to globular actin (G-actin), a precursor to filamentous actin (F-actin). This interaction is thought to hinder the transformation of G-actin into F-actin, a process known as actin sequestration, and is likely to increase the availability of G-actin. The inhibition of F-actin formation by thymosin beta-4 may conceivably modify the structure of the cellular cytoskeleton, impacting cellular abilities for movement and morphological changes. Such changes are tentatively linked to various physiological and pathological states where cell motility is essential, including wound healing, tissue regeneration, and the progression of cancer through metastasis.(3)"
            },
            {
                "p": "Furthermore, Thymosin beta-4 has been detected not only within cells but also extracellularly, such as in blood plasma and wound exudates. Preliminary studies involving vascular cells suggest that Thymosin beta-4 is extracellular, it might influence cellular functions like motility and the formation of new blood vessels (angiogenesis).(11,12) It is postulated that Thymosin beta-4 might exert this potential through its interactions with ATP synthase enzymes located on the cell surface, which are critical for cellular energy production. These findings indicate a broader scope of action for thymosin beta-4, impacting both intra- and extracellular processes."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C212H350N56O78S Molecular Weight: 4963 g/mol Other Known Titles: Thymosin Beta 4"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "TB-500 Peptide and Inflammation"
            },
            {
                "p": "Tβ4, and thus TB-500, is thought to potentially increase the levels of microRNA-146a (miR-146a), which might function as a suppressive regulator of specific cellular signaling pathways, particularly those associated with the functions of inflammation-related cytokines, including L-1 receptor-linked kinase 1 (IRAK1) and tumor necrosis factor receptor-associated factor 6 (TRAF6). The researchers of a study investigating the potential of the peptide on these factors propose this as a possible mechanism of action for TB-500. More specifically, the authors observed that \"transfection of anti-miR-146a nucleotides reversed the inhibitory effect of Tβ4 on IRAK1 and TRAF6,\" thus suggesting this as a potential mechanism. Consequently, it is suggested that TB-500 may contribute to anti-inflammatory potential via these mechanisms.(4)"
            },
            {
                "h3": "TB-500 Peptide and Acute Wounds"
            },
            {
                "p": "In 1999, a research study was conducted on wounded murine test models, who were introduced to TB-500 as a form of synthetic Thymosin Beta 4.(5) Four days after the presentation, it was reported by the researchers that the TB-500 peptide rats exhibited an apparent 41% increase in re-epithelialization than control murine models presented with saline. Seven days after the study, the TB-500 wounds were reported to be contracted by at least 11% more than the saline wounds. Upon analysis, it was concluded that TB-500 may possibly induce angiogenesis and collagen deposition, increasing the wound healing rate.The authors commented that their observations “suggest that Tβ4 is a potent wound healing factor with multiple activities...”"
            },
            {
                "h3": "TB-500 Peptide and Chronic Wounds"
            },
            {
                "p": "Research studies were carried out on normal rats and mice, diabetic mice, aged mice, and steroid-influenced rats. All these animals were served full-thickness punch wounds and introduced to the TB-500 peptide. It was reported that the TB-500 appeared to accelerate the wound-healing process in all test models, regardless of the stated pre-existing conditions. Furthermore, phase 2 clinical trials were conducted on models of stasis and pressure ulcers. It was reported that TB-500 might accelerate the healing process by as much as one month.(6)"
            },
            {
                "h3": "TB-500 Peptide and Heart Cells"
            },
            {
                "p": "Pulmonary hypertension is considered by scientists to be a progressive cardiac disease where the pulmonary arteries restrict the blood ejection by the right ventricle. This may result in increased pulmonary vascular resistance and pressure, potentially leading to ventricular failure of the heart. It was reported by researchers that TB-500 might be action specific on the Notch3-Col 3A-CTGF gene axis in MCT-influenced mice, which appeared to result in the case of the test study in decreasing the right ventricular heart cell hypertrophy by a significant amount.(7) Based on Tβ4 research, TB-500 might also influence the regeneration of cardiac cells. Preliminary research indicates that TB-500 may enhance the resilience of myocardial cells under hypoxic conditions and may also promote angiogenesis, which could facilitate the repair of cardiac cells. There is a suggestion from researchers that cardiac fibroblasts could potentially differentiate into cells akin to cardiomyocytes.(8) Furthermore, it has been proposed that the combination of TB-500 with cardiac reprogramming methods could synergistically mitigate damage to cardiac cells and support their regeneration by activating intrinsic cells in the heart area. Further experimentation employing mouse models, in which coronary arteries were ligated, suggested that TB-500 could potentially increase the activity of integrin-linked kinase (ILK) and protein kinase B (Akt) in cardiac tissue. This observation indicates a possible enhancement in the early survival of cardiomyocytes and an apparent improvement in cardiac function.(9) Further, the research indicates that TB-500 may facilitate the migration of myocardial and endothelial cells in the fetal heart, and this function appears to be preserved in adult cardiomyocytes."
            },
            {
                "h3": "TB-500 and Hair Follicle Growth"
            },
            {
                "p": "In 2003, studies were carried out on mice to examine the potential of TB-500 in hair growth. Under the influence of the TB-500 peptide, it was reported by the researchers that, via histological examination of the mouse skin cells, the peptide appeared to increase the number of hair shafts and hair follicles, thereby inducing hair growth. Upon real-time PCR and western blotting techniques, changes in the expression of m-RNA cells were observed between the TB500 and control mice. The m-RNA and protein levels were reported elevated in TB-500 mice, which might have significantly induced hair growth.(10)"
            },
            {
                "h3": "TB-500 and Blood Vessel Formation"
            },
            {
                "p": "It is hypothesized that TB-500 might influence angiogenesis via several molecular interactions. This is based on studies involving TB-500 overexpression lentiviral vector in transfecting umbilical vein endothelial cells (HUVEC) and murine critical limb ischemia (CLI) models.(13) Researchers have also employed inhibitors such as DAPT, targeting the Notch pathway, and BMS, affecting the NF-κB pathway, in both HUVEC and murine CLI experiments to probe the intricate biological processes involved. The potential of TB-500 on angiogenesis and cellular migration were evaluated using MTT assays to measure cell viability, alongside tube formation and wound healing assays to assess angiogenic and migratory capabilities, respectively. Additionally, a variety of molecular methodologies were utilized, including Western blotting, reverse transcription, quantitative PCR, immunofluorescence, and immunohistochemistry. These techniques were instrumental in investigating the expression levels of angiogenesis-associated markers and elements related to the Notch/NF-κB pathways. Preliminary findings indicate that TB-500 might enhance not only the viability, angiogenesis, and migration of HUVEC but could also elevate the expression of angiopoietin-2 (Ang2), TEK receptor tyrosine kinase 2 (tie2), vascular endothelial growth factor A (VEGFA), NOTCH1 intracellular domain (N1ICD), Notch receptor 3 (Notch3), NF-κB, and phosphorylated (p)-p65 in these cells. In the muscle tissues of murine CLI models, similar increases in the expression of CD31, α-smooth muscle actin (α-SMA), Ang2, tie2, VEGFA, N1ICD, and p-p65 were observed, suggesting a regulatory potential of TB-500 on these molecular targets. Interestingly, the application of DAPT and BMS in these studies seemed to counteract the actions of TB-500, potentially indicating that the mechanisms of action of TB-500 in promoting angiogenesis might be mediated through its interactions with the Notch and NF-κB pathways. Moreover, the apparent reversal of the actions of DAPT and BMS by TB-500 could underscore its role in modulating these pathways, supporting the proposition of its regulatory functions in angiogenesis. Researchers have noted that these observations might imply a role for Tβ4 in promoting angiogenesis through regulation of these critical pathways."
            },
            {
                "h3": "TB-500 and Corneal Tissues"
            },
            {
                "p": "Studies have posited that TB-500 may modulate cytokine production and thus accelerate healing in corneal wound models.(14) Following injury, there is some indication that TB-500 could promote increased expression of IL-1β and IL-6 mRNA in the corneas of murine models. Moreover, TB-500 experimentation after alkali injury might lead to a decrease in the expression of chemoattractants such as MIP-2 and KC for polymorphonuclear neutrophils (PMNs) in mouse corneas, potentially resulting in diminished PMN infiltration. Concerning the inflammatory signaling pathways in the cornea, it is speculated that TB-500 may influence NFκB pathways, possibly exerting anti-inflammatory actions. TB-500 is also theorized to possess anti-apoptotic attributes. An overexpression of TB-500 in cellular models is observed to potentially increase growth rates, diminish basal apoptosis, and confer resistance to factors that induce cell death. In corneal epithelial cells, TB-500 could potentially inhibit apoptosis by blocking caspases and curtailing the release of the pro-apoptotic protein bcl-2 from mitochondria. The mechanism of TB-500’s anti-apoptotic action might include reducing the initiation signals of early cell death and activating the survival kinase Akt via complex interactions with PINCH and integrin-linked kinase. It is conceivable that TB-500’s anti-apoptotic influence operates through several molecular pathways. Nonetheless, it is crucial to acknowledge that these mechanisms remain conjectural and warrant further empirical investigation to be substantiated."
            },
            {
                "p": "TB-500 peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Kleinman HK, Sosne G. Thymosin β4 Promotes Dermal Healing. Vitam Horm. 2016;102:251-75. doi: 10.1016/bs.vh.2016.04.005. Epub 2016 May 24.",
                    "Ho EN, Kwok WH, Lau MY, Wong AS, Wan TS, Lam KK, Schiff PJ, Stewart BD. Doping control analysis of TB-500, a synthetic version of an active region of thymosin β₄, in equine urine and plasma by liquid chromatography-mass spectrometry. J Chromatogr A. 2012 Nov 23;1265:57-69. doi: 10.1016/j.chroma.2012.09.043. Epub 2012 Sep 23.",
                    "Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature. 2008 May 15;453(7193):314-21. doi: 10.1038/nature07039. PMID: 18480812.",
                    "Santra, M., Zhang, Z. G., Yang, J., Santra, S., Santra, S., Chopp, M., & Morris, D. C. (2014). Thymosin β4 up-regulation of microRNA-146a promotes oligodendrocyte differentiation and suppression of the Toll-like proinflammatory pathway. The Journal of biological chemistry, 289(28), 19508–19518. https://doi.org/10.1074/jbc.M113.529966",
                    "Katherine M. Malinda et.al, Thymosin β4 Accelerates Wound Healing, Journal of Investigative Dermatology, Volume 113, Issue 3, 1999, Pages 364-368, ISSN 0022-202X.",
                    "Treadwell T, Kleinman HK, Crockford D, Hardy MA, Guarnera GT, Goldstein AL. The regenerative peptide thymosin β4 accelerates the rate of dermal healing in preclinical animal models and in patients. Ann N Y Acad Sci. 2012 Oct.",
                    "Wei C, Kim IK, Li L, Wu L, Gupta S. Thymosin Beta 4 protects mice from monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy. PLoS One. 2014 Nov 20;9(11):e110598.",
                    "Srivastava, D., Ieda, M., Fu, J., & Qian, L. (2012). Cardiac repair with thymosin β4 and cardiac reprogramming factors. Annals of the New York Academy of Sciences, 1270, 66–72. https://doi.org/10.1111/j.1749-6632.2012.06696.x",
                    "Bock-Marquette, I., Saxena, A., White, M. D., Dimaio, J. M., & Srivastava, D. (2004). Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature, 432(7016), 466–472. https://doi.org/10.1038/nature03000",
                    "Gao, Xy., Hou, F., Zhang, Zp. et al. Role of thymosin beta 4 in hair growth. Mol Genet Genomics 291, 1639–1646 (2016).",
                    "Huff, T., Müller, C. S., Otto, A. M., Netzker, R., & Hannappel, E. (2001). beta-Thymosins, small acidic peptides with multiple functions. The international journal of biochemistry & cell biology, 33(3), 205–220. https://doi.org/10.1016/s1357-2725(00)00087-x",
                    "Freeman, K. W., Bowman, B. R., & Zetter, B. R. (2011). Regenerative protein thymosin beta-4 is a novel regulator of purinergic signaling. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 25(3), 907–915. https://doi.org/10.1096/fj.10-169417",
                    "Lv, S., Cai, H., Xu, Y., Dai, J., Rong, X., & Zheng, L. (2020). Thymosin‑β 4 induces angiogenesis in critical limb ischemia mice via regulating Notch/NF‑κB pathway. International journal of molecular medicine, 46(4), 1347–1358. https://doi.org/10.3892/ijmm.2020.4701",
                    "Sosne, G., Qiu, P., & Kurpakus-Wheater, M. (2007). Thymosin beta 4: A novel corneal wound healing and anti-inflammatory agent. Clinical ophthalmology (Auckland, N.Z.), 1(3), 201–207."
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/09/TB-500-5MG-coa-1.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/09/TB-500-5MG-lc-1.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/09/TB-500-5MG-ms-1.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "TB-500 peptide for sale online. Peptides for sale at 99% purity with top customer service. Get TB 500 research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "TB-500 For Sale (Thymosin beta 4) (5mg / 10mg) | Core Peptides",
            "og:description": "TB-500 peptide for sale online. Peptides for sale at 99% purity with top customer service. Get TB 500 research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/tb-500/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-05-28T11:02:35+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/TB-500.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "TB-500 For Sale (Thymosin beta 4) (5mg / 10mg) | Core Peptides",
            "twitter:description": "TB-500 peptide for sale online. Peptides for sale at 99% purity with top customer service. Get TB 500 research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/TB-500.jpg",
            "twitter:label1": "Availability",
            "twitter:data1": "In stock",
            "product:brand": "Core Peptides",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-TB500",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/semax-25mg/",
                "name": "Semax (25mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Semax-25MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/bpc-157/",
                "name": "BPC-157 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/BPC-157-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/cjc-1295-no-dac-mod-grf-1-29/",
                "name": "CJC-1295 NO DAC (Mod GRF 1-29) (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Mod-GRF-1-29-5mg-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/receptor-grade-igf-1-lr3-100mcg/",
                "name": "Receptor Grade IGF-1 LR3 (100mcg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-100MCG-300x300.jpg.webp",
                "price": ""
            }
        ]
    },
    {
        "id": "33",
        "url": "https://www.corepeptides.com/peptides/syn-coll-palmitoyl-tripeptide-5-topical-200mg/",
        "name": "Syn-Coll (Palmitoyl Tripeptide-5) (200mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2023/04/SYN-COLL-200mg.jpg",
        "display_price": "$176.00",
        "display_specs": [
            "Size: 200mg Contents: Syn-COLL Form: Lyophilized powder Purity: >99% SKU: P-SYN-COLL",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$167.20"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$158.40"
            }
        ],
        "description": [
            {
                "h2": "Syn-Coll Peptide"
            },
            {
                "p": "Syn-Coll is a synthetic peptide compound, also known as palmitoyl tripeptide-5. It was designed to mimic the activity of thrombospondin-1 (TSP-1), a natural extracellular matrix protein that apparently stimulates transforming growth factor beta (TGF-β). TGF-β is a crucial growth factor that plays a vital role in maintaining skin integrity and stimulating the postnatal development of skin structures by promoting collagen synthesis."
            },
            {
                "p": "The short sequence Lys-Arg-Phe-Lys of TSP-1 is considered responsible for TGF-β stimulation.(1) Syn-Coll has the sequence of Palmitoyl-Lys-Val-Lys, and scientists report that it may exert similar action on TGF-β. As a result, animal models and dermal fibroblasts cell culture tests suggest it may stimulate collagen production. More specifically, Syn-Coll may increase the production of Type I and Type III collagen by dermal fibroblasts via stimulating TGF-β activity."
            },
            {
                "p": "Furthermore, Syn-Coll has been extensively studied in animal models and experiments, which all generally hypothesize that it exhibits some potential to increase collagen synthesis but also prevent collagen degradation. Syn-Coll may prevent collagen breakdown by inhibiting the activity of matrix metalloproteinases (MMPs) such as MMP1 and MMP3."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C33H65N5O5 Molecular Weight: 611.9 g/mol Other Known Titles: Palmitoyl-lysyl-valyl-lysine, Palmitoyl Tripeptide-5"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Syn-Coll Peptide and Collagen Synthesis"
            },
            {
                "p": "Collagen is a major component of the extracellular matrix, the network of proteins and fibers that comprise dermal connective tissue. Recent studies have indicated that Syn-Coll may stimulate collagen synthesis. This synthetic peptide is believed to work by mimicking the activity of TSP-1 to activate the growth factor TGF-β. More specifically, Syn-Coll may work by mimicking part of the sequence of TSP-1.(2)"
            },
            {
                "p": "TGF-β is a crucial growth factor that has been suggested to play an important role in regulating collagen production. Studies have suggested that Syn-Coll works by activating latent TGF-β, thereby increasing the production of type I and type III collagen by dermal fibroblasts. As a result, scientists report that activating TGF-β \"causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal [...] dermal fibroblasts.\"(3)"
            },
            {
                "p": "Trials have also indicated that Syn-Coll may increase type 1 collagen synthesis via TGF-β to a greater degree than other peptides, such as palmitoyl pentapeptide.(4) The researchers posited that \"Palmitoyl tripeptide-5 also known as Syn-Coll, increases collagen 1 production via TGF-b reportedly 60% more effective than palmitoyl pentapeptide.\""
            },
            {
                "h3": "Syn-Coll Peptide and Collagen Breakdown"
            },
            {
                "p": "Matrix metalloproteinases (MMPs) are a group of enzymes involved in the degradation of extracellular matrix proteins, including collagen. Scientists consider MMPs to be typically produced by dermal cells, such as fibroblasts, and are involved in tissue remodeling and maintaining the extracellular matrix. However, they further posit when MMPs are overproduced or become dysregulated, they can contribute to dermal collagen breakdown. For example, MMP-1 is considered to be an enzyme that specifically degrades type I collagen."
            },
            {
                "p": "Fibroblasts produce MMP-1, and its activity may be increased by factors such as UV radiation, inflammation, and oxidative stress. Another member of the MMPs is MMP-3, and considered capable of cleaving a wide range of extracellular matrix proteins, including collagens, laminin, fibronectin, proteoglycans, and elastin. It may be particularly active at degrading type II collagen, the main structural component of cartilage. MMP-3 has also been implicated in the degradation of other collagens, such as type III collagen, which is abundant in the skin and blood vessels."
            },
            {
                "p": "Syn-Coll (Palmitoyl tripeptide-5) seems to decrease collagen breakdown by inhibiting matrix metalloproteinases degrading collagen. More specifically, studies suggest that Syn-Coll (palmitoyl tripeptide-5) may prevent collagen breakdown by interfering with MMP1 and MMP3 collagen degradation.(5)"
            },
            {
                "h3": "Syn-Coll Peptide and Anti-Aging"
            },
            {
                "p": "Studies have suggested that Syn-Coll may reduce the appearance of wrinkles to a much greater extent than a placebo.(6) The scientists reported that \"formulation demonstrated a dose-dependent wrinkle reduction, measured by PRIMOS surface topography.\" Ultimately, they concluded that Syn-Coll (palmitoyl tripeptide-5) might exhibit roughly 3.5 times the potential to reduce the appearance of wrinkles than the placebo. One study in 60 test subjects that lasted 84 days reported that Syn-Coll twice daily suggested it may exhibit anti-wrinkle potential and reduce skin roughness better than control groups, placebo, and other peptides.(7) The peptide appeared to reduce wrinkle parameters by 12%."
            },
            {
                "p": "Besides its potential on collagen synthesis and degradation, scientists suggest that Syn-Coll may exert possible anti-wrinkle action through other mechanisms.(8) These include supporting the skin's barrier function by possibly preventing water loss from the skin's surface. This can help to maintain optimal hydration levels in the skin. Furthermore, Syn-Coll may act as a humectant, which can help absorb and retain water in the skin. It may also increase skin surface lipids and act as an emollient, providing partial occlusion, lubrication, and moisturization to the skin."
            },
            {
                "p": "In addition, Syn-Coll may also be modified by adding an L-ascorbate moiety (AA) at the C-terminus (Pal-KVK-AA), which may have a depigmentation impact. Studies have suggested that this conjugation may inhibit melanin synthesis.(9) By blocking melanin production, this modified version of Syn-Coll may help reduce hyperpigmentation caused by photoaging, UV light, oxidative stress, and other factors."
            },
            {
                "p": "Syn-Coll peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Murphy-Ullrich, J. E., & Poczatek, M. (2000). Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology. Cytokine & growth factor reviews, 11(1-2), 59–69. https://doi.org/10.1016/s1359-6101(99)00029-5",
                    "Trookman, N. S., Rizer, R. L., Ford, R., Ho, E., & Gotz, V. (2009). Immediate and Long-term Clinical Benefits of a Treatment for Facial Lines and Wrinkles. The Journal of clinical and aesthetic dermatology, 2(3), 38–43.",
                    "Varga, J., Rosenbloom, J., & Jimenez, S. A. (1987). Transforming growth factor beta (TGF beta) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts. The Biochemical journal, 247(3), 597–604. https://doi.org/10.1042/bj2470597",
                    "Bucay, V. W., & Day, D. (2013). Adjunctive skin care of the brow and periorbital region. Clinics in plastic surgery, 40(1), 225–236. https://doi.org/10.1016/j.cps.2012.09.003",
                    "Errante, F., Ledwoń, P., Latajka, R., Rovero, P., & Papini, A. M. (2020). Cosmeceutical Peptides in the Framework of Sustainable Wellness Economy. Frontiers in chemistry, 8, 572923. https://doi.org/10.3389/fchem.2020.572923",
                    "Gorouhi, F., & Maibach, H. I. (2009). Role of peptides in preventing or treating aged skin. International journal of cosmetic science, 31(5), 327–345. https://doi.org/10.1111/j.1468-2494.2009.00490.x",
                    "Schneider, A. L. (2010). Evaluation of the penetration and efficacy of anti-aging compounds (Doctoral dissertation, Monash University).",
                    "Kim, H. M., An, H. S., Bae, J. S., Kim, J. Y., Choi, C. H., Kim, J. Y., Lim, J. H., Choi, J. H., Song, H., Moon, S. H., Park, Y. J., Chang, S. J., & Choi, S. Y. (2017). Effects of palmitoyl-KVK-L-ascorbic acid on skin wrinkles and pigmentation. Archives of dermatological research, 309(5), 397–402. https://doi.org/10.1007/s00403-017-1731-6"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "",
        "high_performance_liquid_chromatography": "",
        "mass_spectrometry": "",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Syn-Coll (Palmitoyl Tripeptide-5) for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Syn-AKESyn-Coll (Palmitoyl Tripeptide-5) For Sale (200mg) | Core Peptides",
            "og:description": "Syn-Coll (Palmitoyl Tripeptide-5) for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:url": "https://www.corepeptides.com/peptides/syn-coll-palmitoyl-tripeptide-5-topical-200mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T16:19:16+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2023/04/SYN-COLL-200mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Syn-Coll (Palmitoyl Tripeptide-5) For Sale (200mg) | Core Peptides",
            "twitter:description": "Syn-Coll (Palmitoyl Tripeptide-5) for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2023/04/SYN-COLL-200mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$176.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "176.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-SYN-COLL",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/epitalon-25mg/",
                "name": "Epithalon (25mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Epithalon-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ghrp-6/",
                "name": "GHRP-6 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHRP-6-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/selank-10mg/",
                "name": "Selank (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Selank-10MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/dsip-5mg/",
                "name": "DSIP (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/DSIP-5MG-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "id": "34",
        "url": "https://www.corepeptides.com/peptides/syn-ake-topical-200mg/",
        "name": "Syn-AKE (200mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2023/04/SYN-AKE-200mg.jpg",
        "display_price": "$176.00",
        "display_specs": [
            "Size: 200mg Contents: Syn-AKE Form: Lyophilized powder Purity: >99% SKU: P-SYN-AKE",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$167.20"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$158.40"
            }
        ],
        "description": [
            {
                "h2": "Syn-AKE"
            },
            {
                "p": "Syn-AKE is a synthetic peptide with the sequence beta-alanyl-L-prolyl-3-aminomethyl-L-alanine benzyl amide acetic acid known as tripeptide-3. The structure of Syn-AKE is composed of the amino acids alanine, proline, and diamino butyrate, which are linked by peptide bonds.(1) The peptide is designed to mimic the activity of Waglerin-1, a polypeptide. Waglerin-1 is a muscle relaxant that is considered to block the action of acetylcholine in the neuromuscular junction, leading to a decrease in muscle contractions."
            },
            {
                "p": "When developing Syn-AKE, researchers aimed to develop a peptide with similar activity on muscle contractions as Waglerin-1. The peptide’s intended mechanism of action is temporarily inhibiting muscle contractions, which typically leads to a decrease in the depth of wrinkles on the skin of test subjects. This compound has been extensively researched for its potential anti-aging properties for the skin of various species, including reducing fine lines and wrinkles, improving skin texture, and increasing skin hydration solely because of its muscle-relaxing properties."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular formula: C23H37N5O7 Molecular weight: 495.57 g/mol Other known titles: Tripeptide-3, Syn-Ake acetate, SYN-AK, DTXSID40231699, EX-A3743"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Syn-AKE Peptide Mechanism of Action"
            },
            {
                "p": "Syn-AKE has been reported by researchers to mimic the action of Waglerin-1.(2) Waglerin-1 has been considered to have muscle-relaxant properties. According to researchers, this component is a 22-amino acid polypeptide, and may be potentially selective for the form of nicotinic acetylcholine receptors (nAChRs).(3) The nACh receptors transmit signals from nerve cells to muscle cells, ultimately leading to muscle contractions. By blocking the activity of nAChRs, Waglerin-1 apparently prevents the release of acetylcholine and blocks muscle contraction. Waglerin-1 is also suggested to have modulating impacts on the brain's neurotransmitter gamma-aminobutyric acid (GABA) receptors. These receptors are involved in regulating the activity of neurons and by modulating them, Waglerin-1 may cause significant risks in research settings."
            },
            {
                "p": "Contrastingly, initial research suggests Syn-AKE cannot affect GABA receptors in the brain and may lack the risks of Waglerin-1. Syn-AKE was designed to mimic the activity of Waglerin-1 by targeting the same nAChRs in the neuromuscular junctions. Specifically, Syn-AKE is a tripeptide that contains a sequence of amino acids similar to the region of Waglerin-1 that binds to nAChRs."
            },
            {
                "p": "Syn-AKE is thought to have great permeability through the skin and bind to the nAChRs in the muscles beneath it, possibly preventing them from responding to acetylcholine. Researchers suggest that the peptide may be particularly impactful against expression lines by relaxing facial muscles. According to experimental research, the peptide \"was able to reduce the frequency of innervated muscle cell contractions by 82% (...) after 2h of [presentation].\"(4)"
            },
            {
                "p": "The antagonism of Syn-AKE towards the nAChRs may be reversible.(5)(6) Such a reversal may indicates that the potential of tripeptide-3 on the receptors are temporary and can be reversed once the peptide is no longer present."
            },
            {
                "h3": "Syn-AKE Peptide and Fine Lines, Wrinkles"
            },
            {
                "p": "According to researchers, Syn-AKE may induce an immediate minimization of muscle contraction, reducing fine lines and wrinkles.(7)(8) A three-month study including 37 female subjects aged 33 to 45 with mild-to-moderate wrinkles reported that Syn-AKE appeared to exhibit both immediate and long-term potential.(9) Assessments indicated statistically significant improvements in wrinkles shortly after presentation and at months 1 and 3."
            },
            {
                "p": "One of the largest studies conducted on Syn-AKE compared its potential with other peptides and a placebo in 45 test subjects. Syn-AKE was reported to exhibit some potential, gradually exhibiting greater action after repeated presentation and reaching more than 50% after four weeks. Researchers suggested that Syn-AKE \"showed up to a 52% reduction in the appearance of wrinkle size in test volunteers after a 28-day application of a 4% formulation to the forehead twice a day\"(10)(11)"
            },
            {
                "p": "Syn-AKE peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Balaev, A. N., Okhmanovich, K. A., & Osipov, V. N. (2014). A shortened, protecting group free, synthesis of the anti-wrinkle venom analogue Syn-Ake exploiting an optimized Hofmann-type rearrangement. Tetrahedron Letters, 55(42), 5745-5747.",
                    "Molles, B. E., Tsigelny, I., Nguyen, P. D., Gao, S. X., Sine, S. M., & Taylor, P. (2002). Residues in the epsilon subunit of the nicotinic acetylcholine receptor interact to confer selectivity of waglerin-1 for the alpha-epsilon subunit interface site. Biochemistry, 41(25), 7895–7906. https://doi.org/10.1021/bi025732d",
                    "Gorouhi, F., & Maibach, H. I. (2009). Role of peptides in preventing or treating aged skin. International journal of cosmetic science, 31(5), 327–345. https://doi.org/10.1111/j.1468-2494.2009.00490.x",
                    "Reddy, B., Jow, T., & Hantash, B. M. (2012). Bioactive oligopeptides in dermatology: Part I. Experimental dermatology, 21(8), 563–568. https://doi.org/10.1111/j.1600-0625.2012.01528.x",
                    "Munawar, A., Ali, S. A., Akrem, A., & Betzel, C. (2018). Snake venom peptides: Tools of biodiscovery. Toxins, 10(11), 474.",
                    "TATARINGA, G., & ZBANCIOC, A. M. (2021). Antirid peptides in cosmeceutical formula. Romanian Journal of PHARMACEUTICAL PRACTICE| Vol. XIV, 58(3).",
                    "Chhipa, N. M., & Chaudhari, B. (2012). Toxin as a Medicine. Journal of Current Pharmaceutical Research, 9(1), 11-8.",
                    "Trookman, N. S., Rizer, R. L., Ford, R., Ho, E., & Gotz, V. (2009). Immediate and Long-term Clinical Benefits of a Treatment for Facial Lines and Wrinkles. The Journal of clinical and aesthetic dermatology, 2(3), 38–43.",
                    "Reddy, B. Y., Jow, T., & Hantash, B. M. (2012). Bioactive oligopeptides in dermatology: Part II. Experimental dermatology, 21(8), 569–575. https://doi.org/10.1111/j.1600-0625.2012.01527.x",
                    "Pai, V. V., Bhandari, P., & Shukla, P. (2017). Peptides as cosmeceuticals. Indian Journal of Dermatology, Venereology and Leprology, 83, 9."
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "",
        "high_performance_liquid_chromatography": "",
        "mass_spectrometry": "",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Syn-AKE for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Syn-AKE For Sale (200mg) - Core Peptides",
            "og:description": "Syn-AKE for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:url": "https://www.corepeptides.com/peptides/syn-ake-topical-200mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T16:15:50+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2023/04/SYN-AKE-200mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Syn-AKE For Sale (200mg) - Core Peptides",
            "twitter:description": "Syn-AKE for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2023/04/SYN-AKE-200mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$176.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "176.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-SYN-AKE",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/ghrp-6/",
                "name": "GHRP-6 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHRP-6-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/epitalon-25mg/",
                "name": "Epithalon (25mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Epithalon-5MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/oxytocin-10mg/",
                "name": "Oxytocin (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Oxytocin-10mg-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/semax-25mg/",
                "name": "Semax (25mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Semax-25MG-300x300.jpg.webp",
                "price": ""
            }
        ]
    },
    {
        "id": "35",
        "url": "https://www.corepeptides.com/peptides/ss-31-50mg/",
        "name": "SS-31 (50mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2023/11/SS-31-50mg.jpg",
        "display_price": "$263.00",
        "display_specs": [
            "Size: 50mg Contents: SS-31 Form: Lyophilized powder Purity: >99% SKU: P-SS-31-50",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$249.85"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$236.70"
            }
        ],
        "description": [
            {
                "h2": "SS-31 Peptide"
            },
            {
                "p": "SS-31 (Szeto-Schiller-31), also known as MTP-131, is a tetrapeptide that has garnered interest for its potential properties related to mitochondrial dysfunction.(1) With a unique characteristic of holding a cationic 3+ charge at physiological pH, this molecule appears to permeate cell membranes with ease and potentially traverses the blood-brain barrier. It has been suggested to rapidly exit cells, despite not being a substrate for P-glycoprotein. One of the most researched attributes of SS-31 is its potential to accumulate in the inner mitochondrial membrane at concentrations that appear to be over 1000 times greater than in plasma. There, the peptide may display a potential affinity for cardiolipin, an anionic phospholipid exclusively found in the inner mitochondrial membrane. This binding has been suggested to disrupt the interactions between cardiolipin and cytochrome C, leading to a reduction in the oxidative inactivation of cardiolipin by cytochrome C. The mechanism may involve inhibiting the peroxidase activity of cytochrome c, while preserving Met80-heme ligation and favoring its electron carrier activity by SS-31. Given that cardiolipin has been suggested to play a pivotal role in optimizing mitochondrial electron transport and ATP production, this disruption has significant potential. It may help in the formation of mitochondrial cristae, ensuring efficient oxidative phosphorylation and minimizing the leakage of reactive oxygen species."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular formula: C32H49N9O5 Molecular weight: 639.8 g/mol Sequence: D-Arg-dimethylTyr-Lys-Phe-NH2 Other known titles: MTP-131"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "p": "Below we have extracted information from the latest clinical and preclinical data on the potential actions of SS-31 as reported by various research models."
            },
            {
                "h3": "SS-31 and Oxidative Stress"
            },
            {
                "p": "Oxidative stress is posited as the principal factor in the development of a wide range of pathologies, such as retinopathy. Thus a study involving а murine model of diabetic retinopathy aimed to investigate the impact of SS-31.(2) Following two weeks post-diabetes induction, Szeto-Schiller-31 or saline was introduced to these models for a duration of four months. Then, the structural integrity of the inner blood retinal barrier was evaluated using Evans blue dye (EBD) perfusion. To further analyze the potential outcomes, the distribution of claudin-5 and occludin (maintaining the integrity of barriers in tissues), as well as acrolein, 8-OHdG, and nitrotyrosine (markers of oxidative stress and damage) in the retinal tissues was assessed through immunofluorescent staining. Additionally, the intricate retinal structures were examined using transmission electron microscopy. The concentration of proteins related to cell growth and apoptosis such as VEGFR2, Trx-2, Bcl-2, Bax, caspase-3, p53, and NF-κB in the retinas was evaluated using western blot techniques. Four months post-exposure, murine models exposed to SS-31 displayed several apparent results, including improved retinal cell structures, refined capillary basement membrane composition, decreased inner blood retinal barrier permeability, more consistent staining for claudin-5 and occludin, and diminished levels of acrolein, 8-OHdG, nitrotyrosine, Bax, caspase-3, p53, and NF-κB. In contrast, Trx-2 (protects from oxidative stress) and Bcl-2 (protects from cell death) levels appeared to be enhanced. This suggests that SS-31 appears to bolster retinal structures and counteract the degradation of the inner blood retinal barrier."
            },
            {
                "h3": "SS-31 and Aging"
            },
            {
                "p": "SS-31 may exhibit potential actions against aging, as posited by a trial examining the actions of the peptide on cardiac proteins in aged murine models.(3) The study delved into the potential of SS-31 on post-translational modifications of heart proteins. The myocardium of aged murine models had an apparent rise in the oxidation of protein thiols (sulfur-containing groups in proteins), indicated by the enhanced S-glutathionylation of cysteine residues, especially when compared to young murine models. An 8-week intervention with SS-31 appeared to almost entirely reverse this age-associated proteomic oxidation. The authors commented that significant shifts were apparently detected, predominantly in proteins purported as important for mitochondrial or cardiac function. Further, age-correlated modifications in the murine heart appeared to undergo partial reversal post SS-31 exposure. More specifically, the researchers noted “changes in the mouse heart phosphoproteome that were associated with age, some of which were partially restored with elamipretide.” Thus, the findings suggest that alterations in the thiol redox state and phosphorylation status could be pathways through which aging may impact murine heart functionality. Importantly, these age-induced changes seem to be mitigated with SS-31 influence."
            },
            {
                "h3": "SS-31 and Mitochondrial Dysfunction"
            },
            {
                "p": "Mitochondrial dysfunction is thought to be a major part of the mechanisms which occur in pathological processes, as well as certain physiological but unfavorable phenomena such as sarcopenia - the reduction in size of muscle tissue in advanced age.(4) To explore the potential of enhancing mitochondrial function as a countermeasure, a study was conducted using SS-31 to investigate if it could amend redox balance and boost skeletal muscle cells functionality in aged murine models. Young and older female C57BL/6Nia murine models underwent an 8-week exposure to SS-31. Assessments of mitochondrial function in vivo utilized optical and magnetic resonance spectroscopy. Findings suggested that SS-31 may have counteracted the age-related decrease in peak mitochondrial ATP production and enhanced the efficiency of oxidative phosphorylation (P/O). Intriguingly, even with this mitochondrial boost, mitochondrial protein expression remained constant or even declined in the exposed older murine models. The respiration in permeabilized gastrocnemius muscle fibers displayed no significant difference between the older and the SS-31-exposed older models. Additionally, SS-31 was posited to realign redox homeostasis in aged skeletal muscle cells. Apparently, there was a more balanced glutathione redox status, and thiol redox proteomics suggested a significant reversal of cysteine S-glutathionylation post-translational modifications across the skeletal muscle proteome. Furthermore, the gastrocnemius muscle cells in the Szeto-Schiller-31 exposed older murine models showcased potentially increased fatigue resistance and an apparent mass enhancement compared to unexposed controls."
            },
            {
                "h3": "SS-31 and Neuroprotection"
            },
            {
                "p": "SS-31 has been suggested to provide neuroprotection in a range of experimental models. Its function as a mitochondrial reactive oxygen species (ROS) scavenger and the inherent mechanisms in neuronal injury remain elusive. Yet, one trial aimed to delve into the neuroprotective potential of SS-31 and comprehend any apparent mitochondrial alterations using murine models of neuronal injury.(5) Murine models were categorized into sham, neuronal injury, neuronal injury + vehicle, and neuronal injury + SS-31 groups. The peptide SS-31 or vehicle was introduced post-neuronal injury, and brain specimens were procured 24 hours thereafter for analysis. The introduction of SS-31 appeared to counteract mitochondrial impairment and lessened secondary neuronal injury. It may directly reduce the reactive oxygen species content, rejuvenate the activity of superoxide dismutase (SOD), lower malondialdehyde (MDA) levels, and curb the release of cytochrome C, thereby mitigating potential neurological impairments, brain hydration, DNA destruction, and neural apoptosis. Additionally, SS-31 appeared to have reinstated the SIRT1 expression and amplified the nuclear relocation of PGC-1α, as suggested by Western blot and immunohistochemistry. Collectively, these findings suggest that SS-31 enhances mitochondrial function and may confer neuroprotection in murine models post-neuronal injury, possibly via augmented mitochondrial rebirth."
            },
            {
                "h3": "SS-31 and Metabolic Conditions"
            },
            {
                "p": "Studies have investigated the potential mechanisms and effects of SS-31 on leukocytes from models with type 2 diabetes (T2D), focusing on oxidative stress, endoplasmic reticulum (ER) stress, and autophagy.(6) The trial included samples from models of type 2 diabetes and controls. Key metrics such as anthropometric and analytical measurements were considered. Results indicated that leukocytes from the T2D models exhibited increased levels of reactive oxygen species (ROS), elevated calcium content, and pronounced expression of ER stress markers like GRP78 and CHOP. However, exposure to SS-31 appeared to significantly mitigate these elevated levels, hinting at its possible protective effects. Similarly, SS-31 appeared to have led to a decrease in BECN1 gene expression, along with reductions in Beclin1 and LC3 II/I protein expressions. Conversely, the protein levels of p62, which were found to be reduced in type 2 diabetes models, appeared rejuvenated post SS-31 exposure. An interesting observation was that SS-20, a compound without antioxidant activity, did not manifest any noticeable change in the parameters studied. Additionally, SS-31 may have exhibited properties that impacted leukocyte-endothelium interactions. Specifically, in type 2 diabetes models, it appeared to reduce rolling flux and leukocyte adhesion, while enhancing rolling velocity. Thus, the researchers commented that “SS-31 exerts potentially beneficial effects on leukocytes of T2D patients modulating oxidative stress and autophagy, and ameliorating endoplasmic reticulum stress.”"
            },
            {
                "h3": "SS-31 and Kidney Function"
            },
            {
                "p": "Ischemia is a pathological condition which leads to organ injury such as acute kidney injury as a result of ATP depletion. Thus, swift recovery of ATP upon reperfusion is vital to reduce tissue damage. However, ATP recovery is often delayed since ischemia damages the mitochondrial cristae membranes, which are essential for mitochondrial ATP synthesis. The mitochondria-targeted compound SS-31 has been suggested to quicken ATP recovery post-ischemia and potentially diminish acute kidney injury. In one investigation, scientists utilized a polarity-sensitive fluorescent analog of SS-31 to show that SS-31 may bind with high affinity to cardiolipin that is crucial for cristae formation.(7) Moreover, the SS-31/cardiolipin complex appeared to shield its heme iron and thus impede cytochrome C peroxidase activity, a reaction responsible for cardiolipin peroxidation leading to mitochondrial damage during ischemia. When murine models were exposed to SS-31, it appeared to safeguard the cristae membranes during renal ischemia, averting mitochondrial swelling. Immediate recovery of ATP upon reperfusion may also enable the speedy repair of ATP-dependent processes, such as the reformation of the actin cytoskeleton and cell polarity. This swift ATP recovery may also work to suppress apoptosis, fortify tubular barrier function, and alleviate renal dysfunction. Thus, Szeto-Schiller-31 may potentially preserve mitochondrial cristae by engaging with cardiolipin on the inner mitochondrial membrane."
            },
            {
                "h3": "SS-31 and Cachexia"
            },
            {
                "p": "Cachexia is a multifaceted condition representing on a cellular level a diminished oxidative capability accompanied by low intracellular ATP, both of which stem from compromised mitochondrial functionality. Thus, one study aimed to assess the potential of SS-31 in mitigating muscle degradation and metabolic disturbances in C26-bearing (colon adenocarcinoma model) murine models, some of which underwent combination exposure of oxaliplatin and 5-fluorouracil for additional cachexia inducement.(8) C26-bearing murine models showcased mitochondrial impairments that were linked to changes in cardiolipin fatty acid chains. By specifically targeting cardiolipin using SS-31, there was suggested to be an apparent moderate reduction in overall body wasting, and a notable prevention of glycolytic myofiber area reduction. Furthermore, SS-31 may have enhanced the muscle mitochondrial activity of succinate dehydrogenase (SDH) and successfully reinstated intracellular ATP concentrations. However, SS-31 did not appear to negate the loss of mitochondrial proteins. When the SS-31 exposure was increased progressively in C26 OXFU murine models, there were observable short-lived positive outcomes in terms of body and muscle weight retention, prior to these models entering a non-responsive, terminal stage by day 28. Notably, Szeto-Schiller-31 may have been effective in thwarting the loss of mitochondria and aberrant autophagy/mitophagy processes. Comprehensive analyses of metabolomes in skeletal muscles, liver, and plasma unveiled pronounced disruptions in energy and protein metabolic pathways in murine models with C26. SS-31 displayed a potential to partially regulate metabolomes in skeletal muscles and the liver, indicating an apaprent enhancement in systemic energy equilibrium."
            },
            {
                "h3": "SS-31 and Tendinopathies"
            },
            {
                "p": "Studies have investigated the potential role of SS-31 in improving mitochondrial function in tenocytes (cells of tendons), hypothesizing that SS-31 may enhance mitochondrial function in tenocytes from models with tendinopathy. For one study, tenocytes were sourced from two sets: one from healthy hamstring tendons and the other from degenerative supraspinatus tendons. (9) These cells were cultured and then allocated into four distinct categories, including SS-31-exposed and unexposed tenocytes from each category. Several outcome metrics were used, including measurements related to mitochondrial potential, detailed mitochondrial imagery via transmission electron microscopy, and assessments of reactive oxygen species, superoxidative dismutase activity, gene expression, and cell viability. The findings of the study indicated that degenerative tenocytes may have had a higher proportion of cells with depolarized mitochondria. However, post SS-31 exposure, a decrease in this proportion was apparently observed. Transmission electron microscopy also suggested that degenerative tenocytes had fewer mitochondria, and these were also smaller in size. However, Szeto-Schiller-31 seemed to improve these morphological deficits. There was no notable difference in reactive oxygen species levels between the two types of tenocytes, but the activity levels of superoxidative dismutase appeared to be discernibly lower in the degenerative set. This activity level appeared to increase after the introduction of SS-31, implying potential recovery of mitochondrial functionality. Further, certain genes linked to matrix remodeling and fatty infiltration were more active in degenerative tenocytes. Interestingly, the activity of these genes decreased after SS-31 exposure. Other genes related to cellular responses to hypoxic conditions and apoptosis regulation also appeared to exhibit increased activity in the degenerative group. Overall, these findings in the murine models suggest that SS-31 may possess potential benefits in ameliorating mitochondrial dysfunction in tenocytes, offering potential avenues for future research."
            },
            {
                "p": "SS-31 peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Pang, Y., Wang, C., & Yu, L. (2015). Mitochondria-Targeted Antioxidant SS-31 is a Potential Novel Ophthalmic Medication for Neuroprotection in Glaucoma. Medical hypothesis, discovery & innovation ophthalmology journal, 4(3), 120–126.",
                    "Huang, J., Li, X., Li, M., Li, J., Xiao, W., Ma, W., Chen, X., Liang, X., Tang, S., & Luo, Y. (2013). Mitochondria-targeted antioxidant peptide SS31 protects the retinas of diabetic rats. Current molecular medicine, 13(6), 935–945. https://doi.org/10.2174/15665240113139990049",
                    "Whitson, J. A., Martín-Pérez, M., Zhang, T., Gaffrey, M. J., Merrihew, G. E., Huang, E., White, C. C., Kavanagh, T. J., Qian, W. J., Campbell, M. D., MacCoss, M. J., Marcinek, D. J., Villén, J., & Rabinovitch, P. S. (2021). Elamipretide (SS-31) treatment attenuates age-associated post-translational modifications of heart proteins. GeroScience, 43(5), 2395–2412. https://doi.org/10.1007/s11357-021-00447-6",
                    "Campbell, M. D., Duan, J., Samuelson, A. T., Gaffrey, M. J., Merrihew, G. E., Egertson, J. D., Wang, L., Bammler, T. K., Moore, R. J., White, C. C., Kavanagh, T. J., Voss, J. G., Szeto, H. H., Rabinovitch, P. S., MacCoss, M. J., Qian, W. J., & Marcinek, D. J. (2019). Improving mitochondrial function with SS-31 reverses age-related redox stress and improves exercise tolerance in aged mice. Free radical biology & medicine, 134, 268–281. https://doi.org/10.1016/j.freeradbiomed.2018.12.031",
                    "Zhu, Y., Wang, H., Fang, J., Dai, W., Zhou, J., Wang, X., & Zhou, M. (2018). SS-31 Provides Neuroprotection by Reversing Mitochondrial Dysfunction after Traumatic Brain Injury. Oxidative medicine and cellular longevity, 2018, 4783602. https://doi.org/10.1155/2018/4783602",
                    "Escribano-López, I., de Marañon, A. M., Iannantuoni, F., López-Domènech, S., Abad-Jiménez, Z., Díaz, P., Solá, E., Apostolova, N., Rocha, M., & Víctor, V. M. (2019). The Mitochondrial Antioxidant SS-31 Modulates Oxidative Stress, Endoplasmic Reticulum Stress, and Autophagy in Type 2 Diabetes. Journal of clinical medicine, 8(9), 1322. https://doi.org/10.3390/jcm8091322",
                    "Birk, A. V., Liu, S., Soong, Y., Mills, W., Singh, P., Warren, J. D., Seshan, S. V., Pardee, J. D., & Szeto, H. H. (2013). The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin. Journal of the American Society of Nephrology : JASN, 24(8), 1250–1261. https://doi.org/10.1681/ASN.2012121216",
                    "Ballarò, R., Lopalco, P., Audrito, V., Beltrà, M., Pin, F., Angelini, R., Costelli, P., Corcelli, A., Bonetto, A., Szeto, H. H., O'Connell, T. M., & Penna, F. (2021). Targeting Mitochondria by SS-31 Ameliorates the Whole Body Energy Status in Cancer- and Chemotherapy-Induced Cachexia. Cancers, 13(4), 850. https://doi.org/10.3390/cancers13040850",
                    "Zhang, X., Zhang, Y., Zhang, M., Nakagawa, Y., Caballo, C. B., Szeto, H. H., Deng, X. H., & Rodeo, S. A. (2022). Evaluation of SS-31 as a Potential Strategy for Tendinopathy Treatment: An In Vitro Model. The American journal of sports medicine, 50(10), 2805–2816. https://doi.org/10.1177/03635465221107943"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/12/SS-31-COA.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/12/SS-31-LC.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/12/SS-31-MS.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "SS-31 for sale online (50mg). Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "SS-31 for Sale (50mg) - Core Peptides",
            "og:description": "SS-31 for sale online (50mg). Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/ss-31-50mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T15:26:45+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2023/11/SS-31-50mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "SS-31 For Sale (50mg) - Core Peptides",
            "twitter:description": "SS-31 for sale online (50mg). Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2023/11/SS-31-50mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$263.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:brand": "Core Peptides",
            "product:price:amount": "263.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-SS-31-50",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/ghk-cu-50mg-copper/",
                "name": "GHK-Cu (Copper) (50mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHK-CU-50mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/receptor-grade-igf-1-lr3-100mcg/",
                "name": "Receptor Grade IGF-1 LR3 (100mcg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-100MCG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/receptor-grade-igf-1-lr3-1mg/",
                "name": "Receptor Grade IGF-1 LR3 (1mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-1MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ghrp-2/",
                "name": "GHRP-2 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHRP-2-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "id": "36",
        "url": "https://www.corepeptides.com/peptides/snap-8-200mg/",
        "name": "SNAP-8 (200mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2023/03/Snap-8-200mg.jpg",
        "display_price": "$195.00 Original price was: $195.00.$176.00Current price is: $176.00.",
        "display_specs": [
            "Size: 200mg Contents: SNAP-8 Form: Lyophilized powder Purity: >99% SKU: SNAP-8",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$167.20"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$158.40"
            }
        ],
        "description": [
            {
                "h2": "SNAP-8 Peptide"
            },
            {
                "p": "Synaptosomal-associated protein 8, or the SNAP-8 peptide, is a synthetic octapeptide analog of the N-terminal end of the SNAP-25 peptide. The peptide is made of eight amino acids. It is acetylated at the N-terminus and amidated at the C-terminus, which leads to the following structure: Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH2."
            },
            {
                "h3": "Overview"
            },
            {
                "p": "This peptide was developed to compete with the SNAP-25 protein to bind with the vehicle-associated membrane proteins. The SNAP-25 protein, which stands for Synaptosomal-Associated Protein of 25 kDa, is considered a key component in neurotransmitter release. It normally interacts with vehicle-associated membrane proteins to facilitate the fusion of vesicles with the cell membrane, releasing their contents into the synaptic gap. Such a vesicle-associated membrane protein is thought to be synaptic vesicle protein Synaptotagmin 1 (Syt1). Synaptotagmin 1 (Syt1) serves as a calcium sensor and is deemed crucial for regulating neurotransmitter release in response to changes in calcium ion concentrations inside nerve cells."
            },
            {
                "p": "Molecular docking experiments posited that SNAP-8 and other peptides might bind to the C2A–C2B interface, primarily driven by hydrophobic contacts, suggesting a plausible site for inhibitory action on Syt1. The C2A and C2B regions are parts of the protein structure of Synaptotagmin 1 involved in calcium binding and membrane interaction. The binding at this interface by SNAP-8 suggests that the peptide might interfere with Synaptotagmin 1’s ability to respond to calcium signals, potentially disrupting normal neurotransmission. Once the SNAP-8 peptide binds with these proteins, it appears to destabilize the formation of the Soluble N-ethylmaleimide-sensitive factor Attachment Protein Receptor (SNARE) complex."
            },
            {
                "p": "The SNARE complex is instrumental in the docking and fusion of vesicles at the cell membrane. Destabilization of this complex may prevent the release of acetylcholine, reducing localized muscle contractions. Acetylcholine is a neurotransmitter involved in stimulating muscle contractions. Its reduced release may therefore lead to decreased muscle activity and reduced wrinkle depth. Ultimately, all these biological activities induced by SNAP-8 peptide may cause a reduction in lines and wrinkles.(1) Thus, the potential of SNAP-8 to interact at the molecular level with components of the neurotransmitter release mechanism showcases it may act as a modulator of neural and muscular function, specifically in experimental models of skin cell aging."
            },
            {
                "h3": "Chemical Makeup(2)"
            },
            {
                "p": "Molecular Formula: C41H70N16O6S Molecular Weight: 1075.16 g/mol Other Known Titles: SNAP-8 (Acetyl Glutamyl Heptapeptide-3), Synaptosomal-associated protein 8, Acetyl octapeptide-3"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "SNAP-8 Peptide and Skin Wrinkling"
            },
            {
                "p": "A study(3) was conducted in 2021 to study the potential of the peptide on expression lines and wrinkles. In this double-blind, randomized clinical trial, 55 research models were observed. The entire cohort exhibited Fitzpatrick skin type I to VI, and were exposed either the peptide serum or a control compound twice a day for 12 weeks. Short-term peptide impact was measured 15 minutes after exposure, and long-term impact was measured at weeks 4, 8, and 12. After completing this study, it was observed that the peptide appeared to cause a notable reduction in the lines within 15 minutes after introduction. For long-term impact, it was suggested by the researchers that the peptide had the potential to induce significant skin improvement after 12 weeks."
            },
            {
                "p": "In another clinical trial conducted in 2013,(4) scientists focused on the Argireline peptide, a synthetic analog of the N-terminal end of the SNAP-25 peptide, which was developed for anti-aging action within the cell by inhibiting the catecholamine release (as opposed to acetylcholine release). Since both peptides are similar in structure, this study's results may reflect parallel actions of the SNAP-8 peptide. For this trial, 60 models were examined, of which 45 were presented with the peptide, and 15 were presented with a control compound. The peptide or the control was introduced every day for four weeks. After the completion of the study, it was reported that the peptide group appeared to have improved skin, with almost a 49% reduction in lines and decreased skin roughness. As per Yuan Wang et al.:"
            },
            {
                "p": "\"In the subjective evaluation, the total anti-wrinkle efficacy in the argireline group was 48.9%, compared with 0% in the placebo group. In the objective evaluation, the parameters of roughness were all decreased in the argireline group (p < 0.01), while no decrease was obvious in the placebo group (p > 0.05).”"
            },
            {
                "h3": "SNAP-8 Peptide and Skin Topography"
            },
            {
                "p": "A study(5) aimed to evaluate whether the SNAP-8 peptide might be incorporated into an oil and water emulsion form to understand the peptide’s stability. When the 10% peptide oil-in-water emulsion was evaluated over a month-long routine exposure, there appeared to be a ~30% reduction in the depth and appearance of wrinkles. Researchers suggest that the peptide potentially mimics the action of botulinum neurotoxins.(6)"
            },
            {
                "h3": "SNAP-8 Peptide and SNARE Protein Complex"
            },
            {
                "p": "SNAP-8 peptide has shown the potential to reduce muscle contractions by modulating the SNARE protein complex. One study reported that the peptide appeared to reduce the release of glutamate amino acid by almost 43%. Researchers reportedly claimed that the SNAP-8 peptide might reduce wrinkles by an average of 35%, up to a maximum of 62%,(7) a notable improvement in skin texture."
            },
            {
                "p": "SNAP-8 peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References"
            },
            {
                "references": [
                    "Lim SH, Sun Y, Thiruvallur Madanagopal T, Rosa V, Kang L. Enhanced Skin Permeation of Anti-wrinkle Peptides via Molecular Modification. Sci Rep. 2018 Jan 25;8(1):1596. doi: 10.1038/s41598-017-18454-z. Erratum in: Sci Rep. 2018 Apr 20;8(1):6500. PMID: 29371611; PMCID: PMC5785486. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785486/",
                    "National Center for Biotechnology Information (2023). PubChem Compound Summary for CID 86080331, SNAP-8(Acetyl Glutamyl Heptapeptide-3). from https://pubchem.ncbi.nlm.nih.gov/compound/SNAP-8_Acetyl-Glutamyl-Heptapeptide-3",
                    "Nguyen TQ, Zahr AS, Kononov T, Ablon G. A Randomized, Double-blind, Placebo-controlled Clinical Study Investigating the Efficacy and Tolerability of a Peptide Serum Targeting Expression Lines. J Clin Aesthet Dermatol. 2021 May;14(5):14-21. Epub 2021 May 1. PMID: 34188744; PMCID: PMC8211334. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211334/",
                    "Wang Y, Wang M, Xiao S, Pan P, Li P, Huo J. The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: a randomized, placebo-controlled study. Am J Clin Dermatol. 2013 Apr;14(2):147-53. doi: 10.1007/s40257-013-0009-9. PMID: 23417317. https://pubmed.ncbi.nlm.nih.gov/23417317/",
                    "Blanes-Mira C, Clemente J, Jodas G, Gil A, Fernández-Ballester G, Ponsati B, Gutierrez L, Pérez-Payá E, Ferrer-Montiel A. A synthetic hexapeptide (Argireline) with anti-wrinkle activity. Int J Cosmet Sci. 2002 Oct;24(5):303-10. doi: 10.1046/j.1467-2494.2002.00153.x. PMID: 18498523. https://pubmed.ncbi.nlm.nih.gov/18498523/",
                    "Apland JP, Adler M, Oyler GA. Inhibition of neurotransmitter release by peptides that mimic the N-terminal domain of SNAP-25. J Protein Chem. 2003 Feb;22(2):147-53. doi: 10.1023/a:1023423013741. PMID: 12760419. https://pubmed.ncbi.nlm.nih.gov/12760419/",
                    "Errante F, Ledwoń P, Latajka R, Rovero P, Papini AM. Cosmeceutical Peptides in the Framework of Sustainable Wellness Economy. Front Chem. 2020 Oct 30;8:572923. doi: 10.3389/fchem.2020.572923. PMID: 33195061; PMCID: PMC7662462. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662462/",
                    "Sadowski G, Sadowski J. Safety and Efficacy of a Novel Anti-aging Skin Care Regimen Containing Neutraceuticals and Growth Factors on the Facial Skin of Women: A 12-Week Open-label Study. J Clin Aesthet Dermatol. 2020 Jun;13(6):24-34. Epub 2020 Jun 1. PMID: 32884616; PMCID: PMC7442306. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7442306"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "",
        "high_performance_liquid_chromatography": "",
        "mass_spectrometry": "",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "SNAP-8 peptide for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "SNAP-8 For Sale (200mg) - Core Peptides",
            "og:description": "SNAP-8 peptide for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:url": "https://www.corepeptides.com/peptides/snap-8-200mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T16:09:30+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2023/03/Snap-8-200mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "SNAP-8 For Sale (200mg) - Core Peptides",
            "twitter:description": "SNAP-8 peptide for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2023/03/Snap-8-200mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$176.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "176.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "SNAP-8",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/mgf-5mg/",
                "name": "MGF (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/MGF-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/melanotan-2-10mg/",
                "name": "Melanotan 2 (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2023/03/Melanotan-2-10MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/semax-25mg/",
                "name": "Semax (25mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Semax-25MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/cjc-1295-dac-5mg/",
                "name": "CJC-1295 DAC (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/CJC-1295-DAC-5MG-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "id": "37",
        "url": "https://www.corepeptides.com/peptides/sermorelin-ipamorelin-10mg-blend/",
        "name": "Sermorelin & Ipamorelin Blend (10mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Sermorelin-Ipamorelin-5-5MG.jpg",
        "display_price": "$80.00",
        "display_specs": [
            "Size: 10mg Contents: Sermorelin 5mg, Ipamorelin 5mg Form: Lyophilized powder Purity: >99% SKU: P-SERMIPAM-10",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$76.00"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$72.00"
            }
        ],
        "description": [
            {
                "h2": "Sermorelin & Ipamorelin Blend"
            },
            {
                "p": "Both Ipamorelin & Sermorelin are synthetic peptides, and when blended, they may act synergistically to further their individual potential impacts. More specifically, they both appear to upregulate the production of growth hormone. The growth hormone appears to play a vital role in accelerating growth and is considered to function primarily to regulate metabolic functions."
            },
            {
                "h3": "Overview"
            },
            {
                "p": "Sermorelin & Ipamorelin are synthetic peptides, where Sermorelin is composed of 29 amino acids(1) and Ipamorelin is composed of 5 amino acids.(2) Sermorelin seems to serve as a functional equivalent to the naturally occurring growth hormone-releasing hormone (GHRH). Unlike GHRH, which consists of 44 amino acids, Sermorelin is shortened to a sequence of 29 amino acids. This truncated form is also referred to as Growth Hormone Releasing Factor (1-29) or simply GRF (1-29). Ipamorelin was the first synthetic GHS discovered with a proposed high selectivity towards the growth hormone receptors without apparently affecting the synthesis of other pituitary hormones such as ACTH and prolactin.(3)"
            },
            {
                "p": "Sermorelin is also known as GHRF (1-29) amide, and the potential of this fragment was first investigated in the early 1980s. It was suggested that upon introduction, Sermorelin may exhibit affinity towards the GHRH receptors located at the pituitary gland and possibly stimulate the secretion of growth hormone.(4)"
            },
            {
                "p": "Both Ipamorelin & Sermorelin are posited to produce action on the pituitary gland. Upon binding, these peptides are suggested to stimulate the pituitary gland and secrete more growth hormone.(4)(5)"
            },
            {
                "p": "The difference in their mode of action is the pathway by which they exert their action. Sermorelin appears to affect the GHRH receptors while Ipamorelin appears to act via the ghrelin pathway.(5) Thus, it is believed that Sermorelin may retain the core ability of GHRH: to potentially prompt the GHRH receptors in the pituitary gland to intermittently release growth hormone. This action is thought to subsequently elevate levels of insulin-like growth factor-1 (IGF-1), which is viewed as the primary agent responsible for the anabolic action of growth hormone. Ipamorelin does not appear to work via the GHRH receptors. Instead, this synthetic pentapeptide is under investigation for its potential capabilities as a growth hormone secretagogue (GHS). It is thought to function similarly to Growth Hormone Releasing Peptides (GHRPs) and may potentially mimic the natural action of the hunger hormone, ghrelin. The peptide is suspected to target ghrelin receptors in the anterior pituitary gland, also known as Growth Hormone Secretagogue Receptors 1 Alpha (GHS-R1a). This characteristic positions Ipamorelin as a highly selective secretagogue and a potent agonist for the growth hormone/ghrelin secretagogue receptor."
            },
            {
                "p": "Since the mode of action of both the peptides appears to be different, they may complement each other when presented together and thereby provide a potentially greater growth hormone response."
            },
            {
                "p": "A major difference between the two peptides appears to be their respective half-lives, where the half-life of Sermorelin is considered to be 11 to 12 minutes and that of Ipamorelin is approximately 2 hours.(6)"
            },
            {
                "p": "Therefore, research has posited that Sermorelin may trigger an immediate growth hormone response while Ipamorelin may extend this process for longer periods."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula:"
            },
            {
                "p": "Molecular Weight:"
            },
            {
                "p": "Other Known Titles"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "p": "Currently, there is no research and clinical data available for the Ipamorelin & Sermorelin blend together, however both these peptides have been individually studied."
            },
            {
                "h3": "Sermorelin & Ipamorelin Blend and Growth Hormone"
            },
            {
                "p": "Sermorelin and ipamorelin are both peptides that have been investigated for their possible roles in elevating levels of growth hormone and its potential anabolic mediator, IGF-1. One study seems to suggest that Sermorelin may lead to an 82% increase in average growth hormone levels, which appeared to last for around two hours.(7) Another study, lasting 16 weeks, posited that Sermorelin might potentially result in up to a 107% rise in growth hormone levels and up to a 28% uptick in IGF-1 levels.(8 Conversely, Ipamorelin has been associated with what appears to be a substantial increase in growth hormone levels, reaching levels that may be as high as 80mIU/l (approximately a 26.6ng/ml concentration). When these figures are presented as a percentage increase compared to a placebo (1.31mIU/l (0.4ng/ml)), it seems to represent a noteworthy elevation in growth hormone levels, exceeding 6000%. Both peptides appear to have a strong potential for raising growth hormone and IGF-1 levels. However, it is worth noting that the extent of the increase and the duration for which these elevated levels are maintained could vary between the two.(9"
            },
            {
                "h3": "Sermorelin & Ipamorelin Blend and Lean Mass"
            },
            {
                "p": "Both Sermorelin and Ipamorelin appear to exert influence on lean mass and body composition. According to research, Sermorelin has been suggested to increase lean body mass by a margin of 2.78 lbs (1.26 kg), without affecting fat mass. These observations are posited to be due to the potential of the peptide to increase growth hormone and subsequently IGF-1, a purported anabolic mediator of growth hormone.(8) The most notable results commented by the researchers included that “...a gain of 1.26 ± 0.52 kg (P < 0.05) in LBM was found.” and “Skin thickness increased significantly…” Ipamorelin has also been suggested to potentially lead to lean mass increase, related to an increase in appetite and total weight gain. That is related to the proposed impact that Ipamorelin may have on ghrelin receptors."
            },
            {
                "p": "For instance, research suggests that subjects exposed to Ipamorelin exhibited a weight increase by roughly 17%.(10) The compound is thought to potentially elevate fat pad weights in proportion to total body mass. Consequently, measurements taken via dual energy X-ray absorptiometry (DEXA) might indicate a relative increase in body fat. Moreover, there are indications that Ipamorelin may have elevated serum leptin levels, a hormone involved in energy and appetite regulation. The researchers posited that “GHSs increase body fat by GH-independent mechanisms that may include increased feeding.” This has led experts to speculate that heightened food consumption may contribute to the observed weight gain in groups presented with Ipamorelin."
            },
            {
                "h3": "Sermorelin & Ipamorelin Blend and Bone Mineralization"
            },
            {
                "p": "Ipamorelin has been purported to potentially cause an increase in bone mineral density which may be related to its apparent role in increasing lean and total weight. During an investigation, Ipamorelin and a placebo were tested on mouse models to evaluate their action on bone density.(11) The study utilized real-time DEXA scans to track alterations in bone mineral content, with a focus on specific areas such as the femur and L6 vertebrae. Once the study concluded, pQCT scans were performed on the femurs to gather additional data. Preliminary results suggest a potential correlation between Ipamorelin and both weight gain and an increase in bone mineral content in the tibia and vertebrae, as evidenced by DEXA, relative to the placebo group. Furthermore, the pQCT findings hint that the noted increase in cortical BMC could be due to an expansion in the bone's cross-sectional area."
            },
            {
                "p": "Sermorelin & Ipamorelin Blend is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "National Center for Biotechnology Information. “PubChem Compound Summary for CID 16129620, Sermorelin” PubChem, https://pubchem.ncbi.nlm.nih.gov/compound/Sermorelin",
                    "National Center for Biotechnology Information. “PubChem Compound Summary for CID 9831659, Ipamorelin” PubChem, https://pubchem.ncbi.nlm.nih.gov/compound/Ipamorelin",
                    "Raun K, Hansen BS, Johansen NL, Thøgersen H, Madsen K, Ankersen M, Andersen PH. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998 Nov;139(5):552-61. https://pubmed.ncbi.nlm.nih.gov/9849822/",
                    "Clark, R G, and I C Robinson. “Growth induced by pulsatile infusion of an amidated fragment of human growth hormone releasing factor in normal and GHRF-deficient rats.” Nature vol. 314,6008 (1985): 281-3. https://pubmed.ncbi.nlm.nih.gov/2858818/",
                    "Sinha, D. K., Balasubramanian, A., Tatem, A. J., Rivera-Mirabal, J., Yu, J., Kovac, J., Pastuszak, A. W., & Lipshultz, L. I. (2020). Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males. Translational andrology and urology, 9(Suppl 2), S149–S159. https://doi.org/10.21037/tau.2019.11.30",
                    "Junichi I. et al, Growth hormone secretagogues: history, mechanism of action, and clinical development, JSCM Rapid Communications Vol. 3 Issue 1, 09 February 2020. https://onlinelibrary.wiley.com/doi/full/10.1002/rco2.9",
                    "Vittone, J., Blackman, M. R., Busby-Whitehead, J., Tsiao, C., Stewart, K. J., Tobin, J., Stevens, T., Bellantoni, M. F., Rogers, M. A., Baumann, G., Roth, J., Harman, S. M., & Spencer, R. G. (1997). Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men. Metabolism: clinical and experimental, 46(1), 89–96. https://doi.org/10.1016/s0026-0495(97)90174-8",
                    "Khorram, O., Laughlin, G. A., & Yen, S. S. (1997). Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women. The Journal of clinical endocrinology and metabolism, 82(5), 1472–1479. https://doi.org/10.1210/jcem.82.5.3943",
                    "Gobburu, J. V., Agersø, H., Jusko, W. J., & Ynddal, L. (1999). Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers. Pharmaceutical research, 16(9), 1412–1416. https://doi.org/10.1023/a:1018955126402",
                    "Lall, S., Tung, L. Y., Ohlsson, C., Jansson, J. O., & Dickson, S. L. (2001). Growth hormone (GH)-independent stimulation of adiposity by GH secretagogues. Biochemical and biophysical research communications, 280(1), 132–138. https://doi.org/10.1006/bbrc.2000.4065",
                    "Svensson, J., Lall, S., Dickson, S. L., Bengtsson, B. A., Rømer, J., Ahnfelt-Rønne, I., Ohlsson, C., & Jansson, J. O. (2000). The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats. The Journal of endocrinology, 165(3), 569–577. https://doi.org/10.1677/joe.0.1650569"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/09/Sermorelin-Ipamorelin-coa.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/09/Sermorelin-Ipamorelin-lc.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/09/Sermorelin-Ipamorelin-ms.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Sermorelin & Ipamorelin blend for sale online (10mg). Peptides for sale at 99+% purity with unmatched customer service and free shipping.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Sermorelin & Ipamorelin Blend For Sale (10mg) | Core Peptides",
            "og:description": "Sermorelin & Ipamorelin blend for sale online (10mg). Peptides for sale at 99+% purity with unmatched customer service and free shipping.",
            "og:url": "https://www.corepeptides.com/peptides/sermorelin-ipamorelin-10mg-blend/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-05-28T11:02:31+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Sermorelin-Ipamorelin-5-5MG.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Sermorelin & Ipamorelin Blend For Sale (10mg) | Core Peptides",
            "twitter:description": "Sermorelin & Ipamorelin blend for sale online (10mg). Peptides for sale at 99+% purity with unmatched customer service and free shipping.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Sermorelin-Ipamorelin-5-5MG.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$80.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:brand": "Core Peptides",
            "product:price:amount": "80.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-SERMIPAM-10",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/cjc-1295-no-dac-mod-grf-1-29/",
                "name": "CJC-1295 NO DAC (Mod GRF 1-29) (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Mod-GRF-1-29-5mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ghrp-2/",
                "name": "GHRP-2 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHRP-2-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/dsip-5mg/",
                "name": "DSIP (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/DSIP-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ll-37-5mg/",
                "name": "LL-37 (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/LL-37-5mg-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "id": "38",
        "url": "https://www.corepeptides.com/peptides/sermorelin-5mg/",
        "name": "Sermorelin (5mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Sermorelin-5mg.jpg",
        "display_price": "$50.00 Original price was: $50.00.$48.00Current price is: $48.00.",
        "display_specs": [
            "Size: 5mg Contents: Sermorelin Form: Lyophilized powder Purity: >99% SKU: P-SERMORELIN-5",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$45.60"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$43.20"
            }
        ],
        "description": [
            {
                "h2": "Sermorelin Peptide"
            },
            {
                "p": "Sermorelin is a 29 amino acid peptide, the shortest synthetically developed peptide that may potentially induce biological activity at the receptors for the growth hormone-releasing hormone (GHRH).(2) Sermorelin polypeptide is an analog of the GHRH factor consisting of GHRH (1-29 acid)-amide. Due to this structural and functional mimicry, Sermorelin has been studied across multiple branches of scientific research involving growth hormone deficiency models.(3)"
            },
            {
                "p": "It was in the early 1980s that the action of Sermorelin, classified as a growth hormone-releasing fragment GHRF (1-29) amide, was first explored. Several research studies were conducted on rats where exogenous GHRF (1-29) amide was introduced in conscious and anesthetized rats. It was observed that the presence of GHRF appeared to stimulate the pituitary gland and promote growth. Following this theory, Sermorelin and similar compounds have become the subject of further research in growth hormone deficiency models.(4)"
            },
            {
                "h3": "Overview"
            },
            {
                "p": "Sermorelin is suggested to be a growth hormone analog constituting the first 29 amino acids out of the usual 44 amino acids found in growth hormone-releasing hormone (GHRH). Researchers posit that Sermorelin binds with the GHRH receptors found on the pituitary gland and suggest further that the synthetic peptide may stimulate secretion of growth hormone (hGH). Thus, Sermorelin is believed to maintain the fundamental function of GHRH, possibly stimulating the GHRH receptors in the pituitary gland and leading to sporadic release of growth hormone despite its reduced amino acid sequence. This mechanism is thought to result in increased levels of insulin-like growth factor-1 (IGF-1), primarily recognized for its role in the anabolic actions of growth hormone. The estimated half-life of Sermorelin is around 11 to 12 minutes."
            },
            {
                "p": "A major potential advantage of the peptide is that due to its apparent GHRH receptor specificity, it may not induce any significant change in the levels of other endocrine markers such as prolactin, insulin, cortisol, glucose, or thyroid hormones.(6)"
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C149H246N44O42S Molecular Weight: 3357.93 g/mol Other Known Titles: GRF 1-29"
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Sermorelin and GHRH Receptors"
            },
            {
                "p": "Sermorelin is thought to interact with GHRH receptors through complex molecular mechanisms, possibly triggering various cellular signaling pathways. It is hypothesized that upon binding to the GHRH receptor, Sermorelin may alter the receptor's structure, potentially initiating a series of intracellular signaling events.(12) Some researchers propose that Sermorelin might enhance the production of cyclic adenosine monophosphate (cAMP) in specific cells. This enhancement may occur through the activation of adenylate cyclase, which is suggested to convert ATP into cAMP. Higher levels of cAMP might lead to the activation of protein kinase A (PKA), a key enzyme in cellular signaling processes. PKA might phosphorylate various target proteins, thereby initiating further cellular responses. The potential activation of the GHRH receptor by Sermorelin, along with the ensuing cAMP-PKA signaling cascade, is thought to possibly promote the secretion and distribution of growth hormone (hGH) from somatotroph cells in the pituitary gland. The secreted hGH is also believed to contribute to the synthesis of insulin-like growth factor-1 (IGF-1).(12)"
            },
            {
                "h3": "Sermorelin Peptide and Growth Velocity"
            },
            {
                "p": "Researchers reported positive results in the idiopathic GH deficiency when Sermorelin was presented to underdeveloped animal models. Increased growth and height velocity rate was observed within 12 months of consistent, continuous peptide presence. These elevated levels were reported to be sustained for an average of 36 months after continuous presence.(7)"
            },
            {
                "h3": "Sermorelin Peptide and Anabolic Research Outcomes"
            },
            {
                "p": "Preliminary findings from one investigation indicate that Sermorelin may lead to an 82% enhancement in average growth hormone levels, with actions persisting for approximately two hours.(13) A separate study conducted over 16 weeks hypothesizes that Sermorelin might elevate growth hormone levels by as much as 107%, and increase IGF-1 levels by about 28%.(14) The research further suggests a possible increase in lean body mass of approximately 2.78 lbs (1.26 kg), with no significant change in fat mass. These actions are tentatively attributed to the peptide's capacity to boost growth hormone levels, and in turn, IGF-1, which is considered a potential anabolic agent influencing growth hormone activity. The most noteworthy outcomes identified by the researchers include observations that there was “a gain of 1.26 ± 0.52 kg (P < 0.05) in LBM” and that “skin thickness increased significantly.”"
            },
            {
                "h3": "Sermorelin Peptide and Lipodystrophy"
            },
            {
                "p": "Scientists carried out a controlled clinical study involving 31 HIV-positive subjects with lipodystrophy, to investigate the potential impact of Sermorelin.(8) All 31 subjects were divided into two groups, where one was presented with Sermorelin, and the other group with a placebo for 12 weeks. Following the study, it was suggested by the research team that growth hormone levels appeared significantly increased in Sermorelin subjects as compared to the ones given a placebo. Levels of insulin-like growth factor (IGF-1) had apparently increased – resulting in increased lean body mass in the peptide group. Abdominal visceral fat and the ratio of trunk to lower extremity fat were reported by the researchers to be significantly reduced. There was no other reported change in the glucose or insulin levels.(8)"
            },
            {
                "h3": "Sermorelin Peptide and Cognition"
            },
            {
                "p": "In the early 2000s, clinical research studies were conducted with 89 subjects between 68 and 69 years of age to explore the correlation (if any) between tapering growth hormone release and impaired cognition. Scientists consider that with increasing age, levels of growth hormone naturally decline, which may result in reduced physiological functions, including cognition (i.e. ability to collect, process, and recollect information). Following the introduction of Sermorelin, it was observed that there was an apparent improved performance in the Wechsler Adult Intelligence Scale (WAIS) – i.e. improved IQ levels, picture arrangement tests, and verbal tests - amongst the test subjects.(9)"
            },
            {
                "h3": "Sermorelin Peptide and Tumor Cells"
            },
            {
                "p": "A clinical study was designed where 1,018 glioma subjects were presented with over 4,000 compounds each, and following each presentation, a DRS was determined for all compounds, for each subject. Following the results of the study, it appeared that the Sermorelin compound reportedly induced the most sensitivity in the test subjects. Upon analysis, it was suggested by the researchers that this may be due to the potential of Sermorelin to block the tumor cell cycles, thereby possibly preventing tumor cell proliferation.(10)"
            },
            {
                "h3": "Sermorelin Peptide and Hypogonadism"
            },
            {
                "p": "Initial research into the peptide suggested that Sermorelin might be impactful in increasing lean mass. One study sought to explore if Sermorelin had potential in hypogonadism (which is considered to stem from additional fat mass). Test models were divided into two groups where one group was presented with Sermorelin followed by GHRH 1-40, with a one week interval between the two compounds, whereas the other group was given the same combination in reverse order. Following the study, it was reported by the researchers that for both groups, the Sermorelin appeared to stimulate the release of FSH and LH, which might stimulate testosterone production."
            },
            {
                "p": "This initial research spawned additional studies, including one clinical study that included 19 male subjects, 9 of whom were aged between 22 and 33 years of age, and 10 were aged between 60 and 78 years of age. The more elderly subjects were presented with one of two concentrations of Sermorelin for a period of 28 days, with an interval of 14 days in between the two instances. Testosterone levels in the elderly subjects reportedly increased after the presentation of Sermorelin; however, it should be noted that the levels were not statistically significant. Furthermore, researchers suggested that elevated levels of growth hormones, possibly induced by Sermorelin presence, appeared to be at peak during the night time, for all test subjects, as compared during the day.(11)"
            },
            {
                "p": "Sermorelin peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Garcia JM, Merriam GR, Kargi AY. Growth Hormone in Aging. [Updated 2019 Oct 7]. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000. https://www.ncbi.nlm.nih.gov/books/NBK279163/?report=reader",
                    "Prakash, A, and K L Goa. “Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency.” BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy vol. 12,2 (1999): 139-57. https://pubmed.ncbi.nlm.nih.gov/18031173/",
                    "National Center for Biotechnology Information. \"PubChem Compound Summary for CID 16129620, Sermorelin\" PubChem",
                    "Clark, R G, and I C Robinson. “Growth induced by pulsatile infusion of an amidated fragment of human growth hormone releasing factor in normal and GHRF-deficient rats.” Nature vol. 314,6008 (1985): 281-3. https://pubmed.ncbi.nlm.nih.gov/2858818/",
                    "Drugs at FDA: FDA Approved Drugs. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020443",
                    "Junichi I. et al, Growth hormone secretagogues: history, mechanism of action, and clinical development, JSCM Rapid Communications Vol. 3 Issue 1, 09 February 2020. https://onlinelibrary.wiley.com/doi/full/10.1002/rco2.9",
                    "Prakash, A, and K L Goa. “Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency.” BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy vol. 12,2 (1999): 139-57. https://pubmed.ncbi.nlm.nih.gov/18031173/",
                    "Koutkia, Polyxeni et al. “Growth hormone-releasing hormone in HIV-infected men with lipodystrophy: a randomized controlled trial.” JAMA vol. 292,2 (2004): 210-8. https://pubmed.ncbi.nlm.nih.gov/15249570/",
                    "Vitiello, Michael V et al. “Growth hormone releasing hormone improves the cognition of healthy older adults.” Neurobiology of aging vol. 27,2 (2006): 318-23. https://pubmed.ncbi.nlm.nih.gov/16399214/",
                    "Chang, Yuanhao et al. “A potentially effective drug for patients with recurrent glioma: sermorelin.” Annals of translational medicine vol. 9,5 (2021): 406. doi:10.21037/atm-20-6561. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033379/",
                    "Sinha, Deepankar K et al. “Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males.” Translational andrology and urology vol. 9,Suppl 2 (2020): S149-S159. doi:10.21037/tau.2019.11.30. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108996/",
                    "Zhou, F., Zhang, H., Cong, Z., Zhao, L. H., Zhou, Q., Mao, C., Cheng, X., Shen, D. D., Cai, X., Ma, C., Wang, Y., Dai, A., Zhou, Y., Sun, W., Zhao, F., Zhao, S., Jiang, H., Jiang, Y., Yang, D., Eric Xu, H., … Wang, M. W. (2020). Structural basis for activation of the growth hormone-releasing hormone receptor. Nature communications, 11(1), 5205. https://doi.org/10.1038/s41467-020-18945-0",
                    "Vittone, J., Blackman, M. R., Busby-Whitehead, J., Tsiao, C., Stewart, K. J., Tobin, J., Stevens, T., Bellantoni, M. F., Rogers, M. A., Baumann, G., Roth, J., Harman, S. M., & Spencer, R. G. (1997). Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men. Metabolism: clinical and experimental, 46(1), 89–96. https://doi.org/10.1016/s0026-0495(97)90174-8",
                    "Khorram, O., Laughlin, G. A., & Yen, S. S. (1997). Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women. The Journal of clinical endocrinology and metabolism, 82(5), 1472–1479. https://doi.org/10.1210/jcem.82.5.3943"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/12/Sermorelin-COA.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/12/Sermorelin-LC.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/12/Sermorelin-MS.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Sermorelin for sale online (5mg). Peptides for sale at 99% purity with top customer service. Get Sermorelin's research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Sermorelin For Sale (5mg) | Core Peptides",
            "og:description": "Sermorelin for sale online (5mg). Peptides for sale at 99% purity with top customer service. Get Sermorelin's research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/sermorelin-5mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-05-28T11:02:13+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Sermorelin-5mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Sermorelin For Sale (5mg) | Core Peptides",
            "twitter:description": "Sermorelin for sale online (5mg). Peptides for sale at 99% purity with top customer service. Get Sermorelin's research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Sermorelin-5mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$48.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:brand": "Core Peptides",
            "product:price:amount": "48.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-SERMORELIN-5",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/adipotide-10mg/",
                "name": "Adipotide (FTPP) (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Adipotide-FTPP-10MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/mgf-5mg/",
                "name": "MGF (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/MGF-5MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/selank-10mg/",
                "name": "Selank (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Selank-10MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/fragment-176-191/",
                "name": "Fragment 176-191 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Fragment-176-191-300x300.jpg.webp",
                "price": ""
            }
        ]
    },
    {
        "id": "39",
        "url": "https://www.corepeptides.com/peptides/semax-25mg/",
        "name": "Semax (25mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Semax-25MG.jpg",
        "display_price": "$63.00",
        "display_specs": [
            "Size: 25mg Contents: Semax (25mg) Form: Lyophilized powder Purity: >99% SKU: P-SEMAX-25",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$59.85"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$56.70"
            }
        ],
        "description": [
            {
                "h2": "Semax Peptide"
            },
            {
                "p": "Semax peptide is a synthetic polypeptide analog of an adrenocorticotropic hormone fragment 4-7 (ACTH 4-7),(1) a hormone secreted by the anterior pituitary gland. This fragment has been reported by researchers not to exhibit any action characteristic of ACTH itself but may have a potentially specific action within the brain.(2)"
            },
            {
                "p": "Researchers find that naturally occurring peptides may occasionally exhibit instability and easy degradation by biological enzymes, such as those found in gastrointestinal and cerebrospinal fluids. Consequently, researchers aim to synthesize analogs of these naturally occurring but potentially unstable peptides to induce similar biological action with the added value of higher stability. Semax is one such synthetically developed derivative of an endogenous adrenocorticotropic hormone fragment. The Met-Glu-His-Phe sequence in Semax is extended by adding a Pro-Gly-Pro (PGP) sequence at its C-terminal end. This modification with PGP may potentially enhance the molecule's ability to cross the blood-brain barrier (BBB) by increasing its lipophilicity. This increase in lipophilicity may facilitate the molecule’s passive diffusion or uptake through mechanisms such as lipid raft-mediated endocytosis, which may circumvent the tight junctions that typically restrict entry into the brain. Furthermore, the presence of PGP at the peptide's C-terminus might also modify its interactions with specific transporters or receptors on the BBB, potentially favoring its transport via receptor-mediated transcytosis. Moreover, the acetylation of Semax may improve its stability by making it more resistant to enzymatic breakdown, thereby extending its half-life in biological settings."
            },
            {
                "h3": "Overview"
            },
            {
                "p": "Synthetically developed Semax has been widely researched for its potential mechanism of action and lauded for its apparent biological stability. Researchers suggest it may inhibit select enzymes that regulate the degradation of enkephalins, naturally released neurotransmitters secreted in the brain, which scientists consider may regulate several biological functions. Enkephalins are believed to be significantly involved in nociception (the sensory perception of pain) and stress response. Moreover, an elevation in enkephalin concentrations might potentially impact other neurotransmitter systems due to the intricate interconnections between the opioid system and neurotransmitters such as dopamine and serotonin. This interaction may manifest through modulation or alteration of neurotransmitter release, receptor activity, or signal transduction pathways, indicating a sophisticated and multifaceted relationship that remains an area of active research. In addition to enkephalins, Semax has been evaluated for its potential to inhibit other peptide-degrading secreted enzymes."
            },
            {
                "p": "Based on one specific research study,(4) Semax may induce elevated secretion and release of dopamine as well as possibly increasing the levels of brain-derived neurotrophic factor (BDNF). Based on another study,(5) Semax has been speculated to also host the potential to alter gene expressions that modulate the immune system. In altering gene expression, the levels of immune cells and their mobility may be elevated. Semax was reported by researchers to exhibit altering potential in the encoding of chemokines and immunoglobulins, related to the functioning of the vascular system."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C39H54N10O10S Molecular Weight: 854.99 g/mol Other Known Titles: ACTH (4-7)PGP, HY-P1146"
            },
            {
                "p": " "
            },
            {
                "h2": "Research Studies and Clinical Trials"
            },
            {
                "h3": "Semax Peptide and Nootropic Action"
            },
            {
                "p": "An initial study(6) was conducted on ACTH hormone and its analogs, including Semax, to determine its nootropic potential in murine models. After peptide exposure in the models, 5-hydroxyindoleacetic acid (5-HIAA) levels were monitored. 5-HIAA levels appeared elevated by 25% after 2 hours of Semax presence. The levels appeared to increase gradually up to a maximum of 180% within 4 hours of peptide exposure. It was noted by researchers that the peptide, when introduced 20 minutes before D-amphetamine, appeared to lead to an elevation of 5-HIAA as compared to exposure to Semax alone. 5-HIAA is a primary metabolite of serotonin, which indicates that Semax might enhance serotonergic activity. This hypothetical influence on serotonin metabolism might enhance the functions of serotonin-dependent pathways, which may affect operations within the central nervous system. This speculative action underscores a possible modulation of neurotransmitter systems that play critical roles in mood, cognition, and overall brain function."
            },
            {
                "h3": "Semax Peptide and Neonatal Anxiety Models"
            },
            {
                "p": "The main aim of this study(7) was to expose neonatal murine models to an SSRI and then Semax, to evaluate the interaction. Murine models aged between 1 and 14 days received an SSRI, followed by Semax on days 15 to 28. After 28 days, it was noted that upon exposure to the SSRI, the rats exhibited anxiety-like behavior, with an apparently impaired response to stressors and new stimuli during the first 14 days. Following Semax exposure, these SSRI-induced actions appeared to be mitigated, with the rats even exhibiting improved learning abilities and an overall reduction in anxiety-driven behaviors. Researchers posited that Semax might have reestablished normal levels of monoamines in the brain, which may have been initially decreased by the SSRI. By affecting these neurotransmitter systems, Semax might restore or stabilize neural pathways that were previously disrupted. Such changes might balance the excitatory and inhibitory signals in the brain, creating a state more conducive to reduced anxiety. For instance, by potentially increasing serotonin levels, Semax may improve mood and decrease anxiety, while optimizing dopamine might enhance motivation and reward processing. Furthermore, norepinephrine adjustments might improve attention and vigilance. Behavioral assessments conducted in the experiment indicated that these potential actions of Semax appeared temporally stable. The reduction in anxiety-related behaviors was sustained from adolescence through young adulthood, suggesting that Semax might have a lasting influence on neural circuits. This enduring stability implies that Semax might support creating a protective or corrective action on these circuits that persists beyond immediate exposure."
            },
            {
                "h3": "Semax Peptide and the Vascular System"
            },
            {
                "p": "In this study,(8) researchers evaluated the potential of Semax to protect murine heart models from vascular damage after experimental myocardial infarction (MI). The murine models were induced with myocardial infarction, and a cohort of the models were exposed to Semax in an experimental group for the following 6 days. On the 28th day, it was reported by the researchers that the murine models that served as a control group appeared to have developed cardiac hypertrophy along with decreased arterial blood pressure. The Semax-exposed models exhibited signs indicating preventing diastolic pressure growth in the left ventricle, with apparent left ventricle remodeling. Notably, the peptide may have ameliorated both cardiomyocyte hypertrophy and the imbalance between the growth of contractile and mitochondrial apparatus."
            },
            {
                "h3": "Semax Peptide and Neonatal Deprivation"
            },
            {
                "p": "Adolescent rats(9) were separated from their mothers for approximately 5 hours per day during postnatal days 1 to 14. From days 15 to 28, these adolescent rats were then exposed to the Semax peptide. After 28 days, it was found that during maternal deprivation, when Semax was not present, there was an apparent increase in anxiety and physical and emotional reactivity in the rats. Upon Semax exposure, researchers reported that reactions and anxiety in the rats appeared restored to control levels."
            },
            {
                "h3": "Semax Peptide and Neuroprotection"
            },
            {
                "p": "This clinical trial(10) was conducted on 100 models of ischemic stroke. A cohort representing 30% of the models was exposed to Semax, whereas the rest were evaluated as a control group. Following the study, researchers reported that following Semax exposure, there appeared to be an improvement in the rate of restoration of damaged neurological functions. All results were analyzed using EEG mapping."
            },
            {
                "h3": "Semax Peptide and Nootropic Properties"
            },
            {
                "p": "A small-scale clinical trial(11) was conducted in which research models were given Semax under high-stress conditions, and subsequent brain activity was monitored. At the end of the study, after a total of 24 hours, researchers reported that compared to normal pre-trial thresholds, the models appeared to exhibit increased memory recall and increased focus intervals."
            },
            {
                "p": "Semax peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "T. Kolomin et al., A New Generation of Drugs: Synthetic Peptides based on Natural Regulatory peptides. Neuroscience & Medicine, 2013, 223-252. Published Online December 2013. http://dx.doi.org/10.4236/nm.2013.44035",
                    "Dornbush RL, Nikolovski O. ACTH 4-10 and short-term memory. Pharmacol Biochem Behav. 1976;5(Suppl 1):69-72. doi: 10.1016/0091-3057(76)90331-2. PMID: 189333. https://pubmed.ncbi.nlm.nih.gov/189333/",
                    "Kost NV, Sokolov OIu, Gabaeva MV, Grivennikov IA, Andreeva LA, Miasoedov NF, Zozulia AA. Ingibiruiushchee deĭstvie semaksa i selanka na énkefalindegradiruiushchie fermenty syvorotki krovi cheloveka [Semax and selank inhibit the enkephalin-degrading enzymes from human serum]]. Bioorg Khim. 2001 May-Jun;27(3):180-3. Russian. doi: 10.1023/a:1011373002885. PMID: 11443939. https://pubmed.ncbi.nlm.nih.gov/11443939/",
                    "Shih-Jen Tsai, Semax, an analogue of adrenocorticotropin (4–10), is a potential agent for the treatment of attention-deficit hyperactivity disorder and Rett syndrome, Medical Hypotheses, Volume 68, Issue 5, 2007, Pages 1144-1146. https://doi.org/10.1016/j.mehy.2006.07.017",
                    "Medvedeva, E.V., Dmitrieva, V.G., Povarova, O.V. et al. The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis. BMC Genomics 15, 228 (2014). https://doi.org/10.1186/1471-2164-15-228",
                    "Eremin KO, Kudrin VS, Saransaari P, Oja SS, Grivennikov IA, Myasoedov NF, Rayevsky KS. Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents. Neurochem Res. 2005 Dec;30(12):1493-500. doi: 10.1007/s11064-005-8826-8. PMID: 16362768.",
                    "Nataliya Yu. Glazova, Daria M. Manchenko, Maria A. Volodina, Svetlana A. Merchieva, Ludmila A. Andreeva, Vladimir S. Kudrin, Nikolai F. Myasoedov, Natalia G. Levitskaya, Semax, synthetic ACTH(4–10) analogue, attenuates behavioural and neurochemical alterations following early-life fluvoxamine exposure in white rats, Neuropeptides, Volume 86, 2021, 102114, ISSN 0143-4179. https://doi.org/10.1016/j.npep.2020.102114",
                    "Gavrilova SA, Golubeva AV, Lipina TV, Fominykh ES, Shornikova MV, Postnikov AB, Andrejeva LA, Chentsov IuS, Koshelev VB. [Protective effect of peptide semax (ACTH(4-7)Pro-Gly-Pro) on the rat heart rate after myocardial infarction]. Ross Fiziol Zh Im I M Sechenova. 2006 Nov;92(11):1305-21. Russian. PMID: 17385423. https://pubmed.ncbi.nlm.nih.gov/17385423/",
                    "Volodina MA, Sebentsova EA, Glazova NY, Levitskaya NG, Andreeva LA, Manchenko DM, Kamensky AA, Myasoedov NF. Semax attenuates the influence of neonatal maternal deprivation on the behavior of adolescent white rats. Bull Exp Biol Med. 2012 Mar;152(5):560-3. English, Russian. doi: 10.1007/s10517-012-1574-2. PMID: 22803132. https://pubmed.ncbi.nlm.nih.gov/22803132/",
                    "Gusev EI, Skvortsova VI, Miasoedov NF, Nezavibat'ko VN, Zhuravleva EIu, Vanichkin AV. Effektivnost' semaksa v ostrom periode polusharnogo ishemicheskogo insul'ta (klinicheskoe i élektrofiziologicheskoe issledovanie) [Effectiveness of semax in acute period of hemispheric ischemic stroke (a clinical and electrophysiological study)]. Zh Nevrol Psikhiatr Im S S Korsakova. 1997;97(6):26-34. Russian. PMID: 11517472. https://pubmed.ncbi.nlm.nih.gov/11517472/",
                    "Asmarin IP, Nezavibat'ko VN, Miasoedov NF, Kamenskiĭ AA, Grivennikov IA, Ponomareva-Stepnaia MA, Andreeva LA, Kaplan AIa, Koshelev VB, Riasina TV. Nootropnyĭ analog adrenokortikotropina 4-10-semaks (15-letniĭ opyt razrabotki i izucheniia) [A nootropic adrenocorticotropin analog 4-10-semax (l5 years experience in its design and study)]. Zh Vyssh Nerv Deiat Im I P Pavlova. 1997 Mar-Apr;47(2):420-30. Russian. PMID: 9173745. https://pubmed.ncbi.nlm.nih.gov/9173745/"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "",
        "high_performance_liquid_chromatography": "",
        "mass_spectrometry": "",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Semax peptide for sale online. Peptides for sale at 99% purity with top customer service. Get Semax research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Semax For Sale (25mg) | Core Peptides",
            "og:description": "Semax peptide for sale online. Peptides for sale at 99% purity with top customer service. Get Semax research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/semax-25mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T18:27:06+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Semax-25MG.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Semax For Sale (25mg) | Core Peptides",
            "twitter:description": "Semax peptide for sale online. Peptides for sale at 99% purity with top customer service. Get Semax research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Semax-25MG.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$63.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "63.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-SEMAX-25",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/ghrp-6/",
                "name": "GHRP-6 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHRP-6-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/sermorelin-5mg/",
                "name": "Sermorelin (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Sermorelin-5mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/bpc-157/",
                "name": "BPC-157 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/BPC-157-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/cjc-1295-no-dac-mod-grf-1-29/",
                "name": "CJC-1295 NO DAC (Mod GRF 1-29) (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Mod-GRF-1-29-5mg-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "id": "40",
        "url": "https://www.corepeptides.com/peptides/semaglutide-glp-1/",
        "name": "Semaglutide (3mg / 5mg / 10mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2022/12/Semaglutide-GLP-1.jpg",
        "display_price": "$109.00 – $243.00",
        "display_specs": [
            "Size: 3mg / 5mg / 10mg Contents: Semaglutide Form: Lyophilized powder Purity: >99% SKU: P-Semaglutide",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$103.55 – $230.85"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$98.10 – $218.70"
            },
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$230.85"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$218.70"
            },
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$142.50"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$135.00"
            },
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$103.55"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$98.10"
            }
        ],
        "description": [
            {
                "p": "The peptides are available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/12/Semaglutide-3mg-COA.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/12/Semaglutide-3mg-LC.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/12/Semaglutide-3mg-MS.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Semaglutide peptide for sale. Purchase peptides for sale at 99+% purity with unmatched customer service and free shipping.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Semaglutide For Sale (3mg / 5mg / 10mg) - Core Peptides",
            "og:description": "Semaglutide peptide for sale. Purchase peptides for sale at 99+% purity with unmatched customer service and free shipping.",
            "og:url": "https://www.corepeptides.com/peptides/semaglutide-glp-1/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-05-22T16:01:58+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2022/12/Semaglutide-GLP-1.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Semaglutide For Sale (3mg / 5mg / 10mg) - Core Peptides",
            "twitter:description": "Semaglutide peptide for sale. Purchase peptides for sale at 99+% purity with unmatched customer service and free shipping.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2022/12/Semaglutide-GLP-1.jpg",
            "twitter:label1": "Availability",
            "twitter:data1": "In stock",
            "product:brand": "Core Peptides",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-Semaglutide",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/mgf-5mg/",
                "name": "MGF (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/MGF-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/peg-mgf-5mg/",
                "name": "PEG-MGF (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/PEG-MGF-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/fragment-176-191/",
                "name": "Fragment 176-191 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Fragment-176-191-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/receptor-grade-igf-1-lr3-100mcg/",
                "name": "Receptor Grade IGF-1 LR3 (100mcg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-100MCG-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "id": "41",   
        "url": "https://www.corepeptides.com/peptides/selank-10mg/",
        "name": "Selank (10mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Selank-10MG.jpg",
        "display_price": "$52.00",
        "display_specs": [
            "Size: 10mg Contents: Selank (10mg) Form: Lyophilized powder Purity: >99% SKU: P-SELANK-10",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$49.40"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$46.80"
            }
        ],
        "description": [
            {
                "h2": "Selank Peptide"
            },
            {
                "p": "Selank is a short, synthetic heptapeptide composed of seven amino acids. Selank was developed to mimic the naturally occurring peptide Tuftsin,(5) a short fragment from the immunoglobulin G (IgG), a natural tetrapeptide involved in certain biological functions that regulate the immune system. After the discovery and initial isolation of Tuftsin, researchers suggested that the peptide might be involved in the functions of phagocytic cells, including phagocytosis, motility, and immunological cell functions.(2) Since then, various synthetic analogs of Tuftsin have been synthesized in laboratories by conventional and polymeric reagent methods.(4)"
            },
            {
                "h3": "Overview"
            },
            {
                "p": "Selank is a peptide chain composed of two fragments – one is Tuftsin at the N-terminus, and the other is a tripeptide Pro-Gly-Pro (PGP) at the C-terminal end of the molecule. The inclusion of a Pro-Gly-Pro (PGP) sequence in the peptide Selank might enhance its potential to penetrate various biological barriers, including the blood-brain barrier (BBB). The BBB is a highly selective and semi-permeable membrane that delineates the circulating blood from brain tissues and extracellular fluid within the central nervous system. It is deemed to play a pivotal role in controlling the entry of molecules. Integrating the PGP sequence might modify the peptide's hydrophilicity or lipophilicity, which might increase its compatibility with the lipid-rich milieu of the BBB. Moreover, the PGP motif might interact with certain transport systems or receptors on the BBB membrane, potentially facilitating receptor-mediated endocytosis or active transport. These mechanisms may permit Selank to circumvent the tight junctions that typically impede the transit of larger molecules through the BBB. Additionally, the presence of the PGP sequence might alter the tertiary structure of Selank, potentially rendering it more amenable to traversing the BBB. This alteration might arise from changes in the peptide's spatial configuration, which may influence its interaction with the cellular components of the BBB.(6)"
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C33H57N11O9 Molecular Weight: 751.88 g/mol Other Known Titles: TP-7, Selanc"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Selank Peptide and BDNF Levels"
            },
            {
                "p": "There is a possibility that Selank may influence the expression of brain-derived neurotrophic factor (BDNF), deemed a crucial protein in the brain that supports neuronal survival and growth.(1) Research indicates that Selank may markedly increase the levels of BDNF mRNA in the hippocampus, an integral region of the brain involved in memory and emotional responses. The potential of Selank to boost BDNF expression, particularly under conditions where stress and glucocorticoids suppress BDNF levels, suggests its relevance in research studies within the context of neuroplasticity decline. This protein's perceived role in synaptic function and neuronal adaptation underscores the significance of such investigations."
            },
            {
                "h3": "Selank Peptide and Serotonin Signaling"
            },
            {
                "p": "Selank may potentially influence serotonin signaling mechanisms. Serotonin signaling is theorized to play a crucial role in the management of mood and anxiety within the brain. Research utilizing murine models where serotonin synthesis was inhibited has indicated that Selank might be able to alter serotonin levels in cases where the serotonergic system is impaired. It has been proposed by researchers that Selank may potentially boost serotonin metabolism in the brainstem, indicating its potential action on the serotonin system. More specifically, the peptide is thought to facilitate an increase in the metabolic processing of serotonin in brain regions considered essential for mood and anxiety regulation. Additionally, the hypothesis that Selank may enhance serotonin metabolism suggests a potential pathway by which Selank might ameliorate issues stemming from diminished serotonin activity."
            },
            {
                "h3": "Selank Peptide and GABA Signaling"
            },
            {
                "p": "Studies have suggested that Selank may act on the gamma aminobutyric acid (GABA) receptors. GABA is considered an inhibitory neurotransmitter within this context, playing a role in diminishing neuronal excitability, fostering relaxation, and mitigating anxiety observations, as observed in animal research models. In one study,(7) the expression of 84 genes involved in neurotransmission was studied in murine models. The experimental murine models were exposed to either Selank or GABA, and gene expression was studied after one and three hours via a PCR method. All the gene expressions studied for Selank and GABA appeared positively correlated. The results suggested that Selank had the potential to induce several alterations in the neurotransmission process, suggesting by proxy that Selank may exert possible action via modulating the GABAergic system. Moreover, the literature indicates that the influence of Selank might not be confined to mere direct actions on the transcriptional activity of genes associated with GABA receptors. It might also involve allosteric modulation of the GABAergic system. This is inferred from observed variations in gene expression following exposure to Selank compared to GABA, where Selank has been speculated to distinctly affect the expression of specific genes. Such differential gene expression alludes to a more complex interaction of Selank with the GABAergic system, possibly diverging from the direct receptor activation typically seen with GABA. Selank has also been proposed to instigate enduring modifications within neurotransmitter systems, a characteristic that might account for its extended anxiolytic actions observed in experimental frameworks. These alterations suggest a broader and potentially long-term impact on neurotransmitter dynamics beyond potential receptor interaction, emphasizing the complex potential of Selank on neural regulation."
            },
            {
                "h3": "Selank Peptide and Genome Expression"
            },
            {
                "p": "Studies have been conducted to understand the potential of Selank peptide on genome expression and its involvement in the inflammatory process. These studies(8) were conducted on male murine models weighing 250 grams. These murine models were separated into three groups – a control group, an experimental group with a single exposure to Selank, and an experimental group under routine exposure to Selank. After the study, the RNA was isolated from the rat spleen and hippocampus and studied via PCR method. Based on the results, it was suggested by the researchers that Selank might have the potential to impact gene expression, exhibited more definitively in the spleen and the hippocampus. One of the gene expressions reported during the study was the change in CX3CR1, which was involved in the inflammatory process. This suggested that Selank might regulate the inflammatory process through the mechanism of gene expression, mainly the CX3CR1 alteration."
            },
            {
                "h3": "Selank Peptide and Enkephalin Signaling"
            },
            {
                "p": "In a clinical study,(9) 62 research models of Generalized Anxiety Disorder (GAD) were examined. These models were divided into two groups – 48% were exposed to Selank, whereas 52% were exposed to a generic benzodiazepine compound. Following the study, the psychometric levels of all models were analyzed. Results suggested that the impact of Selank appeared to be similar to those of the generic compound. Researchers also reported that enkephalin levels of tau leu-enkephalin were apparently reduced in the Selank-exposed group before the experiment, and the addition of Selank may have reversed this observation. Selank is hypothesized to exert suppressive actions on enzymes that break down enkephalins. Enkephalins, which are endogenous ligands for opioid receptors, have been implicated in the regulation of pain, mood, and stress responses. Therefore, the potential inhibition of these degrading enzymes by Selank might result in increased levels of enkephalins, potentially augmenting their physiological actions. This could lead to a noticeable elevation in tau(1/2) leu-enkephalin concentrations during experiments involving anxiety models where Selank is evaluated."
            },
            {
                "h3": "Selank Peptide and Memory"
            },
            {
                "p": "This study(11) was conducted on murine models that were enrolled in a \"training\" session of four days for learning conditioned avoidance response (CAR). CAR is a learned response in delaying or preventing avoidance behavior. Selank exposure was begun 15 minutes before the training session on all four days. Upon monitoring the behavior of the murine models, researchers suggested that the learning abilities of the murine models appeared to improve with each exposure of the peptide, as the number of errors reduced and the number of correct solutions increased. This potential impact might be mediated through multiple interconnected pathways, including the modulation of neuropeptide systems within the brain. These neuropeptides are deemed critical as they are believed to play significant roles in various cognitive functions, potentially boosting processes related to learning and memory. Additionally, the peptide Selank might alter neural circuits involved in memory consolidation. This alteration may enhance synaptic stability and efficiency in learning processes. Moreover, Selank might indirectly boost cognitive performance by mitigating anxiety-related factors that frequently impede learning efficiency. This suggests that Selank may influence the emotional aspects of cognition, enhancing the overall cognitive process. Furthermore, Selank may promote neural plasticity or the capacity of neurons to adapt, particularly in cognitive circuits that are not performing optimally, thus potentially elevating their function. This enhancement of neural adaptability may be vital for the maintenance and improvement of cognitive abilities, suggesting that Selank might be a valuable compound for further research in neurocognitive fields."
            },
            {
                "h3": "Selank Peptide and Immunomodulation"
            },
            {
                "p": "This clinical study(12) was conducted on research models of GAD with neurasthenia, with a control group and experimental group exposed Selank peptide for 14 days. After the study, the peripheral blood samples were collected and analyzed. The analytical results suggested peak elevation in the levels of IL-6 cytokine and changes in the Th1 and Th2 cytokine ratio, all of which are believed to regulate the immune system."
            },
            {
                "h3": "Selank Peptide and Withdrawal"
            },
            {
                "p": "In this study,(13) murine models were infused with 10% ethanol as their sole fluid source for 24 weeks. Consequently, these murine models were experimentally induced with alcohol withdrawal symptoms once the ethanol drip was removed. The murine models were then exposed to Selank, to study its potential impact on the withdrawal symptoms. After 48 hours, researchers reported that the alcohol withdrawal symptoms appeared to have reduced, based on the results of their social interaction and maze tests."
            },
            {
                "h3": "Selank Peptide and Cardiovascular Activity"
            },
            {
                "p": "In this study,(14) Selank was presented to feline models. The main goal of this study was to examine the cardiovascular and respiratory potential of the peptide in this specific model. Upon exposure to the peptide, it was reported by the researchers that there appeared to be a 32% decrease in arterial blood pressure within 3 minutes of peptide presence. Moreover, the peptide possibly induced a 24% increase in cerebral blood flow within the first 10 minutes, slowly decreasing to optimal levels. Selank was not reported to have induced any action on the respiratory system or the heart rate."
            },
            {
                "h3": "Selank Peptide and Weight, Cholesterol"
            },
            {
                "p": "In this study,(15) murine models were first exposed to a high-fat diet for 6 consecutive weeks until the weights of murine models were measured between 280g to 300g. Later, these murine models were divided into two groups, a control group given sodium chloride, and an experimental group exposed to Selank peptide. Additionally, a group of control murine models were used for this study, which were not presented with either of the agents but were simply monitored for the purpose of the study. Upon analysis, it was suggested by the researchers that the Selank group exhibited apparently decreased levels of cholesterol and fat anywhere between 25% and 58%. Based on the findings, Selank may also reduce specific forms such as low-density lipoprotein (LDL), very-low-density lipoprotein (VLDL) cholesterol, and triglycerides. This indicates that Selank might play either a direct or an indirect role in influencing the mechanisms of lipid metabolism and could potentially display actions that lower cholesterol (hypocholesterolemic) and lipid levels (hypolipidemic). Moreover, the investigation noted discernible enhancements in parameters related to hemostasis, including elevated total fibrinolytic activity and decreased platelet aggregation, which may suggest improvements in conditions that favor clot formation. Additionally, the study points to a possible modulatory action of Selank on glucose homeostasis, which involves maintaining stable blood glucose levels. The fat metabolism rate of the Selank group also was reportedly improved and was eventually measured at the same rate as those in control models. Upon weight determination of the murine models, it was noted that the control group exhibited an average weight gain of 40g throughout the study, whereas the experiment group maintained the same weight throughout the study, with gradual weight reduction upon peptide presentation."
            },
            {
                "p": "Selank peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Inozemtseva, L. S., Karpenko, E. A., Dolotov, O. V., Levitskaya, N. G., Kamensky, A. A., Andreeva, L. A., & Grivennikov, I. A. (2008). Intranasal administration of the peptide Selank regulates BDNF expression in the rat hippocampus in vivo. Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections, 421, 241–243. https://doi.org/10.1134/s0012496608040066",
                    "Najjar VA. Tuftsin, a natural activator of phagocyte cells: an overview. Ann N Y Acad Sci. 1983;419:1-11. doi: 10.1111/j.1749-6632.1983.tb37086.x. https://pubmed.ncbi.nlm.nih.gov/6370072/",
                    "Semenova, T. P., kozlovskiĭ, I. I., Zakharova, N. M., & Kozlovskaia, M. M. (2009). Eksperimental'naia i klinicheskaia farmakologiia, 72(4), 6–8.",
                    "Fridkin M, Stabinsky Y, Zakuth V, Spirer Z. Tuftsin and some analogs: synthesis and interaction with human polymorphonuclear leukocytes. Biochim Biophys Acta. 1977 Jan 24;496(1):203-11. https://pubmed.ncbi.nlm.nih.gov/576412/",
                    "Kozlovskaya MM, Kozlovskii II, Val'dman EA, Seredenin SB. Selank and short peptides of the tuftsin family in the regulation of adaptive behavior in stress. Neurosci Behav Physiol. 2003 Nov;33(9):853-60. https://pubmed.ncbi.nlm.nih.gov/14969422/",
                    "Elena Filatova et al., GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells. https://doi.org/10.3389/fphar.2017.00089",
                    "Volkova, A., Shadrina, M., Kolomin, T., Andreeva, L., Limborska, S., Myasoedov, N., & Slominsky, P. (2016). Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission. Frontiers in pharmacology, 7, 31. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757669/",
                    "T.A Kolomin et al., Transcriptomic Response of Rat Hippocampus and Spleen Cells to Single and Chronic Administration of the Peptide Selank. June 2, 2009. DOI: 10.1134/S1607672910010023",
                    "Zozulia AA, Neznamov GG, Siuniakov TS, Kost NV, Gabaeva MV, Sokolov OIu, Serebriakova EV, Siranchieva OA, Andriushenko AV, Telesheva ES, Siuniakov SA, Smulevich AB, Miasoedov NF, Seredenin SB. Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia. Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108(4):38-48. Russian. https://pubmed.ncbi.nlm.nih.gov/18454096/",
                    "Medvedev VE, Tereshchenko ON, Israelian AIu, Chobanu IK, Kost NV, Sokolov OIu, Miasoedov NF. A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders. Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(7):17-22. Russian. https://pubmed.ncbi.nlm.nih.gov/25176261/",
                    "Kozlovskii II, Danchev ND. The optimizing action of the synthetic peptide Selank on a conditioned active avoidance reflex in rats. Neurosci Behav Physiol. 2003 Sep;33(7):639-43. https://pubmed.ncbi.nlm.nih.gov/14552529/",
                    "Uchakina ON, Uchakin PN, Miasoedov NF, Andreeva LA, Shcherbenko VE, Mezentseva MV, Gabaeva MV, Sokolov OIu, Zozulia AA, Ershov FI. Immunomodulatory effects of selank in patients with anxiety-asthenic disorders. Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108(5):71-5. Russian. https://pubmed.ncbi.nlm.nih.gov/18577961/",
                    "Kolik LG, Nadorova AV, Kozlovskaya MM. Efficacy of peptide anxiolytic selank during modeling of withdrawal syndrome in rats with stable alcoholic motivation. Bull Exp Biol Med. 2014 May;157(1):52-5. https://pubmed.ncbi.nlm.nih.gov/24913576/",
                    "Gan'shina TS, Kozlovskiĭ II. [Effects of the new peptide anxiolytic drug selank on the cardiovascular system functioning and respiration in cats]. Eksp Klin Farmakol. 2005 Jul-Aug;68(4):33-5. Russian. https://pubmed.ncbi.nlm.nih.gov/16193654/",
                    "N.F. Mjasoedov et al, The Influence of Selank on the Parameters of the Hemostasis System, Lipid Profile, and Blood Sugar Level in the Course of Experimental Metabolic Syndrome. April 14, 2014."
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/12/Selank-COA.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/12/Selank-LC.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/12/Selank-MS.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Selank peptide for sale online. Peptides for sale at 99% purity with top customer service. Get Selank research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Selank For Sale (10mg) | Core Peptides",
            "og:description": "Selank peptide for sale online. Peptides for sale at 99% purity with top customer service. Get Selank research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/selank-10mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-04-25T15:03:57+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Selank-10MG.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Selank For Sale (10mg) | Core Peptides",
            "twitter:description": "Selank peptide for sale online. Peptides for sale at 99% purity with top customer service. Get Selank research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Selank-10MG.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$52.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "52.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-SELANK-10",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/ghrp-2/",
                "name": "GHRP-2 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHRP-2-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ghk-cu-50mg-copper/",
                "name": "GHK-Cu (Copper) (50mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHK-CU-50mg-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ghrp-6/",
                "name": "GHRP-6 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHRP-6-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/receptor-grade-igf-1-lr3-100mcg/",
                "name": "Receptor Grade IGF-1 LR3 (100mcg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-100MCG-300x300.jpg.webp",
                "price": ""
            }
        ]
    },
    {
        "id": "42",
        "url": "https://www.corepeptides.com/peptides/retatrutide-8mg/",
        "name": "Retatrutide (8mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2024/05/Retatrutide-8mg.jpg",
        "display_price": "$230.00",
        "display_specs": [
            "Size: 8mg Contents: Retatrutide Form: Lyophilized powder Purity: >99% SKU: P-RETATRUTIDE-8",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$218.50"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$207.00"
            }
        ],
        "description": [
            {
                "p": "The peptides are available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/12/Retatrutide-COA.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/12/Retatrutide-LC.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/12/Retatrutide-MS.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Retatrutide for sale online (8mg). Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Retatrutide for Sale (8mg) - Core Peptides",
            "og:description": "Retatrutide for sale online (8mg). Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/retatrutide-8mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-04-04T15:30:48+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2024/05/Retatrutide-8mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Retatrutide For Sale (8mg) - Core Peptides",
            "twitter:description": "Retatrutide for sale online (8mg). Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2024/05/Retatrutide-8mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$230.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:brand": "Core Peptides",
            "product:price:amount": "230.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-RETATRUTIDE-8",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/bpc-157/",
                "name": "BPC-157 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/BPC-157-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/fragment-176-191/",
                "name": "Fragment 176-191 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Fragment-176-191-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/adipotide-10mg/",
                "name": "Adipotide (FTPP) (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Adipotide-FTPP-10MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ghrp-2/",
                "name": "GHRP-2 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHRP-2-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "id": "43",
        "url": "https://www.corepeptides.com/peptides/receptor-grade-igf-1-lr3-1mg/",
        "name": "Receptor Grade IGF-1 LR3 (1mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-1MG.jpg",
        "display_price": "$150.00 Original price was: $150.00.$95.00Current price is: $95.00.",
        "display_specs": [
            "Size: 1mg Contents: Receptor Grade IGF-1 LR3 (1mg) Form: Lyophilized powder Purity: >99% SKU: P-IGF1LR3-1",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$90.25"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$85.50"
            }
        ],
        "description": [
            {
                "h2": "Receptor Grade IGF-1 LR3 Peptide"
            },
            {
                "p": "Between 1940 and 1950, the growth hormone somatotropin was identified and researched. It was tentatively suggested that this hormone might enhance sulfate uptake in normal control rat serum, implying an increase in amino acid uptake or synthesis. However, this connection was not definitively established. This so-called \"sulfate factor\" was subsequently isolated from the rat serum and named \"somatomedin.\" Concurrently, an independent study explored the components responsible for producing insulin-like activity. It was hypothesized during this investigation that these components might be \"somatomedins,\" leading to the designation of these compounds as \"insulin-like growth factors.\"(1)"
            },
            {
                "p": "Further explorations into the insulin-like growth factors involved gene-targeting approaches to potentially enhance their bioavailability and potency. During these studies, a variant called Receptor Grade IGF-1 LR3 was developed. This variant included an additional arginine residue and featured an elongated structure at the N-terminal (by 13 amino acids), resulting in a protein composed of 83 amino acids, compared to the 70 amino acids found in natural IGF-1.(1)"
            },
            {
                "p": "Receptor Grade IGF-1 LR3 peptide, a polypeptide amino acid also known as Long arginine 3 IGF-1, or LR3-IGF-1, has been suggested to exhibit potential action similar to Insulin-like Growth factor-1, or IGF-1.(2) IGF-1 is a naturally produced protein comprised of 70 amino acids. Structurally similar to insulin, this Receptor Grade IGF-1 LR3 has the potential primarily to regulate cell tissue and development. Several synthetic variations of IGF-1, such as recombinant IGF-1 (rhIGF-1), were developed to mimic the natural protein identically and stimulate similar actions as IGF-1. Another example is Receptor Grade IGF-1 LR3, which researchers speculate exhibits an increased affinity and anabolic potential while binding less to IGF-1 binding proteins (IGF-1BPs). This variant has been developed particularly for evaluation in cell growth studies. Moreover, the designation of Receptor Grade refers to the purity of the material, which is considered higher than Media Grade IGF-1 LR3."
            },
            {
                "p": "Structurally, IGF-1 LR3 contains an extended N-terminal structure and arginine acid at residue 3. Hence, it is named IGF-1 Long R3.(3) Owing to the altered structure, Receptor Grade IGF-1 LR3 has been suggested to bind poorly with IGF-binding proteins, shortening its duration of action."
            },
            {
                "h3": "Overview"
            },
            {
                "p": "IGF proteins appear to exert potential via binding with IGF-1 receptors; however, researchers posit that these IGF binding proteins, including Receptor Grade IGF-1 LR3, may function either via IGF receptor-dependent mechanism or via IGF-independent mechanisms.(1)(4)"
            },
            {
                "p": "A study(1) was conducted where a murine model was exposed to the endogenous IGF-1 with IGF-1 LR3. During this study, it was suggested that upon exposure, the synthetic protein exhibited the potential to quickly clear the serum and distribute into tissues. Increased concentrations of the IGF-1 LR3 tracer were apparently detected in specific organs, including the kidneys, ovaries, and adrenal glands, in mouse models. This distribution pattern indicates that organs critical to metabolism and reproductive processes might have differing abilities to absorb or retain IGF-1 LR3 compared to IGF-I. It is proposed that these variations might arise due to IGF-1 LR3's reduced tendency to bind with IGFBPs. IGFBPs are proteins that regulate the availability of IGFs in circulation, influencing their interaction with various tissues. The decreased binding of IGF-1 LR3 to IGFBPs may affect its bioavailability and interactions with specific tissues in research settings. Researchers suggest Receptor Grade IGF-1 LR3 has the potential to induce a signaling mechanism in the organism, either via autocrine mode (where the tissue cell stimulates itself) or via paracrine mode (where the tissue cell stimulates the nearby cell). The increased potential bioavailability of these autocrine and paracrine IGF-1 LR3 proteins may prove vital to inducing any possible action."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C400H625N111O115S9 Molecular Weight: 9117.5 g/mol Other Known Titles: Long-(arg3) insulin-like growth factor-I, Insulin-like growth factor long chain R3"
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Receptor Grade IGF-1 LR3 Peptide and Tissue Anabolism"
            },
            {
                "p": "The body of research examining the anabolic capabilities of IGF-1 LR3 remains insufficient, primarily because this peptide is designed for evaluation in cell culture studies. However, limited studies using murine models hint at a considerable anabolic potential of IGF-1 LR3. In particular, one investigation involved normal and dexamethasone-induced catabolic murine models.(3) The researchers commented that “LR3IGF-I, were approx. 2.5-fold more potent than IGF-I” in promoting anabolic observations. These included weight gain, increased weight of visceral organs, and potentially improved feed efficiency when the murine models were exposed to it continuously."
            },
            {
                "p": "Another observation from studies on murine models exposed to catabolic agents revealed a reduction in the excretion of Nτ-methylhistidine, a marker of muscle protein degradation, which was notably more pronounced with IGF-1 LR3—potentially three times greater than with IGF-I. These observations indicate that IGF-1 LR3 may exhibit superior anabolic actions under specific experimental conditions, although this is not uniformly seen across all measured parameters. Therefore, it is conceivable that Receptor Grade IGF-1 LR3 may manifest an even greater anabolic capacity than IGF-1, according to multiple comparative studies on the anabolic properties of IGF-1."
            },
            {
                "p": "For example, there is a 2005 clinical study(6) where the action of rhIGF-1 on models of IGF-1 deficiency and growth disorders was studied. RhIGF-1 is the recombinant form of insulin-like growth factor-1, and has been researched for its potential in mitigating growth hormone (GH) insensitivity. RhIGF-1 is a synthetic form of IGF-1.(11) Research models of GH deficiencies were examined in the course of this controlled study, where rhIGF-1 was presented once daily to all the models. The heights and lengths were measured before and after the study. Researchers suggested that results indicated an average increase in height by 7cm per year in all subjects presented with rhIGF-1. Hence, this study posits that IGF-1 analogs may have a positive potential within the context of growth hormone deficiency research."
            },
            {
                "h3": "Receptor Grade IGF-1 LR3 and Metabolic Activity"
            },
            {
                "p": "Studies(7) have suggested that IGF-binding proteins, including Receptor Grade IGF-1 LR3, may have the potential to induce glucose uptake and, thereby, glucose metabolism through the possible activation of signaling mechanisms. Namely, this may have occurred through a signaling mechanism involving PI3K and AMPK pathways. For example, it can be hypothesized that upon binding to their respective receptors, IGF-1 analogs potentially trigger a cascade of biochemical events involving the PI3K pathway. This pathway, integral to cellular growth and survival, might also play a pivotal role in mediating the actions of IGF-1 on glucose uptake. Activation of PI3K might lead to the stimulation of protein kinase B (Akt), a key regulator in the pathway, enhancing glucose transporter translocation to the cell membrane and increasing glucose uptake. Concurrently, the AMPK pathway, studied for its potential in energy balance and metabolism regulation, may be indirectly influenced by IGF-1 analogs. It is conceivable that the modulation of AMPK activity by these analogs may enhance cellular glucose uptake under energy stress conditions. This activation potentially promotes the translocation of GLUT4, a major glucose transporter, to the cell surface, thus facilitating glucose entry into cells."
            },
            {
                "h3": "Receptor Grade IGF-1 LR3 and Muscle"
            },
            {
                "p": "This study(8) was conducted on female mice to examine the action of Receptor Grade IGF-1 LR3 on reducing myostatin. Myostatin is a muscle protein that primarily prevents muscle cell differentiation and growth. Reducing the action of myostatin may potentially increase lean muscle mass and reduce fat mass. In this study(8) it was suggested that different IGF-1 analogs, including IGF-1 LR3, have the potential to counteract the negative action of myostatin protein, possibly helping to prevent apoptosis and protecting muscle cells. Since Receptor Grade IGF-1 LR3 has an apparently longer half-life than IGF-1 (according to the researchers), the potential action of Receptor Grade IGF-1 LR3 was considered."
            },
            {
                "p": "Receptor Grade IGF-1 LR3 peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Yakar, S et al., 40 YEARS OF IGF1: Insulin-like growth factors: actions on the skeleton (Jul 2018). Journal of Molecular Endocrinology, vol. 61 Issue 1. https://doi.org/10.1530/JME-17-0298",
                    "Growth hormone, athletic performance, and aging. Harvard Health Publishing, Harvard Medical School. https://www.health.harvard.edu/diseases-and-conditions/growth-hormone-athletic-performance-and-aging",
                    "Tomas, F. M., Knowles, S. E., Owens, P. C., Chandler, C. S., Francis, G. L., Read, L. C., & Ballard, F. J. (1992). Insulin-like growth factor-I (IGF-I) and especially IGF-I variants are anabolic in dexamethasone-treated rats. The Biochemical journal, 282 ( Pt 1)(Pt 1), 91–97. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1130894/",
                    "Mohan S, Baylink DJ. IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms. J Endocrinol. 2002 Oct;175(1):19-31. https://pubmed.ncbi.nlm.nih.gov/12379487/",
                    "Anderson, L. J., Tamayose, J. M., & Garcia, J. M. (2018). Use of growth hormone, IGF-I, and insulin for anabolic purpose: Pharmacological basis, methods of detection, and adverse effects. Molecular and cellular endocrinology, 464, 65–74. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723243/",
                    "IGF1 Deficiency, Recombinant Human Insulin-Like Growth Factor (rhIGF-1) Treatment of Short Stature Associated with IGF-1 Deficiency. https://clinicaltrials.gov/ct2/show/NCT00125190?cond=IGF1+Deficiency",
                    "Assefa, B., Mahmoud, A. M., Pfeiffer, A., Birkenfeld, A. L., Spranger, J., & Arafat, A. M. (2017). Insulin-Like Growth Factor (IGF) Binding Protein-2, Independently of IGF-1, Induces GLUT-4 Translocation and Glucose Uptake in 3T3-L1 Adipocytes. Oxidative medicine and cellular longevity, 2017 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5750484/",
                    "Naisi Li, Qiyuan Yang, Ryan G. Walker, Thomas B. Thompson, Min Du, Buel D. Rodgers, Myostatin Attenuation In Vivo Reduces Adiposity, but Activates Adipogenesis, Endocrinology, Volume 157, Issue 1, 1 January 2016, Pages 282–291. https://doi.org/10.1210/en.2015-1546",
                    "William E. Sonntag, Anna Csiszar, Raphael de Cabo, Luigi Ferrucci, Zoltan Ungvari, Diverse Roles of Growth Hormone and Insulin-Like Growth Factor-1 in Mammalian Aging: Progress and Controversies, The Journals of Gerontology: Series A, Volume 67A, Issue 6, June 2012, Pages 587–598, https://doi.org/10.1093/gerona/gls115",
                    "Mario Thevis (13 December 2010). Mass Spectrometry in Sports Drug Testing: Characterization of Prohibited Substances and Doping Control Analytical Assays. John Wiley & Sons. pp. 252. https://books.google.ca/books?id=dWHQMev5mHwC&pg=PA252&",
                    "Rosenbloom AL. Mecasermin (recombinant human insulin-like growth factor I). Ad Ther. 2009 Jan; 26(1):40-54. https://pubmed.ncbi.nlm.nih.gov/19198769/"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/12/IGF-1-LR3-1MG-COA-1.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/12/IGF-1-LR3-1MG-LC-1.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/12/IGF-1-LR3-1MG-MS-1.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Receptor Grade IGF-1 LR3 for sale (1mg). Peptides for sale at 99% purity with top customer service. Get Receptor Grade IGF-1 LR3...",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Receptor Grade IGF-1 LR3 For Sale (1mg) | Core Peptides",
            "og:description": "Receptor Grade IGF-1 LR3 for sale (1mg). Peptides for sale at 99% purity with top customer service. Get IGF-1 LR3 Receptor Grade IGF-1 LR3 research results and information.",
            "og:url": "https://www.corepeptides.com/peptides/receptor-grade-igf-1-lr3-1mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-05-28T11:02:34+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-1MG.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Receptor Grade IGF-1 LR3 For Sale (1mg) | Core Peptides",
            "twitter:description": "Receptor Grade IGF-1 LR3 for sale (1mg). Peptides for sale at 99% purity with top customer service. Get Receptor Grade IGF-1 LR3 research results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-1MG.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$95.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "95.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-IGF1LR3-1",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/receptor-grade-igf-1-lr3-100mcg/",
                "name": "Receptor Grade IGF-1 LR3 (100mcg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-100MCG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/oxytocin-10mg/",
                "name": "Oxytocin (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Oxytocin-10mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ll-37-5mg/",
                "name": "LL-37 (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/LL-37-5mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/melanotan-1-10mg/",
                "name": "Melanotan 1 (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Melanotan-1-10MG-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "id": "44",
        "url": "https://www.corepeptides.com/peptides/receptor-grade-igf-1-lr3-100mcg/",
        "name": "Receptor Grade IGF-1 LR3 (100mcg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-100MCG.jpg",
        "display_price": "$28.00",
        "display_specs": [
            "Size: 100mcg Contents: Receptor Grade IGF-1 LR3 (100mcg) Form: Lyophilized powder Purity: >99% SKU: P-IGF1LR3-100",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$26.60"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$25.20"
            }
        ],
        "description": [
            {
                "h2": "Receptor Grade IGF-1 LR3 Peptide"
            },
            {
                "p": "Insulin-like Growth factor-1, or IGF-1, is a naturally produced protein with 70 amino acids. Receptor Grade IGF-1 LR3 is a synthetic variant of the naturally occurring IGF-1, which contains an extended N-terminal structure of 13 amino acids and a replacement of the glutamic acid at residue 3 with arginine. Hence, it is named IGF-1 Long R3.(1)(2) Owing to the altered structure, Receptor Grade IGF-1 LR3 has been suggested to have increased affinity and increased anabolic potential while also binding less to IGF-1 binding proteins (IGF-1BPs). Structurally similar to insulin, this IGF-1 LR3 has the potential primarily to regulate cell tissue growth and development. This potential has been evaluated in cell growth studies, throughout which researchers first prompted the need for developing this high-potency variant. Moreover, the classification of Receptor Grade refers to the purity of the material, which is considered higher than Media Grade IGF-1 LR3."
            },
            {
                "h3": "Chemical Makeup(2,3)"
            },
            {
                "p": "Molecular Formula: C400H625N111O115S9 Molecular Weight: 9117.5 g/mol Other Known Titles: Long-(arg3) insulin-like growth factor-I, Insulin-like growth factor long chain R3"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Receptor Grade IGF-1 LR3 and Anabolic Potential"
            },
            {
                "p": "Unfortunately, research on the anabolic potential of IGF-1 LR3 is lacking, as the peptide is aimed towards cell culture studies. Yet, of the few experiments in murine models, researchers have suggested the significant potential of the peptide.(1) In one study, experiments were carried out on normal and dexamethasone-induced catabolic murine models. It was noted that IGF-1 LR3 might potentially be 1.5 to 2 times as anabolic as IGF-I in inducing weight gain, increasing visceral organ weights, and possibly enhancing feed use efficiency under continuous delivery conditions. Moreover, IGF-1 LR3 appeared to have retained the potential for greater potency than IGF-I in several metrics, even in studies of only intermittent exposure. Additionally, in murine models exposed to dexamethasone, it was observed that the excretion of Nτ-methylhistidine—a marker indicative of muscle protein breakdown—appeared reduced to a greater extent by IGF-1 LR3, potentially threefold more than by IGF-I. This suggests that IGF-1 LR3 may host the potential, though not consistently equivalent across all parameters, to exhibit enhanced anabolic actions under certain laboratory conditions."
            },
            {
                "p": "Therefore, Receptor Grade IGF-1 LR3 may be posited to exert even greater anabolic potential than IGF-1. To provide a comparison, several studies have researched the anabolic potential of IGF-1. For example, a study(4) was conducted in 2005 to study the potential of the peptide in models of IGF-1 deficiency. Following peptide exposure, the length and growth of the models were assessed and analyzed against control thresholds. Based on the study findings, it was observed that total length increased in all peptide-exposed models by a significant margin against the control standards. This study suggests that IGF-1, and possibly also more potent analogs like Receptor Grade IGF-1 LR3 peptide, may have some potential in mitigating growth deficiency."
            },
            {
                "h3": "Receptor Grade IGF-1 LR3 and Insulin Receptor Sensitivity"
            },
            {
                "p": "Research(5) has suggested that IGF proteins typically bind to IGF-1 receptors and may stimulate glucose uptake, potentially through a signaling mechanism involving PI3K and AMPK pathways. However, when studied, peptides like Receptor Grade IGF-1 LR3 appeared to induce glucose uptake not just through IGF-1 receptor interactions but also independently, possibly via other pathways or receptors. This suggests that the mechanism of glucose uptake might involve additional cellular processes beyond the traditional receptor binding. Assefa B Mahmoud et al. stated, \"Multiple [...] studies reported the role of IGF-1 in enhancing insulin sensitivity and glucose metabolism. A low-serum level of IGF-1 has been associated with insulin resistance, and [...] recombinant IGF-1 has been [hypothesized] to improve insulin sensitivity and glucose metabolism.”"
            },
            {
                "h3": "Receptor Grade IGF-1 LR3 and Cell Lifespan"
            },
            {
                "p": "Research(6) on murine models observed that common markers of physiological decline, such as muscle tears and neurological deficiencies, appeared to be mitigated for an extended period following routine exposure to the peptide. While more detailed studies and clinical trials are pending, the above preliminary study suggests that the peptide may indirectly help to increase lifespan of functional cells. As per William E. Sonntag et al.,"
            },
            {
                "p": "“Based on this review, we conclude that the perceived contradictory roles of growth hormone and insulin-like growth factor-1 in the genesis of the aging phenotype should not be interpreted as a controversy on whether growth hormone or insulin-like growth factor-1 increases or decreases life span but rather as an opportunity to explore the complex roles of these hormones during specific stages of the life span.”"
            },
            {
                "h3": "Receptor Grade IGF-1 LR3 and Muscle Cells"
            },
            {
                "p": "A study(7) was conducted on female murine models to identify the IGF-1 LR3 peptide’s potential in decreasing the action of myostatin. Myostatin is considered to prevent cellular differentiation; mitigating the actions of this protein may increase lean muscle and reduce fat cell storage and fatty mass. The study's results suggested that the various IGF-1 analogs, including Receptor Grade IGF-1 LR3, appear to potentially reverse adverse myostatin and prevent apoptosis."
            },
            {
                "h3": "Receptor Grade IGF-1 LR3 and Shorter Action"
            },
            {
                "p": "An experimental mouse model was created for a study(8) where the IGF-1 LR3 peptide was compared to the endogenous IGF-1. Throughout the study, it was observed that when the peptide was exposed to the murine model, it appeared to quickly clear from the serum and evenly distribute into tissue. More specifically, the researchers posited that IGF-1 LR3 cleared faster as it appeared to bind to a lower degree to binding proteins than endogenous IGF-1. This reduced binding affinity means IGF-1 LR3 might circulate more freely than IGF-I. The analysis of tissue distribution patterns of IGF-1 LR3 also suggested a potentially unique localization compared to IGF-I. Elevated levels of the IGF-1 LR3 tracer were observed in tissues such as kidneys, ovaries, and adrenal glands in murine models. This distinct distribution suggests that the organs primarily involved in metabolic and reproductive functions may exhibit varying capacities for the uptake or retention of IGF-1 LR3 in contrast to IGF-I. It is hypothesized that these differences might stem from IGF-1 LR3's diminished propensity to form complexes with IGFBPs, which might influence its bioavailability and interaction with target tissues in experimental models. Nevertheless, further research suggested that a peptide with similar modifications (namely R3) to IGF-1 LR3 may exert increased anabolic potential compared to regular IGF-1 despite the shorter action.(9)"
            },
            {
                "p": "Receptor Grade IGF-1 LR3 peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References"
            },
            {
                "references": [
                    "Tomas, F. M., Knowles, S. E., Owens, P. C., Chandler, C. S., Francis, G. L., Read, L. C., & Ballard, F. J. (1992). Insulin-like growth factor-I (IGF-I) and especially IGF-I variants are anabolic in dexamethasone-treated rats. The Biochemical journal, 282 ( Pt 1)(Pt 1), 91–97. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1130894/",
                    "Human Insulin-like growth factor. Protein Data Bank in Europe, https://www.ebi.ac.uk/pdbe/entry/pdb/1gzr",
                    "National Center for Biotechnology Information (2023). PubChem Substance Record for SID 381123731, M9L22Y19H9, Source: ChemIDplus. Retrieved January 24, 2023 from https://pubchem.ncbi.nlm.nih.gov/substance/381123731.",
                    "Anderson, L. J., Tamayose, J. M., & Garcia, J. M. (2018). Use of growth hormone, IGF-I, and insulin for anabolic purpose: Pharmacological basis, methods of detection, and adverse effects. Molecular and cellular endocrinology, 464, 65–74. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723243/",
                    "Assefa, B., Mahmoud, A. M., Pfeiffer, A., Birkenfeld, A. L., Spranger, J., & Arafat, A. M. (2017). Insulin-Like Growth Factor (IGF) Binding Protein-2, Independently of IGF-1, Induces GLUT-4 Translocation and Glucose Uptake in 3T3-L1 Adipocytes. Oxidative medicine and cellular longevity, 2017 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5750484/",
                    "William E. Sonntag, Anna Csiszar, Raphael de Cabo, Luigi Ferrucci, Zoltan Ungvari, Diverse Roles of Growth Hormone and Insulin-Like Growth Factor-1 in Mammalian Aging: Progress and Controversies, The Journals of Gerontology: Series A, Volume 67A, Issue 6, June 2012, Pages 587–598, https://doi.org/10.1093/gerona/gls115",
                    "Naisi Li, Qiyuan Yang, Ryan G. Walker, Thomas B. Thompson, Min Du, Buel D. Rodgers, Myostatin Attenuation In Vivo Reduces Adiposity, but Activates Adipogenesis, Endocrinology, Volume 157, Issue 1, 1 January 2016, Pages 282–291. https://doi.org/10.1210/en.2015-1546",
                    "Bastian SE, Walton PE, Wallace JC, Ballard FJ. Plasma clearance and tissue distribution of labelled insulin-like growth factor-I (IGF-I) and an analogue LR3IGF-I in pregnant rats. J Endocrinol. 1993 Aug;138(2):327-36. doi: 10.1677/joe.0.1380327. PMID: 7693845.",
                    "Elis S, Wu Y, Courtland HW, Cannata D, Sun H, Beth-On M, Liu C, Jasper H, Domené H, Karabatas L, Guida C, Basta-Pljakic J, Cardoso L, Rosen CJ, Frystyk J, Yakar S. Unbound (bioavailable) IGF1 enhances somatic growth. Dis Model Mech. 2011 Sep;4(5):649-58. doi: 10.1242/dmm.006775. Epub 2011 May 31. PMID: 21628395; PMCID: PMC3180229."
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "",
        "high_performance_liquid_chromatography": "",
        "mass_spectrometry": "",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Receptor Grade IGF-1 LR3 peptide for research. Purchase peptides for sale at 99+% purity with unmatched customer service and Free shipping.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Receptor Grade IGF-1 LR3 for Sale (100mcg) | Core Peptides",
            "og:description": "Receptor Grade IGF-1 LR3 peptide for research. Purchase peptides for sale at 99+% purity with unmatched customer service and Free shipping.",
            "og:url": "https://www.corepeptides.com/peptides/receptor-grade-igf-1-lr3-100mcg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T18:20:41+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-100MCG.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Receptor Grade IGF-1 LR3 for Sale (100mcg) | Core Peptides",
            "twitter:description": "Receptor Grade IGF-1 LR3 peptide for research. Purchase peptides for sale at 99+% purity with unmatched customer service and Free shipping.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-100MCG.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$28.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "28.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-IGF1LR3-100",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/oxytocin-10mg/",
                "name": "Oxytocin (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Oxytocin-10mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/pt-141-10mg-bremelanotide/",
                "name": "PT-141 (Bremelanotide) (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/PT-141-10mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ghrp-2/",
                "name": "GHRP-2 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHRP-2-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/melanotan-2-10mg/",
                "name": "Melanotan 2 (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2023/03/Melanotan-2-10MG-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "id": "45",
        "url": "https://www.corepeptides.com/peptides/ptd-dbm-5mg/",
        "name": "PTD-DBM (5mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2023/03/PTD-DBM-5mg.jpg",
        "display_price": "$89.00",
        "display_specs": [
            "Size: 5mg Contents: PTD-DBM Form: Lyophilized powder Purity: >99% SKU: PTD-DBM",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$84.55"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$80.10"
            }
        ],
        "description": [
            {
                "h2": "PTD-DBM Peptide"
            },
            {
                "p": "PTD-DBM peptide, short for Protein Transduction Domain-fused Dishevelled Binding Motif peptide, has been studied for its potential to stimulate follicle growth. PTD is a short sequence of amino acids that may allow the peptide to enter cells, while DBM is a sequence considered to act as a binding agent with Dishevelled (Dvl) proteins, considered highly involved in the Wnt/β-catenin signaling pathway. More specifically, PTD-DBM has been hypothesized by researchers to disrupt the interaction between CXXC5 and Dishevelled (Dvl) proteins, which appears to potentially enhance the activity of the Wnt/β-catenin signaling pathway. Studies hypothesize that this disruption might facilitate an increase in β-catenin activity. This augmented activity was observed to potentially promote hair follicle growth and induce the anagen phase, which is the growth phase of the follicle, in murine models. More precisely, the exposure of PTD-DBM in conjunction with either Wnt3a or valproic acid (VPA)—both agents believed to activate the Wnt/β-catenin pathway—exhibited an apparent synergistic action. This action was speculated by the increased expression levels of β-catenin, alkaline phosphatase (ALP), and proliferating cell nuclear antigen (PCNA). These markers are intrinsically associated with cell proliferation and are indicators of follicle function.(1)"
            },
            {
                "p": "PTD-DBM peptide appears to activate the Wnt and β-catenin signaling pathway, a complex network of proteins that may be critical in regulating cell growth, migration, and differentiation during embryonic development and the maintenance of tissues. It is also deemed crucial in processes such as cell fate determination, and appears to play a role in follicle development and cell regeneration. It may stimulate the stem cells in hair follicles, leading to the regeneration of hair and the growth of new follicles. The peptide may also increase blood microcirculation, which is believed to enhance the delivery of nutrients and oxygen to follicles to promote increased rates of growth.(1)"
            },
            {
                "p": " "
            },
            {
                "h2": "Chemical Makeup(2)"
            },
            {
                "p": "Molecular Formula: C124H223N61O28S2 Molecular Weight: 3080.7 g/mol Other known titles: Protein Transduction Domain-fused Dishevelled Binding Motif peptide, Hair growth peptide"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "PTD-DBM and Hair Follicles"
            },
            {
                "p": "In an investigation into the biological mechanisms underlying hair loss, coupled with an assessment of potential exposure to compounds structurally similar to PTD-DBM, the study proposed that Prostaglandin D2 (PGD2) may act as a catalyst for hair loss.(3) It purportedly induces this by enhancing the expression of CXXC5, a negative regulator of the Wnt/β-catenin signaling pathway, which plays a pivotal role in developing and regenerating hair follicles. The interaction between CXXC5 and the protein Dishevelled (Dvl) appears to impede this pathway, potentially leading to alopecia. The hypothesis suggests that PGD2 may increase CXXC5 levels through the Bone Morphogenetic Protein (BMP) signaling pathway, which is implicated in the regression of hair follicles during the catagen phase—the transitional stage in hair cycling. This upregulation of CXXC5 by PGD2 seems to inhibit Wnt/β-catenin signaling, which, in turn, may suppress follicle growth. In contrast, PTD-DBM, believed to disrupt the binding between CXXC5 and Dvl, appears to restore the function of the Wnt/β-catenin pathway and thereby may inadvertently promote hair growth. Data supporting this restoration has been published in murine model experiments where the gene for CXXC5 was disabled (knocked out) or the animals were exposed to PTD-DBM, indicating that inhibiting CXXC5 may have counterbalanced the hair loss induced by PGD2. Further, the research points to dihydrotestosterone (DHT), another significant contributor to androgenetic alopecia, intensifying hair loss by stimulating CXXC5 expression through the PGD2-mediated pathways. This suggests a complex interaction where DHT and PGD2 may collaboratively impede hair growth by a concomitant modulation of signaling pathways that involve CXXC5. Intriguingly, the study notes that concurrently inhibiting both CXXC5 and a key enzyme in the β-catenin destruction complex, Glycogen Synthase Kinase-3 beta (GSK-3β), may offer potential in promoting hair growth rather than targeting either component alone."
            },
            {
                "p": "Further studies have investigated the mechanisms behind the peptide’s potential to suppress the interaction between CXXC5 and Dvl proteins.(4) This is presumably achieved by PTD-DBM binding to the PDZ domain of Dvl, thereby possibly preventing the suppressive action of CXXC5 on Wnt/β‐catenin signaling. Furthermore, experimental observations from the study indicated that exposure to PTD-DBM in murine models appeared to have led to hair regrowth and possibly the initiation of wound-induced hair follicle neogenesis (WIHN). In this phenomenon, new hair follicles form as part of the wound-healing process. These outcomes suggest that PTD-DBM might not only promote the anagen phase of the hair cycle but also contribute to the creation of new hair follicles in response to skin injury."
            },
            {
                "h3": "PTD-DBM and Bone Regeneration"
            },
            {
                "p": "A recent study was conducted on a murine model exposed to PTD-DBM routinely over the course of four weeks.(5) After the completion of the study, it was suggested by the researchers that the peptide may have induced the formation of new bones without histological changes. Hyun-Yi Kim et al. stated,"
            },
            {
                "p": "“The inhibitors of Dvl–CXXC5 interaction showed bone-forming effects in ex vivo and in vivo calvaria growth, and […] inhibitor recovered bone loss in postmenopausal model mice. Antibody-based drugs such as anti-Dkk-1 and anti-sclerostin antibodies [...] and PTH-based drugs are expensive [...] Therefore, the development of small-molecule compounds […] would be a valuable addition to osteoporosis [research].”"
            },
            {
                "h3": "PTD-DBM and Tissue Damage"
            },
            {
                "p": "A study presented a detailed examination of the potential mechanisms by which PTD-DBM might facilitate regenerative wound healing, focusing primarily on the modulation of the Wnt/β-catenin signaling pathway.(6) The introduction of PTD-DBM was suggested by researchers to potentially enhance the regenerative healing process. This peptide has been speculated to function by preventing CXXC5 from binding to Dvl proteins, thereby facilitating the activation of the Wnt/β-catenin pathway. Apart from apparent hair growth, such activation is associated with numerous cellular processes deemed crucial for wound healing, including cell proliferation, differentiation, migration, and stem cell activation in tissue regeneration. Moreover, the study notes that the apparent activation of Wnt/β-catenin signaling by PTD-DBM may have led to an increase in markers associated with wound healing and tissue regeneration. This includes the enhancement of fibroblast activity and collagen deposition, which are believed to be essential for the structural rebuilding of damaged tissue."
            },
            {
                "p": "In another study,(7) experimental C3H mice with cutaneous wounds were divided into three groups randomly exposed to the peptide PTD-DBM, valproic acid, or a combination of both. As a control, a separate group of experimental mice was given epidermal growth factor (EGF). After completing the study, it was suggested by the researchers that all three groups appeared to exhibit a gradual improvement in the wound-healing process. However, even more than the EGF alone, the most notable impact was reported in the group presented with the peptide and valproic acid. The research team of Soung-Hoon Lee et al. stated, “Combination [...] with PTD-DBM and VPA significantly induced reepithelialization and enhanced collagen deposition in the large wounds.”"
            },
            {
                "p": "PTD-DBM peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References"
            },
            {
                "references": [
                    "Lee SH, Seo SH, Lee DH, Pi LQ, Lee WS, Choi KY. Targeting of CXXC5 by a Competing Peptide Stimulates Hair Regrowth and Wound-Induced Hair Neogenesis. J Invest Dermatol. 2017 Nov;137(11):2260-2269. doi: 10.1016/j.jid.2017.04.038. Epub 2017 Jun 6. PMID: 28595998. https://pubmed.ncbi.nlm.nih.gov/28595998/",
                    "National Center for Biotechnology Information. \"PubChem Substance Record for SID 476298902, PTD-DBM Acetate, Source: CreativePeptides\" PubChem, https://pubchem.ncbi.nlm.nih.gov/substance/476298902. Accessed 3 May, 2024.",
                    "Ryu YC, Park J, Kim YR, Choi S, Kim GU, Kim E, Hwang Y, Kim H, Han G, Lee SH, Choi KY. CXXC5 Mediates DHT-Induced Androgenetic Alopecia via PGD2. Cells. 2023 Feb 9;12(4):555. doi: 10.3390/cells12040555. PMID: 36831222; PMCID: PMC9954685.",
                    "Ryu YC, Lee DH, Shim J, Park J, Kim YR, Choi S, Bak SS, Sung YK, Lee SH, Choi KY. KY19382, a novel activator of Wnt/β-catenin signalling, promotes hair regrowth and hair follicle neogenesis. Br J Pharmacol. 2021 Jun;178(12):2533-2546. doi: 10.1111/bph.15438. Epub 2021 May 5. PMID: 33751552; PMCID: PMC8251890.",
                    "Hyun-Yi Kim, Sehee Choi, Ji-Hye Yoon, Hwan Jung Lim, Hyuk Lee, Jiwon Choi, Eun Ji Ro, Jung-Nyoung Heo, Weontae Lee, Kyoung Tai No, Kang-Yell Choi, Small molecule inhibitors of the Dishevelled-CXXC5 interaction are new drug candidates for bone anabolic osteoporosis therapy, EMBO Mol Med (2016)8:375-387. https://doi.org/10.15252/emmm.201505714",
                    "Choi S, Yoon M, Choi KY. Approaches for Regenerative Healing of Cutaneous Wound with an Emphasis on Strategies Activating the Wnt/β-Catenin Pathway. Adv Wound Care (New Rochelle). 2022 Feb;11(2):70-86. doi: 10.1089/wound.2020.1284. Epub 2021 Apr 20. PMID: 33573472; PMCID: PMC9831250.",
                    "Lee SH, Kim MY, Kim HY, Lee YM, Kim H, Nam KA, Roh MR, Min do S, Chung KY, Choi KY. The Dishevelled-binding protein CXXC5 negatively regulates cutaneous wound healing. J Exp Med. 2015 Jun 29;212(7):1061-80. doi: 10.1084/jem.20141601. Epub 2015 Jun 8. PMID: 26056233; PMCID: PMC4493411. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493411/"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "",
        "high_performance_liquid_chromatography": "",
        "mass_spectrometry": "",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "PTD-DBM peptide for sale online (5mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "PTD-DBM For Sale (5mg) - Core Peptides",
            "og:description": "PTD-DBM peptide for sale. Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:url": "https://www.corepeptides.com/peptides/ptd-dbm-5mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T16:07:14+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2023/03/PTD-DBM-5mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "PTD-DBM For Sale (5mg) - Core Peptides",
            "twitter:description": "PTD-DBM peptide for sale. Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2023/03/PTD-DBM-5mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$89.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "89.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "PTD-DBM",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/adipotide-10mg/",
                "name": "Adipotide (FTPP) (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Adipotide-FTPP-10MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/oxytocin-10mg/",
                "name": "Oxytocin (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Oxytocin-10mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ghrp-6/",
                "name": "GHRP-6 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHRP-6-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ll-37-5mg/",
                "name": "LL-37 (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/LL-37-5mg-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "id": "46",
        "url": "https://www.corepeptides.com/peptides/pt-141-10mg-bremelanotide/",
        "name": "PT-141 (Bremelanotide) (10mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2020/04/PT-141-10mg.jpg",
        "display_price": "$43.00",
        "display_specs": [
            "Size: 10mg Contents: PT-141 (Bremelanotide) (10mg) Form: Lyophilized powder Purity: >99% SKU: P-PT141-10",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$40.85"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$38.70"
            }
        ],
        "description": [
            {
                "h2": "PT-141 Peptide"
            },
            {
                "p": "Bremelanotide, which is also commonly known by PT-141, is a cyclic synthetic peptide composed of seven amino acids.(1) PT-141 synthetic peptide appears to be agonistic to melanocortin receptors, which is similar to the natural hormone alpha-MSH.(2) It is a by-product of the metabolism of another synthetic analog called melanotan II. Initial studies suggested that melanocortin hormones may regulate various physiological functions. When test animals were presented with the isolated hormone, it was reported to present elevated reproductive functions, which is one of the primary areas of research currently being conducted on PT-141 peptide."
            },
            {
                "h3": "Overview"
            },
            {
                "p": "Studies have suggested that PT-141 shows agonistic properties towards melanocortin receptors, namely MC3R and MC4R, which may result in elevated reactions in the central nervous system. MC3R, which appears to be primarily expressed in the brain, especially within the hypothalamus, might play a role in energy homeostasis. It has been hypothesized by research teams examining melanocortin receptor activity, that MC3R may potentially modulate the actions of other melanocortin receptors in this area. Moreover, MC3R might influence feeding behavior, possibly impacting appetite and food intake, and is thought to be involved in various metabolic processes, including the potential regulation of glucose and lipid metabolism.(3) On the other hand, MC4R is believed to be essential in appetite control. When activated in the brain, it is considered to contribute to appetite regulation. MC4R is also posited to have a role in energy expenditure, with its activation possibly leading to an increase in energy output, which could contribute to weight reduction. This receptor has also been tentatively linked to reproductive function, especially in the potential regulation of the function of penile tissues and overall reproductive behavior.(4) In publically available study, it was suggested by researchers that following binding with MC3R and MC4R receptors, the peptide appeared to lead to the activation of the neurons found in the hypothalamus, leading to apparently increased immunoreactivity.2() Neurons in the surrounding region of the central nervous system may also be stimulated as they intake the chemicals which then reportedly lead to sexual arousal in murine models."
            },
            {
                "h3": "PT-141 Chemical Makeup"
            },
            {
                "p": "Molecular formula: C50H68N14O10 Molecular weight: 1025.18 g/mol Other Known Titles: Bremelanotide  "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "PT-141 Peptide Initial Studies"
            },
            {
                "p": "This early 2000 study was conducted to understand the potential of PT-141 peptide in murine models. The murine models were used as the subject in this study to determine how the peptide may impact their sexual behavior.(5) After presentation, it was reported that the female rats appeared to exhibit elevated sexual desire without any increase/decrease in the sexual pace, lumbar lordosis, or any other sexually-related behaviors. After analysis, it was suggested by the researchers that the peptide did not directly impact a generalized motor activation, instead it may have potential selective pharmacological impact that may stimulate the central nervous system, mainly the melanocortin receptor activities, which might result in elevated sexual arousal. More specifically, the researchers commented that “ The ability of PT-141 to enhance solicitation in two distinctive testing environments indicates that the effect is selective and stable, and suggests that central melanocortin systems are part of the neurochemical network that evokes appetitive sexual behavior in female rats.”(5)"
            },
            {
                "h3": "PT-141 Peptide and Arousal"
            },
            {
                "p": "The potential activation of the MC4R by PT-141 may also upregulate the production of vasodilators like nitric oxide (NO) in penile tissues, leading to improved erection potential, as suggested by research.(6) The peptide is posited to be a metabolite of Melanotan-2 (MT-II), and both appear to activate the same receptors. For example, it has been posited that melanocortin agonists might lead to concentration-related increases in cavernosal pressure. SHU 9119, an agent that is possibly a non-selective antagonist of MC3R and MC4R, appears not to have had a significant impact on cavernosal or systemic blood pressure. However, it seems to have negated the increases in cavernosal pressure that melanocortin agonists potentially induced. This same agent, SHU 9119, also appears to have inhibited the depressor response that was probably produced by melanocortin agonists. Moreover, when a combination containing phentolamine mesylate, papaverine, and PGE1 was introduced directly into the cavernosal tissue, it reportedly led to a 4-fold increase in cavernosal pressure. The study also hypothesized the role of the NO-cyclic GMP-dependent pathway in relation to the melanocortin agonists-induced increases in cavernosal pressure. This was done by performing a bilateral transection of the pudendal nerves and inhibiting NO synthase using L-NAME. The results indicate that either removing the pudendal nerves or pretreating with L-NAME may negate the increases in intracavernosal pressure that melanocortin agonists likely induced in the anesthetized murine models. From the gathered data, it was tentatively inferred that the activation of central melanocortin receptors by melanocortin agonists might lead to an increase in cavernosal pressure, probably achieved through the neuronal release of NO.(6)"
            },
            {
                "h3": "PT-141 Peptide and the Central Nervous System"
            },
            {
                "p": "Studies on PT-141 have aimed to understand the potential of the peptide in the central nervous system (CNS) and possibly also some brain regions.(7) One study was carried out in murine models with rich levels of the female reproductive hormones. Researchers mainly focused on both the sexual behaviors of the rats i.e., appetitive behaviors such as increased pace and agitation, and consummatory behaviors such as lordosis. In this study, the rats were presented with the peptide, which apparently resulted in increased appetitive behavior of solicitation without impacting the sexual pace or lordosis. The actions of PT-141 were noted following both peripheral introductions and introduction directly into the lateral ventricles or medial preoptic area (mPOA), but possibly not the ventromedial hypothalamus. The mPOA may be a significant region for displaying appetitive sexual behaviors in models across various species, though this theory is still being explored. When PT-141 was introduced peripherally, it appeared to activate the mPOA and other hypothalamic and limbic brain regions possibly associated with sexual behavior. The study hypothesizes that PT-141 might function by potentially activating dopamine terminals located in the mPOA, but further research is needed to confirm this. The researchers commented that the peptide “appears to possess the behavioral, pharmacological, and neuroanatomical specificity required” to potentially influence sexual function.(7)"
            },
            {
                "p": "To gain a deeper understanding of these mechanisms, a study was conducted using psychometric, functional neuroimaging, and hormonal analyses. This study was a randomized, double-blinded, placebo-controlled, crossover clinical investigation that aimed to evaluate the impact of MC4R agonism on sexual brain processing. The results indicated that MC4R agonists like PT-141 might elevate sexual desire for up to 24 hours compared to a placebo. Furthermore, during the functional neuroimaging phase, it appeared that MC4R agonism possibly amplified activity in the cerebellar and supplementary motor areas while possibly deactivating the secondary somatosensory cortex, specifically when the subjects were exposed to erotic stimuli, in contrast to the placebo. Moreover, MC4R agonists were hypothesized to boost the functional connectivity between the amygdala and the insula when exposed to erotic stimuli, again compared to the placebo. Based on these observations, researchers posited that MC4R agonists might augment sexual brain processing. This research offers further insights into the mechanisms through which MC4R agonists like PT-141 might influence sexual behavior, shedding light on the ongoing exploration of this class of peptides.(8)"
            },
            {
                "p": "PT-141 peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Pfaus, J., Giuliano, F., & Gelez, H. (2007). Bremelanotide: an overview of preclinical CNS effects on female sexual function. The journal of sexual medicine, 4 Suppl 4, 269–279. https://doi.org/10.1111/j.1743-6109.2007.00610.x",
                    "National Center for Biotechnology Information (2023). PubChem Compound Summary for CID 9941379, Bremelanotide. Retrieved August 10, 2023 from https://pubchem.ncbi.nlm.nih.gov/compound/Bremelanotide.",
                    "Molinoff, P. B., Shadiack, A. M., Earle, D., Diamond, L. E., & Quon, C. Y. (2003). PT-141: a melanocortin agonist for the treatment of sexual dysfunction. Annals of the New York Academy of Sciences, 994, 96–102. https://doi.org/10.1111/j.1749-6632.2003.tb03167.x",
                    "Renquist, B. J., Lippert, R. N., Sebag, J. A., Ellacott, K. L., & Cone, R. D. (2011). Physiological roles of the melanocortin MC₃ receptor. European journal of pharmacology, 660(1), 13–20. https://doi.org/10.1016/j.ejphar.2010.12.025",
                    "Adan, R. A., Tiesjema, B., Hillebrand, J. J., la Fleur, S. E., Kas, M. J., & de Krom, M. (2006). The MC4 receptor and control of appetite. British journal of pharmacology, 149(7), 815–827. https://doi.org/10.1038/sj.bjp.0706929",
                    "Pfaus, J. G., Shadiack, A., Van Soest, T., Tse, M., & Molinoff, P. (2004). Selective facilitation of sexual solicitation in the female rat by a melanocortin receptor agonist. Proceedings of the National Academy of Sciences of the United States of America, 101(27), 10201–10204. https://doi.org/10.1073/pnas.0400491101",
                    "Vemulapalli, R., Kurowski, S., Salisbury, B., Parker, E., & Davis, H. (2001). Activation of central melanocortin receptors by MT-II increases cavernosal pressure in rabbits by the neuronal release of NO. British journal of pharmacology, 134(8), 1705–1710. https://doi.org/10.1038/sj.bjp.0704437",
                    "Thurston, L., Hunjan, T., Mills, E. G., Wall, M. B., Ertl, N., Phylactou, M., Muzi, B., Patel, B., Alexander, E. C., Suladze, S., Modi, M., Eng, P. C., Bassett, P. A., Abbara, A., Goldmeier, D., Comninos, A. N., & Dhillo, W. S. (2022). Melanocortin 4 receptor agonism enhances sexual brain processing in women with hypoactive sexual desire disorder. The Journal of clinical investigation, 132(19), e152341. https://doi.org/10.1172/JCI152341"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/12/PT-141-COA.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/12/PT-141-LC.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/12/PT-141-MS.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "PT-141 peptide for sale online. Peptides for sale at 99% purity with top customer service. Get PT-141 research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "PT-141 (Bremelanotide) For Sale (10mg) | Core Peptides",
            "og:description": "PT-141 peptide for sale online. Peptides for sale at 99% purity with top customer service. Get PT-141 research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/pt-141-10mg-bremelanotide/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-05-28T11:02:10+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/PT-141-10mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "PT-141 (Bremelanotide) For Sale (10mg) | Core Peptides",
            "twitter:description": "PT-141 peptide for sale online. Peptides for sale at 99% purity with top customer service. Get PT-141 research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/PT-141-10mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$43.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "43.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-PT141-10",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/peg-mgf-5mg/",
                "name": "PEG-MGF (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/PEG-MGF-5MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/melanotan-1-10mg/",
                "name": "Melanotan 1 (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Melanotan-1-10MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ghk-cu-50mg-copper/",
                "name": "GHK-Cu (Copper) (50mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHK-CU-50mg-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/fragment-176-191/",
                "name": "Fragment 176-191 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Fragment-176-191-300x300.jpg.webp",
                "price": ""
            }
        ]
    },
    {
        "id": "47",
        "url": "https://www.corepeptides.com/peptides/prostamax-20mg/",
        "name": "Prostamax (20mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2023/11/Prostamax-Lys-Glu-Asp-Pro-20mg.jpg",
        "display_price": "$63.00",
        "display_specs": [
            "Size: 20mg Contents: Prostamax Form: Lyophilized powder Purity: >99% SKU: P-PROSTAMAX-20",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$59.85"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$56.70"
            }
        ],
        "description": [
            {
                "h2": "Prostamax Peptide"
            },
            {
                "p": "Prostamax, aka KEDP, is a synthetic tetrapeptide (Lys-Glu-Asp-Pro) classified among the Khavinson peptides, which researchers have suggested may exhibit primary repair potential on various tissues, notably in prostate cell cultures. It appears to influence the structural dynamics of chromatin, potentially activating previously repressed genes and altering chromosomal dynamics. This may include increasing in the frequency of sister chromatid exchanges and Ag-positive nucleolus organizer regions, indicating enhanced chromosomal exchange activities and changes in ribosomal RNA gene activity as well as reducing the frequency of large segments of C-pericentromeric heterochromatin, suggesting a decondensation action on the chromatin. In prostatic gland tissue cultures, Prostamax may have a role in stimulating reparation processes, reducing inflammation and preventing sclerotic and atrophic processes."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular formula: C20H33N5O9 Molecular weight: 487.5 g/mol Sequence: Lys-Glu-Asp-Pro Other known titles: KEDP, SCHEMBL6660498"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "p": "The content presented here integrates recent findings from preliminary studies about Prostamax's potential, as evidenced by diverse experimental methods."
            },
            {
                "h3": "Prostamax Peptide and Gene Expression Related to Cellular Aging"
            },
            {
                "p": "One study highlights the potential impact of Prostamax on the chromatin structure in lymphocytes.(1) Chromatin, the complex of DNA and proteins found in cells, has been observed to undergo two stages of denaturation at specific temperatures and energy states, denoted as T(d)VII and T(d)VIII. Prostamax appears to induce notable changes in this chromatin structure. Specifically, it appears to cause a redistribution of heat among two endotherms, T(d)III and T(d)IV, and leads to a decrease in their temperatures by 2.9 and 1.0 degrees Celsius, respectively. This redistribution and temperature shift might be linked to a relaxation in the chromatin structure, particularly the 30-nm-thick fiber relaxing into a 10-nm filament. Furthermore, there's a suggestion that Prostamax may lead to minor structural alterations in the nucleosomal organization within the chromatin, indicated by a slight decrease in the temperatures of T(d)VIII and T(d)VII in lymphocytes introduced to Prostamax compared to control cells. These changes are possibly due to adjustments in the structural organization of both the 10-nm filament and the 30-nm fiber."
            },
            {
                "p": "Another trial further investigates the impact of Prostamax on several chromosomal characteristics in aged cells, revealing that Prostamax possibly influences these characteristics.(2) More specifically, the study suggests that Prostamax might have a modifying action on chromatin, particularly in the context of aging cells. This could potentially lead to the activation of previously repressed genes and changes in chromosomal dynamics. For example, Prostamax apparently increases the frequency of sister chromatid exchanges (SCE). In cells introduced to Prostamax, the frequency of SCE rose to an average of 12.0 exchanges per cell, compared to 5.9 exchanges in control cells. This suggests that Prostamax may have a role in enhancing chromosomal exchange activities. Furthermore, the study posits that Prostamax may potentially increase the frequency of Ag-positive nucleolus organizer regions (NORs). In Prostamax-exposed cells, the average was 2.5 Ag-positive NORs per cell, compared to just 0.95 in intact cells. This increase might indicate changes in ribosomal RNA gene activity or chromatin structure modifications. Prostamax also seemingly reduces the frequency of large segments of C-pericentromeric heterochromatin, particularly in chromosomes 1 and 9. This change might imply a decondensation and deheterochromatinization action on the chromatin, possibly leading to the release of genes previously repressed by heterochromatinization. Ultimately, the authors concluded that “basis for the protective action of Prostamax is its modifying effect on chromatin.”"
            },
            {
                "p": "Another trial also reports that Prostamax may exhibit a potential to affect genetic processes in aging cells by modulating chromatin structure and possibly reactivating certain genes.(3) The trial focused on the potential role of Prostamax in the activation of ribosome genes, decondensation of chromatin, and altering the structure of heterochromatin. Prostamax, along with other peptides like Epitalon and Livagen, possibly led to the decondensation of chromosome 1 pericentromeric structural chromatin. This suggests that Prostamax may have a role in modulating the structure of chromatin in aging cells. The decondensation of chromatin is significant as it potentially indicates an activation of previously inactivated genes due to age-related chromatin condensation. The research posited that the peptides, including Prostamax, potentially \"release\" genes repressed as a result of the age-specific condensation of cellular euchromatin regions, referred to as deheterochromatinization of facultative chromatin. This implies that Prostamax may contribute to the reactivation of certain genetic activities that diminish with age. Furthermore, Prostamax possibly induced changes specifically in chromosome 1, suggesting a selective action on certain chromosomal regions. However, the exact mechanisms through which Prostamax exerts these actions, and the full scope of its potential impact on aging and age-related genetic processes, remain somewhat unclear and require further investigation."
            },
            {
                "h3": "Prostamax Peptide and the Prostate Gland"
            },
            {
                "p": "Prostamax has been the subject of research exploring its potential action on prostatic gland tissue cultures. One investigation, utilizing organotypic tissue cultures, incorporated explants from both young and aged murine models as the basis for the study.(4) The focus was to observe any possible stimulating action of Prostamax on these tissues. In the course of this research, Prostamax was introduced at a specific concentration, which was posited to potentially elicit a stimulating action on the prostatic gland tissue cultures. This action was observed when these cultures were compared to control explants, suggesting that Prostamax might have a role in stimulating reparative processes in prostatic tissues, especially during the aging process in these murine models. The authors suggested that peptide such as Prostamax may have potential “for the stimulation of reparative processes in the appropriate tissues while aging.”"
            },
            {
                "p": "Another study explored the potential of Prostamax in models of chronic aseptic prostatitis.(5) Prostamax, through experimental studies, apparently indicated a capacity to reduce the intensity of chronic inflammation, such as swelling, hyperemia of vessels, and lymphoid infiltration in murine models. The experimental setup involved murine models that underwent a procedure designed to induce chronic aseptic inflammation in the prostate gland. Post-procedure, the models were exposed to Prostamax and its impact was then evaluated in contrast to active controls. The primary goal was to gauge the potential of Prostamax in lessening the impact of chronic prostatitis and its associated complications, and to compare its potential to active controls. The authors of this study suggested that Prostamax might have the capability to diminish inflammation-related symptoms such as swelling, vessel hyperemia, and cellular infiltration commonly seen in murine models of chronic prostatitis. Notably, it also seemed to have a role in possibly curtailing the development of sclerotic and atrophic processes in the prostate gland models. These processes are typically seen as complications in such models and their potential mitigation by Prostamax is a point of interest. Prostamax's potential in preventing these processes appeared more pronounced compared to the comparator agents, suggesting its superiority in this regard. Additionally, Prostamax was observed to possibly enhance sexual activity in the animal models, a finding that may indicate broader research potential."
            },
            {
                "p": "Prostamax peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Meskhi T, Khachidze D, Barbakadze Sh, Madzhagaladze G, Gorgoshidze M, Monaselidze D, Lezhava T, Tadumadze N. Vliianie peptidnogo bioreguliatora prostamaksa na geterokhromatin limfotsitov cheloveka in situ [The influence of the peptide bioregulator prostamax on heterochromatin of human lymphocytes in situ]. Biofizika. 2004 Nov-Dec;49(6):1091-3. Russian. PMID: 15612551.",
                    "Dzhokhadze TA, Buadze TZh, Gaĭozishvili MN, Baratashvili NA, Lezhava TA. [Deheterochromatinization of the chromatin in old age induced by oligopeptide bioregulator (Lys-Glu-Asp-Pro)]. Georgian Med News. 2012 Nov;(212):76-82. Russian. PMID: 23221144.",
                    "Khavinson VKh, Lezhava TA, Malinin VV. Effects of short peptides on lymphocyte chromatin in senile subjects. Bull Exp Biol Med. 2004 Jan;137(1):78-81. doi: 10.1023/b:bebm.0000024393.40560.05. PMID: 15085253.",
                    "Zakutskiĭ AN, Chalisova NI, Ryzhak GA, Aniskina AI, Filippov SV, Zeziulin PN. [The tissue-specific effect of synthetic peptides-biologic regulators in organotypic tissues culture in young and old rats]. Adv Gerontol. 2006;19:93-6. Russian. PMID: 17152728.",
                    "Borovskaya, T. G., Pakhomova, A. V., Vychuzhanina, A. V., Poluektova, M. E., Fomina, T. I., Ermolaeva, L. A., ... & Neplochov, E. A. (2013). Experimental studying of the drug efficiency Prostamax in the therapy of chronic aseptic prostatitis and its complications. Modern Research in Inflammation, 2013."
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "",
        "high_performance_liquid_chromatography": "",
        "mass_spectrometry": "",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Prostamax for sale online (20mg). Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Prostamax for Sale (20mg) - Core Peptides",
            "og:description": "Prostamax for sale online (20mg). Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/prostamax-20mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-05-22T16:52:09+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2023/11/Prostamax-Lys-Glu-Asp-Pro-20mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Prostamax For Sale (20mg) - Core Peptides",
            "twitter:description": "Prostamax for sale online (20mg). Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2023/11/Prostamax-Lys-Glu-Asp-Pro-20mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$63.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:brand": "Core Peptides",
            "product:price:amount": "63.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-PROSTAMAX-20",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/ll-37-5mg/",
                "name": "LL-37 (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/LL-37-5mg-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/hexarelin-5mg/",
                "name": "Hexarelin (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Hexarelin-5MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/fragment-176-191/",
                "name": "Fragment 176-191 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Fragment-176-191-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/dsip-5mg/",
                "name": "DSIP (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/DSIP-5MG-300x300.jpg.webp",
                "price": ""
            }
        ]
    },
    {
        "id": "48",
        "url": "https://www.corepeptides.com/peptides/pnc-27-5mg/",
        "name": "PNC-27 (5mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2023/03/PNC-27-5mg.jpg",
        "display_price": "$138.00",
        "display_specs": [
            "Size: 5mg Contents: PNC-27 Form: Lyophilized powder Purity: >99% SKU: PNC-27",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$131.10"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$124.20"
            }
        ],
        "description": [
            {
                "h2": "PNC-27 Peptide"
            },
            {
                "p": "PNC-27 is a 27-amino acid peptide that has been studied for its potential to mitigate the activity and proliferation of cancer cells. It is derived from the third helix of the anti-cancer peptide α-helical segment of p53 (ASPP2), a protein involved in tumor suppression. PNC-27 has been suggested to induce cell death via necrosis in various cancer cell lines, including pancreatic cancer, ovarian cancer, and leukemia, among others."
            },
            {
                "p": "Researchers speculate that the PNC-27 peptide may specifically target cancer cells while not appearing to interact with other cells. Initially synthesized in 2000 as a part of a research project associated with immunodeficiency, specifically HIV, this peptide was reported to exhibit the ability to bind with the double minute (HDM2) protein, which is deemed overly expressed on the membranes of the carcinogenic cells. Interestingly, PNC-27 does not appear to induce apoptosis, a common pathway for many anticancer research chemicals, but rather may act upon the cells via inducing necrosis. This mode of action suggests a direct, physical disruption of the plasma membrane, possibly mediated by the formation of pores that compromise cell integrity, leading to necrosis. More specifically, binding with this protein appears to perforate the membrane of cancer cells by forming holes and causing membranolysis. This allows for the influx of ions and the efflux of cellular contents, ultimately leading to cell death.(1)"
            },
            {
                "p": " "
            },
            {
                "h2": "Chemical Makeup(1)"
            },
            {
                "p": "Molecular Formula: C188H293N53O44S Molecular Weight: 4031.7 g/mol"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "PNC-27 Peptide and Selective Cell Death"
            },
            {
                "p": "In 2009, a study aimed to evaluate whether the PNC-27 peptide may interact (and potentially induce necrosis) within non-cancerous cells. The researchers at the time believed that, based on the peptide structure, it might be able to bind with HDM-2 protein and interact singly with cancerous cells. HDM-2 protein is reportedly only present in cancerous cells. The study suggests that forming a 1:1 complex between PNC-27 and HDM-2 might be a key event in initiating the potential formation of transmembrane pores. The study employed theoretical and experimental approaches to understand the pore formation's interaction and structural basis. Conformational energy calculations indicated that PNC-27 might form stable complexes with HDM-2, possibly aligning the leader sequence to not interfere with the core interaction. Yet, it did appear to participate in the pore structure. Immuno-electron microscopy gave researchers visual data of these complexes at the cancer cell surface, with observed ring-shaped structures at the pore sites, which they speculated may contain PNC-27 bound to HDM-2. Importantly, these pore structures were not observed in normal cells exposed to PNC-27, underscoring the peptide's potentially selective toxicity towards cancer cells. Further, for this study, normal cells were implanted with HDM-2 protein. The PNC-27 peptide, which otherwise might not affect the cells, now showed affinity towards the modified cells.(2)"
            },
            {
                "h3": "PNC-27 Peptide and Lysis of Cancerous Cells"
            },
            {
                "p": "Another study(3) conducted in 2010 aimed at understanding whether fragments of the peptide or the entire peptide might impact the formation of membrane pores. The hypothesis was that if the peptide remained intact, it might more effectively induce the membranolytic activity necessary for killing cancer cells. For this study, the peptide was induced with a green fluorescence chemical to the terminal containing an amino group and a red fluorescence chemical to the terminal containing the carboxyl group. This labeling strategy was crucial as it allowed the researchers to visually track the integrity of the peptide within the cellular environment. The breast tumor and control cells were then exposed to the modified peptide to see which color appeared on the membrane during membranolysis. Half an hour after the peptide, a bright yellow luminescence was reported upon membrane lysis, suggesting that the peptide was fully intact during this cellular membrane-killing process. This observation was critical as it suggested that the peptide's structure was preserved during the interaction with the cell membrane, which would be essential for any cytotoxic activity. As expected, this was only seen in the cancerous cells while the control cells remained viable. The study's researchers suggest that the intact form of PNC-27 may be crucial for its activity, as the peptide appears to selectively induce pore formation in cancer cell membranes—a process associated with the release of lactate dehydrogenase (LDH), a marker of cell lysis. The interaction of PNC-27 with cancer cell membranes was suggested to increase over time, correlating with increased LDH release and cell death. Kelley A. Sookraj et al. stated,"
            },
            {
                "p": "\"PNC-27 induces cancer cell membrane lysis by acting as the unmodified peptide, not fragments. The punctate yellow fluorescence is due to the interaction of PNC-27 with intramembrane targets of MCF-7 cells that do not exist in the membrane of the untransformed cell line. This interaction increases the lifetime of PNC-27. The absence of these targets in the membranes of the untransformed MCF-10-2A cells results in the initial uniform fluorescence of the double-labeled peptide in their membranes, after which the peptide is degraded.\" (3)"
            },
            {
                "h3": "PNC-27 Peptide and Non-solid Tumor Cells"
            },
            {
                "p": "In 2014, another study(4) was initiated to determine the potential of the PNC-27 peptide on non-solid tissue tumor cells. As mentioned in the study, the purpose was “twofold: to investigate if these cells likewise express HDM-2 in their plasma membranes and to determine if our anti-cancer peptide induces tumor cell necrosis in these non-solid tissue tumor cells in a manner that depends on the interaction between the peptide and membrane-bound HDM-2.”(4)"
            },
            {
                "p": "The non-solid tumor cells were exposed to PNC-27, and the action examined. As part of the control, murine leukocyte cells were used. Upon macroscopic analysis, it was suggested that the HDM-2 cells were expressed in the non-solid tissue tumor cells and that the PNC-27 peptide appeared to exhibit potential selectivity towards these cells. Researcher Katlin Davitt et al. stated:"
            },
            {
                "p": "\"... We conclude that the association of PNC-27 with HDM-2 in the cancer cell membrane [may] result in trans-membrane pore formation, which results in cancer cell death, as previously discovered in a number of different solid tissue tumor cells. Since K562 cells lack p53 expression, these effects of PNC-27 on this leukemia cell line [may] occur by a p53-independent pathway.\" (4)"
            },
            {
                "h3": "PNC-27 Peptide and Cancer Cells"
            },
            {
                "p": "A study(5) was conducted on the peptide PNC-28, which is structurally and functionally very similar to the PNC-27 peptide. Both peptides are derived from p53 and appear to act only on the HDM-2 proteins in cancerous cells. In this study, the researchers evaluated the anti-tumor activity of PNC-28 against ovarian cancer cells and mouse xenograft models. They suggested that PNC-28 appeared to inhibit the growth of ovarian cancer cells and reduced tumor size in the mouse models."
            },
            {
                "p": "In another 2020 study,(6) an experiment was conducted to determine the PNC-27 peptide potential on non-stem cells from the leukemia cell lines. Researchers reported the study focused on “acute myelogenous leukemia cell lines: U937, acute monocytic leukemia; OCI-AML3, acute myelomonocytic leukemia and HL60, acute promyelocytic leukemia.” These particular cell lines were selected due to their distinct phenotypic and genotypic characteristics, which might shed light on the peptide's varying potential across different cancer cell types. After peptide exposure, it was observed that the HDM-2 protein appeared to be highly expressed in all leukemia cells, which were all targeted by the PNC-27 peptide.(6)"
            },
            {
                "p": "PNC-27 peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References"
            },
            {
                "references": [
                    "Davitt K, Babcock BD, Fenelus M, Poon CK, Sarkar A, Trivigno V, Zolkind PA, Matthew SM, Grin'kina N, Orynbayeva Z, Shaikh MF, Adler V, Michl J, Sarafraz-Yazdi E, Pincus MR, Bowne WB. The anti-cancer peptide, PNC-27, induces tumor cell necrosis of a poorly differentiated non-solid tissue human leukemia cell line that depends on expression of HDM-2 in the plasma membrane of these cells. Ann Clin Lab Sci. 2014 Summer;44(3):241-8. PMID: 25117093. https://pubmed.ncbi.nlm.nih.gov/25117093/",
                    "Sarafraz-Yazdi E, Mumin S, Cheung D, Fridman D, Lin B, Wong L, Rosal R, Rudolph R, Frenkel M, Thadi A, Morano WF, Bowne WB, Pincus MR, Michl J. PNC-27, a Chimeric p53-Penetratin Peptide Binds to HDM-2 in a p53 Peptide-like Structure, Induces Selective Membrane-Pore Formation and Leads to Cancer Cell Lysis. Biomedicines. 2022; 10(5):945. https://doi.org/10.3390/biomedicines10050945",
                    "Sookraj KA, Bowne WB, Adler V, Sarafraz-Yazdi E, Michl J, Pincus MR. The anti-cancer peptide, PNC-27, induces tumor cell lysis as the intact peptide. Cancer Chemother Pharmacol. 2010 Jul;66(2):325-31. doi: 10.1007/s00280-009-1166-7. Epub 2010 Feb 25. PMID: 20182728. https://pubmed.ncbi.nlm.nih.gov/20182728/",
                    "Davitt K, Babcock BD, Fenelus M, Poon CK, Sarkar A, Trivigno V, Zolkind PA, Matthew SM, Grin'kina N, Orynbayeva Z, Shaikh MF, Adler V, Michl J, Sarafraz-Yazdi E, Pincus MR, Bowne WB. The anti-cancer peptide, PNC-27, induces tumor cell necrosis of a poorly differentiated non-solid tissue human leukemia cell line that depends on expression of HDM-2 in the plasma membrane of these cells. Ann Clin Lab Sci. 2014 Summer;44(3):241-8. PMID: 25117093. https://pubmed.ncbi.nlm.nih.gov/25117093/",
                    "Wilbur B. Bowne et al., The Penetratin Sequence in the Anti-cancer PNC-28 Peptide Causes Tumor Cell Necrosis Rather Than Apoptosis of Human Pancreatic Cancer Cells, Annals of Surgical Oncology 15(12):3588–3600 Published by Springer Science+Business Media, LLC 2008 The Society of Surgical Oncology, Inc. DOI: 10.1245/s10434-008-0147-0. https://webs.iiitd.edu.in/raghava/cancerppd/refpdf/18931881.pdf",
                    "Anusha Thadi et al, Targeting Membrane HDM-2 by PNC-27 Induces Necrosis in Leukemia Cells But Not in Normal Hematopoietic Cells, Anticancer Research 40 (9):4857-4867, September 2020 DOI: 10.21873/anticanres.14488"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/12/PNC-27-COA.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/12/PNC-27-LC.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/12/PNC-27-MS.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "PNC-27 peptide for sale online (5mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "PNC-27 For Sale (5mg) - Core Peptides",
            "og:description": "PNC-27 peptide for sale. Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:url": "https://www.corepeptides.com/peptides/pnc-27-5mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-04-25T15:00:56+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2023/03/PNC-27-5mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "PNC-27 For Sale (5mg) - Core Peptides",
            "twitter:description": "PNC-27 peptide for sale. Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2023/03/PNC-27-5mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$138.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "138.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "PNC-27",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/adipotide-10mg/",
                "name": "Adipotide (FTPP) (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Adipotide-FTPP-10MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/selank-10mg/",
                "name": "Selank (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Selank-10MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/fragment-176-191/",
                "name": "Fragment 176-191 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Fragment-176-191-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/melanotan-2-10mg/",
                "name": "Melanotan 2 (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2023/03/Melanotan-2-10MG-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "id": "49",
        "url": "https://www.corepeptides.com/peptides/pinealon-20mg/",
        "name": "Pinealon (20mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2021/11/Pinealon-20mg.jpg",
        "display_price": "$75.00",
        "display_specs": [
            "Size: 20mg Contents: Pinealon (20mg) Form: Lyophilized powder Purity: >99% SKU: P-PINEALON-20",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$71.25"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$67.50"
            }
        ],
        "description": [
            {
                "h2": "Pinealon Peptide"
            },
            {
                "p": "Pinealon is a short synthetic peptide composed of three amino acids Glu-Asp-Arg, also known as the EDR peptide.(1)(2) Pinealon is suggested to impact the central nervous system, which may lead to behavior modification while also possibly protecting neurons and various cell types from oxidative stress. The primary research focus on this peptide is evaluating its potential to penetrate the blood-brain barrier, cellular membrane, and nuclear membrane. However, researchers have also suggested that it may also interact directly with DNA molecules."
            },
            {
                "p": "Pinealon tripeptide is isolated from another chemical compound, Cortexin.(2) Cortexin is a polypeptide with a particularly low molecular weight. Due to this low weigh, Cortexin has been suggested by researchers to cross the blood-brain barrier to produce potential stimulatory action on the neurotransmitters in the brain.(3)"
            },
            {
                "h3": "Overview"
            },
            {
                "p": "The neuroprotective and anti-apoptotic potential of the Pinealon peptide has been posited by researchers to be exerted via the MAPK / ERK signaling pathway.(2) The ERK signaling cascade may play a role in the phosphorylation of the substrates, which may lead to elevated neuron plasticity and increased cellular stress. In turn, this action may lead to cellular apoptosis. Similarly, MAPK signaling has been associated with certain metabolic disorders and inflammatory reactions. Researchers suggest that Pinealon may potentially reduce the synthesis of reaction oxygen species (ROS) on the cellular level. ROS is considered a messenger to MAPK and ERK signaling pathways, and the reduced synthesis may lead to a reduction in signaling reactions, preventing cellular stress and cell death.(2)"
            },
            {
                "p": "Studies on Pinealon have suggested a concentration-dependent action. At lower concentrations, the peptide may potentially restrict the synthesis and subsequent accumulation of ROS and cell death. In comparison, the peptide might lead to a modulation of the cell cycle at higher concentrations. Researchers reporting this apparent correlation in peptide presence have suggested that it may exert antioxidant potential at lower concentrations while possibly interacting with the cell genome and altering the cell cycle.(4)"
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C15H26N6O8 Molecular Weight: 418.4 g/mol Other Known Titles: EDR, Glu-Asp-Arg"
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Pinealon Peptide and Cell Aging"
            },
            {
                "p": "The main purpose of this clinical study was to analyze the cellular and metabolic aspects of synthetic tripeptides, including Pinealon and a similar peptide called Vesugen. As part of this study,(5) research models of poly-morbidity and organic brain syndrome were observed. Both peptides exhibited apparent anabolic potential; researchers reported improvement in the functioning of the central nervous system and other vital organs compared to control models. The peptides did not appear to affect the degree of chromatin condensation, which the researchers indicated may suggest that the peptides do not act on cellular levels."
            },
            {
                "p": "Another separate study(6) has suggested that the Pinealon peptide may potentially act on muscle cells, modulating the levels of irisin. Scientists consider irisin to be central to muscle cell protection and mainly secreted during physical strain. Irisin may lead to the burning of excessive fat cell stores and is assumed by researchers to induce an elongation of telomeres (DNA caps) as well. By potentially increasing irisin levels, Pinealon may potentially exert protection of DNA telomeres and counteract cell aging action to some degree."
            },
            {
                "h3": "Pinealon Peptide and Prenatal Hyperhomocysteinemia"
            },
            {
                "p": "Scientists characterize hyperhomocysteinemia by the excessive concentration of homocysteine (HC) amino acid in the blood, indicating extreme vitamin deficiency, which might lead to an increased risk of neurological deterioration.(7) The main goal of this study(8) was to determine the potential of Pinealon on experimentally induced hyperhomocysteinemic pregnant female murine models. The female rats were given methionine from their second trimester onwards, which appeared to lead to increased concentration of homocysteine (HC) levels. The rat offspring from the control and the experimental models were then observed for this study. Upon analysis, it was suggested by the researchers that the peptide did not appear to reduce or inhibit the development of homocysteine in the offspring, however, there appeared to be some action seen in the experimental models, as they appeared to exhibit increased cognitive processing. The researchers suggested that the peptide did not appear to induce the metabolism of homocysteine but may have led to reduced toxic action of the compound."
            },
            {
                "h3": "Pinealon Peptide and Serotonin Expression"
            },
            {
                "p": "Studies(9) were conducted on the isolated brain cell cultures where the Pinealon peptide was presented. Upon analysis, it was suggested that the peptide might stimulate levels of serotonin expression in the cell cultures. Preliminary results seemed to indicate that after exposure to Pinealon, there was a notable increase in serotonin synthesis compared to the control groups. This increase was quantitatively assessed to be 1.9 times greater in younger cell cultures. The molecular dynamics behind this observed action might involve Pinealon's interaction with the DNA. It is speculated that this augmentation in serotonin production may be facilitated by Pinealon's potential to bind specifically to a DNA sequence within the promoter region of the gene encoding 5-tryptophan hydroxylase, an enzyme considered to be critical for serotonin synthesis. More specifically, the peptide is hypothesized to bind to a particular nucleotide sequence in the promoter region of the 5-tryptophan hydroxylase gene, potentially enhancing the transcriptional activity of the gene and thus increasing 5-tryptophan hydroxylase enzyme production. Additionally, molecular docking simulations were employed to formulate hypotheses about the peptide’s binding orientation and stability with the DNA. These simulations, which consider factors like hydrophobic interactions, electrostatic forces, and hydrogen bonding, indicated a lower (negative) binding energy for Pinealon compared to another peptide, Lys-Glu-Asp. Such a decrease in binding energy suggests a more stable potential interaction with DNA, which might lead to elevated levels of 5-tryptophan hydroxylase enzyme synthesis and, subsequently, increased serotonin production. Scientists consider serotonin a key mood-stabilizing hormone, and further studies are being conducted to observe the potential of Pinealon on serotonin synthesis."
            },
            {
                "p": "Another study suggests that Pinealon may potentially influence serotonin levels in the cerebral cortex of murine models under conditions of mild hypothermia. The possible elevation of serotonin levels postulated in the research might indicate that Pinealon could be involved in modulating these aspects of brain function, particularly in response to stress induced by mild hypothermia.(10) The same study also suggests that such models may exert an accumulation of adrenergic mediators when exposed to Pinealon and acute hypobaric hypoxia. Adrenergic mediators are chemicals that transmit nerve impulses and may potentially influence various brain functions, particularly under stress. The increase in these mediators might indicate a response mechanism of Pinealon that may be associated with neuroprotective activities."
            },
            {
                "h3": "Pinealon Peptide and Anti-apoptotic Potential"
            },
            {
                "p": "Studies(11) have suggested that Pinealon peptide may impact the levels of the caspase 3 enzyme. Scientists consider the caspase 3 enzyme an initiator of cell apoptosis (controlled cell death). When Pinealon peptide was presented in experimental murine models of ischemic stroke, the peptide appeared to modulate the levels of this enzyme, thereby shutting down the pathway of cellular death. This, in turn, reportedly reduced hypoxia action during the stroke. The research posits that Pinealon may play a role in reducing neuroinflammation and potentially restoring neurogenic processes to their reference levels, presumably those observed under normoxic (normal oxygen) conditions. By potentially fostering an environment conducive to neurogenesis during hypoxic stress, researchers also posit that Pinealon may contribute to the brain's resilience against oxygen deprivation. In addition to its apparent role in modulating the activity of caspase-3, Pinealon was also suggested to influence levels of interleukin-6 and tumor necrosis factor. Interleukin-6 and tumor necrosis factors are cytokines commonly linked with inflammation and cellular stress responses. The implication is that Pinealon might help bring these inflammatory markers back to baseline levels, thus potentially mitigating the inflammatory response and apoptosis triggered by hypoxic conditions."
            },
            {
                "p": "The action of suppressing the caspase 3 enzyme was also observed in skin cells. By reducing cellular apoptosis, the peptide may potentially stimulate cell proliferation, possibly leading to an increased regenerative process.(12)"
            },
            {
                "p": "Pinealon peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Khavinson, V., Linkova, N., Kozhevnikova, E., & Trofimova, S. (2020). EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer's Disease. Molecules (Basel, Switzerland), 26(1), 159. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795577/",
                    "National Center for Biotechnology Information. PubChem Compound Summary for CID 10273502, Glu-Asp-Arg. https://pubchem.ncbi.nlm.nih.gov/compound/Glu-Asp-Arg",
                    "Eroğlu, O., Karlıdağ, T., Kuloğlu, T., Keleş, E., Kaygusuz, İ., & Yalçın, Ş. (2018). The Protective Effect of Cortexin on Cisplatin-Induced Ototoxicity. The journal of international advanced otology, 14(1), 27–33. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354512/",
                    "Khavinson V, Ribakova Y, Kulebiakin K, Vladychenskaya E, Kozina L, Arutjunyan A, Boldyrev A. Pinealon increases cell viability by suppression of free radical levels and activating proliferative processes. Rejuvenation Res. 2011 Oct;14(5):535-41. https://pubmed.ncbi.nlm.nih.gov/21978084/",
                    "Meshchaninov VN, Tkachenko EL, Zharkov SV, Gavrilov IV, Katyreva Iue. EFFECT OF SYNTHETIC PEPTIDES ON AGING OF PATIENTS WITH CHRONIC POLYMORBIDITY AND ORGANIC BRAIN SYNDROME OF THE CENTRAL NERVOUS SYSTEM IN REMISSION. Adv Gerontol. 2015;28(1):62-7. Russian. PMID: 26390612. https://pubmed.ncbi.nlm.nih.gov/26390612/",
                    "Khavinson VKh, Kuznik BI, Tarnovskaya SI, Lin'kova NS. Short Peptides and Telomere Length Regulator Hormone Irisin. Bull Exp Biol Med. 2016 Jan;160(3):347-9. doi: 10.1007/s10517-016-3167-y. Epub 2016 Jan 8. PMID: 26742748. https://pubmed.ncbi.nlm.nih.gov/26742748/",
                    "Homocysteine. https://my.clevelandclinic.org/health/articles/21527-homocysteine",
                    "Arutjunyan, A., Kozina, L., Stvolinskiy, S., Bulygina, Y., Mashkina, A., & Khavinson, V. (2012). Pinealon protects the rat offspring from prenatal hyperhomocysteinemia. International journal of clinical and experimental medicine, 5(2), 179–185. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342713/",
                    "Khavinson, V.K., Lin’kova, N.S., Tarnovskaya, S.I. et al. Short Peptides Stimulate Serotonin Expression in Cells of Brain Cortex. Bull Exp Biol Med 157, 77–80 (2014). https://link.springer.com/article/10.1007/s10517-014-2496-y#citeas",
                    "Mendzheritsky AM, Karantysh GV, Ryzhak GA, Prokofiev VN. [Pinealon and Cortexin influence on behavior and neurochemical processes in 18-month aged rats within hypoxia and hypothermia]. Adv Gerontol. 2015;28(3):532-539. Russian. PMID: 28509493.",
                    "Mendzheritskiĭ AM, Karantysh GV, Ryzhak GA, Dem'ianenko SV. [Regulation of content of cytokines in blood serum and of caspase-3 activity in brains of old rats in model of sharp hypoxic hypoxia with Cortexin and Pinealon]. Adv Gerontol. 2014;27(1):94-7. Russian. PMID: 25051764. https://pubmed.ncbi.nlm.nih.gov/25051764/",
                    "Voicekhovskaya MA, Chalisova NI, Kontsevaya EA, Ryzhak GA. Effect of bioregulatory tripeptides on the culture of skin cells from young and old rats. Bull Exp Biol Med. 2012 Jan;152(3):357-9. doi: 10.1007/s10517-012-1527-9. PMID: 22803085. https://pubmed.ncbi.nlm.nih.gov/22803085/"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/09/Pinealon-20MG-COA.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/09/Pinealon-20MG-LC.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/09/Pinealon-20MG-MS.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Pinealon peptide for sale online. Peptides for sale at 99% purity with top customer service. Get Pinealon research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Pinealon For Sale (20mg) - Core Peptides",
            "og:description": "Pinealon peptide for sale online. Peptides for sale at 99% purity with top customer service. Get Pinealon research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/pinealon-20mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T16:24:01+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2021/11/Pinealon-20mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Pinealon For Sale (20mg) - Core Peptides",
            "twitter:description": "Pinealon peptide for sale online. Peptides for sale at 99% purity with top customer service. Get Pinealon research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2021/11/Pinealon-20mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$75.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "75.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-PINEALON-20",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/melanotan-1-10mg/",
                "name": "Melanotan 1 (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Melanotan-1-10MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/aod-9604-5mg/",
                "name": "AOD 9604 (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/AOD-9604-5MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ghk-cu-50mg-copper/",
                "name": "GHK-Cu (Copper) (50mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHK-CU-50mg-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/adipotide-10mg/",
                "name": "Adipotide (FTPP) (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Adipotide-FTPP-10MG-300x300.jpg.webp",
                "price": ""
            }
        ]
    },
    {
        "id": "50",
        "url": "https://www.corepeptides.com/peptides/pentapeptide-18-leuphasyl-topical-200mg/",
        "name": "Pentapeptide-18 (Leuphasyl) (200mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2023/04/PENTAPEPTIDE-18-200MG.jpg",
        "display_price": "$176.00",
        "display_specs": [
            "Size: 200mg Contents: Pentapeptide-18 Form: Lyophilized powder Purity: >99% SKU: P-Pentapeptide-18",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$167.20"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$158.40"
            }
        ],
        "description": [
            {
                "h2": "Pentapeptide-18 (Leuphasyl)"
            },
            {
                "p": "Pentapeptide-18 is a synthetic peptide composed of five amino acids (H-Tyr-Ala-Gly-Phe-Leu-OH) that were developed to mimic the natural process of suppressing muscle contractions, consequently reducing the development and depth of wrinkling along the epidermal barrier. Pentapeptide-18 has been hypothesized by researchers to interact with the neuroreceptors in the skin, potentially inhibiting the release of acetylcholine, a neurotransmitter that triggers muscle contractions.(1)"
            },
            {
                "p": "Pentapeptide-18 has also been suggested to impact skin cell function. It may potentially help to increase skin barrier elasticity through the stimulation of key proteins collagen and elastin. Both these proteins are considered to be a crucial component of the skin's extracellular matrix, and their production tends to decrease over time."
            },
            {
                "h3": "Chemical Makeup(2)"
            },
            {
                "p": "Molecular Formula: C29H39N5O7 Molecular Weight: 569.65 g/mol Other Known titles H-Tyr-Ala-Gly-Phe-Leu-OH, Leuphasyl"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Pentapeptide-18 and Wrinkling, Skin Structure"
            },
            {
                "p": "A 2014 study investigated the potential of Pentapeptide-18 (Leuphasyl) in reducing the depth and length of wrinkles and creases along the stratum corneum of the skin. This study evaluated the impact on moderate to severe wrinkles exposed to a Pentapeptide-18 formulation twice a day for 28 days. Digital imaging and silicone replicas were used to determine an apparent reduction in the depth of the wrinkles, with an average reduction of 11.31%. As per Anca O. Dragomirescu et al., “Leuphasyl is an active synthesis peptide… The efficiency of this molecule is evidently inferior to botulinum toxin … but it [may be] free from side effects and it confers an aspect of wrinkles’ attenuation.” (1)"
            },
            {
                "p": "Research indicates that Pentapeptide-18 may be highly specific. Clinical studies have suggested a statistically significant reduction of 2% to 9% in the appearance of wrinkles. In a randomized, double-blind, placebo-controlled study, researchers evaluated the depth of wrinkles and skin smoothness following peptide exposure using various methods such as skin imaging, dermatological assessments, and subjective self-assessments. The results suggested an overall reduction in the depth of wrinkles and increased skin smoothness after four weeks.(3)"
            },
            {
                "h3": "Pentapeptide-18 and Fine Lines"
            },
            {
                "p": "Scientists posit that Pentapeptide-18 may reduce fine lines, due to its potential ability to decrease glutamate release by 11%. This potential was apparently noticed following two months of experimentation in one study. This reduction suggests that Pentapeptide-18 might influence neurotransmitter pathways, possibly involved in the control of muscle contractions beneath the skin. The modulation of glutamate, a key excitatory neurotransmitter, might hypothetically lead to decreased muscular activity, thereby reducing the formation and depth of fine lines.(4)"
            },
            {
                "p": "In addition to reducing glutamate, Pentapeptide-18 may also suppress acetylcholine. The potential mechanism suggested involves decreased acetylcholine secretion within the synaptic cleft. This hypothesis is grounded on observing enkephalins’ typical function in modulating neurotransmitter release. Enkephalins, which are part of the endogenous opioid peptides, are believed to potentially inhibit neurotransmitter release, and this property is thought to possibly extend to the action of Pentapeptide-18. Specifically, the interaction between Pentapeptide-18 and neural receptors might lead to an inhibition of acetylcholine release. This inhibition may be mediated through the modulation of calcium influx into presynaptic neurons. Calcium plays a crucial role in the exocytosis of neurotransmitters, and its reduction within neurons is often linked to decreased neurotransmitter secretion. Therefore, it is conceivable that Pentapeptide-18 may contribute to this pathway, possibly by mimicking the regulatory actions of enkephalins on calcium channels.(5)"
            },
            {
                "h3": "Pentapeptide-18 and Melanogenesis"
            },
            {
                "p": "Park et al. (2020) explored the potential actions of D-tyrosine-containing cosmetic Pentapeptide-18 derivatives on melanogenesis.(6) The modifications to these peptides involved substituting the N-terminal L-tyrosine with D-tyrosine or appending L/D-tyrosine at the C-terminus. This research utilized melanoma MNT-1 cells to evaluate these possibilities. The findings tentatively suggest that alterations in the peptide structure may potentially affect melanogenesis. It is hypothesized that the presence of D-tyrosine, particularly when located at the C-terminal end of the peptide chain, might contribute to a reduction in melanogenesis. This observation was notable in Pentapeptide-18 analogs featuring C-terminal D-tyrosine. The results seem to indicate that the positioning and orientation of the tyrosine residues within the peptide might play a significant role. D-tyrosine, the enantiomer of the naturally occurring L-tyrosine, might conceivably modify the peptide’s interactions with enzymes or receptors involved in melanin synthesis, potentially leading to decreased melanin production in the cells."
            },
            {
                "p": "Pentapeptide-18 peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References"
            },
            {
                "references": [
                    "Dragomirescu, A. O., Andoni, M., Ionescu, D. & Andrei, F. The Efficiency and Safety of Leuphasyl—A Botox-Like Peptide. Cosmetics 1, 75–81 (2014). https://www.mdpi.com/2079-9284/1/2/75",
                    "Leucine,L-tyrosyl-L-alanylglycyl-L-phenylalanyl National Center for Biotechnology Information (2023). PubChem Compound Summary for CID 44568, Pentapeptide-18.",
                    "Puig, A., Garcia-Anton, J., Perez, R. & Mangues, M. Eyeseryl and Leuphasyl: Synthetic Peptides as Advanced Cosmetic Actives. Available at http://www.cosmeticsciencetechnology.com/companies/articles/821.pdf.",
                    "Schagen SK. Peptide Treatments with Effective Anti-Aging Results. Cosmetics. 2017; 4(2):16. https://doi.org/10.3390/cosmetics4020016",
                    "Errante F, Ledwoń P, Latajka R, Rovero P, Papini AM. Cosmeceutical Peptides in the Framework of Sustainable Wellness Economy. Front Chem. 2020 Oct 30;8:572923. doi: 10.3389/fchem.2020.572923. PMID: 33195061; PMCID: PMC7662462.",
                    "Park J, Jung H, Jang B, Song HK, Han IO, Oh ES. D-tyrosine adds an anti-melanogenic effect to cosmetic peptides. Sci Rep. 2020 Jan 14;10(1):262. doi: 10.1038/s41598-019-57159-3. PMID: 31937863; PMCID: PMC6959337."
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "",
        "high_performance_liquid_chromatography": "",
        "mass_spectrometry": "",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Pentapeptide-18 (Leuphasyl) for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Pentapeptide-18 (Leuphasyl) For Sale (200mg) - Core Peptides",
            "og:description": "Pentapeptide-18 (Leuphasyl) for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:url": "https://www.corepeptides.com/peptides/pentapeptide-18-leuphasyl-topical-200mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T16:16:40+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2023/04/PENTAPEPTIDE-18-200MG.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Pentapeptide-18 (Leuphasyl) For Sale (200mg) - Core Peptides",
            "twitter:description": "Pentapeptide-18 (Leuphasyl) for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2023/04/PENTAPEPTIDE-18-200MG.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$176.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "176.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-Pentapeptide-18",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/cjc-1295-dac-5mg/",
                "name": "CJC-1295 DAC (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/CJC-1295-DAC-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/receptor-grade-igf-1-lr3-1mg/",
                "name": "Receptor Grade IGF-1 LR3 (1mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-1MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/pt-141-10mg-bremelanotide/",
                "name": "PT-141 (Bremelanotide) (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/PT-141-10mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/selank-10mg/",
                "name": "Selank (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Selank-10MG-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "id": "51",
        "url": "https://www.corepeptides.com/peptides/peg-mgf-5mg/",
        "name": "PEG-MGF (5mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2020/04/PEG-MGF-5MG.jpg",
        "display_price": "$63.00",
        "display_specs": [
            "Size: 5mg Contents: PEG-MGF (5mg) Form: Lyophilized powder Purity: >99% SKU: P-PEGMGF-5",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$59.85"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$56.70"
            }
        ],
        "description": [
            {
                "h2": "PEG-MGF Peptide"
            },
            {
                "p": "MGF is an acronym for Mechano Growth Factor, a research peptide that scientists consider to belong to the class of IGF-1 (insulin-like growth factor) family.(1) An isoform of IGF-1, MGF is also known as IGF-1Ec, and is believed to primarily be produced in the liver.(2) The IGF-1 gene appears to undergo transcription and may generate the three mRNA isoforms: IGF-1Ea, IGF-1Eb, and IGF-1Ec. This indicates that MGF (or IGF-1Ec) may be identical to IGF-1 but with a different E domain. Synthesis of each isoform appears to possess specific functions in different tissues as a response to diverse stimuli."
            },
            {
                "p": "PEG-MGF, or polyethylene glycol (PEG)-ylated MGF, is a synthetic form of MGF. Pegylation connects polyethylene glycol (PEG) to another compound to alter its structure. Scientists consider that MGF by itself may have a short half-life; however, once bound with PEG, the half-life may be extended by some days."
            },
            {
                "p": "Research studies posit that PEG IGF-1 may be more impactful than recombinant IGF-1 for muscle cell regeneration and improving muscle function. The main reasoning was attributed to the hypothesis that PEG may not easily bind with any other compounds, and may thereby lead to delayed clearance. In addition, modifying the C terminus of IGF-1 with the addition of PEG may increase the peptide's potential impact on tissues.(3)"
            },
            {
                "h3": "Overview"
            },
            {
                "p": "Researchers suggested the existence of three IGF-1 precursor proteins formed upon the splicing of the mature IGF-1. Each precursor comprises 70 amino acid residues from the mature IGF-1, and may only differ in the amino acid sequence attached to the COOH terminal, possibly determining its function. During the late 1990s and early 2000s, it was suggested that one of the three precursors, IGF-1EC (MGF), may increase upon muscle injury.(4)"
            },
            {
                "p": "Several studies have been carried out thereafter(3) to isolate and synthesize the (PEG)-ylated MGF to modify and potentially improve the impact and action of the peptide. The studies have suggested that under muscle stress the mature IGF-1 may become spliced as a response to stress and may thereby produce and release one of the isoforms called IGF-1EC, also known as Mechano Growth Factor (MGF).(4)"
            },
            {
                "p": "One research hypothesis suggests that as MGF increases, the amino acid sequence attached to the COOH terminal of MGF may become activated and promote cell proliferation in muscle stem cells. Further studies indicated that PEG-MGF may stimulate the proliferation of C2C12 muscle cells and myoblasts upon presentation. Based on these results, it was suggested that the MGF peptide may be biologically active and inert by nature. PEG-MGF may induce stronger, more durable action of normal MGF."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C121H200N42O39 Molecular Weight: N/A Other Known Titles: PEG-MGF-E, PEG-MGF-Ct24E"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "PEG-MGF Peptide and Muscle Structure"
            },
            {
                "p": "Muscle resistance activity seems to activate mechano-growth factor (MGF) mRNA in muscle tissues, which researchers suggest manifests as a substantial 163% rise from baseline levels.(5) This pronounced increase suggests a potentially direct response of MGF to mechanical stimuli within the muscles. Concurrently, an observed surge in growth hormone levels, which typically accompanies muscle resistance, may add complexity to this molecular interplay. Data suggests a 456% augmentation in MGF mRNA coinciding with resistance activities, whereas an increase in growth hormone levels alone appears to influence MGF mRNA expression by about 80% compared to baseline. The scientists commented “This may reflect an overall up-regulation of transcription of the IGF-I gene prior to splicing.” Consequently, it is hypothesized that MGF may play a critical role in the organism’s intrinsic mechanism to mitigate muscle damage and promote tissue repair in response to mechanical stress. This hypothesis underscores the intricate and coordinated molecular responses triggered by physical exertion, reflecting a sophisticated biological adaptation to preserve muscle integrity and function."
            },
            {
                "p": "To further investigate this, a study(6) was conducted to examine the potential of MGF on muscle repair and wound healing. Experimental murine models induced with muscle contusion and muscular macrophage depletion were used as study subjects. Based on comprehensive analyses following the study, the researchers theorized that MGF might induce muscular repair in the wounded tissues. MGF appeared to decline the rate of fibrosis in the contused muscles and reduced the expressions of inflammatory cytokines, chemokines, and stress factors. Preliminary analyses indicated that MGF might affect fibrosis in damaged muscle tissue through the likely suppression of collagen types I and III expression. These collagens are considered essential components of the extracellular matrix involved in fibrotic processes. Additionally, there appeared to be a noticeable decrease in oxidative stress markers and matrix metalloproteinases (MMPs), which might suggest that MGF may attenuate certain inflammatory processes associated with muscle injury. Moreover, the prevalence of contused muscles seemed to decrease, potentially facilitating the repair mechanisms in the injured tissues. The investigation also proposed that MGF's influence on the functional dynamics of satellite cells post-injury and immune cell presence at the injury site—both deemed critical to muscle regeneration—might be minimal. This proposition is based on the stable expression levels of MyoD and myogenin, which are considered to be pivotal markers of satellite cell proliferation and differentiation, respectively. Therefore, while MGF may alleviate some facets of the muscle injury response, its direct impact on satellite cell functionality in these specific circumstances may not definitively be established. The study further suggested that MGF might modify the inflammatory environment within the injured muscle tissue. This modulation is tentatively evidenced by a reported decrease in the expression of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α), interferon-gamma (IFN-γ), interleukin-1 beta (IL-1β), and transforming growth factor-beta (TGF-β), alongside chemokines like CCL2, CCL5, and CXCR4 following MGF experimentation. Additionally, there was a speculative indication that MGF might help mitigate oxidative stress in injured muscles, as suggested by a possible reduction in the expression of gp91phox, an element of NADPH oxidase that appears to play a significant role in the generation of reactive oxygen species."
            },
            {
                "h3": "PEG-MGF Peptide and Cardioprotection"
            },
            {
                "p": "The main goal of this study(7) was to evaluate the potential of MGF action on cardiac muscles undergoing programmed cell death following hypoxia, a condition characterized by limited supply of oxygen. Rats were experimentally induced with hypoxia with only 1% oxygen supply, leading to cellular apoptosis. Once the peptide was given to the rat models, the study reported that the peptide appeared to induce increased migration of stem cells to the heart, possibly leading to apoptosis inhibition. More specifically, MGF is suggested to potentially enhance the migration of mesenchymal stem cells (hMSCs). This process suggests a chemotactic action, which may be strategically employed to guide stem cells to areas affected by injury or disease. The basis for this proposition stems from apparent increases in the levels of the Bcl-2 gene, which is believed to play a critical role in enhancing cell survival, thus suggesting that MGF may possess qualities that inhibit apoptotic processes in cells. This observation underscores the possibility of MGF as a potential agent in enhancing tissue regeneration by modulating cellular mechanisms that may prevent programmed cell death."
            },
            {
                "h3": "PEG-MGF Peptide and Bone Fracture"
            },
            {
                "p": "The main goal of this study(8) was to evaluate the potential of MGF on bone injury. 27 rabbits were experimentally induced with a 5-mm bone defect and were then divided into three groups that were given MGF, or a control substance for 5 consecutive days. Post-trial, when the bone tissues were histologically examined, the researchers reported that the control tissue appeared to be the least healed, whereas the bone tissue with MGF appeared to be the most healed. Comparatively, MGF-exposed tissues also exhibited a superior healing process relative to those exposed to Insulin-like Growth Factor 1 (IGF-1), suggesting that MGF may interact with cellular processes in a distinct manner from IGF-1. Further insights from the study suggest that MGF might influence the cell cycle by potentially halting it at specific stages, and it may also activate the Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase 1/2 (MAPK-Erk1/2) signaling pathway. These mechanisms indicate that MGF might employ a multifaceted strategy to enhance cell proliferation, which likely involves altering cell cycle progression and triggering particular molecular pathways crucial for cellular repair and regeneration. This nuanced approach underscores MGF's potentially complex and targeted action in bone healing models."
            },
            {
                "h3": "PEG-MGF Peptide and Neuroprotection"
            },
            {
                "p": "Several studies(9) were conducted on mice who were experimented on in order to increase the levels of MGF and thereby study the action of increased MGF concentration on their brain cells. One study included the breeding of mice to constitutively overproduce MGF in the hippocampus area of the brain. The hippocampus is considered primarily responsible for regulating the neurogenesis phenomenon in the body. This overproduction of MGF appeared to result in high concentrations of BrdU, a biological marker representative of proliferative action. Another study was conducted where mice were bred to conditional MGF production at 1, 3, and 12 months old. Behavioral analysis and biological responses were examined after 2 years. These mice were reported to exhibit elevated levels of BrdU and neurogenesis."
            },
            {
                "h3": "MGF Peptide and Muscle Tissue Hypertrophy"
            },
            {
                "p": "The main aim of one pivotal study on MGF(10) was to assess its potential on muscle cells of varying ages. In this study, muscle cell cultures, from neonatal to aged stages, underwent evaluation after being exposed to MGF. It was observed that in younger cells, MGF seemed to postpone the onset of cellular senescence, which is the gradual deterioration of cellular function. This delay suggests that MGF might be able to maintain muscle function and its regenerative properties, which typically decline with age. Additionally, the study noted an enhancement in cell proliferation among cells ranging from neonatal to young; however, such proliferation did not appear to extend to the older aged cells. In these older cells, there was a noticeable increase in muscle hypertrophy, characterized by an augmented muscle cell size. Yet, there was a marked reduction in the number of reserve cells. These reserve cells, which typically do not immediately differentiate or amalgamate into myotubes, were apparently at a reduced proportion in the culture. Myotubes, crucial structures in muscle development, are formed through the fusion of muscle cells. This fusion process was apparently enhanced across all age groups by MGF, which not only increased the myotube size but potentially also the muscle’s functional capabilities through the augmented expression of muscle-specific contractile proteins. This observation is significant as it implicates a reduced presence of reserve cells, suggesting that MGF might encourage these cells to participate more actively in muscle formation. In conclusion, the researchers posited that “MGF-24aa-E peptide alone has a marked ability to enhance satellite cell activation, proliferation and fusion for muscle repair and maintenance.”"
            },
            {
                "p": "PEG-MGF is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Philippou A, Papageorgiou E, Bogdanis G, Halapas A, Sourla A, Maridaki M, Pissimissis N, Koutsilieris M. Expression of IGF-1 isoforms after exercise-induced muscle damage in humans: characterization of the MGF E peptide actions in vitro. In Vivo. 2009 Jul-Aug;23(4):567-75. https://pubmed.ncbi.nlm.nih.gov/19567392/",
                    "Zabłocka, B., Goldspink, P. H., Goldspink, G., & Górecki, D. C. (2012). Mechano-Growth Factor: an important cog or a loose screw in the repair machinery? Frontiers in endocrinology, 3, 131. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3485521/",
                    "Janssen, J. A., Hofland, L. J., Strasburger, C. J., van den Dungen, E. S., & Thevis, M. (2016). Potency of Full-Length MGF to Induce Maximal Activation of the IGF-I R Is Similar to Recombinant Human IGF-I at High Equimolar Concentrations. PloS one, 11(3), e0150453. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4798685/",
                    "Rotwein P. (2014). Editorial: the fall of mechanogrowth factor?. Molecular endocrinology (Baltimore, Md.), 28(2), 155–156. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3896639/",
                    "Hameed M, Lange KH, Andersen JL, Schjerling P, Kjaer M, Harridge SD, Goldspink G. The effect of recombinant human growth hormone and resistance training on IGF-I mRNA expression in the muscles of elderly men. J Physiol. 2004 Feb 15;555(Pt 1):231-40. doi: 10.1113/jphysiol.2003.051722. Epub 2003 Oct 17. PMID: 14565994; PMCID: PMC1664832.",
                    "Liu X, Zeng Z, Zhao L, Chen P, Xiao W. Impaired Skeletal Muscle Regeneration Induced by Macrophage Depletion Could Be Partly Ameliorated by MGF Injection. Front Physiol. 2019 May 17;10:601. https://pubmed.ncbi.nlm.nih.gov/31164836/",
                    "Doroudian G, Pinney J, Ayala P, Los T, Desai TA, Russell B. Sustained delivery of MGF peptide from microrods attracts stem cells and reduces apoptosis of myocytes. Biomed Microdevices. 2014 Oct;16(5):705-15. https://pubmed.ncbi.nlm.nih.gov/24908137/",
                    "Deng M, Zhang B, Wang K, Liu F, Xiao H, Zhao J, Liu P, Li Y, Lin F, Wang Y. Mechano growth factor E peptide promotes osteoblasts proliferation and bone-defect healing in rabbits. Int Orthop. 2011 Jul;35(7):1099-106. https://pubmed.ncbi.nlm.nih.gov/21057789/",
                    "Alec Walker. Hearts and Minds of Mice and Men: Mechano Growth Factor a new tool in the battle against age-related neuron loss? 20 Jul 2017.",
                    "Kandalla PK, Goldspink G, Butler-Browne G, Mouly V. Mechano Growth Factor E peptide (MGF-E), derived from an isoform of IGF-1, activates human muscle progenitor cells and induces an increase in their fusion potential at different ages. Mech Ageing Dev. 2011 Apr. https://pubmed.ncbi.nlm.nih.gov/21354439/"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/12/PEG-MGF-COA.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/12/PEG-MGF-LC.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/12/PEG-MGF-MS.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "PEG-MGF for sale online (5mg). Peptides for sale at 99% purity with top customer service. Get Peg Mgf research study results, benefits, and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "PEG-MGF For Sale (5mg) | Core Peptides",
            "og:description": "PEG-MGF for sale online (5mg). Peptides for sale at 99% purity with top customer service. Get Peg Mgf research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/peg-mgf-5mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-24T15:55:08+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/PEG-MGF-5MG.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "PEG-MGF For Sale (5mg) | Core Peptides",
            "twitter:description": "PEG-MGF for sale online (5mg). Peptides for sale at 99% purity with top customer service. Get Peg Mgf research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/PEG-MGF-5MG.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$63.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "63.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-PEGMGF-5",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/bpc-157/",
                "name": "BPC-157 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/BPC-157-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/melanotan-1-10mg/",
                "name": "Melanotan 1 (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Melanotan-1-10MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/mgf-5mg/",
                "name": "MGF (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/MGF-5MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/cjc-1295-no-dac-mod-grf-1-29/",
                "name": "CJC-1295 NO DAC (Mod GRF 1-29) (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Mod-GRF-1-29-5mg-300x300.jpg.webp",
                "price": ""
            }
        ]
    },
    {
        "id": "52",
        "url": "https://www.corepeptides.com/peptides/pe-22-28-8mg/",
        "name": "PE-22-28 (8mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2022/04/PE-22-28-8mg.jpg",
        "display_price": "$54.00",
        "display_specs": [
            "Size: 8mg Contents: PE-22-28 (8mg) Form: Lyophilized powder Purity: >99% SKU: P-PE2228-8",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$51.30"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$48.60"
            }
        ],
        "description": [
            {
                "h2": "PE-22-28 Peptide"
            },
            {
                "p": "PE-22-28 is a synthetic derivative of the naturally occurring protein called spadin.(1) Spadin is a natural peptide derived from sortilin, an abundant protein in the central nervous system. PE-22-28 peptide is one such shortened peptide derivative of this protein; similar to spadin, PE-22-28 research indicates it primarily acts via the TREK-1 receptor. Researchers Djillani et al. commented that PE-22–28 may be \"the shortest, most efficient sequence capable of blocking the TREK-1 channel\" and may have a potentially higher potency in research settings than spadin.(2)"
            },
            {
                "p": "TREK-1 (TWIK-related potassium channel) receptor is a two-pore potassium channel recently identified as a potential target for studying and modifying animal models of depression. In 2010, research(3) suggested that when TREK-1 receptors were removed from murine models, they became more resistant to depression. TREK-1 receptor is primarily found in the brain region, including the prefrontal cortex and hippocampus, i.e., areas governing mood, memory, and learning. Simulating the TREK-1 receptor may reduce neuron excitability, whereas reducing the receptor activity may increase neuron excitability.(4) While mainly evaluated in the study of depression models, this receptor may also play a strong role in anesthesia, pain perception, and protection of neurons."
            },
            {
                "h3": "Overview"
            },
            {
                "p": "Studies(1) have suggested that naturally occurring spadin blocks the TREK-1 channel, possibly exerting antidepressant activity for a specific duration. In order to improve the compound’s bioavailability and stability, scientists conducted several studies on spadin derivatives and analogs. One such study(1) was conducted on the seven amino acid spadin derivatives called PE-22-28. More specifically, the peptide corresponds to the chain from the 22nd to 28th amino acids of the original spadin sequence; hence, the reason behind the name PE-22-28. Similar to spadin, researchers theorized that these synthetic derivatives might bind to the TREK-1 channel, blocking activity and thereby producing mind stability and mood enhancement."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C35H55N11O9 Molecular Weight: 773.89 g/mol Sequence: GVSWGLR"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "PE-22-28 Peptide and Depression"
            },
            {
                "p": "Researchers have suggested brain models of depression exhibit a smaller volume in the hippocampus. When presented with the PE-22-28 compound, the smaller volume may be increased and brought to an optimal threshold, potentially mitigating instances of synaptic feedback that lead to depressive episodes. Researchers propose that the peptide may have antidepressant potential through its proposed action in neurogenesis, which is supported by the cAMP signal cascade mechanism.(5)"
            },
            {
                "h3": "PE-22-28 Peptide and Post Stroke Depression (PSD)"
            },
            {
                "p": "A study(4) was conducted where the experimental mice, induced with PSD, were presented with either the spadin peptide, or an SSRI compound (selective serotonin reuptake inhibitors). An SSRI, as the name suggests, is an antidepressant that is considered to prevent the reabsorption of serotonin neurotransmitters. While both compounds reportedly exhibited improvements in the mice, SSRIs may induce a wide range of additional unintended impacts, while PE-22-28 peptide is hypothesized not to. The SSRI compound also reportedly took longer to exhibit any action while the peptide was apparently fast-acting."
            },
            {
                "h3": "PE-22-28 Peptide and Neurogenesis"
            },
            {
                "p": "Studies have suggested that the peptide may exert neurogenesis (formation of neurons) and synaptogenesis (formation of synapses). Studies(6) were conducted where spadin derivatives were exposed in neuron cultures of mouse tissues."
            },
            {
                "p": "One study conducted in 2010 indicated subsequent MAPK and PI3K pathway activation, which might lead to neuron protection and formation. The other study suggested the peptide's potential to increase mRNA expression and concentration of brain-derived neurotrophic factor (BDNF) in the hippocampus.The hippocampus is considered critical in learning and memory processes. Hence, studies suggest that PE-22-28 may exhibit nootropic potential via possible action in the hippocampus region. Over time, organisms may exhibit a decline or downregulation of transcription factor cAMP response element-binding protein (CREB) activity in the brain, i.e., cAMP response element binding activity. CREB is considered critical for the growth and formation of neurons and may support memory recall and neuronal plasticity.(7)"
            },
            {
                "p": "The findings of this 2010 study also suggested that spadin appeared to increase the number of bromodeoxyuridine (BrdU) positive cells in the hippocampus compared to saline-treated mice, hinting that PE-22-28, an analog of spadin, may potentially induce similar hippocampal neurogenesis. BrdU is considered a thymidine analog that integrates into the DNA of proliferating cells during the S-phase of the cell cycle, serving as a marker for cell division. Spadin apparently induced a rapid increase in BrdU-positive cells within 4 days, suggesting a quick activation of neurogenic pathways. This action persisted with long-term experimentation (15 days). As mentioned, a key component of spadin's rapid action might involve the activation of CREB, which may involve a specific link between CREB activation and hippocampal neurogenesis. The research analysis indicated that 4-day experimentation with spadin led to an apparent increase in phosphorylated CREB (pCREB), with levels four times higher than those seen in saline-treated controls. This phosphorylation suggests activation of CREB, confirmed by Western blot analysis showing the active form of CREB, while total CREB levels remained constant."
            },
            {
                "p": "Furthermore, the researchers observed a significant colocalization of pCREB with doublecortin (DCX), a marker of neuronal precursors, suggesting that CREB activation might be closely linked with the neurogenic process, specifically affecting neuronal rather than glial cells. These observations suggest that spadin, potentially through rapid CREB activation, may significantly enhance both the extent and speed of hippocampal neurogenesis, raising the possibility that PE-22-28 might similarly influence neurogenesis through these pathways.(3)"
            },
            {
                "h3": "PE-22-28 Peptide and Muscle Function"
            },
            {
                "p": "TREK-1 receptor is also considered to impact muscles' ability to respond to outer stimulation. Upon stimulation, this receptor reportedly induces relaxation of the muscles, and consequently, blocks the receptors may lead to muscle contraction. Based on this understanding of the receptor, the PE-22-28 peptide is involved in ongoing research to establish its correlation with muscle relaxation and contraction.(8)"
            },
            {
                "h3": "PE-22-28 Peptide and Serotonin Signaling"
            },
            {
                "p": "As mentioned, studies suggest that PE-22-28 may act as a blocker of the TREK-1 channel, akin to its natural analog spadin. This hypothesis is bolstered by research exploring these potential actions, particularly focusing on the connectivity between the medial prefrontal cortex (mPFC) and dorsal raphé serotonergic neurons in experimental models. The researchers observed that spadin might stimulate serotonin neurons and noted that the actions of spadin combined with serotonin agonists appeared additive, operating independently. Notably, adding a mGluR2/3 antagonist was suggested to inhibit the action of spadin, pointing towards a dependency of spadin on mPFC TREK-1 channels that are possibly linked to mGluR2/3 receptors. Consequently, it seems plausible that PE-22-28 may similarly interact with mGluR2/3 receptors, promoting the activation of serotonin neurons in a parallel fashion to spadin."
            },
            {
                "p": "Further investigations using immunohistochemical labeling revealed apparent interactions between spadin and the selective serotonin agonist RS 67333's actions on Zif268 expression in the dorsal raphé nucleus (DRN), indicating both additive and synergistic actions. Specifically, while individual concentrations of spadin or RS 67333 appeared to increase the number of Zif268-positive cells, their combination elevated these numbers dramatically, suggesting a strong depolarization of a subset of DRN neurons."
            },
            {
                "p": "Experiments involving the mGluR2/3 antagonist LY 341495 indicated that these may enhance the average firing rate of DRN serotonin neurons, a result that was abolished by an electrolytic lesion of the mPFC. This finding further implicates the mPFC TREK-1 channels linked to mGluR2/3 receptors regulating serotonin neuron activity. These observations are complemented by fluorescence microscopy studies using the ratiometric dye Fura2-AM to measure intracellular Ca2+ levels in cultured cortical neurons. The data posits that experiments combining spadin with LY 341495 or RS 67333 may increase intracellular Ca2+ levels compared to control or single exposures, with the most pronounced actions observed with the RS 67333 combination. This potentiation may be dependent on the stimulation of serotonin receptors, as blocking these receptors with GR 125487 appeared to eliminate the synergistic actions observed with RS 67333."
            },
            {
                "p": "Collectively, these findings underline a complex interplay between TREK-1 channel activity, mGluR2/3 receptor interaction, and serotonin neuron firing, mediated through the mPFC. The data suggest that spadin (and potentially PE-22-28 as a spadin-analog) may leverage these molecular mechanisms to influence serotonergic signaling, highlighting a nuanced interdependency between these pathways.(9) Indeed, scientists have theorized that by inhibiting TREK-1, PE-22–28 may increase serotonin transmission. They have commented that when “PE-22-28 is [presented to] the dorsal raphé nucleus, the peptide will block the channel and thereby activate the serotonergic neurons, resulting in the facilitation of serotonergic transmission”.(10)"
            },
            {
                "p": "PE-22-28 peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Djillani A, Pietri M, Moreno S, Heurteaux C, Mazella J, Borsotto M. Shortened Spadin Analogs Display Better TREK-1 Inhibition, In Vivo Stability and Antidepressant Activity. Front Pharmacol. 2017 Sep 12;8:643. https://pubmed.ncbi.nlm.nih.gov/28955242/",
                    "Djillani, A., Pietri, M., Mazella, J., Heurteaux, C., & Borsotto, M. (2019). Fighting against depression with TREK-1 blockers: Past and future. A focus on spadin. Pharmacology & therapeutics, 194, 185–198. https://doi.org/10.1016/j.pharmthera.2018.10.003",
                    "Mazella J, Pétrault O, Lucas G, Deval E, Béraud-Dufour S, Gandin C, El-Yacoubi M, Widmann C, Guyon A, Chevet E, Taouji S, Conductier G, Corinus A, Coppola T, Gobbi G, Nahon JL, Heurteaux C, Borsotto M. Spadin, a sortilin-derived peptide, targeting rodent TREK-1 channels: a new concept in the antidepressant drug design. PLoS Biol. 2010 Apr 13;8(4):e1000355. https://pubmed.ncbi.nlm.nih.gov/20405001/",
                    "Djillani, A., Mazella, J., Heurteaux, C., & Borsotto, M. (2019). Role of TREK-1 in Health and Disease, Focus on the Central Nervous System. Frontiers in pharmacology, 10, 379. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470294/",
                    "Duman, R., Nakagawa, S. & Malberg, J. Regulation of Adult Neurogenesis by Antidepressant Treatment. Neuropsychopharmacol 25, 836–844 (2001). https://doi.org/10.1016/S0893-133X(01)00358-X",
                    "Devader C, Khayachi A, Veyssière J, Moha Ou Maati H, Roulot M, Moreno S, Borsotto M, Martin S, Heurteaux C, Mazella J. In vitro and in vivo regulation of synaptogenesis by the novel antidepressant spadin. Br J Pharmacol. https://pubmed.ncbi.nlm.nih.gov/25598009/",
                    "Mental health: spadin, a fast-acting antidepressant. https://journals.biologists.com/dmm/article/3/7-8/398/2435/Mental-health-spadin-a-fast-acting-antidepressant",
                    "Lei Q, Pan XQ, Chang S, Malkowicz SB, Guzzo TJ, Malykhina AP. Response of the human detrusor to stretch is regulated by TREK-1, a two-pore-domain (K2P) mechano-gated potassium channel. J Physiol. 2014 Jul 15;592(14):3013-30. https://pubmed.ncbi.nlm.nih.gov/24801307",
                    "Moha ou Maati, Hamid et al. “The peptidic antidepressant spadin interacts with prefrontal 5-HT(4) and mGluR(2) receptors in the control of serotonergic function.” Brain structure & function vol. 221,1 (2016): 21-37. doi:10.1007/s00429-014-0890-x",
                    "Okada, Masayoshi, and Ernesto Ortiz. \"Viral vector-mediated expressions of venom peptides as novel gene therapy for anxiety and depression.\" Medical Hypotheses 166 (2022): 110910."
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/12/PE-22-28-COA.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/12/PE-22-28-LC.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/12/PE-22-28-MS.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "PE-22-28 peptide for sale online (8mg). Read research study results and information. Peptides for sale at 99% purity with top customer service.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "PE-22-28 For Sale (8mg) - Core Peptides",
            "og:description": "PE-22-28 peptide for sale online (8mg). Read research study results and information. Peptides for sale at 99% purity with top customer service.",
            "og:url": "https://www.corepeptides.com/peptides/pe-22-28-8mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T16:30:56+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2022/04/PE-22-28-8mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "PE-22-28 For Sale (8mg) - Core Peptides",
            "twitter:description": "PE-22-28 peptide for sale online (8mg). Read research study results and information. Peptides for sale at 99% purity with top customer service.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2022/04/PE-22-28-8mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$54.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:brand": "Core Peptides",
            "product:price:amount": "54.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-PE2228-8",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/receptor-grade-igf-1-lr3-100mcg/",
                "name": "Receptor Grade IGF-1 LR3 (100mcg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-100MCG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ipamorelin-5mg/",
                "name": "Ipamorelin (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Ipamorelin-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ghrp-6/",
                "name": "GHRP-6 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHRP-6-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ll-37-5mg/",
                "name": "LL-37 (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/LL-37-5mg-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "id": "53",
        "url": "https://www.corepeptides.com/peptides/pancragen-20mg/",
        "name": "Pancragen (20mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2023/10/Pancragen-Lys-Glu-Asp-Trp-20mg.jpg",
        "display_price": "$63.00",
        "display_specs": [
            "Size: 20mg Contents: Pancragen Form: Lyophilized powder Purity: >99% SKU: P-PANCRAGEN-20",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$59.85"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$56.70"
            }
        ],
        "description": [
            {
                "h2": "Pancragen Peptide"
            },
            {
                "p": "Pancragen is a tetrapeptide with the sequence Lys-Glu-Asp-Trp (KEDW). It is a synthetic structural analog of a peptide isolated from cattle pancreatic cells, which is posited to be a prospective peptide bioregulator for pancreatic function and aging-related metabolic problems. Pancragen has been suggested by researchers to act by penetrating cellular membranes and interacting with the nucleus and nucleolus. This suggests it could influence gene transcription associated with cell differentiation within the pancreatic cells. Key differentiation factors like Ptf1a, Pdx1, Pax6, Foxa2, Nkx2.2, and Pax4 are thought to play essential roles in the proper differentiation of pancreatic cells. Pancragen might up-regulate the expression of these factors, implying a positive action on the maturation of pancreatic cells. Pancragen may also influence the expression of molecules such as MMP2, MMP9, serotonin, CD79alpha, Mcl1, PCNA, and Ki67, suggesting it might boost the functional activity of pancreatic cells. Another mechanism may include a decrease in proapoptotic protein p53 and increase in antiapoptotic protein Mcl1 hinting at an antiapoptotic potential. Last but not least, Pancragen may influence aging biomarkers, reducing caspase-3 and cathepsin B activities and modulating levels of TNF-α and IGF-I. IGF-I, researched for its antiapoptotic actions, suggests that Pancragen's actions might be linked to metabolic correction and antiapoptotic mechanisms. Pancragen also seems to affect the methylation patterns of genes like PDX1, PAX6, and NGN3, which might mediate some of its anti-aging potential on the pancreatic cells."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular formula: C26H36N6O9 Molecular weight: 576.25 g/mol Sequence: Lys-Glu-Asp-Trp Other known titles: KEDW, DWa (amidate)"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "p": "In the information below, we have broken down the latest clinical and preclinical research on Pancragen’s potential as observed in various experimental models."
            },
            {
                "h3": "Pancragen and the Pancreas"
            },
            {
                "p": "The tetrapeptide Pancragen has been studied for its potential impact on pancreatic cells, particularly in relation to cell differentiation and the regulation of insulin and glucagon release, crucial elements in the pancreatic cells’ endocrine function. (1) Research posited that Pancragen might penetrate cellular membranes to interact with the nucleus and nucleolus, thereby possibly influencing the transcription of genes crucial for cellular differentiation within the pancreatic gland. Key differentiation factors such as Ptf1a, Pdx1, Pax6, Foxa2, Nkx2.2, and Pax4 are crucial for the proper functioning and differentiation of various pancreatic cell types. It is posited that Pancragen's interaction may potentially up-regulate the expression of these factors, which may play a role in the cellular maturation process of both acinar and islet cells in the pancreatic gland. The experiments conducted on embryonic cultures of pancreatic acinar cells in this study suggested that Pancragen might significantly enhance the expression of Ptf1a and Pdx1 proteins, which are known to be crucial for the maturation of acinar and islet cells. The study suggested that Pancragen's actions might be more pronounced in aged cultures, where an apparent decrease in the expression of these proteins is observed as a part of the cellular aging process. This potential up-regulation of key differentiation factors by Pancragen is posited to possibly lead to an increased differentiation of pancreatic cells, and, subsequently, may aid in restoring the functional activity of the pancreatic cells to a state akin to that observed in younger cell cultures. The researchers also posited that “transcription factors that regulate differentiation of pancreatic cells are a pharmacological target for Pancragen, which allows considering it as an effective tool in the treatment of diabetes mellitus and pancreatitis.”"
            },
            {
                "p": "Another research study using murine models to gauge the impact of Pancragen on the pancreas's functional morphology, also yielded interesting findings.(2) Initially, when DM was induced in murine models, there was a noted decrease in insulin-producing B cells and an uptick in glucagon-producing A cells. Such changes point to disrupted pancreatic cell functionality. However, upon exposure to Pancragen, potentially encouraging shifts were observed. Murine models showed evident compensatory changes in pancreatic cells and tissue. Specifically, Pancragen seemed to bolster insulin production from B cells while tempering glucagon production from A cells. Additionally, the proliferative activity of certain cells and their apoptosis seemed to normalize, closely resembling control murine models."
            },
            {
                "p": "Further research has also suggested that Pancragen might play a pivotal role in the modulation of various cellular markers and proteins associated with the vitality of pancreatic cells. When applied to aging pancreatic cells, there was an observed increase in the expression of matrix metalloproteinase MMP2 and MMP9, serotonin, glycoprotein CD79alpha, the antiapoptotic protein Mcl1, and proliferation markers PCNA and Ki67. Conversely, there was a decrease in the expression of the proapoptotic protein p53 in aged pancreatic cell cultures. From these observations, it can be posited that the tetrapeptide potentially holds the capability to activate the expression of signaling molecules that serve as markers of the functional activity of pancreatic cells.(3)"
            },
            {
                "h3": "Pancragen and Metabolic Problems"
            },
            {
                "p": "Studies have delved into the potential of Pancragen on metabolic problems in aged test subjects. For example, in one study, the focus was mainly on carbohydrate metabolism and the potential role Pancragen may play in regulating it.(4) The introduction of Pancragen was observed to significantly lower fasting glucose levels during a standard glucose tolerance test, alongside a reduction in insulin concentrations and the insulin resistance index. This suggests a potential utility of Pancragen in addressing the disturbances in carbohydrate metabolism, especially given the observed persistence of its glucose-lowering action post-exposure. It is critical to note that the study was focused on august test subjects, and the scope of Pancragen’s potential may be contingent on several other variables, including the severity of insulin resistance and other factors. The researchers also commented that “Administration of the tetrapeptide Pancragen is a promising approach to the correction of insulin resistance in elderly.”"
            },
            {
                "p": "Another study aimed to investigate the potential impact of Pancragen on the endocrine function of the pancreatic cells and the metabolic status of test models.(5) Aged test models used in this research were used to understand the potential of Pancragen in addressing age-related dysfunctions in the overall metabolism as well as the pancreatic islet apparatus. In older test models, there was a noted reduced rate of glucose utilization compared to younger counterparts. Moreover, higher insulin and C-peptide peaks were observed 5 and 15 minutes post-glucose introduction. However, when Pancragen was introduced per test model daily over 10 days, there was a marked improvement in the glucose utilization rate. This intervention also seemed to normalize the dynamics of plasma insulin and C-peptide in response to glucose. Intriguingly, the actions of Pancragen lingered, with some aspects of metabolic status and pancreatic cell function remaining improved even three weeks after the cessation of the trial."
            },
            {
                "p": "In a study examining the actions of Pancragen on endothelial function within the setting of chronic hyperglycemia using murine models, it was observed that the introduction of Pancragen may have potential role in restoring endothelial adhesive characteristics. (6) Restoring these endothelial adhesive characteristics is crucial because, in models of metabolic problems, proper endothelial function plays a vital role in blood flow regulation and preventing complications such as atherosclerosis. Deficiencies or abnormalities in endothelial adhesion may increase susceptibility to vascular damage, making this restoration a key target for averting it."
            },
            {
                "h3": "Pancragen and Aging"
            },
            {
                "p": "Pancragen has been posited as a possible bioregulator for adjusting metabolic problems associated with aging. To understand Pancragen's impact on aging, a study examined its potential on murine models across different age groups.(7) There was a noted decrease in certain aging biomarkers like caspase-3 and cathepsin B activities when Pancragen was introduced to the younger murine models. Interestingly, in the mature murine models, Pancragen application resulted in a significant reduction of TNF-α levels and an elevation in IGF-I, both of which are critical indicators related to aging and metabolic processes. The study also delved into a rapid experimental aging model by inducing diabetes mellitus in murine models. It was observed that Pancragen potentially normalized blood glucose levels, emphasizing its previously identified hypoglycemic properties. Furthermore, the presence of Pancragen might have suppressed certain apoptotic enzymatic components in the pancreatic cells, suggesting that its biological actions may be associated with both metabolic correction and antiapoptotic mechanisms. The actions of Pancragen on natural biological aging are potentially realized at the IGF-I level, known for its \"survival factor\" antiapoptotic actions. Moreover, the tetrapeptide's potential interaction with certain genes suggests that its influence might extend to the proteolytic processing level."
            },
            {
                "p": "According to another trial, Pancragen has been posited to tissue-specifically influence gene expression in pancreatic cell cultures.(8) The study suggests that variations in the methylation patterns of the PDX1, PAX6, and NGN3 gene promoter regions in pancreatic cells may be associated with aging and could potentially be the cause behind the alterations in their expression levels. This implies that long-standing changes in gene expression upon aging might be driven by modifications in these promoter methylation patterns. However, the expression levels of the PAX4 and FOXA2 genes in pancreatic cells seem to deviate during aging and in response to Pancragen, even when the methylation patterns of the PAX4 gene remain stable. Curiously, the FOXA2 gene's promoter region in pancreatic cells exhibited only a handful of methylated CpG sites, with their methylation levels being influenced by both cell culture aging and Pancragen. Yet, this did not correlate straightforwardly with changes in gene expression levels. This suggests that, despite the influence of Pancragen on certain gene methylation patterns, the exact relationship between methylation and gene expression may be intricate and possibly regulated by other, yet unidentified, mechanisms."
            },
            {
                "p": "Pancragen peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Khavinson, V. K.h, Durnova, A. O., Polyakova, V. O., Tolibova, G. H., Linkova, N. S., Kvetnoy, I. M., Kvetnaia, T. V., & Tarnovskaya, S. I. (2013). Effects of pancragen on the differentiation of pancreatic cells during their ageing. Bulletin of experimental biology and medicine, 154(4), 501–504. https://doi.org/10.1007/s10517-013-1987-6",
                    "Kvetnoi, I. M., Ryzhak, A. P., Kostyuchek, I. N., & Tafeev, Y. A. (2007). Effect of tetrapeptide pancragene on functional morphology of the pancreas in rats with experimental diabetes mellitus. Bulletin of experimental biology and medicine, 143(3), 368–371. https://doi.org/10.1007/s10517-007-0114-y",
                    "Khavinson, V. K.h, Sevost'ianova, N. N., Durnova, A. O., Lin'kova, N. S., Tarnovskaia, S. I., Dudkov, A. V., & Kvetnaia, T. V. (2012). Advances in gerontology = Uspekhi gerontologii, 25(4), 680–684.",
                    "Korkushko, O. V., Khavinson, V. K.h, Shatilo, V. B., Antonyk-Sheglova, I. A., & Bondarenko, E. V. (2011). Prospects of using pancragen for correction of metabolic disorders in elderly people. Bulletin of experimental biology and medicine, 151(4), 454–456. https://doi.org/10.1007/s10517-011-1354-4",
                    "Goncharova, N. D., Ivanova, L. G., Oganyan, T. E., Vengerin, A. A., & Khavinson, V. K. (2015). Advances in gerontology = Uspekhi gerontologii, 28(3), 579–585.",
                    "Khavinson, V. K.h, Gavrisheva, N. A., Malinin, V. V., Chefu, S. G., & Trofimov, E. L. (2007). Effect of pancragen on blood glucose level, capillary permeability and adhesion in rats with experimental diabetes mellitus. Bulletin of experimental biology and medicine, 144(4), 559–562. https://doi.org/10.1007/s10517-007-0377-3",
                    "Khavinson, V. K.h, Gapparov, M. M., Sharanova, N. E., Vasilyev, A. V., & Ryzhak, G. A. (2010). Study of biological activity of Lys-Glu-Asp-Trp-NH2 endogenous tetrapeptide. Bulletin of experimental biology and medicine, 149(3), 351–353. https://doi.org/10.1007/s10517-010-0944-x",
                    "Ashapkin, V. V., Linkova, N. S., Khavinson, V. K.h, & Vanyushin, B. F. (2015). Epigenetic mechanisms of peptidergic regulation of gene expression during aging of human cells. Biochemistry. Biokhimiia, 80(3), 310–322. https://doi.org/10.1134/S0006297915030062"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "",
        "high_performance_liquid_chromatography": "",
        "mass_spectrometry": "",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Pancragen for sale online (20mg). Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Pancragen for Sale (20mg) - Core Peptides",
            "og:description": "Pancragen for sale online (20mg). Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/pancragen-20mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-17T18:37:08+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2023/10/Pancragen-Lys-Glu-Asp-Trp-20mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Pancragen For Sale (20mg) - Core Peptides",
            "twitter:description": "Pancragen for sale online (20mg). Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2023/10/Pancragen-Lys-Glu-Asp-Trp-20mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$63.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:brand": "Core Peptides",
            "product:price:amount": "63.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-PANCRAGEN-20",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/oxytocin-10mg/",
                "name": "Oxytocin (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Oxytocin-10mg-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/cjc-1295-dac-5mg/",
                "name": "CJC-1295 DAC (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/CJC-1295-DAC-5MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/selank-10mg/",
                "name": "Selank (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Selank-10MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/bpc-157/",
                "name": "BPC-157 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/BPC-157-300x300.jpg.webp",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/palmitoyl-tetrapeptide-7-topical-200mg/",
        "name": "Palmitoyl Tetrapeptide-7 (200mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2023/04/Palmitoyl-Tetrapeptide-7-200MG-1.jpg",
        "display_price": "$197.00",
        "display_specs": [
            "Size: 200mg Contents: Palmitoyl Tetrapeptide-7 Form: Lyophilized powder Purity: >99% SKU: P-PAL-TETRA-7",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$187.15"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$177.30"
            }
        ],
        "description": [
            {
                "h2": "Palmitoyl Tetrapeptide-7"
            },
            {
                "p": "Palmitoyl Tetrapeptide-7 is a small peptide composed of four amino acids: palmitoyl, glycine, glutamine, and arginine.(1) It is a synthetic peptide analog of the natural matrikine peptide, which is considered to play a vital role in regulating extracellular matrix (ECM) turnover and other related cellular activities."
            },
            {
                "p": "Initial research suggests that the Palmitoyl Tetrapeptide-7 peptide may stimulate the synthesis of ECM components, such as collagen and elastin, and may inhibit the production of pro-inflammatory cytokines. It has also been hypothesized to modulate gene expression involved in ECM remodeling, cell proliferation, and inflammation.(2)"
            },
            {
                "p": "Moreover, Palmitoyl Tetrapeptide-7 may function by suppressing the activity of interleukin-6 (IL-6), a pro-inflammatory cytokine that plays a role in the apoptosis of skin cells (cell aging and death) and inflammation. IL-6 secretion is considered to increase with time, leading to the degradation of the ECM, and resulting in a loss of flexibility and structural integrity in the skin barrier."
            },
            {
                "h3": "Chemical Makeup(1)"
            },
            {
                "p": "Molecular Formula: C34H62N8O7 Molecular Weight: 694.9 g/mol Other Known Titles: Pal-Gly-Gln-Pro-Arg-OH, N-Palmitoylrigin , Palmitoyl-GQPR, Rigin"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Palmitoyl Tetrapeptide-7 Mechanism of Action"
            },
            {
                "p": "Based on animal studies, Palmitoyl Tetrapeptide-7 has been suggested to potentially inhibit the activity of matrix metalloproteinases (MMPs) in animal models.(3) MMPs are a group of enzymes that may degrade ECM proteins during normal tissue growth. By downregulating MMP activity, Palmitoyl Tetrapeptide-7 may prevent ECM damage and may allow cells to restore and maintain the ECM. More specifically, the peptide might stimulate the production of key components of the skin's extracellular matrix, such as laminin IV and V as well as collagen VII. Laminins may be essential for the structural stability and integrity of the basement membrane, while collagen VII is considered critical in anchoring fibrils that connect the dermis to the epidermis. By potentially enhancing the production of these molecules, Palmitoyl Tetrapeptide-7 might contribute to the maintenance and repair of the skin barrier, thereby improving skin tissue resilience. The peptide is also thought to potentially decrease IL-6 secretion, a cytokine that is believed to play a pivotal role in promoting inflammation. By possibly reducing the levels of IL-6, Palmitoyl Tetrapeptide-7 may act to diminish inflammation, particularly following UVB exposure, which is considered to trigger inflammatory responses in the skin.(4)"
            },
            {
                "h3": "Palmitoyl Tetrapeptide-7 and Oral Conditions"
            },
            {
                "p": "Given the inhibitory potential of the peptide on matrix metalloproteinases (MMPs), research teams have thought to examine the potential action of Palmitoyl Tetrapeptide-7 in mitigating the symptoms of certain oral conditions. MMPs enzymes may break down extracellular matrix (ECM) proteins, including those in the oral cavity. While these enzymes are considered to play a role in various physiological and pathological processes, including tissue repair, wound healing, and inflammation, excessive MMP activity might result in tissue damage and may cause various oral diseases, such as periodontitis, caries, and oral cancer. Studies have also suggested that MMP activity may be upregulated in some oral conditions, including periodontitis, characterized by the destruction of periodontal tissues. The possible inhibition of MMP activity by Palmitoyl Tetrapeptide-7 might potentially prevent or slow the progression of periodontitis (and other oral ailments) by preserving the integrity of the ECM.(3)"
            },
            {
                "h3": "Palmitoyl Tetrapeptide-7 and Skin Damage"
            },
            {
                "p": "Studies suggest that the peptide may stimulate the synthesis of collagen, a key component of the extracellular matrix in the skin, and may produce anti-inflammatory action, which might reduce damage caused by environmental factors such as UV radiation and pollution."
            },
            {
                "p": "Research has suggested that combining Palmitoyl Tetrapeptide-7 with Palmitoyl Oligopeptide (Matrixyl 3000) may synergistically stimulate collagen production and reduce inflammation. This synergy, which the study describes as \"dramatic,\" may help improve skin texture and reduce the depth and length of wrinkling that may occur along the stratum corneum of the epidermal barrier.(5)"
            },
            {
                "p": "According to the studies, “Matrixyl 3000 is a synergistic combination of two skin-active peptides, Palmitoyl oligopeptide and Palmitoyl-tetrapeptide-7, which appears promising based on the preliminary data from the manufacturer… However, it remains to be proven effective by independent published clinical studies.”"
            },
            {
                "p": "As discussed, Palmitoyl Tetrapeptide-7 may be particularly targeting stimulation of collagen type VII.(4) Collagen type VII is posited to be a vital component of the skin tissues' architecture, primarily contributing to the stability and structural integrity of the dermal-epidermal junction. It is thought to play a key role in anchoring fibrils that connect the outer epidermis to the deeper dermis. This specific collagen might form a crucial part of the basement membrane, potentially serving as a scaffold that maintains the structural cohesion between these skin layers. The presence and functionality of collagen type VII are considered essential for the prevention of blistering disorders, which occur when there is a breakdown in this connection between the dermis and epidermis. Moreover, collagen type VII may also play a role in skin tissue healing. This type of collagen could be critical in skin recovery and repair by possibly facilitating the reattachment of the epidermis to the underlying tissue after an injury. It is posited that enhancing the synthesis of collagen VII might improve wound healing outcomes, particularly in environments compromised by age or dermal afflictions."
            },
            {
                "h3": "Palmitoyl Tetrapeptide-7 and Wrinkle Depth"
            },
            {
                "p": "The peptide, sometimes classified as an “anti-aging” compound, is so named due to its perceived potential action and enhancement of integral protein production within the skin, as discussed above. In a randomized, double-blind, placebo-controlled clinical study, 20 research models were presented with a cream containing Palmitoyl Tetrapeptide-7 for 12 weeks. The cream was applied twice daily to observable wrinkles along the skin."
            },
            {
                "p": "At the end of the study period, the researchers reported that the cream containing Palmitoyl Tetrapeptide-7 appeared to have reduced the depth and length of the wrinkles compared to the placebo cream.(6) The researchers also observed an apparently significant increase in skin elasticity in the group that received the Palmitoyl Tetrapeptide-7 cream."
            },
            {
                "p": "In another study, 20 research models were exposed to the peptide compound twice a day for four weeks, and instrumental measurements were taken to assess the improvement of biomarkers of cell aging and ECM decline. The study reported an apparent reduction in fine wrinkles by 5.97% after two weeks and 14.07% after four weeks, and a reported increase in skin elasticity by 6.81% after two weeks, and 8.79% after four weeks. Dermal density was reportedly increased by 16.74% after two weeks, and 27.63% after four weeks.(7)"
            },
            {
                "p": "Palmitoyl Tetrapeptide-7 is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References"
            },
            {
                "references": [
                    "National Center for Biotechnology Information (2023). PubChem Compound Summary for CID 10078408, Palmitoyl tetrapeptide-7.",
                    "Mondon P, Hillion M, Peschard O, Andre N, Marchand T, Doridot E, Feuilloley MG, Pionneau C, Chardonnet S. Evaluation of dermal extracellular matrix and epidermal-dermal junction modifications using matrix-assisted laser desorption/ionization mass spectrometric imaging, in vivo reflectance confocal microscopy, echography, and histology: effect of age and peptide applications. J Cosmet Dermatol. 2015 Jun;14(2):152-60. doi: 10.1111/jocd.12135. Epub 2015 Mar 27. PMID: 25817264. https://pubmed.ncbi.nlm.nih.gov/25817264/",
                    "Sorsa T, Tjäderhane L, Salo T. Matrix metalloproteinases (MMPs) in oral diseases. Oral Dis. 2004 Nov;10(6):311-8. doi: 10.1111/j.1601-0825.2004.01038.x. PMID: 15533204. https://pubmed.ncbi.nlm.nih.gov/15533204/",
                    "Resende, Diana I S P et al. “Usage of Synthetic Peptides in Cosmetics for Sensitive Skin.” Pharmaceuticals (Basel, Switzerland) vol. 14,8 702. 21 Jul. 2021, doi:10.3390/ph14080702",
                    "Matrixyl 3000 (palmitoyl oligopeptide & palmitoyl tetrapeptide-7): Back to the future of skin care.",
                    "Marta Salvador-Ferreira et al. Trending Anti-Aging Peptides. MDPI Journal, Vol 7, Issue 4. https://www.mdpi.com/2079-9284/7/4/91",
                    "Hahn Hyung Jin et al. Instrumental evaluation of anti‑aging effects of cosmetic formulations containing palmitoyl peptides, Silybum marianum seed oil, vitamin E and other functional ingredients on aged human skin, Experimental and Therapeutic Medicine, Jun 2016."
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "",
        "high_performance_liquid_chromatography": "",
        "mass_spectrometry": "",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Palmitoyl Tetrapeptide-7 for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Palmitoyl Tetrapeptide-7 For Sale (200mg) | Core Peptides",
            "og:description": "Palmitoyl Tetrapeptide-7 for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:url": "https://www.corepeptides.com/peptides/palmitoyl-tetrapeptide-7-topical-200mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-05-20T21:48:24+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2023/04/Palmitoyl-Tetrapeptide-7-200MG-1.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Palmitoyl Tetrapeptide-7 For Sale (200mg) | Core Peptides",
            "twitter:description": "Palmitoyl Tetrapeptide-7 for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2023/04/Palmitoyl-Tetrapeptide-7-200MG-1.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$197.00",
            "twitter:label2": "Availability",
            "twitter:data2": "Out of stock",
            "product:price:amount": "197.00",
            "product:price:currency": "USD",
            "og:availability": "out of stock",
            "product:availability": "out of stock",
            "product:retailer_item_id": "P-PAL-TETRA-7",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/pt-141-10mg-bremelanotide/",
                "name": "PT-141 (Bremelanotide) (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/PT-141-10mg-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/dsip-5mg/",
                "name": "DSIP (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/DSIP-5MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/receptor-grade-igf-1-lr3-1mg/",
                "name": "Receptor Grade IGF-1 LR3 (1mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-1MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/melanotan-1-10mg/",
                "name": "Melanotan 1 (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Melanotan-1-10MG-300x300.jpg.webp",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/pal-ghk-topical-200mg/",
        "name": "Pal-GHK (200mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2023/05/PAL-GHK-200mg.jpg",
        "display_price": "$176.00",
        "display_specs": [
            "Size: 200mg Contents: Pal-GHK Form: Lyophilized powder Purity: >99% SKU: P-PAL-GHK",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$167.20"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$158.40"
            }
        ],
        "description": [
            {
                "h2": "Pal-GHK Peptide"
            },
            {
                "p": "Palmitoyl-GHK, also known as palmitoyl-tripeptide-1, is a synthetic hybrid molecule consisting of a chain of three amino acids attached to a palmitic acid molecule. The GHK sequence, which consists of the amino acids Gly-His-Lys, is found naturally in plasma, discovered in 1973 by Pickart et al.(1) The addition of palmitoyl to the molecule is thought to result in better penetration through the stratum corneum of the epidermal barrier.(2) The palmitoyl group, which is a fatty acid chain, is thought to increase lipophilicity, which may potentially enhance the compatibility of the molecule with the lipid-rich environment of the stratum corneum. The added palmitoyl group might also act as a penetration enhancer by disrupting the tightly packed lipid structure of the stratum corneum. This disruption could temporarily loosen the lipid matrix, allowing Pal-GHK and other agents to permeate through various skin tissue models."
            },
            {
                "p": "Researchers have suggested that Pal-GHK may stimulate collagen production, a key component of the skin's extracellular matrix (ECM). This hypothesis was initially developed because the Gly-His-Lys sequence is also a structural fragment of the protein collagen. Gly-His-Lys is believed to be released during collagen hydrolysis, typically induced in tissue repair and to mitigate inflammation. Therefore, the tripeptide is believed to act as a natural feedback signal to fibroblasts, the cells responsible for producing collagen and other ECM components."
            },
            {
                "p": "Pal-GHK may also exhibit antioxidant potential against damage caused by free radicals. Free radicals are unstable molecules that may damage cell structures and are considered to contribute to the aging process. By potentially neutralizing free radicals, Palmitoyl-GHK may reduce cellular aging and inflammation."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular formula: C30H54N6O5 Molecular weight: 578.8 g/mol Other Known Titles: Palmitoyl Tripeptide-1, Palmitoyl oligopeptide, Biopeptide-CL"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Pal-GHK and Collagen Synthesis"
            },
            {
                "p": "Research by Maquart et al. dating back to 1988 and published in the journal FEBS Letters suggests that the Gly-His-Lys in Pal-GHK is a fragment produced during the hydrolysis of collagen.(3) Such fragments are produced when collagen is damaged, and they may signal fibroblasts to initiate the process of collagen synthesis. Pal-GHK may have a similar potential to stimulate collagen, elastin, and glycosaminoglycans, important components of the extracellular matrix of the skin. The researchers concluded, \"The presence of a GHK triplet in the alpha 2(I) chain of type I collagen suggests that the tripeptide might be liberated by proteases at the site of a wound and exert in situ healing effects.\""
            },
            {
                "p": "A placebo-controlled clinical study suggests that Pal-GHK may stimulate collagen synthesis, as concluded following the assessment of the apparent effect of the peptide on skin thickness. The trial involved twenty-three subjects, and the researchers reported a small but statistically significant increase in skin thickness of about 4% compared to the placebo.(5)"
            },
            {
                "h3": "Pal-GHK and Wrinkle Depth"
            },
            {
                "p": "A clinical study was conducted to ascertain the peptide’s potential in reducing the depth and length of wrinkles along the stratum corneum. The study evaluated the action of the peptide in a cream form (6) and included fifteen subjects. The scientists reported an apparent reduction in wrinkle length, depth, and texture inconsistency (roughness) following the study period."
            },
            {
                "p": "Another clinical experiment involved a combination of Pal-GHK tripeptide and another palmitoylated peptide called Pal-GQPR.(7) Pal-GQPR is a tetrapeptide with the sequence of Pal-Gly-Gln-Pro-Arg, and it is a fragment of immunoglobulin G (IgG) which is considered to play an important role in reducing the amount of interleukin 6 (IL6) production. The design was a blind, randomized clinical study that included twenty-eight subjects. There was an apparent reduction of wrinkle depth, volume, density, texture inconsistency, and the area occupied by deep wrinkles following exposure to the combination of the two palmitoylated peptides."
            },
            {
                "h3": "Pal-GHK and Antioxidation"
            },
            {
                "p": "A 2018 laboratory experiment by Sakuma et al. suggested that the amino-acid sequence of Pal-GHK may have antioxidative potential.(8) The researchers also reported that this potential was apparently more powerful than other compounds classified as antioxidative and commonly used in research, such as carnosine and reduced glutathione. More specifically, the researchers shared that \"Experiments utilizing an ESR spin-trapping technique revealed that, among hydroxyl (·OH), superoxide (O2-·), and peroxyl (ROO·) radicals generated by respective chemical reaction systems, GHK diminished signals of both ·OH and ROO·.\""
            },
            {
                "p": "Active radicals appear to be apparent mediators of photodamage. Examples of such active radicals include reactive oxygen species (ROS), reactive nitrogen species (RNS), and reactive carbonyl species (RCS), which are considered to cause harm to lipids, DNA, and proteins. Studies have suggested that the amino acid sequence found in Pal-GHK may potentially prevent protein glycation and may possess anti-RCS properties against various radicals like acrolein, malondialdehyde, and 4-hydroxynoneal.(9)"
            },
            {
                "p": "Additionally, Pal-GHK has been suggested to have the potential to reduce the release of iron from ferritin, which catalyzes lipid peroxidation. In other words, Pal-GHK may lead to a lower rate of lipid peroxidation, ostensibly preserving the integrity of cell membranes and reducing cellular damage. In the context of skin tissue integrity, this might contribute to enhanced skin cell function and survival. One study shared results of an apparent 87% decrease in the iron release from damaged tissue using Pal-GHK, which appeared to have reduced oxidation in the affected tissues.(10) By potentially lowering lipid peroxidation, Pal-GHK might indirectly help mitigate the alteration of DNA and proteins, potentially reducing risk factors that may otherwise lead to cellular damage."
            },
            {
                "p": "Pal-GHK may also potentially reduce the production of reactive oxygen species and inflammatory cytokines while increasing the activity of antioxidant enzymes. During one experiment using a murine model, Pal-GHK was suggested to suppress the activation of Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-κB) and p38 mitogen-activated protein kinase (MAPK) signaling pathways, both of which are associated with inflammation.(11) Pal-GHK might potentially inhibit the activation of p38 MAPK either by blocking the upstream kinases that activate it or by interfering with the signaling molecules that initiate its phosphorylation. The inhibition may conceivably suppress the inflammatory response, reducing the overall stress on cells. This may lead to reduced infiltration of inflammatory cells in the tissues of murine models of lung tissue damage and lower levels of TNF-1 and IL-6 production."
            },
            {
                "p": "Researchers have also speculated about Pal-GHK's potential to alleviate the oxidative stress of smoke inhalation. Research findings have led to the proposal that the amino-acid sequence of Pal-GHK might impede oxidative stress in alveolar epithelial cells by increasing Nrf2 (Nuclear factor erythroid 2-related factor 2) expression and reducing the levels of reactive oxygen species in cell cultures.(12) Nrf2 is a protein that may regulate the expression of antioxidant proteins that protect against oxidative damage triggered by injury and inflammation."
            },
            {
                "p": "Pal-GHK peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Pickart, L., & Thaler, M. M. (1973). Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver. Nature: New biology, 243(124), 85–87.",
                    "Gorouhi, F., & Maibach, H. I. (2009). Role of peptides in preventing or treating aged skin. International journal of cosmetic science, 31(5), 327-345.",
                    "Maquart, F. X., Pickart, L., Laurent, M., Gillery, P., Monboisse, J. C., & Borel, J. P. (1988). Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS letters, 238(2), 343–346. https://doi.org/10.1016/0014-5793(88)80509-x",
                    "Trookman, N. S., Rizer, R. L., Ford, R., Mehta, R., & Gotz, V. (2009). Clinical assessment of a combination lip treatment to restore moisturization and fullness. The Journal of clinical and aesthetic dermatology, 2(12), 44–48.",
                    "Lintner, K., & Peschard, O. (2000). Biologically active peptides: from a laboratory bench curiosity to a functional skin care product. International journal of cosmetic science, 22(3), 207–218. https://doi.org/10.1046/j.1467-2494.2000.00010.x",
                    "Schagen, S. K. (2017). Peptide treatments with effective anti-aging results. Cosmetics, 4(2), 16.",
                    "Fournial, A., & Mondon, P. New Cosmetic or Dermopharmaceutical Use of a Mixture of a Ghk Tripeptide and Gqpr Tetrapeptide.",
                    "Sakuma, S., Ishimura, M., Yuba, Y., Itoh, Y., & Fujimoto, Y. (2018). The peptide glycyl-ʟ-histidyl-ʟ-lysine is an endogenous antioxidant in living organisms, possibly by diminishing hydroxyl and peroxyl radicals. International journal of physiology, pathophysiology and pharmacology, 10(3), 132–138.",
                    "Cebrián, J., Messeguer, A., Facino, R. M., & García Antón, J. M. (2005). New anti-RNS and -RCS products for cosmetic treatment. International journal of cosmetic science, 27(5), 271–278. https://doi.org/10.1111/j.1467-2494.2005.00279.x",
                    "Park, J. R., Lee, H., Kim, S. I., & Yang, S. R. (2016). The tri-peptide GHK-Cu complex ameliorates lipopolysaccharide-induced acute lung injury in mice. Oncotarget, 7(36), 58405–58417. https://doi.org/10.18632/oncotarget.11168",
                    "Sakuma, S., Ishimura, M., Yuba, Y., Itoh, Y., & Fujimoto, Y. (2018). The peptide glycyl-ʟ-histidyl-ʟ-lysine is an endogenous antioxidant in living organisms, possibly by diminishing hydroxyl and peroxyl radicals. International journal of physiology, pathophysiology and pharmacology, 10(3), 132–138.",
                    "Zhang, Q., Yan, L., Lu, J., & Zhou, X. (2022). Glycyl-L-histidyl-L-lysine-Cu2+ attenuates cigarette smoke-induced pulmonary emphysema and inflammation by reducing oxidative stress pathway. Frontiers in molecular biosciences, 9, 925700. https://doi.org/10.3389/fmolb.2022.925700"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "",
        "high_performance_liquid_chromatography": "",
        "mass_spectrometry": "",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Pal-GHK for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Pal-GHK For Sale (200mg) | Core Peptides",
            "og:description": "Pal-GHK for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:url": "https://www.corepeptides.com/peptides/pal-ghk-topical-200mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T15:17:09+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2023/05/PAL-GHK-200mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Pal-GHK For Sale (200mg) | Core Peptides",
            "twitter:description": "Pal-GHK for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2023/05/PAL-GHK-200mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$176.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "176.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-PAL-GHK",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/cjc-1295-no-dac-mod-grf-1-29/",
                "name": "CJC-1295 NO DAC (Mod GRF 1-29) (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Mod-GRF-1-29-5mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/cjc-1295-dac-5mg/",
                "name": "CJC-1295 DAC (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/CJC-1295-DAC-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/pt-141-10mg-bremelanotide/",
                "name": "PT-141 (Bremelanotide) (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/PT-141-10mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ipamorelin-5mg/",
                "name": "Ipamorelin (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Ipamorelin-5MG-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/pal-ahk-topical-200mg/",
        "name": "Pal-AHK (200mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2023/04/PAL-AHK-200mg.jpg",
        "display_price": "$176.00",
        "display_specs": [
            "Size: 200mg Contents: Pal-AHK Form: Lyophilized powder Purity: >99% SKU: P-Pal-AHK",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$167.20"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$158.40"
            }
        ],
        "description": [
            {
                "h2": "Pal-AHK"
            },
            {
                "p": "Pal-AHK is a synthetic peptide composed of amino acids alanine, histidine, and lysine, with the addition of a palmitoyl group. Studies have only investigated the action of non-palmitoylated AHK. Still, Pal-AHK likely exerts similar impacts since adding palmitoyl to the AHK molecule is not likely to significantly alter the compound's mechanism of action. Palmitoylation is typically considered only to enhance a compound’s capacity for cell penetration, which may make it more capable of exerting action. Research suggests one key potential action of AHK and Pal-AHK may be to stimulate the production of collagen and elastin, two proteins considered essential within the extracellular matrix (ECM) of skin cells."
            },
            {
                "p": "Collagen is a major structural protein that lends strength and durability to the skin barrier, while elastin is considered responsible for supporting its elasticity. In addition to its potential for collagen and elastin production, Pal-AHK may also exhibit anti-oxidative action. Oxidative stress is considered to cause quantitative damage to cells and tissues. Antioxidants may help to neutralize free radicals, the main cause of oxidative stress. By scavenging these free radicals, antioxidants may prevent or reduce damage and environmental exposure biomarkers, including limiting wrinkle depth and length along the skin barrier. Studies have suggested that Pal-AHK may also have the potential to induce hair follicle growth due to anti-oxidative action and interaction with various molecules and growth factors. Examples include transforming growth factor-β1 (TGF-β1), Bcl-2/Bax ratio, vascular endothelial growth factor (VEGF), caspase-3, poly-(ADP-ribose) polymerase (PARP), and others."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular formula: C31H56N6O5 Molecular weight: 592.8 g/mol Other Known Titles: Palmitoyl AHK"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Pal-AHK Peptide and Antioxidation"
            },
            {
                "p": "Tripeptide AHK was first developed from albumin hydrolysate.(2)(3) The addition of palmitoyl may improve the skin cell permeability of the peptide. Scientists report that the tripeptide may potentially reduce the expression of TGF-β1.(3) TGF-β1 is a molecule that supports the formation of new blood vessels and is considered to stimulate the production of extracellular matrix components, regulating the inflammatory response. Excessive activity may lead to chronic inflammation and tissue damage in certain contexts. Thus, reducing TGF-β1 levels may help to mitigate this action. The potential antioxidant action of Pal-AHK may be attributable to its unique amino acid composition.(4) Researchers suggest that the peptide “provides an increased dermal cell multiplication and viability to help to the production of collagen.” Researchers posit that this supposed action of AHK may directly impact the ECM through cell and protein production."
            },
            {
                "h3": "Pal-AHK Peptide and Hair"
            },
            {
                "p": "No research exists on Pal-AHK's impact on hair/fur growth. However, derivatives of AHK suggest that similarly structured compounds may promote the growth of hair follicles via the proliferation of dermal papilla cells (DPCs) and blocking their apoptosis.(5) The researchers suggested that AHK-analogs “stimulated the elongation of [...] hair follicles [...] and the proliferation of DPCs.”"
            },
            {
                "p": "Pal-AHK may achieve similar potential by elevating the Bcl-2/Bax ratio and reducing negative growth factors such as cleaved caspase-3 and PARP. The Bcl-2/Bax ratio is considered important in regulating apoptosis (programmed cell death). Bcl-2 is classified an anti-apoptotic protein that may inhibit cell death, while Bax is a pro-apoptotic protein that may promote cell death. Thus, a higher Bcl-2/Bax ratio would indicate a predominance of Bcl-2, which may inhibit apoptosis and promote cell survival."
            },
            {
                "p": "The theoretical potential of Pal-AHK to promote hair growth by preventing dermal papilla cell apoptosis is a hypothesis founded on research that suggests the peptide’s involvement in reducing the levels of the cleaved forms of caspase-3 and PARP. Caspase-3 is considered to be a primary player in the process of apoptosis and is believed to contribute to the loss of dermal papilla cells when present in its cleaved, active form. When cleaved by caspase-3, PARP may facilitate cellular disassembly, a hallmark of apoptosis. Thus, inhibiting caspase-3 activation and reducing the cleaved forms of PARP as part of the same apoptotic pathway may plausibly contribute to decreased cell death in the hair follicles, potentially fostering an environment more conducive to hair retention and growth. Research also suggests this action possibly lowered apoptosis levels in these cell types under experimental observation.(6) Furthermore, studies report that Pal-AHK may increase the expression of vascular endothelial growth factor (VEGF), which, combined with reducing TGF-β1, may also help reduce shedding and promote hair growth.(7)"
            },
            {
                "p": "VEGF is a protein that is considered to play an important role in angiogenesis. It is also thought to promote the growth of blood vessels around hair follicles, which may help supply nutrients and oxygen to the hair follicle and support growth."
            },
            {
                "h3": "Pal-AHK Peptide and Skin Cells"
            },
            {
                "p": "Although blocking TGF-β1 tends to have antiproliferative action, researchers suggest that Pal-AHK may stimulate the proliferation of skin cells and collagen synthesis via other pathways. The specific potential of Pal-AHK on the skin is yet to be investigated. Still, researchers have suggested that the main molecule, AHK, may yield positive action in preliminary laboratory research. One such potential is the viability and proliferation of dermal fibroblasts, key cells responsible for producing the essential proteins of the ECM, including collagen."
            },
            {
                "p": "Cell culture studies using normal dermal fibroblasts found that AHK appeared to increase cell growth and viability while potentially promoting the production of collagen type I.(8) This was determined by isolating the amount of collagen type I produced by fibroblasts in cell culture after incubation with various amounts of AHK. Results suggested that AHK may increase collagen type I production, with studies reporting a 300% increase compared to a control group. The findings suggest that AHK may potentially renew the extracellular matrix."
            },
            {
                "p": "Pal-AHK peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Tsuge, N., Eikawa, Y., Nomura, Y., Yamamoto, M., & Sugisawa, K. (1991). The anti-oxidative activity of peptides prepared by enzymatic hydrolysis of egg-white albumin. Journal of the Agricultural Chemical Society of Japan.",
                    "Shimura, H., Tanaka, R., Shimada, Y., Yamashiro, K., Hattori, N., & Urabe, T. (2017). Glycyl-alanyl-histidine protects PC12 cells against hydrogen peroxide toxicity. BMC biochemistry, 18(1), 14. https://doi.org/10.1186/s12858-017-0089-x",
                    "Nirmal, B. (2018). Key MessAges. IADVL Textbook of Trichology, 163.",
                    "Kecel-Gunduza, S., Kocb, E., Bicaka, B., Kokcub, Y., Ozela, A. E., & Akyuzc, S. (2020). IN SILICO ANALYSIS FOR CHARACTERIZING THE STRUCTURE AND BINDING PROPERTIES OF ALA-HIS-LYS (AHK) TRIPEPTIDE. The Online Journal of Science and Technology-July, 10(3).",
                    "Pyo, H. K., Yoo, H. G., Won, C. H., Lee, S. H., Kang, Y. J., Eun, H. C., Cho, K. H., & Kim, K. H. (2007). The effect of tripeptide-copper complex on human hair growth in vitro. Archives of pharmacal research, 30(7), 834–839. https://doi.org/10.1007/BF02978833",
                    "Anastassakis, K. (2022). Copper Tripeptides Copper tripeptides. In Androgenetic Alopecia From A to Z: Vol. 2 Drugs, Herbs, Nutrition and Supplements (pp. 225-230). Cham: Springer International Publishing.",
                    "Sadgrove, N. J., & Simmonds, M. S. J. (2021). Nutricosmetic products for healthy hair and dermal antiaging using “dual-acting” (2 for 1) plant-based peptides, hormones, and cannabinoids. FASEB bioAdvances, 3(8), 601–610. https://doi.org/10.1096/fba.2021-00022",
                    "Patt, L. M., & Procyte, A. (2009). Neova® DNA Repair Factor Nourishing Lotion Stimulates Collagen and Speeds Natural Repair Process. skin, 1, 2."
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "",
        "high_performance_liquid_chromatography": "",
        "mass_spectrometry": "",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Pal-AHK for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Pal-AHK For Sale (200mg) - Core Peptides",
            "og:description": "Pal-AHK for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:url": "https://www.corepeptides.com/peptides/pal-ahk-topical-200mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T16:15:04+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2023/04/PAL-AHK-200mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Pal-AHK For Sale (200mg) - Core Peptides",
            "twitter:description": "Pal-AHK for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2023/04/PAL-AHK-200mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$176.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "176.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-Pal-AHK",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/cjc-1295-dac-5mg/",
                "name": "CJC-1295 DAC (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/CJC-1295-DAC-5MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/melanotan-2-10mg/",
                "name": "Melanotan 2 (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2023/03/Melanotan-2-10MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/adipotide-10mg/",
                "name": "Adipotide (FTPP) (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Adipotide-FTPP-10MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/semax-25mg/",
                "name": "Semax (25mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Semax-25MG-300x300.jpg.webp",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/p21-5mg/",
        "name": "P21 (5mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2023/04/P21-5mg.jpg",
        "display_price": "$116.00",
        "display_specs": [
            "Size: 5mg Contents: P21 Form: Lyophilized powder Purity: >99% SKU: P-P21",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$110.20"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$104.40"
            }
        ],
        "description": [
            {
                "h2": "P21 Peptide"
            },
            {
                "p": "The P21 (also identified as P021) is a synthetic peptide designed to mimic the activity of ciliary neurotrophic factor (CNTF) on the brain without triggering an allergic response. CNTF is a protein that promotes the survival and differentiation of various neural cells, including neurons and oligodendrocytes. CNTF has been suggested to exhibit possible neuroprotective and neurodegenerative activity in animal models of neurodegenerative diseases and injuries. Scientists identified CNTF's most active regions based on epitope mapping of neutralizing antibodies to CNTF.(1) This led to the development of Peptide 6, made of 11 amino acids (Ac-VGDGGLFEKKL-NH(2)) and a subsequence of just 4 amino acids called Peptide 6c (Ac-DGGL-NH(2))."
            },
            {
                "p": "These amino acids have been theorized to support hippocampus-dependent learning and memory, increase neurogenesis, and potentially boost neuronal plasticity, as posited in murine models. To improve the stability of the peptide and boost its potential to pass through the blood-brain barrier, the scientists report that they \"added adamantane building blocks to the C-terminus or both C- and N-termini of Peptide 6c.” The result is P21, which appears to have the potential to mimic the action of CNTF by activating the CNTF receptor complex and downstream signaling pathways, possibly leading to enhanced cognition, increased proliferation, and neuronal differentiation of adult hippocampal progenitors in murine models."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula:C30H54N6O5 Molecular Weight: 578.3 g/mol Sequence: Ac-DGGL-adamatanylglycine-NH2 Other Known Titles: P021"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "P21 Peptide and Cognitive impairment"
            },
            {
                "p": "P21 has been extensively researched in experimental models of cognitive impairment. One notable study examined the impact of P21 peptide exposure in 3xTg-AD murine models between 6-9 months prior to the onset of amyloid beta (Aβ) or tau pathology and during the period of synaptic compensation.(2) The study suggested that P21 appeared to rescue dendritic and synaptic deficits, boost neurogenesis, and reverse cognitive impairment in the 3xTg-AD murine models. The study suggests that P21 may contribute to the mitigation of synaptic deficits and cognitive impairment by potentially providing neurotrophic support during synaptic compensation. According to the researchers, this potential may be achieved via the proposed influence of the peptide on synaptic plasticity, as the peptide appears to increase the levels of several markers essential for synaptic function, such as synapsin, PSD-95, and MAP2. Synapsin may regulate neurotransmitter release, which is considered crucial for communication between neurons. PSD-95 is posited to organize components within postsynaptic densities, ensuring signals are received and processed at synaptic junctions. MAP2 is thought to stabilize microtubules in dendrites, supporting their structure and possibly influencing the formation and maintenance of synaptic connections. Overall, these proteins may support the regulation of neurotransmitter release, potentially stabilizing synaptic changes and maintaining the structural integrity of dendrites. These are essentially nerve cell projections that may receive information from other neurons, called presynaptic neurons, or from the environment. By boosting these markers, P21 is posited to help preserve and enhance synaptic functionality."
            },
            {
                "p": "Another study suggested that the P21 may reduce the natural decline in learning and memory in aged Fisher murine models by inhibiting neurogenesis deficit and possibly increasing the expression of brain-derived neurotrophic factor (BDNF) and restoring synaptic deficits in the cortex and hippocampus.(3) BDNF is posited to be a key protein in the survival and differentiation of neurons and the growth of dendrites. BDNF may work by activating pathways that may prevent cell death and promote the differentiation of progenitor cells into mature neurons, especially in the hippocampus, which may aid in ongoing neurogenesis. BDNF is also thought to be instrumental in enhancing synaptic plasticity. It may help strengthen synaptic connections and modulate neurotransmitter release, facilitating better cognition in models of cognitive impairment. BDNF may also contribute to the structural complexity of neurons by encouraging the growth and branching of dendrites, thereby increasing neural connectivity. The study also indicated that P21 appeared to reduce the concentration of myoinositol, a metabolite that naturally increases in murine models. The study suggests that \"stimulating endogenous neuroprotective mechanisms using P21 may be [an interesting research] approach for cognitive aging, Alzheimer's disease, and associated neurodegenerative disorders.\""
            },
            {
                "h3": "P21 Peptide and Alzheimer's Disease (AD) Models"
            },
            {
                "p": "Experiments are actively investigating the potential research outcomes of P21 in Alzheimer's models. One study focusing on the potential of P21 suggested that chronic exposure of P21 appeared to possibly reduce the brain level of total tau in aged Fisher rats and possibly also reduce tau levels in the cerebrospinal fluid (CSF) to that of young adult rats.(4) The study also observed that \"P21 [may be] blood-brain-barrier-permeable and [may] not induce any detectable immune reaction.\" The exact mechanism for the apparent reduction of tau protein levels remains unknown. Yet, the researchers posit that the increased BDNF activity may modulate downstream effectors such as glycogen synthase kinase-3 (GSK-3). GSK-3 is posited to be a kinase involved in the phosphorylation of tau. Phosphorylated tau is prone to aggregation, forming neurofibrillary tangles, a hallmark of Alzheimer’s (AD) models. By modulating BDNF levels, P21 may indirectly inhibit GSK-3 activity, potentially reducing tau phosphorylation."
            },
            {
                "p": "Another study investigated the potential of P21 on neurobehavior and AD-like pathology in a transgenic murine model of AD.(5) The compound was presented during the mice's prenatal to early postnatal development. Results suggested that the peptide appeared to rescue cognitive deficits, reduce abnormal accumulation of tau and Aβ plaque load, ameliorate certain markers of postsynaptic deficits, and decrease neuroinflammation in the brain. The purported mechanism may have involved improving PSD-95 levels and cAMP response element-binding protein (CREB) activity, which are considered markers of synaptic function and memory formation. Additionally, P21 may have reduced glial fibrillary acidic protein (GFAP) levels, indicating a potential decrease in neuroinflammation."
            },
            {
                "p": "In another experiment, the researchers investigated the neurotrophic potential of the P21 compound in preventing neurodegeneration, amyloid-β, and tau pathologies in 3xTg-AD murine models.(6) The researchers started P21 exposure during the period of synaptic compensation several months before the appearance of any overt pathology. They observed that P21 initiated during this period might have prevented neurodegeneration, Aβ, and tau pathologies, rescued episodic memory impairment, and may have potentially reduced the mortality rate."
            },
            {
                "p": "One trial also investigated the potential of P21 on cognitive function and synaptic plasticity in a transgenic murine model of AD.(7) Results indicated that the peptide might mitigate cognitive impairment, increase expressions of pCREB and BDNF, and ameliorate synaptic protein deficit in the murine models. These actions may lead to the activation of three key signaling pathways: PLC/PKC, MEK/ERK, and PI3K/Akt. These pathways are purported to play a potential role in neuronal survival, growth, and synaptic plasticity. By enhancing these signaling cascades, the peptide is posited to improve synaptic protein expression. The study also suggests that P21 might potentially rescue synaptic deficits and cognitive impairment in familial AD and related tauopathies during early development."
            },
            {
                "h3": "P21 Peptide and Macular Degeneration"
            },
            {
                "p": "Age-related macular degeneration (AMD) affects the macula, the central part of the retina responsible for central vision. It is considered a common neurodegenerative disease that may lead to vision loss at its end stage. Recent research has suggested that consistent exposure to the neurotrophic peptidergic compound may help prevent the occurrence of AMD pathology."
            },
            {
                "p": "A study conducted in aged and 3xTg-AD murine models reported that chronic presentation of P21 appeared to possibly prevent several pathological changes associated with AMD.(8) The study reported identifying photoreceptor degeneration, lipofuscin granules, vacuoles, atrophy in retinal pigment epithelium (RPE), and Bruch's membrane (BM) thickening. The study also reported a rosette-like structure formation in aged murine models, a hallmark of AMD pathology. Microgliosis and astrogliosis, inflammatory responses in the retina, were also observed in different retinal layers. Furthermore, the study indicated that total tau, phosphorylated tau, Aβ/APP, and VEGF appeared widely distributed in the sub-retina of aged and 3xTg murine models. These molecules are associated with Alzheimer's disease pathology, and their presence suggests that retinal changes associated with aging and Alzheimer's disease may share some common features. Importantly, consistent exposure to P21 for three months in rats and 18 months in 3xTg murine models appeared to ameliorate the pathological changes described above."
            },
            {
                "p": "P21 peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References"
            },
            {
                "references": [
                    "Li, B., Wanka, L., Blanchard, J., Liu, F., Chohan, M. O., Iqbal, K., & Grundke-Iqbal, I. (2010). Neurotrophic peptides incorporating adamantane improve learning and memory, promote neurogenesis and synaptic plasticity in mice. FEBS letters, 584(15), 3359–3365. https://doi.org/10.1016/j.febslet.2010.06.025",
                    "Baazaoui, N., & Iqbal, K. (2017). Prevention of dendritic and synaptic deficits and cognitive impairment with a neurotrophic compound. Alzheimer's research & therapy, 9(1), 45. https://doi.org/10.1186/s13195-017-0273-7",
                    "Bolognin, S., Buffelli, M., Puoliväli, J., & Iqbal, K. (2014). Rescue of cognitive-aging by administration of a neurogenic and/or neurotrophic compound. Neurobiology of aging, 35(9), 2134–2146. https://doi.org/10.1016/j.neurobiolaging.2014.02.017",
                    "Khatoon, S., Chalbot, S., Bolognin, S., Puoliväli, J., & Iqbal, K. (2015). Elevated Tau Level in Aged Rat Cerebrospinal Fluid Reduced by Treatment with a Neurotrophic Compound. Journal of Alzheimer's disease : JAD, 47(3), 557–564. https://doi.org/10.3233/JAD-142799",
                    "Wei, W., Wang, Y., Liu, Y., Dai, C. L., Tung, Y. C., Liu, F., & Iqbal, K. (2020). Prenatal to early postnatal neurotrophic treatment prevents Alzheimer-like behavior and pathology in mice. Alzheimer's research & therapy, 12(1), 102. https://doi.org/10.1186/s13195-020-00666-7",
                    "Baazaoui, N., & Iqbal, K. (2017). Prevention of Amyloid-β and Tau Pathologies, Associated Neurodegeneration, and Cognitive Deficit by Early Treatment with a Neurotrophic Compound. Journal of Alzheimer's disease : JAD, 58(1), 215–230. https://doi.org/10.3233/JAD-170075",
                    "Wei, W., Liu, Y., Dai, C. L., Baazaoui, N., Tung, Y. C., Liu, F., & Iqbal, K. (2021). Neurotrophic Treatment Initiated During Early Postnatal Development Prevents the Alzheimer-Like Behavior and Synaptic Dysfunction. Journal of Alzheimer's disease : JAD, 82(2), 631–646. https://doi.org/10.3233/JAD-201599",
                    "Liu, Y., Wei, W., Baazaoui, N., Liu, F., & Iqbal, K. (2019). Inhibition of AMD-Like Pathology With a Neurotrophic Compound in Aged Rats and 3xTg-AD Mice. Frontiers in aging neuroscience, 11, 309. https://doi.org/10.3389/fnagi.2019.00309"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/09/P21-coa.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/09/P21-lc.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/09/P21-ms.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "P21 peptide for sale online (5mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "P21 For Sale (5mg) - Core Peptides",
            "og:description": "P21 peptide for sale online (5mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:url": "https://www.corepeptides.com/peptides/p21-5mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T16:12:25+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2023/04/P21-5mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "P21 For Sale (5mg) - Core Peptides",
            "twitter:description": "P21 peptide for sale online (5mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2023/04/P21-5mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$116.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "116.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-P21",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/receptor-grade-igf-1-lr3-1mg/",
                "name": "Receptor Grade IGF-1 LR3 (1mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-1MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/aod-9604-5mg/",
                "name": "AOD 9604 (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/AOD-9604-5MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/oxytocin-10mg/",
                "name": "Oxytocin (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Oxytocin-10mg-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/dsip-5mg/",
                "name": "DSIP (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/DSIP-5MG-300x300.jpg.webp",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/oxytocin-10mg/",
        "name": "Oxytocin (10mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Oxytocin-10mg.jpg",
        "display_price": "$52.00",
        "display_specs": [
            "Size: 10mg Contents: Oxytocin (10mg) Form: Lyophilized powder Purity: >99% SKU: P-OXYTOCIN-10",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$49.40"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$46.80"
            }
        ],
        "description": [
            {
                "h2": "Oxytocin Peptide"
            },
            {
                "p": "Oxytocin is a naturally occurring cyclic peptide hormone composed of nine amino acids. Scientists consider the peptide hormone to be secreted by the pituitary gland and to act as a neurotransmitter within the brain.(1) The synthetic form of the peptide, Recombinant Oxytocin, is a cyclic nonapeptide developed to be analogous to the naturally occurring peptide.(2)"
            },
            {
                "p": "The first isolation of the peptide was carried out in 1920, followed by its structure discovery in the 1950s. Several research studies were conducted to fully explore the peptide's action and characteristics. Scientists consider it to be created by the hypothalamus, and Oxytocin is then secreted and stored in the posterior pituitary gland, potentially released in the event of a specific stimulation.(3) Unlike other hormones, naturally occurring Oxytocin has been posited to work via a positive feedback mechanism. This means that the initial secretion of the hormone peptide may lead to further release of the peptide in higher concentrations and with higher intensity.(3) Both synthetic and natural forms appear to work through the same potential mechanisms."
            },
            {
                "p": "Considered to be especially pivotal in the process of gestation and labor, Oxytocin, once secreted into the system, may bind with the G-protein coupled receptors to potentially increase intracellular calcium levels. This calcium secretion may have various downstream impacts, such as inducing uterine contractions. Once the uterine contractions begin, they may stimulate further release of Oxytocin, leading to higher frequency and intensity of the contractions via a positive feedback mechanism.(3) The peptide appears to contribute to the contractions of myoepithelial cells found in the alveolar ducts of mammary glands. These contractions may stimulate milk ejection from alveolar ducts into the larger sinuses, thereby expelling milk. The positive feedback mechanism may also work here, with initial milk expulsion potentially stimulating increased Oxytocin circulation and continuous milk release.(3)"
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C43H66N12O12S2 Molecular Weight: 1007.193 g/mol Other Known Titles: endopituitrina"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Oxytocin Peptide and Dopamine Signaling"
            },
            {
                "p": "Oxytocin might play a role in shaping sexual behavior by possibly influencing the activity of dopamine within central nervous system regions associated with the rewards system, notably the ventral tegmental area (VTA) and the nucleus accumbens.(4) This influence may stem from projections of Oxytocin to the VTA, where the peptide may either augment dopamine release, or enhance the sensitivity of dopaminergic neurons. Such an increase in dopaminergic activity may, in turn, potentially boost sexual motivation and the perception of reward, possibly aiding the anticipatory aspects of mating and copulatory behavior. The hypothesis suggests that Oxytocin may directly interact with dopaminergic neurons within the VTA by activating specific oxytocin receptors, initiating a sequence of events that culminates in heightened dopamine release within the nucleus accumbens. This sequence may include the stimulation of nitric oxide synthesis within the VTA, hinting at an intricate interplay involving Oxytocin, dopamine, and nitric oxide. Additionally, there is the potential for Oxytocin to exert an indirect action on dopaminergic activity across other cerebral locales, including the hippocampus and amygdala, adding further depth to its complex role. Such indirect influences might modulate the activity of either glutamatergic or GABAergic neurons, which may, in turn, influence dopaminergic neurons located within the VTA and nucleus accumbens.(4)"
            },
            {
                "h3": "Oxytocin Peptide and Neuroplasticity"
            },
            {
                "p": "Researchers are actively exploring Oxytocin's impact on developing or maintaining neuroplasticity. The peptide is posited to engage with G-protein coupled receptors, which may increase intracellular calcium levels.(5) This elevation in calcium is thought to play a role in neuronal excitability and synaptic modulation, affecting the transmission of signals across neurons. Oxytocin's potential influence in the brain may extend to neurogenesis and synaptic plasticity, which may impact the intricate dance of neural circuit formation and function. The presence of Oxytocin receptors across various neural cell types hints at the peptide's broad potential impact, possibly modulating the behavior of neural progenitor cells and influencing the fate of these cells. This action might stretch into early brain development, where Oxytocin's presence might subtly shape the emerging neural circuits by modulating neurotransmitter dynamics, including those of glutamate and GABA, which serve as the brain's primary excitatory and inhibitory signals, respectively. At the synaptic level, Oxytocin's actions appear to diverge, potentially enhancing neurotransmitter release in some contexts, while diminishing it in others. This dual action may reflect Oxytocin's potential to modulate the balance between excitation and inhibition within the neural circuits, a balance considered crucial for maintaining the functional integrity of the brain. Such modulation may manifest through alterations in the release of neurotransmitters or changes in membranes, indirectly influencing neuronal excitability and the flow of neural information. The interactions of Oxytocin with glial cells, such as astrocytes, further complicate its role in neurotransmitter dynamics, suggesting a broader regulatory influence that extends beyond the neurons to the supportive environment that nurtures and maintains synaptic connections. This interaction may influence the synaptic plasticity and overall function of neural circuits, offering a glimpse into the complex regulatory roles Oxytocin might play in the neural ecosystem.(5)"
            },
            {
                "h3": "Oxytocin Peptide and Labor Induction"
            },
            {
                "p": "The main aim of this clinical study(6) was to determine the rate of cesarean delivery in pregnant females after removing Oxytocin presence once active labor starts (5 cm cervical dilation) compared to pregnant females where Oxytocin was given until the maintenance level as determined in clinical trial study protocol. A randomized study was conducted on 252 female subjects between 18 to 50 years. The subjects were divided into two groups, with 127 subjects (Group A) continuously given the peptide per study protocol even after the subjects reached active labor, and 125 subjects (Group B) given Oxytocin, discontinued after active labor induction. After a 24-72 hour study period, there were 32 reported cesarean deliveries in Group A, with 10 infants exhibiting one or more abnormalities that warranted further observation. In contrast, there were 24 reported cesarean deliveries in Group B, with 9 infants exhibiting abnormalities."
            },
            {
                "h3": "Oxytocin Peptide and Lactation"
            },
            {
                "p": "The main goal of this clinical study(7) was to evaluate the potential action of peptide supplementation during the course of breastfeeding. A retrospective study(7) was conducted where 100 pregnant females given Oxytocin during labor were compared with 100 pregnant females not exposed to Oxytocin. Following the study result analysis, the researchers reported that the new mothers exposed to Oxytocin exhibited apparently impaired breastfeeding for the first hour. During the first three months after delivery, subjects from both groups (27% exposed to Oxytocin and 14% without) were not apparently able to breastfeed. Following three months, breastfeeding was reported to significantly increase in the Oxytocin-exposed subjects. The reason suggested by researchers for impaired breastfeeding during the first three months was the high pre-gestational body mass index in the test subjects."
            },
            {
                "h3": "Oxytocin Peptide and Vasodilation"
            },
            {
                "p": "Vasodilation is the dilation of blood vessels, which is considered to be a mechanism to increase blood flow. The main purpose of this study(8) was to evaluate the potential of Oxytocin on cardiac function and tone in the heart muscles. The study observed a set of pregnant females in the first trimester, divided into two groups, one given Oxytocin and the other a placebo. Heart rate and blood pressure were recorded. The results suggested that the peptide may have exhibited vasodilatory properties on the small and outlying arteries and elevated left ventricular ejection time."
            },
            {
                "h3": "Oxytocin Peptide and Autism"
            },
            {
                "p": "The main aim of this clinical study(9) was to evaluate what action, if any, the peptide may exert on research models of autism. Autism is considered to be a psychiatric disorder related to poor brain development impacting how the subject socializes and communicates. A total of 59 autistic males, aged 6 to 11 years, were examined in this study. Out of the 59 test subjects, 29 were autistic, and the rest were considered control subjects by the researchers. The plasma levels of Oxytocin were measured in this study, and the researchers reported that autistic subjects exhibited lower levels of peptide hormone than the control subjects. Once the levels of Oxytocin were elevated as part of the study, the VABS score (analytic behavior score) of autistic subjects appeared to improve."
            },
            {
                "p": "Oxytocin peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "National Center for Biotechnology Information. \"PubChem Compound Summary for CID 439302, Oxytocin\" PubChem",
                    "Recombinant Oxytocin (Code C724). https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=NCI_Thesaurus&code=C724",
                    "Osilla EV, Sharma S. Oxytocin. [Updated 2021 Jul 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan. https://www.ncbi.nlm.nih.gov/books/NBK507848/",
                    "Melis, Maria Rosaria, and Antonio Argiolas. “Oxytocin, Erectile Function and Sexual Behavior: Last Discoveries and Possible Advances.” International journal of molecular sciences vol. 22,19 10376. 26 Sep. 2021, doi:10.3390/ijms221910376",
                    "Bakos, Jan et al. “Molecular Mechanisms of Oxytocin Signaling at the Synaptic Connection.” Neural plasticity vol. 2018 4864107. 2 Jul. 2018, doi:10.1155/2018/4864107",
                    "Diven, Liany C et al. “Oxytocin discontinuation during active labor in women who undergo labor induction.” American journal of obstetrics and gynecology vol. 207,6 (2012): 471.e1-8. doi:10.1016/j.ajog.2012.08.035",
                    "Gomes M, Trocado V, Carlos-Alves M, Arteiro D, Pinheiro P. Intrapartum synthetic oxytocin and breastfeeding: a retrospective cohort study. J Obstet Gynaecol. 2018 Aug;38(6):745-749. Epub 2018 Mar 9. https://pubmed.ncbi.nlm.nih.gov/29523035/",
                    "Rabow, S., Hjorth, U., Schönbeck, S. et al. Effects of oxytocin and anaesthesia on vascular tone in pregnant women: a randomized, double-blind placebo-controlled study using non-invasive pulse wave analysis. BMC Pregnancy Childbirth 18, 453 (2018).",
                    "Cochran, D. M., Fallon, D., Hill, M., & Frazier, J. A. (2013). The role of oxytocin in psychiatric disorders: a review of biological and therapeutic research findings. Harvard review of psychiatry, 21(5), 219–247. https://doi.org/10.1097/HRP.0b013e3182a75b7d"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/09/Oxytocin-10MG-coa.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/09/Oxytocin-10MG-lc.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/09/Oxytocin-10MG-ms.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Oxytocin peptide for sale online (10mg). Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Oxytocin For Sale (10mg) | Core Peptides",
            "og:description": "Oxytocin peptide for sale online (10mg). Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/oxytocin-10mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T18:27:59+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Oxytocin-10mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Oxytocin For Sale (10mg) | Core Peptides",
            "twitter:description": "Oxytocin peptide for sale online (10mg). Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Oxytocin-10mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$52.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "52.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-OXYTOCIN-10",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/bpc-157/",
                "name": "BPC-157 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/BPC-157-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/cjc-1295-dac-5mg/",
                "name": "CJC-1295 DAC (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/CJC-1295-DAC-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/aod-9604-5mg/",
                "name": "AOD 9604 (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/AOD-9604-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ll-37-5mg/",
                "name": "LL-37 (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/LL-37-5mg-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/nonapeptide-1-topical-200mg/",
        "name": "Nonapeptide-1 (200mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2023/04/NONAPEPTIDE-1-200mg.jpg",
        "display_price": "$214.00",
        "display_specs": [
            "Size: 200mg Contents: Nonapeptide-1 Form: Lyophilized powder Purity: >99% SKU: P-NONAPEPTIDE-1",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$203.30"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$192.60"
            }
        ],
        "description": [
            {
                "h2": "Nonapeptide-1"
            },
            {
                "p": "Nonapeptide-1 is a nine amino acid peptide that was first developed in the 1990s, sparking research interest due to its potential to inhibit the synthesis of melanin, the main pigment in mammals responsible for color in the skin, fur, hair, eyes, etc. The research on Nonapeptide-1 is still in its early stages, and much is still unknown about its potential and mechanisms of action."
            },
            {
                "p": "Studies on Nonapeptide-1 have primarily focused on its potential to inhibit melanin production by interfering with the signaling pathway involved in melanogenesis. Specifically, Nonapeptide-1 is thought by researchers to possibly inhibit the melanocortin-1 receptors, which may prevent the action of melanocyte-stimulating hormones and the activation of the enzyme tyrosinase, which is necessary for the synthesis of melanin.(1) By doing so, Nonapeptide-1 may have a reducing potential on hyperpigmentation and skin tone in animal studies. Nevertheless, further studies are needed to fully understand the potential of this peptide."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular formula: C61H87N15O9S Molecular weight: 1206.5 g/mol"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Nonapeptide-1 Discovery and Mechanism of Action"
            },
            {
                "p": "Scientists have investigated a peptide library of 31,360 structurally different melanocortin-1 receptor antagonists with the aim of finding the most potentially potent inhibitor of these receptors.(2) These melanocortin-1 receptors may be found in melanocytes, which are pigment-producing cells. One of the main agonists of these receptors is considered to be the alpha-melanocyte-stimulating hormone (α-MSH)."
            },
            {
                "p": "α-MSH is a neuropeptide thought to be involved in regulating pigmentation, energy homeostasis, and immune function. The pituitary gland and the skin produce it. α-MSH may stimulate melanin production by binding to the melanocortin-1 receptor on melanocytes and activating a signaling cascade that increases tyrosinase activity and melanin production. Tyrosinase is the rate-limiting enzyme in melanogenesis.(3) In addition, α-MSH may also act as an antagonist for the agouti signaling protein (ASP), which inhibits MC1R activity and reduces melanin production."
            },
            {
                "p": "The researchers suggested that the most potent antagonist of all 31,360 peptides was Met-Pro-D-Phe-Arg-D-Trp-Phe-Lys-Pro-Val-NH2, aka nonapeptide-1.(2) The scientists reported that it \"has an IC50 value of 11 +/- 7 nM'' and the \"analysis revealed that D-Trp5 and Phe6 were crucial to its antagonistic properties which could be potentiated by D-Phe3.\""
            },
            {
                "h3": "Nonapeptide-1 and Skin Pigmentation"
            },
            {
                "p": "The potential action of Nonapeptide-1 has been researched in both clinical and laboratory settings. In one in vitro study, keratinocyte cell line (HaCaT) cells and epidermal melanocytes (HEM) were exposed to UVA and imbued with different concentrations of the acetate salt of Nonapeptide-1.(4)"
            },
            {
                "p": "The scientists accessed cell viability, melanin content, and tyrosinase activity. The scientists suggested that Nonapeptide-1 downregulated melanocortin 1 receptor expression without affecting α-MSH levels, and might significantly decrease the expression of tyrosinase, TRP1 (tyrosinase-related protein-1), TRP2 (tyrosinase-related protein-2), and MITF (microphthalmia-associated transcription factor) with or without concomitant UVA radiation. Besides, the researchers further posited that cells infused with nonapeptide-1 may significantly increase the ability to resist melanin production."
            },
            {
                "p": "More recent research on nonapeptide-1 also hypothesizes that the peptide may produce an apparent skin lightening by at least 33% and suggested a continued improvement over time.(5) The only clinical trial on the topic was a prospective double-blinded parallel-group randomized controlled pilot study that lasted eight months and had three phases.(6) The researchers reported an apparent improvement in severity scores of melasma and mean melanin index. They also commented, \"The melasma area and severity index score showed a consistent reduction in the case group, whereas it increased in the control group from baseline.\""
            },
            {
                "h3": "Nonapeptide-1 and Future Research Potential"
            },
            {
                "p": "Apart from melanocytes, the melanocortin 1 receptors that Nonapeptide-1 potentially inhibits may be expressed in other cells, such as nerve cells and immune cells. More specifically, the melanocortin 1 receptors may be found in the periaqueductal gray matter, which plays a major role in nociception.(7)"
            },
            {
                "p": "Scientists have conducted experiments on mice with overexpression of an endogenous antagonist of the melanocortin 1 receptor compared to control mice.(8) They tested their response to painful and non-painful stimuli and their response to inflammatory and neuropathic pain. Additionally, they tested their aversion to capsaicin, which may activate the TRPV1 noxious heat receptor, using a paired preference paradigm."
            },
            {
                "p": "The scientists indicated that mice overexpressing the melanocortin 1 receptor antagonist exhibited an apparently reduced inflammatory pain response and a slower onset of inflammation-induced hypersensitivity and allodynia. They were also observed to exhibit a decreased aversion to moderate concentrations of capsaicin. The scientists highlighted that these results occurred only in female mice and that \"mice of either sex did not show any effect of mutant genotype on neuropathic pain.\""
            },
            {
                "p": "Studies also suggest that melanocortin 1 receptors may play a role in the growth and survival of melanoma tumor cells.(9) Melanoma is a type of skin cancer with a high mortality rate, and mutations in the melanocortin 1 receptor gene may be associated with changes in the risk of developing melanoma. In this study, the researchers inhibited melanocortin 1 receptors using natural inhibitors, which reduced melanin synthesis and morphological heterogeneity in murine B16-F10 melanoma cells. They found that the inhibition resulted in slower tumor cell growth and a more homogeneous size and morphology of the tumors."
            },
            {
                "p": "The study suggests that melanocortin 1 receptors may play an important role in regulating melanoma growth and morphology, and persistent inhibition of melanocortin 1 receptors may significantly slow the growth rate of the tumor cells that express these receptors. Nonapeptide-1 hasn't been researched regarding its potential impact on melanoma tumor cells."
            },
            {
                "p": "Nonapeptide-1 is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Dhatt S (2006) Rebuilding the dermal matrix with this new in-demand ingredient in skin care products. Aesthetic Trends Technol 17–20",
                    "Jayawickreme, C. K., Quillan, J. M., Graminski, G. F., & Lerner, M. R. (1994). Discovery and structure-function analysis of alpha-melanocyte-stimulating hormone antagonists. Journal of Biological Chemistry, 269(47), 29846-29854.",
                    "Gaston, L. S., & Majzoub, J. A. (2022). Adrenocorticotrophin. In The Pituitary (pp. 51-89). Content Repository Only!.",
                    "Chen, J., Li, H., Liang, B., & Zhu, H. (2022). Effects of tea polyphenols on UVA-induced melanogenesis via inhibition of α-MSH-MC1R signalling pathway. Postepy dermatologii i alergologii, 39(2), 327–335. https://doi.org/10.5114/ada.2022.115890",
                    "Mohammed, Y. H., Moghimi, H. R., Yousef, S. A., Chandrasekaran, N. C., Bibi, C. R., Sukumar, S. C., Grice, J. E., Sakran, W., & Roberts, M. S. (2017). Efficacy, Safety and Targets in Transdermal Active and Excipient Delivery. Percutaneous Penetration Enhancers Drug Penetration Into/Through the Skin: Methodology and General Considerations, 369–391. https://doi.org/10.1007/978-3-662-53270-6_23",
                    "Chatterjee, M., Neema, S., & Rajput, G. R. (2021). A randomized controlled pilot study of a proprietary combination versus sunscreen in melasma maintenance. Indian journal of dermatology, venereology and leprology, 88(1), 51–58. https://doi.org/10.25259/IJDVL_976_18",
                    "Xia, Y., Wikberg, J. E., & Chhajlani, V. (1995). Expression of melanocortin 1 receptor in periaqueductal gray matter. Neuroreport, 6(16), 2193-2196.",
                    "Delaney, A., Keighren, M., Fleetwood-Walker, S. M., & Jackson, I. J. (2010). Involvement of the melanocortin-1 receptor in acute pain and pain of inflammatory but not neuropathic origin. PloS one, 5(9), e12498. https://doi.org/10.1371/journal.pone.0012498",
                    "Kansal, R. G., McCravy, M. S., Basham, J. H., Earl, J. A., McMurray, S. L., Starner, C. J., Whitt, M. A., & Albritton, L. M. (2016). Inhibition of melanocortin 1 receptor slows melanoma growth, reduces tumor heterogeneity and increases survival. Oncotarget, 7(18), 26331–26345. https://doi.org/10.18632/oncotarget.8372"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "",
        "high_performance_liquid_chromatography": "",
        "mass_spectrometry": "",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Nonapeptide-1 for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Nonapeptide-1 For Sale (200mg) | Core Peptides",
            "og:description": "Nonapeptide-1 for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:url": "https://www.corepeptides.com/peptides/nonapeptide-1-topical-200mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T15:15:14+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2023/04/NONAPEPTIDE-1-200mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Nonapeptide-1 For Sale (200mg) | Core Peptides",
            "twitter:description": "Nonapeptide-1 for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2023/04/NONAPEPTIDE-1-200mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$214.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "214.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-NONAPEPTIDE-1",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/pt-141-10mg-bremelanotide/",
                "name": "PT-141 (Bremelanotide) (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/PT-141-10mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/cjc-1295-no-dac-mod-grf-1-29/",
                "name": "CJC-1295 NO DAC (Mod GRF 1-29) (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Mod-GRF-1-29-5mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/melanotan-1-10mg/",
                "name": "Melanotan 1 (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Melanotan-1-10MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/receptor-grade-igf-1-lr3-1mg/",
                "name": "Receptor Grade IGF-1 LR3 (1mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-1MG-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/nad-100mg-750mg/",
        "name": "NAD+ (100mg / 750mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2021/08/NAD.jpg",
        "display_price": "$47.00 – $292.00",
        "display_specs": [
            "Size: 100mg / 750mg Contents: NAD+ Form: Lyophilized powder Purity: >99% SKU: P-NADPLUS-100-750",
            "FREE Shipping on $100+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$44.65 – $277.40"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$42.30 – $262.80"
            },
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$277.40"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$262.80"
            },
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$44.65"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$42.30"
            }
        ],
        "description": [
            {
                "h2": "NAD+ Peptide"
            },
            {
                "p": "NAD+ is an acronym for Nicotinamide Adenine Dinucleotide, an endogenous nucleotide that is considered to regulate primary functions such as metabolism, energy production, and DNA repair. It is also considered to act as a secondary messenger via calcium-dependent signaling mechanisms, possibly serving as an immunoregulatory component.(1)(2) NAD+ is considered by researchers to be naturally synthesized via the de novo mechanism of converting the amino acid tryptophan through several enzymatic steps. Researchers posit that there are five components to NAD+ synthesis, including tryptophan, nicotinamide, nicotinic acid, nicotinamide riboside, and nicotinamide mononucleotide.(3) Once synthesized, research suggests it exerts over 500 enzymatic reactions and cellular processes(12) to aid metabolic activities. Essentially, it is suggested to act as a coenzyme in redox functions, converted to NADH (the energy-carrying form of NAD+), which may involve other metabolic pathways."
            },
            {
                "h3": "Overview"
            },
            {
                "p": "Researchers have suggested Nicotinamide Adenine Dinucleotide (NAD+) to act as a coenzyme, with three major classes of enzymes including:"
            },
            {
                "p": "Research suggests that each class of enzymes interacts with NAD+ in the following possible respects:"
            },
            {
                "p": "Researchers suggest the above-mentioned enzymes to be NAD+ dependent enzymes, possibly acting based on the presence of Nicotinamide Adenine Dinucleotide (NAD). Researchers suggest that should all three enzymes be dependent on NAD+, they may potentially compete amongst themselves for bioavailability. It has been posited that the potential function of SIRTs, for instance, may lead to reduced PARPs activity and, thereby, potentially lead to weakened systems. Hence, it may be critical to maintain a balance between the availability and consumption of NAD+ to obtain optimal potential impact.(5)"
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C21H27N7O14P2 Molecular Weight: 663.43 g/mol Other Known Titles: nicotinamide adenine dinucleotide"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "NAD+ Peptide and Productive Aging"
            },
            {
                "p": "Researchers suggest that NAD+ has two key intermediates: nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN). Studies have indicated that these intermediates may be potent agents for promoting 'productive aging.' In a study,(7) normal-aging mice were exposed to the NMN intermediate for 12 months. Following the study, the researchers suggested that NMN may promote NAD+ synthesis in the mice. Peptide exposure may have been the catalyst for the observed reduced weight gain, increased energy metabolism, enhanced physical activity, improved lipid profile, and other physiological impacts in the mice."
            },
            {
                "h3": "NAD+ Peptide and Neurodegenerative Activity"
            },
            {
                "p": "Scientists consider mitochondrial dysfunction to lead to various functional limitations in the electron transport chain and ATP (energy) synthesis, possibly resulting in various neurodegenerative diseases. A study(8) was conducted where aged mice were exposed to NMN, a NAD+ intermediate, for 3 to 12 months. The study's main aim was to evaluate the potential impact of the peptide on mitochondrial respiratory processes, for which fluorescent NMN protein was presented to the mice models. After peptide introduction, the mitochondrial oxygen consumption rates in the nerve and brain cells of the mice were studied. Upon analysis, it was suggested that mitochondrial functions had been restored in the aged mice, suggesting that NMN may be immediately utilized by the cells to produce NAD+, exerting a possible positive impact."
            },
            {
                "h3": "NAD+ Peptide and DNA Repair After Ischemic Stress"
            },
            {
                "p": "The main aim of this study(11) was to determine the neuroprotective potential of Nicotinamide Adenine Dinucleotide against ischemic stress induced in mice. For this study, ischemic stress was induced in the neuronal cultures in rats via deprivation of oxygen and glucose for about 2 hours. NAD+ was directly replenished into the culture medium before or after the induced ischemic stress. After 72 hours of introducing NAD+ into the cultures, it was reported by the researchers that the DNA base excision repair activity (DNA BER), cell viability, and oxidative DNA damage repair appeared to be significantly improved, irrespective of whether Nicotinamide Adenine Dinucleotide was added before or after inducing the ischemic stress."
            },
            {
                "p": "Indeed, NAD+ appears crucial for DNA integrity, with studies focusing on the enzyme poly(ADP-ribose) polymerase (PAR polymerase or PARP), which might depend on NAD+ for activating DNA repair. In the event of DNA damage, it is thought that PARP might be triggered, potentially attaching itself to the DNA's damaged parts. Researchers suggest that PARP might utilize NAD+ molecules to add ADP-ribose units to itself and other proteins in a process known as PARylation, potentially aiding in the attraction and activation of other DNA repair proteins and thereby assisting in repairing DNA damage.(15) This PARylation may lead to the formation of PAR chains, which might signal the DNA repair systems to identify and address DNA damage. PARP is also considered to have a role in detecting and mending single-strand DNA breaks. If NAD+ is confirmed as a necessary cofactor, PARP may be important in preserving genomic stability by initiating DNA repair mechanisms. However, this activity could also reduce NAD+ levels within cells, potentially affecting other NAD+-dependent processes like energy production and cellular signaling. It has been noted that DNA damage may cause a rapid increase in PAR synthesis, possibly using up significant amounts of NAD+. Consequently, researchers are exploring the idea that NAD+ depletion, triggered by PAR polymerase activation, might influence the NAD+/SIRT1 pathway, potentially affecting mitochondrial function, ROS production, DNA repair, and cell survival.(16) Consequently, the reintroduction of NAD+ in such settings may compensate for this and may be posited to support the process of DNA repair and cell survival."
            },
            {
                "h3": "NAD+ Peptide and the Liver, Kidney"
            },
            {
                "p": "Upon introducing experimental mice with the NAD+ peptide and stimulating an increase in Nicotinamide Adenine Dinucleotide levels up to normal concentrations, researchers suggested the peptide exhibited positive potential in preventing obesity and alcoholic hepatitis while possibly improving glucose homeostasis and overall liver function. When aged mice kidney cells were supplemented with NAD+, the results indicated that adding the peptide possibly promoted SIRTs activity, which exhibited neuroprotective potential against glucose-induced kidney cell hypertrophy. Furthermore, when presented with NMN, NAD+ intermediate, it appeared to promote neuroprotective impact against cisplatin-induced kidney injury.(12)"
            },
            {
                "h3": "NAD+ Peptide and Skeletal Function"
            },
            {
                "p": "Upon presenting aged mice with NMN daily for 7 days, researchers suggested that the peptide possibly increased ATP production, reduced inflammation, and elevated mitochondrial functions.(13) The researchers considered this may have been due to the role that NAD+ appears to play in cellular respiration and energy production, specifically acting as a helper molecule in redox reactions, which may be vital to converting nutrients into energy. This process, known as cellular respiration, is thought to allow cells to produce usable energy through a series of steps, and NAD+ is believed to play a key role in two specific phases: glycolysis and the citric acid cycle (or Krebs cycle). In glycolysis, the initial breakdown of glucose into pyruvate is suggested to be produced by a small amount of ATP and NADH. Here, NAD+ is thought to accept electrons and a hydrogen ion from glucose, turning into NADH. This transformation might allow NADH to transport these high-energy electrons to a later stage of energy production. Following glycolysis, pyruvate is further broken down in the citric acid cycle, potentially releasing more energy. NAD+ is implicated in various reactions during this cycle, possibly accepting electrons and hydrogen ions to form NADH. These crucial steps are considered to happen directly within the mitochondria. The NADH formed during both glycolysis and the citric acid cycle is presumed to carry high-energy electrons to the electron transport chain, the last step of cellular respiration. At this stage, NADH may give up its electrons, creating an electrochemical gradient and a chain reaction that drives protons across the mitochondrial membrane. This action appears to lead to the combination of electrons and protons with oxygen to produce water, and the energy released during this process may be used to generate ATP through oxidative phosphorylation. As NADH relinquishes its electrons, it may be transformed back into NAD+, ready to assist in another glycolysis and citric acid cycle. This regeneration of NAD+ is considered to be crucial for the ongoing production of ATP, thus maintaining the cell's energy supply."
            },
            {
                "h3": "NAD+ Peptide and Cardiac Functions"
            },
            {
                "p": "Researchers have suggested Nicotinamide Adenine Dinucleotide deficiency may lead to reduced SIRT activity, which may in turn cause reduced energy production and aortic constriction. When mice were exposed to NMN 30 minutes prior to induced-ischemia, the peptide reportedly produced a cardioprotective function against ischemic injury.(14)"
            },
            {
                "p": "NAD+ peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Schultz, Michael B, and David A Sinclair. \"Why NAD(+) Declines during Aging: It's Destroyed.\" Cell metabolism vol. 23,6 (2016): 965-966. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088772/",
                    "Braidy N, Liu Y. NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis. Exp Gerontol. 2020 Apr;132:110831. doi: 10.1016/j.exger.2020.110831. https://pubmed.ncbi.nlm.nih.gov/31917996/",
                    "Johnson, Sean, and Shin-Ichiro Imai. \"NAD + biosynthesis, aging, and disease.\" F1000Research vol. 7 132. 1 Feb 2018. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795269/",
                    "Bieganowski P, Brenner C. Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans. Cell. 2004 May 14;117(4):495-502. https://pubmed.ncbi.nlm.nih.gov/15137942/",
                    "Fang, E. F., Lautrup, S., Hou, Y., Demarest, T. G., Croteau, D. L., Mattson, M. P., & Bohr, V. A. (2017). NAD+ in Aging: Molecular Mechanisms and Translational Implications. Trends in molecular medicine, 23(10), 899–916. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494058/",
                    "Harden, A; Young, WJ (24 October 1906). \"The alcoholic ferment of yeast-juice Part II.--The coferment of yeast-juice\". Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character. 78 (526): 369–375. https://royalsocietypublishing.org/doi/10.1098/rspb.1906.0070",
                    "Mills KF, Yoshida S, Stein LR, Grozio A, Kubota S, Sasaki Y, Redpath P, Migaud ME, Apte RS, Uchida K, Yoshino J, Imai SI. Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice. Cell Metab. 2016 Dec 13;24(6):795-806. https://pubmed.ncbi.nlm.nih.gov/28068222/",
                    "Long AN, Owens K, Schlappal AE, Kristian T, Fishman PS, Schuh RA. Effect of nicotinamide mononucleotide on brain mitochondrial respiratory deficits in an Alzheimer's disease-relevant murine model. BMC Neurol. 2015 Mar 1;15:19. https://pubmed.ncbi.nlm.nih.gov/25884176/",
                    "Safety & Efficacy of Nicotinamide Riboside Supplementation for Improving Physiological Function in Middle-Aged and Older Adults. https://clinicaltrials.gov/ct2/show/NCT02921659",
                    "Braidy N, Liu Y. NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis. Exp Gerontol. 2020 Apr;132:110831. https://pubmed.ncbi.nlm.nih.gov/31917996/",
                    "Wang S, Xing Z, Vosler PS, Yin H, Li W, Zhang F, Signore AP, Stetler RA, Gao Y, Chen J. Cellular NAD replenishment confers marked neuroprotection against ischemic cell death: role of enhanced DNA repair. Stroke. 2008 Sep;39(9):2587-95. https://pubmed.ncbi.nlm.nih.gov/18617666/",
                    "Rajman, Luis et al. \"Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence.\" Cell metabolism vol. 27,3 (2018): 529-547. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6342515/",
                    "Heer C, et al, Coronavirus infection and PARP expression dysregulate the NAD metabolome: An actionable component of innate immunity. Journal of Biological Chemistry. Volume 295, Issue 52, Dec 2020. https://www.jbc.org/article/S0021-9258(17)50676-6/fulltext",
                    "Mehmel, Mario et al. \"Nicotinamide Riboside-The Current State of Research and Therapeutic Uses.\" Nutrients vol. 12,6 1616. 31 May. 2020, doi:10.3390/nu12061616 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352172/",
                    "Leung A, Todorova T, Ando Y, Chang P. Poly(ADP-ribose) regulates post-transcriptional gene regulation in the cytoplasm. RNA Biol. 2012 May;9(5):542-8. doi: 10.4161/rna.19899. Epub 2012 May 1. PMID: 22531498; PMCID: PMC3495734.",
                    "Croteau DL, Fang EF, Nilsen H, Bohr VA. NAD+ in DNA repair and mitochondrial maintenance. Cell Cycle. 2017 Mar 19;16(6):491-492. doi: 10.1080/15384101.2017.1285631. Epub 2017 Feb 1. PMID: 28145802; PMCID: PMC5384578."
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/09/NAD-100mg-coa.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/09/NAD-100mg-lc.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/09/NAD-100mg-ms.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "NAD+ for sale online (100mg / 750mg). Review NAD+ peptide potential for DNA repair, cell aging, and possible improved cellular functioning.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "NAD+ For Sale (100mg / 750mg) | Core Peptides",
            "og:description": "NAD+ for sale online (100mg / 750mg). Review NAD+ peptide potential for DNA repair, cell aging, and possible improved cellular functioning.",
            "og:url": "https://www.corepeptides.com/peptides/nad-100mg-750mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-04-23T18:50:27+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2021/08/NAD.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "NAD+ For Sale (100mg / 750mg) | Core Peptides",
            "twitter:description": "NAD+ for sale online (100mg / 750mg). Review NAD+ peptide potential for DNA repair, cell aging, and possible improved cellular functioning.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2021/08/NAD.jpg",
            "twitter:label1": "Availability",
            "twitter:data1": "In stock",
            "product:brand": "Core Peptides",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-NADPLUS-100-750",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/mgf-5mg/",
                "name": "MGF (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/MGF-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/fragment-176-191/",
                "name": "Fragment 176-191 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Fragment-176-191-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ipamorelin-5mg/",
                "name": "Ipamorelin (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Ipamorelin-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/epitalon-25mg/",
                "name": "Epithalon (25mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Epithalon-5MG-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/n-acetyl-semax-25mg/",
        "name": "N-Acetyl Semax (25mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2023/03/N-acetyl-Semax-25mg.jpg",
        "display_price": "$60.00",
        "display_specs": [
            "Size: 25mg Contents: N-Acetyl Semax Form: Lyophilized powder Purity: >99% SKU: N-Acetyl-Semax",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$57.00"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$54.00"
            }
        ],
        "description": [
            {
                "h2": "N-Acetyl Semax Peptide"
            },
            {
                "p": "N-Acetyl Semax is a synthetic polypeptide analogous to the naturally occurring adrenocorticotropic hormone (ACTH). The peptide is similar to a fragment from the adrenocorticotropic hormone ACTH (4-7), specifically Met-Glu-His-Phe, combined with a Pro-Gly-Pro extension at the C-terminus.(1) The addition of Pro-Gly-Pro (PGP) to N-Acetyl Semax might enable an enhanced permeability through the blood-brain barrier (BBB) by increasing the peptide's lipophilicity via improving passive diffusion or uptake via lipid raft-mediated endocytosis, which may potentially allow it to bypass the tight junctions of the BBB. The PGP addition at the C-terminus might also alter the peptide's interaction with specific BBB transporters or receptors, possibly promoting receptor-mediated transcytosis. Additionally, the acetylation of the peptide might increase its resistance to enzymatic degradation, prolonging its half-life in experimental models."
            },
            {
                "h3": "Overview"
            },
            {
                "p": "N-Acetyl Semax appears to exhibit potential nootropic (memory enhancing) and neuroprotective characteristics, which researchers have proposed may be produced via several routes:"
            },
            {
                "p": "Based on studies suggesting that the peptide may inhibit serum enkephalin-degrading enzymes, it is plausible to hypothesize about the interactions between Semax and enkephalins. Researchers suggest Semax's inhibitory potential on enkephalin-degrading enzymes may lead to an increase in the levels of enkephalins by preventing their degradation. Enkephalins are endogenous opioids that are considered to play roles in nociception and stress response. Further, an increase in enkephalin levels might also influence other neurotransmitter systems due to the complex interplay between the opioid system and neurotransmitters like dopamine and serotonin.(2)"
            },
            {
                "p": "According to studies, Semax may potentially increase the striatal levels of 5-hydroxyindoleacetic acid (5-HIAA), a serotonin metabolite, suggesting a possible enhancement of serotonergic activity. This potential action on serotonin metabolism might amplify serotonin-mediated pathways, possibly influencing central nervous system functioning. On the other hand, Semax does not appear to directly alter dopamine levels or its metabolites. Still, it may modulate the dopaminergic system's responsiveness, enhancing the dopaminergic agonists' action.(5)"
            },
            {
                "h3": "Chemical Makeup(6)"
            },
            {
                "p": "Molecular Formula: C37H51N9O10S Molecular Weight: 858.97 g/mol Other known titles: ACTH (4-7)PGP, HY-P1146"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "N-Acetyl Semax and Nootropic Potential"
            },
            {
                "p": "A study(5) was conducted on experimental rodents to determine the nootropic potential of ACTH hormone and its analogs, such as Semax. After exposure to Semax, all tested rodents were examined for 5-hyrodxyindoleacetic acid (5-HIAA) levels. Based on the results, it was noted that the 5-HIAA levels increased by 25% after just 2 hours following exposure; they increased progressively up to a maximum of 180% after 4 hours. As per Kirill O Eremin et al., “Our results reveal the positive modulatory [action] of Semax on the striatal serotonergic system and the ability of Semax to enhance both the striatal release of dopamine and locomotor behavior elicited by D-amphetamine.”"
            },
            {
                "p": "In another research study,(7) experimental models under excessive stress conditions were exposed to Semax. Upon analyzing behavior 24 hours after peptide exposure, it was noted that they appeared to show signs of enhanced memory and attention. As per the reports, \"In the majority of cases, the peptide exhibited positive [actions], and in no case did it produce negative side actions or complications connected with its administration. There is good reason to believe that … potentialities of Semax have not been exhausted and in the future new possibilities … will be revealed.\" The study is shared here for educational and research purposes, and studies on the Semax peptide are still being conducted."
            },
            {
                "h3": "N-Acetyl Semax and SSRI Interaction"
            },
            {
                "p": "Selective Serotonin reuptake inhibitors (SSRIs) are a class of antidepressants. In pregnant research models, the compounds may risk passing through the placenta and impacting fetal brain development. In a preclinical research study,(8) experimental rats aged between 1 and 14 days were presented first with an SSRI compound, followed by the Semax peptide. After 4 weeks, it was observed that the rats exposed to SSRIs showcased anxious behavior, especially when exposed to new stimuli. When they were given the Semax peptide, these same rats later reportedly exhibited a reduction in their anxiety levels and potential enhancement in their learning abilities."
            },
            {
                "h3": "N-Acetyl Semax and Separation Anxiety"
            },
            {
                "p": "Young offspring face separation anxiety when they are away from their mothers. Separating for a prolonged period may lead to impaired emotional reactivity. A research study(9) examined young rats facing maternal deprivation. After four weeks of separation from their mothers, these rats reportedly exhibited increased anxiety and excessive physical activity. When the rats were presented with Semax, their reactions improved, indicating reduced anxiety. As per M. A. Volodina et al., these results suggest that “Semax [weakens] the impact of deprivation on animal body weight and [normalizes] the levels of anxiety in rats.”"
            },
            {
                "h3": "N-Acetyl Semax and the Cardiovascular System"
            },
            {
                "p": "For this study,(10) rodents were induced with myocardial infarction (MI), which may lead to vascular damage. These rodents were then divided into two groups – one was given Semax peptide for six days, and the second was given a placebo. Following 28 days after the occurrence of myocardial infarction, it was reported by the researchers that the control rodents appeared to exhibit reduced arterial blood pressure and cardiac hypertrophy, both of which may signal impending heart failure. In contrast, the peptide-exposed rodents reportedly exhibited signs of prevention of diastolic blood pressure, which may indicate possible remodeling of the heart ventricle and inhibition of heart failure."
            },
            {
                "h3": "N-Acetyl Semax and Neuroprotection"
            },
            {
                "p": "In a clinical study,(11) research models of ischemic strokes were evaluated for 10 days. Of these, 30% were presented with conventional compounds and the Semax peptide, while the remaining 70% were presented with conventional compounds only. After 10 days, all models were examined via electroencephalogram (EEG). Based on the EEG mapping, the researchers reported that the experimental group exposed to both the peptide and compound exhibited apparently notable improvement in restoring damaged brain activity."
            },
            {
                "p": "N-Acetyl Semax peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References"
            },
            {
                "references": [
                    "T. Kolomin et al., A New Generation of Drugs: Synthetic Peptides based on Natural Regulatory peptides. Neuroscience & Medicine, 2013, 223-252. Published Online December 2013. http://dx.doi.org/10.4236/nm.2013.44035",
                    "Kost NV, Sokolov OIu, Gabaeva MV, Grivennikov IA, Andreeva LA, Miasoedov NF, Zozulia AA. Ingibiruiushchee deĭstvie semaksa i selanka na énkefalindegradiruiushchie fermenty syvorotki krovi cheloveka [Semax and selank inhibit the enkephalin-degrading enzymes from human serum]]. Bioorg Khim. 2001 May-Jun;27(3):180-3. Russian. doi: 10.1023/a:1011373002885. PMID: 11443939. https://pubmed.ncbi.nlm.nih.gov/11443939/",
                    "Shih-Jen Tsai, Semax, an analogue of adrenocorticotropin (4–10), is a potential agent for the treatment of attention-deficit hyperactivity disorder and Rett syndrome, Medical Hypotheses, Volume 68, Issue 5, 2007, Pages 1144-1146. https://doi.org/10.1016/j.mehy.2006.07.017",
                    "Medvedeva, E.V., Dmitrieva, V.G., Povarova, O.V. et al. The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis. BMC Genomics 15, 228 (2014). https://doi.org/10.1186/1471-2164-15-228",
                    "Eremin KO, Kudrin VS, Saransaari P, Oja SS, Grivennikov IA, Myasoedov NF, Rayevsky KS. Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents. Neurochem Res. 2005 Dec;30(12):1493-500. doi: 10.1007/s11064-005-8826-8. PMID: 16362768. https://pubmed.ncbi.nlm.nih.gov/16362768/",
                    "National Center for Biotechnology Information (2023). PubChem Compound Summary for CID 9811102, Semax.",
                    "Asmarin IP, Nezavibat'ko VN, Miasoedov NF, Kamenskiĭ AA, Grivennikov IA, Ponomareva-Stepnaia MA, Andreeva LA, Kaplan AIa, Koshelev VB, Riasina TV. Nootropnyĭ analog adrenokortikotropina 4-10-semaks (15-letniĭ opyt razrabotki i izucheniia) [A nootropic adrenocorticotropin analog 4-10-semax (l5 years experience in its design and study)]. Zh Vyssh Nerv Deiat Im I P Pavlova. 1997 Mar-Apr;47(2):420-30. Russian. PMID: 9173745. https://pubmed.ncbi.nlm.nih.gov/9173745/",
                    "Nataliya Yu. Glazova, Daria M. Manchenko, Maria A. Volodina, Svetlana A. Merchieva, Ludmila A. Andreeva, Vladimir S. Kudrin, Nikolai F. Myasoedov, Natalia G. Levitskaya, Semax, synthetic ACTH(4–10) analog, attenuates behavioural and neurochemical alterations following early-life fluvoxamine exposure in white rats, Neuropeptides, Volume 86, 2021, 102114, ISSN 0143-4179. https://doi.org/10.1016/j.npep.2020.102114",
                    "Volodina MA, Sebentsova EA, Glazova NY, Levitskaya NG, Andreeva LA, Manchenko DM, Kamensky AA, Myasoedov NF. Semax attenuates the influence of neonatal maternal deprivation on the behavior of adolescent white rats. Bull Exp Biol Med. 2012 Mar;152(5):560-3. English, Russian. doi: 10.1007/s10517-012-1574-2. PMID: 22803132. https://pubmed.ncbi.nlm.nih.gov/22803132/",
                    "Gavrilova SA, Golubeva AV, Lipina TV, Fominykh ES, Shornikova MV, Postnikov AB, Andrejeva LA, Chentsov IuS, Koshelev VB. [Protective effect of peptide semax (ACTH(4-7)Pro-Gly-Pro) on the rat heart rate after myocardial infarction]. Ross Fiziol Zh Im I M Sechenova. 2006 Nov;92(11):1305-21. Russian. PMID: 17385423. https://pubmed.ncbi.nlm.nih.gov/17385423/",
                    "Gusev EI, Skvortsova VI, Miasoedov NF, Nezavibat'ko VN, Zhuravleva EIu, Vanichkin AV. Effektivnost' semaksa v ostrom periode polusharnogo ishemicheskogo insul'ta (klinicheskoe i élektrofiziologicheskoe issledovanie) [Effectiveness of semax in acute period of hemispheric ischemic stroke (a clinical and electrophysiological study)]. Zh Nevrol Psikhiatr Im S S Korsakova. 1997;97(6):26-34. Russian. PMID: 11517472. https://pubmed.ncbi.nlm.nih.gov/11517472/"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/12/N-acetyl-Semax-COA.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/12/N-acetyl-Semax-LC.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/12/N-acetyl-Semax-MS.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "N-Acetyl Semax peptide for sale online (25mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "N-Acetyl Semax For Sale (25mg) - Core Peptides",
            "og:description": "N-Acetyl Semax peptide for sale. Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:url": "https://www.corepeptides.com/peptides/n-acetyl-semax-25mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T16:08:04+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2023/03/N-acetyl-Semax-25mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "N-Acetyl Semax For Sale (25mg) - Core Peptides",
            "twitter:description": "N-Acetyl Semax peptide for sale. Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2023/03/N-acetyl-Semax-25mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$60.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "60.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "N-Acetyl-Semax",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/ll-37-5mg/",
                "name": "LL-37 (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/LL-37-5mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/receptor-grade-igf-1-lr3-1mg/",
                "name": "Receptor Grade IGF-1 LR3 (1mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-1MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/aod-9604-5mg/",
                "name": "AOD 9604 (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/AOD-9604-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/cjc-1295-no-dac-mod-grf-1-29/",
                "name": "CJC-1295 NO DAC (Mod GRF 1-29) (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Mod-GRF-1-29-5mg-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/n-acetyl-selank-10mg/",
        "name": "N-Acetyl Selank (10mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2023/03/N-acetyl-Selank-10mg.jpg",
        "display_price": "$71.00",
        "display_specs": [
            "Size: 10mg Contents: N-Acetyl Selank Form: Lyophilized powder Purity: >99% SKU: N-Acetyl-Selank",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$67.45"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$63.90"
            }
        ],
        "description": [
            {
                "h2": "N-Acetyl Selank Peptide"
            },
            {
                "p": "N-Acetyl Selank is a short, synthetic heptapeptide analogous to the naturally occurring peptide called Tuftsin.(1) Tuftsin is an endogenous tetrapeptide that appears to regulate the immune system. Selank peptide may exhibit immunomodulatory potential; however, it has also been studied in models of anxiety and cognitive decline for its nootropic potential. Apart from the homology with tuftsin, the peptide appears to have a Pro-Gly-Pro fragment at its C-terminus, which may provide an enhancement of Selank's potential to traverse through different tissues and models including the blood-brain barrier (BBB). The BBB is a highly selective, semi-permeable border that separates the circulating blood from the tissues and extracellular fluid in the central nervous system, and is considered to play a crucial role in regulating the passage of substances. Pro-Gly-Pro addition might enhance BBB permeability by potentially impacting the peptide's overall hydrophilicity or lipophilicity, thereby increasing its affinity for the lipid-rich environment of the BBB. Additionally, the Pro-Gly-Pro sequence may interact with specific transport mechanisms or receptors at the BBB, potentially triggering a facilitated transport or receptor-mediated endocytosis. Such processes might allow Selank to bypass the tight junctions that normally restrict the passage of large molecules. Pro-Gly-Pro fragment may also influence the peptide's tertiary structure in a way that makes it more conducive to crossing the BBB."
            },
            {
                "p": "Further, N-Acetyl Selank Amidate has an additional acetyl group attached to the N-terminus. Adding an acetyl group to the N-terminus in N-Acetyl Selank Amidate may improve the peptide's stability through several speculative mechanisms. Acetylation might potentially shield the peptide from rapid enzymatic degradation by exopeptidases, as it might make the N-terminus less accessible or recognizable to these enzymes. Additionally, acetylation may induce changes in the peptide's structure, possibly leading to a more stable conformation that resists denaturation."
            },
            {
                "h3": "Overview"
            },
            {
                "p": "Studies suggest that the Selank peptide produces possible action in several ways:"
            },
            {
                "h3": "Chemical Makeup(8)"
            },
            {
                "p": "Molecular Formula: C33H57N11O9 Molecular Weight: 751.9 g/mol Other known titles: TP-7, Selanc"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "p": "Unfortunately, research on N-Acetyl Selank in its acetylated form is still sparse. However, the peptide is expected to have similar impacts as its unacetylated counterpart, Selank, with the addition possibly only affecting the peptide by providing higher stability. Because of this lack of research data, we cite only Selank studies below."
            },
            {
                "h3": "N-Acetyl Selank and Anxiolytic Action"
            },
            {
                "p": "In 2008, a clinical study(5) was conducted on research models of generalized anxiety disorder (GAD). The research models were divided into two groups – half were presented with allopathic anxiety compounds, and the other half were presented with Selank peptide. After completing this study, the psychometric levels of all models were examined."
            },
            {
                "p": "Based on the results, it was suggested that the Selank peptide appeared to be potentially as impactful as the control compound in reducing the models’ anxiety levels. The peptide-exposed group also exhibited reportedly positive psychostimulant reactions. As per A A Zozulia et al., “The clinical-biological study revealed that [models] with GAD and neurasthenia had the decreased level of tau(1/2) leu-enkephalin [...]. The increase of this parameter and stronger positive correlations with anxiety level were observed during the [exposure to] Selank.”"
            },
            {
                "h3": "N-Acetyl Selank and Anxiety"
            },
            {
                "p": "In this clinical study,(9) research models of standard anxiety and phobia thresholds were examined. The research models were separated into an experimental and control group; the controls were exposed to an allopathic compound, and the experimental group was exposed to Selank peptide. After this study's completion, the results appeared to indicate the peptide's anxiolytic and nootropic potential."
            },
            {
                "h3": "N-Acetyl Selank and Mental Cognition"
            },
            {
                "p": "Research studies(10) evaluated experimental murine models following exposure to Selank peptide, after which the mice underwent ‘training’ exercises for four days to learn conditioned avoidance response (CAR). Observing the behavior of the models throughout the training period, researchers observed that the learning abilities of murine models appeared to improve as the number of errors reduced over time, compared to control models under the same conditions. These researchers suggested that the peptide may have exhibited nootropic potential. It is posited that such actions on learning and memory might involve several interconnected mechanisms, such as the modulation of neuropeptide systems in the brain, leveraging the potential role these peptides may play in cognitive functions to enhance learning and memory processes. Further, Selank may influence the neural pathways associated with memory consolidation, possibly improving synaptic stability and efficiency, deemed essential for learning. Selank might also facilitate cognitive performance indirectly by reducing anxiety-related parameters, which may often hinder learning efficiency, suggesting a role in the affective components of cognition. The peptide may also have the unique potential to enhance neural plasticity or resilience in underperforming cognitive circuits, thereby improving their functionality."
            },
            {
                "h3": "N-Acetyl Selank and Immunomodulation"
            },
            {
                "p": "Research models of anxiety and neurasthenia were evaluated in this study(11) following routine exposure to Selank for two weeks. After two weeks, blood samples were collected and analyzed. It was reported that there was a significant rise in the levels of interleukin-6 cytokines and alteration in the Th1 to Th2 cytokine ratio. As per O.N. Uchakina et al., \"The cytokine regulating effects revealed in the study suggest that Selank [might act as] a novel immunomodulator in … anxiety-asthenic disorders. Additionally, the adaptogenic properties of Selank may benefit … environmental stressors to prevent infectious diseases.”"
            },
            {
                "h3": "N-Acetyl Selank and Substance Withdrawal"
            },
            {
                "p": "A study(12) in experimental murine models infused the animals with 10% ethanol for 24 weeks. Upon discontinuing alcohol infusion, these murine models exhibited significant alcohol withdrawal symptoms. At this time, the peptide was then given to all affected murine models. 48 hours after the peptide, it was suggested by the researchers that the alcohol withdrawal symptoms were reportedly reduced in all murine models."
            },
            {
                "h3": "N-Acetyl Selank and Cholesterol Control"
            },
            {
                "p": "In one study,(13) murine models were subjected to a high-fat diet for six consecutive weeks until they gained a standard set weight. At that time, the models were divided into two groups – one exposed to a sodium chloride solution and the rest to the Selank peptide. Upon analysis, it was observed that the peptide group exhibited apparently improved fat metabolism, with a reported reduction of cholesterol levels up to 58%. Most notably, the researchers suggested that Selank may potentially decrease total cholesterol, low-density lipoprotein (LDL), very-low-density lipoprotein (VLDL) cholesterol, and triglycerides. This suggests Selank may have either a direct or indirect role in modulating lipid metabolism and may possibly exhibit hypocholesterolemic and/or hypolipidemic action. Furthermore, the study observed apparent improvements in hemostasis parameters, such as increased total fibrinolytic activity and a reduction in platelet aggregation, which might imply amelioration of prothrombotic states. The research also hints at a potential regulatory action of Selank on glucose homeostasis."
            },
            {
                "p": "N-Acetyl Selank peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References"
            },
            {
                "references": [
                    "Kozlovskaya MM, Kozlovskii II, Val'dman EA, Seredenin SB. Selank and short peptides of the tuftsin family in the regulation of adaptive behavior in stress. Neurosci Behav Physiol. 2003 Nov;33(9):853-60. https://pubmed.ncbi.nlm.nih.gov/14969422/",
                    "Volkova, A., Shadrina, M., Kolomin, T., Andreeva, L., Limborska, S., Myasoedov, N., & Slominsky, P. (2016). Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission. Frontiers in pharmacology, 7, 31. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757669/",
                    "Semenova, T. P., kozlovskiĭ, I. I., Zakharova, N. M., & Kozlovskaia, M. M. (2009). Eksperimental'naia i klinicheskaia farmakologiia, 72(4), 6–8.",
                    "Kost, N. V., Sokolov, O. I.u, Gabaeva, M. V., Grivennikov, I. A., Andreeva, L. A., Miasoedov, N. F., & Zozulia, A. A. (2001). Ingibiruiushchee deĭstvie semaksa i selanka na énkefalindegradiruiushchie fermenty syvorotki krovi cheloveka [Semax and selank inhibit the enkephalin-degrading enzymes from human serum]]. Bioorganicheskaia khimiia, 27(3), 180–183. https://doi.org/10.1023/a:1011373002885",
                    "Zozulia, A. A., Neznamov, G. G., Siuniakov, T. S., Kost, N. V., Gabaeva, M. V., Sokolov, O. I.u, Serebriakova, E. V., Siranchieva, O. A., Andriushenko, A. V., Telesheva, E. S., Siuniakov, S. A., Smulevich, A. B., Miasoedov, N. F., & Seredenin, S. B. (2008). Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 108(4), 38–48.",
                    "Inozemtseva, L. S., Karpenko, E. A., Dolotov, O. V., Levitskaya, N. G., Kamensky, A. A., Andreeva, L. A., & Grivennikov, I. A. (2008). Intranasal administration of the peptide Selank regulates BDNF expression in the rat hippocampus in vivo. Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections, 421, 241–243. https://doi.org/10.1134/s0012496608040066",
                    "T.A Kolomin et al., Transcriptomic Response of Rat Hippocampus and Spleen Cells to Single and Chronic Administration of the Peptide Selank. June 2, 2009.",
                    "National Center for Biotechnology Information (2023). PubChem Compound Summary for CID 11765600, Selank. https://pubchem.ncbi.nlm.nih.gov/compound/Selank",
                    "Medvedev VE, Tereshchenko ON, Israelian AIu, Chobanu IK, Kost NV, Sokolov OIu, Miasoedov NF. A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders. Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(7):17-22. Russian. https://pubmed.ncbi.nlm.nih.gov/25176261/",
                    "Kozlovskii II, Danchev ND. The optimizing action of the synthetic peptide Selank on a conditioned active avoidance reflex in rats. Neurosci Behav Physiol. 2003 Sep;33(7):639-43. https://pubmed.ncbi.nlm.nih.gov/14552529/",
                    "Uchakina ON, Uchakin PN, Miasoedov NF, Andreeva LA, Shcherbenko VE, Mezentseva MV, Gabaeva MV, Sokolov OIu, Zozulia AA, Ershov FI. Immunomodulatory effects of selank in patients with anxiety-asthenic disorders. Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108(5):71-5. Russian. https://pubmed.ncbi.nlm.nih.gov/18577961/",
                    "Kolik LG, Nadorova AV, Kozlovskaya MM. Efficacy of peptide anxiolytic selank during modeling of withdrawal syndrome in rats with stable alcoholic motivation. Bull Exp Biol Med. 2014 May;157(1):52-5. https://pubmed.ncbi.nlm.nih.gov/24913576/",
                    "N.F. Mjasoedov et al, The Influence of Selank on the Parameters of the Hemostasis System, Lipid Profile, and Blood Sugar Level in the Course of Experimental Metabolic Syndrome. April 14, 2014."
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/09/N-acetyl-Selank-coa.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/09/N-acetyl-Selank-lc.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/09/N-acetyl-Selank-ms.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "N-Acetyl Selank peptide for sale online (10mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "N-Acetyl Selank For Sale (10mg) - Core Peptides",
            "og:description": "N-Acetyl Selank peptide for sale. Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:url": "https://www.corepeptides.com/peptides/n-acetyl-selank-10mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T16:04:31+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2023/03/N-acetyl-Selank-10mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "N-Acetyl Selank For Sale (10mg) - Core Peptides",
            "twitter:description": "N-Acetyl Selank peptide for sale. Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2023/03/N-acetyl-Selank-10mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$71.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "71.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "N-Acetyl-Selank",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/bpc-157/",
                "name": "BPC-157 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/BPC-157-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ll-37-5mg/",
                "name": "LL-37 (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/LL-37-5mg-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/melanotan-1-10mg/",
                "name": "Melanotan 1 (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Melanotan-1-10MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ghrp-6/",
                "name": "GHRP-6 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHRP-6-300x300.jpg.webp",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/mots-c-10mg/",
        "name": "MOTS-C (10mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2022/12/Mots-C-10MG.jpg",
        "display_price": "$116.00",
        "display_specs": [
            "Size: 10mg Contents: MOTS-C Form: Lyophilized powder Purity: >99% SKU: P-MOTS-C-10mg",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$110.20"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$104.40"
            }
        ],
        "description": [
            {
                "h2": "MOTS-c Peptide"
            },
            {
                "p": "MOTS-c (mitochondrial open-reading-frame of the 12S rRNA-c) peptide is a novel mitochondria-derived peptide. It is a short peptide composed of 16 amino acids, expressed in tissues and plasma, indicating a cell-specific and hormonal role.(1) With the potential to work both as a cell-specific compound and as a hormone, this peptide possibly acts by stimulating the AMP-activated protein kinase (AMPK) pathway. Only two mitochondrial-derived peptides (MDPs) have been studied, Humanin and MOTS-c. When metabolic stress occurs in the organism, the peptide is believed to translocate to the cellular nuclei and alter the gene expression. MOTS-c peptide may also be released extracellularly and is known as \"mitochondrial hormone\" or simply as \"mitokine.” (2)(3)"
            },
            {
                "h3": "Chemical Makeup(4)"
            },
            {
                "p": "Molecular Formula: C101H152N28O22S2 Molecular Weight: 2174.64 g/mol Other Titles: Mitochondrial-derived peptide MOTS-c, Mitochondrial open reading frame of the 12S rRNA-c"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "p": "Animal research models have indicated multiple potential actions from MOTS-c peptide, including increased physical performance, regulated cellular and tissue metabolism, and myoblast adaptation.(2) Research suggests that these actions may primarily depend on age and age-related changes in MOTS-c expression. The researchers suggest MOTS-c levels and activity might decline, hinting at a role in the cell aging process and the development of age-related metabolic dysfunction. Furthermore, MOTS-c may interact with known aging regulators, such as NAD+ and sirtuins, suggesting its involvement in pathways potentially modulating the lifespan of the cell.(1) As per Joseph C Reynolds et al., “Mitochondria are chief metabolic organelles with strong implications in cell aging that also coordinate broad physiological functions, in part, using peptides that are encoded within their independent genome.”(4) The peptide endogenous expression has also been posited to be boosted via physical activity, potentially enhancing cellular metabolism.(5)"
            },
            {
                "h3": "MOTS-c Peptide and Muscle Metabolism"
            },
            {
                "p": "With increasing age, skeletal muscles tend to gain insulin resistance, leading to decreased glucose uptake. Upon peptide exposure, skeletal muscles may be stimulated with an improved response toward AMPK activation. As a result, glucose transporter expression may increase, potentially improving skeletal muscle metabolism and enhancing skeletal muscle functioning and growth. Further, MOTS-c's actions are posited to include targeting metabolic pathways such as the folate-methionine cycle and purine biosynthesis. This targeting may potentially lead to a modulation of cellular metabolism, including actions on glucose uptake and lipid utilization. The peptide's impact might involve a shift in metabolic priorities within the cell, possibly affecting the balance between anabolic and catabolic processes. In systemic metabolism, MOTS-c is posited to function as a mitochondrial hormone, with circulating peptide levels appearing to affect metabolic functions in skeletal muscle and possibly adipose tissue. Its potential regulatory actions on glucose homeostasis and insulin action suggest a broader hormonal role in energy balance and nutrient sensing across different tissues.(1)"
            },
            {
                "h3": "MOTS-c Peptide and Fat Cell Metabolism"
            },
            {
                "p": "Research has suggested that the peptide may potentially leave the mitochondrial site, translocate to cellular nuclei, and possibly alter gene expression. More specifically, the peptide may interact with a broad range of genes, particularly those with antioxidant response elements (ARE), hinting at a potential regulatory relationship with stress-responsive transcription factors like NRF2. Such findings suggest a genetically integrated system of mitonuclear communication, where both mitochondrial and nuclear genomes may encode factors that cross-regulate each other. This action, in turn, may alter glucose uptake restriction.(6) This hypothesis was first suggested from a study in which the experimental mice were given high-fat food, and only half were presented with the peptide. The researchers indicated that MOTS-c may potentially impact cellular metabolism by inhibiting the folate cycle directly tethered de novo purine biosynthesis, consequently leading to AMPK activation. Such actions hint at a broader role of the peptide in regulating insulin sensitivity and metabolic homeostasis, offering insights into its preventive potential against age-dependent and high-fat-induced insulin resistance and diet-induced obesity. The study presents supportive data to suggest that the peptide may stimulate glucose utilization, affect the methionine-folate cycle, and promote AMPK activation. These cellular actions suggest that MOTS-c might coordinate various metabolic processes, including glucose and lipid metabolism. Consequently, the murine models exposed to the peptide were lean and more energetic than the rest, further indicating that the peptide might prevent fat accumulation and induce glucose uptake via the AMPK pathway.(3)"
            },
            {
                "h3": "MOTS-c Peptide and Bone"
            },
            {
                "p": "MOTS-c peptide has been suggested to regulate the transforming growth factor beta (TGF-beta)/SMAD pathway, which may profoundly affect bone tissues.(7) More specifically, MOTS-c's actions may involve the upregulation of TGF-β/Smad pathway-related genes, including TGF-β1, TGF-β2, and Smad7, suggesting a pivotal role of this pathway in MOTS-c mediated osteogenic differentiation. This hypothesis is further supported when the osteogenic differentiation promoted by MOTS-c is reversed upon TGF-β1 knockdown, indicating that MOTS-c's actions may be at least partly mediated through the TGF-β/Smad pathway. The peptide may also stimulate the expression of osteogenesis-related genes such as ALP, Bglap, and Runx2. Thus, this peptide may stimulate the SMAD pathway in the osteoblast cells, possibly improving bone density and strength. When studied in bone marrow cells, this compound appeared to trigger the differentiation of the stem cells, which may lead to bone tissue development."
            },
            {
                "h3": "MOTS-c Peptide and Cardiac Function"
            },
            {
                "p": "The peptide has not been suggested by researchers to directly influence cardiac function; instead, researchers posit that the peptide exerts potential on the endothelial cells that line the blood vessels inside. These endothelial tissues are considered to affect blood pressure and clotting. The researchers suspect a positive correlation exists between MOTS-c levels and microvascular and epicardial endothelial function. Such findings tentatively suggest MOTS-c as a potential biomarker for endothelial function, with the study revealing a nuanced relationship between MOTS-c levels and vascular reactivity. Further, the research suggested that when mice were exposed to MOTS-c, it appeared to improve the endothelial tissues' functioning, thereby possibly facilitating dysfunction. The mechanistic basis for MOTS-c's action on endothelial function remains speculative but may involve the activation of AMPK.(8)"
            },
            {
                "h3": "MOTS-c Peptide and Cell Lifespan"
            },
            {
                "p": "Research has suggested that the peptide may be associated with enhanced longevity on a cellular level. The peptide typically contains glutamate residue, but when this is replaced by lysine, the new compound may exert a functional change. Scientists so far are aware that the functionality of the glutamate and lysine groups are vastly different, but how this specific structural change affects peptide functionality is yet to be understood. Noriyuki Fuku et al. suggests that there is “a biological link between MOTS-c and extended lifespan through the putative endocrine action of this mitokine. Further mechanistic research is needed to determine the functional signiﬁcance of polymorphism and the potential inﬂuence of MOTS-c in the [...] aging process.” (9)"
            },
            {
                "p": "The peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Lee C, Kim KH, Cohen P. MOTS-c: A novel mitochondrial-derived peptide regulating muscle and fat metabolism. Free Radic Biol Med. 2016 Nov;100:182-187. doi: 10.1016/j.freeradbiomed.2016.05.015. Epub 2016 May 20. PMID: 27216708; PMCID: PMC5116416. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116416/",
                    "Mohtashami Z, Singh MK, Salimiaghdam N, Ozgul M, Kenney MC. Most Recent Mitochondrial Derived Peptide in Human Aging and Age-Related Diseases. Int J Mol Sci. 2022 Oct 9;23(19):11991. doi: 10.3390/ijms231911991. PMID: 36233287; PMCID: PMC9570330.",
                    "Lee C, Zeng J, Drew BG, Sallam T, Martin-Montalvo A, Wan J, Kim SJ, Mehta H, Hevener AL, de Cabo R, Cohen P. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015 Mar 3;21(3):443-54. doi: 10.1016/j.cmet.2015.02.009. PMID: 25738459; PMCID: PMC4350682.",
                    "Lu H, Wei M, Zhai Y, Li Q, Ye Z, Wang L, Luo W, Chen J, Lu Z. MOTS-c peptide regulates adipose homeostasis to prevent ovariectomy-induced metabolic dysfunction. J Mol Med (Berl). 2019 Apr;97(4):473-485. doi: 10.1007/s00109-018-01738-w. Epub 2019 Feb 6. PMID: 30725119. https://pubmed.ncbi.nlm.nih.gov/30725119/",
                    "Reynolds JC, Lai RW, Woodhead JST, Joly JH, Mitchell CJ, Cameron-Smith D, Lu R, Cohen P, Graham NA, Benayoun BA, Merry TL, Lee C. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nat Commun. 2021 Jan 20;12(1):470. https://pubmed.ncbi.nlm.nih.gov/33473109/",
                    "Kim KH, Son JM, Benayoun BA, Lee C. The Mitochondrial-Encoded Peptide MOTS-c Translocates to the Nucleus to Regulate Nuclear Gene Expression in Response to Metabolic Stress. Cell Metab. 2018 Sep 4;28(3):516-524.e7. doi: 10.1016/j.cmet.2018.06.008. Epub 2018 Jul 5. PMID: 29983246; PMCID: PMC6185997. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6185997/",
                    "Hu BT, Chen WZ. MOTS-c improves osteoporosis by promoting osteogenic differentiation of bone marrow mesenchymal stem cells via TGF-β/Smad pathway. Eur Rev Med Pharmacol Sci. 2018 Nov;22(21):7156-7163. doi: 10.26355/eurrev_201811_16247. PMID: 30468456. https://pubmed.ncbi.nlm.nih.gov/30468456/",
                    "Qin Q, Delrio S, Wan J, Jay Widmer R, Cohen P, Lerman LO, Lerman A. Downregulation of circulating MOTS-c levels in patients with coronary endothelial dysfunction. Int J Cardiol. 2018 Mar 1;254:23-27. doi: 10.1016/j.ijcard.2017.12.001. Epub 2017 Dec 6. PMID: 29242099. https://pubmed.ncbi.nlm.nih.gov/29242099/",
                    "Noriyuki Fuku el al., The mitochondrial-derived peptide: A player in exceptional longevity?, http://dx.doi.org/10.1111/acel.12389."
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/12/Mots-C-COA.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/12/Mots-C-LC.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/12/Mots-C-MS.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "MOTS-C peptide for sale online (10mg). Purchase peptides for sale at 99+% purity with unmatched customer service and free shipping.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "MOTS-C For Sale (10mg) - Core Peptides",
            "og:description": "MOTS-C peptide for sale. Purchase peptides for sale at 99+% purity with unmatched customer service and free shipping.",
            "og:url": "https://www.corepeptides.com/peptides/mots-c-10mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T16:02:30+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2022/12/Mots-C-10MG.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "MOTS-C For Sale (10mg) - Core Peptides",
            "twitter:description": "MOTS-C peptide for sale. Purchase peptides for sale at 99+% purity with unmatched customer service and free shipping.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2022/12/Mots-C-10MG.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$116.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "116.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-MOTS-C-10mg",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/ghrp-6/",
                "name": "GHRP-6 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHRP-6-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/oxytocin-10mg/",
                "name": "Oxytocin (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Oxytocin-10mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/aod-9604-5mg/",
                "name": "AOD 9604 (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/AOD-9604-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ipamorelin-5mg/",
                "name": "Ipamorelin (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Ipamorelin-5MG-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/mod-grf-ipamorelin-10mg-blend/",
        "name": "Mod GRF 1-29 & Ipamorelin Blend (10mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Mod-GRF-1-29-Ipamorelin-5-5MG.jpg",
        "display_price": "$84.00",
        "display_specs": [
            "Size: 10mg Contents: Mod GRF 1-29 (5mg) & Ipamorelin (5mg) Form: Lyophilized powder Purity: >99% SKU: P-MODGRFIPAM-10",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$79.80"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$75.60"
            }
        ],
        "description": [
            {
                "h2": "Mod GRF 1-29 & Ipamorelin Peptide Blend"
            },
            {
                "p": "The Ipamorelin peptide has been studied for its potential as a growth hormone secretagogue (GHS). This synthetic pentapeptide is thought to operate in a manner akin to Growth Hormone Releasing Peptides (GHRPs) and may simulate the natural action of the hunger hormone, ghrelin. Specifically, it is believed that Ipamorelin may activate ghrelin receptors in the anterior pituitary gland, also known as Growth Hormone Secretagogue Receptors 1 Alpha (GHS-R1a). This makes it a notably selective secretagogue and a strong agonist for the growth hormone/ghrelin secretagogue receptor."
            },
            {
                "p": "What sets Ipamorelin apart is its selectivity, as it does not appear to influence the release of other hormones from the pituitary gland, such as prolactin, follicle-stimulating hormone (FSH), luteinizing hormone (LH), thyroid-stimulating hormone (TSH), or Adrenocorticotropic hormone (ACTH). Modified GRF (1-29) peptide, also known as Mod GRF 1-29, is a synthetic analog of natural growth hormone-releasing hormone (GHRH). Comprising the initial 29 amino acids of the native hormone, this analog appears to stimulate GHRH receptors located in the somatotroph cells of the anterior pituitary gland, thereby facilitating the release of growth hormone. While it shares structural similarities with GRF 1-29, Mod GRF 1-29 has been slightly altered by replacing four amino acids in its original sequence. These adjustments seem to improve the peptide's pharmacokinetic properties. When presented together as a blend, these peptides appear to yield synergistic results, possibly stimulating the pituitary gland and triggering the release of growth hormone."
            },
            {
                "h3": "Chemical Makeup (1)(2)(3)"
            },
            {
                "p": "Molecular Formula:"
            },
            {
                "p": "Molecular Weight:"
            },
            {
                "p": "Other Known Titles"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Mod GRF 1-29 & Ipamorelin Blend General Research"
            },
            {
                "p": "A 1998 study(4) was carried out where these growth hormone secretagogues were presented in the rat pituitary gland as well as in anesthetized rats and conscious swine. Results of all three studies suggested that these peptides are agonists of GHRP-like receptors, as they bind to these receptors and help secrete higher concentrations of growth hormone. While some growth hormone secretagogues also appeared to trigger increased levels of other hormones such as cortisol and ACTH, Ipamorelin and Modified GRF 1-29 peptides appeared to exhibit selectivity towards growth hormones only, suggesting that these peptides may be particular in their functions."
            },
            {
                "p": "In one 1999 clinical study,(5) eight test subjects were enrolled to examine the potential of growth hormone secretagogues at different concentrations. The concentrations were increased every 15 minutes for up to two hours. After the study was completed, the concentration of growth hormones appeared to have significantly risen throughout the study period."
            },
            {
                "h3": "Mod GRF 1-29 & Ipamorelin Blend and Potency"
            },
            {
                "p": "In this preliminary study,(6) experimental rats were examined after being introduced to GHRH peptide analogs such as Modified GRF 1-29 peptide. The results suggested that the peptide may be considerably more potent than regular GRF 1-29."
            },
            {
                "h3": "Mod GRF 1-29 & Ipamorelin Blend and the Pituitary"
            },
            {
                "p": "When Mod GRF 1-29 interacts with GHRH receptors on the somatotroph cells of the anterior pituitary gland, it is theorized to act as a catalyst for ensuing cellular activities that may contribute to the release of growth hormone. This interaction is thought to set off a chain of intracellular signaling events. One such signaling route that seems to be engaged is the adenylyl cyclase pathway, potentially leading to the transformation of ATP (adenosine triphosphate) into cAMP (cyclic adenosine monophosphate).(7) The subsequent elevation in cAMP levels is speculated to activate protein kinase A (PKA), which in turn may result in the phosphorylation of various proteins. Among these proteins are the voltage-dependent calcium channels located on the cell membrane. The phosphorylation of these channels is conjectured to facilitate the influx of calcium ions into the somatotrophic cells. Elevated levels of intracellular calcium are considered to be a key factor in the subsequent stages that may lead to growth hormone release. It is further theorized that these high calcium concentrations within the cell could prompt the secretory vesicles in the somatotroph cells to release growth hormone into the bloodstream."
            },
            {
                "p": "It seems that Ipamorelin may also engage with cells in the front part of the pituitary gland by targeting the N-terminal region of GHS-R1a. This region contains specific binding sites that are likely sensitive to particular sequences in the secretagogue. When Ipamorelin encounters this receptor, it may form a temporary bond, facilitated by hydrogen bonds and van der Waals interactions. This transient bonding may induce a conformational change in the receptor, potentially triggering intracellular signaling pathways, predominantly those associated with G-proteins.(8) Specifically, GHS-R1a is thought to collaborate with a specialized subunit of G-proteins known as Gαq/11. Gαq/11 is believed to interact with PLC, which may then cleave a lipid molecule called phosphatidylinositol 4,5-bisphosphate (PIP2) into two secondary messengers: IP3 (Inositol trisphosphate) and DAG (Diacylglycerol). IP3 may bind to specific sites on an organelle known as the endoplasmic reticulum, possibly leading to the release of calcium ions (Ca2+) and activation of proteins that facilitate the secretion of growth hormone from pituitary cells.(9)"
            },
            {
                "h3": "Mod GRF 1-29 & Ipamorelin Blend and the Gastrointestinal System"
            },
            {
                "p": "In a particular study, scientists explored how Ipamorelin might influence gastric function, specifically focusing on its potential to accelerate gastric emptying. They used a specialized method to measure gastric emptying, which involves tracking the percentage of radioactivity remaining in the stomach 15 minutes after introducing a specific substance via intragastric gavage. The team noted that the surgical procedures performed on the abdomen could have contributed to a slower rate of gastric emptying, especially evident in the control group that received a vehicle substance. Contrastingly, Ipamorelin seemed to significantly hasten the emptying process when compared to the control group. This led the researchers to consider the possibility that Ipamorelin could enhance the speed of gastric emptying. Further investigations were carried out to understand the compound's impact on the contractile behavior of gastric smooth muscles, which were stimulated by acetylcholine and electrical field stimulation. The findings indicated that surgical intervention and manipulation of the intestines might substantially suppress the contractile responses of these muscles to both stimuli. Interestingly, this suppression appeared to be counteracted when both Ipamorelin and ghrelin were introduced together. This raises the speculative notion that Ipamorelin may not only stimulate the contractility of gastric smooth muscles but also potentially negate the inhibitory action induced by certain surgical procedures.(10)"
            },
            {
                "h3": "Mod GRF 1-29 & Ipamorelin Blend and Appetite"
            },
            {
                "p": "The potential impact of Ipamorelin on ghrelin receptors suggests it may possibly boost appetite and, maybe, contribute to weight gain. A study indicates that experimental subjects experienced an approximate 15% increase in body weight when exposed to Ipamorelin.(11) Researchers theorize that this compound may have proportionally increased fat pad weights relative to overall body mass.(11) As a result, dual-energy X-ray absorptiometry (DEXA) measurements may show a relative uptick in body fat. Additionally, data suggests that Ipamorelin may have raised levels of serum leptin, a hormone implicated in regulating energy and appetite. This leads scientists to hypothesize that increased food intake may be a factor in the observed weight gain among the Ipamorelin groups. They commented that “GHSs increase body fat by GH-independent mechanisms that may include increased feeding.”"
            },
            {
                "h3": "Mod GRF 1-29 & Ipamorelin Blend and Bone Density"
            },
            {
                "p": "In a study involving murine models, Ipamorelin and a control substance were introduced to assess their potential on bone mass. Real-time DEXA was employed to monitor changes in bone mineral content, focusing on specific regions like the femur and L6 vertebrae. After the research period, mid-diaphyseal peripheral quantitative computed tomography (pQCT) scans were conducted on the femurs of the subjects. Initial findings indicate that Ipamorelin may be linked to a potential increase in weight as well as a possible uptick in bone mineral content in the tibia and vertebrae, as revealed by DEXA, when compared to the control group. Moreover, pQCT data suggests that the observed rise in cortical BMC may be attributable to an enlargement in the bone's cross-sectional area.(12) The researchers also posited that “small stimulatory effects on linear bone growth may not have been detected statistically in the GH- and ipamorelin-treated groups,”"
            },
            {
                "p": "Mod GRF 1-29 & Ipamorelin Blend is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References"
            },
            {
                "references": [
                    "National Center for Biotechnology Information (2023). PubChem Compound Summary for CID 91976842, CJC1295 Without DAC. https://pubchem.ncbi.nlm.nih.gov/compound/CJC1295-Without-DAC.",
                    "National Center for Biotechnology Information (2023). PubChem Compound Summary for CID 9831659, Ipamorelin. https://pubchem.ncbi.nlm.nih.gov/compound/Ipamorelin.",
                    "Jetté L, Léger R, Thibaudeau K, Benquet C, Robitaille M, Pellerin I, Paradis V, van Wyk P, Pham K, Bridon DP. Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog. Endocrinology. 2005 Jul;146(7):3052-8. doi: 10.1210/en.2004-1286. Epub 2005 Apr 7. PMID: 15817669. https://pubmed.ncbi.nlm.nih.gov/15817669/",
                    "Raun K, Hansen BS, Johansen NL, Thøgersen H, Madsen K, Ankersen M, Andersen PH. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998 Nov;139(5):552-61. doi: 10.1530/eje.0.1390552. PMID: 9849822. https://pubmed.ncbi.nlm.nih.gov/9849822/",
                    "Gobburu, J.V.S., Agersø, H., Jusko, W.J. et al. Pharmacokinetic-Pharmacodynamic Modeling of Ipamorelin, a Growth Hormone Releasing Peptide, in Human Volunteers. Pharm Res 16, 1412–1416 (1999). https://doi.org/10.1023/A:1018955126402",
                    "Schally AV, Zhang X, Cai R, Hare JM, Granata R, Bartoli M. Actions and Potential Therapeutic Applications of Growth Hormone-Releasing Hormone Agonists. Endocrinology. 2019 Jul 1;160(7):1600-1612. https://pubmed.ncbi.nlm.nih.gov/31070727/",
                    "Sinha, D. K., Balasubramanian, A., Tatem, A. J., Rivera-Mirabal, J., Yu, J., Kovac, J., Pastuszak, A. W., & Lipshultz, L. I. (2020). Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males. Translational andrology and urology, 9(Suppl 2), S149–S159. https://doi.org/10.21037/tau.2019.11.30",
                    "Yin, Y., Li, Y., & Zhang, W. (2014). The growth hormone secretagogue receptor: its intracellular signaling and regulation. International journal of molecular sciences, 15(3), 4837–4855. https://doi.org/10.3390/ijms15034837",
                    "Bill, C. A., & Vines, C. M. (2020). Phospholipase C. Advances in experimental medicine and biology, 1131, 215–242. https://doi.org/10.1007/978-3-030-12457-1_9",
                    "Greenwood-Van Meerveld, B., Tyler, K., Mohammadi, E., & Pietra, C. (2012). Efficacy of ipamorelin, a ghrelin mimetic, on gastric dysmotility in a rodent model of postoperative ileus. Journal of experimental pharmacology, 4, 149–155. https://doi.org/10.2147/JEP.S35396",
                    "Lall, S., Tung, L. Y., Ohlsson, C., Jansson, J. O., & Dickson, S. L. (2001). Growth hormone (GH)-independent stimulation of adiposity by GH secretagogues. Biochemical and biophysical research communications, 280(1), 132–138. https://doi.org/10.1006/bbrc.2000.4065",
                    "Svensson, J., Lall, S., Dickson, S. L., Bengtsson, B. A., Rømer, J., Ahnfelt-Rønne, I., Ohlsson, C., & Jansson, J. O. (2000). The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats. The Journal of endocrinology, 165(3), 569–577. https://doi.org/10.1677/joe.0.1650569"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "",
        "high_performance_liquid_chromatography": "",
        "mass_spectrometry": "",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Mod GRF 1-29 Ipamorelin Blend (10mg) for sale . Purchase peptides for sale at 99+% purity with unmatched customer service and free shipping.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Buy Mod GRF 1-29 Ipamorelin blend online (10mg)",
            "og:description": "Buy Mod GRF 1-29 Ipamorelin Blend (10mg). Purchase peptides for sale at 99+% purity with unmatched customer service and Free shipping.",
            "og:url": "https://www.corepeptides.com/peptides/mod-grf-ipamorelin-10mg-blend/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T17:07:09+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Mod-GRF-1-29-Ipamorelin-5-5MG.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Buy Mod GRF 1-29 Ipamorelin blend online (10mg)",
            "twitter:description": "Buy Mod GRF 1-29 Ipamorelin Blend (10mg). Purchase peptides for sale at 99+% purity with unmatched customer service and Free shipping.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Mod-GRF-1-29-Ipamorelin-5-5MG.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$84.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:brand": "Core Peptides",
            "product:price:amount": "84.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-MODGRFIPAM-10",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/hexarelin-5mg/",
                "name": "Hexarelin (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Hexarelin-5MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/semax-25mg/",
                "name": "Semax (25mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Semax-25MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/fragment-176-191/",
                "name": "Fragment 176-191 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Fragment-176-191-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/oxytocin-10mg/",
                "name": "Oxytocin (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Oxytocin-10mg-300x300.jpg.webp",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/mod-grf-1-29-ghrp-6-blend-10mg/",
        "name": "Mod GRF 1-29 & GHRP-6 Blend (10mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2023/03/Mod-GRF-1-29-GHRP-6-5-5mg.jpg",
        "display_price": "$75.00",
        "display_specs": [
            "Size: 10mg Contents: Mod GRF 1-29 (5mg) & GHRP-6 (5mg) Form: Lyophilized powder Purity: >99% SKU: GRF-1-29-GHRP-6",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$71.25"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$67.50"
            }
        ],
        "description": [
            {
                "h2": "Mod GRF 1-29 & GHRP-6 Peptide Blend"
            },
            {
                "p": "GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic peptide developed to stimulate the release of growth hormone from the pituitary gland by mimicking the effects of ghrelin. It is classified as ghrelin mimetic or GHS (growth hormone secretagogue). It is composed of six amino acids and is classified as a hexapeptide. GHRP-6 has been studied to explore its potential action, which includes possible mitigation of growth hormone deficiency and cachexia (muscle wasting).(1)"
            },
            {
                "p": "Modified (Mod) GRF 1-29, also known as CJC-1295 without DAC (Drug Affinity Complex), is a synthetic peptide developed to act as a growth hormone-releasing hormone (GHRH) analog. It comprises 29 amino acids and is a tetrasubstituted version of the GRF 1-29 (Growth-Releasing Factor). GRF 1-29 is the smallest fragment of the GHRH peptide sequence, which may have the same potential for stimulating growth hormone release."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula:"
            },
            {
                "p": "Molecular Weight:"
            },
            {
                "p": "Other Known Titles"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Mod GRF 1-29 & GHRP-6 Peptide and the Pituitary"
            },
            {
                "p": "Mod GRF 1-29 and GHRP-6 has been suggested by researchers to work to upregulate growth hormone and insulin-like growth factor-1 (IGF-1) by activating the GHRH-receptors and the ghrelin receptors, respectively.(2) Mod GRF 1-29 appears to bind to the GHRH receptors on somatotroph cells in the anterior pituitary gland. It is hypothesized that this binding might be a potential trigger for subsequent intracellular events that possibly lead to growth hormone release. Upon binding to the receptors, Mod GRF 1-29 may potentially initiate a series of intracellular signaling cascades.(2) One pathway that appears to be activated is the adenylyl cyclase pathway, which might lead to the conversion of ATP (adenosine triphosphate) into cAMP (cyclic adenosine monophosphate). The rise in cAMP levels may possibly activate protein kinase A (PKA). This activation may result in the phosphorylation of various proteins, including the voltage-dependent calcium channels on the cell membrane."
            },
            {
                "p": "It is posited that the phosphorylation and potential opening of these calcium channels allow calcium ions to flow into the somatotropic cells. Elevated intracellular calcium concentrations are believed to play a role in subsequent steps of growth hormone release. It has also been hypothesized that high intracellular calcium concentrations may stimulate the secretory vesicles within the somatotroph cells to release growth hormone into the circulation. On the other hand, GHRP-6 has been suggested by researchers to bind to and potentially activate the ghrelin receptor, known as GHS-R1a (Growth Hormone Secretagogue Receptor 1a), which might hypothetically cause the release of growth hormone. GHRP-6 is believed to be a synthetic hexapeptide that may have a high affinity for the GHS-R1a.(3) Upon binding, GHRP-6 appears to induce a hypothetical conformational change, potentially activating the receptor."
            },
            {
                "p": "The apparent binding of GHRP-6 to GHS-R1a might activate several intracellular signaling pathways. One pathway that seems to be activated is the phospholipase C (PLC) pathway, which might lead to the production of inositol trisphosphate (IP3) and diacylglycerol (DAG). IP3 which then may initiate the release of calcium from intracellular stores, possibly leading to a rise in intracellular calcium levels. This increase in calcium is posited to play a role in the release of GH from the pituitary."
            },
            {
                "h3": "Mod GRF 1-29 & GHRP-6 Peptide and Potential Synergism"
            },
            {
                "p": "It is hypothesized that GHRP-6 may exert a synergistic effect when introduced alongside Mod GRF 1-29. While both GHRP-6 and Mod GRF 1-29 have been suggested to potentially stimulate GH release individually, their combined effect appears to be more significant than their individual impacts. This suggests that GHRP-6 and Mod GRF 1-29 might influence different somatotroph populations or that they may affect different phases of the growth hormone release process."
            },
            {
                "p": "Several studies suggest the existence of such synergisms. For example, one study reported an apparent increase in IGF-1 levels of over 65% after the combined introduction of GHRP-6 and the unmodified version of Mod GRF 1-29.(4) In comparison, previous research has suggested that Mod GRF 1-29 may potentially lead to a 27-28% increase in IGF-1, which is considerably lower increase.(5) A subsequent study appears to suggest that the original, possibly unaltered version of Mod GRF 1-29, which may be akin to native GHRH, potentially led to a 20-fold surge in pulsatile growth hormone release. At the same time, a GHRP that seems similar to GHRP-6 was apparently observed to cause a 47-fold rise in pulsatile growth hormone levels. Interestingly, when GHRH and GHRP were possibly combined, the mixture may have resulted in a 54-fold increase in pulsatile GH release compared to baseline, which may hint at a synergistic effect. This combination might, in theory, offer enhanced stimulation of growth hormone secretion.(6)"
            },
            {
                "h3": "Mod GRF 1-29 & GHRP-6 Peptide and Muscle Mass"
            },
            {
                "p": "GHRP-6 and Mod GRF 1-29 have been suggested by researchers to exert anabolic properties by increasing growth hormone levels. For example, clinical studies with GRF 1-29 suggest that it may increase nocturnal growth hormone levels, serum levels of IGF-I and IGFBP-3, and GHBP concentrations.(5) As a result, male test subjects who were presented the peptide for four months reportedly experienced a significant increase in lean body mass by 1.26 kg. The peptide also appeared to induce a possible increase in skin thickness in male subjects and possible improved insulin sensitivity."
            },
            {
                "p": "Another trial supported the hypothesis that GRF (1-29) might increase GH and IGF-I levels and improve skeletal muscle function and metabolism in ambulatory, non-obese subjects aged 64 to 76 years with low baseline IGF-I.(7) More specifically, GRF (1-29) appeared to increase mean nocturnal GH release, GH peak amplitude, and two measures of muscle strength and a muscle endurance test."
            },
            {
                "p": "GHRP-6 also may have anabolic potential, according to certain study findings. This potential is likely mediated via its alleged growth hormone and IGF-1 stimulating action. One experiment with cultured myoblast cells reported that the peptide appeared to increase the expression of myogenic marker proteins, insulin-like growth factor-1, collagen type I, and metabolic activity in the myoblasts.(8) Thus, the scientists concluded that the peptide GHRP-6 might improve muscle condition by stimulating collagen type I synthesis and key proteins."
            },
            {
                "h3": "Mod GRF 1-29 & GHRP-6 Peptide and Growth Hormone Deficiency"
            },
            {
                "p": "GRF 1-29 and GHRP-6 have been investigated for their potential to stimulate growth in models of growth hormone deficiencies. One clinical study investigated the potential of GRF 1-29 for growth hormone deficiency.(9) In total, 110 subjects were presented with the peptide once daily for up to one year, and the main outcomes measured were linear growth enhancement and bone age progression. The peptide appeared to exhibit a significant increase in height velocity, with 74% of the subjects having a reportedly enhanced response after six months. The bone age to height age ratio was reported to remain stable. The researchers concluded, “No change in fasting glucose concentration or excessive generation of insulin-like growth factor I occurred, and overall GHRH was well tolerated.”"
            },
            {
                "p": "Another clinical trial aimed to investigate the potential of GHRP-6 in stimulating growth hormone (GH) secretion in subjects with normal height.(10) The study included 13 subjects, and the results suggested that the GH response to GHRP-6 was reportedly significant and comparable to that of other GHSs."
            },
            {
                "h3": "Mod GRF 1-29 & GHRP-6 Peptide and Wasting, Cachexia"
            },
            {
                "p": "Mod GRF 1-29 and GHRP-6 reportedly exhibits some potential to increase growth hormone and IGF-1 levels, which may have anti-catabolic actions on muscle tissue. For example, GRF 1-29 was suggested to significantly increase growth hormone peak levels in research models, even though the potential appeared slightly attenuated in those with growth hormone deficiency.(11) Despite no direct research on Mod GRF 1-29 (without DAC), studies on Mod GRF 1-29 with DAC report apparently increased HGH and IGF-1 levels in the test subjects.(12)"
            },
            {
                "p": "GHRP-6 may also cause a dramatic increase in growth hormone levels, according to researchers in clinical trials. For example, Cordido et al. suggested that GHRP-6 might increase GH secretion in 19 obese subjects.(13) The scientists noted that GHRP-6 appeared more impactful than GHRH alone, stating, “GH responses to GHRP-6 were almost twice those to GHRH in obese patients.” GHRP-6 was developed with the intention of having potential as a ghrelin mimetic. Studies suggest that mimetics have shown promise in reversing protein breakdown and weight loss in catabolic states.(14) Ghrelin has various potential actions on regulating appetite, body composition, growth hormone secretion, and energy expenditure. It may also have anti-inflammatory, anti-apoptotic, and anxiolytic potential as well."
            },
            {
                "p": "Mod GRF 1-29 & GHRP-6 peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Cabrales, A., Gil, J., Fernández, E., Valenzuela, C., Hernández, F., García, I., Hernández, A., Besada, V., Reyes, O., Padrón, G., Berlanga, J., Guillén, G., & González, L. J. (2013). Pharmacokinetic study of Growth Hormone-Releasing Peptide 6 (GHRP-6) in nine healthy male volunteers. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 48(1-2), 40–46. https://doi.org/10.1016/j.ejps.2012.10.006",
                    "Sinha, D. K., Balasubramanian, A., Tatem, A. J., Rivera-Mirabal, J., Yu, J., Kovac, J., Pastuszak, A. W., & Lipshultz, L. I. (2020). Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males. Translational andrology and urology, 9(Suppl 2), S149–S159. https://doi.org/10.21037/tau.2019.11.30",
                    "Abizaid, A., & Hougland, J. L. (2020). Ghrelin Signaling: GOAT and GHS-R1a Take a LEAP in Complexity. Trends in endocrinology and metabolism: TEM, 31(2), 107–117. https://doi.org/10.1016/j.tem.2019.09.006",
                    "Sigalos, J. T., Pastuszak, A. W., Allison, A., Ohlander, S. J., Herati, A., Lindgren, M. C., & Lipshultz, L. I. (2017). Growth Hormone Secretagogue Treatment in Hypogonadal Men Raises Serum Insulin-Like Growth Factor-1 Levels. American journal of men's health, 11(6), 1752–1757. https://doi.org/10.1177/1557988317718662",
                    "Khorram, O., Laughlin, G. A., & Yen, S. S. (1997). Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women. The Journal of clinical endocrinology and metabolism, 82(5), 1472–1479. https://doi.org/10.1210/jcem.82.5.3943",
                    "Veldhuis, J. D., & Keenan, D. M. (2008). Secretagogues govern GH secretory-burst waveform and mass in healthy eugonadal and short-term hypogonadal men. European journal of endocrinology, 159(5), 547–554. https://doi.org/10.1530/EJE-08-0414",
                    "Vittone, J., Blackman, M. R., Busby-Whitehead, J., Tsiao, C., Stewart, K. J., Tobin, J., Stevens, T., Bellantoni, M. F., Rogers, M. A., Baumann, G., Roth, J., Harman, S. M., & Spencer, R. G. (1997). Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men. Metabolism: clinical and experimental, 46(1), 89–96. https://doi.org/10.1016/s0026-0495(97)90174-8",
                    "Lim, C. J., Jeon, J. E., Jeong, S. K., Yoon, S. J., Kwon, S. D., Lim, J., Park, K., Kim, D. Y., Ahn, J. K., & Kim, B. W. (2015). Growth hormone-releasing peptide-biotin conjugate stimulates myocytes differentiation through insulin-like growth factor-1 and collagen type I. BMB reports, 48(9), 501–506. https://doi.org/10.5483/bmbrep.2015.48.9.258",
                    "Thorner, M., Rochiccioli, P., Colle, M., Lanes, R., Grunt, J., Galazka, A., Landy, H., Eengrand, P., & Shah, S. (1996). Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group. The Journal of clinical endocrinology and metabolism, 81(3), 1189–1196. https://doi.org/10.1210/jcem.81.3.8772599",
                    "Bellone, J., Ghizzoni, L., Aimaretti, G., Volta, C., Boghen, M. F., Bernasconi, S., & Ghigo, E. (1995). Growth hormone-releasing effect of oral growth hormone-releasing peptide 6 (GHRP-6) administration in children with short stature. European journal of endocrinology, 133(4), 425–429. https://doi.org/10.1530/eje.0.1330425",
                    "Achermann, J. C., Hindmarsh, P. C., Robinson, I. C., Matthews, D. R., & Brook, C. G. (1999). The relative roles of continuous growth hormone-releasing hormone (GHRH(1-29)NH2) and intermittent somatostatin(1-14)(SS) in growth hormone (GH) pulse generation: studies in normal and post cranial irradiated individuals. Clinical endocrinology, 51(5), 575–585. https://doi.org/10.1046/j.1365-2265.1999.00839.x",
                    "Teichman, S. L., Neale, A., Lawrence, B., Gagnon, C., Castaigne, J. P., & Frohman, L. A. (2006). Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. The Journal of clinical endocrinology and metabolism, 91(3), 799–805. https://doi.org/10.1210/jc.2005-1536",
                    "Sigalos, J. T., & Pastuszak, A. W. (2018). The Safety and Efficacy of Growth Hormone Secretagogues. Sexual medicine reviews, 6(1), 45–53. https://doi.org/10.1016/j.sxmr.2017.02.004",
                    "Khatib, M. N., Gaidhane, A., Gaidhane, S., & Quazi, Z. S. (2018). Ghrelin as a Promising Therapeutic Option for Cancer Cachexia. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 48(5), 2172–2188. https://doi.org/10.1159/000492559"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "",
        "high_performance_liquid_chromatography": "",
        "mass_spectrometry": "",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Mod GRF 1-29 & GHRP-6 Blend for sale (10mg). Purchase peptide blends at 99+% purity with unmatched customer service and free shipping.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Mod GRF 1-29 & GHRP-6 Blend For Sale (10mg) - Core Peptides",
            "og:description": "Mod GRF 1-29 & GHRP-6 Blend for sale (10mg). Purchase peptide blends at 99+% purity with unmatched customer service and free shipping.",
            "og:url": "https://www.corepeptides.com/peptides/mod-grf-1-29-ghrp-6-blend-10mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T16:03:36+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2023/03/Mod-GRF-1-29-GHRP-6-5-5mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Mod GRF 1-29 & GHRP-6 Blend For Sale (10mg) - Core Peptides",
            "twitter:description": "Mod GRF 1-29 & GHRP-6 Blend for sale (10mg). Purchase peptide blends at 99+% purity with unmatched customer service and free shipping.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2023/03/Mod-GRF-1-29-GHRP-6-5-5mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$75.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "75.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "GRF-1-29-GHRP-6",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/dsip-5mg/",
                "name": "DSIP (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/DSIP-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/bpc-157/",
                "name": "BPC-157 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/BPC-157-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ghk-cu-50mg-copper/",
                "name": "GHK-Cu (Copper) (50mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHK-CU-50mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/mgf-5mg/",
                "name": "MGF (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/MGF-5MG-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/mod-grf-ghrp-2-10mg-blend/",
        "name": "Mod GRF 1-29 & GHRP-2 Blend (10mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Mod-GRF-1-29-GHRP-2-5-5mg.jpg",
        "display_price": "$73.00",
        "display_specs": [
            "Size: 10mg Contents: Mod GRF 1-29 (5mg) & GHRP-2 (5mg) Form: Lyophilized powder Purity: >99% SKU: P-MODGRFGHR2-10",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$69.35"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$65.70"
            }
        ],
        "description": [
            {
                "h2": "Mod GRF 1-29 & GHRP-2 Peptide Blend"
            },
            {
                "p": "GHRP-2 and Modified GRF 1-29 peptides are synthetic peptides developed with the intention to aid in synthesis, secretion, and regulation of growth hormone synthesis. These peptides appear to exert synergistic action when taken together as a blend."
            },
            {
                "p": "GHRP-2 is a synthetic peptide that apparently activates the receptors for ghrelin.(1) Ghrelin is a naturally occurring peptide containing 28 amino acids that is considered by scientists to regulate growth hormones, and increase appetite.(2) This is why it is also referred to as ‘the hunger hormone.’ GHRP-2 appears to activate the ghrelin receptors in the pituitary gland, which are also called growth hormone secretagogue receptors, and thus may potentially stimulate growth hormone release. Thus, GHRP-2 has been characterized by researchers as a growth hormone secretagogue (GHS)."
            },
            {
                "p": "Modified GRF 1-29 (or Mod GRF 1-29) is a man-made peptide analog to the naturally occurring growth hormone-releasing hormones (GHRH). It is made of the first 29 amino acids of the native hormone, which appears sufficient for activating the GHRH receptors in the somatotroph cells in the anterior pituitary gland and triggering growth hormone release. Structurally similar to GRF 1-29, the peptide contains a chain of 29 amino acids and is slightly modified for proposed durability by substituting four of the amino acids in the original amino acid-chain.(3) These modifications appear to enhance the pharmacokinetics of the peptide."
            },
            {
                "p": "GHRP-2 and Mod GRF 1-29 have been studied for their individual potential to stimulate the somatotroph cells in the pituitary gland, possibly triggering the secretion of growth hormone.(4)"
            },
            {
                "h3": "Chemical Makeup (3)(5)"
            },
            {
                "p": "Molecular formula:"
            },
            {
                "p": "Molecular weight:"
            },
            {
                "p": "Other known titles:"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Modified GRF 1-29 & GHRP-2 Peptide Blend and Tolerability"
            },
            {
                "p": "Research studies in animal models(5) have conducted to understand the various potential actions of GHSs such as GHRP-2. According to researchers, the presentation of the peptides in both guinea pigs and rabbits did not result in any serious or profound action on the tested experimental models. The only reported change was seen was an increase in the motility rate of the isolated ileum of rabbits and increased muscle contractions in the isolated ileum of the guinea pigs. No other impacts were observed on the kidneys, respiratory, gastric, and blood systems. As per Furuta S et al., these results suggest that the peptide “has no serious general pharmacological effects at dose levels showing GH-releasing activity in the experimental animals. Therefore, it is concluded that the peptide [may be useful in] diagnosing serious GH deficiency and treating short stature.” (5)"
            },
            {
                "h3": "Modified GRF 1-29 & GHRP-2 Peptide Blend and Appetite"
            },
            {
                "p": "Due to its potential to activate the ghrelin receptors not just in the pituitary gland but also in other areas, GHRP-2 is considered the likely compound for inducing hunger and appetite increase in this peptide blend. A clinical trial(6) was carried out in which seven test subjects were observed. The subjects in the trial were divided into two groups – one experimental peptide group and a placebo (saline) group receiving each of the compounds for approximately 5 hours. After peptide presentation, all subjects were taken to buffet-style meals to measure their food intake. The peptide group were reported to have consumed approximately 35% more food measured in kilocalories than the saline group, with each subject exhibiting increased appetite when measured against their body weight. Moreover, the concentration of growth hormone also appeared to increase significantly in the peptide test subjects. These results indicate a possibility that one of the additional actions of the peptide blend may be increased food intake and appetite, particularly due to the presence of GHRP-2."
            },
            {
                "h3": "General Research in Growth Hormone Secretagogues (GSHs), Growth Hormone Releasing Peptides (GHRPs)"
            },
            {
                "p": "A literature review(7) aimed to evaluate the potential impacts of growth hormone secretagogues (GSHs) such as GHRP-2. As part of some of the studies included in the review, subjects were monitored for physiological changes after being presented with the peptide. The results suggested that these peptides appeared to yield an increased growth rate in younger subjects, with increased appetite, and increased lean mass in mature subjects. In obese test subjects, these peptides appeared to stimulate a reduction in bone turnover, increased lean mass, and improved sleep cycle. The researchers stated that these peptides appear to “increase lean body mass, reduce fat mass, increase exercise tolerance and maximum oxygen uptake, enhance muscle strength, and improve linear growth.”(7)"
            },
            {
                "h3": "Modified GRF 1-29 & GHRP-2 Peptide Blend and Growth Hormone Deficiency"
            },
            {
                "p": "Since 2000, several clinical studies have been conducted on test models of growth hormone deficiency. Models presented with the GHRP-2 peptide stimulating growth hormone release indicated that this peptide might produce action in two ways, including (i) possibly stimulating the pituitary gland to release growth hormones and (ii) acting on the arcuate nucleus of the hypothalamus. While GHRP-2 appears to yield high concentrations of growth hormone, it remains to be seen how its action is exerted. In addition, these studies suggested that these peptides may impact food intake and sleep cycle via receptor-specific agonist actions.(8)"
            },
            {
                "p": "In another GHRP-2 study focusing on young test subjects, six growth hormone-deficient subjects facing growth failure were presented with different concentrations of the peptide for eight months.(9) All subjects were monitored for any significant rise in growth hormone levels and toxicity levels during this period. Throughout the study, there appeared to be a steep rise in the levels of growth hormones in all subjects for the duration of the study and a little time after. As per V Mericq et al., the study suggested that the peptide was “well tolerated and [may] stimulate GH secretion.”"
            },
            {
                "h3": "Modified GRF 1-29 & GHRP-2 Peptide Blend and Hormones"
            },
            {
                "p": "In one clinical study,(10) the primary objective was to understand the impact of GHRP-2 presentation on growth hormones, cortisol, prolactin, and adrenocorticotropic hormone (ACTH) levels in male test subjects. All subjects were divided into two groups based on their age – the first group had six mature subjects aged between 22 and 27 years, and the second group had 6 mature subjects aged between 66 and 73 years. Both groups were presented with GHRP-2. While the growth hormone levels increased in both groups, the younger group was observed to have a significant increase compared to the elderly subjects. It also appeared to stimulate increased levels of ACTH and cortisol hormones and a mild increase in prolactin levels. The results supported the hypothesis that the peptide may have profound hormonal secretion capabilities in both mature and young male test subjects."
            },
            {
                "h3": "Modified GRF 1-29 & GHRP-2 Peptide Blend and the GHRH receptors"
            },
            {
                "p": "While GHRP-2 appears to function by binding to the GHS-R1a receptor, often referred to as the growth hormone secretagogue receptor type 1a, Mod GRF 1-29 appears to promote growth hormone release by potentially engaging with the GHRH receptors located on the somatrophs of the anterior pituitary gland. Upon binding to these receptors, Mod 1-29 appears to potentially trigger a series of intracellular signals. A notable pathway that gets activated is the adenylyl cyclase pathway, which might lead to the transformation of ATP (adenosine triphosphate) into cAMP (cyclic adenosine monophosphate). The subsequent increase in cAMP levels seems to stimulate protein kinase A (PKA), possibly resulting in the phosphorylation of specific proteins, such as the voltage-dependent calcium channels on the cellular membrane. The opening of these channels might allow calcium ions to flow into the somatotropic cells. This surge in intracellular calcium seems to encourage the secretory vesicles within these cells to discharge growth hormone into the bloodstream. Researchers have suggested that Mod GRF 1-29, through these cellular processes, may aid in the release and production of growth hormone upon interaction with GHRH receptors."
            },
            {
                "h3": "Modified GRF 1-29 & GHRP-2 Peptide Blend and the Insulin-like Growth Factor-1 (IGF-1)"
            },
            {
                "p": "A comprehensive review of the literature suggests that both the GHRH-mimetics like Mod GRF-1 and the GHS GHRP-2 may upregulate growth hormone levels and consecutively its main anabolic mediator IGF-1. The researchers comment that the unmodified version of Mod GRF-1 may apparently boost mean growth hormone levels by 82% in research conditions, as indicated by area under the curve (AUC) measurements. The growth hormone concentrations appeared elevated for about two hours after the intervention.(11)"
            },
            {
                "p": "Other trials have also suggested a potential 64% increase in mean growth hormone levels as measured by AUC, and the increase appeared greater in studies conducted in the evening, compared to those conducted in the morning. This apparent increase in growth hormone levels has also been suggested to occur in modified versions of GRF 1-29 which closely resemble Mod GRF-1 and have been posited to reach 70-107% increase in growth hormone levels measured by AUC. This potentially translates to a significant increase in IGF-1 levels of 27-28%.(11)"
            },
            {
                "p": "Another trial covered in the aforementioned review also suggested that the combination of unmodified Mod GRF 1-29 and GHSs like GHRP-2 might result in whopping 65% increase in IGF-1 levels.(11)"
            },
            {
                "h3": "Modified GRF 1-29 & GHRP-2 Peptide Blend and Synergistic Potential"
            },
            {
                "p": "As mentioned, both Mod GRF 1-29 and GHRP-2 appear to stimulate the release of growth hormone. The available research suggests that GHRP-2 may lead to a 47-fold increase in pulsatile growth hormone secretion. Unfortunately, there is a lack of experiments revealing how much exactly Mod GRF 1-29 may upregulate growth hormone synthesis. Yet trials on another GHRH-mimetic, more specifically the non-truncated and unmodified version of Mod GRF 1-29 which has shorter half life, appear to lead to a 20-fold increase in pulsatile growth hormone secretion. It has been hypothesized that the combination of such GHRH-mimetics and the secretagogue GHRP-2 may potentially exhibit synergistic potential in regards to their apparent stimulation of growth hormone secretion. Notably, when combining GHRH and GHRP-2, the blend was observed to induce a 54-fold increase in pulsatile GH secretion compared to controls, suggesting a synergistic potential.(11)"
            },
            {
                "p": "Mod GRF 1-29 & GHRP-2 blend is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References"
            },
            {
                "references": [
                    "Garcia JM, Merriam GR, Kargi AY. Growth Hormone in Aging. [Updated 2019 Oct 7]. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com https://www.ncbi.nlm.nih.gov/books/NBK279163/",
                    "Phung LT, Sasaki A, Lee HG, Vega RA, Matsunaga N, Hidaka S, Kuwayama H, Hidari H. Effects of the administration of growth hormone-releasing peptide-2 (GHRP-2) orally by gavage and in feed on growth hormone release in swine. Domest Anim Endocrinol. 2001 Jan;20(1):9-19. https://pubmed.ncbi.nlm.nih.gov/11164330/",
                    "National Center for Biotechnology Information (2023). PubChem Compound Summary for CID 91976842, CJC1295 Without DAC. https://pubchem.ncbi.nlm.nih.gov/compound/CJC1295-Without-DAC.",
                    "Roh SG, He ML, Matsunaga N, Hidaka S, Hidari H. Mechanisms of action of growth hormone-releasing peptide-2 in bovine pituitary cells. J Anim Sci. 1997 Oct;75(10):2744-8. doi: 10.2527/1997.75102744x. PMID: 9331879. https://pubmed.ncbi.nlm.nih.gov/9331879/",
                    "Furuta S, Shimada O, Doi N, Ukai K, Nakagawa T, Watanabe J, Imaizumi M. General pharmacology of KP-102 (GHRP-2), a potent growth hormone-releasing peptide. Arzneimittelforschung. 2004;54(12):868-80. doi: 10.1055/s-0031-1297042. PMID: 15646371. https://pubmed.ncbi.nlm.nih.gov/15646371/",
                    "Laferrère, Blandine et al. “Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men.” The Journal of clinical endocrinology and metabolism vol. 90,2 (2005): 611-4. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824650/",
                    "Sigalos, John T, and Alexander W Pastuszak. “The Safety and Efficacy of Growth Hormone Secretagogues.” Sexual medicine reviews vol. 6,1 (2018): 45-53. doi:10.1016/j.sxmr.2017.02.004 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632578/",
                    "Rogério G. Gondo et al, Growth Hormone-Releasing Peptide-2 Stimulates GH Secretion in GH-Deficient Patients with Mutated GH-Releasing Hormone Receptor, The Journal of Clinical Endocrinology & Metabolism, Volume 86, Issue 7, 1 July 2001, Pages 3279–3283, https://doi.org/10.1210/jcem.86.7.7694.",
                    "Mericq V, Cassorla F, Salazar T, Avila A, Iñiguez G, Bowers CY, Merriam GR. Effects of eight months treatment with graded doses of a growth hormone (GH)-releasing peptide in GH-deficient children. J Clin Endocrinol Metab. 1998 Jul;83(7):2355-60. https://pubmed.ncbi.nlm.nih.gov/9661608/",
                    "Emanuela Arvat, Lidia Di Vito, Barbara Maccagno, Fabio Broglio, Muni F Boghen, Romano Deghenghi, Franco Camanni, Ezio Ghigo, Effects of GHRP-2 and Hexarelin, Two Synthetic GH-Releasing Peptides, on GH, Prolactin, ACTH and Cortisol Levels in Man. Comparison with the Effects of GHRH, TRH and hCRH, Peptides, Volume 18, Issue 6, 1997, Pages 885-891, ISSN 0196-9781, https://doi.org/10.1016/S0196-9781(97)00016-8",
                    "Sinha, D. K., Balasubramanian, A., Tatem, A. J., Rivera-Mirabal, J., Yu, J., Kovac, J., Pastuszak, A. W., & Lipshultz, L. I. (2020). Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males. Translational andrology and urology, 9(Suppl 2), S149–S159. https://doi.org/10.21037/tau.2019.11.30"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "",
        "high_performance_liquid_chromatography": "",
        "mass_spectrometry": "",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Mod GRF 1-29 & GHRP-2 Blend for Sale (10mg). Purchase peptides at 99+% purity with unmatched customer service and free shipping.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Mod GRF 1-29 & GHRP-2 Blend for Sale (10mg)",
            "og:description": "Mod GRF 1-29 & GHRP-2 Blend for Sale (10mg). Purchase peptides at 99+% purity with unmatched customer service and free shipping.",
            "og:url": "https://www.corepeptides.com/peptides/mod-grf-ghrp-2-10mg-blend/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T17:05:51+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Mod-GRF-1-29-GHRP-2-5-5mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Mod GRF 1-29 & GHRP-2 Blend for Sale (10mg)",
            "twitter:description": "Mod GRF 1-29 & GHRP-2 Blend for Sale (10mg). Purchase peptides at 99+% purity with unmatched customer service and free shipping.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Mod-GRF-1-29-GHRP-2-5-5mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$73.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:brand": "Core Peptides",
            "product:price:amount": "73.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-MODGRFGHR2-10",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/cjc-1295-dac-5mg/",
                "name": "CJC-1295 DAC (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/CJC-1295-DAC-5MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ghk-cu-50mg-copper/",
                "name": "GHK-Cu (Copper) (50mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHK-CU-50mg-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/bpc-157/",
                "name": "BPC-157 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/BPC-157-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ghrp-6/",
                "name": "GHRP-6 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHRP-6-300x300.jpg.webp",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/mgf-5mg/",
        "name": "MGF (5mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2020/04/MGF-5MG.jpg",
        "display_price": "$50.00",
        "display_specs": [
            "Size: 5mg Contents: MGF (5mg) Form: Lyophilized powder Purity: >99% SKU: P-MGF-5",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$47.50"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$45.00"
            }
        ],
        "description": [
            {
                "h2": "Mechano Growth Factor (MGF) Peptide"
            },
            {
                "p": "MGF stands for Mechano Growth Factor, an endogenous, naturally occurring peptide that belongs to the class of IGF-1 (insulin-like growth factor) family.(1) What differentiates MGF from systemic IGF-1 is that it contains 49 base pairs at exon 5 in its structural composition, which may possibly introduce a frameshift to exert unique characteristics.(2) Researchers consider MGF to be an isoform of IGF-1, also known as IGF-1Ec (otherwise referred to as full-length MGF).(3)"
            },
            {
                "p": "As IGF-1 undergoes alternative splicing and transcription, it appears to produce three isoforms. IGF-1 undergoes splicing under stress conditions, such as during resistance activities within muscle groups.(4) As a result of this splicing and due to the unique 49 base pair insert added to the peptide, it may produce a mature isoform of IGF-1, namely, naturally occurring MGF.(4)"
            },
            {
                "h3": "Overview"
            },
            {
                "p": "During IGF-1 research studies, scientists first posited the phenomenon of IGF-1 splicing and isoform production. The only factor identified by the researchers that distinguished the three isoforms appears to be the amino acid sequence attached to the COOH terminal. It was only in the late 1990s and early 2000s that the uniqueness of IGF-1Ec was suggested when it was theorized that its levels increased upon muscle injury.(5)"
            },
            {
                "p": "There is a synthetic version of the MGF peptide composed of 24 amino acids attached to the C-terminal of the isolated MGF domain, called MGF-Ct24E peptide, or E-domain of IGF-1Ec.(6) During the studies conducted in the early 2000s,(6) it was suggested that the MGF-Ct24E peptide may exhibit potential to induce muscle precursor cell proliferation. Muscle precursor cells are ‘satellite’ cells in myofiber, which increase to form new muscles."
            },
            {
                "p": "MGF is posited to increase in a growth hormone-dependent fashion, akin to IGF-1, which is also considered to potentially represent the main anabolic mediator of growth hormone. Studies suggest that growth hormones may also impact MGF expression by approximately 80%, relative to the baseline. In stark contrast, resistance activity in muscle tissue alone appears to elicit a response in MGF mRNA, with an increase of 163% from baseline. This immediate response may suggest a more direct or sensitive reaction of MGF to mechanical stimuli, yet the extent and nature of this sensitivity remain speculative. An apparent elevation of growth hormone that occurs in addition to resistance training might further complicate this response, as supported by a reported 456% increase in MGF mRNA.(7)"
            },
            {
                "p": "Research studies are still underway to determine the mechanism of action of both the naturally occurring and synthetically developed MGF peptide. Hypotheses under investigation include the peptide's potential impact on damaged muscle cells, tissue repair and recovery, possible neuroprotective and cardioprotective characteristics, and potential impact on muscle cell apoptosis."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C124H204N42O41S1 Molecular Weight: 2971.99 g/mol Other Known Titles: MGF-E, MGF-Ct24E"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "MGF Peptide and Muscle Mass"
            },
            {
                "p": "The main aim of one critical study on MGF(8) was to determine the potential of the synthetic peptide, aka the MGF-E domain made of 24 amino acids, on different aged cells. This was a study where muscle cell cultures, which ranged from neonatal to aged, were evaluated. The culture cells were analyzed after exposure to MGF-E. The peptide seemed to delay the onset of cellular senescence in younger cells, suggesting a potential to preserve muscle function and repair capabilities that diminish naturally. Furthermore, the results suggested cell proliferation in all cells isolated from neonatal to young cells; however, this was not the case in aged cells. Muscle hypertrophy appeared to be increased in the older cells, with a significant decrease in the reserve cells. It appeared to have induced hypertrophy in muscle cells across all ages by increasing the fusion index and the size of myotubes, which are formed from the fusion of muscle cells. The researchers observed that MGF-E may potentially also increase the expression of muscle-specific contractile proteins, indicating not only an increase in muscle cell size but also in functional capacity. Furthermore, the reduction in reserve cells appears notable as this may be a subpopulation of cells that do not initially differentiate or fuse into myotubes. MGF-E apparently led to a decreased proportion of these reserve cells in culture, suggesting that the peptide might prompt these cells to contribute to muscle formation. This finding is particularly noteworthy as it points to a mechanism by which MGF might potentially enhance muscle regeneration and maintenance."
            },
            {
                "h3": "MGF Peptide and Muscle Recovery"
            },
            {
                "p": "The main aim of another study(9) was to evaluate the potential of MGF on skeletal muscle injury repair and healing. This study was performed on mice that were experimentally induced with muscle contusion. Following Mechano Growth Factor (MGF) exposure and analysis of the muscle tissues, researchers suggested that MGF may have reduced the expressions of inflammatory markers such as cytokines and chemokines. Further, there was an apparent reduction of oxidative stress markers and matrix metalloproteinases (MMPs), suggesting that MGF might mitigate some inflammatory and fibrotic responses in muscle injury. As a result, the rate of contused muscles appeared to decline, which might induce long-term muscular repair of the wounded tissues. Moreover, the study hints that MGF may potentially not markedly impact the functional state of satellite cells following injury and immune cell depletion at the injury site, which is integral to muscle regeneration. This inference is drawn from observing unaltered expression levels of MyoD and myogenin—key satellite cell proliferation and differentiation indicators, respectively. This suggests that while MGF might potentially ease certain aspects of the muscle injury response, its direct action on satellite cell activity under the explored conditions remains uncertain. Subsequent examinations suggest that MGF exposure might influence fibrosis in injured muscle by possibly reducing the expression of collagen types I and III, crucial for the extracellular matrix and fibrotic development. The study further hints that MGF may play a part in adjusting the inflammatory setting within injured muscles. This is somewhat illustrated by a purported reduction in the expression of pro-inflammatory cytokines (TNF-α, IFN-γ, IL-1β, TGF-β) and chemokines (CCL2, CCL5, CXCR4) post-MGF exposure. Moreover, there's a speculative suggestion that MGF might assist in alleviating oxidative stress in injured muscle, indicated by a possible decrease in the expression of gp91phox, a vital component of NADPH oxidase implicated in the production of reactive oxygen species."
            },
            {
                "h3": "MGF Peptide and Anti-Apoptotic Potential"
            },
            {
                "p": "The main goal of this study(10) was to evaluate the potential of MGF on cardiac muscles undergoing programmed cell death (apoptosis) following hypoxia, a condition characterized by limited supply of oxygen. The study reported that the peptide appeared to induce increased migration of stem cells to the heart tissues exposed to hypoxia, which possibly led to inhibition of apoptosis. This suggests that MGF may play a dual role in cardiac function, acting as a potential anti-apoptotic compound and a stem cell-homing factor. The researchers highlight that MGF potentially enhances the migration of mesenchymal stem cells (hMSCs), indicating a chemotactic action that might be leveraged to direct stem cells toward regions of damage or injury. Moreover, in an environment simulating hypoxic stress—a condition akin to that experienced by heart tissue during ischemic events—MGF is suggested to exhibit protective potential in cardiac cells. This hypothesis was raised by observation of increases in the expression of Bcl-2, a gene associated with cell survival, underscoring MGF's potential anti-apoptotic action."
            },
            {
                "h3": "MGF Peptide and Skeletal Injury"
            },
            {
                "p": "The main goal of this study(11) was to evaluate the potential of MGF on bone injury. A total of 27 rabbits were experimentally induced with a 5-mm bone defect and were then divided into three groups that were presented with MGF or with a control substance for 5 consecutive days. Post-study, the researchers reported that the placebo tissue appeared to be the least healed when the bone tissues were histologically examined. In contrast, the bone tissue with MGF appeared to be the most healed tissue. Regarding the potential impact on osteoblast-like cell proliferation, the investigation hints that MGF might potentially enhance proliferation. This enhancement appears to be more pronounced when compared with IGF-1, leading to the speculation that MGF may activate cellular mechanisms somewhat differently from IGF-1. The study points out that MGF might play a role in arresting the cell cycle in certain phases and could be involved in activating the MAPK-Erk1/2 signaling pathway. Such actions imply that MGF may have a complex approach to promoting cell proliferation, perhaps through a blend of influencing cell cycle dynamics and engaging specific signaling pathways. Moreover, the study ventured into assessing the possible actions of MGF utilizing a rabbit model with established bone defects. Here, MGF was introduced, and its influence on bone healing was monitored via radiographic and histological evaluations. The findings tentatively indicate that bone healing might be improved in defects exposed to MGF, as suggested by seemingly better rates of radiographically healed defects and improved histological scores for bone healing."
            },
            {
                "h3": "MGF Peptide and Brain Ischemia"
            },
            {
                "p": "The main purpose of a 2005 study(12) was to combat ischemic stroke through the potential action of MGF peptides. The actions were studied in experiments conducted on gerbil research models of brain ischemia. The synthetic Mechano Growth Factor peptide was presented as an ischemic mitigator. Researchers reported that MGF appeared to lead to increased protection of brain cells. Interestingly, in the same model, it was also reported that ischemia appeared to lead to elevated endogenous MGF production in the ischemia-resistant neurons. Additional studies were carried out in degenerated hippocampal cell culture, to which MGF was added. MGF exhibited reportedly similar results of muscle proliferation. This potential action is believed to be due to the C-terminal of the MGF peptide, which may exert some level of neuroprotective action."
            },
            {
                "h3": "MGF Peptide and Brain Cells"
            },
            {
                "p": "A notable study (13) was conducted on a murine model to study the action of increased MGF concentration on brain cells. One study included breeding mice to constitutively overproduce MGF in the hippocampus area of the brain. The hippocampus is primarily responsible for regulating the neurogenesis phenomenon in the organism. This overproduction of MGF appeared to result in high concentrations of BrdU, a biological marker representative of proliferative actions in the organism. More specifically, the mice were bred for conditional MGF production at 1, 3, and 12 months old. Behavioral analysis and biological responses were examined after 2 years. These mice were reported to exhibit elevated levels of BrdU and neurogenesis."
            },
            {
                "p": "MGF peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Philippou A, Papageorgiou E, Bogdanis G, Halapas A, Sourla A, Maridaki M, Pissimissis N, Koutsilieris M. Expression of IGF-1 isoforms after exercise-induced muscle damage in humans: characterization of the MGF E peptide actions in vitro. In Vivo. 2009 Jul-Aug;23(4):567-75. https://pubmed.ncbi.nlm.nih.gov/19567392/",
                    "Goldspink G. Impairment of IGF-I gene splicing and MGF expression associated with muscle wasting. Int J Biochem Cell Biol. 2006 Mar;38(3):481-9. https://pubmed.ncbi.nlm.nih.gov/16463438/",
                    "Zabłocka, B., Goldspink, P. H., Goldspink, G., & Górecki, D. C. (2012). Mechano-Growth Factor: an important cog or a loose screw in the repair machinery? Frontiers in endocrinology, 3, 131. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3485521/",
                    "G Goldspink. Research on mechano growth factor: its potential for optimising physical training as well as misuse in doping. Department of Surgery, Royal Free and University College Medical School, Hampstead Campus, Rowland Hill Street, London NW3 2PF. https://bjsm.bmj.com/content/39/11/787",
                    "Rotwein P. (2014). Editorial: the fall of mechanogrowth factor?. Molecular endocrinology (Baltimore, Md.), 28(2), 155–156. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3896639/",
                    "Mills P, Dominique JC, Lafrenière JF, Bouchentouf M, Tremblay JP. A synthetic mechano growth factor E Peptide enhances myogenic precursor cell transplantation success. Am J Transplant. 2007 Oct;7(10):2247-59. https://pubmed.ncbi.nlm.nih.gov/17845560/",
                    "Hameed M, Lange KH, Andersen JL, Schjerling P, Kjaer M, Harridge SD, Goldspink G. The effect of recombinant human growth hormone and resistance training on IGF-I mRNA expression in the muscles of elderly men. J Physiol. 2004 Feb 15;555(Pt 1):231-40. doi: 10.1113/jphysiol.2003.051722. Epub 2003 Oct 17. PMID: 14565994; PMCID: PMC1664832.",
                    "Kandalla PK, Goldspink G, Butler-Browne G, Mouly V. Mechano Growth Factor E peptide (MGF-E), derived from an isoform of IGF-1, activates human muscle progenitor cells and induces an increase in their fusion potential at different ages. Mech Ageing Dev. 2011 Apr. https://pubmed.ncbi.nlm.nih.gov/21354439/",
                    "Liu X, Zeng Z, Zhao L, Chen P, Xiao W. Impaired Skeletal Muscle Regeneration Induced by Macrophage Depletion Could Be Partly Ameliorated by MGF Injection. Front Physiol. 2019 May 17;10:601. https://pubmed.ncbi.nlm.nih.gov/31164836/",
                    "Doroudian, G., Pinney, J., Ayala, P., Los, T., Desai, T. A., & Russell, B. (2014). Sustained delivery of MGF peptide from microrods attracts stem cells and reduces apoptosis of myocytes. Biomedical microdevices, 16(5), 705–715. https://doi.org/10.1007/s10544-014-9875-z",
                    "Deng M, Zhang B, Wang K, Liu F, Xiao H, Zhao J, Liu P, Li Y, Lin F, Wang Y. Mechano growth factor E peptide promotes osteoblasts proliferation and bone-defect healing in rabbits. Int Orthop. 2011 Jul;35(7):1099-106. https://pubmed.ncbi.nlm.nih.gov/21057789/",
                    "Dluzniewska J, Sarnowska A, Beresewicz M, Johnson I, Srai SK, Ramesh B, Goldspink G, Górecki DC, Zabłocka B. A strong neuroprotective effect of the autonomous C-terminal peptide of IGF-1 Ec (MGF) in brain ischemia. FASEB J. 2005 Nov;19(13):1896-8. https://pubmed.ncbi.nlm.nih.gov/16144956/",
                    "Tang JJ, Podratz JL, Lange M, Scrable HJ, Jang MH, Windebank AJ. Mechano growth factor, a splice variant of IGF-1, promotes neurogenesis in the aging mouse brain. Mol Brain. 2017 Jul 7;10(1):23. doi: 10.1186/s13041-017-0304-0. PMID: 28683812; PMCID: PMC5501366."
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "",
        "high_performance_liquid_chromatography": "",
        "mass_spectrometry": "",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "MGF peptide for sale online. Peptides for sale at 99% purity with top customer service. Get MGF research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "MGF For Sale (5mg) | Core Peptides",
            "og:description": "MGF peptide for sale online. Peptides for sale at 99% purity with top customer service. Get MGF research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/mgf-5mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T18:25:10+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/MGF-5MG.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "MGF For Sale (5mg) | Core Peptides",
            "twitter:description": "MGF peptide for sale online. Peptides for sale at 99% purity with top customer service. Get MGF research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/MGF-5MG.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$50.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "50.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-MGF-5",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/receptor-grade-igf-1-lr3-1mg/",
                "name": "Receptor Grade IGF-1 LR3 (1mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-1MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ghrp-6/",
                "name": "GHRP-6 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHRP-6-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ghk-cu-50mg-copper/",
                "name": "GHK-Cu (Copper) (50mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHK-CU-50mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/oxytocin-10mg/",
                "name": "Oxytocin (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Oxytocin-10mg-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/melanotan-2-10mg/",
        "name": "Melanotan 2 (10mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2023/03/Melanotan-2-10MG.jpg",
        "display_price": "$41.00",
        "display_specs": [
            "Size: 10mg Contents: Melanotan 2 (10mg) Form: Lyophilized powder Purity: >99% SKU: P-MELANTN2-10",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$38.95"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$36.90"
            }
        ],
        "description": [
            {
                "h2": "Melanotan 2 Peptide"
            },
            {
                "p": "Melanotan 2 peptide is a synthetic compound, which is an analog of the α-melanocyte-stimulating hormone.(1) The peptide is a cyclic heptapeptide that appears to have a modified affinity towards the receptors that the endogenous hormone may interact with. In addition to possibly stimulating melanogenesis (the production of melanin pigment) in dermal cells, this peptide may have increased affinity towards other receptors that play a role in the regulation of appetite and various types of arousal.(2)"
            },
            {
                "h3": "Overview"
            },
            {
                "p": "Melanotan 2 likely serves as a non-selective agonist with the potential to bind with four out of the five different subtypes of melanocortin receptors (MC-R).(3) Depending on the localization, the receptor-Melanotan 2 bond may induce different actions. Namely, the four receptors that Melanotan 2 may interact with include:"
            },
            {
                "p": "For example, the potential interaction between Melanotan 2 and the MC1Rs may lead to increased production of eumelanin, which causes darkening of the epidermal layer’s pigment.(4)"
            },
            {
                "p": "On the other hand, when Melanotan 2 binds with the MC4R, it may induce supraspinal centers in the brain, which may lead to increased libido. These signals may then be carried to the sympathetic and parasympathetic centers in the spinal cord and thoracolumbar region.(3)"
            },
            {
                "h2": "Chemical Makeup"
            },
            {
                "p": "Other Known Titles: MT-II Molecular Weight: 1024.19 g/mol Molecular Formula: C50H69N15O9"
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Melanotan 2 Peptide and Nerve Cell Regeneration"
            },
            {
                "p": "Research(5) in a murine model of an induced peripheral nerve injury has been employed to investigate the neurotrophic potential of Melanotan 2. 48 hours after half of the murine models were presented with the peptide, it was noted that the Melanotan 2 research models appeared to indicate a recovery in their sensory function. Furthermore, when the murine models were presented with a chemotherapeutic compound, Melanotan 2 appeared to exhibit neuroprotective properties, which protected the nerves from the compound's induced neurotoxicity to a certain extent. This potential is posited to be mediated via the MC4 receptors, which might even promote neurite outgrowth and possibly support the intrinsic capacity of neuronal tissue to recover after injury."
            },
            {
                "p": "Although the exact signaling pathways are not fully understood, it is often suggested that the pro-opiomelanocortin (POMC)-derived melanocortin peptides, including compounds analogous to a-melanocyte-stimulating hormone (a-MSH), may influence neuronal structures by increasing the number and length of neurites and potentially promoting nerve sprouting in damaged regions. Since Melanotan 2 is considered a potent melanocortin receptor agonist, it may trigger a cascade of intracellular events that theoretically lead to a better-supported ability of nerve fibers to regenerate after various forms of insult, as well as a partial protective response against toxic neuropathic conditions. Therefore, the researchers concluded that they “observed that Melanotan-II also possesses neuroprotective properties, as it partially protected the nerve from a toxic neuropathy induced by cisplatin.”"
            },
            {
                "h3": "Melanotan 2 Peptide and Arousal Neurosignaling"
            },
            {
                "p": "In a clinical study,(6) Melanotan 2 has been suggested to induce increased arousal neuron signaling in more than 80% of cases, compared to only 20% success with a placebo. This research peptide may act via the MC4 receptors and downstream of established neuromodulators, including dopaminergic and oxytocinergic signals, possibly integrating their actions within discrete hypothalamic centers. These regions are thought to coordinate various homeostatic and motivational behaviors, and the introduction of an agonist like Melanotan 2 may potentially reframe the balance of neuronal activity. These researchers also posit that the involvement of MC5 receptors in certain peripheral glands may potentially provide a parallel route that links central neuro signaling with peripheral modulatory factors. However, this remains an area where mechanisms are only hypothesized."
            },
            {
                "h3": "Melanotan 2 Peptide and Neurodevelopmental Modulation"
            },
            {
                "p": "Researchers have said that Melanotan 2 may potentially influence aberrant neural mechanisms by possibly stimulating populations of neurons that may govern social cognition through endogenous oxytocinergic signaling.(7) These MC4R-sensitive circuits, potentially located in regions such as the paraventricular nucleus of the hypothalamus, might release endogenous oxytocin in response to Melanotan 2, possibly recalibrating imbalanced neurochemical activity thought to underlie key aspects of social impairment. This oxytocin release may, in turn, modulate neurotransmission involving serotonin, glutamate, dopamine, and GABA, all of which are implicated in shaping social adaptation."
            },
            {
                "p": "By engaging these systems, Melanotan 2 may alter the functional connectivity of cortical and subcortical networks—regions including, for instance, the anterior cingulate cortex—where oxytocin receptor distribution may differ in atypical neurodevelopmental contexts. In doing so, researchers have been able to hypothesize that Melanotan 2 might restore or modify synaptic communication and synaptic plasticity, which may go so far as to reshape the underlying neuroarchitecture."
            },
            {
                "h3": "Melanotan 2 Peptide and Models of Sunless Tanning"
            },
            {
                "p": "Melanotan 2 may increase melanin production and thereby induce darker pigmentation without the need for ultraviolet irradiation by engaging the MC1R on melanocytes.(8) Moreover, the peptide's cyclic structure supports a more prolonged metabotropic activity compared to other MSH analogs."
            },
            {
                "p": "Although the precise intracellular signaling cascades remain incompletely understood, current data suggest that receptor interactions might lead to the elevated synthesis of eumelanin. This might offer a potential pathway for the development of sunless tanning models in a controlled research environment. Specifically, researchers have made comments about their observation of outcomes in research models, such as “increased [darkened] pigmentation in the face, upper body, and buttock” in experimental settings."
            },
            {
                "p": "Melanotan 2 peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Ryakhovsky, Vladimir V et al. “The first preparative solution phase synthesis of Melanotan II.” Beilstein Journal of Organic Chemistry vol. 4 (2008): 39. doi:10.3762/bjoc.4.39. https://pubmed.ncbi.nlm.nih.gov/19043625/",
                    "Mac E. Hadley, Discovery that a melanocortin regulates sexual functions in male and female humans, Peptides, Volume 26, Issue 10, 2005, Pages 1687-1689, ISSN 0196-9781, https://doi.org/10.1016/j.peptides.2005.01.023",
                    "King, Stephen H et al. “Melanocortin receptors, melanotropic peptides and penile erection.” Current topics in medicinal chemistry vol. 7,11 (2007): 1098-1106. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694735/",
                    "Peters, Björn, et al. “Melanotan II: a possible cause of renal infarction: review of the literature and case report.” CEN case reports vol. 9,2 (2020): 159-161. doi:10.1007/s13730-020-00447-z. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148395/",
                    "Ter Laak, Mariël P, et al. “The potent melanocortin receptor agonist melanotan-II promotes peripheral nerve regeneration and has neuroprotective properties in the rat.” European Journal of Pharmacology vol. 462,1-3 (2003): 179-83. doi:10.1016/s0014-2999(02)02945-x. https://pubmed.ncbi.nlm.nih.gov/12591111/",
                    "Wessells, H et al. “Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II.” International journal of impotence research vol. 12 Suppl 4 (2000): S74-9. doi:10.1038/sj.ijir.3900582. https://pubmed.ncbi.nlm.nih.gov/11035391/",
                    "Minakova E, Lang J, Medel-Matus JS, Gould GG, Reynolds A, Shin D, Mazarati A, Sankar R. Melanotan-II reverses autistic features in a maternal immune activation mouse model of autism. PLoS One. 2019 Jan 10;14(1):e0210389. Doi: 10.1371/journal.pone.0210389. PMID: 30629642; PMCID: PMC6328175.",
                    "Dorr RT, Lines R, Levine N, Brooks C, Xiang L, Hruby VJ, Hadley ME. Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study. Life Sci. 1996;58(20):1777-84. doi: 10.1016/0024-3205(96)00160-9. PMID: 8637402."
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/01/Melanotan-2-coa.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/01/Melanotan-2-lc.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/01/Melanotan-2-ms.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Melanotan 2 (MT-2) for sale online 10mg. Peptides for sale at 99% purity with top customer service. Get Melanotan 2 research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Melanotan 2 For Sale (10mg) | Core Peptides",
            "og:description": "Melanotan 2 (MT-2) for sale online 10mg. Peptides for sale at 99% purity with top customer service. Get Melanotan 2 research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/melanotan-2-10mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-05-28T11:02:09+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2023/03/Melanotan-2-10MG.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Melanotan 2 For Sale (10mg) | Core Peptides",
            "twitter:description": "Melanotan 2 (MT-2) for sale online 10mg. Peptides for sale at 99% purity with top customer service. Get Melanotan 2 research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2023/03/Melanotan-2-10MG.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$41.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "41.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-MELANTN2-10",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/sermorelin-5mg/",
                "name": "Sermorelin (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Sermorelin-5mg-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/oxytocin-10mg/",
                "name": "Oxytocin (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Oxytocin-10mg-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/cjc-1295-dac-5mg/",
                "name": "CJC-1295 DAC (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/CJC-1295-DAC-5MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/fragment-176-191/",
                "name": "Fragment 176-191 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Fragment-176-191-300x300.jpg.webp",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/melanotan-1-10mg/",
        "name": "Melanotan 1 (10mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Melanotan-1-10MG.jpg",
        "display_price": "$43.00",
        "display_specs": [
            "Size: 10mg Contents: Melanotan 1 (10mg) Form: Lyophilized powder Purity: >99% SKU: P-MELANTN1-10",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$40.85"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$38.70"
            }
        ],
        "description": [
            {
                "h2": "Melanotan 1 Peptide"
            },
            {
                "p": "Melanotan 1 is a synthetic peptide similar to the endogenous alpha-melanocyte stimulating hormone (α-MSH).(1) Melanotan 1 comprises 13 amino acids, the same as α-MSH, but differs by only two amino acids from the endogenous peptide hormone. This structural difference is why researchers suggest the synthetic peptide may exert a higher affinity towards the target cells and boast a longer half-life. According to research, the two notable modifications include the substitution of methionine and L-phenylalanine at the fourth and seventh positions with norleucine and D-phenylalanine, respectively.(1)"
            },
            {
                "h3": "Overview"
            },
            {
                "p": "Melanotan 1 appears to mimic the function of the endogenous α-MSH and may bind to the melanocortin receptors to stimulate the production of eumelanin, a photoprotective compound. This eumelanin may protect tissues from any damage induced by UV exposure.(1) Moreover, eumelanin production also reportedly contributes to increasing levels of pigmentation in skin cells."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C78H111N21O19 Molecular Weight: 1646.87 g/mol Other Known Titles: MT1; afamelanotide"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Melanotan 1 and The Melanocortin System"
            },
            {
                "p": "Melanotan 1 is hypothesized to exert its actions by interacting with melanocortin receptors (MCRs), which are considered to be crucial signaling pathways in widespread biological processes. It is believed that five distinct melanocortin receptors exist, labeled melanocortin 1 receptors (MC1Rs) through melanocortin 5 receptors (MC5Rs), each associated with specific potential roles:(2,3)"
            },
            {
                "p": "Researchers have suggested that Melanotan 1 may exhibit a particular specificity towards MC1R, ostensibly enhancing melanin production, which, in turn, is thought to result in a tanned appearance of the skin tissues. Notably, the peptide is believed to possess a greater affinity for MC1R over α-MSH, suggesting that it might increase melanin production, thereby promoting skin pigmentation even in the absence of sunlight exposure.(4) More specifically, researchers posit that “when Melanotan I activates MC1R, cAMP is produced, and it activates microphthalmia transcription factor (MITF) expression, which induces the expression of enzymes for eumelanin production.” These proposed interactions underscore the complexity of Melanotan 1's mode of action and highlight the need for further investigative research to fully understand its mechanisms and potential implications in certain biological processes."
            },
            {
                "h3": "Melanotan 1 and The Melanocortin Type 1 Receptors"
            },
            {
                "p": "Melanocortin 1 Receptor (MC1R) is a Gs protein-coupled receptor found on melanocytes.(5) Its activation is considered potentially integral for regulating skin tissue pigmentation and UV resistance by activating adenylyl cyclase and the subsequent generation of cyclic adenosine monophosphate (cAMP). The cAMP signaling pathway potentially enhances melanin production and deposition, which serves as a natural defense against UV penetration and facilitates nucleotide excision repair (NER), a crucial process for potentially removing UV-induced DNA lesions and averting mutagenesis. Researchers posit that the receptor's activation and signaling are modulated by various ligands, including the positive agonist Melanotan 1, which might increase cAMP levels to promote melanogenesis and enhance DNA repair capabilities. This suggests Melanotan 1 may enhance the skin's natural defense mechanisms against UV damage and possibly reduce the risk of skin cell mutagenesis. However, it is also crucial to consider the receptor's polymorphism and how loss-of-function variants are associated with unpigmented skin, UV sensitivity, and a heightened skin tissue damage risk due to impaired melanization and suboptimal DNA repair mechanisms. Furthermore, MC1R's role may extend beyond pigmentation to include potential actions on anti-inflammatory signaling and the genomic stability of melanocytes, underlining the receptor's multifaceted potential in skin function and disease prevention. The potential interplay between MC1R signaling, melanin production, and NER efficiency underscores the potential for targeted research to bolster UV protection. Yet, the potential of such approaches may be contingent upon individual variations in MC1R function and expression, highlighting the need for further research to fully understand and leverage MC1R's protective mechanisms in skin cells.(5)"
            },
            {
                "h3": "Melanotan 1 and Inflammation"
            },
            {
                "p": "Studies suggest that α-MSH and its analogs, such as Melanotan 1, may exert potential anti-inflammatory action. Researchers have exposed murine models to α-MSH analogs to evaluate the impact of the peptide on tissue inflammation in cases of liver fibrosis through various biomolecular techniques.(6) The study suggested that peptide analogs may reverse the established liver fibrosis and may also mitigate the upregulation of fibrogenic and proinflammatory gene expressions triggered by fibrosis induction. This suggests that analogs may potentially influence the fibrotic process by modulating the expressions of genes involved in fibrogenesis and inflammation. One possible mechanism of action for such potentially protective actions against liver fibrosis may be the modulation of matrix metalloproteinase (MMP) activity and the apparent inactivation of tissue inhibitors of matrix metalloproteinase (TIMP). MMPs are considered to play a crucial role in the degradation of the extracellular matrix, and their activity is posited to be intricately balanced with TIMPs. Researchers have observed that peptide analogs may significantly increase MMP activity while attenuating the activation of α-smooth muscle actin (α-SMA) and cyclooxygenase-2 (COX-2), markers associated with inflammation and fibrogenesis. Furthermore, α-MSH analogs like Melanotan 1 appear to downregulate the mRNA expressions of liver transforming growth factor β1 (TGF-β1), collagen α1, and various cell adhesion molecules, which are posited to be key players in the progression of fibrosis. It is also noteworthy that analogs may have a role in suppressing the expression of COX-2 and cell adhesion molecules, suggesting a potential anti-inflammatory pathway through which Melanotan 1 and similar compounds may exert anti-fibrogenic actions.(6)"
            },
            {
                "h3": "Melanotan 1 Peptide and Erythropoietic Porphyria"
            },
            {
                "p": "Three clinical trials(6) were conducted to examine Melanotan's action on erythropoietic porphyria. In each of the three trials, research models were divided into an experimental and control group: the experimental group was exposed to the peptide, and the control group was exposed to a placebo. This exposure was routinely conducted every two months, and results were monitored for 180 days. The researchers documented the number of hours the research models were exposed to direct sunlight and pain perception during the UV exposure. The outcome of this study was that the experimental peptide group appeared to be able to spend more time in sunlight with little to no pain (approximately 64 hours) compared to the control group, who were exposed to a placebo (approximately 40 hours)."
            },
            {
                "h3": "Melanotan 1 and UV Radiation"
            },
            {
                "p": "The main aim of this study(7) was to understand the peptide's mechanism of action when introduced in combination with UV-B light or sunlight. The study was divided into three phase 1 clinical trials. In the first study, 50% of the cohort were presented with the peptide, and 50% were presented with a placebo for 10 days. In the second study, 58% were exposed to UV irradiation, and 42% were exposed to UV radiation. The final study was conducted in a 50/50 split, where 50% were exposed to the peptide and 50% to a placebo. Following sunlight exposure, the results were analyzed. Researchers reported that the results across all three trials indicated that the peptide may have a positive correlation with exposure and melanin production, as observed on a cellular level and in the relative tanning gradation."
            },
            {
                "p": "Melanotan 1 peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "PubChem [Internet]. Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information; 2004-. PubChem Compound Summary for CID 16154396, Scenesse; [cited 2024 Apr. 2]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Scenesse",
                    "Cai, M., & Hruby, V. J. (2016). The Melanocortin Receptor System: A Target for Multiple Degenerative Diseases. Current protein & peptide science, 17(5), 488–496. https://doi.org/10.2174/1389203717666160226145330",
                    "Ji, L. Q., Hong, Y., & Tao, Y. X. (2022). Melanocortin-5 Receptor: Pharmacology and Its Regulation of Energy Metabolism. International journal of molecular sciences, 23(15), 8727. https://doi.org/10.3390/ijms23158727",
                    "Mun, Y., Kim, W., & Shin, D. (2023). Melanocortin 1 Receptor (MC1R): Pharmacological and Therapeutic Aspects. International journal of molecular sciences, 24(15), 12152. https://doi.org/10.3390/ijms241512152",
                    "Wolf Horrell EM, Boulanger MC, D'Orazio JA. Melanocortin 1 Receptor: Structure, Function, and Regulation. Front Genet. 2016 May 31;7:95. doi: 10.3389/fgene.2016.00095. PMID: 27303435; PMCID: PMC4885833.",
                    "Lee TH, Jawan B, Chou WY, Lu CN, Wu CL, Kuo HM, Concejero AM, Wang CH. Alpha-melanocyte-stimulating hormone gene therapy reverses carbon tetrachloride induced liver fibrosis in mice. J Gene Med. 2006 Jun;8(6):764-72. doi: 10.1002/jgm.899. PMID: 16508911.",
                    "Drug Trials Snapshots: Scenesse. https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-scenesse",
                    "Dorr RT, Ertl G, Levine N, Brooks C, Bangert JL, Powell MB, Humphrey S, Alberts DS. Effects of a superpotent melanotropic peptide in combination with solar UV radiation on tanning of the skin in human volunteers. Arch Dermatol. 2004 Jul. https://pubmed.ncbi.nlm.nih.gov/15262693/"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/12/Melanotan-1-10MG-COA.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/12/Melanotan-1-10MG-LC.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/12/Melanotan-1-10MG-MS.jpg\" /></p>\n",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Melanotan 1 for sale online 10mg. Peptides for sale at 99% purity with top customer service. Get Melanotan 1 research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Melanotan 1 For Sale (10mg) | Core Peptides",
            "og:description": "Melanotan 1 for sale online 10mg. Peptides for sale at 99% purity with top customer service. Get Melanotan 1 research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/melanotan-1-10mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-05-28T11:02:12+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Melanotan-1-10MG.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Melanotan 1 For Sale (10mg) | Core Peptides",
            "twitter:description": "Melanotan 1 for sale online 10mg. Peptides for sale at 99% purity with top customer service. Get Melanotan 1 research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Melanotan-1-10MG.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$43.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "43.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-MELANTN1-10",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/dsip-5mg/",
                "name": "DSIP (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/DSIP-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/melanotan-2-10mg/",
                "name": "Melanotan 2 (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2023/03/Melanotan-2-10MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/fragment-176-191/",
                "name": "Fragment 176-191 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Fragment-176-191-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ll-37-5mg/",
                "name": "LL-37 (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/LL-37-5mg-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/matrixyl-topical-200mg/",
        "name": "Matrixyl (200mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2023/03/Matrixyl-200mg.jpg",
        "display_price": "$171.00",
        "display_specs": [
            "Size: 200mg Contents: Matrixyl Form: Lyophilized powder Purity: >99% SKU: P-Matrixyl",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$162.45"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$153.90"
            }
        ],
        "description": [
            {
                "h2": "Matrixyl"
            },
            {
                "p": "Matrixyl, also known as as palmitoyl pentapeptide-4 or palmitoyl pentapeptide-3, is a synthetic peptide currently under scientific investigation for its potential to stimulate collagen production in the skin. It is classified as a matrikine - a messenger peptide that may regulate cell activities by interacting with their specific receptors. Collagen is a protein that is considered to support flexibility and structural integrity in the extracellular matrix of the skin. The conjugation with the palmitoyl introduces the potential for more consistent delivery across the skin and better stability to skin proteases.(1)"
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular formula: C39H75N7O10 Molecular weight: 802.05 g/mol Other known titles: Palmitoyl pentapeptide-4, (palmitoyl pentapeptide-3 prior to 2006)"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Matrixyl Peptide and Collagen Synthesis"
            },
            {
                "p": "Studies suggest that Matrixyl may act as a signal peptide fragment of the C-terminal propeptide of type I collagen.(2) The scientists indicate that it may act by signaling fibroblasts and \"stimulates feedback regulation of new collagen synthesis and ECM proteins.\" Fibroblasts are a type of cell that is found in connective tissue. They play a crucial role in forming and maintaining the extracellular matrix (ECM), a complex network of proteins and carbohydrates that provides structural support to tissues and organs. The main extracellular matrix proteins are collagens, elastins, fibronectins, and laminins. Fibroblasts produce and secrete collagen, the ECM's main structural protein. Collagen provides tensile strength to tissues and organs and is essential for maintaining their shape and integrity. During wound healing, fibroblasts are responsible for depositing new collagen fibers to replace damaged tissue. Researchers suggested that Matrixyl may potentially stimulate collagen production in a concentration-dependent manner close to the critical aggregation concentration, indicating that self-assembly and collagen production are interrelated.(3) Self-assembly of peptides includes hydrogen bonds, electrostatic interactions, hydrophobic interactions, aromatic interactions (π–π stacking), and van der Waals forces."
            },
            {
                "h3": "Matrixyl Peptide and Wrinkles"
            },
            {
                "p": "Several studies suggest some potential for Matrixyl to induce action on fibroblasts and collagen synthesis. One research study examined its potential in research models of bi-lateral exposure to Matrixyl peptide and placebo, respectively.(5) The study reported that the peptide appeared to have reduced overall wrinkle depth compared to the placebo control."
            },
            {
                "p": "An additional study aimed to investigate the cellular activity of Matrixyl.(6) A compound infused with Matrixyl was introduced twice daily to the periorbital area of the research model for a duration of 8 weeks. The results indicated improvements via the exposure to Matrixyl, which appeared to exhibit better results when compared to other peptides and placebo based on measured data."
            },
            {
                "p": "Another study aimed to isolate the potential of Matrixyl to improve skin surface texture and wrinkle depth in the periorbital region.(7) Two double-blind, randomized, controlled studies were conducted in research models of moderate to distinct periorbital wrinkles. After 4 weeks, the peptide was reported by researchers to have appeared to reduced the texture of periorbital skin and reduced the apparent depth of larger wrinkles."
            },
            {
                "h3": "Matrixyl Peptide and Scarring"
            },
            {
                "p": "One study investigated the potential of Matrixyl on fibroblast contractility and its potential role in scar formation.(8) Matrixyl was reported to reduce the expression of α-SMA (alpha-smooth muscle actin) and inhibit the trans-differentiation of fibroblasts to myofibroblasts. Scientists indicate alpha smooth muscle actin (α-SMA) is a protein commonly found in smooth muscle cells, including those in blood vessels and hollow organs such as the intestines and bladder. It is also considered to be expressed by a specialized type of cell called a myofibroblast, which plays a key role in wound healing and tissue repair. In the context of fibrotic scarring, the expression of α-SMA by myofibroblasts is associated with the deposition of excess collagen and the development of scar tissue."
            },
            {
                "h3": "Matrixyl Peptide and Tissue Repair"
            },
            {
                "p": "One animal study investigated the potential of Matrixyl in promoting wound healing. Animals were divided into seven groups and monitored for 21 days.(9) Results suggested that Matrixyl may positively impact wound healing, with larger potential seen in the high-concentration Matrixyl groups compared to a positive control group. The scientists reported that \"the macroscopic results showed that wound healing was improved from 63.5 up to 81.81% in treatment groups compared to that in the negative control group.\""
            },
            {
                "p": "Another article described the development of a novel conjugate of Matrixyl with imidazolium-based ionic liquid.(10) Imidazolium-based ionic liquids have antimicrobial and skin penetration properties. These conjugates also have collagenesis-inducing activity comparable to the proposed efficacy of Matrixyl."
            },
            {
                "p": "Matrixyl peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Choi, Y. L., Park, E. J., Kim, E., Na, D. H., & Shin, Y. H. (2014). Dermal Stability and In Vitro Skin Permeation of Collagen Pentapeptides (KTTKS and palmitoyl-KTTKS). Biomolecules & therapeutics, 22(4), 321–327. https://doi.org/10.4062/biomolther.2014.053",
                    "Errante, F., Ledwoń, P., Latajka, R., Rovero, P., & Papini, A. M. (2020). Cosmeceutical Peptides in the Framework of Sustainable Wellness Economy. Frontiers in chemistry, 8, 572923. https://doi.org/10.3389/fchem.2020.572923",
                    "Jones, R. R., Castelletto, V., Connon, C. J., & Hamley, I. W. (2013). Collagen stimulating effect of peptide amphiphile C16-KTTKS on human fibroblasts. Molecular pharmaceutics, 10(3), 1063–1069. https://doi.org/10.1021/mp300549d",
                    "Tałałaj, U., Uścinowicz, P., Bruzgo, I., Surażyński, A., Zaręba, I., & Markowska, A. (2019). The Effects of a Novel Series of KTTKS Analogues on Cytotoxicity and Proteolytic Activity. Molecules (Basel, Switzerland), 24(20), 3698. https://doi.org/10.3390/molecules24203698",
                    "Robinson, L. R., Fitzgerald, N. C., Doughty, D. G., Dawes, N. C., Berge, C. A., & Bissett, D. L. (2005). Palmitoyl pentapeptide provides improvement in photoaged human facial skin. International journal of cosmetic science, 27(3), 155–160. https://doi.org/10.1111/j.1467-2494.2005.00261.x",
                    "Aruan, R. R., Hutabarat, H., Widodo, A. A., Firdiyono, M. T. C. C., Wirawanty, C., & Fransiska, L. (2023). Double-blind, Randomized Trial on the Effectiveness of Acetylhexapeptide-3 Cream and Palmitoyl Pentapeptide-4 Cream for Crow's Feet. The Journal of clinical and aesthetic dermatology, 16(2), 37–43.",
                    "Kaczvinsky, J. R., Griffiths, C. E., Schnicker, M. S., & Li, J. (2009). Efficacy of anti-aging products for periorbital wrinkles as measured by 3-D imaging. Journal of cosmetic dermatology, 8(3), 228–233. https://doi.org/10.1111/j.1473-2165.2009.00444.x",
                    "Park H, An E, Cho Lee AR. Effect of Palmitoyl-Pentapeptide (Pal-KTTKS) on Wound Contractile Process in Relation with Connective Tissue Growth Factor and α-Smooth Muscle Actin Expression. Tissue Eng Regen Med. 2017 Jan 19;14(1):73-80. doi: 10.1007/s13770-016-0017-y. PMID: 30603464; PMCID: PMC6171572.",
                    "Kachooeian, M., Mousivand, Z., Sharifikolouei, E., Shirangi, M., Firoozpour, L., Raoufi, M., & Sharifzadeh, M. (2022). Matrixyl Patch vs Matrixyl Cream: A Comparative In Vivo Investigation of Matrixyl (MTI) Effect on Wound Healing. ACS omega, 7(28), 24695–24704. https://doi.org/10.1021/acsomega.2c02592",
                    "Gomes A, Bessa LJ, Fernandes I, Aguiar L, Ferraz R, Monteiro C, Martins MCL, Mateus N, Gameiro P, Teixeira C, Gomes P. Boosting Cosmeceutical Peptides: Coupling Imidazolium-Based Ionic Liquids to Pentapeptide-4 Originates New Leads with Antimicrobial and Collagenesis-Inducing Activities. Microbiol Spectr. 2022 Aug 31;10(4):e0229121. doi: 10.1128/spectrum.02291-21. Epub 2022 Aug 11. PMID: 35950860; PMCID: PMC9431032."
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "",
        "high_performance_liquid_chromatography": "",
        "mass_spectrometry": "",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Matrixyl peptide for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Matrixyl For Sale (200mg) - Core Peptides",
            "og:description": "Matrixyl peptide for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:url": "https://www.corepeptides.com/peptides/matrixyl-topical-200mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T16:11:42+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2023/03/Matrixyl-200mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Matrixyl For Sale (200mg) - Core Peptides",
            "twitter:description": "Matrixyl peptide for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2023/03/Matrixyl-200mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$171.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "171.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-Matrixyl",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/cjc-1295-no-dac-mod-grf-1-29/",
                "name": "CJC-1295 NO DAC (Mod GRF 1-29) (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Mod-GRF-1-29-5mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ll-37-5mg/",
                "name": "LL-37 (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/LL-37-5mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ipamorelin-5mg/",
                "name": "Ipamorelin (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Ipamorelin-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/hexarelin-5mg/",
                "name": "Hexarelin (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Hexarelin-5MG-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/ll-37-5mg/",
        "name": "LL-37 (5mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2020/04/LL-37-5mg.jpg",
        "display_price": "$89.00",
        "display_specs": [
            "Size: 5mg Contents: LL-37 (5mg) Form: Lyophilized powder Purity: >99% SKU: P-LL37-5",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$84.55"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$80.10"
            }
        ],
        "description": [
            {
                "h2": "LL-37 Peptide"
            },
            {
                "p": "LL-37, also known as Cathelicidin, is a cationic peptide composed of 37 amino acids and is primarily found in neutrophils.(1) The peptide appears to be produced by the extracellular breakdown of the hCAP18 proteins caused by protease enzymes. Researched for its potential antimicrobial characteristics, the peptide appears to form agglomerates and lipid bilayers, which may prevent it from easily degrading and protect it from enzymatic action.(1)"
            },
            {
                "h3": "Overview"
            },
            {
                "p": "Antimicrobial peptides are structured with the potential to fight against bacteria, fungi, and some virus strains. These peptides may interact with targets in a non-specific fashion, which supports researchers' belief that once the peptide is introduced, pathogens are unable to develop resistance against these peptides.(2)"
            },
            {
                "p": "LL-37 is a α-helical peptide that scientists believe is required to maintain immunity against all microbes.(3) To understand the functioning of the peptide, a peptide model was created as part of a study(4) based on the assumption that the peptide might interact directly with the bacterial membrane. This study suggested that the peptide first interacts with the lipids on the bacterial membrane via electrostatic characteristics, followed by lateral diffusion and consequent assembly of the peptide on the membrane. This potential interaction may lead to membrane interference and degradation of the bacterial cell."
            },
            {
                "p": "Several other studies hypothesize how the peptide interacts with microbial membranes, including pore formation on the membrane(3)(5) and extreme membrane disruption caused by the peptide and lipid complexes.(6) These studies universally suggest that peptides have the potential to interact with the microbial membrane, leading to membrane breakdown."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C205H340N50O53 Molecular Weight: 4493.34 g/mol Other Known Titles: CAP-18"
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "LL-37 Peptide and Inflammatory Response"
            },
            {
                "p": "The main aim of this study(7) was to determine the inflammatory potential of this peptide. Tissue culture was used, half without alteration and the other half with added U1 RNA. U1 RNA is a non-coding RNA released upon tissue injury. LL-37 peptide was then added to both cultures. Upon genetic analysis, it was suggested by the researchers that the culture that was given both U1 RNA and LL-37 peptide stimulated a reportedly significant response towards epidermal inflammation and defense response. The study proposes that the peptide might potentially enhance the immune system's response to damaged cells by influencing how self-nucleic acids (DNA and RNA) are recognized. This recognition is apparently facilitated when the peptide interacts with specific cellular receptors, including scavenger receptors (SRs), which may lead to clathrin-dependent endocytosis. This process appears critical for the subsequent activation of inflammatory pathways within the cells. Moreover, the study indicates that LL-37 might enable the binding of dsRNA (double-stranded RNA) to these scavenger receptors, which in turn might lead to a series of signaling events culminating in cytokine expression. Notably, the interaction between LL37 and scavenger receptors such as SR-A6 and SR-B1 may be essential for this process, as blocking these receptors with a competitive inhibitor like fucoidan or silencing their expression significantly reduced cytokine production."
            },
            {
                "p": "Another interesting aspect of the study is the hypothesis that LL-37 may modulate the immune system by potentially altering how intracellular signaling pathways, such as those involving Toll-like receptors (TLR) and the interferon regulatory factors, and may be activated in response to foreign nucleic acids. As detailed in the study, the involvement of clathrin-mediated endocytosis suggests that LL-37 may help orchestrate the entry of these immune-modulating molecules into cells, which is a vital step for triggering an immune response."
            },
            {
                "h3": "LL-37 Peptide and Autoimmunity Models"
            },
            {
                "p": "The main aim of this study(1) was to understand the role of LL-37 in models of autoimmunity such as psoriasis. This disease pathogenesis study suggested that endogenous peptide may form complex DNA, increasing interferon mechanisms and more inflammatory responses. This study theorized that LL-37 may be favorable for tissue and wound injury; however, in some cases, LL-37 levels appeared to indicate psoriasis presence. In fact, it might potentially exert anti-apoptotic actions on keratinocytes, which might be linked to the observed cellular proliferation in psoriatic lesions. LL-37 is a naturally occurring antimicrobial peptide that forms part of the immune system, playing various roles in immune responses. This action may potentially contribute to developing the thick, scaly skin that is a hallmark of psoriasis."
            },
            {
                "p": "While LL-37 has been implicated in promoting inflammation via type I interferon (IFN) pathways, it appears to simultaneously offer a protective action against the activation of the AIM2 inflammasome by cytosolic double-stranded DNA (dsDNA). Cytosolic dsDNA often triggers immune responses that may lead to inflammation. In cases where LL-37 forms complexes with DNA, these complexes seemingly do not promote the production of interleukin-1β (IL-1β), a pro-inflammatory cytokine, nor activate the inflammasome. This implies that LL37 might protect keratinocytes from the inflammatory responses typically triggered by the AIM2 inflammasome in the presence of dsDNA. This dual potential of LL-37 underscores its complex involvement in immune regulation and inflammatory processes."
            },
            {
                "h3": "LL-37 Peptide and Arthritis"
            },
            {
                "p": "The main objective of this study(1)(8) was to evaluate the potential of LL-37 in arthritic joints. A group of rats were used in this study,(8) with one control group and one group experimentally induced with rheumatoid arthritis. Upon inducing the condition, researchers reported an apparent increased regulation of rCRAMP, the rat analog of LL-37 peptide, in inflammatory cells. Researchers suggested that LL-37 peptide might further induce apoptosis of osteoblasts, thereby leading to decreased bone formation in the joints. This study suggested that increased LL-37 levels are characteristic of joint aches and arthritis and may potentially be used for diagnostic purposes."
            },
            {
                "p": "Besides these, study(1) has suggested that LL-37 elevation is seen in other inflammatory circumstances, such as arteriosclerosis. Scientists report that LL-37 activation and the consequent upregulation of interferons are characteristic of arteriosclerosis-induced cells. The researchers of this study suggested that the peptide may have potential as an immunomodulatory agent."
            },
            {
                "h3": "LL-37 Peptide and Tissue Repair"
            },
            {
                "p": "In this study,(9) mice presented with an anti-inflammatory compound were then presented with LL-37 to study the potential of this peptide on angiogenesis and wound healing. The researchers suggested that the peptide mice exhibited an apparent increase in vascularization and skin cell formation. This study suggested that LL-37 has the potential to induce endothelial skin cell proliferation and formation of tubule-like structures, which are both required in angiogenesis mechanisms."
            },
            {
                "p": "Further, the study indicates that LL37 possibly counteracts the activation of macrophages triggered by lipopolysaccharide (LPS), a component known to provoke immune responses. Furthermore, it seems to foster endothelial cell behaviors essential for wound healing, such as proliferation, migration, and the formation of tubule-like structures, all indicative of angiogenesis. Experiments on catabolism-induced murine models, utilizing both synthetic and recombinant forms of LL-37, suggest that exposure to the peptide may enhance vascularization and re-epithelialization. These observations collectively lead to the hypothesis that the peptide might be crucial in promoting wound regeneration, potentially through its actions on vascularization."
            },
            {
                "h3": "LL-37 Peptide and Cancer Cells"
            },
            {
                "p": "Studies(10) are ongoing to explore the potential of the peptide in cancer cell development. These studies have suggested that the peptide may inhibit gastric cancer cell proliferation by activating the bone morphogenetic protein signaling system. The main aim of this research was to consider the potential of LL-37 as an immunotherapeutic agent or consider the potential of LL-37 peptide as an adjuvant in eliminating cancer cells from the host system. CpG oligodeoxynucleotides are widely considered to be immunotherapeutic compounds as they appear to promote the tumor-suppressing activity. When presented with LL-37, researchers reported that the peptide LL-37 appeared to increase the CpG oligodeoxynucleotides sensitivity in lymphocytes."
            },
            {
                "h3": "LL-37 Peptide and GI Tract"
            },
            {
                "p": "LL-37 may potentially impact ailments associated with the gastrointestinal (GI) tract. There appears to be an increased expression of LL-37 in research models of gastrointestinal ulcers. This upregulation might be mediated through the activation of Toll-like receptor 3 (TLR-3) by its ligand, polyinosinic-polycytidylic acid (poly(I)). Poly(I) stimulation possibly enhances LL-37 expression by triggering intracellular signaling cascades involving proteins such as Toll/IL-1R domain-containing adaptor-inducing interferon (TRIF), tumor necrosis factor receptor-associated factor 6 (TRAF6), and transforming growth factor β-activated kinase 1 (TAK1). Owing to its antimicrobial potential, LL-37 may be capable of protecting GI mucosa from microbial damage.(12) The protective potential of this peptide in the gastrointestinal tract may involve its interaction with lipopolysaccharide (LPS), a component of bacterial cell walls. LL-37 may be able to suppress LPS-induced secretion of pro-inflammatory cytokines such as interleukin-6 (IL-6) and IL-8 in colonic subepithelial myofibroblasts (SEMFs), which possibly contributes to a protective action by moderating local inflammation."
            },
            {
                "p": "LL-37 peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Kahlenberg, J Michelle, and Mariana J Kaplan. “Little peptide, big effects: the role of LL-37 in inflammation and autoimmune disease.” Journal of immunology (Baltimore, Md. : 1950) vol. 191,10 (2013): 4895-901. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836506/",
                    "Seil, M., Nagant, C., Dehaye, J. P., Vandenbranden, M., & Lensink, M. F. (2010). Spotlight on Human LL-37, an Immunomodulatory Peptide with Promising Cell-Penetrating Properties. Pharmaceuticals, 3(11), 3435–3460. h https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4034075/",
                    "Zeth, Kornelius, and Enea Sancho-Vaello. “The Human Antimicrobial Peptides Dermcidin and LL-37 Show Novel Distinct Pathways in Membrane Interactions.” Frontiers in chemistry vol. 5 86. 7 Nov. 2017. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681987/",
                    "Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol. 2005 Mar;3(3):238-50. https://pubmed.ncbi.nlm.nih.gov/15703760/",
                    "Ludtke SJ, He K, Heller WT, Harroun TA, Yang L, Huang HW. Membrane pores induced by magainin. Biochemistry. 1996 Oct 29;35(43):13723-8. https://pubmed.ncbi.nlm.nih.gov/8901513/",
                    "Bechinger B, Lohner K. Detergent-like actions of linear amphipathic cationic antimicrobial peptides. Biochim Biophys Acta. 2006 Sep;1758(9):1529-39. https://pubmed.ncbi.nlm.nih.gov/16928357/",
                    "Takahashi, T., Kulkarni, N.N., Lee, E.Y. et al. Cathelicidin promotes inflammation by enabling binding of self-RNA to cell surface scavenger receptors. Sci Rep 8, 4032 (2018). https://doi.org/10.1038/s41598-018-22409-3",
                    "Hoffmann MH, Bruns H, Bäckdahl L, Neregård P, Niederreiter B, Herrmann M, Catrina AI, Agerberth B, Holmdahl R. The cathelicidins LL-37 and rCRAMP are associated with pathogenic events of arthritis in humans and rats. Ann Rheum Dis. 2013 Jul;72(7): https://pubmed.ncbi.nlm.nih.gov/23172753/",
                    "Ramos R, Silva JP, Rodrigues AC, Costa R, Guardão L, Schmitt F, Soares R, Vilanova M, Domingues L, Gama M. Wound healing activity of the human antimicrobial peptide LL37. Peptides. 2011 Jul;32(7):1469-76. doi: 10.1016/j.peptides.2011.06.005. Epub 2011 Jun 13. https://pubmed.ncbi.nlm.nih.gov/21693141/",
                    "Wu, W. K., Wang, G., Coffelt, S. B., Betancourt, A. M., Lee, C. W., Fan, D., Wu, K., Yu, J., Sung, J. J., & Cho, C. H. (2010). Emerging roles of the host defense peptide LL-37 in human cancer and its potential therapeutic applications. International journal of cancer, 127(8), 1741–1747. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2930073/",
                    "Wang, C., Wang, S., Li, D., Chen, P., Han, S., Zhao, G., Chen, Y., Zhao, J., Xiong, J., Qiu, J., Wei, D. Q., Zhao, J., & Wang, J. (2021). Human Cathelicidin Inhibits SARS-CoV-2 Infection: Killing Two Birds with One Stone. ACS infectious diseases, 7(6), 1545–1554.",
                    "Kusaka; et al. Expression of human cathelicidin peptide LL-37 in inflammatory bowel disease. Clin Exp Immunol. 2018 Jan;19(11). Epub 2017 Sep 28. https://pubmed.ncbi.nlm.nih.gov/28872665/"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/12/LL-37-COA-1.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/12/LL-37-LC-1.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/12/LL-37-MS-1.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "LL-37 peptide for sale online. Purchase peptides for sale at 99+% purity with unmatched customer service and Free shipping.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "LL-37 For Sale (5mg) | Core Peptides",
            "og:description": "LL-37 peptide for sale online. Purchase peptides for sale at 99+% purity with unmatched customer service and Free shipping.",
            "og:url": "https://www.corepeptides.com/peptides/ll-37-5mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-30T18:29:24+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/LL-37-5mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "LL-37 For Sale (5mg) | Core Peptides",
            "twitter:description": "LL-37 peptide for sale online. Purchase peptides for sale at 99+% purity with unmatched customer service and Free shipping.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/LL-37-5mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$89.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "89.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-LL37-5",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/selank-10mg/",
                "name": "Selank (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Selank-10MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/fragment-176-191/",
                "name": "Fragment 176-191 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Fragment-176-191-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/adipotide-10mg/",
                "name": "Adipotide (FTPP) (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Adipotide-FTPP-10MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ghrp-2/",
                "name": "GHRP-2 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHRP-2-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/livagen-20mg/",
        "name": "Livagen (20mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2022/11/Livagen-20MG.jpg",
        "display_price": "$73.00",
        "display_specs": [
            "Size: 20mg Contents: Livagen (20mg) Form: Lyophilized powder Purity: >99% SKU: P-Livagen",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$69.35"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$65.70"
            }
        ],
        "description": [
            {
                "h2": "Livagen Peptide"
            },
            {
                "p": "Livagen is a short peptide containing four amino acids: lysine, alanine, aspartic acid, and glutamic acid. Considered to be a bioregulator, this peptide may act on the DNA structure and impact functionality. The primary potential of Livagen is identified in how it acts on chromatin, DNA, and genes."
            },
            {
                "p": "Scientists have formalized that DNA is a double helix structure surrounded by proteins called \"histones.\" These histones bind together, forming chromatin, and several chromatins then condense together, forming the chromosomes. These chromosomes appear crucial to forming genetic material specific to each organism.(1)"
            },
            {
                "p": "Livagen has been considered by researchers for its potential to 'de-condense' these chromatin materials. As a result, some genes that had become non-functional might become active, possibly improving cell activity and production.(2) Researchers posit that Livagen may increase energy levels and skin elasticity and possibly induce improvements in immune system functionality via this mechanism."
            },
            {
                "p": "Researchers have suggested that the lipid peptide acts on the lymphocytes, possibly reactivating the ribosomes by 'unpacking' the chromatin and modifying gene expression. These lymphocytes are white blood cells that are deemed essential in attacking foreign impurities entering the system and enhancing immunity. In this manner, Livagen may exhibit potential to improve the immune system by coordinating cellular responses and controlling inflammatory responses.(3) T. Lezhava et al., who conducted a clinical research study stated that “These results indicate that peptide bioregulators Epitalon, Livagen, and Vilon cause activation (deheterochromatinization) of chromatin in lymphocytes of [aged models].”"
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C18H31N5O9 Molecular Weight: 461.5 g/mol Other Known Titles: KEDA"
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Livagen and Gene Regulation"
            },
            {
                "p": "Cardiac disorders such as hypertrophic cardiomyopathy (HCM), atherosclerosis, and cardiac injury are considered to be characterized by dysregulation in gene expression and chromatin structure. A bioregulatory peptide such as Livagen has been suggested by researchers to enact potential mitigation of such gene regulation dysfunctions. Studies(4,5) have suggested that Livagen peptides may help reduce specific long-term impacts of such conditions when applied to cell culture models of HCM. A publication related to the same study(6) also reported on the potential of the peptide’s exposure in the presence of cobalt ions to evaluate their combined potential on chromatin structures in experimental models of hypertrophic cardiomyopathy. The study suggested that this combination possibly induces the de-condensation of chromatin. The results of this study are stated to be critical “because it provides new information about the protective effect of Livagen and Livagen + Cobalt ions on the lymphocytes” in hypertrophic cardiomyopathy models.(6) Livagen, either alone or in combination with cobalt ions, appears to modify the activity of nucleolar organizer regions (NORs) and the associative behavior of acrocentric chromosomes. The study posits that the combined application of Livagen and cobalt ions increases frequency, scoring 2 NORs, which are integral to ribosomal RNA synthesis. Such an action on NORs may indicate enhanced or altered protein synthesis capabilities in these cells, which might be crucial in understanding how cellular function is modified in the context of cardiac hypertrophy seen in HCM. Additionally, an increase in the association of acrocentric chromosomes was noted, which is speculated to be more pronounced with the combined exposure of Livagen and cobalt ions compared to each agent alone. This phenomenon might reflect changes in the chromatin state, specifically the decondensation of heterochromatin. The study suggests that this chromatin remodeling might facilitate the exposure and possible transcriptional activation of previously inactivated genes within these regions."
            },
            {
                "h3": "Livagen and Nociception"
            },
            {
                "p": "Enkephalins are considered to be naturally occurring neurotransmitters that may bind with mu- and delta- receptors and reduce pain signal transmission. Bioregulatory peptides such as Livagen may possibly act on enzymes and prevent the degradation of these neurotransmitters, possibly increasing enkephalin levels. The activity of these degrading enzymes was assessed in vitro, based on the rate of hydrolysis of 3H-Leu-enkephalin, a labeled enkephalin peptide.(7) The study also explored whether Livagen might interact directly with mu- and delta- receptors in the brain, using a radioreceptor method with the tracer [3H][D-Ala2, D-Leu5]-enkephalin. This component of the study posited that there appeared to be no observable interaction between Livagen and the mu- or delta-opioid receptors of the membrane fraction from murine models' brains. This outcome suggests that while Livagen may influence opioid peptide levels by inhibiting their degradation, it does not appear to directly bind or affect opioid receptors in the brain."
            },
            {
                "h3": "Livagen and Antioxidant Systems"
            },
            {
                "p": "A study explored the potential hepatoprotective and immunoprotective properties of the Livagen, particularly in liver fibroid induration and both acute and chronic hepatitis models. The findings suggest that Livagen may help normalize immune response and antioxidant status, which might restore liver function during episodes of hepatitis, particularly in cases where liver function typically declines. Livagen potentially offers positive actions in mitigating liver fibroid induration and combating various forms of hepatitis, though the exact mechanisms of action remain unclear.(8)"
            },
            {
                "h3": "Livagen and DNA Repair"
            },
            {
                "p": "DNA alteration over time is considered to lead to increased chromatin condensation and decreased cellular repair.(9) Researchers have suggested the Livagen peptide to inhibit and possibly reverse these alterations, improving cellular functions and 'reversing' cell aging.(3) Thus, specific chromosomal abnormalities may also be addressed through Livagen based on the exact mechanism. However, no direct studies have been conducted."
            },
            {
                "p": "Livagen peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "National Human Genome Research Institute. Chromatin. May 10, 2022. https://www.genome.gov/genetics-glossary/Chromatin",
                    "Khavinson VKh, Lezhava TA, Monaselidze JG, Dzhokhadze TA, Dvalishvili NA, Bablishvili NK, Ryadnova IY. Effects of Livagen peptide on chromatin activation in lymphocytes from old people. Bull Exp Biol Med. 2002 Oct;134(4):389-92. https://pubmed.ncbi.nlm.nih.gov/12533768/",
                    "Lezhava T, Monaselidze J, Kadotani T, Dvalishvili N, Buadze T. Anti-aging peptide bioregulators induce reactivation of chromatin. Georgian Med News. 2006 Apr;(133):111-5. PMID: 16705247. https://pubmed.ncbi.nlm.nih.gov/16705247/",
                    "Dzhokhadze Ta et al., Functional regulation of genome with peptide bioregulators by hypertrophic cardiomyopathy (by patients and relatives), December 1, 2013. https://www.semanticscholar.org/paper/Functional-regulation-of-genome-with-peptide-by-(by-Ta-TZh/ddda519986d5793a0aedc2293f00f0e5fa540b4d",
                    "Lezhava T et al., Activation of pericentromeric and telomeric heterochromatin in cultured lymphocytes from old individuals, 01 Apr 2007. https://europepmc.org/article/MED/17460203",
                    "[Effect of peptide bioregulator and cobalt ions on the activity of NORs and associations of acrocentric chromosomes in lymphocytes of patients with hypertrophic cardiomyopathy and their relatives]. Georgian Med News. 2014 Sep;(234):134-7. Russian. https://pubmed.ncbi.nlm.nih.gov/25341254/",
                    "Kost NV, Sokolov OIu, Gabaeva MV, Zolotarev IuA, Malinin VV, Khavinson VKh. Vliianie novykh peptidnykh bioreguliatorov livagena i épitalona na énkefalindegradiruiushchie fermenty syvorotki krovi cheloveka [Effect of new peptide bioregulators livagen and epitalon on enkephalin-degrading enzymes in human serum]. Izv Akad Nauk Ser Biol. 2003 Jul-Aug;(4):427-9. https://pubmed.ncbi.nlm.nih.gov/12942748/",
                    "Kuznik BI, Khasanova NB, Ryzhak GA, Mezsheriakova IE, Khavinson VK. [The influence of polypeptide liver complex and tetrapeptide KEDA on organism physiological function in norm and age-related pathology.]. Adv Gerontol. 2020;33(1):159-164. Russian. PMID: 32362099.",
                    "Lezhava TA. Funktsional'nye osobennosti khromosom cheloveka i starenie [Human chromosome functional characteristics and aging]. Adv Gerontol. 2001;8:34-43. Russian. PMID: 11582753. https://pubmed.ncbi.nlm.nih.gov/11582753/"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/12/Livagen-COA-1.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/12/Livagen-LC-1.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/12/Livagen-MS-1.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Livagen peptide for sale online (20mg). Peptides are for sale at 99+% purity with unmatched service, bulk purchase discounts, and free shipping from Core.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Livagen For Sale (20mg) - Core Peptides",
            "og:description": "Livagen peptide for sale online (20mg). Peptides are for sale at 99+% purity with unmatched service, bulk purchase discounts, and free shipping from Core.",
            "og:url": "https://www.corepeptides.com/peptides/livagen-20mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T16:34:45+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2022/11/Livagen-20MG.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Livagen For Sale (20mg) - Core Peptides",
            "twitter:description": "Livagen peptide for sale online (20mg). Peptides are for sale at 99+% purity with unmatched service, bulk purchase discounts, and free shipping from Core.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2022/11/Livagen-20MG.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$73.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "73.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-Livagen",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/dsip-5mg/",
                "name": "DSIP (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/DSIP-5MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ll-37-5mg/",
                "name": "LL-37 (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/LL-37-5mg-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/epitalon-25mg/",
                "name": "Epithalon (25mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Epithalon-5MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ghrp-2/",
                "name": "GHRP-2 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHRP-2-300x300.jpg.webp",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/liraglutide-glp-1-3mg/",
        "name": "Liraglutide (3mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2022/11/Liraglutide-GLP-1-3mg-1.jpg",
        "display_price": "$51.00",
        "display_specs": [
            "Size: 3mg Contents: Liraglutide (3mg) Form: Lyophilized powder Purity: >99% SKU: P-Liraglutide",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$48.45"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$45.90"
            }
        ],
        "description": [
            {
                "h2": "Liraglutide Peptide"
            },
            {
                "p": "Liraglutide is a polypeptide analog of the naturally occurring protein GLP-1 (glucagon-like peptide), containing 31 amino acids. It is 97% structurally similar to GLP-1, and scientists classify it as a lipopeptide, comprising the amino acid arginine and a hexadecanoyl group.(1)"
            },
            {
                "p": "Researchers speculate that due to its structural similarities, Liraglutide may mimic the action of GLP-1, an endogenous hormone produced in the intestine. GLP-1 is considered to increase insulin production and delay gastric emptying following consumption. Liraglutide may also activate the satiety centers in the central nervous system, inducing a feeling of fullness. Furthermore, it may stimulate insulin release from the beta cells in the pancreas, lowering postprandial blood glucose levels and supporting blood sugar control."
            },
            {
                "h3": "Overview"
            },
            {
                "p": "Liraglutide, similar to GLP-1, may induce what scientists call an \"incretin action,\" a term coined by Dr. Holst.(2) Incretins are considered to be the metabolic hormones released in the gastrointestinal tract to stimulate insulin secretion to diminish blood sugar levels. More specifically, GLP-1 receptors are located on the surface of beta cells found in the pancreas, indicating a potential for GLP-1 to bind to this receptor, thereby inducing insulin release exocytosis."
            },
            {
                "p": "When combined with other compounds, the action of Liraglutide may be amplified. A 2007 study was conducted where the Liraglutide peptide was introduced into a rat pancreas alongside a sulfonylurea compound. The study results noted that: \"GLP-1 administration to isolated perfused rat pancreases at low perfusate glucose concentrations normally does not affect insulin secretion but resulted in dramatic stimulation of insulin secretion after pretreatment with sulfonylurea\".(2)"
            },
            {
                "p": "Here is a summary of some of the most notable Liraglutide experiments:"
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C172H265N43O51 Molecular Weight: 3751.24 g/mol Other Known Titles: NN2211"
            },
            {
                "h2": "Liraglutide Research and Clinical Studies"
            },
            {
                "h3": "Liraglutide and Pancreatic Receptors"
            },
            {
                "p": "Studies posit that the Liraglutide peptide may have distinct actions on pancreatic α-cells and β-cells, particularly regarding cell viability, apoptosis, and secretion capabilities.(7) This differentiation is apparently mediated by the cAMP-PKA signaling pathway and the regulation of microRNA-375 (miR-375). For α-cells, represented in vitro by the α-TC1-6 cell line, Liraglutide seems to increase miR-375 levels and promote apoptosis through inhibition of the cAMP-PKA signal pathway. This action potentially leads to a reduction in glucagon secretion from α-cells. Glucagon is posited to be a hormone that increases blood sugar levels. More specifically, the process seems to involve the decrease of cAMP levels and subsequent modulation of the cAMP-PKA pathway activity. Conversely, in β-cells, represented by the β-TC-tet cell line, Liraglutide appears to activate the cAMP-PKA signal pathway, possibly resulting in the down-regulation of miR-375 and improved cell viability. This activation may be associated with an enhancement of insulin secretion in a concentration-dependent manner, suggesting that Liraglutide may promote β-cell function through these mechanisms. These observations indicate that Liraglutide may have the potential to differentially regulate pancreatic α and β cell functions through mechanisms involving the cAMP-PKA signaling pathway and miR-375. The study highlights the complexity of Liraglutide's actions at the cellular level, suggesting that its actions on α-cells and β-cells may be mediated through distinct molecular mechanisms. These findings offer a possible explanation for Liraglutide's potential in improving glycemic control by simultaneously enhancing insulin secretion and suppressing glucagon secretion.(7)"
            },
            {
                "h3": "Liraglutide and Gastric Motility"
            },
            {
                "p": "Studies have observed that 1-hour gastric emptying may be reduced by 23% following exposure to Liraglutide, as observed in studies comparing the peptide to a placebo compound. This suggests that Liraglutide may initially delay gastric emptying. However, there was no significant difference in the 5-hour gastric emptying time (AUC0–300 min) between Liraglutide and the placebo. This apparent short-term postprandial reduction in motility may, however, be sufficient to induce early satiety.(8) Liraglutide has been hypothesized to slow down gastric emptying through a multifaceted mechanism, potentially involving complex interactions with neural circuits that engage GLP-1 receptors both in the central nervous system (CNS) and the peripheral nervous system. This intricate process may begin when Liraglutide activates GLP-1Rs expressed on enteroendocrine cells in the gut. These cells are posited to respond to food intake by secreting GLP-1, which Liraglutide may mimic, thereby enhancing the hormone's natural actions. Upon activation by Liraglutide, GLP-1Rs on enteroendocrine cells may signal through the enteric nervous system, which governs the gastrointestinal tract's motility. The engagement of these receptors is thought to modulate neural pathways responsible for controlling the pace at which the stomach contracts and releases its contents into the small intestine. This modulation likely reduces the gastric motility rate, leading to slower gastric emptying. Simultaneously, Liraglutide’s activation of GLP-1Rs may also signal through the vagal nerve to the CNS. This central signaling pathway may further influence gastric motility by modulating autonomic outputs back to the stomach, reinforcing the slowdown in gastric emptying.(9)"
            },
            {
                "h3": "Liraglutide and Central Satiety-Inducing Mechanisms"
            },
            {
                "p": "Research has posited that Liraglutide‘s potential action on weight reduction in murine models may possibly be independent of GLP-1 receptors (GLP-1Rs) in the vagus nerve, area postrema, and paraventricular nucleus.(10) Researchers suggest the possibility that Liraglutide's pathways for influencing weight may circumvent or operate alongside traditional GLP-1R-mediated mechanisms within complex neural circuits. Following the introduction of fluorescently labeled Liraglutide in murine models, researchers reported an observed presence of the compound in the circumventricular organs of the brain, indicating a direct pathway through which Liraglutide might impact brain functions associated with appetite control and weight. The hypothalamus's arcuate nucleus (ARC) is considered a pivotal brain region for energy balance and appetite regulation. It is considered to house two critical populations of neurons: one that produces proopiomelanocortin (POMC) and cocaine- and amphetamine-regulated transcript (CART), which are involved in reducing appetite, and another that produces neuropeptide Y (NPY) and agouti-related peptide (AgRP), which are involved in increasing appetite. Liraglutide was apparently found to bind to neurons within the ARC and other hypothalamic regions, specifically associating with GLP-1R. This selective binding in GLP-1R competent models, and not in GLP-1R deficient (Glp1r–/–) murine models, implies the ARC's potentially significant role in mediating Liraglutide’s actions, possibly through a direct engagement with GLP-1Rs in this area."
            },
            {
                "p": "POMC/CART neurons may play a central role in satiety and energy expenditure, partly through the release of α-melanocyte-stimulating hormone (α-MSH), which is considered to bind to melanocortin-4 receptors (MC4R) to reduce food intake. Conversely, NPY and AgRP neurons may have the potential to stimulate appetite, with NPY acting as a potent orexigenic peptide and AgRP acting as an antagonist/inverse agonist at MC4R, promoting food intake. The apparent balance between these neurons may be essential for maintaining energy homeostasis. It is hypothesized that Liraglutide might be internalized in neurons expressing POMC and CART, which have been linked to appetite suppression. Electrophysiological measurements suggested that GLP-1 might directly stimulate POMC/CART neurons and indirectly inhibit neurotransmission in neurons expressing NPY and AgRP via GABA-dependent signaling. Gamma-aminobutyric acid (GABA), considered the brain's primary inhibitory neurotransmitter, may play a significant role in this mechanism. By facilitating GABAergic signaling, Liraglutide may potentially reduce the activity of orexigenic NPY/AgRP neurons, further tilting the balance towards satiety. These findings propose a dual mechanism through which Liraglutide may potentially foster satiety and decrease food intake by activating anorexigenic POMC/CART pathways and inhibiting orexigenic NPY/AgRP pathways through GABA-dependent signaling.(10)"
            },
            {
                "h3": "Liraglutide and Adipose Tissue Interactions"
            },
            {
                "p": "Studies have speculated that Liraglutide may interact with adipose tissue and influence the levels of critical hormones such as leptin and peptide YY (PYY), which are considered to contribute pivotal roles in regulating energy balance and satiety.(11) Adipose tissue is considered a key player in energy storage and hormone production and may potentially be influenced by Liraglutide’s mechanisms. While direct data remains to be seen, it is conceivable that Liraglutide might enhance the functionality of adipocytes, possibly contributing to a more favorable metabolic profile. This might involve the modulation of adipokines, cytokines produced by adipose tissue, by potentially improving insulin sensitivity and reducing inflammation associated with obesity. Leptin, which adipocytes may primarily secrete, signals the brain to potentially reduce food intake and increase energy expenditure. It has been hypothesized that weight loss may lead to decreased leptin levels, which might signal the organism to increase food intake and decrease metabolic rate, thereby counteracting the weight loss. Liraglutide's potential to moderate leptin levels, perhaps by minimizing the decrease in leptin following weight loss or by improving leptin sensitivity, may represent a mechanism by which it can aid in weight loss maintenance. PYY, a hormone released by the gut in response to food intake, has also been suggested to increase satiety and reduce appetite. Speculative data suggests that Liraglutide might elevate PYY levels, augmenting its appetite-suppressing actions. This interaction may play a role in the observed reduction in energy intake and body weight in research models exposed to Liraglutide in controlled laboratory environments.(11)"
            },
            {
                "p": "Liraglutide peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "p": "Not for human consumption."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "National Center for Biotechnology Information (2022). PubChem Compound Summary for CID 16134956, Liraglutide.",
                    "Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev. 2007 Oct;87(4):1409-39. DOI: 10.1152/physrev.00034.2006. PMID: 17928588. https://pubmed.ncbi.nlm.nih.gov/17928588/",
                    "Tandong Yang, Meng Chen, Jeffrey D. Carter, Craig S. Nunemaker, James C. Garmey, Sarah D. Kimble, Jerry L. Nadler, Combined treatment with lisofylline and exendin-4 reverses autoimmune diabetes, Biochemical and Biophysical Research Communications, Volume 344, Issue 3, 2006, Pages 1017-1022, ISSN 0006-291X, https://www.sciencedirect.com/science/article/pii/S0006291X06007066",
                    "Blonde L, Klein EJ, Han J, Zhang B, Mac SM, Poon TH, Taylor KL, Trautmann ME, Kim DD, Kendall DM. Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes. https://pubmed.ncbi.nlm.nih.gov/16776751/",
                    "Bose AK, Mocanu MM, Carr RD, Brand CL, Yellon DM. Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury. Diabetes. 2005. https://pubmed.ncbi.nlm.nih.gov/15616022/",
                    "During MJ, Cao L, Zuzga DS, Francis JS, Fitzsimons HL, Jiao X, Bland RJ, Klugmann M, Banks WA, Drucker DJ, Haile CN. Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. Nat Med. 2003 Sep; https://pubmed.ncbi.nlm.nih.gov/12925848",
                    "Xu X, Chen J, Hu L, Liang M, Wang X, Feng S, Shen J, Luan X. Liraglutide regulates the viability of pancreatic α-cells and pancreatic β-cells through cAMP-PKA signal pathway. Life Sci. 2018 Feb 15;195:87-94. doi: 10.1016/j.lfs.2017.12.012. Epub 2017 Dec 7. PMID: 29225111.",
                    "van Can J, Sloth B, Jensen CB, Flint A, Blaak EE, Saris WH. Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults. Int J Obes (Lond). 2014 Jun;38(6):784-93. doi: 10.1038/ijo.2013.162. Epub 2013 Sep 3. PMID: 23999198; PMCID: PMC4052428.",
                    "Drucker DJ. Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1. Cell Metab. 2018 Apr 3;27(4):740-756. doi: 10.1016/j.cmet.2018.03.001. PMID: 29617641.",
                    "Secher A, Jelsing J, Baquero AF, Hecksher-Sørensen J, Cowley MA, Dalbøge LS, Hansen G, Grove KL, Pyke C, Raun K, Schäffer L, Tang-Christensen M, Verma S, Witgen BM, Vrang N, Bjerre Knudsen L. The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss. J Clin Invest. 2014 Oct;124(10):4473-88. doi: 10.1172/JCI75276. Epub 2014 Sep 9. PMID: 25202980; PMCID: PMC4215190.",
                    "Ard J, Fitch A, Fruh S, Herman L. Weight Loss and Maintenance Related to the Mechanism of Action of Glucagon-Like Peptide 1 Receptor Agonists. Adv Ther. 2021 Jun;38(6):2821-2839. doi: 10.1007/s12325-021-01710-0. Epub 2021 May 11. PMID: 33977495; PMCID: PMC8189979."
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/12/Liraglutide-GLP-1-COA.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/12/Liraglutide-GLP-1-LC.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/12/Liraglutide-GLP-1-MS.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Liraglutide peptide for sale (3mg). Peptides for sale at 99% purity with top customer service. Get Liraglutide research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Liraglutide For Sale (3mg) - Core Peptides",
            "og:description": "Liraglutide peptide for sale (3mg). Peptides for sale at 99% purity with top customer service. Get Liraglutide research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/liraglutide-glp-1-3mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T16:33:16+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2022/11/Liraglutide-GLP-1-3mg-1.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Liraglutide For Sale (3mg) - Core Peptides",
            "twitter:description": "Liraglutide peptide for sale (3mg). Peptides for sale at 99% purity with top customer service. Get Liraglutide research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2022/11/Liraglutide-GLP-1-3mg-1.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$51.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:brand": "Core Peptides",
            "product:price:amount": "51.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-Liraglutide",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/fragment-176-191/",
                "name": "Fragment 176-191 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Fragment-176-191-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/adipotide-10mg/",
                "name": "Adipotide (FTPP) (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Adipotide-FTPP-10MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/oxytocin-10mg/",
                "name": "Oxytocin (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Oxytocin-10mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/receptor-grade-igf-1-lr3-100mcg/",
                "name": "Receptor Grade IGF-1 LR3 (100mcg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-100MCG-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/lipopeptide-topical-200mg/",
        "name": "Lipopeptide (200mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2023/12/LIPOPETIDE-200MG.jpg",
        "display_price": "$214.00",
        "display_specs": [
            "Size: 200mg Contents: GHK-Cu Form: Lyophilized powder Purity: >99% SKU: P-LIPOPEPTIDE-200",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$203.30"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$192.60"
            }
        ],
        "description": [
            {
                "h2": "Lipopeptide Peptide"
            },
            {
                "p": "Lipopeptide, characterized by the sequence Palmitoyl-Gly-Gln-Pro-Arg, is a palmitoylated fragment derived from immunoglobulin G (IgG). IgG is a type of antibody, considered a crucial component of the immune system that apparently mediates various inflammatory processes. The palmitoylation of this peptide fragment, which involves the attachment of a palmitic acid molecule, may also enhance its experimental potential. This modification appears to improve the lipopeptide's ability to penetrate through the corneal layers of skin tissue models. The increased penetration appears to be due to the added lipid (fat) component, which aids in traversing the lipid-rich environment of the outer layers of skin tissue."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular formula: C38H68N6O8 Molecular weight: 736.9 g/mol Sequence: Pal-Gly-Gln-Pro-Arg Other known titles: Pal-GQPR, Palmitoyl Tetrapeptide-7/3"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "p": "The summary below reflects the latest findings from preliminary studies on the functionalities of Lipopeptide, as revealed through diverse experimental methods."
            },
            {
                "h3": "Lipopeptide and the Extracellular Dermal Matrix"
            },
            {
                "p": "One study conducted a series of evaluations on a blend of peptides including Lipopeptide (Pal-GQPR) for their potential action on skin cell structure.(1) Echography tests suggested that this blend might reduce the thickness of the subepidermal low-echogenic band and support its density, indicating a possible improvement in skin structure. Moreover, studies in murine models hinted that these peptides might potentially enhance the extracellular dermal matrix structure compared to a placebo. More specifically it was posited that this compound might also play a role in decreasing the secretion of interleukin-6 (IL-6), a cytokine involved in inflammatory responses. IL-6 is a molecule that is typically associated with immune responses and appears to be elevated during inflammation, potentially contributing to various inflammatory skin conditions. The possible reduction of IL-6 secretion by Lipopeptide suggests that it may aid in mitigating inflammation, especially following UVB radiation exposure, a common cause of skin cell inflammation and damage. Additionally, Lipopeptide is thought to potentially stimulate the production of critical structural components around skin cells, such as laminin IV and V, as well as collagen VII. Laminins, particularly types IV and V, are integral components of the basement membrane, a layer that supports epithelial cells and is considered essential for tissue integrity. They play a crucial role in cell adhesion, differentiation, and migration, which are vital for skin repair and maintenance. Collagen VII, on the other hand, is a key component of anchoring fibrils that provide structural support and stability to the skin. It is essential for the attachment of the epidermis to the underlying dermis. The stimulation of these components by Lipopeptide may imply a potential role in enhancing the skin's structural framework.(2) Other researchers have also commented that Lipopeptide may have an action “as an anti-inflammatory agent and has anti-aging and skin firming [potential].”(3)"
            },
            {
                "h3": "Lipopeptide and Photoaged Skin Cells"
            },
            {
                "p": "The potential of Lipopeptide was investigated in a randomized controlled trial (RCT) as a blend alongside other peptides and active ingredients. This peptide, along with other compounds, such as retinyl palmitate and natural extracts, was assessed for its potential in improving the appearance of photoaged skin cells. Twelve days into the experiment, the peptide was observed to have stimulated the deposition of fibrillin-1 in the skin, a marker for skin repair, compared to the baseline levels. This was comparable to the apparent results observed with all-trans retinoic acid (RA), considered to be a clinical standard for photoaged skin cells. The accumulation of fibrillin-1 indicates a potential structural change in the skin, although this alone does not confirm the success of the experiment. In a 6-month RCT the peptide appeared to potentiate an improvement in skin wrinkles compared to the baseline. Interestingly, this potential improvement became more pronounced after 12 months. The vehicle formulation, which lacked the active ingredients, did not show similar results, suggesting that the ingredients in the test product, including Lipopeptide, may contribute to the observed effects. Furthermore, the study investigated the distribution of fibrillin-1 in skin biopsies from the RCT. Skin applied with the Lipopeptide appeared to have a significant increase in fibrillin-1 in the papillary dermis compared to the placebo group. This supports the idea that long-term experiments with Lipopeptide may lead to a visible improvement in the photoaged skin. The researchers concluded that Lipopeptide may “produce significant improvement in the appearance of wrinkles and further supports the [study] of fibrillin-1 as a robust biomarker for the repair of photoaged dermis.”(4)"
            },
            {
                "p": "Lipopeptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Mondon, P., Hillion, M., Peschard, O., Andre, N., Marchand, T., Doridot, E., Feuilloley, M. G., Pionneau, C., & Chardonnet, S. (2015). Evaluation of dermal extracellular matrix and epidermal-dermal junction modifications using matrix-assisted laser desorption/ionization mass spectrometric imaging, in vivo reflectance confocal microscopy, echography, and histology: effect of age and peptide applications. Journal of cosmetic dermatology, 14(2), 152–160. https://doi.org/10.1111/jocd.12135",
                    "Resende, D. I. S. P., Ferreira, M. S., Sousa-Lobo, J. M., Sousa, E., & Almeida, I. F. (2021). Usage of Synthetic Peptides in Cosmetics for Sensitive Skin. Pharmaceuticals (Basel, Switzerland), 14(8), 702. https://doi.org/10.3390/ph14080702",
                    "Fadilah, N. I. M., Rahman, M. B. A., Yusof, L. M., Mustapha, N. M., & Ahmad, H. (2021). The Therapeutic Effect and In Vivo Assessment of Palmitoyl-GDPH on the Wound Healing Process. Pharmaceutics, 13(2), 193. https://doi.org/10.3390/pharmaceutics13020193",
                    "Watson, R. E., Ogden, S., Cotterell, L. F., Bowden, J. J., Bastrilles, J. Y., Long, S. P., & Griffiths, C. E. (2009). Effects of a cosmetic 'anti-ageing' product improves photoaged skin [corrected]. The British journal of dermatology, 161(2), 419–426. https://doi.org/10.1111/j.1365-2133.2009.09216.x"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "",
        "high_performance_liquid_chromatography": "",
        "mass_spectrometry": "",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Lipopeptide for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Lipopeptide For Sale (200mg) - Core Peptides",
            "og:description": "Lipopeptide for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:url": "https://www.corepeptides.com/peptides/lipopeptide-topical-200mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T15:40:03+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2023/12/LIPOPETIDE-200MG.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Lipopeptide For Sale (200mg) - Core Peptides",
            "twitter:description": "Lipopeptide for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2023/12/LIPOPETIDE-200MG.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$214.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "214.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-LIPOPEPTIDE-200",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/ghrp-2/",
                "name": "GHRP-2 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHRP-2-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/epitalon-25mg/",
                "name": "Epithalon (25mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Epithalon-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/fragment-176-191/",
                "name": "Fragment 176-191 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Fragment-176-191-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/adipotide-10mg/",
                "name": "Adipotide (FTPP) (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Adipotide-FTPP-10MG-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/kpv-4mg/",
        "name": "KPV (4mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2022/01/KPV-4mg.jpg",
        "display_price": "$45.00 Original price was: $45.00.$38.00Current price is: $38.00.",
        "display_specs": [
            "Size: 4mg Contents: KPV (4mg) Form: Lyophilized powder Purity: >99% SKU: P-KPV-4",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$36.10"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$34.20"
            }
        ],
        "description": [
            {
                "h2": "KPV Peptide"
            },
            {
                "p": "Alpha melanocyte-stimulating hormone (a-MSH) is also classified as a melanotropin. a-MSH is an endogenous peptide hormone, composed of 13 amino acids, and considered to play a role in metabolic function, as well as other biological processes. Scientists isolated a fragment of this protein hormone and identified its potential biological action, naming it KPV peptide. KPV comprises three amino acids: Lysine, Proline, and Valine.(1) This peptide is a C-terminal fragment of the a-MSH protein hormone, which is considered the primary amino acid sequence in the hormone responsible for its properties.(2)"
            },
            {
                "p": "A study(2) was published in 1989 explaining how the tripeptide was isolated and its biological potential determined. Upon discovering that the COOH terminal peptide in the a-MSH hormone is the primary amino acid messenger sequence, scientists conducted preliminary research to determine if KPV might prevent an excessive increase in vasopermeability and excessive swelling of blood vessels. As a part of the study, scientists isolated the KPV peptide and presented it to experimental mice to determine its potential to mitigate swelling in their ears. After the completion of the study, the researchers reported that the isolated fragment appeared to have inhibited the swelling. KPV's potential anti-inflammatory action may be induced by inactivating the inflammatory pathways.(3) It may also possibly inhibit the synthesis and release of the pro-inflammatory cytokine cells in intestinal and immune cells."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C16H30N4O4 Molecular Weight: 342.43 g/mol Other Known Titles: MSH (11-13), ACTH(11-13), alpha-MSH(11-13)"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "KPV Peptide and Intestinal Protection"
            },
            {
                "p": "A study(4) was conducted on murine models to determine the peptide's potential on intestinal inflammation. The experiment was conducted on mice induced with bowel dysfunction. These mice were divided into two groups: one group was given the peptide, and the other was given the placebo. After the study, researchers reported that the peptide mice exhibited reduced inflammatory cells and anti-enzymatic symptoms."
            },
            {
                "p": "Another study(4) was conducted on a murine model of inflamed intestines, which involved the exposure of a chemical-induced compound of KPV and a chemical called hyaluronic acid. This chemical-induced KPV compound was given to the mice, with the added hyaluronic acid supplementation, intended to aid targeted delivery of the peptide to specific locations in the intestine. The results observed mitigated swelling in the intestine."
            },
            {
                "h3": "KPV Peptide and Intestinal Cells"
            },
            {
                "p": "One study(5) was conducted on a cell culture of inflamed intestinal cells. The main purpose of this study was to determine the peptide’s potential against inflammation. Inflamed intestinal cells were isolated and exposed to either the KPV peptide or a placebo. Upon exposure to the peptide, these cells were examined, and results indicated that even nanomolar concentrations of the peptide appeared to have led to anti-inflammatory results. The researchers suggested that the KPV peptide appeared to mainly act via PepT1 expression in these intestinal cells, suggesting that PepT1 may play a role in transporting the peptide to the site of inflammation."
            },
            {
                "p": "Another study delved into the potential of KPV in addressing ulcerative inflammation of the colonic mucosa cells.(6) The researchers hypothesized that KPV might mitigate inflammatory responses within colonic cells, by accelerating mucosal healing and alleviating inflammation of the colonic mucosa. The action mechanism was suggested to involve the targeted delivery of KPV to inflamed colonic tissues, where it may exert anti-inflammatory potential. The researchers found that KPV may have exhibited a capacity to protect mucosal surfaces and downregulate TNF-α, a key marker of inflammation."
            },
            {
                "p": "Further trials in two murine models of intestinal inflammation suggest that KPV may have led to significant improvements, including earlier recovery, significant regain of body weight, and a reduction in inflammatory infiltrates, in the colonic tissue.(7) These outcomes were further supported by a notable decrease in myeloperoxidase (MPO) activity, indicating reduced neutrophil accumulation and inflammation in colonic tissue following KPV exposure. Moreover, the study explored whether KPV's anti-inflammatory actions may have been linked to the melanocortin-1 receptor (MC1R), suggesting that the action of KPV might at least be partially independent of MC1R signaling."
            },
            {
                "p": "One 1984 study aimed to evaluate the potential antipyretic action of the peptide,(8) wherein rabbits were given KPV peptide to examine its potential action on the nervous system. Following the study, researchers suggested that the peptide exhibited antipyretic potential, reducing the rabbits’ body temperature to optimal levels."
            },
            {
                "h3": "KPV Peptide and Inflammation Studies"
            },
            {
                "p": "A comparative study analysis(9) was conducted to examine the potential of a-MSH and KPV on the swelling (inflammation) of organs. An experiment was conducted on the mice with swollen ears due to skin rashes and dermatitis. The mice were divided into two groups - one was given an irritant (to induce ear swelling) and then exposed to the peptide, and the other with the irritant and the a-MSH molecule. After 24 hours, both groups exhibited apparently equal improvement in reducing ear swelling. After 2 weeks, researchers ceased exposure to both compounds, and only the irritant was given, with the results observing that the a-MSH mice appeared to continue to show reduced swelling compared to the other group."
            },
            {
                "h3": "KPV Peptide and Wound Healing"
            },
            {
                "p": "Wound healing is a complex biological process comprised of three general phases: inflammation, proliferation, and remodeling of the skin, tissue, or cells. This process is characterized by different types of cells and concentrations of cytokines in the wounded area. Though every wound and associated cells affected by the wound may differ, most cells possess a melanocortin 1 receptor (MC1R) receptor. This receptor is where the a-MSH hormone binds, and researchers suggest that a-MSH hormone analogs, such as KPV peptide, may also bind to these receptors.(10)"
            },
            {
                "p": "Another study explored the potential of KPV in enhancing corneal epithelial wound healing with a particular focus on the possible involvement of nitric oxide (NO) in these actions. Following mechanical abrasion to damage the corneal epithelium, the tissue was exposed to variable concentrations of the KPV peptide. The progress of epithelial wound healing was meticulously tracked and analyzed through computerized software, comparing the mean area of the epithelial defect among experimental groups at multiple time intervals. The findings suggested a potential acceleration in the healing process in corneal tissues compared to placebo. Specifically, within 60 hours, all corneas exposed to KPV appeared to have complete re-epithelialization, a stark contrast to the placebo group, where none of the corneas appeared to have achieved full healing."
            },
            {
                "p": "This accelerated healing effect was apparently hindered by pre-treatment with the nitric oxide synthase inhibitor, Nω-nitro-l-arginine methyl ester (l-NAME), suggesting that the facilitating impact of KPV on corneal epithelial wound healing might be linked to NO activity within the corneal tissue. Further in vitro experiments with corneal epithelial cells (RCE) exposed to different concentrations of KPV reportedly exhibited a stimulation of cell viability at 1 and 10 μM concentrations. These results suggest that KPV may not only accelerate corneal epithelial wound healing but also might stimulate cell viability, hinting at a broader reparative role that may involve NO dynamics.(11)"
            },
            {
                "h3": "KPV Peptide and Scar Formation"
            },
            {
                "p": "A study(12) was conducted to further understand the potential of KPV peptide in scar recovery. The experiment was conducted in murine models, half of the group of young mice were exposed to KPV, and the other served as a control group. Half an hour after exposure, these mice underwent two surgical 6.5 mm wide incisions in their dorsal skin under anesthesia. The wound healing and scar formation were analyzed on days 3, 7, 40, and 60. On days 3 and 7, researchers observed that the peptide mice appeared to show improved healing on the skin, possibly due to reduced levels of inflammatory cells such as leukocytes and mast cells. On days 40 and 60, it was observed that the peptide mice exhibited a lesser scar area than the control group."
            },
            {
                "p": "KPV peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Dalmasso, G., Charrier-Hisamuddin, L., Nguyen, H. T., Yan, Y., Sitaraman, S., & Merlin, D. (2008). PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology, 134(1), 166–178. https://doi.org/10.1053/j.gastro.2007.10.026",
                    "Hiltz ME, Lipton JM. Antiinflammatory activity of a COOH-terminal fragment of the neuropeptide alpha-MSH. FASEB J. 1989 Sep;3(11):2282-4. https://pubmed.ncbi.nlm.nih.gov/2550304/",
                    "Brzoska T, Luger TA, Maaser C, Abels C, Böhm M. Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocr Rev. 2008 Aug;29(5):581-602. doi: 10.1210/er.2007-0027. Epub 2008 Jul 8. https://pubmed.ncbi.nlm.nih.gov/18612139/",
                    "Klaus Kannengiesser, MD, Christian Maaser, MD, Jan Heidemann, MD, Andreas Luegering, MD, Matthias Ross, MD, Thomas Brzoska, PhD, Markus Bohm, MD, Thomas A. Luger, MD, Wolfram Domschke, MD, Torsten Kucharzik, MD, Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease, Inflammatory Bowel Diseases, Volume 14, Issue 3, 1 March 2008, Pages 324–331, https://doi.org/10.1002/ibd.20334",
                    "Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, Yan Y, Sitaraman S, Merlin D. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008 Jan;134(1):166-78. https://pubmed.ncbi.nlm.nih.gov/18061177/",
                    "Xiao, B., Xu, Z., Viennois, E., Zhang, Y., Zhang, Z., Zhang, M., Han, M. K., Kang, Y., & Merlin, D. (2017). Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis. Molecular therapy : the journal of the American Society of Gene Therapy, 25(7), 1628–1640. https://doi.org/10.1016/j.ymthe.2016.11.020",
                    "Kannengiesser K, Maaser C, Heidemann J, Luegering A, Ross M, Brzoska T, Bohm M, Luger TA, Domschke W, Kucharzik T. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflamm Bowel Dis. 2008 Mar;14(3):324-31. doi: 10.1002/ibd.20334. PMID: 18092346.",
                    "D.B. Richards, J.M. Lipton, Effect of α-MSH 11–13 (lysine-proline-valine) on fever in the rabbit, Peptides, Volume 5, Issue 4, 1984, Pages 815-817, ISSN 0196-9781, https://doi.org/10.1016/0196-9781(84)90027-5",
                    "Luger, T. A., & Brzoska, T. (2007). alpha-MSH related peptides: a new class of anti-inflammatory and immunomodulating drugs. Annals of the rheumatic diseases, 66 Suppl 3(Suppl 3), iii52–iii55. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2095288/#!po=3.33333",
                    "Brzoska T, Luger TA, Maaser C, Abels C, Böhm M. Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocr Rev. 2008 Aug;29(5):581-602. https://pubmed.ncbi.nlm.nih.gov/18612139/",
                    "Bonfiglio V, Camillieri G, Avitabile T, Leggio GM, Drago F. Effects of the COOH-terminal tripeptide alpha-MSH(11-13) on corneal epithelial wound healing: role of nitric oxide. Exp Eye Res. 2006 Dec;83(6):1366-72. doi: 10.1016/j.exer.2006.07.014. Epub 2006 Sep 11. PMID: 16965771.",
                    "de Souza KS, Cantaruti TA, Azevedo GM Jr, Galdino DA, Rodrigues CM, Costa RA, Vaz NM, Carvalho CR. Improved cutaneous wound healing after intraperitoneal injection of alpha-melanocyte-stimulating hormone. Exp Dermatol. 2015 Mar;24(3):198-203. https://pubmed.ncbi.nlm.nih.gov/25431356/"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/09/KPV-coa.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/09/KPV-lc.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/09/KPV-ms.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "KPV peptide for sale (4mg). Offering peptides for sale at 99% purity with top service, bulk purchase discounts, and free shipping from Core.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "KPV For Sale (4mg) - Core Peptides",
            "og:description": "KPV peptide for sale (4mg). Offering peptides for sale at 99% purity with top service, bulk purchase discounts, and free shipping from Core.",
            "og:url": "https://www.corepeptides.com/peptides/kpv-4mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T16:28:51+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2022/01/KPV-4mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "KPV For Sale (4mg) - Core Peptides",
            "twitter:description": "KPV peptide for sale (4mg). Offering peptides for sale at 99% purity with top service, bulk purchase discounts, and free shipping from Core.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2022/01/KPV-4mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$38.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:brand": "Core Peptides",
            "product:price:amount": "38.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-KPV-4",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/oxytocin-10mg/",
                "name": "Oxytocin (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Oxytocin-10mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/selank-10mg/",
                "name": "Selank (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Selank-10MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ipamorelin-5mg/",
                "name": "Ipamorelin (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Ipamorelin-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/aod-9604-5mg/",
                "name": "AOD 9604 (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/AOD-9604-5MG-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/kisspeptin-10mg/",
        "name": "Kisspeptin-10 (10mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2021/10/Kisspeptin-10-10MG.jpg",
        "display_price": "$63.00",
        "display_specs": [
            "Size: 10mg Contents: Kisspeptin-10 (10mg) Form: Lyophilized powder Purity: >99% SKU: P-KISSPEPT-10",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$59.85"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$56.70"
            }
        ],
        "description": [
            {
                "h2": "Kisspeptin-10 Peptide"
            },
            {
                "p": "Kisspeptin-10 is a naturally occurring peptide protein encoded by the KISS1 gene.(2) Kisspeptin is a product of the KISS1 gene, produced by the cleavage of the original 145-amino acid polypeptide to a smaller peptide. This smaller peptide, composed of 54-amino acids, is cleaved further to become Kisspeptin 45-54, also known as Kisspeptin 10.(6)"
            },
            {
                "p": "KISS1 is a gene that is considered to suppress metastases of melanomas and breast carcinomas, thereby inhibiting abnormal cell growth and potentially preventing cancer.(2) Initially considered to be a metastasis suppressor, Kisspeptin-10 was later suggested to possess a different expression profile, which may potentially allow it to function on the hypothalamus and pituitary gland, thereby impacting the reproductive system.(3)"
            },
            {
                "p": "Several independent studies in the mid-2000s suggested that Kisspeptin-10 may play a role in hypogonadotropic hypogonadism, as the peptide is considered to be a ligand of the G-protein coupled receptor 54 (GPR54).(5) Research continues to explore this potential aspect of the Kisspeptin-10 peptide."
            },
            {
                "p": "Hypogonadism is a system disorder wherein reproductive organs produce less or no sex hormones. One of the forms of hypogonadism is called hypogonadotropic hypogonadism, where the organism suffers from hypogonadism due to under-functioning of the pituitary gland or hypothalamus.(1) GnRH is considered to stimulate the pituitary gland to release follicle-stimulating hormone (FSH) and luteinizing hormone (LH). Both FSH and LH are considered to regulate reproductive function.(1) Lack of these hormones, i.e. GnRH, FSH, and LH, are considered the main factors of hypogonadotropic hypogonadism."
            },
            {
                "h3": "Overview"
            },
            {
                "p": "GPR54, also called the KISS1 receptor (KISS1R),(7) has been suggested by researchers to be an important GnRH receptor.(1) They further suggest that Kisspeptin-10 exhibits action by possibly binding to GPR54 receptors, which may activate the reproductive axis by stimulating the release of GnRH and gonadotropin neurons.(7)"
            },
            {
                "p": "Kisspeptin-10 is a 54 amino acid peptide which is considered to be a product of the KISS1 gene. Researchers have isolated smaller peptide fragments such as Kisspeptin 10, 13, and 14, which all have been suggested to possess some biological activity towards GPR54.(7) These smaller peptides have been posited to bind with a low affinity to the GPR54 receptors and possibly stimulate calcium mobilization, arachidonic acid release, and extracellular protein kinase phosphorylation.(7) These events may depolarize the Kisspeptin-10 neurons, possibly leading to the depolarization of the GnRH neurons and modulating gonadotropin release, to some extent.(9)"
            },
            {
                "p": "Research studies on Kisspeptin-10 have explored its potential in a wide variety of functions and impacts, and several hypotheses have been presented on the peptide's possible mechanisms of action, including some notable hypotheses below:(8)"
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C63H83N17O14 Molecular Weight: 1302.4 g/mol Other Known Titles: Kisspeptin 45-54"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Kisspeptin-10 and Reproduction"
            },
            {
                "p": "As part of one 2017 study,(10) a literature review was conducted for all articles published from 1999 to 2016. Upon review of the articles, it was suggested that experimental data may support the hypothesis that the Kisspeptin-10 system (including the KISS1 gene and its products, GPR54 receptors) may possibly regulate the release of gonadotropin hormones."
            },
            {
                "p": "Furthermore, certain studies were conducted in experimental animal models with similar characteristics as hypogonadotropic hypogonadism (HH) and polycystic ovarian syndrome (PCOS). These studies suggested that reproductive disorders such as HH and PCOS may occur due to abnormalities in the KISS1 and GPR54 system. The outcome of this literature review suggested that Kisspeptin-10 may be a neuropeptide regulator of GnRH release."
            },
            {
                "h3": "Kisspeptin-10 and Delayed Hormonal Development"
            },
            {
                "p": "The main goal of this study(13) was to evaluate the potential of Kisspeptin-10 peptide in research models of stunted development. Researchers hypothesized that the peptide might stimulate the gonadal hormonal release and regulate the reproductive system in the experimental models. The study randomly introduced either Kisspeptin-10 or gonadotropin-releasing hormone (GnRH). The levels of luteinizing hormone (LH) were monitored overnight. All research models were then exposed to GnRH for 6 days, then evaluated for LH levels. A total 47% of the experimental group exhibited positive impacts as a possible result of Kisspeptin-10 presence, with increased levels of LH hormone. An additional 6% of the group exhibited an intermediate response, and the remaining 47% exhibited no response as a result of peptide exposure."
            },
            {
                "h3": "Kisspeptin-10 and Emotional Modulation"
            },
            {
                "p": "The main purpose of this study(14) was to understand the potential of Kisspeptin-10 on limbic brain activity. Following Kisspeptin-10 exposure in the research models, results were monitored via neuroimaging and psychometric analysis. The data from the study suggested that the peptide appeared to have led to some enhanced limbic brain activity. The models appeared to exhibit an increased response towards sexual and bonding stimuli."
            },
            {
                "h3": "Kisspeptin-10 and Reproductive Hormone Release"
            },
            {
                "p": "The key objective of this study(15) was to establish the potential of Kisspeptin-10 on reproductive hormone release. Kisspeptin-10 was presented to both male and female experimental models. Results in the males indicated that the levels of FSH and LH were increased following peptide exposure. In the females, no alterations were reported in the levels of LH and FSH during the menstrual cycle. However, during the preovulatory phase, the levels of FSH and LH were reportedly elevated."
            },
            {
                "h3": "Kisspeptin-10 and Food Intake"
            },
            {
                "p": "Kisspeptin-10 is considered to be widely distributed in brain sites, including the hippocampus, cerebellum, posterior hypothalamus, and septum. Owing to its apparently vast distribution and presence in the food intake regulating nuclei, such as Arc, found in the hypothalamus, this study(11) was conducted to examine the potential impact of Kisspeptin-10 on food intake. This experiment was conducted on adult male mice aged between 6 and 8 weeks, caged under normal temperatures and conditions. These mice were subjected to a standard rodent diet and tap water. Overnight fasted mice and the experimentally fed mice were presented with different concentrations of Kisspeptin-10 or placebo. Results suggested that the peptide in the overnight fasted mice may have decreased food intake during the first 3-to-12-hour period. The food intake then reportedly increased during the 12-to-16-hour period, resulting in a similar food intake compared to the placebo group. This result suggested that the peptide led to a decrease in meal frequency and total meal time and increased intervals between meals. However, meal size and eating rate were almost similar to that of the placebo mice."
            },
            {
                "p": "To delve deeper into the subject, researchers have undertaken studies to investigate the potential actions of Kisspeptin-10 on food intake by examining the apparent influence of the peptide on appetite regulation in the central nervous system. The scientists suggested that the peptide may have some influence on the expression of genes related to neuropeptide Y (NPY) and brain-derived neurotrophic factor (BDNF). It has also been posited to have a potential impact on the concentrations of dopamine, norepinephrine, serotonin (also known as 5-hydroxytryptamine or 5-HT), dihydroxyphenylacetic acid, and 5-hydroxyindoleacetic acid within hypothalamic cells (specifically Hypo-E22 cells). Findings indicate that Hypo-E22 cells might be receptive to Kisspeptin-10, which may potentially elevate NPY gene expression. Conversely, it appeared to suppress the expression of BDNF. Furthermore, Kisspeptin-10 may have reduced serotonin and dopamine concentrations, though norepinephrine levels seemed to remain stable. This reduction in dopamine and serotonin was reflected by an increase in the ratios of their metabolites, dihydroxyphenylacetic acid to dopamine and 5-hydroxyindoleacetic acid to serotonin, respectively, following exposition to the peptide. The observed enhancement in NPY gene expression, alongside the diminution of BDNF expression and serotonin activity, may suggest the hunger-influencing potential of Kisspeptin-10.(12)"
            },
            {
                "h3": "Studies in Impaired Kisspeptin-10 Systems"
            },
            {
                "p": "As part of this study,(13) the energetic and metabolic potential of Kisspeptin-10 was compared between control mice and mice with impaired Kisspeptin systems. Results suggested that female mice with impaired Kisspeptin systems exhibited dramatic increases in body weight and significantly impaired glucose tolerance levels. While the peptide exposed and impaired female mice ate less than the control female mice, they were more obese, with reduced locomotor activity and respiratory rate. No reported difference was found between control male mice and male mice with impaired Kisspeptin systems. Both exhibited normal body weight and glucose levels."
            },
            {
                "h3": "Kisspeptin-10 and Neuroprotection"
            },
            {
                "p": "The accumulation of amyloid-beta (Aβ) and alpha-synuclein (α-syn) within cholinergic neurons is believed to damage and potentially cause dysfunction within important central nervous system structures. However, it has been proposed that Kisspeptin-10 may attach to Aβ on the outside of cells, which may, in turn, possibly reduce the harmful actions of Aβ.(16) Studies have suggested that Kisspeptin-10 peptides may counteract the damaging actions of Aβ, prion protein (PrP), and Islet Amyloid Polypeptide (IAPP) without being hindered by the antagonists of the kisspeptin receptor (GPR-54) or the neuropeptide FF (NPFF) receptor. Given the resemblance between the non-amyloid-β component (NAC) of α-syn and the C-terminus of Aβ, it has been speculated that Kisspeptin-10 might also lessen the toxicity caused by α-syn in cholinergic neurons.(17) Research involving cholinergic cells has indicated that while high concentrations of Kisspeptin-10 may increase toxicity, lower concentrations may potentially decrease the toxicity induced by both the wild-type and the E46K mutant forms of α-syn. Computational studies have supported these observations by suggesting a potentially actionable interaction between Kisspeptin-10 and the C-terminal residues of α-syn. The molecular dynamics simulations indicated that the complexes formed between Kisspeptin-10 and α-syn appeared to have demonstrated good stability."
            },
            {
                "p": "Researchers have also delved into investigating whether the activation of GPR54 (the receptor for the Kisspeptin gene) is crucial for the potential of Kisspeptin-10 to bind to the C-terminal pockets of α-syn. In one study, ChAT-positive SH-SY5Y neurons were genetically modified to produce either the wild-type or the E46K mutant version of α-syn, and the actions of Kisspeptin-10 on the neuronal damage caused by α-syn were assessed through flow cytometry and immunocytochemistry methods.(18) Results suggested that Kisspeptin-10 may have lessened both apoptosis and mitochondrial damage in cholinergic neurons affected by either form of α-syn. Notably, the seeming protective action of Kisspeptin-10 did not appear to be impacted when introduced alongside a GPR54 antagonist, kisspeptin-234 (KP-234), implying that the activation of GPR54 may not be necessary for the actions of Kisspeptin-10. Additionally, it was observed that Kisspeptin-10 may have reduced the presence of α-syn and choline acetyltransferase (ChAT) in neurons that overexpressed the wild-type and E46K mutant α-syn, further highlighting its potential neuroprotective capacity."
            },
            {
                "p": "Kisspeptin-10 peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Hypogonadotropic hypogonadism. US National Library of Medicine. https://medlineplus.gov/ency/article/000390.htm",
                    "KISS1 KiSS-1 metastasis suppressor [Homo sapiens (humans)]. https://www.ncbi.nlm.nih.gov/gene/3814",
                    "Hussain, Mehboob A et al. “There is Kisspeptin - And Then There is Kisspeptin.” Trends in endocrinology and metabolism: TEM vol. 26,10 (2015): 564-572. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4587393/",
                    "Pasquier, J., Kamech, N., Lafont, A., Vaudry, H., Rousseau, K., & Dufour, S. (2014). MOLECULAR EVOLUTION OF GPCRS: Kisspeptin/kisspeptin receptors, Journal of Molecular Endocrinology, 52(3), T101-T117. https://jme.bioscientifica.com/view/journals/jme/52/3/T101.xml",
                    "Messager, S., Chatzidaki, E. E., Ma, D., Hendrick, A. G., Zahn, D., Dixon, J., Thresher, R. R., Malinge, I., Lomet, D., Carlton, M. B., Colledge, W. H., Caraty, A., & Aparicio, S. A. (2005). Kisspeptin directly stimulates gonadotropin-releasing hormone release via G protein-coupled receptor 54. Proceedings of the National Academy of Sciences of the United States of America, 102(5), 1761–1766. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC545088/",
                    "Mead, E. J., Maguire, J. J., Kuc, R. E., & Davenport, A. P. (2007). Kisspeptins: a multifunctional peptide system with a role in reproduction, cancer and the cardiovascular system. British journal of pharmacology, 151(8), 1143–1153. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2189831/",
                    "Rønnekleiv, O. K., & Kelly, M. J. (2013). Kisspeptin excitation of GnRH neurons. Advances in experimental medicine and biology, 784, 113–131. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019505/",
                    "Prague JK, Dhillo WS. Potential Clinical Use of Kisspeptin. Neuroendocrinology. 2015;102(3):238-45. doi: 10.1159/000439133. Epub 2015 Aug 7. https://pubmed.ncbi.nlm.nih.gov/26277870/",
                    "Tng E. L. (2015). Kisspeptin signalling and its roles in humans. Singapore medical journal, 56(12), 649–656. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678402/",
                    "Zeydabadi Nejad, S., Ramezani Tehrani, F., & Zadeh-Vakili, A. (2017). The Role of Kisspeptin in Female Reproduction. International journal of endocrinology and metabolism, 15(3), e44337. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702467/",
                    "Stengel, A., Wang, L., Goebel-Stengel, M., & Taché, Y. (2011). Centrally injected kisspeptin reduces food intake by increasing meal intervals in mice. Neuroreport, 22(5), 253–257. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3063509/",
                    "Orlando G, Leone S, Ferrante C, Chiavaroli A, Mollica A, Stefanucci A, Macedonio G, Dimmito MP, Leporini L, Menghini L, Brunetti L, Recinella L. Effects of Kisspeptin-10 on Hypothalamic Neuropeptides and Neurotransmitters Involved in Appetite Control. Molecules. 2018 Nov 24;23(12):3071. doi: 10.3390/molecules23123071. PMID: 30477219; PMCID: PMC6321454.",
                    "Kristen P. Tolson et.al, Impaired kisspeptin signaling decreases metabolism and promotes glucose intolerance and obesity. The Journal of Clinical Investigation. Published June 17, 2014. https://www.jci.org/articles/view/71075",
                    "Chan, Y. M., Lippincott, M. F., Kusa, T. O., & Seminara, S. B. (2018). Divergent responses to kisspeptin in children with delayed puberty. JCI insight, 3(8), e99109. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931121/",
                    "Comninos, A. N., Wall, M. B., Demetriou, L., Shah, A. J., Clarke, S. A., Narayanaswamy, S., Nesbitt, A., Izzi-Engbeaya, C., Prague, J. K., Abbara, A., Ratnasabapathy, R., Salem, V., Nijher, G. M., Jayasena, C. N., Tanner, M., Bassett, P., Mehta, A., Rabiner, E. A., Hönigsperger, C., Silva, M. R., Dhillo, W. S. (2017). Kisspeptin modulates sexual and emotional brain processing in humans. The Journal of clinical investigation, 127(2), 709–719. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5272173/",
                    "Milton NG, Chilumuri A, Rocha-Ferreira E, Nercessian AN, Ashioti M. Kisspeptin prevention of amyloid-β peptide neurotoxicity in vitro. ACS Chem Neurosci. 2012 Sep 19;3(9):706-19. doi: 10.1021/cn300045d. Epub 2012 May 30. PMID: 23019497; PMCID: PMC3447396.",
                    "Simon, C., Soga, T., Ahemad, N., Bhuvanendran, S., & Parhar, I. (2022). Kisspeptin-10 Rescues Cholinergic Differentiated SHSY-5Y Cells from α-Synuclein-Induced Toxicity In Vitro. International journal of molecular sciences, 23(9), 5193. https://doi.org/10.3390/ijms23095193",
                    "Simon, C., Soga, T., & Parhar, I. (2023). Kisspeptin-10 Mitigates α-Synuclein-Mediated Mitochondrial Apoptosis in SH-SY5Y-Derived Neurons via a Kisspeptin Receptor-Independent Manner. International journal of molecular sciences, 24(7), 6056. https://doi.org/10.3390/ijms24076056"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/09/Kisspeptin-10-coa.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/09/Kisspeptin-10-lc.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/09/Kisspeptin-10-ms.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Kisspeptin-10 for sale online (10mg). Offering peptides for sale at 99+% purity with unmatched service and bulk purchase discounts from Core.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Kisspeptin-10 For Sale (10mg) | Core Peptides",
            "og:description": "Kisspeptin-10 for sale online (10mg). Offering peptides for sale at 99+% purity with unmatched service and bulk purchase discounts from Core.",
            "og:url": "https://www.corepeptides.com/peptides/kisspeptin-10mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T17:40:19+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2021/10/Kisspeptin-10-10MG.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Kisspeptin-10 For Sale (10mg) | Core Peptides",
            "twitter:description": "Kisspeptin-10 for sale online (10mg). Offering peptides for sale at 99+% purity with unmatched service and bulk purchase discounts from Core.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2021/10/Kisspeptin-10-10MG.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$63.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:brand": "Core Peptides",
            "product:price:amount": "63.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-KISSPEPT-10",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/selank-10mg/",
                "name": "Selank (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Selank-10MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/melanotan-2-10mg/",
                "name": "Melanotan 2 (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2023/03/Melanotan-2-10MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ghk-cu-50mg-copper/",
                "name": "GHK-Cu (Copper) (50mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHK-CU-50mg-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/semax-25mg/",
                "name": "Semax (25mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Semax-25MG-300x300.jpg.webp",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/ipamorelin-5mg/",
        "name": "Ipamorelin (5mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Ipamorelin-5MG.jpg",
        "display_price": "$46.00 Original price was: $46.00.$43.00Current price is: $43.00.",
        "display_specs": [
            "Size: 5mg Contents: Ipamorelin (5mg) Form: Lyophilized powder Purity: >99% SKU: P-IPAMORELIN-5",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$40.85"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$38.70"
            }
        ],
        "description": [
            {
                "h2": "Ipamorelin Peptide"
            },
            {
                "p": "Ipamorelin is a synthetic peptide that is composed of five amino acids, otherwise known as a pentadecapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2), formally classified as a Growth Hormone Secretagogue (GHS). Its name is derived from the intention of its development. Ipamorelin peptide was designed to act via ghrelin receptor binding. The ghrelin receptors on the pituitary gland (the gland naturally involved with growth hormone, or hGH synthesis) are also known as Growth Hormone Secretagogue receptors (GHS-R). Through its implied action, Ipamorelin may host the potential to trigger the GHS-Rs on the pituitary gland and potentially stimulate the release of growth hormone.(1)"
            },
            {
                "h3": "Overview"
            },
            {
                "p": "Ipamorelin is the first synthetic GHS that appears highly selective and may have the potential to augment the production of hGH without affecting other pituitary hormones such as prolactin or adrenocorticotropic hormone (ACTH). The potential increase in hGH might promote lipolysis and insulin-like growth factor-1 (IGF-1) production synthesis. Consequently, IGF-1 may become a mediator of hGH’s anabolic actions, and thereby the peptide may act to increase cellular proliferation and bone and muscle anabolism.(1)"
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C38H49N9O5 Molecular Weight: 711.86 g/mol Other Known Titles: NNC 26-0161"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Ipamorelin Peptide and Selective Agonism"
            },
            {
                "p": "Based on one 1998 murine model-based research study, researchers suggested that Ipamorelin may release growth hormones from the pituitary cells. When Ipamorelin was presented to swine and pentobarbitone anesthetized rats, it reportedly exhibited release in growth hormones. Upon further observation, the researchers hypothesized that similar to other growth hormone (GH) stimulating peptides, Ipamorelin may be a growth receptor agonist stimulating GH release through potential affinity in growth hormone receptors. Moreover, the researchers commented that Ipamorelin appears to be the first GHS-R “agonist with a selectivity for GH release similar to that displayed by GHRH. The specificity of Ipamorelin makes this compound a very interesting candidate for future clinical development.”(1) Scientific research studies have also suggested that Ipamorelin may lead to increased hGH secretion, possibly without significantly affecting other pituitary hormones such as the levels of prolactin or ACTH.(2)"
            },
            {
                "h3": "Ipamorelin Peptide and Growth Hormone Synthesis"
            },
            {
                "p": "Studies conducted in vitro suggest that the interaction of Ipamorelin with GHS receptors may potentially affect somatotroph cells in the anterior pituitary gland by triggering a series of cellular signaling events.(3) This theorized pathway involves the activation of phospholipase C (PLC), which some researchers believe may lead to the increased release of inositol triphosphate (IP3) and diacylglycerol (DAG). This release of secondary messenger molecules such as IP3 might potentially stimulate the discharge of calcium ions (Ca2+) from the cell's internal stores, while DAG might activate protein kinase C (PKC). The subsequent rise in intracellular calcium levels and the possible activation of PKC are thought to result in the exocytosis of vesicles filled with growth hormones from these pituitary cells.(3)"
            },
            {
                "p": "In late 1999, a clinical trial was carried out on eight test subjects where Ipamorelin was presented every 15 minutes for a set period. Two hours post-study, it was suggested by the researchers that the levels of growth hormone had apparently increased. More specifically, Ipamorelin appeared to have tended to boost growth hormone levels, potentially soaring to as much as 80mIU/l (roughly equivalent to a concentration of about 26.6ng/ml). When this increase is measured as a percentage compared to a placebo (with a baseline of 1.31mIU/l or 0.4ng/ml), the enhancement appeared to have exceeded a 60-fold uplift.(4)"
            },
            {
                "h3": "Ipamorelin Peptide and Bone Tissue"
            },
            {
                "p": "It is conceivable that Ipamorelin may positively influence bone mineral density. The theory posits that Ipamorelin might stimulate osteoblasts (cells responsible for bone formation) via hGH-mediated mechanisms, potentially leading to their enhanced proliferation, growth, and specialization. In a particular study, murine models were exposed to either Ipamorelin or a placebo.(5) The impact of Ipamorelin on bone mineral density in these mice was monitored closely through real-time dual X-ray absorptiometry (DEXA) assessments at critical sites, including the femur and L6 vertebra. Post-experiment, the femur bones were further examined using mid-diaphyseal peripheral quantitative computed tomography (pQCT) scans. Preliminary findings implied that the peptide may have contributed to increased body mass and a probable elevation in the overall tibial and vertebral BMC (bone mineral content) as detected by DEXA compared to the placebo group. Further, the pQCT data appeared to suggest that the observed augmentation in cortical BMC may have stemmed from an enlargement in the cross-sectional area of the bone. In contrast, the cortical volumetric bone mineral density (BMD, which denotes the ratio of BMC to area) appeared to remain steady. Thus, there may have been an enlargement in the volumes of the femur and the L6 vertebrae since BMC appeared to increase while the volumetric BMDs appeared unchanged.(5)"
            },
            {
                "h3": "Ipamorelin Peptide and Digestion"
            },
            {
                "p": "Researchers have delved into the potential of Ipamorelin in the functionality of the stomach, with a keen interest in its ability to possibly expedite the process of gastric emptying. For example, one study employed a technique to ascertain gastric emptying rates, which entailed monitoring the proportion of a marked substance that lingered in the stomach 15 minutes after its introduction through intragastric gavage.(6) The scientists conducted surgeries to purposefully decelerate the gastric emptying process in murine models. This deceleration was particularly noticeable in the control group. In contrast, Ipamorelin appeared to have markedly accelerated the emptying process compared to the control. This observation led the team to hypothesize that Ipamorelin might be able to increase the velocity of gastric emptying. Additional research was initiated to delve deeper into the action of the compound on the contractile potential of the stomach's smooth muscles, which were activated by acetylcholine and electrical field stimulation. Indeed, the decelerated peristalsis appeared to be mitigated when Ipamorelin and ghrelin were studied together, suggesting the idea that Ipamorelin may enhance the contractility of gastric smooth muscles.(6)"
            },
            {
                "h3": "Ipamorelin Peptide and Appetite"
            },
            {
                "p": "The potential actions of Ipamorelin on ghrelin receptors may lead to an enhancement in hunger signals and, perhaps, an ensuing augmentation in body mass. Research suggests that research models exposed to Ipamorelin were observed to sustain an estimated 15% surge in body weight.(7) Researchers speculate that this substance might have led to a proportional increase in the weight of fat pads in comparison to the total body weight. Consequently, DEXA scans might indicate a comparative rise in body fat percentage. Moreover, there is speculation among researchers that Ipamorelin might elevate serum leptin levels, a hormone considered to play a crucial role in energy balance and hunger regulation. This observation has prompted scientists to consider increased food consumption as a potential contributor to the weight gain noted in research models exposed to Ipamorelin. They have posited that \"GHSs increase body fat by GH-independent mechanisms that may include increased feeding.”(7)"
            },
            {
                "h3": "Ipamorelin Peptide and Nitrogen Balance"
            },
            {
                "p": "Researchers have suggested that Ipamorelin may potentially mediate anabolic action, which may be due to its potential in hGH and IGF-1 synthesis and may be assessed through its impact on nitrogen balance. In a distinct investigation, researchers aimed to explore the action of Ipamorelin on specific liver markers associated with alpha-amino-nitrogen conversion during induced catabolic states.(8) The study focused on the liver’s capacity to synthesize urea-N (CUNS), which may serve as an indicator of the organ's ability to process nitrogen. The levels of messenger RNA (mRNA) related to liver urea cycle enzymes were scrutinized, alongside an assessment of the overall nitrogen balance and a hypothesis regarding nitrogen distribution across various organs. The findings suggested that Ipamorelin might have contributed to a possible 20% reduction in CUNS compared to the artificially induced catabolic condition. Furthermore, it might have diminished the expression of urea cycle enzymes, possibly restored nitrogen balance, and, in theory, altered or improved nitrogen concentrations in different organs.(8)"
            },
            {
                "p": "Ipamorelin peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "K. Raun et al., Ipamorelin, the first selective growth hormone secretagogue, Endocrinology, November 1998.",
                    "Sinha DK, Balasubramanian A, Tatem AJ, Rivera-Mirabal J, Yu J, Kovac J, Pastuszak AW, Lipshultz LI. Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males. Transl Androl Urol. 2020 Mar;9(Suppl 2):S149-S159. doi: 10.21037/tau.2019.11.30. PMID: 32257855; PMCID: PMC7108996 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108996/",
                    "Jiménez-Reina, L., Cañete, R., de la Torre, M. J., & Bernal, G. (2002). Influence of chronic treatment with the growth hormone secretagogue Ipamorelin, in young female rats: somatotroph response in vitro. Histology and histopathology, 17(3), 707–714. https://doi.org/10.14670/HH-17.707",
                    "Gobburu, J.V.S., Agersø, H., Jusko, W.J. et al. Pharmacokinetic-Pharmacodynamic Modeling of Ipamorelin, a Growth Hormone Releasing Peptide, in Human Volunteers. Pharm Res 16, 1412–1416 (1999).",
                    "Svensson, J., Lall, S., Dickson, S. L., Bengtsson, B. A., Rømer, J., Ahnfelt-Rønne, I., Ohlsson, C., & Jansson, J. O. (2000). The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats. The Journal of endocrinology, 165(3), 569–577. https://doi.org/10.1677/joe.0.1650569",
                    "Greenwood-Van Meerveld, B., Tyler, K., Mohammadi, E., & Pietra, C. (2012). Efficacy of ipamorelin, a ghrelin mimetic, on gastric dysmotility in a rodent model of postoperative ileus. Journal of experimental pharmacology, 4, 149–155. https://doi.org/10.2147/JEP.S35396",
                    "Lall, S., Tung, L. Y., Ohlsson, C., Jansson, J. O., & Dickson, S. L. (2001). Growth hormone (GH)-independent stimulation of adiposity by GH secretagogues. Biochemical and biophysical research communications, 280(1), 132–138. https://doi.org/10.1006/bbrc.2000.4065",
                    "Aagaard, N. K., Grøfte, T., Greisen, J., Malmlöf, K., Johansen, P. B., Grønbaek, H., Ørskov, H., Tygstrup, N., & Vilstrup, H. (2009). Growth hormone and growth hormone secretagogue effects on nitrogen balance and urea synthesis in steroid treated rats. Growth hormone & IGF research: official journal of the Growth Hormone Research Society and the International IGF Research Society, 19(5), 426–431. https://doi.org/10.1016/j.ghir.2009.01.001"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/09/Ipamorelin-coa.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/09/Ipamorelin-lc.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/09/Ipamorelin-ms.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Ipamorelin peptide for sale online (5mg). Peptides for sale at 99% purity with top customer service. Get Ipamorelin research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Ipamorelin For Sale (5mg) | Core Peptides",
            "og:description": "Ipamorelin peptide for sale online (5mg). Peptides for sale at 99% purity with top customer service. Get Ipamorelin research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/ipamorelin-5mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-05-28T11:02:30+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Ipamorelin-5MG.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Ipamorelin For Sale (5mg) | Core Peptides",
            "twitter:description": "Ipamorelin peptide for sale online (5mg). Peptides for sale at 99% purity with top customer service. Get Ipamorelin research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Ipamorelin-5MG.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$43.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "43.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-IPAMORELIN-5",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/selank-10mg/",
                "name": "Selank (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Selank-10MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/epitalon-25mg/",
                "name": "Epithalon (25mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Epithalon-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/oxytocin-10mg/",
                "name": "Oxytocin (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Oxytocin-10mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/receptor-grade-igf-1-lr3-100mcg/",
                "name": "Receptor Grade IGF-1 LR3 (100mcg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-100MCG-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/humanin-10mg/",
        "name": "Humanin (10mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2021/10/Humanin-10mg.jpg",
        "display_price": "$147.00",
        "display_specs": [
            "Size: 10mg Contents: Humanin (10mg) Form: Lyophilized powder Purity: >99% SKU: P-HUMANIN-10",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$139.65"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$132.30"
            }
        ],
        "description": [
            {
                "h2": "Humanin Peptide"
            },
            {
                "p": "Humanin is a short natural peptide with suggested potential in cell metabolism and inflammation response.(3) Researchers have suggested that a mitochondrial genome called ‘16S ribosomal RNA gene’ encodes the Humanin peptide.(4) Researchers further posit that the peptide's length may depend on the location of its synthesis. The peptide may contain 21 amino acids if synthesized inside the mitochondria, whereas it may contain 24 amino acids if synthesized outside the mitochondria but inside the cytosol.(5) Both of these peptides exhibit potential biological activity."
            },
            {
                "p": "Mitochondria are considered the powerhouses of the cell, and are formed from the engulfment of individual prokaryotes. Eventually, the eukaryotes appear to engulf the prokaryotic (single-celled) organism, and the prokaryotes form an endosymbiotic relationship with the host cell and gradually develop into mitochondria.(1)"
            },
            {
                "p": "Mitochondria are considered to be responsible for several vital cellular activities, including energy production, regulation of apoptosis, hemostasis, and formation of heme proteins, among several other functions. All these functions appear to be regulated by mitochondria via their communications to the cell through several retrograde signals. These signals may be encoded by the nuclear genome present in the mitochondria, possibly due to its prokaryotic origin.(2)"
            },
            {
                "p": "A small peptide called Humanin is derived from this genome. Since this genome appears to play an important role, this peptide has been explored for its potential action in several biological functions."
            },
            {
                "h3": "Overview"
            },
            {
                "p": "The peptide appears to exert potential actions via binding with intracellular molecules and cell membrane receptors, possibly inducing cytoprotective and/or neuroprotective functions.(9) Researchers suggest that Humanin may bind with the Bcl-2-associated X protein (also called Bax protein). Bax protein is considered to play a vital role in cellular death (apoptosis). Upon binding with the inactive form of the Bax protein, Humanin may inhibit the changes in the Bax protein and potentially thereby prevent cellular apoptosis.(9)"
            },
            {
                "p": "Apart from research into its possible interaction with Bax, Humanin studies suggest the peptide may also bind with other intracellular molecules, such as actinin-4 and phosphoprotein 8, which are both involved in cellular apoptosis. Upon binding with these proteins, Humanin may induce cytoprotective actions. Researchers suggest Humanin may bind with two G protein-coupled peptide receptors, namely FPRL-1 and FPRL-2 receptors, which are considered to be involved with neurological function.(9) By binding with this receptor, Humanin may potentially prevent amyloid β binding with the FPRL-1 and FPRL-2 receptors, which may mitigate some instances of neurological degradation."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C119H204N34O32S2 Molecular Weight: 2687.3 g/mol Other Known Titles: HNGF6A protein"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Humanin Peptide and Mitochondrial Functions"
            },
            {
                "p": "Mitochondria appear to be susceptible to reactive oxygen species (ROS), and the presence of such ROS may reduce its functioning. Studies in Humanin mechanisms of action suggest that the peptide may inhibit these reactive oxygen species to some degree, thereby mitigating mitochondria degeneration.(10) One study was produced wherein the researchers attempted to explore the peptide's action on retinal pigment epithelial cells. These cells were isolated and introduced to tert-butyl hydroperoxide to exert oxidative stress in the cells. Some of these cells were then presented with Humanin peptide for 24 hours. When examined, the cells exposed to Humanin reportedly inhibited the formation of tert-butyl hydroperoxide-induced reactive oxygen species. The researchers suggested the peptide may have restored the bioenergetics in the retinal pigment epithelial cells and increased the functioning of mitochondria."
            },
            {
                "h3": "Humanin Peptide and Cellular Longevity"
            },
            {
                "p": "Studies(11) were conducted on several murine models to determine the relation between Humanin with growth hormone (GH) and immunoglobulin (IGF-1). In GH-transgenic murine models, the levels of growth hormone and IGF-1 appeared to be extremely high, which the researchers suggested led to increased body size, accelerated cell aging, and reduced life span. Researchers reported that the levels of Humanin naturally present in the murine models were extremely low, about 70% lower than the control."
            },
            {
                "p": "Another set of murine models had undetectable levels of GH and IGF-1, along with a reported 40% increase in the Humanin levels. These murine models showed an increased life span compared to normal murine models. These results supported the researchers' hypothesis that Humanin may be negatively correlated to GH and IGF-1 levels and directly correlated to cellular longevity."
            },
            {
                "h3": "Humanin Peptide and Neurological Deterioration"
            },
            {
                "p": "A study(12) was conducted on 9-month-old murine models, all of which reportedly possessed high levels of amyloid proteins. These amyloid chemicals are indicative of some neurological deterioration. Some murine models were presented with Humanin, while others were given a placebo. Following the study, the researchers suggested that the placebo models showed impaired memory and poor learning skills. In contrast, the murine models presented with Humanin for 3 months reportedly exhibited significantly improved learning ability and enhanced memory."
            },
            {
                "p": "In another study,(13) murine models with experimentally induced impairment in neurological functioning were exposed to Humanin and a similarly structured peptide, PAGA, to determine the potential of both peptides on the brain function of the murine models. Both the peptides showed some modest improvement in the impairment of the brain, as suggested by the researchers."
            },
            {
                "p": "Another study explored the potential neuroprotective action of Humanin on neurotoxicities induced by Calyculin A in cortical neurons as a model of exposure to neurotoxins. The researchers focused on the potential capability of the peptide to safeguard cortical neurons from Calyculin A-induced neurotoxic action. In this investigation, cortical neurons were preincubated with Humanin to examine its protective role against neurotoxicity. The methodologies utilized in this research included employing 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), lactate dehydrogenase (LDH), and Calcein-AM assays to evaluate the extent of neural damage. Furthermore, caspase 3 signaling and TUNEL assays were conducted to assess neural apoptosis. The study also used Western blot analysis to detect potential expressions of phosphorylated tau, a protein associated with neurodegenerative diseases. Additionally, the study measured the apparent contents of malondialdehyde (MDA) and superoxide dismutase (SOD), and the activity of protein phosphatase 2A (PP2A), which are potential indicators of oxidative stress in neurons."
            },
            {
                "p": "The results from these investigations posited that preincubation with Humanin may preserve cell viability and potentially protect neurons from Calyculin A-induced damage. Notably, the peptide appeared to alleviate oxidative stress in the neurons and preserved the activity of PP2A, an enzyme involved in dephosphorylating tau proteins. Humanin also may have inhibited the over-phosphorylation of tau at specific sites (Ser199/202, Ser396, and Thr231), which are considered critical to the pathological changes observed in neurodegenerative diseases. From these findings, it was inferred that Humanin potentially offered protective action against neurotoxicities induced by harmful agents like Calyculin A.(14)"
            },
            {
                "h3": "Humanin Peptide and Insulin Resistance"
            },
            {
                "p": "To determine the potential of Humanin on insulin resistance, a study(15) was conducted on nonobese diabetic murine models. When a group of these models were presented with Humanin, it appeared to restore to some degree the levels of glucose tolerance within 6 weeks. Furthermore, Humanin also potentially delayed the onset of diabetes in the murine models presented with the peptide for 20 weeks. Researchers suggested that following the study results, Humanin may exhibit some action in insulin resistance."
            },
            {
                "p": "In another study,(16) 12-week-old murine models were subjected to a 60% high-fat diet and were presented with Humanin for 4 weeks. After the study, there appeared to be no difference in the food intake. However, the weight gain had reportedly been reduced by about 20%. Furthermore, there appeared to be a high expenditure of energy, decreased fasting glucose levels, and increased insulin levels."
            },
            {
                "p": "Another study also explored the potential role of Humanin in influencing insulin sensitivity. The investigation suggested that continuous exposure of Humanin to the central nervous system of murine models appeared to enhance overall insulin sensitivity. This improvement in insulin action seemed to be linked to the activation of STAT-3 (Signal Transducer and Activator of Transcription 3) signaling within the hypothalamus. However, this action was negated when hypothalamic STAT-3 was co-inhibited, suggesting a potential role of this signaling pathway in mediating Humanin actions on insulin sensitivity. Furthermore, centrally-acting Humanin also appeared to improve insulin resistance in peripheral tissues such as liver cells. Ultimately, this appeared to result in reduced blood glucose levels in the murine models.(17)"
            },
            {
                "h3": "Humanin Peptide and Hypoxia"
            },
            {
                "p": "A study(18) was conducted in which the isolated retinal cells were exposed to cobalt chloride, which appeared to induce hypoxia, leading to cell apoptosis. When the hypoxia-induced cells were presented with Humanin, researchers reported that the peptide appeared to reverse the impact of cobalt chloride and protect the cell from reduced oxygen levels."
            },
            {
                "p": "Additional studies (19) have suggested that Humanin may possibly increase metabolic activity and, thereby, cell survival rates in the event of lymphocyte death, which has some implications in ischemia."
            },
            {
                "h3": "Humanin Peptide and Ischemia"
            },
            {
                "p": "This study(20) was conducted to further examine the neuroprotective potential of Humanin in the presence of cerebral ischemia. In this study, murine models were experimentally induced with cerebral artery occlusion. Murine models were presented with low concentrations of Humanin for 30 minutes and then, following the procedure, were reintroduced to Humanin at 0, 2, 4, and 6 hours after ischemia. Other murine models were solely presented with Humanin one hour before ischemia. It was suggested that continual introduction to the peptide appeared to reduce the ischemia volume by almost 30%. Humanin presence following ischemia reportedly further reduced the ischemic impact."
            },
            {
                "p": "Another study on Humanin investigating its potential in mitigating ischemia in cells suggests that the peptide may be capable of reducing infarct size in murine models.(21) In this notable study, researchers suggested that Humanin may exhibit a potential to significantly reduce infarct size by 41% in a large animal model when introduced alongside standard reperfusion intervention after an ischemic period of 60 minutes, followed by 48 hours of reperfusion. However, it is important to note that the beneficial action of Humanin was not observed when the ischemic period was extended to 75 minutes, followed by the same duration of reperfusion, highlighting a potentially critical window for Humanin. The study also highlights that Humanin has been implicated in various protective roles across multiple organs, attributed to the potential to modulate oxidative stress, regulate insulin sensitivity, and inhibit apoptotic signaling, among other actions."
            },
            {
                "h3": "Humanin Peptide Additional Studies"
            },
            {
                "p": "Studies(22) have suggested that Humanin may bind with the FPR2 receptor in the brain, producing possible anxiolytic action. Consequently, the researchers of this study suggested that Humanin may potentially reduce anxiety symptoms."
            },
            {
                "p": "In this study,(23) murine carcinogenesis models were exposed twice weekly with an antineoplastic agent (used in cancer cases) and Humanin to explore their potential impact on the carcinogenic cells. While the control agent appeared to induce cell apoptosis, the combination of Humanin and the agent exhibited some potential, somewhat reversing the apoptosis of the healthy cells."
            },
            {
                "p": "Humanin peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "The origin of mitochondria and chloroplasts. https://www.nature.com/scitable/content/the-origin-of-mitochondria-and-chloroplasts-14747702/",
                    "Lee, Changhan et al. “Humanin: a harbinger of mitochondrial-derived peptides?.” Trends in endocrinology and metabolism: TEM vol. 24,5 (2013). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641182/",
                    "Gong, Zhenwei et al. “Humanin and age-related diseases: a new link?.” Frontiers in endocrinology vol. 5 210. 4 Dec. 2014. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255622/",
                    "Hashimoto Y, Niikura T, Tajima H, Yasukawa T, Sudo H, Ito Y, Kita Y, Kawasumi M, Kouyama K, Doyu M, Sobue G, Koide T, Tsuji S, Lang J, Kurokawa K, Nishimoto I. A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Abeta. Proc Natl Acad Sci U S A. 2001 May 22;98(11):6336-41. https://pubmed.ncbi.nlm.nih.gov/11371646/",
                    "Yen K, Lee C, Mehta H, Cohen P. The emerging role of the mitochondrial-derived peptide humanin in stress resistance. J Mol Endocrinol. 2013 Jan 11;50(1):R11-9. https://pubmed.ncbi.nlm.nih.gov/23239898/",
                    "Gong, Zhenwei et al. “Humanin and age-related diseases: a new link?.” Frontiers in endocrinology vol. 5 210. 4 Dec. 2014. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255622/",
                    "Guo B, Zhai D, Cabezas E, Welsh K, Nouraini S, Satterthwait AC, Reed JC. Humanin peptide suppresses apoptosis by interfering with Bax activation. Nature. 2003 May 22;423(6938):456-61. https://pubmed.ncbi.nlm.nih.gov/12732850/",
                    "Ikonen M, Liu B, Hashimoto Y, Ma L, Lee KW, Niikura T, Nishimoto I, Cohen P. Interaction between the Alzheimer's survival peptide humanin and insulin-like growth factor-binding protein 3 regulates cell survival and apoptosis. Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):13042-7. https://pubmed.ncbi.nlm.nih.gov/14561895/",
                    "Gong, Zhenwei et al. “Humanin and age-related diseases: a new link?.” Frontiers in endocrinology vol. 5 210. 4 Dec. 2014. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255622/",
                    "Sreekumar PG, Ishikawa K, Spee C, Mehta HH, Wan J, Yen K, Cohen P, Kannan R, Hinton DR. The Mitochondrial-Derived Peptide Humanin Protects RPE Cells From Oxidative Stress, Senescence, and Mitochondrial Dysfunction. Invest Ophthalmol Vis Sci. 2016 Mar;57(3):1238-53. https://pubmed.ncbi.nlm.nih.gov/26990160/",
                    "Changhan Lee et al, IGF-I regulates the age-dependent signaling peptide humanin. Published 18 July 2014, Vol 13 Issue 5. https://onlinelibrary.wiley.com/doi/full/10.1111/acel.12243",
                    "Zhang W, Zhang W, Li Z, Hao J, Zhang Z, Liu L, Mao N, Miao J, Zhang L. S14G-humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice. Pharmacol Biochem Behav. 2012 Jan;100(3):361-9. https://pubmed.ncbi.nlm.nih.gov/21993310/",
                    "Krejcova G, Patocka J, Slaninova J. Effect of humanin analogues on experimentally induced impairment of spatial memory in rats. J Pept Sci. 2004 Oct;10(10):636-9. https://pubmed.ncbi.nlm.nih.gov/15526713/",
                    "Zhao, J., Zeng, Y., Wang, Y., Shi, J., Zhao, W., Wu, B., & Du, H. (2021). Humanin protects cortical neurons from calyculin A-induced neurotoxicities by increasing PP2A activity and SOD. The International journal of neuroscience, 131(6), 527–535. https://doi.org/10.1080/00207454.2020.1769617",
                    "Hoang PT, Park P, Cobb LJ, Paharkova-Vatchkova V, Hakimi M, Cohen P, Lee KW. The neurosurvival factor Humanin inhibits beta-cell apoptosis via signal transducer and activator of transcription 3 activation and delays and ameliorates diabetes in nonobese diabetic mice. Metabolism. 2010 Mar;59(3):343-9. https://pubmed.ncbi.nlm.nih.gov/19800083/",
                    "Zhenwei Gong et al, Central effects of humanin on hepatic triglyceride secretion, Endocrinology and Metabolism.",
                    "Muzumdar, R. H., Huffman, D. M., Atzmon, G., Buettner, C., Cobb, L. J., Fishman, S., Budagov, T., Cui, L., Einstein, F. H., Poduval, A., Hwang, D., Barzilai, N., & Cohen, P. (2009). Humanin: a novel central regulator of peripheral insulin action. PloS one, 4(7), e6334. https://doi.org/10.1371/journal.pone.0006334",
                    "Men J, Zhang X, Yang Y, Gao D. An AD-related neuroprotector rescues transformed rat retinal ganglion cells from CoCl₂-induced apoptosis. J Mol Neurosci. 2012 May;47(1):144-9. doi: 10.1007/s12031-011-9701-5. Epub 2012 Jan 5. https://pubmed.ncbi.nlm.nih.gov/22222604/",
                    "Kariya S, Takahashi N, Hirano M, Ueno S. Humanin improves impaired metabolic activity and prolongs survival of serum-deprived human lymphocytes. Mol Cell Biochem. 2003 Dec;254(1-2):83-9. https://pubmed.ncbi.nlm.nih.gov/14674685/",
                    "Xu X, Chua CC, Gao J, Hamdy RC, Chua BH. Humanin is a novel neuroprotective agent against stroke. Stroke. 2006 Oct;37(10):2613-9. Epub 2006 Sep 7. https://pubmed.ncbi.nlm.nih.gov/16960089/",
                    "Sharp, T. E., 3rd, Gong, Z., Scarborough, A., Goetzman, E. S., Ali, M. J., Spaletra, P., Lefer, D. J., Muzumdar, R. H., & Goodchild, T. T. (2020). Efficacy of a Novel Mitochondrial-Derived Peptide in a Porcine Model of Myocardial Ischemia/Reperfusion Injury. JACC. Basic to translational science, 5(7), 699–714.",
                    "Zhao H, Sonada S, Yoshikawa A, Ohinata K, Yoshikawa M. Rubimetide, humanin, and MMK1 exert anxiolytic-like activities via the formyl peptide receptor 2 in mice followed by the successive activation of DP1, A2A, and GABAA receptors. Peptides. 2016 Sep;83:16-20. https://pubmed.ncbi.nlm.nih.gov/27475912/",
                    "Emma Eriksson, Malin Wickström, Lova Segerström Perup, John I. Johnsen, Staffan Eksborg, Per Kogner, Lars Sävendahl, Protective Role of Humanin on Bortezomib-Induced Bone Growth Impairment in Anticancer Treatment, JNCI: Journal of the National Cancer Institute, Volume 106, Issue 3, March 2014, djt459, https://doi.org/10.1093/jnci/djt459"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/12/Humanin-COA-1.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/12/Humanin-LC-1.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/12/Humanin-MS-1.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Humanin for sale online. Review Humanin benefits for memory, neuroprotective props (Alzheimer's), increased longevity, and insulin resistance.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Humanin For Sale (10mg) | Core Peptides",
            "og:description": "Humanin for sale online. Review Humanin benefits for memory, neuroprotective props (Alzheimer's), increased longevity, and insulin resistance.",
            "og:url": "https://www.corepeptides.com/peptides/humanin-10mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-02-18T15:19:06+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2021/10/Humanin-10mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Humanin For Sale (10mg) | Core Peptides",
            "twitter:description": "Humanin for sale online. Review Humanin benefits for memory, neuroprotective props (Alzheimer's), increased longevity, and insulin resistance.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2021/10/Humanin-10mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$147.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:brand": "Core Peptides",
            "product:price:amount": "147.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-HUMANIN-10",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/receptor-grade-igf-1-lr3-100mcg/",
                "name": "Receptor Grade IGF-1 LR3 (100mcg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-100MCG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ll-37-5mg/",
                "name": "LL-37 (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/LL-37-5mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/semax-25mg/",
                "name": "Semax (25mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Semax-25MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/fragment-176-191/",
                "name": "Fragment 176-191 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Fragment-176-191-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/hexarelin-5mg/",
        "name": "Hexarelin (5mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Hexarelin-5MG.jpg",
        "display_price": "$57.00 Original price was: $57.00.$47.00Current price is: $47.00.",
        "display_specs": [
            "Size: 5mg Contents: Hexarelin (5mg) Form: Lyophilized powder Purity: >99% SKU: P-HEXARELIN-5",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$44.65"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$42.30"
            }
        ],
        "description": [
            {
                "h2": "Hexarelin Peptide"
            },
            {
                "p": "Hexarelin is a growth hormone-releasing peptide (GHRP) that researchers consider may host a potential action parallel tothat of peptide GHRP-6.(1) Hexarelin, or Examorelin, is a synthetic peptide composed of six amino acids.(2) Regarding its mechanism of action, Hexarelin is believed to work by mimicking the naturally occurring peptide ghrelin, which contains 28 amino acids and is considered by scientists to stimulate the release of growth hormone (GH) and induce hunger. Several synthetic compounds, including Hexarelin, which appears to exhibit actions similar to those of ghrelin, were developed more than 25 years ago.(3) Since their development, continuous studies and research have been conducted to fully examine the actions and potential of these peptides."
            },
            {
                "h3": "Overview"
            },
            {
                "p": "Hexarelin is hypothesized to operate by imitating ghrelin's role in activating ghrelin receptors throughout the organism, notably those within the pituitary gland and hypothalamus. Known as growth hormone secretagogue receptors (GHS-Rs), more specifically the GHSR-1a, their stimulation may lead to the secretion of GH, positioning Hexarelin as a potential growth hormone secretagogue (GHS). This appears to be an alternative mechanism regulating the synthesis of GH by the anterior pituitary cells, compared to the direct stimulation of the hypothalamus via the native growth hormone-releasing hormone (GHRH)."
            },
            {
                "p": "The GHSR-1a is found on the hypothalamus and pituitary gland and across various parts of the nervous system and other tissues. Thus, Hexarelin's action is posited to encompass both direct and indirect triggers of GH release, potentially impacting GHS-Rs in the pituitary and indirectly affecting the hypothalamus.(4) When Hexarelin engages GHS-Rs, it is hypothesized that it might cause a structural change, possibly activating intracellular signaling pathways that largely depend on G-proteins, such as the potential activation of protein kinase C (PKC), possibly amplifying the signaling pathway and facilitating GH release from pituitary cells. However, exposure to Hexarelin has also been posited to lead to transient receptor desensitization that may last for days or weeks.(5)"
            },
            {
                "p": "Furthermore, Hexarelin has been posited to be unselective towards the apparent synthesis of GH, and researchers suggest the peptide may also induce the production of other pituitary hormones. Namely, these hormones may include the adrenocorticotropic hormone (ACTH) and prolactin.(6) In general, the upregulation of these hormones in experimental settings is undesired by researchers."
            },
            {
                "p": "Researchers note that Hexarelin's potential to activate GHS-Rs also in other nervous system areas might initiate cellular processes that increase the production of hunger-related neuropeptides, such as Neuropeptide Y (NPY) and Agouti-related peptide (AgRP). These are considered critical in managing energy balance and appetite control. Concurrently, Hexarelin might also reduce the secretion of the appetite-suppressing hormone, melanocyte-stimulating hormone (α-MSH), thus tipping the balance towards increased hunger and encouraging food intake. Hexarelin may also influence the mesolimbic reward system, associated with craving regulation for flavorful food, through potential GHSR-1a activation. This could theoretically amplify the motivation for eating, possibly by activating cyclic adenosine monophosphate (cAMP) pathways, thereby suggesting Hexarelin's potential role in altering feeding behavior and reward-driven eating practices.(7)"
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C47H58N12O6 Molecular Weight: 887.05 g/mol Other Known Titles: examorelin"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Hexarelin Peptide and Growth Hormone Release"
            },
            {
                "p": "A study(8) was conducted on three groups of research models at the adolescent, maturation, and elderly stages of development to evaluate the GH-releasing potential of the peptide. All models were presented with Hexarelin, GHRH alone, or GHRH combined with arginine. In adolescent models, the GH levels were reportedly elevated by GHRH + arginine combination, while GH levels did not appear to be raised by Hexarelin alone. On the other hand, Hexarelin appeared to induce higher GH levels than the increased GH levels induced by GHRH alone and GHRH + arginine combination in adolescent and mature models. In elderly models, Hexarelin reportedly induced higher GH levels in comparison to GHRH. However, the GH levels were reportedly lower than GHRH + arginine combination. These results suggest that Hexarelin may potentially elevate GH levels in adolescent and mature models. While it might increase GH levels in the elderly and adolescent groups, no significant effects were reported."
            },
            {
                "h3": "Hexarelin Peptide and Potential GHRH Synergism"
            },
            {
                "p": "The main aim of this study(9) was to determine the potential of Hexarelin on the GH1 murine tumor cell line, which may be insensitive towards GHRH. Furthermore, this study monitored the potential involvement of GHRH in the possible action of Hexarelin on the GH1 murine tumor cells. Hexarelin was presented in normal control murine pituitary cells and GH1 murine cells. Researchers reported that GHRH appeared to increase GH levels in the control rat cells without presenting any apparent effects on GH1 cells. Moreover, when presented with Hexarelin, GHRH appeared to cause no impact on GH release. These results suggest that GHRPs and GHRHs may act on two distinct sites, and GHRPs, such as Hexarelin, may have the potential to act on cells that are not sensitive to GHRH effects. Most importantly, the researchers commented, \"In this latter cell model, GHRH and Hexarelin were [posited] to have additive stimulatory effects on GH secretion.” Thus, it may be suggested that due to the distinct pathways of GH-stimulation by Hexarelin and GHRH, they may have complementary action on the GH synthesis and potentially result in greater stimulation than either agent alone."
            },
            {
                "h3": "Hexarelin Peptide and Cardiovascular Activity"
            },
            {
                "p": "Studies(10) have suggested that the acute presentation of Hexarelin may induce positive inotropic activity in the cardiovascular system. When presented to research models, the peptide reportedly increased the left ventricular ejection fraction (LVEF), possibly without affecting blood pressure. When presented to research models of disrupted coronary artery flow, the Hexarelin reportedly exhibited the potential to increase cardiac output and arterial pressure without changing heart rate. Furthermore, when presented in ischemic rat hearts, Hexarelin appeared to have restored the electrophysiological properties of the heart cells, and inhibited cell apoptosis, thereby producing positive inotropic activity and potentially promoting heart cell survival.(11)"
            },
            {
                "p": "Another study(12) was conducted in which Hexarelin was presented daily to murine heart cells that were experimentally induced to undergo myocardial infarction. The results suggested that the peptide had the potential to increase stroke volume and cardiac output while decreasing peripheral resistance."
            },
            {
                "h3": "Hexarelin Peptide and Composition"
            },
            {
                "p": "One study(13) aimed to determine the possible fluctuation of sex-based weight composition with the growth hormone-releasing potential of Hexarelin. This study evaluated the impact of Hexarelin exposure, and upon analyzing the test samples, researchers suggested that the stimulus of Hexarelin and the consequent peak growth hormone release appeared to be negatively correlated to fat mass. Increased fat mass may lead to a reduction in GH release following Hexarelin exposure. Gender reportedly exhibited no significant impact on GH release."
            },
            {
                "h3": "Hexarelin Peptide and Muscle Tissue"
            },
            {
                "p": "Preliminary experiments suggest that Hexarelin may have sparing effects on muscle tissue in research models exposed to catabolic conditions. Several such experiments have reported an apparent reduction in muscle mass loss and muscle strength loss, potentially due to the action of Hexarelin. For example, one of the studies suggested that a group of research models exposed to catabolic agents lost 12% muscle mass. In comparison, the addition of Hexarelin may have lowered that loss to 7%.(14) A similar experiment also commented that the peptide may have attenuated the reduction in strength levels associated with exposure to catabolic agents.(15)"
            },
            {
                "p": "Hexarelin peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Giustina A, Bonfanti C, Licini M, Ragni G, Stefana B. Hexarelin, a novel GHRP-6 analog, stimulates growth hormone (GH) release in a GH-secreting rat cell line (GH1) insensitive to GH-releasing hormone. Regul Pept. 1997 May 14;70(1):49-54. https://pubmed.ncbi.nlm.nih.gov/9250581/",
                    "National Center for Biotechnology Information (2021). PubChem Compound Summary for CID 6918297, Examorelin. Retrieved August 19, 2021 from https://pubchem.ncbi.nlm.nih.gov/compound/Examorelin",
                    "Fabio Broglio et al, Ghrelin: Much more than a natural growth hormone secretagogue. Division of Endocrinology and Metabolism, Department of Internal Medicine; Division of Pathological Anatomy, Department of Biomedical Sciences and Oncology https://www.ima.org.il/FilesUploadPublic/IMAJ/0/56/28152.pdf",
                    "Torsello A, Grilli R, Luoni M, Guidi M, Ghigo MC, Wehrenberg WB, Deghenghi R, Müller EE, Locatelli V. Mechanism of action of Hexarelin. I. Growth hormone-releasing activity in the rat. Eur J Endocrinol. 1996 Oct;135(4):481-8. https://pubmed.ncbi.nlm.nih.gov/8921832/",
                    "Rahim, A., O'Neill, P. A., & Shalet, S. M. (1998). Growth hormone status during long-term hexarelin therapy. The Journal of clinical endocrinology and metabolism, 83(5), 1644–1649. https://doi.org/10.1210/jcem.83.5.4812",
                    "Massoud, A. F., Hindmarsh, P. C., & Brook, C. G. (1996). Hexarelin-induced growth hormone, cortisol, and prolactin release: a dose-response study. The Journal of clinical endocrinology and metabolism, 81(12), 4338–4341. https://doi.org/10.1210/jcem.81.12.8954038",
                    "Bresciani, E., Pitsikas, N., Tamiazzo, L., Luoni, M., Bulgarelli, I., Cocchi, D., Locatelli, V., & Torsello, A. (2008). Feeding behavior during long-term hexarelin administration in young and old rats. Journal of endocrinological investigation, 31(7), 647–652. https://doi.org/10.1007/BF03345618",
                    "Bellone J, Bartolotta E, Sgattoni C, Aimaretti G, Arvat E, Bellone S, Deghenghi R, Ghigo E. Hexarelin, a synthetic GH-releasing peptide, is a powerful stimulus of GH secretion in pubertal children and in adults but not in prepubertal children and in elderly subjects. J Endocrinol Invest. 1998 Sep;21(8):494-500. https://pubmed.ncbi.nlm.nih.gov/9801989/",
                    "Giustina A, Bonfanti C, Licini M, Ragni G, Stefana B. Hexarelin, a novel GHRP-6 analog, stimulates growth hormone (GH) release in a GH-secreting rat cell line (GH1) insensitive to GH-releasing hormone. Regul Pept. 1997 May 14;70(1):49-54. https://pubmed.ncbi.nlm.nih.gov/9250581/",
                    "Mao, Yuanjie et al. “The cardiovascular action of hexarelin.” Journal of geriatric cardiology : JGC vol. 11,3 (2014): 253-8. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4178518/",
                    "Ma Y, Zhang L, Edwards JN, Launikonis BS, Chen C. Growth hormone secretagogues protect mouse cardiomyocytes from in vitro ischemia/reperfusion injury through regulation of intracellular calcium. PLoS One. 2012;7(4):e35265. https://pubmed.ncbi.nlm.nih.gov/22493744/",
                    "Tivesten A, Bollano E, Caidahl K, Kujacic V, Sun XY, Hedner T, Hjalmarson A, Bengtsson BA, Isgaard J. The growth hormone secretagogue hexarelin improves cardiac function in rats after experimental myocardial infarction. Endocrinology. 2000 Jan;141(1):60-6. https://pubmed.ncbi.nlm.nih.gov/10614623/",
                    "Rahim A, O'Neill P, Shalet SM. The effect of body composition on hexarelin-induced growth hormone release in normal elderly subjects. Clin Endocrinol (Oxf). 1998 Nov;49(5):659-64. https://pubmed.ncbi.nlm.nih.gov/10197083/",
                    "Bresciani, E., Rizzi, L., Molteni, L., Ravelli, M., Liantonio, A., Ben Haj Salah, K., Fehrentz, J. A., Martinez, J., Omeljaniuk, R. J., Biagini, G., Locatelli, V., & Torsello, A. (2017). JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia. Endocrine, 58(1), 106–114. https://doi.org/10.1007/s12020-016-1184-2",
                    "Conte, E., Camerino, G. M., Mele, A., De Bellis, M., Pierno, S., Rana, F., Fonzino, A., Caloiero, R., Rizzi, L., Bresciani, E., Ben Haj Salah, K., Fehrentz, J. A., Martinez, J., Giustino, A., Mariggiò, M. A., Coluccia, M., Tricarico, D., Lograno, M. D., De Luca, A., Torsello, A., … Liantonio, A. (2017). Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia. Journal of cachexia, sarcopenia and muscle, 8(3), 386–404. https://doi.org/10.1002/jcsm.12185"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/09/Hexarelin-COA.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/09/Hexarelin-LC.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/09/Hexarelin-MS.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Hexarelin for sale online (5mg). Peptides for sale at 99% purity with top customer service. Get Hexarelin research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Hexarelin For Sale (5mg) | Core Peptides",
            "og:description": "Hexarelin for sale online (5mg). Peptides for sale at 99% purity with top customer service. Get Hexarelin research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/hexarelin-5mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T18:15:57+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Hexarelin-5MG.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Hexarelin For Sale (5mg) | Core Peptides",
            "twitter:description": "Hexarelin for sale online (5mg). Peptides for sale at 99% purity with top customer service. Get Hexarelin research study results and informatino.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Hexarelin-5MG.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$47.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "47.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-HEXARELIN-5",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/ghrp-6/",
                "name": "GHRP-6 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHRP-6-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/bpc-157/",
                "name": "BPC-157 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/BPC-157-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/fragment-176-191/",
                "name": "Fragment 176-191 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Fragment-176-191-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/mgf-5mg/",
                "name": "MGF (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/MGF-5MG-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/gonadorelin-10mg/",
        "name": "Gonadorelin (GnRH) (10mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2021/12/Gonadorelin-GnRH-10MG.jpg",
        "display_price": "$90.00",
        "display_specs": [
            "Size: 10mg Contents: Gonadorelin (10mg) Form: Lyophilized powder Purity: >99% SKU: P-GONADRLN-10",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$85.50"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$81.00"
            }
        ],
        "description": [
            {
                "h2": "Gonadorelin Peptide"
            },
            {
                "p": "Gonadorelin is the synthetic version of the naturally occurring gonadotropin hormone-releasing hormone (GnRH). GnRH is considered to be a major regulator in the secretion of gonadotropins, i.e. follicle-stimulating hormone (FSH) and luteinizing hormone (LH), both of which are considered to manage and regulate the endocrine functioning and maturation of the gonads.(1)"
            },
            {
                "p": "Gonadorelin is a synthetic peptide composed of ten amino acids, all joined to one another in a sequential form.(2) Gonadorelin is structurally similar to the endogenous GnRH.(3) Structurally identical to the endogenous GnRH hormones, Gonadorelin has been dubbed a GnRH agonist by researchers and exhibits some potential in regulating the levels of gonadotropins and maintaining regular reproductive functions.(2)"
            },
            {
                "h3": "Overview"
            },
            {
                "p": "The peptide has been suggested to stimulate the synthesis and release of gonadotropins, the luteinizing hormone, and the follicle-stimulating hormone by possibly stimulating the GnRH receptors in the anterior pituitary gland cells.(4) This is mainly the reason why Gonadorelin is referred to by researchers as a \"GnRH agonist,\" as it may possibly induce the same action as GnRH."
            },
            {
                "p": "Researchers have also suggested that excessive exposure to Gonadorelin may induce the opposite action - namely, the downregulation of GnRH receptors at the pituitary gland. This peptide hormone binds to the receptors, which, for a short period, may at first stimulate the secretion of the gonadotropins. Eventually, scientists believe the receptors become less sensitive towards this peptide, aka downregulation of the receptors, which then reversibly inhibits the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH).(4) Research on this peptide and other GnRH analogs are underway, and several research hypotheses have been presented, which may be summarized thus:"
            },
            {
                "p": "All of these hypotheses are under examination in ongoing scientific research."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C55H75N17O13 Molecular Weight: 1182.31 g/mol Other Known Titles: Growth Hormone Releasing Factor, Somatocrinin, Somatoliberin"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Gonadorelin Peptide and Post-Cycle Recovery"
            },
            {
                "p": "Exogenous androgens may potentially suppress the function of the hypothalamic-pituitary-gonadal (HPG) axis, which is considered to form between the structures of the hypothalamus, the pituitary gland, and the gonads. For example, exogenous androgens are suggested to mediate negative feedback to the pituitary gland, thereby suppressing the release of LH and FSH. Once the exposure to exogenous androgens has ceased, HPG may slowly recover, but Gonadorelin may offer a potential mechanism to speed up the process. For example, one study reported exogenous androgen exposure, which led to LH and FSH being suppressed to less than 0.5 IU/L while endogenous testosterone produced by testicular cells was down to 4.5 nmol/L. Short exposure to Gonadorelin resulted in apparent increases up to 7.9 IU/L for LH, up to 2.4 IU/L for FSH, and 13.3 nmol/L for endogenous testosterone. Moreover, these improvements were apparently sustained for over 12 months without further exposition to the peptide.(5)"
            },
            {
                "h3": "Gonadorelin Peptide and Testicular Function"
            },
            {
                "p": "Studies have investigated the potential of intermittent Gonadorlein exposure on the HPG axis, which may mimic the natural synthesis of GnRH and its action on the pituitary cells. In particular, this scenario was studied in models of hypothalamic dysfunction, where the production of native GnRH appeared to have been disturbed. Researchers have shared that Gonadorelin may effectively \" kick-start” the HPG axis in such scenarios, which involves sequential stimulation of the pituitary gland cells to synthesize LH and FSH, and then the testicular cells to produce androgens. They comment that intermittent exposure to the peptide for 5 to 6 months may ultimately result in successful spermatogenesis. This process appears to be highly dependent on the endogenous production of testosterone by testicular cells.(6)(7)"
            },
            {
                "p": "Further research has also suggested that Gonadorelin may help facilitate the descent of the testes, which is considered a part of the development of the HPG axis. Researchers posit that the peptide may have roughly 40% success rate at inducing such processes, related to the maturation of the HPG axis and testicular structures in particular.(8)"
            },
            {
                "h3": "Gonadorelin Peptide and Cancer Cells"
            },
            {
                "p": "Research in cancer cell proliferation in both clinical and animal studies suggests that excessive exposure of breast cells to mitogens, namely estrogen and progesterone, may increase the risk of their transformation into cancer cells. Potentially blocking the action of these mitogens, thereby reducing the exposure of the healthy cells to them, may reduce the risk of cancer development.(9) Researchers suggest that GnRH agonists such as Gonadorelin may exhibit some potential in mitigating the action of mitogens in healthy cells. Studies(10) examining research models of high testosterone, a marker for hyperandrogenemia (a condition characterized by excessive androgen synthesis), are at higher risk of developing breast cancer. The source of androgen, and thereby the potential source of breast cancer, may possibly be counteracted with GnRH analogs, as researchers are hypothesizing that the peptide may induce a reduction in the substrate for estrogen synthesis but may not necessarily inhibit the synthesis of estrogen completely."
            },
            {
                "p": "Researchers have also explored the potential of Gonadorelin in experimental studies intended to inhibit the production of luteinizing hormones. The researchers suggested that due to the potential for downregulating GnRH receptors, the peptide may lead to a decline in the production of testosterone and dihydrotestosterone. The development of carcinogenic cells from prostate cells may depend on these testosterone levels, which the exposure to GnRH analogs such as Gonadorelin might inhibit.(11)"
            },
            {
                "h3": "Gonadorelin Peptide and Spermatogenesis"
            },
            {
                "p": "In a clinical trial,(12) seven male test subjects were presented with a GnRH analog similar to Gonadorelin every day for up to 16 weeks and a compound of testosterone enanthate bimonthly (a form of TRT). Basal serum follicle-stimulating hormone, luteinizing hormones, and testosterone levels were monitored throughout the study period. Between 14 to 16 weeks, it was noted by the researchers that the average sperm count in the test subjects had reportedly reduced by an average of 93%, also causing azoospermia in three of the subjects, which is characterized by a complete absence of sperms in the ejaculate. Subsequently, once the study was completed, the average sperm count returned to normal, indicating that the possible action of the peptide hormone may be reversible and act as a temporary contraceptive (when combined with TRT)."
            },
            {
                "h3": "Gonadorelin Peptide and Neuroprotection"
            },
            {
                "p": "Research(13) has suggested that luteinizing hormones may have some impact on the brain, primarily the hippocampus, which is the memory center of the brain, and in some scenarios, may possibly induce some dysfunction. These researchers posited that one way of mitigating neurological dysfunction might be to block the production and release of luteinizing hormones, which may potentially be achieved through the introduction of GnRH analogs such as Gonadorelin. Testosterone has also been studied by scientists for its potential to preserve memory function and may be beneficial to brain function. Hence, inhibiting the entire gonadal axis may not be fully beneficial. This is why GnRH, which researchers suggest only induces selective inhibitory action on luteinizing hormones, may exhibit potential in future research studies.(13)"
            },
            {
                "h3": "Gonadorelin Peptide and Diagnostics"
            },
            {
                "p": "In this clinical study,(14) the synthetically developed peptide Gonadorelin was presented in 11 female test subjects during the middle of the follicular phase of the menstrual cycle. All subjects exhibited an apparent increase in the basal levels of gonadotropins following peptide presence. In addition, 10 test subjects with amenorrhea were presented with the peptide. Amenorrhea is characterized by a lack of menstruation. After the study, researchers reported that basal levels of gonadotropins, particularly the luteinizing hormone levels, appeared to increase in the short term but remained steady in the long term. This study suggested that Gonadorelin's potential pituitary secretion of luteinizing hormones and follicle-stimulating hormones may not depend on the basal levels of these hormones. However, it may depend on the functioning of the hypothalamic and pituitary axis."
            },
            {
                "p": "Gonadorelin peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Marques P, Skorupskaite K, George JT, et al. Physiology of GNRH and Gonadotropin Secretion. [Updated 2018 Jun 19]. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext. South Dartmouth (MA): MDText.com, Inc. https://www.ncbi.nlm.nih.gov/books/NBK279070/",
                    "National Center for Biotechnology Information. PubChem Compound Summary for CID 638793, Gonadorelin.",
                    "Philip GA Thomas, Alain Fontbonne, Drugs and reproduction. https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/gonadorelin-acetate",
                    "van Breda, E., Keizer, H. A., Kuipers, H., & Wolffenbuttel, B. H. (2003). Androgenic anabolic steroid use and severe hypothalamic-pituitary dysfunction: a case study. International journal of sports medicine, 24(3), 195–196. https://doi.org/10.1055/s-2003-39089",
                    "Blumenfeld, Z., Makler, A., Frisch, L., & Brandes, J. M. (1988). Induction of spermatogenesis and fertility in hypogonadotropic azoospermic men by intravenous pulsatile gonadotropin-releasing hormone (GnRH). Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2(2), 151–164. https://doi.org/10.3109/09513598809023623",
                    "Zhang, L., Cai, K., Wang, Y., Ji, W., Cheng, Z., Chen, G., & Liao, Z. (2019). The Pulsatile Gonadorelin Pump Induces Earlier Spermatogenesis Than Cyclical Gonadotropin Therapy in Congenital Hypogonadotropic Hypogonadism Men. American journal of men's health, 13(1), 1557988318818280. https://doi.org/10.1177/1557988318818280",
                    "Muzzi, G., Bartolotta, E., Cherubini, V., & Lomiento, D. (1990). Effetti del trattamento con LH-RH sintetico spray nasale nel criptorchidismo [Effects of the treatment using synthetic LH-RH nasal spray in cryptorchism]. La Pediatria medica e chirurgica : Medical and surgical pediatrics, 12(1), 53–55.",
                    "Lepor, Herbert. “Comparison of single-agent androgen suppression for advanced prostate cancer.” Reviews in urology vol. 7 Suppl 5,Suppl 5 (2005): S3-S12. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1477619/",
                    "Spicer DV, Pike MC. Sex steroids and breast cancer prevention. J Natl Cancer Inst Monogr. 1994;(16):139-47. https://pubmed.ncbi.nlm.nih.gov/7999456/",
                    "Secreto G, Sieri S, Agnoli C, Grioni S, Muti P, Zumoff B, Sant M, Meneghini E, Krogh V. A novel approach to breast cancer prevention: reducing excessive ovarian androgen production in elderly women. Breast Cancer Res Treat. 2016 Aug;158(3):553-61. https://pubmed.ncbi.nlm.nih.gov/27393623/",
                    "Zerbib M. Analogues de la GnRH dans le traitement du cancer de la prostate [GnRH analogs and prostate cancer treatment]. Ann Urol (Paris). 2005 Oct;39 Suppl 3:S66-72. French. doi: 10.1016/s0003-4401(05)80011-7. https://pubmed.ncbi.nlm.nih.gov/16302714/",
                    "Bhasin S, Yuan QX, Steiner BS, Swerdloff RS. Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in men: effects of long term treatment with GnRH agonist infusion and androgen. J Clin Endocrinol Metab. 1987 Sep;65(3):568-74. https://pubmed.ncbi.nlm.nih.gov/3114307/",
                    "R.L Bowen, et al, Not All Androgen Deprivation Therapies Are Created Equal: Leuprolide and the Decreased Risk of Developing Alzheimer's Disease, J. Clin. Oncol., vol 34, no. 23, p.2800, Aug 2016. https://ascopubs.org/doi/full/10.1200/JCO.2015.66.3997",
                    "Vesper B, Rohde W, Groot-Wassink T. Ein Beitrag zur klinischen Anwendung von Gonadorelin als Diagnostikum im Einfach- und Doppelbelastungstest [Clinical use of Gonadorelin as a diagnostic agent in one- and two-step tests]. Zentralbl Gynakol. 1986;108(23):1442-52. https://pubmed.ncbi.nlm.nih.gov/3103350/"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/12/Gonadorelin-GnRH-COA.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/12/Gonadorelin-GnRH-LC.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/12/Gonadorelin-GnRH-MS.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Gonadorelin for sale online (10mg). Peptides for sale at 99% purity with top customer service. Get Gonadorelin research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Gonadorelin For Sale (10mg) - Core Peptides",
            "og:description": "Gonadorelin for sale online (10mg). Peptides for sale at 99% purity with top customer service. Get Gonadorelin research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/gonadorelin-10mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T16:24:52+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2021/12/Gonadorelin-GnRH-10MG.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Gonadorelin For Sale (10mg) - Core Peptides",
            "twitter:description": "Gonadorelin for sale online (10mg). Peptides for sale at 99% purity with top customer service. Get Gonadorelin research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2021/12/Gonadorelin-GnRH-10MG.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$90.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:brand": "Core Peptides",
            "product:price:amount": "90.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-GONADRLN-10",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/selank-10mg/",
                "name": "Selank (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Selank-10MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/oxytocin-10mg/",
                "name": "Oxytocin (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Oxytocin-10mg-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ghk-cu-50mg-copper/",
                "name": "GHK-Cu (Copper) (50mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHK-CU-50mg-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/hexarelin-5mg/",
                "name": "Hexarelin (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Hexarelin-5MG-300x300.jpg.webp",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/ghrp-6/",
        "name": "GHRP-6 (5mg / 10mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHRP-6.jpg",
        "display_price": "$20.00 – $29.00",
        "display_specs": [
            "Size: 5mg / 10mg Contents: GHRP-6 Form: Lyophilized powder Purity: >99% SKU: P-GHRP6",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$19.00 – $27.55"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$18.00 – $26.10"
            },
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$27.55"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$26.10"
            },
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$19.00"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$18.00"
            }
        ],
        "description": [
            {
                "h2": "GHRP-6 Peptide"
            },
            {
                "p": "Growth hormone releasing hexapeptide, or GHRP-6, belongs to a group of synthetic peptides developed with the potential to stimulate the secretion and regulate growth hormone levels. Similar to most such peptides, GHRP-6 is an analog of the naturally occurring opioid peptide and neuromediator called met-enkephalin. Yet, researchers suggest it may lack the opioid activity generally associated with these enkephalins.(1) Instead, GHRP-6 appears to interact with the so-called growth hormone secretagogue receptors (GHS-Rs) which eventually turn out to be ghrelin receptors. Thus, the peptide may also be defined as growth hormone secretagogue (GHS). It is a small, low molecular weight, synthetic peptide, which has been researched for its potential in growth hormone stimulation.(2)"
            },
            {
                "p": "Initially, growth hormone releasing peptides (GHRP) were developed with the intention of mimicking the mechanism of action of growth hormone releasing hormones (GHRHs). When GHRH was first isolated in 1984, scientists hypothesized that these compounds might operate differently; with GHRPs exhibiting an apparent affinity to bind with ghrelin receptors.(3) Ghrelin is also known as the hunger hormone, and it is naturally produced by the stomach when empty. Researchers suspected that GHRPs, like the endogenously found hormone ghrelin, may appear to govern action via hypothalamic stimulation and may have the potential to influence various functions, including metabolism and nutrient absorption."
            },
            {
                "h3": "Overview"
            },
            {
                "p": "Research was conducted to determine if GHRP-6 requires endogenous GHRH presence in order to exert its potential. In one study,(4) the researchers evaluated the impact of GHRP-6 exposure following either GHRH antagonist or saline presence in the research models. Blood samples were collected incrementally for the next few hours and the concentrations of growth hormones was measured. Following the study, the researchers suggested that hGH levels were lower in models presented with GHRH antagonist. They posited further that endogenous GHRH may be necessary for GHRP-6 to exert potential action."
            },
            {
                "p": "While the mechanism of GHRP-6 remains under study,(4) further research studies have suggested that GHRPs may act by binding with two receptors, GHS-R1a, and CD36. In addition to hGH release, GHRP-6 also appears to have the potential to reduce cellular death through binding with CD36 receptors, possibly stimulating prosurvival cellular pathways.(2) This remains under investigation."
            },
            {
                "p": "Earlier it was hypothesized that GHRP-6 may work through a double mechanism, producing possible activities at the pituitary gland and hypothalamus. In a study to investigate this mechanism of action,(5) two research model groups were evaluated, one group of hypothalamus-pituitary disconnection and one control model. Each subject was either presented GHRH, GHRP-6, or a combination of both. After presentation, the hGH levels were measured in all. In the control group, the highest levels of hGH were found in models given both GHRH and GHRP-6, followed by GHRP-6 models, and lastly the GHRH models. These results appeared to be converse in the research models of hypothalamic pituitary disconnection, with the least levels of HGH reported in those exposed to both GHRP-6 and GHRH. The GHRH subjects appeared to have the same levels of hGH as controls, whereas the hGH levels were reportedly reduced in models exposed to GHRP-6 alone. Two hypotheses were extended by the researchers from this study – first, GHRP-6 action may be induced primarily in the presence of GHRH and second, that GHRP-6 may act on hypothalamic pituitary axis in order to produce its potential."
            },
            {
                "p": "Furthermore, researchers posited that GHRP-6 may potentially show an affinity toward CD36 receptors. These receptors are thought to fulfill various functions, such as possibly playing a part in lipid metabolism by acting as a scavenger receptor for lipids, aiding in their absorption, and possibly influencing immune responses by controlling phagocytosis and inflammation. The pathways involving CD36 might also have a role in the regulation of angiogenesis.(6)"
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C46H56N12O6 Molecular Weight: 873.03 g/mol Other Known Titles: Growth Hormone Releasing Peptide-6"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "GHRP-6 Peptide and Hypothyroidism"
            },
            {
                "p": "Hypothyroidism is typically characterized by reduced levels of growth hormone secretion. The main aim of this study(7) was to determine whether GHRP-6, a supposed hGH release-stimulating agent, might be used to mitigate hGH level reduction. Research models of hypothyroidism were evaluated following random exposure to three different concentrations of GHRH, and GHRP-6. Following the completion of the study, it was observed by the researchers that the models exposed to GHRP-6 alone and with combination of GHRP-6 and GHRH appeared to induce significantly higher levels of growth hormones than GHRH alone. The possible reasoning behind this is that GHRP-6 may differ from GHRH, with the potential as a functional antagonist of somatostatin at the pituitary level, which may be potentially why GHRP-6 may exert possibly increased action on hypothyroidism compared to GHRH."
            },
            {
                "h3": "GHRP-6 Peptide and Cortisol Hormone Release"
            },
            {
                "p": "In this study,(8) the action of GHRP-6 peptide on the hormone release and sleep electroencephalogram (EEG) during the night time was studied. Research models were exposed with either the GHRP-6 peptide or a placebo. After the peptide, it was observed by the researchers that GHRP-6 appeared to induce higher secretion of both growth hormones and cortisol (ACTH) hormones. Throughout the night, particularly during the first half, cortisol hormone release and stage 2 sleep appeared to be enhanced, while the other sleep EEG variables remained apparently unchanged. This study suggested that not only may GHRP-6 possibly induce growth hormone release, but it also may act on the hypothalamus and pituitary gland axis, mobilizing cortisol hormone release."
            },
            {
                "h3": "GHRP-6 Peptide and Organ Function"
            },
            {
                "p": "The main goal of this study(9) was to determine the action of GHRP-6, either alone or in combination with epidermal growth factor (EGF), on multiple organ failure. The first iteration of this study was conducted on the experimental models of injury and multiple organ failure, while the second iteration of the study was conducted on rat intestine and colonic cancer cells. The first study suggested that GHRP-6 may impact the gut epithelial cells and increase cell migration by three times a control rate, without an apparent impact on cell proliferation. In the second model, multiple organ failure caused severe hepatic and intestinal damage and lipid peroxidation. Presentation of GHRP-6 appeared to reduce these damages by a reported 50-85%, with additional activity when GHRP-6 was presented in combination with EGF."
            },
            {
                "h3": "GHRP-6 Peptide and GI transit"
            },
            {
                "p": "The main aim of this study(10) was to investigate the potential of GHRP-6 on delayed gastrointestinal (GI) transit induced by diabetes. An experimental mouse model, with alloxan-induced diabetes, was used for this study. Alloxan is a synthetic uric acid derivative compound, commonly used for experiments, which induces diabetes upon presentation.(11) All experimental mice were presented with GHRP-6 at interval concentrations. Based on the study analysis, researchers posited that the diabetes appeared to reduce the levels of gastric emptying (GE), intestinal transit (IT) and colonic transit (CT) in mice. Upon GHRP-6 presentation, the levels of GE and IT reportedly improved, with no reported fluctuation in CT levels."
            },
            {
                "h3": "GHRP-6 Peptide and Neuroprotection"
            },
            {
                "p": "The peptide GHRP-6 has been associated by researchers with the safeguarding and restoration of nerve tissue. Research explored its impact on the IGF-1 (insulin-like growth factor-1) system within the brains of mouse models.(12) The potential benefits of GH, especially its apparent growth-promoting action, are often believed to be mediated via IGF-1. One study concentrated on the impact of peptides such as GHRP-6 on the brain's IGF-1 system. Results indicated that exposure to GHRP-6 for a week appeared to elevate IGF-1 mRNA levels in the hypothalamus, cerebellum, and hippocampus, but not in the cerebral cortex, suggesting that GH and GHRP-6 might enhance IGF-1 production in specific areas of the brain. The study also examined the expression of the IGF receptor and IGFBP-2, a protein that binds IGF, finding no notable changes in their activity following the introduction of the peptide. However, the phosphorylation of Akt and the Bcl-2-associated death promoter (BAD) was observed in areas with increased IGF-1 levels, indicating that GH and GHRP-6 may initiate cellular survival pathways in reaction to growth factors. Bcl-2-associated death promoter belongs to the Bcl-2 family of proteins, which is vital for cell death regulation, whereas Akt is a kinase that plays a role in various cellular processes including metabolism, apoptosis, growth, transcription, and migration. There were no observed alterations in MAPK or glycogen synthase kinase-3beta activity. The study noted an increase in the antiapoptotic protein Bcl-2 in areas with raised IGF-1, while the proapoptotic protein Bax levels remained consistent, hinting at a shift towards cell preservation over apoptosis. Lastly, IGFBP-5, linked with neuronal survival, showed significant elevation primarily in the hypothalamus, pointing to a potential neuroendocrine role."
            },
            {
                "h3": "GHRP-6 Peptide and Muscle Tissue"
            },
            {
                "p": "Some research suggests that GHRP-6 may exhibit anabolic capabilities, possibly through a presumed stimulation of growth hormone and IGF-1. An experiment involving cultured myoblast cells indicated that this peptide might enhance the production of myogenic marker proteins, insulin-like growth factor-1, collagen type I, and the metabolic processes within the myoblasts.(13) Therefore, the researchers inferred that GHRP-6 might potentially enhance muscle tissue by promoting the synthesis of collagen type I and crucial proteins."
            },
            {
                "p": "GHRP-6 may also have anabolic potential through a possible stimulatory effect in GH synthesis, and consequently may induce a possible increase in IGF-1. GHRP-6 has been posited to potentially trigger GH release in a specific manner across multiple species which may be considerably greater than physiological GH synthesis by the anterior pituitary gland cells. To delve deeper into the mechanisms behind the potential of the peptide, a study experimented with both GHRP-6 and GHRH. The researchers commented that GHRP-6 apparently elicited a GH secretion with a peak of 15.7 ± 4.4 μg/L and an area under the curve (AUC) of 674 ± 187 μg/L/90mins. These figures appeared to be higher than those elicited by GHRH stimulation that mimics the natural synthesis, and led to an increase of 6.8 ± 1.1 μg/L for the peak and 412 ± 71 μg/L/90mins for the AUC, respectively.(14) Another similar study also reported an apparent GH peak of about 15.4 μg/L produced by the anterior pituitary cells, under the potential influence of GHRP-6, while the the physiological peak in GH levels was reported to have reached a maximum of just 5.5 μg/L.(15)"
            },
            {
                "h3": "GHRP-6 Peptide and Tissue Recovery"
            },
            {
                "p": "As indicated, GHRP-6 is believed to stimulate not only ghrelin (GHS-Rs) receptors, which are linked to GH production, but also CD36 receptors, potentially mediating anti-inflammatory and other advantageous effects. A preclinical study involving murine models exposed to GHRP-6 for 30 days suggested a possibility for faster wound healing and diminished hypertrophic scar development by lessening inflammation and the expression of fibrotic cytokines, pointing to its potential utility in enhancing wound appearance.(16) Similarly, in a separate preclinical investigation, the stimulation of ghrelin receptors was posited to improve wound healing in rats subjected to combined radiation and burn injury, through a reduction in pro-inflammatory agents, particularly TNF-α, and the alteration of signaling pathways related to inflammation and healing.(17) Furthermore, it was reported that following 60 days of GHRP-6 exposure, there was a potential decrease in liver fibrosis and a reduction in fibrogenic factors such as TGF-β and CTGF, with fibrotic areas and nodularity decreasing by 75% and more than 60%, respectively.(18) This indicates the potential for GHRP-6 to possibly mitigate fibrosis and enhance the healing process in experimental settings."
            },
            {
                "p": "GHRP-6 peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Rico M, Lorenzo MT, Pazo JA, Vega FV, De la Cruz LF. GHRP-6 in heifer and cow adenohypophisial cells separated by elutriation. J Physiol Biochem. 1999 Mar;55(1):33-9. PMID: 10494658.",
                    "Berlanga-Acosta, Jorge et al. “Synthetic Growth Hormone-Releasing Peptides (GHRPs): A Historical Appraisal of the Evidences Supporting Their Cytoprotective Effects.” Clinical Medicine Insights. Cardiology vol. 11 1179546817694558. 2 Mar. 2017, doi:10.1177/1179546817694558. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392015/",
                    "Bowers, C.Y., et al (2012). Ghrelin: A history of its discovery. In Ghrelin in Health and Disaeas (pp. 1-35), Human press Inc. https://mayoclinic.pure.elsevier.com/en/publications/ghrelin-a-history-of-its-discovery",
                    "Naushira Pandya, Roberta DeMott-Friberg, Cyril Y. Bowers, Ariel L. Barkan, Craig A. Jaffe, Growth Hormone (GH)-Releasing Peptide-6 Requires Endogenous Hypothalamic GH-Releasing Hormone for Maximal GH Stimulation, The Journal of Clinical Endocrinology & Metabolism, Volume 83, Issue 4, 1 April 1998, Pages 1186–1189. https://academic.oup.com/jcem/article-abstract/83/4/1186/2865313",
                    "Popovic V, Damjanovic S, Micic D, Djurovic M, Dieguez C, Casanueva FF. Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP-6 main action is exerted at the hypothalamic level. J Clin Endocrinol Metab. 1995 Mar;80(3):942-7. doi: 10.1210/jcem.80.3.7883854. PMID: 7883854. https://pubmed.ncbi.nlm.nih.gov/7883854/",
                    "Demers, A., McNicoll, N., Febbraio, M., Servant, M., Marleau, S., Silverstein, R., & Ong, H. (2004). Identification of the growth hormone-releasing peptide binding site in CD36: a photoaffinity cross-linking study. The Biochemical journal, 382(Pt 2), 417–424. https://doi.org/10.1042/BJ20040036",
                    "Pimentel-Filho FR, Ramos-Dias JC, Ninno FB, Façanha CF, Liberman B, Lengyel AM. Growth hormone responses to GH-releasing peptide (GHRP-6) in hypothyroidism. Clin Endocrinol (Oxf). 1997 Mar;46(3):295-300. doi: 10.1046/j.1365-2265.1997.1270942.x. https://pubmed.ncbi.nlm.nih.gov/9156038/",
                    "Frieboes RM, Murck H, Maier P, Schier T, Holsboer F, Steiger A. Growth hormone-releasing peptide-6 stimulates sleep, growth hormone, ACTH and cortisol release in normal man. Neuroendocrinology. 1995 May;61(5):584-9. https://doi.org/10.1159/000126883",
                    "Cibrián D, Ajamieh H, Berlanga J, León OS, Alba JS, Kim MJ, Marchbank T, Boyle JJ, Freyre F, Garcia Del Barco D, Lopez-Saura P, Guillen G, Ghosh S, Goodlad RA, Playford RJ. Use of growth-hormone-releasing peptide-6 (GHRP-6) for the prevention of multiple organ failure. Clin Sci (Lond). 2006 May;110(5):563-73. https://pubmed.ncbi.nlm.nih.gov/16417467/",
                    "Zheng, Q., Qiu, W. C., Yan, J., Wang, W. G., Yu, S., Wang, Z. G., & Ai, K. X. (2008). Prokinetic effects of a ghrelin receptor agonist GHRP-6 in diabetic mice. World journal of gastroenterology, 14(30), 4795–4799. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2739343/",
                    "Kristina Szabadfi, et al., Therapeutic Areas I: Central Nervous System, Pain, Metabolic Syndrome, Urology, Gastrointestinal and Cardiovascular, in Comprehensive Medicinal Chemistry II, 2007. https://www.sciencedirect.com/topics/medicine-and-dentistry/alloxan",
                    "Frago LM, Pañeda C, Dickson SL, Hewson AK, Argente J, Chowen JA. Growth hormone (GH) and GH-releasing peptide-6 increase brain insulin-like growth factor-I expression and activate intracellular signaling pathways involved in neuroprotection. Endocrinology. 2002 Oct;143(10):4113-22. doi: 10.1210/en.2002-220261. PMID: 12239123.",
                    "Lim, C. J., Jeon, J. E., Jeong, S. K., Yoon, S. J., Kwon, S. D., Lim, J., Park, K., Kim, D. Y., Ahn, J. K., & Kim, B. W. (2015). Growth hormone-releasing peptide-biotin conjugate stimulates myocytes differentiation through insulin-like growth factor-1 and collagen type I. BMB reports, 48(9), 501–506. https://doi.org/10.5483/bmbrep.2015.48.9.258",
                    "Cordido, F., Peñalva, A., Dieguez, C., & Casanueva, F. F. (1993). Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity. The Journal of clinical endocrinology and metabolism, 76(4), 819–823. https://doi.org/10.1210/jcem.76.4.8473389",
                    "Frieboes, R. M., Murck, H., Maier, P., Schier, T., Holsboer, F., & Steiger, A. (1995). Growth hormone-releasing peptide-6 stimulates sleep, growth hormone, ACTH and cortisol release in normal man. Neuroendocrinology, 61(5), 584–589. https://doi.org/10.1159/000126883",
                    "Mendoza Marí, Y., Fernández Mayola, M., Aguilera Barreto, A., García Ojalvo, A., Bermúdez Alvarez, Y., Mir Benítez, A. J., & Berlanga Acosta, J. (2016). Growth Hormone-Releasing Peptide 6 Enhances the Healing Process and Improves the Esthetic Outcome of the Wounds. Plastic surgery international, 2016, 4361702. https://doi.org/10.1155/2016/4361702",
                    "Liu, C., Huang, J., Li, H., Yang, Z., Zeng, Y., Liu, J., Hao, Y., & Li, R. (2016). Ghrelin accelerates wound healing through GHS-R1a-mediated MAPK-NF-κB/GR signaling pathways in combined radiation and burn injury in rats. Scientific reports, 6, 27499. https://doi.org/10.1038/srep27499",
                    "Berlanga-Acosta, J., Vázquez-Blomquist, D., Cibrián, D., Mendoza, Y., Ochagavía, M. E., Miranda, J., ... & Guillén-Nieto, G. E. (2012). Growth Hormone Releasing Peptide 6 (GHRP6) reduces liver fibrosis in CCl4 chronically intoxicated rats. Biotecnología Aplicada, 29(2), 60-72."
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/12/GHRP-6-5MG-COA.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/12/GHRP-6-5MG-LC.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/12/GHRP-6-5MG-MS.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "GHRP-6 for sale online (5mg / 10mg). Peptides for sale at 99% purity with top customer service. Get GHRP-6 research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "GHRP-6 For Sale (5mg / 10mg) | Core Peptides",
            "og:description": "GHRP-6 for sale online (5mg / 10mg). Peptides for sale at 99% purity with top customer service. Get GHRP-6 research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/ghrp-6/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-05-28T11:02:34+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHRP-6.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "GHRP-6 For Sale (5mg / 10mg) | Core Peptides",
            "twitter:description": "GHRP-6 for sale online (5mg / 10mg). Peptides for sale at 99% purity with top customer service. Get GHRP-6 research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHRP-6.jpg",
            "twitter:label1": "Availability",
            "twitter:data1": "In stock",
            "product:brand": "Core Peptides",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-GHRP-6",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/mgf-5mg/",
                "name": "MGF (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/MGF-5MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ghk-cu-50mg-copper/",
                "name": "GHK-Cu (Copper) (50mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHK-CU-50mg-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/melanotan-1-10mg/",
                "name": "Melanotan 1 (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Melanotan-1-10MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ghrp-2/",
                "name": "GHRP-2 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHRP-2-300x300.jpg.webp",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/ghrp-2/",
        "name": "GHRP-2 (5mg / 10mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHRP-2.jpg",
        "display_price": "$20.00 – $29.00",
        "display_specs": [
            "Size: 5mg / 10mg Contents: GHRP-2 Form: Lyophilized powder Purity: >99% SKU: P-GHRP2",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$19.00 – $27.55"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$18.00 – $26.10"
            },
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$27.55"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$26.10"
            },
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$19.00"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$18.00"
            }
        ],
        "description": [
            {
                "h2": "GHRP-2 Peptide"
            },
            {
                "p": "GHRP-2 is a synthetic peptide made of five amino acids (pentapeptide) analogous to the endogenous neurotransmitter met-enkephalin.(1) Yet, the peptide appears to lack any neurotransmitter-like properties and instead appears to activate the receptors for the hormone ghrelin. Ghrelin is a naturally occurring hormone that is posited to regulate food intake.(11) Growth hormone-releasing peptide GHRP-2 may induce the secretion of growth hormone (GH) by apparently activating the ghrelin receptors on the pituitary gland, also termed as growth hormone secretagogue receptors (GHS-Rs)."
            },
            {
                "h3": "Overview of GHRP-2 Mechanisms"
            },
            {
                "p": "Bovine studies have suggested that GHRP-2 peptide exhibits multifaceted impacts, but its main mechanism of action appears to involve the GHS-Rs. These receptors are naturally triggered by ghrelin and may be found in various parts of the nervous system and other tissues. In the nervous system, they are located in the hypothalamus and the pituitary, among other structures. When GHRP-2 appears to engage with GHS-Rs, it's believed that a structural transformation might be triggered upon attachment, possibly initiating intracellular signaling networks primarily mediated through G-proteins. The release of Gαq/11, a component of the G-proteins, might commence, potentially setting off subsequent signaling sequences. Phospholipase C (PLC) may split phosphatidylinositol 4,5-bisphosphate (PIP2) into secondary signaling molecules, IP3 and DAG (diacylglycerol). IP3 is thought to prompt the release of calcium ions. In contrast, DAG may activate protein kinase C (PKC), potentially heightening the signaling pathway and possibly facilitating the secretion of growth hormone from pituitary cells. Moreover, this process may also involve the activation of cyclic AMP (cAMP), which plays a crucial role in cellular signaling. Increasing cAMP levels may further enhance the signaling cascade, potentially boosting GH synthesis.(13)(14) Nevertheless, GHRP-2 appears to induce desensitization at these receptors immediately after exposure, potentially reducing sensitivity lasting a complete four hours before reversal.(5)"
            },
            {
                "p": "By apparently activating the GHS-Rs on other parts of the nervous system, GHRP-2 might trigger a series of cellular events leading to the enhanced synthesis of hunger-promoting neuropeptides, namely Neuropeptide Y (NPY) and Agouti-related peptide (AgRP). These peptides are thought to be integral to the regulation of energy balance and the control of appetite. At the same time, GHRP-2 is believed to possibly inhibit the secretion of the appetite-reducing hormone, melanocyte-stimulating hormone (α-MSH), thus shifting the equilibrium towards increased hunger and encouraging dietary intake. Moreover, GHRP-2 might affect the mesolimbic reward system, a neural pathway associated with regulating the craving for food, via the activation of GHSR-1a receptors. This action might theoretically heighten the drive for food consumption, potentially through the activation of cyclic adenosine monophosphate (cAMP) pathways, further implicating GHRP-2 in the modulation of feeding behavior and reward-based eating."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C45H55N9O6 Molecular Weight: 817.97 g/mol Other Known Titles: pralmorelin"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "GHRP-2 Peptide and Growth Hormone Synthesis"
            },
            {
                "p": "This study(7) was conducted to understand the action of two synthetic GHRPs, GHRP-2 and Hexarelin (HEX), on growth hormone, prolactin, adrenocorticotropic hormone (ACTH), and cortisol concentrations. Two groups of various stages of mature development were evaluated, and both groups experienced a higher GH increase compared to the physiological increase induced by native growth hormone-releasing hormone (GHRH). Unfortunately, GHRP-2 also may induce an apparent increase in the levels of ACTH and cortisol."
            },
            {
                "p": "Further studies have reported that exposure to GHRP-2 in laboratory settings may induce a significant increase in peak GH levels, mean pulsatile GH secretion by the anterior pituitary gland cells, and may potentially upregulate mediators of GH’s anabolic actions such as insulin-like growth factor-1 (IGF-1):"
            },
            {
                "h3": "GHRP-2 Peptide and Appetite"
            },
            {
                "p": "In one study,(2) two groups were evaluated, one following GHRP-2 exposure and the other with saline. They were then taken to a buffet meal to measure their food intake. The researchers reported that the GHRP-2 models ate an average of 36% more than the saline group, with each model reportedly exhibiting increased food intake when measured against their respective body weight. The researchers reported that the energy intake per kilogram of body weight increased up to 136.0±13.0 kJ/kg vs 101.3±10.5 kJ/kg for the placebo group. Furthermore, the GH levels also presented significant incremental increases in GHRP-2 models compared to saline. The levels of the hormone measured as “area under the curve” (AUC) increased up to 5550±1090 μg/L/240 min vs. 412±161 μg/L/240 min. The researchers concluded that “GHRP-2, like ghrelin, increases food intake, suggesting that GHRP-2 [may be] a valuable tool for investigating ghrelin effects on eating behavior.”"
            },
            {
                "h3": "GHRP-2 Peptide and Muscle Tissues"
            },
            {
                "p": "Murine models of thermal injury have suggested that GHRP-2 may significantly decrease in proinflammatory markers such as IL-6 and E3 ubiquitin ligases (MuRF-1 and MAFbx), which are associated with muscle wasting in critical conditions. The authors also posited that the peptide may directly reduce total muscle protein breakdown in the experimental models, therefore suggesting a muscle-sparing action GHRP-2.(20) Case studies have also suggested that the peptide may induce muscle and weight gain.(21)"
            },
            {
                "h3": "GHRP-2 Peptide and Antioxidative Actions"
            },
            {
                "p": "Studies indicate that GHRP-2 may display antioxidative potential, with researchers noting its possible affinity for CD36, a receptor thought to play a key role in capturing oxidized low-density lipoprotein (OxLDL). This interaction could potentially limit the cellular absorption of OxLDL, which is reputed to contribute to atherogenic processes. In experiments conducted on mouse models lacking the ApoE gene (ApoE(-/-)), GHRP-2 exposure over 12 weeks seemed to elevate circulating levels of IGF-I, with increases observed to be between 1.2 to 1.6 times the initial measurements. Additionally, a reduction of approximately 66% in circulating interferon-gamma levels was reported. Although GHRP-2's introduction did not appear to significantly alter the extent of atherosclerotic plaque coverage, it is suggested to have reduced superoxide production in the aorta, as indicated by dihydroethidium staining. Furthermore, GHRP-2 is reported to have notably decreased, by about 92%, the aortic gene expression of 12/15-lipoxygenase, and also diminished the aortic expressions of interferon-gamma and macrophage migration inhibitory factors. Observations in cultured aortic smooth muscle cells suggested that GHRP-2 may counter the production of peroxides triggered by OxLDL, prevent the suppression of the IGF-I receptor, and potentially block apoptosis. In macrophages exposed to OxLDL, GHRP-2 is hypothesized to reduce lipid accumulation, further illustrating its potential antioxidative and protective roles against proatherogenic agents.(15)"
            },
            {
                "h3": "GHRP-2 Peptide and Inflammation"
            },
            {
                "p": "To further elucidate the potential action of GHRP-2 on oxidative stress and inflammation, a study on murine models with artificially induced acute lung injury suggested that exposure to GHRP-2 may reduce lung edema, neutrophil infiltration, and levels of pro-inflammatory cytokines. The peptide was also posited to have suppressed nuclear factor-kappaB activation, a major mediator of inflammation. The cascades that follow its activation often lead to tissue damage.(16)"
            },
            {
                "h3": "GHRP-2 Peptide and GH Deficiency"
            },
            {
                "p": "The most common diagnostic tool for GH deficiency is the insulin tolerance test (ITT), which may cause contraindications. A study(8) aimed to explore the potential of GHRP-2 as a diagnostic resource for GH deficiency. The study evaluated research models first tested via ITT. Of these, the study indicated 77 models exhibited normal insulin tolerance and 58 exhibited GH peak levels of less than three. Post overnight fasting, all research models were presented GHRP-2. After 2 hours, their blood samples were collected and tested. Upon analysis, the researchers reported that the GH levels peaked after one hour of GHRP-2 in all cases. These results were reportedly reproducible upon repetition of the tests. An additional study(9) was conducted to research the diagnostic properties of GHRP-2 on still-developing research models of GH deficiency (GHD) in comparison to a conventionally-used compound. Research models of GHD were enrolled in this study, presented with at least one conventional compound, and later presented with GHRH and GHRP-2. All models were first given GHRP-2. When measured, the serum GH levels appeared to have significantly increased. Models who demonstrated a robust response to the peptide were then presented with GHRP-2 and GHRH in combination. All models exhibited an apparent positive response in their GH levels, according to the researchers."
            },
            {
                "h3": "Combination Studies with TRH and GnRH"
            },
            {
                "p": "This study(10) was conducted on research models of prolonged hypo-somatotropism, hypogonadism, or hypothyroid complications to evaluate the action of compounds of GHRP 2, Thyrotropin-releasing hormone (TRH), and Gonadotropin-releasing hormone (GnRH) with GHRP-2 alone and with GHRP-2 and TRH in combination. Over 5 days, one group was presented with a placebo, one group with GHRP-2 every hour, another group with GHRP-2 + TRH every hour, and the remaining group with GHRP-2 + TRH + GnRH every 90 minutes. Serum samples were collected on the first and last night of the study. After the results were analyzed, researchers suggested that the combination of GHRP-2 + GnRH + TRH induced the greatest apparent activation of growth hormones along thyroid stimulating hormone and luteinizing hormone axes, along with other possible metabolic effects. These actions were reported to be absent with GHRP-2 solo presentation and only partially seen with GHRP-2 and TRH combination."
            },
            {
                "p": "GHRP 2 peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Garcia JM, Merriam GR, Kargi AY. Growth Hormone in Aging. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext. South Dartmouth (MA): MDText.com https://www.ncbi.nlm.nih.gov/books/NBK279163/",
                    "Laferrère, Blandine et al. “Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men.” The Journal of clinical endocrinology and metabolism vol. 90,2 (2005): 611-4. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824650/",
                    "Bowers CY. History to the discovery of ghrelin. Methods Enzymol. 2012;514:3-32. doi: 10.1016/B978-0-12-381272-8.00001-5. PMID: 22975043. https://pubmed.ncbi.nlm.nih.gov/22975043/",
                    "Roh SG, He ML, Matsunaga N, Hidaka S, Hidari H. Mechanisms of action of growth hormone-releasing peptide-2 in bovine pituitary cells. J Anim Sci. 1997 Oct;75(10):2744-8. doi: 10.2527/1997.75102744x. PMID: 9331879. https://pubmed.ncbi.nlm.nih.gov/9331879/",
                    "Asad Rahim, Stephen M. Shalet, in Growth Hormone Secretagogues, 1999. Does desensitization to growth hormone secretagogues occur? https://www.sciencedirect.com/topics/medicine-and-dentistry/pralmorelin",
                    "Furuta S, Shimada O, Doi N, Ukai K, Nakagawa T, Watanabe J, Imaizumi M. General pharmacology of KP-102 (GHRP-2), a potent growth hormone-releasing peptide. Arzneimittelforschung. 2004;54(12):868-80. doi: 10.1055/s-0031-1297042. PMID: 15646371. https://pubmed.ncbi.nlm.nih.gov/15646371/",
                    "Emanuela Arvat, Lidia Di Vito, Barbara Maccagno, Fabio Broglio, Muni F Boghen, Romano Deghenghi, Franco Camanni, Ezio Ghigo, Effects of GHRP-2 and Hexarelin, Two Synthetic GH-Releasing Peptides, on GH, Prolactin, ACTH and Cortisol Levels in Man. Comparison with the Effects of GHRH, TRH and hCRH, Peptides, Volume 18, Issue 6, 1997, Pages 885-891, ISSN 0196-9781, https://doi.org/10.1016/S0196-9781(97)00016-8",
                    "Chihara K, Shimatsu A, Hizuka N, Tanaka T, Seino Y, Katofor Y; KP-102 Study Group. A simple diagnostic test using GH-releasing peptide-2 in adult GH deficiency. Eur J Endocrinol. 2007 Jul;157(1):19-27. doi: 10.1530/EJE-07-0066. https://pubmed.ncbi.nlm.nih.gov/17609397/",
                    "Pihoker C, Middleton R, Reynolds GA, Bowers CY, Badger TM. Diagnostic studies with intravenous and intranasal growth hormone-releasing peptide-2 in children of short stature. J Clin Endocrinol Metab. 1995 Oct;80(10):2987-92. https://pubmed.ncbi.nlm.nih.gov/7559885/",
                    "Van den Berghe G, Baxter RC, Weekers F, Wouters P, Bowers CY, Iranmanesh A, Veldhuis JD, Bouillon R. The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone. Clin Endocrinol (Oxf). 2002 May;56(5):655-69. https://pubmed.ncbi.nlm.nih.gov/12030918/",
                    "GHRP 2, GPA 748, Growth Hormone-Releasing Peptide 2, KP-102 D, KP-102 LN, KP-102D, KP-102 LN. https://link.springer.com/article/10.2165/00126839-200405040-00011#",
                    "Phung LT, Sasaki A, Lee HG, Vega RA, Matsunaga N, Hidaka S, Kuwayama H, Hidari H. Effects of the administration of growth hormone-releasing peptide-2 (GHRP-2) orally by gavage and in feed on growth hormone release in swine. Domest Anim Endocrinol. 2001 Jan;20(1):9-19. https://pubmed.ncbi.nlm.nih.gov/11164330/",
                    "Yin, Y., Li, Y., & Zhang, W. (2014). The growth hormone secretagogue receptor: its intracellular signaling and regulation. International journal of molecular sciences, 15(3), 4837–4855. https://doi.org/10.3390/ijms15034837",
                    "Sinha, D. K., Balasubramanian, A., Tatem, A. J., Rivera-Mirabal, J., Yu, J., Kovac, J., Pastuszak, A. W., & Lipshultz, L. I. (2020). Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males. Translational andrology and urology, 9(Suppl 2), S149–S159. https://doi.org/10.21037/tau.2019.11.30",
                    "Titterington JS, Sukhanov S, Higashi Y, Vaughn C, Bowers C, Delafontaine P. Growth hormone-releasing peptide-2 suppresses vascular oxidative stress in ApoE-/- mice but does not reduce atherosclerosis. Endocrinology. 2009 Dec;150(12):5478-87. doi: 10.1210/en.2009-0283. Epub 2009 Oct 9. PMID: 19819949; PMCID: PMC2795722.",
                    "Li, G., Li, J., Zhou, Q., Song, X., Liang, H., & Huang, L. (2010). Growth hormone releasing peptide-2, a ghrelin agonist, attenuates lipopolysaccharide-induced acute lung injury in rats. The Tohoku journal of experimental medicine, 222(1), 7–13. https://doi.org/10.1620/tjem.222.7",
                    "Veldhuis, J. D., Keenan, D. M., Bailey, J. N., Adeniji, A. M., Miles, J. M., & Bowers, C. Y. (2009). Novel relationships of age, visceral adiposity, insulin-like growth factor (IGF)-I and IGF binding protein concentrations to growth hormone (GH) releasing-hormone and GH releasing-peptide efficacies in men during experimental hypogonadal clamp. The Journal of clinical endocrinology and metabolism, 94(6), 2137–2143. https://doi.org/10.1210/jc.2009-0136",
                    "Veldhuis, J. D., & Keenan, D. M. (2008). Secretagogues govern GH secretory-burst waveform and mass in healthy eugonadal and short-term hypogonadal men. European journal of endocrinology, 159(5), 547–554. https://doi.org/10.1530/EJE-08-0414",
                    "Bowers, C. Y., Granda, R., Mohan, S., Kuipers, J., Baylink, D., & Veldhuis, J. D. (2004). Sustained elevation of pulsatile growth hormone (GH) secretion and insulin-like growth factor I (IGF-I), IGF-binding protein-3 (IGFBP-3), and IGFBP-5 concentrations during 30-day continuous subcutaneous infusion of GH-releasing peptide-2 in older men and women. The Journal of clinical endocrinology and metabolism, 89(5), 2290–2300. https://doi.org/10.1210/jc.2003-031799",
                    "Sheriff, S., Joshi, R., Friend, L. A., James, J. H., & Balasubramaniam, A. (2009). Ghrelin receptor agonist, GHRP-2, attenuates burn injury-induced MuRF-1 and MAFbx expression and muscle proteolysis in rats. Peptides, 30(10), 1909–1913. https://doi.org/10.1016/j.peptides.2009.06.029",
                    "Sigalos, J. T., & Pastuszak, A. W. (2018). The Safety and Efficacy of Growth Hormone Secretagogues. Sexual medicine reviews, 6(1), 45–53. https://doi.org/10.1016/j.sxmr.2017.02.004"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/09/GHRP-2-5MG-coa.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/09/GHRP-2-5MG-lc.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/09/GHRP-2-5MG-ms.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "GHRP-2 for sale online (5mg / 10mg). Peptides for sale at 99% purity with top customer service. Get GHRP-2 research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "GHRP-2 For Sale (5mg / 10mg) | Core Peptides",
            "og:description": "GHRP-2 for sale online (5mg / 10mg). Peptides for sale at 99% purity with top customer service. Get GHRP-2 research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/ghrp-2/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-05-28T11:02:30+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHRP-2.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "GHRP-2 For Sale (5mg / 10mg) | Core Peptides",
            "twitter:description": "GHRP-2 for sale online (5mg / 10mg). Peptides for sale at 99% purity with top customer service. Get GHRP-2 research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHRP-2.jpg",
            "twitter:label1": "Availability",
            "twitter:data1": "In stock",
            "product:brand": "Core Peptides",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-GHRP2",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/cjc-1295-dac-5mg/",
                "name": "CJC-1295 DAC (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/CJC-1295-DAC-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/cjc-1295-no-dac-mod-grf-1-29/",
                "name": "CJC-1295 NO DAC (Mod GRF 1-29) (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Mod-GRF-1-29-5mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/hexarelin-5mg/",
                "name": "Hexarelin (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Hexarelin-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/selank-10mg/",
                "name": "Selank (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Selank-10MG-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/ghk-cu-50mg-copper/",
        "name": "GHK-Cu (Copper) (50mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHK-CU-50mg.jpg",
        "display_price": "$69.00 Original price was: $69.00.$58.00Current price is: $58.00.",
        "display_specs": [
            "Size: 50mg Contents: GHK-Cu (50mg) Form: Lyophilized powder Purity: >99% SKU: P-GHKCU-50",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$55.10"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$52.20"
            }
        ],
        "description": [
            {
                "h2": "GHK-Cu (Copper) Peptide"
            },
            {
                "p": "GHK-Cu is a naturally occurring copper-binding peptide composed of 3 amino acids, i.e. glycyl-L-histidyl-L-lysine.(1) -Cu refers to the chemical addition of copper. GHK-Cu (Copper) is a small tripeptide found in plasma and reportedly releases at the time of injury. The concentration of GHK-Cu declines with age. At 20 years, the average concentration of GHK-Cu of 200 ng/mL declines to 80 ng/mL by 60 years.(1)"
            },
            {
                "p": "Studies(4) have suggested when the plasma GHK peptide is added to the cell culture in nanomolar amounts; the peptide has the potential to induce a wide range of responses from growth stimulation to toxic cell differentiation. During the isolation of the peptide, researchers suggested that it exhibited potential chelating properties and might co-isolate with almost the same amount of copper ions and a fifth of the amount of iron found in the cells. When the peptide was incubated in the isolated cells as a bound complex with copper and iron molecules, maximal potential was reported."
            },
            {
                "h3": "Overview"
            },
            {
                "p": "Studies(5) have suggested that the peptide exhibits potential in gene expression and may to reset elements of the genome. By this potential mechanism, GHK-Cu peptide may restore impaired cells, including carcinogenic cells and COPD cells. GHK-Cu peptide has been researched for its potential across a variety of functions(1) including that it may tighten and reverse the thinning of aging skin structure, supporting the extracellular matrix, that it may restore the skin barrier and moderate texture, hyperpigmentation and lesions, may support tissue repair and mitigate inflammation, may stimulate increasing hair follicle size, may exert antioxidant properties and, finally, may exhibit gene restructuring potential."
            },
            {
                "h3": "Specifications"
            },
            {
                "p": "Molecular Formula: C14H23CuN6O4 Molecular Weight: 340.38 g/mol Other Known Titles: glycyl-L-histidyl-L-lysine-copper 2+"
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "GHK Peptide Initial Research"
            },
            {
                "p": "This 1980s study(6) suggested the biological potential of the naturally occurring peptide in tissue repair. GHK peptide may host copper (II) ions due to possible copper affinity and may thereby stimulate the synthesis of collagen and increase the accumulation of total proteins and DNA at the injury site. Dermal wounded rats were used for this study. At the time of injury, the release of GHK peptide was induced. ‘Emergency response molecules’ were released from the matrix at the site of injury. Once released, GHK appeared to bind with Cu ions found in the blood and then stimulate the synthesis of decorin protein. Decorin protein is responsible for the synthesis of collagen and regulation of wound healing and anti-tumor defense mechanism. Further studies in the 2000s,(7) suggested that the GHK-Cu peptide hosts the potential to not only stimulate the collagen synthesis but also stimulate the production of tissue inhibitors, TIMP-1 and TIMP-2."
            },
            {
                "h3": "GHK Peptide and Tissue Repair"
            },
            {
                "p": "In this study,(8) the main aim was to understand the action of the GHK-Cu peptide complex when applied to the open wounds in comparison to zinc oxide. 18 New Zealand white rabbits were used for this study, divided into three groups – one group was presented with GHK-Cu, second group with zinc oxide and third group with placebo. Woulds were induced on each rabbit and the rabbits were presented with the respective compounds for 21 consecutive days. After 21 days, it was suggested by the researchers that the group delivered with the GHK-Cu peptide complex appeared to exhibit increased healing compared to the group given zinc oxide or placebo."
            },
            {
                "p": "In this study,(9) the main aim was to understand the action of the GHK-Cu peptide complex as compared to helium neon laser. Laser applications were measured at 1 J cm2 and 3 J cm2. 24 New Zealand white rabbits were used for this study, divided into three groups and presented with respective concentrations of the GHK-Cu peptide complex and helium neon laser application. Experimental wounds were created on all the rabbits and all rabbits were studied for 28 consecutive days with the respective compounds. After the study, it was suggested by the researchers that rabbits studied with GHK-Cu peptide and higher concentration of the laser application appeared more receptive toward wound healing than the other group. The rabbits presented with GHK-Cu peptide exhibited an apparent decline in neutrophil counts and increase in neovascularization."
            },
            {
                "h3": "GHK Peptide and Metastasis"
            },
            {
                "p": "In this 1983 study,(1) the actions of the mixture of GHK-Cu complex and ascorbic acid (Vitamin C) on the growth of the sarcoma (tumor) cells was observed. 180 mice with cancerous growths were exposed to this mixture. Researchers suggested the mixture had the potential to induce a decline in the growth of carcinogenic cells in the subject mice. It was later reported by the researchers that GHK-Cu peptide complex exhibited some potential in increasing the expression of caspase and the associated genes, as well as gene expression associated with DNA repair. Specifically, this peptide seemed to suppress the growth of two types of cancer cells in experimental settings: SH-SY5Y neuroblastoma cells, which are a model for studying nerve cell behavior and pathology, and U937 histiocytic lymphoma cells, which are used to study the immune system's response to cancer. Additionally, the peptide might have reactivated the apoptosis pathway, a type of programmed cell death crucial for removing faulty cells, as evidenced by activity in caspases 3 and 7, which are enzymes that play key roles in apoptosis. Conversely, in a study of non-cancerous cells, GHK appeared to promote the growth of NIH-3T3 fibroblasts, which are healthy cells often used as a standard model to examine cell division and growth."
            },
            {
                "h3": "GHK Peptide and Ulcers"
            },
            {
                "p": "This clinical study(10) was carried out in diabetic subjects with neuropathic ulcers. All subjects were enrolled in a standard wound care protocol, where only the subjects with sharp ulcer wound or debridement were entered into this randomized, placebo controlled clinical trial. The study was carried out using GHK-Cu peptide complex gel. All subjects were divided into different groups, where one group was presented with the peptide gel, whereas others were given standard care with a placebo application. Following the study, researchers suggested that the subjects given the gel exhibited apparently elevated healing at 98%+. The gel complex appeared to have the potential to induce closure of 98.5% of plantar ulcers whereas the control only reportedly induced 60.8% of ulcer healing."
            },
            {
                "h3": "GHK Peptide and Behavioral Properties"
            },
            {
                "p": "In this study,(1) GHK-Cu was delivered to mice to measure pain mitigation. Mice were placed on a moderately hot plate. Due to heat and the pain, it would usually take longer for mice to lick their paws; however, upon delivery the peptide, the time taken to lick their paws reduced compared to control environments. Researchers suggested the mice got ‘comfortable’ and their pain was eased faster with the presence of GHK-Cu."
            },
            {
                "p": "In this study,(11) male rats were deposited into a maze, which was intended to induce anxiety and cause behavioral changes. If anxious, rats were observed to restrict arm movement, keeping \"close arms\"; whereas \"open arm\" behavior was shown in rats with lessened levels of anxiety. As a part of the study, once the peptide was delivered, the time spent by the rats in \"open arms\" state in the maze was monitored. After the study, it was reported by the researchers that the peptide exhibited some potential in increasing \"open arms\" states in the subjects."
            },
            {
                "p": "In an additional study,(12) two rats were placed in a small cage and were then given minor electric shocks. As a result of these shocks, the rat would become agitated and attack the second rat. Twelve minutes before this experiment, GHK-Cu peptide was delivered to both rats. It was noted by the researchers that the number of attacks, after the electric shocks, reduced by 5 times than usual."
            },
            {
                "h3": "GHK-Cu and Antioxidative potential"
            },
            {
                "p": "A study has investigated the potential of Glycyl-L-histidyl-L-lysine (GHK) to regulate the presence of reactive oxygen species (ROS) within laboratory cells, with a focus on its ability to mitigate oxidative stress through interactions with various ROS types.(13) GHK is proposed to act as an endogenous antioxidant, potentially due to its selective targeting and neutralization of certain radicals, specifically hydroxyl (·OH) and peroxyl (ROO·) radicals. The antioxidant properties of GHK were assessed using two primary techniques: flow cytometry, a method for analyzing various cellular characteristics, and electron spin resonance (ESR) spin-trapping, which is employed to detect free radicals. Throughout these evaluations, GHK appeared to lower ROS levels induced by tert-butyl hydroperoxide (t-BOPD), a chemical known to promote oxidative stress within cells. The ESR data revealed that GHK was notably positive in reducing the concentrations of ·OH and ROO· radicals, although it had a seemingly modest action on superoxide (O2 -·) radicals. Additional examinations utilizing ESR assessed the relative potential of GHK in neutralizing ·OH radicals compared to other antioxidants like carnosine and reduced glutathione (GSH), both recognized for their antioxidant capabilities. Preliminary results suggest that GHK could be more proficient at neutralizing ·OH radicals compared to these alternatives."
            },
            {
                "h3": "GHK-Cu and Antioxidative potential"
            },
            {
                "p": "A study has investigated the possible mechanisms through which the peptide complex GHK-Cu could influence anti-inflammatory actions, particularly against lung tissue inflammation induced by cigarette smoke (CS).(14) It is hypothesized that GHK-Cu may influence various biochemical pathways and molecular markers related to inflammation and oxidative stress, although the specific mechanisms remain somewhat uncertain. In experiments involving mouse models exposed to CS, exposure to GHK-Cu was linked to a potential decrease in the production of pro-inflammatory cytokines, including interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α), found in bronchoalveolar lavage fluid—fluid used to capture cells and soluble factors from the airways and lung tissues. These results tentatively suggest that GHK-Cu might help mitigate the inflammatory responses triggered by cigarette smoke. Additionally, there was a noted possible reduction in the activity of myeloperoxidase (MPO), an enzyme that serves as a marker for neutrophil-driven inflammation and oxidative stress, in lung tissues that received GHK-Cu exposure. This observation could indicate a potential role of GHK-Cu in limiting the activation or mobilization of neutrophils, possibly curtailing the oxidative bursts and consequent inflammation. At the molecular level, the research proposes that GHK-Cu may interact with the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling pathway. NF-κB plays a critical role in the initiation and perpetuation of inflammation. The peptide complex is thought to possibly inhibit NF-κB activation by affecting the phosphorylation of IκBα, a protein that inhibits NF-κB. This interaction could hypothetically result in lower expression of genes that promote inflammation, controlled by NF-κB. Furthermore, the study suggests that GHK-Cu could potentially influence the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway. Nrf2 is integral to cellular defenses against oxidative damage. GHK-Cu is posited to possibly boost the expression and nuclear translocation of Nrf2 in lung tissues, thereby promoting the transcription of genes that combat oxidative stress and possibly enhancing the cellular resilience against oxidative damage. The investigation further examines how GHK-Cu interacts with markers of oxidative stress, such as malondialdehyde (MDA) and glutathione (GSH). MDA is a product of lipid peroxidation and an indicator of oxidative stress, while GSH is a vital antioxidant that plays a crucial role in cellular defense mechanisms. The experimentation with GHK-Cu is associated with a tentative reduction in MDA levels and a possible restoration of GSH levels, suggesting a potential ameliorative action on oxidative stress."
            },
            {
                "h3": "GHK-Cu and Lipid Peroxidation"
            },
            {
                "p": "A theoretical model posits that GHK could play a role in mitigating the discharge of iron from ferritin.(15) Ferritin, a protein complex that stores iron, releases it in a form that can facilitate lipid peroxidation, a process where free radicals attack lipids, leading to cell damage. It is suggested that GHK might inhibit the assembly of iron complexes within injured tissues, which could, in turn, decrease inflammation. Further exploration of GHK's role reveals that it may interact with specific biological pathways that govern the release of iron from ferritin. This interaction might restrict the release of iron by up to 87%, although this is a provisional estimate. Such a significant reduction in iron release could conceivably diminish both inflammation and oxidative stress, the latter being a condition where damaging oxidative processes occur more rapidly than the body's ability to counteract them, in the affected tissues."
            },
            {
                "p": "GHK-Cu peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Pickart, Loren, and Anna Margolina. “Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data.” International journal of molecular sciences vol. 19,7 1987. 7 Jul. 2018, doi:10.3390/ijms19071987. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073405/",
                    "Pickart L, Freedman JH, Loker WJ, Peisach J, Perkins CM, Stenkamp RE, Weinstein B. Growth-modulating plasma tripeptide may function by facilitating copper uptake into cells. Nature. 1980 Dec 25;288(5792):715-7. doi: 10.1038/288715a0. PMID: 7453802. https://pubmed.ncbi.nlm.nih.gov/7453802/",
                    "L.O. Pilgeram, L.R. Pickart, Control of fibrinogen biosynthesis: The role of free fatty acid, Journal of Atherosclerosis Research, Volume 8, Issue 1, 1968, Pages 155-166, ISSN 0368-1319, https://doi.org/10.1016/S0368-1319(68)80089-4",
                    "Pickart L, Freedman JH, Loker WJ, Peisach J, Perkins CM, Stenkamp RE, Weinstein B. Growth-modulating plasma tripeptide may function by facilitating copper uptake into cells. Nature. 1980 Dec 25;288(5792):715-7. doi: 10.1038/288715a0. PMID: 7453802. https://pubmed.ncbi.nlm.nih.gov/7453802/",
                    "Pickart L, Vasquez-Soltero JM, Margolina A. GHK and DNA: resetting the human genome to health. Biomed Res Int. 2014;2014:151479. doi: 10.1155/2014/151479. Epub 2014 Sep 11. PMID: 25302294; PMCID: PMC4180391. https://pubmed.ncbi.nlm.nih.gov/25302294/",
                    "Maquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett. 1988 Oct 10;238(2):343-6. doi: 10.1016/0014-5793(88)80509-x. PMID: 3169264. https://pubmed.ncbi.nlm.nih.gov/3169264/",
                    "Siméon A, Emonard H, Hornebeck W, Maquart FX. The tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ stimulates matrix metalloproteinase-2 expression by fibroblast cultures. Life Sci. 2000 Sep 22;67(18):2257-65. doi: 10.1016/s0024-3205(00)00803-1. PMID: 11045606. https://pubmed.ncbi.nlm.nih.gov/11045606/",
                    "Cangul IT, Gul NY, Topal A, Yilmaz R. Evaluation of the effects of tripeptide-copper complex and zinc oxide on open-wound healing in rabbits. Vet Dermatol. 2006 Dec;17(6):417-23. doi: 10.1111/j.1365-3164.2006.00551.x. PMID: 17083573. https://pubmed.ncbi.nlm.nih.gov/17083573/",
                    "Gul NY, Topal A, Cangul IT, Yanik K. The effects of tripeptide copper complex and helium-neon laser on wound healing in rabbits. Vet Dermatol. 2008 Feb;19(1):7-14. doi: 10.1111/j.1365-3164.2007.00647.x. PMID: 18177285. https://pubmed.ncbi.nlm.nih.gov/18177285/",
                    "Mulder GD, Patt LM, Sanders L, Rosenstock J, Altman MI, Hanley ME, Duncan GW. Enhanced healing of ulcers in patients with diabetes by treatment with glycyl-l-histidyl-l-lysine copper. Wound Repair Regen. 1994 Oct;2(4):259-69. doi: 10.1046/j.1524-475X.1994.20406.x. PMID: 17147644. https://pubmed.ncbi.nlm.nih.gov/17147644/",
                    "Bobyntsev II, Chernysheva OI, Dolgintsev ME, Smakhtin MY, Belykh AE. Anxiolytic effects of Gly-His-Lys peptide and its analogs. Bull Exp Biol Med. 2015 Apr;158(6):726-8. doi: 10.1007/s10517-015-2847-3. Epub 2015 Apr 23. PMID: 25900608. https://pubmed.ncbi.nlm.nih.gov/25900608/",
                    "Sever'yanova LА, Dolgintsev ME. Effects of Tripeptide Gly-His-Lys in Pain-Induced Aggressive-Defensive Behavior in Rats. Bull Exp Biol Med. 2017 Dec;164(2):140-143. doi: 10.1007/s10517-017-3943-3. Epub 2017 Nov 27. PMID: 29181666. https://pubmed.ncbi.nlm.nih.gov/29181666/",
                    "Sakuma, S., Ishimura, M., Yuba, Y., Itoh, Y., & Fujimoto, Y. (2018). The peptide glycyl-ʟ-histidyl-ʟ-lysine is an endogenous antioxidant in living organisms, possibly by diminishing hydroxyl and peroxyl radicals. International journal of physiology, pathophysiology and pharmacology, 10(3), 132–138.",
                    "Zhang, Q., Yan, L., Lu, J., & Zhou, X. (2022). Glycyl-L-histidyl-L-lysine-Cu2+ attenuates cigarette smoke-induced pulmonary emphysema and inflammation by reducing oxidative stress pathway. Frontiers in molecular biosciences, 9, 925700. https://doi.org/10.3389/fmolb.2022.925700",
                    "Miller, D. M., DeSilva, D., Pickart, L., & Aust, S. D. (1990). Effects of glycyl-histidyl-lysyl chelated Cu(II) on ferritin dependent lipid peroxidation. Advances in experimental medicine and biology, 264, 79–84. https://doi.org/10.1007/978-1-4684-5730-8_11"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/09/GHK-CU-50MG-coa.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/09/GHK-CU-50MG-lc.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/09/GHK-CU-50MG-ms.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "GHK-Cu (Copper) for sale online. Peptides for sale at 99% purity with top customer service. Get GHK-Cu research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "GHK-Cu (Copper) For Sale (50mg) | Core Peptides",
            "og:description": "GHK-Cu (Copper) for sale online. Peptides for sale at 99% purity with top customer service. Get GHK-Cu research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/ghk-cu-50mg-copper/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-02-25T18:29:08+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHK-CU-50mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "GHK-Cu (Copper) For Sale (40mg) | Core Peptides",
            "twitter:description": "GHK-Cu (Copper) for sale online. Peptides for sale at 99% purity with top customer service. Get GHK-Cu research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHK-CU-50mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$58.00",
            "twitter:label2": "Availability",
            "twitter:data2": "Out of stock",
            "product:price:amount": "58.00",
            "product:price:currency": "USD",
            "og:availability": "out of stock",
            "product:availability": "out of stock",
            "product:retailer_item_id": "P-GHKCU-50",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/aod-9604-5mg/",
                "name": "AOD 9604 (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/AOD-9604-5MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/cjc-1295-dac-5mg/",
                "name": "CJC-1295 DAC (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/CJC-1295-DAC-5MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/receptor-grade-igf-1-lr3-100mcg/",
                "name": "Receptor Grade IGF-1 LR3 (100mcg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-100MCG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/receptor-grade-igf-1-lr3-1mg/",
                "name": "Receptor Grade IGF-1 LR3 (1mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-1MG-300x300.jpg.webp",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/ghk-cu-topical-200mg/",
        "name": "GHK-Cu (200mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2023/04/GHK-CU-200mg.jpg",
        "display_price": "$197.00",
        "display_specs": [
            "Size: 200mg Contents: GHK-Cu Form: Lyophilized powder Purity: >99% SKU: P-GHK-CU",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$187.15"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$177.30"
            }
        ],
        "description": [
            {
                "h2": "GHK-Cu Peptide"
            },
            {
                "p": "GHK-Cu is a naturally occurring complex molecule composed of a tripeptide called GHK (made up of glycine, histidine, and lysine amino acids) bound to a copper ion. The copper ion appears to stabilize and deliver GHK to cells. Research suggests that GHK-Cu may play a potentially essential role in restoring damaged tissues, wound repair, and may support immune response. These hypotheses have sprung from it’s perceived potential to stimulate the production of collagen, elastin, and glycosaminoglycans, crucial intercellular matrix components."
            },
            {
                "p": "In addition to its potential on the intercellular matrix, GHK-Cu may also have antioxidant and anti-inflammatory characteristics that may protect cells from damage caused by free radicals."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C14H23CuN6O4 Molecular Weight: 340.38 g/mol Other Known Titles: Cu-GHK, Copper tripeptide-1, 6BJQ43T1I9"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "GHK-Cu and Collagen Synthesis"
            },
            {
                "p": "Studies suggest that GHK-Cu may stimulate collagen synthesis and induce in situ tissue recovery. The researchers suggest that these actions may be due to “the presence of a GHK triplet in the alpha 2(I) chain of type I collagen”.(1) More specifically, the tripeptide sequence composed of glycine, histidine, and lysine, abbreviated as Gly-His-Lys, may be derived during the breakdown of collagen through hydrolysis. This breakdown is typically associated with the disintegration of collagen fibers, frequently resulting from either tissue damage or the natural degradation process. It is proposed that this specific peptide sequence may have a significant impact on cellular communication processes, specifically targeting fibroblasts. Fibroblasts are specialized cells deemed essential in producing new collagen fibers, vital components for structural support in various tissues."
            },
            {
                "p": "The interaction between the Gly-His-Lys peptide and fibroblasts is believed to potentially initiate a cascade of biological events leading to the synthesis of collagen, thereby playing a potential role in the mechanisms of tissue repair and regeneration. This process of collagen synthesis by fibroblasts may be critical to contribute to the overall restoration and healing of damaged tissues. One study, lasted a month, reported that GHK-Cu might stimulate type 1 collagen production in clinical settings.(2) The scientists compared the potential of GHK-Cu to other peptides and vitamin C and vitamin A derivatives on photodamaged skin. The research primarily investigated the potential action of the peptide on dermal procollagen synthesis, keratinocyte proliferation, differentiation, and cutaneous inflammation. The peptide appeared to improve all indicators, and the researchers reported an apparent increase in skin thickness, elasticity, and hydration."
            },
            {
                "p": "Another study explored the potential interaction between GHK-Cu and hyaluronic acid (HA) on collagen synthesis, particularly focusing on their potential collaborative actions in dermal fibroblasts and an ex-vivo skin model.(3) HA is portrayed as a significant component of skin cells, noted for its moisture-binding potential and actions on cell proliferation and inflammation, with different molecular weights (LMW and HMW) showing distinct biological activities. The experimental setup involved exposure of dermal fibroblasts with various combinations of GHK-Cu and HA, measuring the synthesis of collagen types I, IV, and VII. It was suggested that certain combinations, particularly at a GHK-Cu to LMW HA ratio of 1:9, appeared to have significantly boosted the synthesis of collagen IV—more so than when either compound was studied independently. This suggests a potential synergistic action between GHK-Cu and HA, specifically in enhancing collagen IV levels. The synergy might arise from the combined action of GHK-Cu in stimulating glycosaminoglycan production, promoting collagen synthesis, and HA's role in reducing collagen degradation by scavenging reactive oxygen species and inhibiting matrix metalloproteinases. The research highlights that the molecular weight of HA and the ratio of GHK-Cu to HA may be crucial in maximizing this action, with optimal results observed at specific ratios. Further studies employing an ex-vivo skin model supported these findings, suggesting a notable increase in collagen IV synthesis at the dermal-epidermal junction when exposed to the optimized GHK-Cu and LMW HA mixture. This action was visually corroborated through increased fluorescence intensity in immunofluorescence assays, indicating higher collagen IV content."
            },
            {
                "h3": "GHK-Cu and Wound Infection"
            },
            {
                "p": "Both animal and clinical studies have hypothesized that GHK-Cu may reduce inflammation and the risk of infection in wounds. One murine study investigated the potential of GHK-Cu on ischemic open wounds.(4) The researchers reported, \"On days 6, 10, and 13, tripeptide-copper complex-treated wounds contained significantly lower concentrations of TNF-alpha and MMP-2 and MMP-9 than control wounds.” Tumor necrosis factor-alpha (TNF-alpha), a cytokine involved in systemic inflammation, along with matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9) — enzymes that break down extracellular matrix proteins — might potentially influence both the inflammatory processes and the remodeling of tissues. This suggests that GHK-Cu, a copper complex recognized for its healing capacities, might have a role in reducing inflammation and preventing tissue breakdown in models of ischemic wounds, where blood flow restriction potentially causes tissue damage."
            },
            {
                "p": "A clinical trial that involved GHK-Cu in addition to standard wound care also reported an apparently reduced risk of infection compared to standard processes alone.(5) The study was conducted on models of diabetic neuropathic ulcers, and the rate of infections was only 7% in the GHK-Cu models compared to 34% in the control models."
            },
            {
                "h3": "GHK-Cu and Wound Healing"
            },
            {
                "p": "Studies in rabbits report that GHK-Cu has been tested regarding its potential in wound healing and laser exposure at different intensities.(6) The results were compared to control wounds without intervention. Wounds were observed daily, and biopsies were taken weekly for four weeks to evaluate the inflammation rate and neovascularization. The GHK-Cu and high-intensity laser groups appeared to have a shorter average time for healing and greater neutrophil and vessel counts. There was an apparently shorter median time for the first observable granulation tissue and an apparently faster filling of an open wound with granulation tissue compared to the control group. Granular tissue is composed of newly formed connective tissue and minuscule blood vessels that appear on wound surfaces as part of the healing process. It is suggested that there might be a link between the emergence of this tissue and heightened activity of antioxidant enzymes. These enzymes are proteins that assist in shielding cells from the harmful action of oxidative stress, a process where cell components are damaged due to the presence of unstable molecules known as free radicals. Furthermore, there is a potential enhancement in vascular development observed in these scenarios. This vascular development is considered vital for transporting essential nutrients and oxygen to the damaged area, thereby facilitating the repair of tissue."
            },
            {
                "p": "The previously mentioned study on rats with open ischemic wounds also reported an apparent decrease in wound area of the GHK-Cu group that was greater compared to the control group on days 3 to 5, 6 to 9, and 11 to 13.(4)"
            },
            {
                "p": "Similarly, the clinical study on models of diabetic neuropathic ulcers reported that GHK-Cu, combined with standard wound care, appeared more impactful for wound closure than standard care alone.(5) The apparent closure rate was three times faster than standard care. The researchers also suggested that “The enhancement of wound closure was more pronounced (median of 89.2% compared with -10.3% for vehicle; p < 0.01) in larger (greater than 100 mm(2) initial area at study entry) plantar ulcers caused by the failure of this size of ulcer to respond adequately to standardized wound care.”"
            },
            {
                "p": "In research involving both standard murine models and those adapted to mimic diabetic conditions, wound dressings composed of collagen and infused with GHK were observed to potentially enhance wound healing.(7) The observations suggest that by the conclusion of the third week, wounds exposed to dressings containing biotinylated GHK (a tripeptide with skin regenerative properties) nearly achieved full closure, registering at 99.39%. This is potentially a significant enhancement compared to the 69.49% closure rate observed with control dressings lacking this modification. Further analysis indicated that the wounds exposed to GHK might have shown elevated levels of glutathione and ascorbic acid. These are considered critical antioxidants for their potential roles in facilitating tissue repair by protecting cells from oxidative stress. There was also a tentative observation of increased epithelialization, a process essential for the regeneration of the skin's outer layer, in these experimental conditions. Apart from the enhanced activity of fibroblasts, which are pivotal in collagen synthesis, tissue repair, and regeneration, there was also noted a potential rise in mast cell activation. Mast cells are important for mediating inflammatory responses, which are deemed crucial during the initial phases of wound healing."
            },
            {
                "h3": "GHK-Cu and Active Radicals"
            },
            {
                "p": "Photodamage of tissues such as the skin involves the formation of reactive oxygen species (ROS), reactive nitrogen species (RNS), and reactive carbonyl species (RCS), which may induce damage to proteins, DNA, and lipids. Studies suggest that the amino acid sequence in GHK-Cu may have anti-RCS potential against radicals such as 4-hydroxynoneal, acrolein, malondialdehyde, and others.(8) Furthermore, it may potentially prevent protein glycation. Moreover, researchers have suggested that GHK-Cu may have potential action in reducing iron release from ferritin. Ferritin is a lipid peroxidation catalyst, and GHK-Cu may help to reduce the formation of iron complexes in damaged tissues and thus decrease inflammation. One study suggested an 87% decrease in iron release with the help of GHK-Cu to lower oxidation in damaged tissues.(9)"
            },
            {
                "p": "GHK-Cu may also reduce the production of reactive oxygen species and inflammatory cytokines while increasing the activity of antioxidant enzymes. This was proposed by an animal study investigating the potential of GHK-Cu on lipopolysaccharide-induced lung inflammation in mice.(10) The peptide was suggested to suppress the activation of NF-κB and p38 MAPK signaling pathways associated with inflammation. This might potentially lead to reduced infiltration of inflammatory cells in the lungs of mice with lung damage and lower levels of TNF-1 and IL-6 production to minimize damage."
            },
            {
                "p": "Further studies also suggest that the amino-acid sequence of GHK-Cu may have an antioxidative potential on ROS, such as hydroxyl radicals, and it may be even stronger than generic antioxidative peptides.(12)"
            },
            {
                "h3": "GHK-Cu and Wrinkles in Skin Tissue Models"
            },
            {
                "p": "GHK-Cu has been suggested to host potential for improving experimental models of disturbed skin topography, such as wrinkles and fine lines. One study posited that a GHK-Cu possibly reduces visible bioindicators, improving skin laxity, and clarity. The peptide apparently also reduced the depth of wrinkles while potentially increasing skin density and thickness after 12 weeks of experimentation in skin cell models with varying degrees of photodamage.(13)"
            },
            {
                "p": "Another investigation focused on the actions of GHK-Cu compared to a control compound and vitamin K. Over a period of 12 weeks, the GHK-Cu ostensibly performed better than the controls in reducing epidermal wrinkles. The peptide may also have increased skin density and thickness.(14)"
            },
            {
                "p": "In a separate 12-week study in mild to advanced photodamage, GHK-Cu seemingly improved skin attributes such as laxity, clarity, and firmness. This peptide was also associated with a reduction in coarse wrinkles, and mottled pigmentation. Additionally, the peptide apparently stimulated dermal keratinocyte proliferation, as evidenced by histological analysis of biopsies.(15)"
            },
            {
                "p": "GHK-Cu peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References"
            },
            {
                "references": [
                    "Maquart, F. X., Pickart, L., Laurent, M., Gillery, P., Monboisse, J. C., & Borel, J. P. (1988). Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS letters, 238(2), 343–346. https://doi.org/10.1016/0014-5793(88)80509-x",
                    "Abdulghani, A. A., Sherr, A., Shirin, S., Solodkina, G., Tapia, E. M., Wolf, B., & Gottlieb, A. B. (1998). Effects of creams containing vitamin C, a copper-binding peptide cream and melatonin compared with tretinoin on the ultrastructure of normal skin-A pilot clinical, histologic, and ultrastructural study. Disease Management and Clinical Outcomes, 4(1), 136-141.",
                    "Jiang F, Wu Y, Liu Z, Hong M, Huang Y. Synergy of GHK-Cu and hyaluronic acid on collagen IV upregulation via fibroblast and ex-vivo skin tests. J Cosmet Dermatol. 2023 Sep;22(9):2598-2604. doi: 10.1111/jocd.15763. Epub 2023 Apr 16. PMID: 37062921.",
                    "Canapp, S. O., Jr, Farese, J. P., Schultz, G. S., Gowda, S., Ishak, A. M., Swaim, S. F., Vangilder, J., Lee-Ambrose, L., & Martin, F. G. (2003). The effect of tripeptide-copper complex on healing of ischemic open wounds. Veterinary surgery : VS, 32(6), 515–523. https://doi.org/10.1111/j.1532-950x.2003.00515.x",
                    "Mulder, G. D., Patt, L. M., Sanders, L., Rosenstock, J., Altman, M. I., Hanley, M. E., & Duncan, G. W. (1994). Enhanced healing of ulcers in patients with diabetes by treatment with glycyl-l-histidyl-l-lysine copper. Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society, 2(4), 259–269. https://doi.org/10.1046/j.1524-475X.1994.20406.x",
                    "Gul, N. Y., Topal, A., Cangul, I. T., & Yanik, K. (2008). The effects of tripeptide copper complex and helium-neon laser on wound healing in rabbits. Veterinary dermatology, 19(1), 7–14. https://doi.org/10.1111/j.1365-3164.2007.00647.x",
                    "Alven, S., Peter, S., Mbese, Z., & Aderibigbe, B. A. (2022). Polymer-Based Wound Dressing Materials Loaded with Bioactive Agents: Potential Materials for the Treatment of Diabetic Wounds. Polymers, 14(4), 724. https://doi.org/10.3390/polym14040724",
                    "Cebrián, J., Messeguer, A., Facino, R. M., & García Antón, J. M. (2005). New anti-RNS and -RCS products for cosmetic treatment. International journal of cosmetic science, 27(5), 271–278. https://doi.org/10.1111/j.1467-2494.2005.00279.x",
                    "Miller, D. M., DeSilva, D., Pickart, L., & Aust, S. D. (1990). Effects of glycyl-histidyl-lysyl chelated Cu(II) on ferritin dependent lipid peroxidation. Advances in experimental medicine and biology, 264, 79–84. https://doi.org/10.1007/978-1-4684-5730-8_11",
                    "Park, J. R., Lee, H., Kim, S. I., & Yang, S. R. (2016). The tri-peptide GHK-Cu complex ameliorates lipopolysaccharide-induced acute lung injury in mice. Oncotarget, 7(36), 58405–58417. https://doi.org/10.18632/oncotarget.11168",
                    "Zhang, Q., Yan, L., Lu, J., & Zhou, X. (2022). Glycyl-L-histidyl-L-lysine-Cu2+ attenuates cigarette smoke-induced pulmonary emphysema and inflammation by reducing oxidative stress pathway. Frontiers in molecular biosciences, 9, 925700. https://doi.org/10.3389/fmolb.2022.925700",
                    "Sakuma, S., Ishimura, M., Yuba, Y., Itoh, Y., & Fujimoto, Y. (2018). The peptide glycyl-ʟ-histidyl-ʟ-lysine is an endogenous antioxidant in living organisms, possibly by diminishing hydroxyl and peroxyl radicals. International journal of physiology, pathophysiology and pharmacology, 10(3), 132–138.",
                    "Leyden J., Stephens T., Finkey M., Appa Y., Barkovic S. Skin care benefits of copper peptide containing facial cream. Proceedings of the American Academy of Dermatology Meeting; February 2002; New York, NY, USA.",
                    "Leyden J., Stephens T., Finkey M., Barkovic S. Skin Care Benefits of Copper Peptide Containing Eye Creams. University of Pennsylvania; 2002.",
                    "Finkley M., Appa Y., Bhandarkar S. Copper peptide and skin. In: Elsner P., Maibach H., editors. Cosmeceuticals and Active Cosmetics: Drugs vs. Cosmetics. New York, NY, USA: Marcel Dekker; 2005. pp. 549–563."
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "",
        "high_performance_liquid_chromatography": "",
        "mass_spectrometry": "",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "GHK-Cu for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "GHK-Cu For Sale (200mg) - Core Peptides",
            "og:description": "GHK-Cu for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:url": "https://www.corepeptides.com/peptides/ghk-cu-topical-200mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-16T18:02:38+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2023/04/GHK-CU-200mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "GHK-Cu For Sale (200mg) - Core Peptides",
            "twitter:description": "GHK-Cu for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2023/04/GHK-CU-200mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$197.00",
            "twitter:label2": "Availability",
            "twitter:data2": "Out of stock",
            "product:price:amount": "197.00",
            "product:price:currency": "USD",
            "og:availability": "out of stock",
            "product:availability": "out of stock",
            "product:retailer_item_id": "P-GHK-CU",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/ipamorelin-5mg/",
                "name": "Ipamorelin (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Ipamorelin-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/cjc-1295-no-dac-mod-grf-1-29/",
                "name": "CJC-1295 NO DAC (Mod GRF 1-29) (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Mod-GRF-1-29-5mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/hexarelin-5mg/",
                "name": "Hexarelin (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Hexarelin-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/receptor-grade-igf-1-lr3-1mg/",
                "name": "Receptor Grade IGF-1 LR3 (1mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-1MG-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/ghk-basic-tripeptide-1-200mg/",
        "name": "GHK Basic (Tripeptide-1) (200mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2023/04/GHK-BASIC-200MG.jpg",
        "display_price": "$157.00",
        "display_specs": [
            "Size: 200mg Contents: GHK Basic (Tripeptide-1) Form: Lyophilized powder Purity: >99% SKU: P-GHK-TP-1",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$149.15"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$141.30"
            }
        ],
        "description": [
            {
                "h2": "GHK Basic (Tripeptide-1)"
            },
            {
                "p": "GHK Basic is a tripeptide composed of glycine, histidine, and lysine amino acids. It is a naturally occurring tripeptide in plasma, urine, saliva, and other fluids. GHK is produced by various cells, including fibroblasts, lymphocytes, and macrophages. It is also found in high concentrations in platelets and certain tissues, such as the liver and brain. GHK appears to have a high affinity to copper and may regulate numerous biological processes, including wound healing, tissue repair, and immune response."
            },
            {
                "p": "GHK also has been suggested to have a role in regulating ion channels, enzymes, receptors, and gene expression. The levels of GHK appear to fluctuate over the course of cell lifespan, and it has been suggested that these changes contribute to cell aging. This may result in impaired tissue repair and regeneration and a decline in immune function. GHK may stimulate collagen production and play a role in wound healing and skin cell function. GHK may also have antioxidant and anti-inflammatory characteristics."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular formula: C14H24N6O4 Molecular weight: 340.4 g/mol Other known titles: Glycyl-L-histidyl-L-lysine, Tripeptide 1, NSC 379527, Copper peptide"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "GHK Basic Peptide and Wound Healing"
            },
            {
                "p": "GHK has been primarily studied for its potential in wound healing. One clinical study evaluated GHK (its copper-bound version) in research models of diabetic neuropathic ulcers.(1) The models were subjected to a wound care protocol, and GHK was reported to increase ulcer closure compared to the vehicle. Larger plantar ulcers had a more pronounced enhancement of closure, with the incidence of ulcer infections reportedly lower in the GHK group. The scientists highlighted that the “incidence of ulcer infections was significantly lower (7% incidence compared with 34% for vehicle, p < 0.05) in the plantar ulcers treated immediately after debridement.”"
            },
            {
                "p": "Animal studies also suggest the potential of GHK in rapid wound healing. A study compared the actions of GHK on wound healing with control (not exposed to GHK) wounds in rabbits.(2) The wounds were evaluated daily, and planimetry was performed on days 7, 14, 21, and 28 to measure the unhealed wound area and the percentage of total wound healing. Results indicated that the GHK group exhibited greater neutrophil and vessel counts than the control group. The research team proposed that the peptide in question might potentially accelerate the recovery of wounds and the development of granular tissue, which refers to the new connective tissue and microscopic blood vessels that form on the surfaces of a wound during the recovery process. It is hypothesized that this action might be associated with increased activity of antioxidant enzymes—proteins that help protect cells from damage due to oxidative stress. Additionally, there might be an improvement in vascular development, meaning the formation and growth of new blood vessels within the wound, which is deemed crucial for delivering nutrients and oxygen that support tissue repair."
            },
            {
                "p": "Another study also aimed to evaluate the actions of GHK on the recovery of ischemic open wounds in rats.(3) The GHK group appeared to exhibit a significant decrease in wound area compared to the control group. Wounds exposed to GHK were reported to contain lower concentrations of the pro-inflammatory markers, including tumor necrosis factor-alpha (TNF-alpha), matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-9 (MMP-9). Each of these markers plays a role in the inflammatory response and tissue remodeling, indicating that GHK may mitigate inflammation and tissue degradation in ischemic wound environments."
            },
            {
                "p": "In subsequent studies using typical murine models and those modified to simulate diabetic conditions, dressings made of collagen and enriched with GHK appeared to enhance the recuperation of wounds. The data indicates that by the end of the third week, wounds addressed with films containing biotinylated GHK approached near-total closure at 99.39%, which may represent a notable improvement over the 69.49% closure rate seen with control films. Moreover, these GHK-exposed wounds appeared to have exhibited higher concentrations of glutathione and ascorbic acid. These molecules are important antioxidants that may contribute to tissue repair. There was also a possible increase in epithelialization, which is the process of renewing the outer layer of the skin tissue in experimental models. Additionally, there may have been a stimulation of collagen production, which is vital for the skin's structural integrity, enhanced activity of fibroblasts—cells crucial for wound recovery —and an increase in mast cell activation, which plays a role in the inflammatory responses."
            },
            {
                "h3": "GHK Basic Peptide and Skin Cells"
            },
            {
                "p": "GHK may exhibit implications within the development of creasing and wrinkling along the stratum corneum of the skin barrier by potentially influencing the upregulation of collagen production.(5) It has been hypothesized that the underlying mechanisms for this observed phenomena may involve the presence of the tripeptide sequence Gly-His-Lys as a fragment typically released during the hydrolysis process of collagen. Hydrolysis of collagen, which occurs when collagen fibers are broken down, often results from tissue damage or degradation. Scientists have posited that \"the presence of a GHK triplet in the alpha 2(I) chain of type I collagen suggests that the tripeptide might be liberated by proteases at the site of a wound and exert in situ healing.\" These peptide fragments might play a role in cellular signaling, particularly influencing fibroblasts, which are cells deemed critical for synthesizing new collagen fibers. This signaling is essential as it appears to trigger the fibroblasts to begin synthesizing collagen, thus contributing to tissue repair and regeneration. GHK may also stimulate elastin and glycosaminoglycans. Elastin is another vital protein contributing to the skin's elastic properties, while glycosaminoglycans are long polysaccharide molecules that play a role in maintaining and supporting the extracellular matrix. Together, these components are considered essential for maintaining the skin's structural integrity and functional characteristics."
            },
            {
                "p": "Another clinical study reported that GHK appeared to improve collagen production and stimulated dermal keratinocyte proliferation under specific research conditions.(6) The studies also reported an apparent increase in skin thickness, improved skin hydration, and smoothing by stimulating collagen synthesis, skin elasticity, and increased production of type 1 collagen."
            },
            {
                "p": "A further clinical study evaluated the efficacy of GHK for managing CO2 laser-resurfaced skin - a procedure that removes the epidermis and heats the derma.(7) A cohort of 13 models were randomly assigned to receive either post-procedure skin regimens with or without GHK. While there was no statistically significant difference in erythema resolution, both groups were reported to experience improvement in wrinkles and overall skin quality. Furthermore, models exposed to the GHK substance reported higher satisfaction with post-exposure improvement in overall skin quality than those without."
            },
            {
                "h3": "GHK Basic Peptide and Inflammation, Oxidative Stress"
            },
            {
                "p": "GHK may have antioxidant and anti-inflammatory potential that protect cells from damage caused by active radicals and lipid peroxidation. Studies report that the peptide may inactivate damaging free radicals that are by-products of lipid peroxidation and UV-light exposure.(8) The specific radicals reported by the researchers included 4-hydroxynoneal, acrolein, malondialdehyde, and others. Furthermore, GHK may completely block the oxidation of low-density lipoproteins. Additionally, GHK was suggested to have potential action in reducing iron release from ferritin, a lipid peroxidation catalyst."
            },
            {
                "p": "Researchers report that GHK may reduce the formation of iron complexes in damaged tissues and thus reduce inflammation.(9) The study suggested that GHK acts by binding to the channels of ferritin involved in the iron release and may physically reduce the release of -Fe by a reported 87%, which may prevent inflammation and oxidation in damaged tissues."
            },
            {
                "p": "The anti-inflammatory potential of GHK may also extend to organs such as the lungs. One animal model study investigated the actions of GHK on lipopolysaccharide-induced lung inflammation in mice.(10) The study suggested that GHK may reduce the production of reactive oxygen species and inflammatory cytokines while increasing the activity of antioxidant enzymes. It also may suppress the activation of NF-κB and p38 MAPK signaling pathways, decreasing TNF-1 and IL-6 production. Furthermore, the researchers reported that GHK appeared to attenuate lung histological alterations and reduce inflammatory damage in the lungs of mice with lung damage. The scientists reported that the peptide “suppressed the infiltration of inflammatory cells into the lung parenchyma in LPS-induced ALI in mice.”"
            },
            {
                "p": "GHK may also help reduce the oxidative stress caused by smoking. Scientists reported that GHK appeared to inhibit oxidative stress in alveolar epithelial cells by upregulating Nrf2 expression.(11) A study investigated the potential of GHK to reduce levels of reactive oxygen species in cell cultures.(12) The researchers suggested that the GHK action on the signal of hydroxyl radicals may be stronger than those of other antioxidative, endogenous peptides, such as carnosine and reduced glutathione."
            },
            {
                "p": "GHK Basic peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Mulder, G. D., Patt, L. M., Sanders, L., Rosenstock, J., Altman, M. I., Hanley, M. E., & Duncan, G. W. (1994). Enhanced healing of ulcers in patients with diabetes by treatment with glycyl-l-histidyl-l-lysine copper. Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society, 2(4), 259–269. https://doi.org/10.1046/j.1524-475X.1994.20406.x",
                    "Gul, N. Y., Topal, A., Cangul, I. T., & Yanik, K. (2008). The effects of tripeptide copper complex and helium-neon laser on wound healing in rabbits. Veterinary dermatology, 19(1), 7–14. https://doi.org/10.1111/j.1365-3164.2007.00647.x",
                    "Canapp, S. O., Jr, Farese, J. P., Schultz, G. S., Gowda, S., Ishak, A. M., Swaim, S. F., Vangilder, J., Lee-Ambrose, L., & Martin, F. G. (2003). The effect of tripeptide-copper complex on healing of ischemic open wounds. Veterinary surgery : VS, 32(6), 515–523. https://doi.org/10.1111/j.1532-950x.2003.00515.x",
                    "Alven, S., Peter, S., Mbese, Z., & Aderibigbe, B. A. (2022). Polymer-Based Wound Dressing Materials Loaded with Bioactive Agents: Potential Materials for the Treatment of Diabetic Wounds. Polymers, 14(4), 724. https://doi.org/10.3390/polym14040724",
                    "Maquart, F. X., Pickart, L., Laurent, M., Gillery, P., Monboisse, J. C., & Borel, J. P. (1988). Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS letters, 238(2), 343–346. https://doi.org/10.1016/0014-5793(88)80509-x",
                    "Abdulghani, A. A., Sherr, A., Shirin, S., Solodkina, G., Tapia, E. M., Wolf, B., & Gottlieb, A. B. (1998). Effects of creams containing vitamin C, a copper-binding peptide cream and melatonin compared with tretinoin on the ultrastructure of normal skin-A pilot clinical, histologic, and ultrastructural study. Disease Management and Clinical Outcomes, 4(1), 136-141.",
                    "Miller, T. R., Wagner, J. D., Baack, B. R., & Eisbach, K. J. (2006). Effects of copper tripeptide complex on CO2 laser-resurfaced skin. Archives of facial plastic surgery, 8(4), 252–259. https://doi.org/10.1001/archfaci.8.4.252",
                    "Cebrián, J., Messeguer, A., Facino, R. M., & García Antón, J. M. (2005). New anti-RNS and -RCS products for cosmetic treatment. International journal of cosmetic science, 27(5), 271–278. https://doi.org/10.1111/j.1467-2494.2005.00279.x",
                    "Miller, D. M., DeSilva, D., Pickart, L., & Aust, S. D. (1990). Effects of glycyl-histidyl-lysyl chelated Cu(II) on ferritin dependent lipid peroxidation. Advances in experimental medicine and biology, 264, 79–84. https://doi.org/10.1007/978-1-4684-5730-8_11",
                    "Park, J. R., Lee, H., Kim, S. I., & Yang, S. R. (2016). The tri-peptide GHK-Cu complex ameliorates lipopolysaccharide-induced acute lung injury in mice. Oncotarget, 7(36), 58405–58417. https://doi.org/10.18632/oncotarget.11168",
                    "Zhang, Q., Yan, L., Lu, J., & Zhou, X. (2022). Glycyl-L-histidyl-L-lysine-Cu2+ attenuates cigarette smoke-induced pulmonary emphysema and inflammation by reducing oxidative stress pathway. Frontiers in molecular biosciences, 9, 925700. https://doi.org/10.3389/fmolb.2022.925700",
                    "Sakuma, S., Ishimura, M., Yuba, Y., Itoh, Y., & Fujimoto, Y. (2018). The peptide glycyl-ʟ-histidyl-ʟ-lysine is an endogenous antioxidant in living organisms, possibly by diminishing hydroxyl and peroxyl radicals. International journal of physiology, pathophysiology and pharmacology, 10(3), 132–138."
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "",
        "high_performance_liquid_chromatography": "",
        "mass_spectrometry": "",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "GHK Basic (Tripeptide-1) for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "GHK Basic (Tripeptide-1) For Sale (200mg) | Core Peptides",
            "og:description": "GHK Basic (Tripeptide-1) for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:url": "https://www.corepeptides.com/peptides/ghk-basic-tripeptide-1-200mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T16:14:13+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2023/04/GHK-BASIC-200MG.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "GHK Basic (Tripeptide-1) For Sale (200mg) | Core Peptides",
            "twitter:description": "GHK Basic (Tripeptide-1) for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2023/04/GHK-BASIC-200MG.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$157.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "157.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-GHK-TP-1",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/ghrp-2/",
                "name": "GHRP-2 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHRP-2-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/bpc-157/",
                "name": "BPC-157 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/BPC-157-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/semax-25mg/",
                "name": "Semax (25mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Semax-25MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/selank-10mg/",
                "name": "Selank (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Selank-10MG-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/ghk-basic-50mg/",
        "name": "GHK Basic (50mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2022/11/GHK-Basic-50MG.jpg",
        "display_price": "$49.00",
        "display_specs": [
            "Size: 50mg Contents: GHK Basic (50mg) Form: Lyophilized powder Purity: >99% SKU: P-GHK-Basic",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$46.55"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$44.10"
            }
        ],
        "description": [
            {
                "h2": "GHK Basic Peptide"
            },
            {
                "p": "GHK Basic is a tripeptide containing the amino acid sequence glycyl-histidyl-lysine. This short-chain peptide is considered to help cell communication for a wide range of actions."
            },
            {
                "p": "Research on the GHK has yielded a variety of potential biological activities, including possible stimulation of blood vessels and nerve outgrowth, increasing elastin, glycosaminoglycan, collagen synthesis, and possibly promoting dermal fibroblast functions. The tissue repair potential of this peptide has been researched in lung connective tissue, bone tissue, liver, stomach lining, and skin.(1)"
            },
            {
                "p": "The peptide has also been suggested to play some role in DNA repair, lung protection, fibroblast reactivation, and possibly in suppressing proinflammatory and pro-aging molecules like NFκB. GHK Basic has also been suggested to have the potential to repair protective proteins in the skin barrier."
            },
            {
                "h3": "Chemical Makeup(2)"
            },
            {
                "p": "Molecular Formula: C14H24N6O4 Molecular Weight: 340.4 g/mol"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "GHK Basic and Skin Cell Regeneration"
            },
            {
                "p": "According to research, adding plasma to aged liver tissue may cause the aged tissues to produce proteins identical to those seen in plasma.(2,3,4) Several studies have suggested that GHK proteins may increase collagen production, glycosaminoglycans, and small proteoglycans such as decorin. Furthermore, research indicates that GHK might also influence the activities of metalloproteinases – enzymes that initiate extracellular matrix protein breakdown – and antiprotease actions. This GHK action may regulate skin protein breakdown, potentially preventing damaged protein accumulation and excessive proteolysis."
            },
            {
                "h3": "GHK Basic and Wound Healing"
            },
            {
                "p": "Animal model studies suggest the peptide may promote wound healing through two possible mechanisms. First, GHK, when combined with a high-concentration helium-neon laser, was reported to accelerate wound contraction and granular tissue production while hosting antioxidant enzyme activities and increasing blood vessel growth.(5) Second, wound healing in control and diabetic murine models was reported to be improved by collagen dressing loaded with GHK. The researchers commented that “the wounds were almost closed by 99.39% when [exposed to] biotinylated GHK-loaded films on day 21 when compared to 69.49% wound closure for plain films.” Increased glutathione and ascorbic acid levels were found, as well as enhanced epithelialization and increased collagen synthesis, fibroblasts, and mast cell activation in wounds.(6)"
            },
            {
                "p": "GHK and its analogs may also have potential in follicular stimulation and growth. Researchers reported the naturally occurring copper complex GHK-Cu to increase vascular endothelial growth factor production, possibly leading to growth and new blood vessel formation. In one murine experiment, the copper-containing version of GHK appeared to mediate a significant decrease in wound area compared to placebo. Wounds exposed to the copper-containing version of GHK were suggested to have lower concentrations of the pro-inflammatory markers MMP-2, MMP-9, and TNF-alpha.(7)"
            },
            {
                "p": "Notably, the copper-containing versions of GHK may also help reduce some potential complications that may negatively impact wound healing, such as colonization of the wound with pathogenic microorganisms. A study of GHK on diabetic ulcers stated that the peptide may have sped up wound closure in larger ulcers and reduced the risk of wound infections compared to the study group that received only a vehicle (placebo). More specifically, the researchers commented that “the enhancement of wound closure was more pronounced (median of 89.2% compared with −10.3% for vehicle; p < 0.01) in larger (greater than 100 mm2 initial area at study entry) plantar ulcers.” The incidence of ulcer infections was also significantly lower, equal to about 7% in the GHK group compared to 34% for vehicle.(8)"
            },
            {
                "h3": "GHK Basic and Anti-inflammatory, Antioxidant Activities"
            },
            {
                "p": "GHK has been suggested to exhibit potential antioxidant action, specifically in its posited interaction with lipid peroxidation, a process which produces adverse free radicals capable of DNA, protein, and cell damage. GHK may help minimize this damage by binding the byproducts of this process.(9) The specific radicals suggested by the scientists include 4-hydroxynoneal, acrolein, malondialdehyde, and others."
            },
            {
                "p": "Further, it has also been proposed that GHK might play a role in diminishing the release of iron from ferritin, an agent that catalyzes lipid peroxidation. More specifically, studies have suggested that GHK could potentially limit the creation of iron compounds in injured tissues, thereby mitigating inflammation.(10) It is believed that GHK's mechanism may involve attaching to ferritin's iron release pathways, potentially decreasing -Fe release by an estimated 87%, which might, in theory, curb inflammation and oxidation in affected tissues."
            },
            {
                "p": "The anti-inflammatory potential of GHK might benefit specific tissues like the lungs. An experiment in murine models examined GHK's impact on lipopolysaccharide-induced lung inflammation.(11) The findings suggest that GHK may lower the generation of reactive oxygen species and inflammatory cytokines while boosting the efficacy of antioxidant enzymes. It is thought to hinder the activation of NF-κB and p38 MAPK signaling pathways, reducing TNF-1 and IL-6 levels. Moreover, the study noted that GHK seemed to mitigate lung tissue alterations and lessen inflammation in murine models suffering from lung damage. More specifically, the peptide was reported to have decreased the influx of inflammatory cells into the lung tissue in cases of experimentally induced acute lung injury in these models. GHK might also contribute to alleviating oxidative stress in lung tissues related to smoke exposure. Research indicates that GHK may suppress oxidative stress in alveolar epithelial cells through the upregulation of Nrf2 expression.(12)"
            },
            {
                "h3": "GHK Basic and Fibrinogen"
            },
            {
                "p": "High fibrinogen levels are considered to increase blood viscosity by increasing rouleaux formation, which research suggests are risk factors for cardiovascular disease.(13) Studies on the peptide generally suggest that it has the potential to inhibit fibrinogen synthesis, thereby possibly lowering the risk of coronary occurrences."
            },
            {
                "p": "GHK Basic peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References"
            },
            {
                "references": [
                    "Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018 Jul 7;19(7):1987",
                    "National Center for Biotechnology Information (2024). PubChem Compound Summary for CID 378611, Cu-GHK. Retrieved March 17, 2024 from https://pubchem.ncbi.nlm.nih.gov/compound/Cu-GHK.",
                    "Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015;2015:648108. DOI: 10.1155/2015/648108.",
                    "Dou Y, Lee A, Zhu L, Morton J, Ladiges W. The potential of GHK as an anti-aging peptide. Aging Pathobiol Ther. 2020 Mar 27;2(1):58-61. DOI: 10.31491/apt.2020.03.014.",
                    "Gul, N. Y., Topal, A., Cangul, I. T., & Yanik, K. (2008). The effects of tripeptide copper complex and helium-neon laser on wound healing in rabbits. Veterinary dermatology, 19(1), 7–14. https://doi.org/10.1111/j.1365-3164.2007.00647.x",
                    "Alven, S., Peter, S., Mbese, Z., & Aderibigbe, B. A. (2022). Polymer-Based Wound Dressing Materials Loaded with Bioactive Agents: Potential Materials for the Treatment of Diabetic Wounds. Polymers, 14(4), 724. https://doi.org/10.3390/polym14040724",
                    "Canapp, S. O., Jr, Farese, J. P., Schultz, G. S., Gowda, S., Ishak, A. M., Swaim, S. F., Vangilder, J., Lee-Ambrose, L., & Martin, F. G. (2003). The effect of tripeptide-copper complex on healing of ischemic open wounds. Veterinary surgery : VS, 32(6), 515–523. https://doi.org/10.1111/j.1532-950x.2003.00515.x",
                    "Mulder, G. D., Patt, L. M., Sanders, L., Rosenstock, J., Altman, M. I., Hanley, M. E., & Duncan, G. W. (1994). Enhanced healing of ulcers in patients with diabetes by treatment with glycyl-l-histidyl-l-lysine copper. Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society, 2(4), 259–269. https://doi.org/10.1046/j.1524-475X.1994.20406.x",
                    "Cebrián, J., Messeguer, A., Facino, R. M., & García Antón, J. M. (2005). New anti-RNS and -RCS products for cosmetic treatment. International journal of cosmetic science, 27(5), 271–278. https://doi.org/10.1111/j.1467-2494.2005.00279.x",
                    "Miller, D. M., DeSilva, D., Pickart, L., & Aust, S. D. (1990). Effects of glycyl-histidyl-lysyl chelated Cu(II) on ferritin dependent lipid peroxidation. Advances in experimental medicine and biology, 264, 79–84. https://doi.org/10.1007/978-1-4684-5730-8_11",
                    "Park, J. R., Lee, H., Kim, S. I., & Yang, S. R. (2016). The tri-peptide GHK-Cu complex ameliorates lipopolysaccharide-induced acute lung injury in mice. Oncotarget, 7(36), 58405–58417. https://doi.org/10.18632/oncotarget.11168",
                    "Zhang, Q., Yan, L., Lu, J., & Zhou, X. (2022). Glycyl-L-histidyl-L-lysine-Cu2+ attenuates cigarette smoke-induced pulmonary emphysema and inflammation by reducing oxidative stress pathway. Frontiers in molecular biosciences, 9, 925700. https://doi.org/10.3389/fmolb.2022.925700",
                    "Pickart L, Vasquez-Soltero JM, Margolina A. GHK and DNA: resetting the human genome to health. Biomed Res Int. 2014;2014:151479. DOI: 10.1155/2014/151479."
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/12/GHK-Basic-50mg-COA-2.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/12/GHK-Basic-50mg-LC-2.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/12/GHK-Basic-50mg-MS-2.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "GHK Basic peptide for sale (50mg). Peptides for sale at 99% purity with top customer service. Get GHK Basic research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "GHK Basic For Sale (50mg) - Core Peptides",
            "og:description": "GHK Basic peptide for sale (50mg). Peptides for sale at 99% purity with top customer service. Get GHK Basic research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/ghk-basic-50mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T16:34:03+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2022/11/GHK-Basic-50MG.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "GHK Basic For Sale (50mg) - Core Peptides",
            "twitter:description": "GHK Basic peptide for sale (50mg). Peptides for sale at 99% purity with top customer service. Get GHK Basic research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2022/11/GHK-Basic-50MG.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$49.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:brand": "Core Peptides",
            "product:price:amount": "49.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-GHK-Basic",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/ll-37-5mg/",
                "name": "LL-37 (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/LL-37-5mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/pt-141-10mg-bremelanotide/",
                "name": "PT-141 (Bremelanotide) (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/PT-141-10mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ghrp-6/",
                "name": "GHRP-6 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHRP-6-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/melanotan-1-10mg/",
                "name": "Melanotan 1 (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Melanotan-1-10MG-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/fragment-176-191-mod-grf-1-29-ipamorelin-blend-12mg/",
        "name": "Fragment 176-191 & Mod GRF 1-29 & Ipamorelin Blend (12mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Frag-176-191-Mod-GRF-1-29-Ipamorelin-6-3-3MG.jpg",
        "display_price": "$73.00",
        "display_specs": [
            "Size: 12mg Contents: Fragment 176-191 (6mg), Mod GRF 1-29 (3mg), Ipamorelin (3mg) Form: Lyophilized powder Purity: >99% SKU: P-FRAGMODIPAM-12",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$69.35"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$65.70"
            }
        ],
        "description": [
            {
                "h2": "Fragment 176-191 & Mod GRF 1-29 & Ipamorelin Peptide Blend"
            },
            {
                "p": "Modified GRF 1-29 is a truncated version of Growth Hormone-Releasing Hormone (GHRH). Unlike GHRH, Mod GRF 1-29 is not a full-length peptide but rather a shorter version containing only 29 amino acids. In Mod GRF 1-29, four of the original amino acids have been modified, to enhance its stability. These modifications serve to make the molecule more resistant to degradation by dipeptidyl peptidase-4 (DPP-4) enzymes, which would otherwise break down the peptide structure. By reducing susceptibility to enzymatic degradation, these modifications may potentially increase the peptide's half-life and improve its pharmacokinetics.(1)"
            },
            {
                "p": "Ipamorelin is a synthetic pentapeptide, falling under the growth hormone secretagogue receptor (GHSR) agonist category. The peptide was derived from GHRP-1, which in turn is an analog of met-enkephalin, but potentially may not possess affinity to the opioid receptors. It appears to activate the ghrelin receptors (GHSR) which appear to trigger growth hormone synthesis."
            },
            {
                "p": "Fragment 176-191, as the name implies, is a small ‘fragment’ of the growth hormone (hGH), also referred to as the “fat-burning peptide” for its potential in that area.(2) Fragment 176-191 peptide, composed of 16 amino acids, including the last 15 amino acids from 177 to 191 found in hGH, has tyrosine added at the N-terminus (beginning). The peptide is also known as AOD 9604.(3)"
            },
            {
                "h3": "Chemical Makeup(1)(3)(4)"
            },
            {
                "p": "Molecular formula"
            },
            {
                "p": "Molecular weight"
            },
            {
                "p": "Other known titles"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Fragment 176-191 & Modified GRF 1-29 & Ipamorelin Blend, and Lipolytic Action"
            },
            {
                "p": "The peptide in the blend that is believed to possess the most potent lipolytic (fat-breaking) action is likely Fragment 176-191. In one study,(2) obese experimental murine models were subjected to the peptide for two consecutive weeks. After the completion of the study, it was noted that there appeared to be a significant reduction in the body weight of these murine models, including a reduction of excess body lipids. These results were deemed correlated to the increased concentration of the lipolytic ß3-AR receptors, indicating the peptides may work via the beta-adrenergic pathway. Further studies were conducted on the experimental mice with knocked-out lipolytic receptors. The peptide mice were reported to have experienced considerable weight loss, suggesting that the peptide may not depend on the lipolytic receptors to exert any action. Instead, it may possibly produce some fat-burning action via energy expenditure and fat oxidation. As per M Heffernan and his team, “this study demonstrates that the lipolytic actions of both hGH and AOD9604 are not mediated directly through the beta(3)-AR although both compounds increase beta(3)-AR expression, which may subsequently contribute to enhanced lipolytic sensitivity.” (2)"
            },
            {
                "h3": "Fragment 176-191 & Modified GRF 1-29 & Ipamorelin Blend, and the Pituitary Gland"
            },
            {
                "p": "One review of the available literature(5) suggested that these peptides appeared to yield various physiological changes, including “increase lean body mass, reduce fat mass, increase exercise tolerance and maximum oxygen uptake, enhance muscle strength, and improve linear growth…” in obese test models.(5) While Fragment 176-191 was suggested to exert its potential action for weight loss via peripheral mechanisms, the aforementioned observation in the review are related to the apparent central action of peptides like Mod GRF 1-29 and Ipamorelin on the pituitary gland."
            },
            {
                "p": "For example, Ipamorelin appears to work by potentially binding to the GHS-R1a receptor, also known as the growth hormone secretagogue receptor type 1a, which is found in the pituitary gland and the hypothalamus. Upon binding, this receptor activation may trigger a series of intracellular events that potentially culminate in the release of stored growth hormone from somatotroph cells (GH-producing cells) in the anterior pituitary. The apparent activation of the GHS-R1a receptor by Ipamorelin may lead to increased intracellular calcium ions through the phospholipase C pathway. The elevated calcium levels may prompt the secretory vesicles inside somatotropic cells to release growth hormone."
            },
            {
                "p": "On the other hand, Mod GRF 1-29 appears to interact with the GHRH receptors on somatotrophs in the anterior pituitary gland. Upon binding to the GHRH receptors, Mod GRF 1-29 appears to instigate a cascade of intracellular signaling events. One of the key pathways activated appears to be the adenylyl cyclase pathway. Activation of this pathway may result in the conversion of ATP (adenosine triphosphate) into cAMP (cyclic adenosine monophosphate). This rise in cAMP appears to activate protein kinase A (PKA), which then may lead to the phosphorylation of various proteins, including voltage-dependent calcium channels on the cell membrane. The subsequent opening of these calcium channels potentially facilitates the influx of calcium ions into the somatotropic cells. Elevated intracellular calcium concentrations, in turn, appear to prompt the secretory vesicles inside these cells to release growth hormone into the bloodstream. It is posited that through this series of intracellular events that Mod GRF 1-29, upon binding to GHRH receptors, the peptide might facilitate the release and synthesis of growth hormone. The combination of Mod GRF 1-29 with certain growth hormone-releasing peptides like Ipamorelin, may potentially lead to a synergistic action, apparently amplifying the release of growth hormone."
            },
            {
                "h3": "Fragment 176-191 & Modified GRF 1-29 & Ipamorelin Blend, and Fat Burning"
            },
            {
                "p": "In 2004, a clinical trial(6) was launched, consisting of 300 obese test subjects. All these subjects were presented with the Fragment 176-191 peptide for 12 consecutive weeks. All subjects were divided into 6 groups – one group was presented with saline placebo, and the rest were given different peptide concentrations. After 12 weeks, when the subjects were examined, the group presented with the minor concentration appeared to exhibit the highest reduction in subject body weight (up to an average of 2.8 kilograms). Moreover, the trial also suggested that the peptide may have helped to improve these candidates’ cholesterol profiles and glucose tolerance levels. As per Chris Belyea, “The evidence from the trial is that over 12 weeks AOD9604 induces competitive weight loss with accompanying health benefits at a low dose and has superior tolerability.” (6)"
            },
            {
                "h3": "Fragment 176-191 & Modified GRF 1-29 & Ipamorelin Blend, and Regeneration"
            },
            {
                "p": "In one 2015 study,(7) 32 experimental rabbits were enrolled and divided into four groups of eight. All four groups were presented with placebo, Fragment 176-191 peptide, hyaluronic acid, or a combination of the peptide and hyaluronic acid. This study was conducted for approximately 7 weeks. After the completion of the study, all rabbits were examined for cartilage damage. Among all groups, the rabbits presented with the peptide and hyaluronic acid combination appeared to exhibit minor cartilage degeneration. The report concluded that “Intra-articular AOD9604 [administration] using ultrasound guidance enhanced cartilage regeneration, and combined AOD9604 and HA [administration] were more effective than HA or AOD9604 [doses] alone in the collagenase-induced knee OA rabbit model.” (7)"
            },
            {
                "h3": "Fragment 176-191 & Modified GRF 1-29 & Ipamorelin Blend and Bone Mineralization"
            },
            {
                "p": "Considering the different peptides in the blend, Ipamorelin appears to be the one with a potential for improving bone mass and mineralization in experimental models. Preliminary experiments on murine models suggest that Ipamorelin may have mitigated the loss of muscle strength, which can occur in artificially-induced catabolic conditions.(8) The researchers also commented that introduction of the peptide appeared to have increased bone mineralization in the murine models subjected to a combination of Ipamorelin and catabolism-inducing agents, in contrast to the control group receiving only catabolism-inducing agents."
            },
            {
                "p": "Other trials on experimental murine models also suggest that Ipamorelin may elevate bone mineral content, pointing toward denser and more robust bone formation.(9) The researchers utilized dual X-ray absorptiometry (DEXA) to observe the potential impact of Ipamorelin on bone mineral density in real-time, focusing on areas like the femur and L6 vertebrae. Post-research, the femurs of the murine subjects were analyzed using mid-diaphyseal peripheral quantitative computed tomography (pQCT) scans. The DEXA observations hint at a possible increase in tibial and vertebral BMC (bone mineral content) due to the peptide, differing from the control group. Additionally, the pQCT findings imply that the enhanced cortical BMC might stem from an expanded cross-sectional bone area, suggesting that the femur and L6 vertebrae could have seen heightened bone mineralization."
            },
            {
                "h3": "Fragment 176-191 & Modified GRF 1-29 & Ipamorelin Blend and Appetite"
            },
            {
                "p": "Ipamorelin appears to activate the ghrelin receptors in the pituitary (GHSR1a) but may also trigger the receptors for ghrelin in other systems. Considering its potential impact on ghrelin receptors, Ipamorelin may enhance appetite, possibly leading to weight gain. Research indicates that Ipamorelin might have contributed to an approximate 15% increase in the body weight of murine models.(10) Some theories suggest that Ipamorelin may have proportionally increased fat pad weights relative to total body weight, resulting in a noticeable rise in body fat, as detected by DEXA. Additionally, there are hints that Ipamorelin may have boosted serum leptin levels, a hormone associated with energy and appetite control. As a result, researchers theorize that murine models in the Ipamorelin groups could have consumed more food, leading to the observed weight gain."
            },
            {
                "p": "Fragment 176-191 & Modified GRF 1-29 & Ipamorelin peptide blend is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References"
            },
            {
                "references": [
                    "National Center for Biotechnology Information (2023). PubChem Compound Summary for CID 91976842, CJC1295 Without DAC. https://pubchem.ncbi.nlm.nih.gov/compound/CJC1295-Without-DAC.",
                    "Heffernan M, Summers RJ, Thorburn A, Ogru E, Gianello R, Jiang WJ, Ng FM. The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice. Endocrinology. 2001 Dec;142(12):5182-9. doi: 10.1210/endo.142.12.8522. PMID: 11713213. https://pubmed.ncbi.nlm.nih.gov/11713213/",
                    "National Center for Biotechnology Information (2023). PubChem Substance Record for SID 319360420, 386264-39-7, Source: ToxPlanet. https://pubchem.ncbi.nlm.nih.gov/substance/319360420",
                    "National Center for Biotechnology Information (2023). PubChem Compound Summary for CID 9831659, Ipamorelin. https://pubchem.ncbi.nlm.nih.gov/compound/Ipamorelin.",
                    "Sigalos, John T, and Alexander W Pastuszak. “The Safety and Efficacy of Growth Hormone Secretagogues.” Sexual medicine reviews vol. 6,1 (2018): 45-53. doi:10.1016/j.sxmr.2017.02.004 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632578/",
                    "News, Medical and Life Sciences, Obesity drug codenamed AOD 9604 highly successful in trials, 16 December 2004, https://www.news-medical.net/news/2004/12/16/6878.aspx.",
                    "Kwon DR, Park GY. Effect of Intra-articular Injection of AOD9604 with or without Hyaluronic Acid in Rabbit Osteoarthritis Model. Ann Clin Lab Sci. 2015 Summer;45(4):426-32. PMID: 26275694. https://pubmed.ncbi.nlm.nih.gov/26275694/",
                    "Andersen, N. B., Malmlöf, K., Johansen, P. B., Andreassen, T. T., Ørtoft, G., & Oxlund, H. (2001). The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation of adult rats. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 11(5), 266–272. https://doi.org/10.1054/ghir.2001.0239",
                    "Svensson, J., Lall, S., Dickson, S. L., Bengtsson, B. A., Rømer, J., Ahnfelt-Rønne, I., Ohlsson, C., & Jansson, J. O. (2000). The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats. The Journal of endocrinology, 165(3), 569–577. https://doi.org/10.1677/joe.0.1650569",
                    "Lall, S., Tung, L. Y., Ohlsson, C., Jansson, J. O., & Dickson, S. L. (2001). Growth hormone (GH)-independent stimulation of adiposity by GH secretagogues. Biochemical and biophysical research communications, 280(1), 132–138. https://doi.org/10.1006/bbrc.2000.4065"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "",
        "high_performance_liquid_chromatography": "",
        "mass_spectrometry": "",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Fragment 176-191 & Mod GRF 1-29 & Ipamorelin blend for sale. Purchase peptides for sale at 99+% purity with unmatched customer service and Free shipping.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Fragment 176-191 & Mod GRF 1-29 & Ipamorelin blend (12mg)",
            "og:description": "Fragment 176-191 & Mod GRF 1-29 & Ipamorelin blend for sale. Purchase peptides for sale at 99+% purity with unmatched customer service and Free shipping.",
            "og:url": "https://www.corepeptides.com/peptides/fragment-176-191-mod-grf-1-29-ipamorelin-blend-12mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-05-28T11:02:35+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Frag-176-191-Mod-GRF-1-29-Ipamorelin-6-3-3MG.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Fragment 176-191 & Mod GRF 1-29 & Ipamorelin blend (12mg)",
            "twitter:description": "Fragment 176-191 & Mod GRF 1-29 & Ipamorelin blend for sale. Purchase peptides for sale at 99+% purity with unmatched customer service and Free shipping.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Frag-176-191-Mod-GRF-1-29-Ipamorelin-6-3-3MG.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$73.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:brand": "Core Peptides",
            "product:price:amount": "73.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-FRAGMODIPAM-12",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/selank-10mg/",
                "name": "Selank (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Selank-10MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/hexarelin-5mg/",
                "name": "Hexarelin (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Hexarelin-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/mgf-5mg/",
                "name": "MGF (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/MGF-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/oxytocin-10mg/",
                "name": "Oxytocin (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Oxytocin-10mg-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/fragment-176-191-cjc-1295-ipamorelin-blend-12mg/",
        "name": "Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Frag-176-191-CJC-1295-Ipamorelin-6-3-3MG.jpg",
        "display_price": "$73.00",
        "display_specs": [
            "Size: 12mg Contents: Fragment 176-191 (6mg), CJC-1295 NO DAC (3mg), Ipamorelin (3mg) Form: Lyophilized powder Purity: >99% SKU: P-FRAGCJCIPAM-12",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$69.35"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$65.70"
            }
        ],
        "description": [
            {
                "h2": "Fragment 176-191 & CJC-1295 & Ipamorelin Peptide Blend"
            },
            {
                "p": "Researchers have suggested that growth hormone-releasing peptides (GHRPs), growth hormone secretagogues (GSHs), and analogs of growth hormones (hGH) may exhibit potential to promote growth hormone secretion. When combined, they have been suggested by researchers to exert significant action. These include increased fat metabolism, increased lean mass, regulated sleep cycle, and enhanced intestinal and cardiac functioning."
            },
            {
                "p": "CJC-1295 is a synthetic peptide composed of 29 amino acids. The peptide appears to work by activating the Growth Hormone-Releasing Hormone (GHRH) receptors in the pituitary gland. These receptors are typically activated by the native GHRH. CJC-1295 appears to be a synthetic analog made of the first 29 amino acids from the GHRH sequence, which has additional modifications, including the replacement of four amino acids in its structure and the attachment of a Drug Affinity Complex (DAC) to potentially extend the pharmacokinetics of the peptide."
            },
            {
                "p": "Ipamorelin is a synthetic pentapeptide and has been categorized by scientists as a growth hormone secretagogue (GHS). It has been posited to function similarly to Growth Hormone Releasing Peptides (GHRPs) and to potentially emulate the natural hunger hormone, ghrelin, particularly its potential to stimulate the release of hGH from the cells in the anterior pituitary gland. More specifically, Ipamorelin may mimic the function of ghrelin by activating the ghrelin receptors there, which are also known as the Growth Hormone Secretagogue receptors 1 Alpha (GHS-R1a)"
            },
            {
                "p": "Fragment 176-191 peptide, as the name suggests, is a small ‘fragment’ of the growth hormone hGH composed of 15 amino acids. This peptide might target the beta-3 adrenergic receptors (ADRB3), which may potentially induce weight loss downstream. Through these receptors, it is suggested that the peptide may boost fat burning in adipose tissue cells and possibly promote 'thermogenesis' in skeletal muscle cells."
            },
            {
                "p": "Presented together, this blend may trigger a small portion of the pituitary gland, possibly stimulating the release of growth hormones. This blend has been posited by scientists to potentially synergistically enhance and regulate growth hormone concentration and maintain equilibrium levels."
            },
            {
                "h3": "Chemical Makeup(1)(2)(3)"
            },
            {
                "p": "Molecular formula"
            },
            {
                "p": "Molecular weight"
            },
            {
                "p": "Other known titles"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Fragment 176-191 & CJC-1295 & Ipamorelin Blend, and Growth Hormones"
            },
            {
                "p": "While the fragment 176-191 appears to directly mimic the function of hGH, the peptides CJC-1295 and Ipamorelin appear to exert potential by upregulating the synthesis of hGH itself. For example, CJC-1295 has been suggested to have significant hGH-boosting potential in several phase-1 clinical trials."
            },
            {
                "p": "In the first, test subjects aged between 20 and 40 were enrolled.(4) All subjects were divided into two groups – one was presented with a saline placebo and the rest with the CJC-1295 peptide. A blood sample was collected from all subjects before and after the peptide presentation. After completion of the study, it was reported by the researchers that the peptide group appeared to exhibit a 7.5-fold increase in their growth hormone levels compared to the standard group. The trend suggested that these hormones increased gradually throughout the study and remained unchanged for at least 7 days after discontinuing presentation."
            },
            {
                "p": "Another study(5) was conducted on male test subjects aged between 20 and 60. Similar to the previous study, these subjects were divided into two groups – one was presented with a placebo while the rest were given the CJC-1295 peptide. The peptide group was given gradually increasing concentrations of the compound during the study. Upon analyzing the blood samples collected from these subjects, it was observed that there appeared to be a concentration-dependent increase, of up to 10 times, in the concentration of growth hormones among the peptide subjects. As per Madalina Ionescu et al., “The marked enhancement of trough GH levels by continuous GHRH stimulation implicates the importance of this effect on increasing IGF-I. Long-acting GHRH preparations may benefit patients with intact pituitary GH secretory capability.” (4)"
            },
            {
                "p": "Similarly, Ipamorelin has also been suggested to potentially increase hGH synthesis. In one clinical study it was posited that a single presentation of the peptide may boost hGH levels by over 60-fold compared to placebo.(6)"
            },
            {
                "h3": "Fragment 176-191 & CJC-1295 & Ipamorelin Blend, and Lipolytic Action"
            },
            {
                "p": "A clinical trial(7) was conducted in 2004 to study the peptide’s potential lipolytic (fat-burning) action. In the trial, 300 subjects were enrolled and presented with the Fragment 176-191 peptide for 12 weeks. These subjects were divided into 6 groups – one given a saline placebo, and the rest presented with different peptide concentrations. The group presented with minimal peptide presence appeared to exhibit a notable reduction in their body weight (up to 2.8 kilograms). These peptides may have also helped improve these subjects’ cholesterol profiles and glucose tolerance levels. The research team stated, “The evidence from the trial is that over 12 weeks, [the peptide] induces competitive weight loss with accompanying health benefits…”"
            },
            {
                "h3": "Fragment 176-191 & CJC-1295 & Ipamorelin Blend, and Regeneration"
            },
            {
                "p": "Thirty-two experimental rabbits were examined as part of this 2015 study,(8) all of whom were divided into four groups of eight. All four groups were presented with placebo, Fragment 176-191 peptide, hyaluronic acid, or a combination of the peptide and hyaluronic acid for about 7 weeks. After the completion of the study, all rabbits were checked for any signs of cartilage damage. Among all groups, the rabbits presented with peptide and hyaluronic acid combination appeared to show minimal cartilage degeneration. These results suggest that the peptide may have the capability to enhance cartilage regeneration and repair. The report concluded that “Intra-articular AOD9604 using ultrasound guidance enhanced cartilage regeneration, and combined AOD9604 and HA were more effective than HA or AOD9604 alone in the collagenase-induced knee OA rabbit model.” (8)"
            },
            {
                "h3": "Fragment 176-191 & CJC-1295 & Ipamorelin Blend, and Body Composition"
            },
            {
                "p": "As mentioned, Fragment 176-191 may potentiate a favorable shift in body composition by reducing adiposity. Yet, CJC-1295 & Ipamorelin also appear to have a significant potential via different impacts, which may include increasing lean mass for CJC-1295, and increasing overall body weight in the case of Ipamorelin. Research in the lab suggests that Ipamorelin might potentially play a role in weight gain including muscle mass gain but also adiposity, possibly due to both an elevation in hGH levels and its potential to stimulate appetite through ghrelin receptor activation. An investigation into Ipamorelin's potential impact on body fat was conducted in both hGH-deficient and hGH-intact murine models. The results indicated that Ipamorelin may have led to a modest 15% rise in body weight within a span of 2 weeks. Additionally, in both murine models, there was a relative increase in fat pad weights when compared to overall body weight.(9)"
            },
            {
                "p": "On the other hand, CJC-1295 may potentially improve body composition while apparently increasing muscle mass without affecting or even possibly decreasing adiposity. Research involving murine models with a GHRH gene deletion (known as GHRHKO) noted that CJC-1295 might upregulate the synthesis of GH and potentially induce such a favorable shift in body composition. When these GHRHKO murine models were exposed to CJC-1295, they seemed to maintain standard lean mass, compared to unexposed models which failed to achieve normal lean mass. Moreover, the subcutaneous fat mass remained at control levels across all peptide-associated groups, while the GHRHKO murine models not exposed to CJC-1295 appeared to have increased adiposity.(10) Considering the potential lipolytic action of Fragment 176-191 and CJC-1295, researchers may want to consider the hypothesis that the blend of these peptides may counteract the fat-increasing potential of Ipamorelin, while further increasing its muscle building potential."
            },
            {
                "h3": "Fragment 176-191 & CJC-1295 & Ipamorelin Blend, and Bone Mineral Content"
            },
            {
                "p": "By increasing lean and muscle mass, the peptides and especially Ipamorelin may provide potential benefits in bone mass. In an experiment, murine subjects were either introduced to Ipamorelin or a control substance. The impact of Ipamorelin on bone mineral content was observed in real-time using dual X-ray absorptiometry (DXA) at select areas, notably the femur and L6 vertebrae. Following the study period, the femurs of the murine subjects were examined using mid-diaphyseal peripheral quantitative computed tomography (pQCT) scans. Preliminary results suggest that the peptide might have played a role in a possible weight increase and a potential rise in the tibial and vertebral bone mineral content as detected by DXA, compared to the control group. The pQCT findings hint that the increase in cortical BMC might be due to an expansion in the cross-sectional bone area.(11)"
            },
            {
                "p": "Fragment 176-191 & CJC-1295 & Ipamorelin Peptide Blend is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References"
            },
            {
                "references": [
                    "National Center for Biotechnology Information (2023). PubChem Compound Summary for CID 91976842, CJC1295 Without DAC. https://pubchem.ncbi.nlm.nih.gov/compound/CJC1295-Without-DAC",
                    "National Center for Biotechnology Information (2023). PubChem Compound Summary for CID 9831659, Ipamorelin. https://pubchem.ncbi.nlm.nih.gov/compound/Ipamorelin",
                    "National Center for Biotechnology Information (2023). PubChem Substance Record for SID 319360420, 386264-39-7, Source: ToxPlanet. https://pubchem.ncbi.nlm.nih.gov/substance/319360420",
                    "Ionescu M, Frohman LA. Pulsatile growth hormone secretion (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. J Clin Endocrinol Metab. 2006 Dec;91(12):4792-7. doi: 10.1210/jc.2006-1702. Epub 2006 Oct 3. PMID: 17018654. https://pubmed.ncbi.nlm.nih.gov/17018654/",
                    "Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 2006 Mar;91(3):799-805. doi: 10.1210/jc.2005-1536. Epub 2005 Dec 13. PMID: 16352683. https://pubmed.ncbi.nlm.nih.gov/16352683/",
                    "Gobburu, J. V., Agersø, H., Jusko, W. J., & Ynddal, L. (1999). Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers. Pharmaceutical research, 16(9), 1412–1416. https://doi.org/10.1023/a:1018955126402",
                    "News, Medical and Life Sciences, Obesity drug codenamed AOD 9604 highly successful in trials, 16 December 2004, https://www.news-medical.net/news/2004/12/16/6878.aspx",
                    "Kwon DR, Park GY. Effect of Intra-articular Injection of AOD9604 with or without Hyaluronic Acid in Rabbit Osteoarthritis Model. Ann Clin Lab Sci. 2015 Summer;45(4):426-32. PMID: 26275694. https://pubmed.ncbi.nlm.nih.gov/26275694/",
                    "Lall, S., Tung, L. Y., Ohlsson, C., Jansson, J. O., & Dickson, S. L. (2001). Growth hormone (GH)-independent stimulation of adiposity by GH secretagogues. Biochemical and biophysical research communications, 280(1), 132–138. https://doi.org/10.1006/bbrc.2000.4065",
                    "Alba M, Fintini D, Sagazio A, Lawrence B, Castaigne JP, Frohman LA, Salvatori R. Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse. Am J Physiol Endocrinol Metab. 2006 Dec;291(6):E1290-4. doi: 10.1152/ajpendo.00201.2006. Epub 2006 Jul 5. PMID: 16822960.",
                    "Svensson, J., Lall, S., Dickson, S. L., Bengtsson, B. A., Rømer, J., Ahnfelt-Rønne, I., Ohlsson, C., & Jansson, J. O. (2000). The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats. The Journal of endocrinology, 165(3), 569–577. https://doi.org/10.1677/joe.0.1650569"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "",
        "high_performance_liquid_chromatography": "",
        "mass_spectrometry": "",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Fragment 176-191 & CJC-1295 & Ipamorelin Blend for sale. Purchase peptides for sale at 99+% purity with unmatched customer service and Free shipping.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg)",
            "og:description": "Fragment 176-191 & CJC-1295 & Ipamorelin Blend for sale. Purchase peptides for sale at 99+% purity with unmatched customer service and Free shipping.",
            "og:url": "https://www.corepeptides.com/peptides/fragment-176-191-cjc-1295-ipamorelin-blend-12mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-05-28T11:02:13+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Frag-176-191-CJC-1295-Ipamorelin-6-3-3MG.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg)",
            "twitter:description": "Fragment 176-191 & CJC-1295 & Ipamorelin Blend for sale. Purchase peptides for sale at 99+% purity with unmatched customer service and Free shipping.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Frag-176-191-CJC-1295-Ipamorelin-6-3-3MG.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$73.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "73.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-FRAGCJCIPAM-12",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/peg-mgf-5mg/",
                "name": "PEG-MGF (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/PEG-MGF-5MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/oxytocin-10mg/",
                "name": "Oxytocin (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Oxytocin-10mg-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ghk-cu-50mg-copper/",
                "name": "GHK-Cu (Copper) (50mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHK-CU-50mg-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/dsip-5mg/",
                "name": "DSIP (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/DSIP-5MG-300x300.jpg.webp",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/fragment-176-191/",
        "name": "Fragment 176-191 (5mg / 10mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Fragment-176-191.jpg",
        "display_price": "$44.00 – $72.00",
        "display_specs": [
            "Size: 5mg / 10mg Contents: Fragment 176-191 Form: Lyophilized powder Purity: >99% SKU: P-FRAG176-191",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$41.80 – $68.40"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$39.60 – $64.80"
            },
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$68.40"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$64.80"
            },
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$41.80"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$39.60"
            }
        ],
        "description": [
            {
                "h2": "Fragment 176-191 Peptide"
            },
            {
                "p": "Fragment 176-191 peptide, also known as hGH Fragment 176-191, tyr-hGH 177-191, or AOD-9604, has been suggested by researchers that it may stimulate weight loss and fat burn in a fashion similar to that of the growth hormone (hGH). hGH is a naturally occurring hormone, which, apart from stimulating growth, as the name suggests, may also stimulate catabolism of adipose tissue and the release of lipids from fat cells. Fragment 176-191 is a small ‘fragment’ of the growth hormone hGH composed of 16 amino acids. This involves the last 16 amino acids of the hGH molecule, which scientists propose to be the “lipolytic fragment” of hGH. Lipolythic, as a term, reflects the purported fat-burning properties of the molecule. To potentially improve the stability of the peptide, the first amino acid in the hGH Fragment 176-191 sequence is also replaced by tyrosine. Thus, the peptide is also labeled as Fragment tyr-hGH 177-191.(1)(2)"
            },
            {
                "h3": "Overview"
            },
            {
                "p": "This peptide could, in theory, aim at the beta-3 adrenergic receptors (ß3-AR), which might, in turn, lead to a potential weight loss action. It is posited that through these receptors, the peptide may encourage fat burning in adipose tissue and foster 'thermogenesis' in skeletal muscle cells. In a study involving obese murine models exposed to the peptide for two weeks, there seemed to be an apparent decrease in weight, including a reduction in excess fat. These observations are thought to be linked to a rise in the activity of lipolytic beta-3 adrenergic receptors, hinting that the peptide's actions could be connected to the beta-adrenergic pathway. The researchers commented that Fragment 176-191 may be “capable of increasing the repressed levels of beta(3)-AR RNA in obese mice to levels comparable with those in lean mice.” Unfortunately, the data may not be conclusive, as the research on murine models with disabled lipolytic receptors suggested that the peptide still led to apparent weight loss, suggesting its actions might not solely rely on these receptors. Thus, it was also considered that the peptide might help burn fat through mechanisms like energy expenditure and fat oxidation, though this remains an area for further investigation.(3)"
            },
            {
                "p": "As mentioned, the presence of tyrosine at the N-terminus of the fragment increases the stability of the peptide. In addition, there appears to be a naturally occurring disulfide bridge between the two cysteine amino acids in the molecule of hGH and hGH Fragment 176-191. This bridge appears to further stabilize the molecule and may increase its resistance against degradation in various environments, including stomach acid.(4)(5)"
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C78H125N23O23S2 Molecular Weight: 1817.12 g/mol Other Known Titles: hGH Fragment 176-191; Lipolytic fragment"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Fragment 176-191 and Fat Cells"
            },
            {
                "p": "As mentioned, Fragment 176-191 is believed to potentially increase fat burning through different mechanisms, which may include the upregulation of the beta-3 adrenergic receptors. More specifically, the peptide might elevate the expression levels of beta(3)-AR RNA in fat cells. This suggests that Fragment 176-191 may influence signaling pathways or transcription factors that enhance the production of beta-3 adrenergic receptor mRNA, leading to increased synthesis of the beta-3 adrenergic receptors protein. With more beta-3 adrenergic receptors present on the surface of adipocytes (fat cells), the cells may become more sensitive to lipolytic signals. This posits that even though Fragment 176-191 may not directly activate beta-3 adrenergic receptors, the increased number of receptors might amplify the natural lipolytic response to endogenous catecholamines (like adrenaline), which are suggested to engage these receptors directly. Fragment 176-191 might also activate other cellular signaling mechanisms that indirectly boost fat burning. For example, it may influence pathways that either upregulate the expression of enzymes involved in the lipolysis process or enhance the cellular response to lipolytic signals by modulating the activity of secondary messengers within the cell."
            },
            {
                "p": "This has been explored by clinical trials, the most notable of which was METAOD005. This trial was initiated to explore the possible fat-burning action of a peptide. 300 test subjects were involved in this investigation, which lasted 12 weeks. There were six groups, including one control group and five Fragment 176-191 groups. It was suggested that one of the Fragment 176-191 groups experienced an apparent decrease in body weight, potentially by around 5.7 pounds. Moreover, it was posited that the peptide may have possibly contributed to improvements in the cholesterol levels and glucose tolerance of these participants.(6)"
            },
            {
                "h3": "Fragment 176-191 and Cartilage Regeneration"
            },
            {
                "p": "Some researchers have posited that Fragment 176-191 peptide may have some of the proposed regenerative properties of hGH, in addition to its apparent fat-burning potential. To explore these potential impacts of Fragment 176-191 peptide, researchers used a knee osteoarthritis model caused by collagenase. The experimental models were introduced with type II collagenase to apparently induce damage to the knee cartilage. Following this, for a period of 4-7 weeks, the models were split into four groups including saline (Group 1), hyaluronic acid (Group 2), Fragment 176-191 peptide (Group 3), and a combination of Fragment 176-191 peptide with hyaluronic acid (Group 4). The severity of the cartilage damage was evaluated through both morphological and histopathological analysis, and the degree of lameness was observed 8 weeks after the beginning of the trial. The researchers commented, \"Mean gross morphological and histopathological scores were significantly higher in Group 1 than in Groups 2, 3, and 4, and the scores were significantly lower in Group 4 than in Groups 2 and 3. The lameness period in Group 4 was significantly shorter than those in Groups 1, 2, and 3.” This suggested that both hyaluronic acid and Fragment 176-191 peptide may be better than saline in stimulating an apparent cartilage regeneration, and the best research outcome may be achieved with a combination of Fragment 176-191 peptide and hyaluronic acid.(7)"
            },
            {
                "h3": "Fragment 176-191 and Hyperglycemia"
            },
            {
                "p": "In one study,(8) several synthetic hGH peptides, including Fragment 176-191, were presented in normal functioning murine models to determine its potential on glycogen metabolism. Upon delivery, it was reported that the peptide appeared to induce a slight increment in levels of blood glucose and lactate, with a slight reduction in the ratio of glycogen synthase in muscle, adipose tissues, and the liver. It was suggested that this outcome was due to the peptide's apparent action of converting the enzymes from their active state to inactive state, as the total synthase levels appeared to remain at constant concentrations."
            },
            {
                "p": "Fragment 176-191 peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Cox HD, Smeal SJ, Hughes CM, Cox JE, Eichner D. Detection and in vitro metabolism of AOD9604. Drug Test Anal. 2015 Jan;7(1):31-8. doi: 10.1002/dta.1715. Epub 2014 Sep 10. PMID: 25208511.",
                    "Heffernan, Mark, et al. \"The Effects of Human GH and Its Lipolytic Fragment (AOD9604) on Lipid Metabolism Following Chronic Treatment in Obese Mice andβ 3-AR Knock-Out Mice.\" Endocrinology 142.12 (2001): 5182-5189.",
                    "Heffernan M, Summers RJ, Thorburn A, Ogru E, Gianello R, Jiang WJ, Ng FM. The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice. Endocrinology. 2001 Dec;142(12):5182-9. doi: 10.1210/endo.142.12.8522. PMID: 11713213.",
                    "Stier, Heike, Evert Vos, and David Kenley. \"Safety and Tolerability of the Hexadecapeptide AOD9604 in Humans.\" Journal of Endocrinology and Metabolism 3.1-2 (2013): 7-15.",
                    "Moré, Margret I., and David Kenley. \"Safety and metabolism of AOD9604, a novel nutraceutical ingredient for improved metabolic health.\" Journal of Endocrinology and Metabolism 4.3 (2014): 64-77.",
                    "Valentino, M A et al. “Central and peripheral molecular targets for antiobesity pharmacotherapy.” Clinical pharmacology and therapeutics vol. 87,6 (2010): 652-62. doi: 10.1038/clpt.2010.57",
                    "Kwon, Dong Rak, and Gi Young Park. “Effect of Intra-articular Injection of AOD9604 with or without Hyaluronic Acid in Rabbit Osteoarthritis Model.” Annals of clinical and laboratory science vol. 45,4 (2015): 426-32.",
                    "Ma GY, Macaulay SL, Maggs JA, Armstrong JM, Bornstein J. The mechanism of the hyperglycaemic action of synthetic peptides related to the C-terminal sequence of human growth hormone. Biochim Biophys Acta. 1982 Jun 16;716(3):400-9. doi: 10.1016/0304-4165(82)90033-2. PMID: 6810951."
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "",
        "high_performance_liquid_chromatography": "",
        "mass_spectrometry": "",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Fragment 176-191 for sale online. Peptides for sale at 99% purity with superior customer service. Read Frag 176-191 research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Fragment 176-191 For Sale (5mg /10mg) | Core Peptides",
            "og:description": "Fragment 176-191 for sale online. Peptides for sale at 99% purity with top customer service. Get Frag 176-191 research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/fragment-176-191/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T18:09:29+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Fragment-176-191.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Fragment 176-191 For Sale (5mg /10mg) | Core Peptides",
            "twitter:description": "Fragment 176-191 for sale online. Peptides for sale at 99% purity with top customer service. Get Frag 176-191 research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Fragment-176-191.jpg",
            "twitter:label1": "Availability",
            "twitter:data1": "In stock",
            "product:brand": "Core Peptides",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-FRAG176-191",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/ghrp-2/",
                "name": "GHRP-2 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHRP-2-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ll-37-5mg/",
                "name": "LL-37 (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/LL-37-5mg-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ghrp-6/",
                "name": "GHRP-6 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHRP-6-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/receptor-grade-igf-1-lr3-1mg/",
                "name": "Receptor Grade IGF-1 LR3 (1mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-1MG-300x300.jpg.webp",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/foxo4-dri-10mg/",
        "name": "FOXO4-DRI (10mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2022/01/FOXO4-DRI-10mg.jpg",
        "display_price": "$235.00",
        "display_specs": [
            "Size: 10mg Contents: FOXO4-DRI (10mg) Form: Lyophilized powder Purity: >99% SKU: P-FOXO4-10",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$223.25"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$211.50"
            }
        ],
        "description": [
            {
                "h2": "FOXO4-DRI Peptide"
            },
            {
                "p": "Organisms host multiple transcription factor proteins. One such class of transcription factor proteins is the FOXO group or forkhead family of transcription factor-O,(2) which includes four members: FOXO1, FOXO3, FOXO4, and FOXO6. The FOXO4 factor is considered to regulate various cell pathways, including insulin signaling, cell cycle progression, and other functions that regulate growth and differentiation."
            },
            {
                "p": "A synthetic version of the FOXO4 protein is FOXO4-DRI, which was developed to be identical to a fragment of the endogenously available FOXO4 protein, except for the alteration in its amino acid structure. It includes only a specific part of the FOXO4 sequence crucial for interacting with p53. FOXO4-DRI peptide, or Proxofim, is an acronym for Forkhead box O transcription factor 4-D-Retro-Inverso peptide.(3) FOXO4-DRI peptide is the same as FOXO4 protein, except that the L amino acids in its structure are replaced by D amino acids. As a result of this, FOXO4-DRI peptide may be less susceptible to the normal clearance mechanism as compared to FOXO4. It is important to note that this alteration not only potentially increases its stability but also may affect how it interacts with other cellular components compared to its natural counterpart."
            },
            {
                "h3": "Overview"
            },
            {
                "p": "The retro inverso peptides (DRI peptides) are linear chains of amino acids, where the sequence is \"reversed,\" reversing the chirality of the structure (i.e., L amino acid structure altered to D amino acid and vice versa). D amino acids represent the mirror image of the naturally occurring L amino acids in the biological proteins. The main potential advantage of exchanging L amino acid with D amino acid is that the latter may be more resistant to degradation, making the protein structure more durable."
            },
            {
                "p": "The main focus of FOXO4-DRI peptide research is focused on its potential to prevent the binding of the FOXO4 protein with p53 protein.(4) This interaction may be crucial as FOXO4, when bound to p53, may inhibit some of p53's key functions involved in cell cycle regulation and apoptosis. The p53 protein is an endogenous regulator protein, considered to regulate the progression of the cell cycle, including cell death. p53’s potential as a tumor suppressor is well-documented, primarily functioning to stop the proliferation of cells that have suffered DNA damage. When FOXO4 protein binds with p53, it does not appear to allow p53 to bind with DNA, thereby preventing apoptosis and cell death. This interruption may lead to the accumulation of senescent cells - those that have stopped dividing but do not die, contributing to cell aging. This process may be inhibited in the presence of FOXO4-DRI peptide, allowing p53 to bind with DNA and thereby help the cell cycle to continue to death. This potential restoration of p53’s function by the FOXO4-DRI peptide might enable it to trigger the programmed cell death of senescent cells, essentially clearing out cells that might otherwise contribute to the decline in tissue function seen in aged cell cultures."
            },
            {
                "p": "FOXO4-DRI peptide is selective in nature and exerts this potential action only on cells that have become dysfunctional over time due to aging, known as senescent cells.(5) As a result of this biological pathway, the functioning of the tissues may be improved, aiding cell growth and differentiation."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C228H388N86O64 Molecular Weight: 5358.05 g/mol Other Known Titles: Forkhead box protein O4, Proxofim, FOXO4a, AFX, AFX1, MLLT7"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "FOXO4-DRI Peptide and Senescence"
            },
            {
                "p": "FOXO4-DRI peptide research indicates that the peptide may not wholly stop cell senescence; however, it does appear to have the potential to slow down the process by possibly preventing naturally occurring FOXO4-mediated resistance to apoptosis during senescence. More specifically, researchers have observed that senescent cells resisted apoptosis due to elevated FOXO4 levels, which seem to regulate this process by interacting with p53.(6) By inducing apoptosis in senescent and damaged cells, this peptide may increase the regeneration of cells. One 2017 study(6) experimented on aged mouse models, including a fast-aging model (XpdTTD/TTD mice), presented with either the protein compound or a control. The experimental murine models appeared to have exhibited improved fitness, better renal functioning, and increased fur density. This may be related to its potential to decrease the burden of senescent cells. These cells appear to contribute to the aging process and age-related diseases through the senescence-associated secretory phenotype (SASP), which fosters a pro-inflammatory environment detrimental to tissue function and integrity. By potentially reducing the presence and impact of senescent cells, FOXO4-DRI might thereby restore tissue homeostasis and reduce biomarkers of cell aging."
            },
            {
                "h3": "FOXO4-DRI Peptide and Cardiovascular Function"
            },
            {
                "p": "Research from 2002(7) has suggested that levels of proteasome enzymes decrease over time. These enzymes are considered to play a primary role in removing cells identified as damaged or dysfunctional within an organism. The naturally occurring FOXO4 protein appears to regulate the levels of proteasome enzymes, but it does not necessarily help reduce damaged cells. Studies in the FOXO4-DRI peptide suggest it may boost natural processes while possibly also eliminating dysfunctional cells."
            },
            {
                "h3": "FOXO4-DRI and Insulin Signaling"
            },
            {
                "p": "In the context of longevity, FOXO4's activities are often linked through the insulin and insulin-like growth factor signaling (IIS) pathway. This pathway influences how cells respond to stress and growth signals, potentially extending lifespan by enhancing stress resistance and cellular survival mechanisms.(8) Furthermore, FOXO4's role in the IIS pathway suggests it might modulate the actions of diet and environmental factors on cell aging, acting as a mediator between external factors and cellular longevity pathways."
            },
            {
                "h3": "FOXO4-DRI and Oxidative Stress"
            },
            {
                "p": "Scientific hypotheses posit that FOXO4 may act as a regulatory linchpin cellular response to oxidative stress. By mediating the transcription of crucial antioxidative enzymes, FOXO4 may help mitigate oxidative stress and maintain cellular integrity and function during episodes of high oxidative load or inflammation. This dual potential in responding to both oxidative stress and inflammation may enhance the protective capabilities of FOXO4, making it a potential factor in the cell’s longevity and resilience."
            },
            {
                "p": "2017(9) studies suggest that when cells encounter oxidative stress—marked by excess free radicals—this imbalance may trigger several defensive responses within the cell. One key player in this response is posited to be MST1, a protein that increases its activity in the presence of oxidative stress. MST1's activation may create a cascade within the cell, signaling through the p38 AMPK and JNK pathways. These pathways are posited to play a role in communicating stress signals and preparing the cell to counteract the incoming damage. Further into the cascade, H2O2, a common reactive oxygen species, activates the small GTPase Ral. The activation of Ral leads to the phosphorylation of FOXO4 at specific sites. This phosphorylation, which occurs via the JNK pathway, is considered to be crucial as it modifies FOXO4, preparing it for its role in the cell's nucleus."
            },
            {
                "p": "Interestingly, the same pathway may also be utilized during inflammatory responses, mediated by the tumor necrosis factor-alpha (TNF-α). This overlap suggests that FOXO4’s activation by oxidative stress and inflammation might follow similar mechanisms, pointing to a broader role of FOXO4 in stress and immune response contexts. Once phosphorylated, FOXO4 translocates to the nucleus—the command center of the cell. In the nucleus, FOXO4 activates the transcription of genes encoding antioxidant enzymes like manganese superoxide dismutase (MnSOD), catalase (CAT), and glutathione peroxidase (GPX). These enzymes may play critical roles in detoxifying reactive oxygen species, thereby protecting the cell from oxidative damage. FOXO4-DRI may inhibit the FOXO4 translocation to the nucleus, potentially reducing oxidative stress defenses but primarily in senescent cells."
            },
            {
                "h3": "FOXO4-DRI and Neurological Function"
            },
            {
                "p": "While the pathophysiology of certain neurological diseases remains unclear, it is presumed by researchers that there are changes in the proteasome enzyme activity over time, which may lead to cognitive impairment. Research(10) has suggested that proteasome activities are downregulated in neurological disorders. It is unknown whether this downregulation is the primary cause of the disorder, but it is likely to be a contributing factor. Clinical research has suggested that the levels of FOXO proteins in the central nervous system may be altered in research models of neurodegenerative disorders (NDDs).(11) This has led to the hypothesis that exogenous FOXO protein, such as FOXO4-DRI peptide, may help regulate optimal levels of FOXO proteins, thereby preventing or alleviating the progression of any NDDs associated with this mechanism."
            },
            {
                "h3": "FOXO4-DRI Peptide and Hypogonadism"
            },
            {
                "p": "A study(4) was conducted to explore the potential of FOXO4-DRI peptide in age-related male late-onset hypogonadism. An in vitro model composed of senescent Leydig cells was used. Leydig cells are considered crucial for testosterone production. These Leydig cells were previously isolated from male mice and given a hydrogen peroxide chemical to induce senescence. The researchers observed that FOXO4 transitions into the nucleus following the induction of the senescence in the cell. This nuclear presence of FOXO4 seems to be involved in maintaining the viability of senescent cells by possibly modulating downstream senescence-associated pathways, detailed by changes in p53, Ser15-phospho-p53, and p21 protein levels. When these isolated senescence cells were presented with FOXO4-DRI peptide, researchers reported that the peptide appeared to block FOXO4 proteins, allowing p53 to bind with DNA, which led to the nuclear exclusion of p53 and induction of apoptosis of the senescent Leydig cells. This suggests that FOXO4-DRI may selectively target and eliminate senescent cells, potentially alleviating some dysfunctions associated with aged Leydig cells, such as reduced testosterone synthesis."
            },
            {
                "p": "FOXO4-DRI peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Babu MM, Luscombe NM, Aravind L, Gerstein M, Teichmann SA. Structure and evolution of transcriptional regulatory networks. Curr Opin Struct Biol. 2004 Jun;14(3):283-91. https://pubmed.ncbi.nlm.nih.gov/15193307/",
                    "Sun, Yan et al. “FOXO4 Inhibits the Migration and Metastasis of Colorectal Cancer by Regulating the APC2/β-Catenin Axis.” Frontiers in cell and developmental biology vol. 9 659731. 23 Sep. 2021. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495124/",
                    "Huang, Yuzhao et al. “Senolytic Peptide FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes.” Frontiers in bioengineering and biotechnology vol. 9 677576. 29 Apr. 2021, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116695/",
                    "Zhang, C., Xie, Y., Chen, H., Lv, L., Yao, J., Zhang, M., Xia, K., Feng, X., Li, Y., Liang, X., Sun, X., Deng, C., & Liu, G. (2020). FOXO4-DRI alleviates age-related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice. Aging, 12(2), 1272–1284. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053614/",
                    "Krimpenfort P, Berns A. Rejuvenation by Therapeutic Elimination of Senescent Cells. Cell. 2017 Mar 23;169(1):3-5. https://pubmed.ncbi.nlm.nih.gov/28340347/",
                    "Marjolein P. Baar et al, Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging. Vol 169 Issue 1, https://doi.org/10.1016/j.cell.2017.02.031",
                    "Anne-Laure Bulteau, Luke I. Szweda, Bertrand Friguet, Age-Dependent Declines in Proteasome Activity in the Heart, Archives of Biochemistry and Biophysics, Volume 397, Issue 2, 2002, Pages 298-304, ISSN 0003-9861, https://doi.org/10.1006/abbi.2001.2663",
                    "Murtaza G, Khan AK, Rashid R, Muneer S, Hasan SMF, Chen J. FOXO Transcriptional Factors and Long-Term Living. Oxid Med Cell Longev. 2017;2017:3494289. doi: 10.1155/2017/3494289. Epub 2017 Aug 15. https://pubmed.ncbi.nlm.nih.gov/28894507",
                    "Lee, S., & Dong, H. H. (2017). FoxO integration of insulin signaling with glucose and lipid metabolism. The Journal of endocrinology, 233(2), R67–R79. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5480241/",
                    "Ciechanover A, Brundin P. The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. Neuron. 2003 Oct 9;40(2):427-46. https://pubmed.ncbi.nlm.nih.gov/14556719/",
                    "Wei Hu, Zhi Yang, Wenwen Yang, Mengzhen Han, Baoping Xu, Zihao Yu, Mingzhi Shen, Yang Yang, Roles of forkhead box O (FoxO) transcription factors in neurodegenerative diseases: A panoramic view, Progress in Neurobiology, Volume 181, 2019, 101645, ISSN 0301-0082, https://doi.org/10.1016/j.pneurobio.2019.101645"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/09/FOXO4-DRI-coa.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/09/FOXO4-DRI-lc.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/09/FOXO4-DRI-ms.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "FOXO4-DRI peptide for sale online (10mg). Research peptides for sale at 99+% purity with unmatched service and bulk purchase discounts from Core",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "FOXO4-DRI For Sale (10mg) - Core Peptides",
            "og:description": "FOXO4-DRI peptide for sale online (10mg). Research peptides for sale at 99+% purity with unmatched service and bulk purchase discounts from Core",
            "og:url": "https://www.corepeptides.com/peptides/foxo4-dri-10mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T16:29:33+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2022/01/FOXO4-DRI-10mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "FOXO4-DRI For Sale (10mg) - Core Peptides",
            "twitter:description": "FOXO4-DRI peptide for sale online (10mg). Research peptides for sale at 99+% purity with unmatched service and bulk purchase discounts from Core",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2022/01/FOXO4-DRI-10mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$235.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:brand": "Core Peptides",
            "product:price:amount": "235.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-FOXO4-10",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/receptor-grade-igf-1-lr3-100mcg/",
                "name": "Receptor Grade IGF-1 LR3 (100mcg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-100MCG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/hexarelin-5mg/",
                "name": "Hexarelin (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Hexarelin-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/oxytocin-10mg/",
                "name": "Oxytocin (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Oxytocin-10mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/adipotide-10mg/",
                "name": "Adipotide (FTPP) (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Adipotide-FTPP-10MG-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/follistatin-344-1mg/",
        "name": "Follistatin-344 (1mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2021/12/Follistatin-344-1MG.jpg",
        "display_price": "$138.00",
        "display_specs": [
            "Size: 1mg Contents: Follistatin-344 (1mg) Form: Lyophilized powder Purity: >99% SKU: P-FOLLISTN-1",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$131.10"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$124.20"
            }
        ],
        "description": [
            {
                "h2": "Follistatin-344 Peptide"
            },
            {
                "p": "Follistatin-344 is a naturally occurring glycoprotein that is considered to be present in almost all tissues. It is considered an autocrine chemical, meaning that the cell produces a chemical messenger through a cell signal, which binds to its autocrine receptors, resulting in cell modification.(1) Follistatin naturally occurs in two isoforms, FST 317 and FST 344, each containing 288 and 315 amino acids, respectively. These two isoforms may be produced through an alternative splicing process of the mRNA.(2) Their names are based on the parent molecules from which they are derived and contain 317 and 344 amino acids, respectively. Follistatin-344 is considered to be the predominantly expressed molecule in most tissues, while the Follistatin-317 isoform may account for less than 5% of the encoded mRNA."
            },
            {
                "p": "Follistatin-344 is a synthetic version of the endogenous Follistatin-344 protein isoform. Although the number of amino acids differs in Follistatin isoforms, at its core, the protein comprises 63 amino acid residues and three domains: FSD1, FSD2, and FSD3, with an identical structure in the synthetic peptide.(3) These domains comprise 73-77 amino acid residues and are characterized by 10 conserved cysteine residues."
            },
            {
                "h3": "Overview"
            },
            {
                "p": "Researchers posit that Follistatin's primary potential may exist in activin-binding action.(4) Follistatin has been suggested to have a collaborative role in reproductive functioning alongside other chemicals like activin and inhibins. Scientists posit that the ovarian follicle mainly releases activin to enhance the secretion of follicle-stimulating hormone. Follistatin may bind with activin and attenuate its action by inhibiting the secretion of the FSH hormone."
            },
            {
                "p": "While the origin and mechanism of the peptide hormone are not entirely understood, it has been suggested that Follistatin-344 is locally produced in the pituitary gland, gonads, testes, and ovaries. Additionally, Follistatin may be vastly distributed in various organs and potentially may be present in blood circulation due to its secretion from the blood vessels."
            },
            {
                "p": "Further, Follistatin-344 is hypothesized to interact with various proteins within the Transforming Growth Factor-beta (TGFβ) superfamily.(16) This superfamily includes several key regulatory proteins in cellular growth and differentiation. One potential interaction is with the Bone Morphogenetic Proteins (BMPs), which are believed to play roles in bone formation, embryonic development, and cellular growth. It is conjectured that Follistatin-344 might modulate the activity of certain BMPs, though the specific proteins and mechanisms remain uncertain and require further exploration. Another possible interaction involves Growth Differentiation Factor 9 (GDF9), crucial for ovarian follicle development in female organisms. The binding of Follistatin-344 to GDF9 may suggest a regulatory role in reproductive processes, but this interaction is not fully understood and is subject to ongoing research."
            },
            {
                "p": "However, the most notable of these interactions is with Growth Differentiation Factor 8 (GDF8), commonly known as myostatin. Myostatin is deemed integral to controlling muscle cell growth and differentiation, acting as a natural inhibitor to prevent excessive muscle development. It is proposed that Follistatin-344 binds to myostatin, potentially inhibiting its function. This inhibition may theoretically facilitate an increase in muscle mass by allowing muscle cells greater freedom to grow and differentiate. The potential for Follistatin-344 to enhance muscle growth through myostatin inhibition presents a significant area of interest, although the actual outcomes may vary and are highly dependent on singular biological conditions."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: N/A Molecular Weight: 3780 g/mol Other Known Titles: Activin-Binding Protein, FSH-Suppressing Protein, FST"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Follistatin-344 and Muscle Development"
            },
            {
                "p": "Myostatin is a protein considered to be synthesized by muscle cells, hindering muscle cell differentiation and growth. As mentioned, myostatin protein belongs to the transforming growth factor-beta (TGF-beta) protein, which Follistatin may inhibit. During one 1997 study,(5) it was suggested that mice given Follistatin-344 exhibited reduced levels of myostatin, which might have led to the improved skeletal muscle mass with each mouse weighing 2 to 3 times more than usual, and the increase in mass appeared to result from a combination of muscle cell hyperplasia and hypertrophy."
            },
            {
                "p": "In another study,(6) Follistatin-344 was induced in mice via a nanoparticle-mediated mode of delivery of mRNA in the liver. The researchers reported that the mRNA messenger appeared to stimulate the hepatic liver cells to naturally synthesize and secrete Follistatin. Results of this study suggested that the peptide mice, given this mRNA-containing nanoparticle, exhibited apparently increased serum levels of Follistatin within three days as compared to the levels in control mice."
            },
            {
                "p": "The research posits that Follistatin mRNA is translated in the liver, leading to increased serum levels of Follistatin. This elevation in Follistatin was suggested to persist for up to 72 hours post-presentation and was associated with decreased serum concentrations of myostatin and activin A. Activin A is a protein considered to be involved in a myriad of biological processes. It is a member of the transforming growth factor-beta (TGF-β) superfamily. It appears to play significant roles in regulating various cellular functions such as proliferation, differentiation, and apoptosis in numerous cell types. In the context of muscle physiology, activin A is particularly noteworthy for its role in muscle metabolism and remodeling. It is thought to be a critical regulator of muscle mass, as it appears to negatively influence muscle growth by promoting catabolic pathways that lead to muscle atrophy. This action is mediated primarily through its interaction with the activin type IIB receptor (ActRIIB) on muscle cells. Upon binding to this receptor, activin A activates intracellular signaling pathways that increase muscle protein breakdown and inhibit muscle protein synthesis. After 8 weeks of continuous peptide presentation, the lean muscle mass of the peptide mice was reportedly 10% more than the control mice."
            },
            {
                "p": "In contrast to experiments targeting myostatin—such as anti-myostatin antibodies—Follistatin offers a broader research approach by also antagonizing activin A. Myostatin-specific experiments primarily focus on inhibiting pathways that directly limit muscle growth, thus promoting hypertrophy. However, they might not address other pathways that contribute to muscle loss, such as fibrosis or inflammation, which are influenced by activin A. Follistatin’s dual antagonistic action might lead to more comprehensive impact in muscle dystrophy models. By inhibiting both myostatin and activin A, Follistatin may not only enhance muscle mass but also reduce muscle stiffness and weakness associated with fibrotic changes. This potential dual action is particularly advantageous because it may address both the loss of muscle mass and the quality of the remaining muscle tissue, potentially leading to improvements in muscle function and strength that surpass those achieved by solely blocking myostatin.(7)"
            },
            {
                "h3": "Follistatin-344 and Carcinogenic Cells"
            },
            {
                "p": "  Breast Cancer Cells"
            },
            {
                "p": "Through reverse transcription polymerase chain reaction study (RT-PCR), researchers suggested that Follistatin levels may fluctuate in animal models of breast cancer.(8) One study(9) examined the available gene expression data of mice with breast cancer. In most cases, Follistatin was reportedly under-expressed in carcinogenic breast cells, possibly leading to the increased spread of cancer cells caused by activin proteins. As Follistatin is suggested to bind to and inhibit activin proteins, it was further posited by the researchers that restoring Follistatin in these mice might prevent the prognosis of activin-induced metastasis and improve overall survival."
            },
            {
                "p": "  Esophageal Cancer Cells"
            },
            {
                "p": "Research suggests that bone morphogenic protein (BMP) is one of the causative factors in the transition of normal esophageal tissue to cancerous tissues. Follistatin, speculated to host the capacity to bind and neutralize activin and myostatin, may also interact with BMPs. By modulating the activity of BMP, Follistatin may serve a protective role against the over-proliferation of cellular pathways often seen in cancerous tissues. Experimental studies in Follistatin-344 suggest that the peptide may counteract acid reflux actions, thereby possibly preventing an over-activation of BMP and the development of esophageal cancer cells. More specifically, Follistatin's potential to inhibit BMP might theoretically prevent the initial steps required for the transformation of normal tissue into cancerous tissue, particularly in environments exacerbated by chronic inflammation or external insults like acid reflux.(10)"
            },
            {
                "h3": "Follistatin-344 and Cell Proliferation"
            },
            {
                "p": "There is an odd contrast in the working of Follistatin: it may potentially inhibit metastasis, as well as possibly promote cell proliferation. This is why the peptide is researched in studies scrutinizing increased tumor growth (tumorigenesis) and metastasis.(12) Research has suggested that hepatocytes (i.e., liver cells) may require Follistatin to proliferate. When studied in experimental rats, it was reported by the researchers that the inactivation of activin by Follistatin-344 may be a precondition for cell proliferation to occur. They believed there might be some energy exchange amongst the cells where the energy used for cell migration is shut off to switch with cellular growth and proliferation."
            },
            {
                "h3": "Follistatin-344 and Liver Protection"
            },
            {
                "p": "One study(13) was conducted to determine the potential of Follistatin on early liver fibrosis. In this study, rats were divided into one control group and one Follistatin-exposed group for a period of four weeks. Researchers reported that the peptide group showed a 32% decrease in liver fibrosis compared to the control group. They further reported that hepatocytic apoptosis was decreased by almost 90% in the Follistatin mice."
            },
            {
                "h3": "Follistatin-344 and Follicle Growth"
            },
            {
                "p": "Follistatin may exhibit wound healing potential via possible stimulation of interfollicular stem cells, which may lead to increased hair growth. A clinical study was conducted where the potential of this synthetic protein formulation, Hair Stimulating Complex (HSC), was studied in subjects with hair loss.(14) A cohort of 26 subjects were presented with the peptide for a period of 52 weeks. Histopathological evaluation of the tissues reportedly showed improved hair growth after 52 weeks compared to the control group. Besides hair growth, researchers reported an apparent improvement in hair thickness and density by almost 13%."
            },
            {
                "h3": "Follistatin-344 and Diabetic Mice Models"
            },
            {
                "p": "Researchers suggested that when Follistatin-344 was presented to diabetic murine models, it appeared to lead to overexpression of the protein in the pancreatic cells, resulting in increased pancreatic beta cell (β-cell) mass, reduced glucose level, and overall reduction in diabetic symptoms.(15) β-cells are a population of cells in the pancreas primarily tasked with producing insulin to lower glucose levels. The data suggest that this β-cell proliferation is possibly due to the inhibition of SMAD2/3 signaling, a pathway typically activated by transforming growth factor-beta (TGF-β) superfamily members such as activin and myostatin, which are believed to be antagonized by Follistatin. This inhibition might indirectly activate the insulin-phosphoinositide 3-kinase (PI3K)-Akt pathway, posited as crucial for cell growth and survival, potentially contributing to increased β-cell mass and improved glucose homeostasis. The researcher’s comments suggest that β-cell specific overexpression of Follistatin may lead to several notable outcomes in the tested db/db mice: a substantial increase in pancreatic islet mass, enhanced β-cell proliferation indicated by co-immunofluorescent staining for Ki67 and insulin, and improved overall metabolic profiles including reduced hyperglycemia."
            },
            {
                "p": "It is also noted that these actions were accompanied by changes in insulin signaling within the pancreas, as detailed by elevated insulin levels and enhanced activation of the insulin-PI3K-Akt signaling pathway. Moreover, the study posits that Follistatin may influence the expression of other regulatory proteins and genes within the pancreas. For instance, the increased mRNA levels of myostatin and activin, along with their inhibitors BAMBI and inhibin-α, suggest a complex interplay where Follistatin may act to modulate these signaling molecules, possibly leading to an enhanced β-cell proliferative environment."
            },
            {
                "p": "Additionally, the study explores the potential modulation of betatrophin, a hormone implicated in β-cell proliferation. The researchers observed a significant increase in betatrophin expression in the Follistatin groups, which might be facilitated by the suppressed activity of activin and myostatin due to Follistatin action. This suggests that Follistatin may be enhancing β-cell proliferation not only through direct inhibition of negative growth regulators but also by promoting positive growth signals such as betatrophin."
            },
            {
                "p": "Follistatin-344 peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Hiroyuki Kaneko, Handbook of Hormones, 2016.",
                    "FST follistatin [Homo sapiens (human)]. https://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=DetailsSearch&Term=10468",
                    "Shi, L., Resaul, J., Owen, S., Ye, L., & Jiang, W. G. (2016). Clinical and Therapeutic Implications of Follistatin in Solid Tumours. Cancer genomics & proteomics, 13(6), 425–435. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5219916/",
                    "Rodino-Klapac, L. R., Haidet, A. M., Kota, J., Handy, C., Kaspar, B. K., & Mendell, J. R. (2009). Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease. Muscle & nerve, 39(3), 283–296. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2717722/",
                    "McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature. 1997 May 1;387(6628):83-90. https://pubmed.ncbi.nlm.nih.gov/9139826/",
                    "Schumann C, Nguyen DX, Norgard M, Bortnyak Y, Korzun T, Chan S, Lorenz AS, Moses AS, Albarqi HA, Wong L, Michaelis K, Zhu X, Alani AWG, Taratula OR, Krasnow S, Marks DL, Taratula O. Increasing lean muscle mass in mice via nanoparticle-mediated hepatic delivery of follistatin mRNA. Theranostics 2018; 8(19):5276-5288. doi:10.7150/thno.27847. https://www.thno.org/v08p5276.htm",
                    "Iskenderian A, Liu N, Deng Q, Huang Y, Shen C, Palmieri K, Crooker R, Lundberg D, Kastrapeli N, Pescatore B, Romashko A, Dumas J, Comeau R, Norton A, Pan J, Rong H, Derakhchan K, Ehmann DE. Myostatin and activin blockade by engineered follistatin results in hypertrophy and improves dystrophic pathology in mdx mouse more than myostatin blockade alone. Skelet Muscle. 2018 Oct 27;8(1):34. https://pubmed.ncbi.nlm.nih.gov/30368252/",
                    "Zabkiewicz C, Resaul J, Hargest R, Jiang WG, Ye L. Increased Expression of Follistatin in Breast Cancer Reduces Invasiveness and Clinically Correlates with Better Survival. Cancer Genomics Proteomics. 2017 Jul-Aug;14(4):241-251. https://pubmed.ncbi.nlm.nih.gov/28647698/",
                    "Seachrist DD, Sizemore ST, Johnson E, Abdul-Karim FW, Weber Bonk KL, Keri RA. Follistatin is a metastasis suppressor in a mouse model of HER2-positive breast cancer. Breast Cancer Res. 2017 Jun 5;19(1):66. target=\"_blank\" rel=\"noopener\"https://pubmed.ncbi.nlm.nih.gov/28583174/",
                    "Lau MC, Ng KY, Wong TL, Tong M, Lee TK, Ming XY, Law S, Lee NP, Cheung AL, Qin YR, Chan KW, Ning W, Guan XY, Ma S. FSTL1 Promotes Metastasis and Chemoresistance in Esophageal Squamous Cell Carcinoma through NFκB-BMP Signaling Cross-talk. Cancer Res. 2017 Nov 1. https://pubmed.ncbi.nlm.nih.gov/28883005/",
                    "Shi L, Resaul J, Owen S, Ye L, Jiang WG. Clinical and Therapeutic Implications of Follistatin in Solid Tumours. Cancer Genomics Proteomics. 2016 11-12;13(6):425-435. https://pubmed.ncbi.nlm.nih.gov/27807065/",
                    "Ooe H, Chen Q, Kon J, Sasaki K, Miyoshi H, Ichinohe N, Tanimizu N, Mitaka T. Proliferation of rat small hepatocytes requires follistatin expression. J Cell Physiol. 2012 Jun;227(6):2363-70. https://pubmed.ncbi.nlm.nih.gov/21826650/",
                    "Patella S, Phillips DJ, Tchongue J, de Kretser DM, Sievert W. Follistatin attenuates early liver fibrosis: effects on hepatic stellate cell activation and hepatocyte apoptosis. Am J Physiol Gastrointest Liver Physiol. 2006 Jan;290(1):G137-44. https://pubmed.ncbi.nlm.nih.gov/16123203/",
                    "Zimber MP, Ziering C, Zeigler F, Hubka M, Mansbridge JN, Baumgartner M, Hubka K, Kellar R, Perez-Meza D, Sadick N, Naughton GK. Hair regrowth following a Wnt- and follistatin containing treatment: safety and efficacy in a first-in-man phase 1 clinical trial. J Drugs Dermatol. 2011 Nov;10(11):1308-12. https://pubmed.ncbi.nlm.nih.gov/22052313/",
                    "Zhao C, Qiao C, Tang RH, Jiang J, Li J, Martin CB, Bulaklak K, Li J, Wang DW, Xiao X. Overcoming Insulin Insufficiency by Forced Follistatin Expression in β-cells of db/db Mice. Mol Ther. 2015 May;23(5):866-874. doi: 10.1038/mt.2015.29. Epub 2015 Feb 13. PMID: 25676679; PMCID: PMC4427879. https://pubmed.ncbi.nlm.nih.gov/25676679/",
                    "Reichel C, Gmeiner G, Thevis M. Detection of black market follistatin 344. Drug Test Anal. 2019 Nov;11(11-12):1675-1697. doi: 10.1002/dta.2741. Erratum in: Drug Test Anal. 2020 Oct;12(10):1522-1533. PMID: 31758732."
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "",
        "high_performance_liquid_chromatography": "",
        "mass_spectrometry": "",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Follistatin-344 for sale online (1mg). Peptides for sale at 99+% purity with unmatched service, bulk purchase discounts & free shipping",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Follistatin-344 For Sale (1mg) - Core Peptides",
            "og:description": "Follistatin-344 for sale online (1mg). Peptides for sale at 99+% purity with unmatched service, bulk purchase discounts & free shipping",
            "og:url": "https://www.corepeptides.com/peptides/follistatin-344-1mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T16:25:26+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2021/12/Follistatin-344-1MG.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Follistatin-344 For Sale (1mg) - Core Peptides",
            "twitter:description": "Follistatin-344 for sale online (1mg). Peptides for sale at 99+% purity with unmatched service, bulk purchase discounts & free shipping",
            "twitter:label1": "Price",
            "twitter:data1": "$138.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:brand": "Core Peptides",
            "product:price:amount": "138.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-FOLLISTN-1",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/melanotan-2-10mg/",
                "name": "Melanotan 2 (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2023/03/Melanotan-2-10MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ghrp-2/",
                "name": "GHRP-2 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHRP-2-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ll-37-5mg/",
                "name": "LL-37 (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/LL-37-5mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/cjc-1295-no-dac-mod-grf-1-29/",
                "name": "CJC-1295 NO DAC (Mod GRF 1-29) (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Mod-GRF-1-29-5mg-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/epitalon-25mg/",
        "name": "Epithalon (25mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Epithalon-5MG.jpg",
        "display_price": "$90.00",
        "display_specs": [
            "Size: 25mg Contents: Epitalon (25mg) Form: Lyophilized powder Purity: >99% SKU: P-EPITALON-25",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$85.50"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$81.00"
            }
        ],
        "description": [
            {
                "h2": "Epithalon Peptide"
            },
            {
                "p": "Research has suggested that Epithalon, (also known as AEDG peptide, tetrapeptide Epitalon, Epithalon, or Epithalone) may regulate the function of the brain, the pineal gland, and the eye retina. Studies in the peptide have spurred numerous research hypotheses, which include possible sleep regulation via pineal gland stimulation, releasing more melatonin. Studies also speculate that the peptide may stimulate the generation of telomerase, may exhibit strong antioxidant characteristics, and extend the retina's workable integrity."
            },
            {
                "p": "With recent technology and ongoing advances in the scientific field, methods have been developed to synthesize complex peptide preparations from the extracts of several different tissues. One such peptide in the tissues is ‘Epithalamin,’ naturally produced in the pineal gland. Epithalamin has been suggested to be functional in increasing melatonin production, improving the immunological and anti-carcinogenic functions in rats and mice, and restoring reproductive function in aged rodents. Utilizing the recent advancements in science, a peptide similar to Epithalamin was synthesized and titled ‘Epithalon.’ Epithalon is derived from a naturally occurring peptide belonging to both the pineal gland and eye retina.(1)"
            },
            {
                "h3": "Overview"
            },
            {
                "p": "Epithalon is a synthetic tetrapeptide, also known as AEDG peptide, composed of amino acids Ala-Glu-Asp-Gly.(2) The peptide has been suggested to exhibit action similar to Epithalamin via various modes. Epithalamin is a related pineal peptide preparation containing Epithalon, that has been purported to potentially increase the average lifespan of various experimental models by 11–31% and may reduce mortality in murine models by a suggested 52%.(3) This potential mechanism and further studies are described below."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C14H22N4O9 Molecular Weight: 390.34 g/mol Other Known Titles: Epitalon, Epithalone"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Epithalon Peptide and Longevity"
            },
            {
                "p": "A study investigated the potential mechanisms of Epithalon in influencing gene expression and protein synthesis in stem cells such as gingival mesenchymal stem cells (hGMSCs). The study(2) has suggested that the peptide binds with the histones - HI/6 and HI/3 – located at different sites in tissue, which then interact with the DNA. More specifically, the study posits that Epithalon may alter chromatin structure by specifically interacting with histones, thereby modulating gene expression. This interaction might involve the peptide acting as a histone mimic, facilitating changes in chromatin dynamics. Epithalon's epigenetic regulation might involve competitive binding with histones at DNA interaction sites, increasing transcription of genes involved in neuronal differentiation. Such binding may displace other regulatory proteins, making DNA more accessible for transcriptional machinery, potentially inducing neuronal cell differentiation in retinal and periodontal ligament stem cells (hPDLSCs). This experimentation led to an upregulation of neurogenic differentiation markers, including Nestin, GAP43, β Tubulin III, and Doublecortin, in hGMSCs. Specifically, mRNA expression of these markers increased by 1.6 to 1.8 times. Considering the changes in these markers, the potential upregulation of neuronal differentiation and protein synthesis in retinal and ligament stem cells may lead to enhanced functionality."
            },
            {
                "h3": "Epithalon Peptide and Oxidative Stress"
            },
            {
                "p": "A recent study suggested that Epithalon might reduce intracellular reactive oxygen species (ROS) levels in aged oocyte cells, potentially exhibiting antioxidative actions.(4) The peptide was suggested to significantly lower ROS levels, unlike higher concentrations that did not demonstrate similar protective actions. Such a reduction might be critical, as oxidative stress is considered a significant factor in cellular aging. Additionally, Epithalon may help preserve the structural integrity of oocytes. It was observed to possibly decrease fragmentation in post-ovulatory aged oocytes and during parthenogenetic activation—a process where an egg develops into an embryo without fertilization. The peptide also potentially maintains spindle integrity and correct distribution of cortical granules (CG). Spindles, which are crucial structures in cell division that distribute chromosomes to daughter cells, and cortical granules, secretory vesicles important for preventing polyspermy (the fertilization of an egg by multiple sperm), are essential for normal cell division and fertilization. Epithalon might correct spindle abnormalities and prevent the misplacement of CGs, which are common issues in aged oocytes. Moreover, Epithalon exposure was associated with potential improvements in mitochondrial function, which is vital for oocyte viability. Mitochondria, known as the cell's powerhouses, are deemed crucial for ATP production and maintaining cellular metabolism. There were indications of enhanced mitochondrial membrane potential and increased mtDNA copy numbers, suggesting that Epithalon might support mitochondrial integrity and functionality as oocytes age. Finally, the peptide was suggested to reduce DNA damage and apoptosis (cell death) in aged oocytes. It appeared to lower the intensity of γH2AX signals—a marker of DNA damage—and seemed to decrease apoptosis rates, as indicated by reduced Annexin-V staining. These observations imply that Epithalon might enhance oocyte survival by potentially mitigating oxidative damage and preserving genomic stability, which are considered crucial for maintaining the overall functionality of the cells."
            },
            {
                "h3": "Epithalon Peptide and Anti-Aging"
            },
            {
                "p": "In order to understand the anti-aging action of various synthetic peptides, studies have been widely conducted to study their potential in cell proliferation, cell regeneration and aging, cellular apoptosis, and matrix modeling.(5) It was suggested that Epithalon may inhibit the synthesis of MM-9, which usually increases with time, and increase the proliferation and cellular regeneration process, which usually decreases with time. More specifically, the researchers posited that the peptide may have “enhanced the expression of Ki-67 and CD98hc that are less intensively synthesized during cell aging.” Epithalon also seemed to inhibit the activity of Caspase-3, a crucial enzyme believed to facilitate apoptosis (programmed cell death). The researchers commented that the peptide “suppressed caspase-dependent apoptosis that increases during aging of cell cultures.” By potentially restraining Caspase-3 activity, Epithalon might support cellular longevity and decrease apoptosis, enhancing its regenerative capabilities."
            },
            {
                "h3": "Epithalon Peptide and Fetal Studies"
            },
            {
                "p": "This study(6) was conducted to understand the proliferative potential of the peptide on fetal fibroblastic cells. Pulmonary fibroblasts were isolated from the 24-week-old fetus, and it was observed that these fibroblasts appeared to lose their proliferative function at the 34th passage. These cells possessed extremely small telomeres sizes – smaller than what they originally were during the 10th passage. When Epithalon was presented in these otherwise aging cells, it appeared to stimulate the development of telomeres, causing them to increase and restore their normal size. As a result of this size elongation, the telomeres appeared to cause 10 extra cell divisions than usual seen in the control cells. Thus, this study suggested that Epithalon overcame the Hayflick limit and extended the normal cell cycle in the cells.(6)"
            },
            {
                "h3": "Epithalon Peptide and Lymphocytic Cells"
            },
            {
                "p": "In this clinical study,(7) lymphocytic cells were isolated and cultured from subjects aged between 76 and 80 years. The purpose of this study was to determine the action of Epithalon on ribosomal cell activity and its impact on denaturation and polymorphism of heterochromatin. The outcome of this study, following the delivery of the cell culture with Epithalon, was that the peptide appeared to induce activation of the ribosomal genes and decondensation of the heterochromatin. Consequently, it appeared to induce the release of genes that were otherwise suppressed due to the aging of the chromosomal regions. This study suggested that Epithalon might have the potential to modify the chromosome regions in the aging cells, activate chromatin, and restore cellular activities that were otherwise suppressed or delayed in geriatric subjects."
            },
            {
                "h3": "Epithalon Peptide and Anti-Mutagenic Action"
            },
            {
                "p": "In this 2011 study,(8) three different mice models were used to determine the action of the peptide on chromosomal aberrations. The three mice models were – SAMP-1 female mice with accelerated aging and wild rats SAMR-1 and SHR (both female mice). Upon delivery of Epithalon, it was observed that the incidence of the chromosomal aberrations in the bone marrow of SAMP-1 mice with accelerated aging appeared to be almost 2 times higher than the other two models. When the peptide was presented at 2 months in the mice, it appeared to decrease the chromosomal aberrations in all three models, the highest being in the SAMP-1 mice with accelerated cell aging. In combination with melatonin at night, given with water, there was no reported impact on the action of the peptide. This study suggested that Epithalon may possess anti-mutagenic potential."
            },
            {
                "h3": "Epithalon Peptide and Cancer Cells"
            },
            {
                "p": "In this study,(9) one-year-old female (C3H/He) mice with tumors on the reproductive organs (mammary glands and ovaries) were observed. The tumors on the mammary glands included several variants of the invasive ductal carcinogenic cells, whereas, in the ovaries, the tumors found were granulosa cell tumors. These mice, kept in standard conditions for six months, were divided into control and experimental groups. Epithalon was presented five times a week. Once the study was completed, it was reported that three out of the nine mice in the control group appeared to exhibit metastasis and increased tumor cells. Meanwhile, the peptide mice exhibited a decrease in the number of tumor cells. Epithalon, upon delivery, appeared to inhibit the process of metastasis in the mice, preventing tumor cell cycle and growth. Researchers of this study posited the anti-metastatic potential of the peptide."
            },
            {
                "h3": "Epithalon Peptide and Research in Hypophysectomized Birds"
            },
            {
                "p": "In this study,(10) hypophysectomized birds, both young and old, were used to study the action of Epithalon peptide on the morphology of the thymus gland. Hypophysectomized birds are birds in which the pituitary gland has been surgically removed. Upon delivery of the peptide, it was discovered that the morphology of the thymus gland appeared to be restored in all birds, regardless of their age. The most improved results were observed on birds (mainly chickens) that underwent neonatal hypophysectomy before the peptide was presented."
            },
            {
                "h3": "Epithalon Peptide and Melatonin Levels"
            },
            {
                "p": "This study(11) was carried out on aging monkeys to determine the actions of Epithalon on melatonin levels. With increasing age, the melatonin levels tend to decrease due to reduced secretion, which may cause difficulty in sleep regulation. This is mainly due to the functioning of the pineal gland deteriorating with increased age and a reduction of hormone circadian rhythm amplitude. Upon delivery of Epithalon, it appeared to stimulate actions similar to those caused by the natural secretion of the pineal gland. The melatonin levels appeared to increase to \"normal\" levels."
            },
            {
                "h3": "Epithalon Peptide and Retinal Cells"
            },
            {
                "p": "In this clinical study,(12) it was suggested that when Epithalon was presented in geriatric subjects, it appeared to elevate the bioelectric and functional activities in the retina, thereby preserving the morphological structure of the retina. More specifically, the researchers posited that the peptide “participates in the mechanisms of transcription common for the epiphysis and retina.”As a result, age-related retinal degeneration may be reversed in the older subjects, which is supported by the positive clinical outcome in 90% of the subjects presented with the peptide."
            },
            {
                "h3": "Epithalon and Geroprotective Properties"
            },
            {
                "p": "This study(13) was conducted on 266 elderly subjects (over the age of 60 years) throughout 6 to 8 years, where some subjects were presented with peptide-bioregulator Thymalin, others with Epithalon, and the rest with the combination of the two. After the study, it was observed that both the peptides appeared to have the potential to restore basic bodily functions in geriatric subjects – including improved functions in the cardiovascular, endocrinal, immune, and nervous systems, along with normalized metabolic and hemostatic activities. The peptide groups appeared to exhibit a 2-fold decrease in the common geriatric disorders such as acute respiratory disorder, heart diseases, and bone disorders. Additionally, the mortality rate in the peptide subjects appeared to significantly decrease, with a 2-fold decrease in the Thymalin subjects, a 1.8-fold decrease in the Epithalon subjects, and 2.5-fold decrease in the subjects presented with both peptides."
            },
            {
                "p": "Epithalon peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Khavinson VKh. Peptides and Ageing. Neuro Endocrinol Lett. 2002;23 Suppl 3:11-144. PMID: 12374906. https://pubmed.ncbi.nlm.nih.gov/12374906/",
                    "Khavinson, Vladimir et al. “AEDG Peptide (Epithalon) Stimulates Gene Expression and Protein Synthesis during Neurogenesis: Possible Epigenetic Mechanism.” Molecules (Basel, Switzerland) vol. 25,3 609. 30 Jan. 2020, doi:10.3390/molecules25030609. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037223/",
                    "Anisimov VN, Mylnikov SV, Khavinson VK. Pineal peptide preparation epithalamin increases the lifespan of fruit flies, mice and rats. Mech Ageing Dev. 1998 Jun 15;103(2):123-32. doi: 10.1016/s0047-6374(98)00034-7. PMID: 9701766.",
                    "Yue X, Liu SL, Guo JN, Meng TG, Zhang XR, Li HX, Song CY, Wang ZB, Schatten H, Sun QY, Guo XP. Epithalon protects against post-ovulatory aging-related damage of mouse oocytes in vitro. Aging (Albany NY). 2022 Apr 12;14(7):3191-3202. doi: 10.18632/aging.204007. Epub 2022 Apr 12. PMID: 35413689; PMCID: PMC9037278.",
                    "Lin’kova, N.S., Drobintseva, A.O., Orlova, O.A. et al. Peptide Regulation of Skin Fibroblast Functions during Their Aging In Vitro . Bull Exp Biol Med 161, 175–178 (2016).",
                    "Khavinson VKh, Bondarev IE, Butyugov AA, Smirnova TD. Peptide promotes overcoming of the division limit in human somatic cell. Bull Exp Biol Med. 2004 May;137(5):503-6. doi: 10.1023/b:bebm.0000038164.49947.8c. PMID: 15455129. https://pubmed.ncbi.nlm.nih.gov/15455129/",
                    "Khavinson VKh, Lezhava TA, Monaselidze JR, Jokhadze TA, Dvalishvili NA, Bablishvili NK, Trofimova SV. Peptide Epithalon activates chromatin at the old age. Neuro Endocrinol Lett. 2003 Oct;24(5):329-33. PMID: 14647006. https://pubmed.ncbi.nlm.nih.gov/14647006/",
                    "Rosenfeld SV, Togo EF, Mikheev VS, Popovich IG, Khavinson VKh, Anisimov VN. Effect of Epithalon on the incidence of chromosome aberrations in senescence-accelerated mice. Bull Exp Biol Med. 2002 Mar;133(3):274-6. doi: 10.1023/a:1015899003974. PMID: 12360351. https://pubmed.ncbi.nlm.nih.gov/12360351/",
                    "Kossoy G, Anisimov VN, Ben-Hur H, Kossoy N, Zusman I. Effect of the synthetic pineal peptide Epithalon on spontaneous carcinogenesis in female C3H/He mice. In Vivo. 2006 Mar-Apr;20(2):253-7. PMID: 16634527. https://pubmed.ncbi.nlm.nih.gov/16634527/",
                    "Pateyk AV, Baranchugova LM, Rusaeva NS, Obydenko VI, Kuznik BI. Effect of peptides Lys-Glu-Asp-Gly and Ala-Glu-Asp-Gly on the morphology of the thymus in hypophysectomized young and old birds. Bull Exp Biol Med. 2013 Mar;154(5):681-5. doi: 10.1007/s10517-013-2029-0. PMID: 23658898. https://pubmed.ncbi.nlm.nih.gov/23658898/",
                    "Korkushko OV, Lapin BA, Goncharova ND, Khavinson VKh, Shatilo VB, Vengerin AA, Antoniuk-Shcheglova IA, Magdich LV. [Normalizing effect of the pineal gland peptides on the daily melatonin rhythm in old monkeys and elderly people]. Adv Gerontol. 2007;20(1):74-85. Russian",
                    "Khavinson V, Razumovsky M, Trofimova S, Grigorian R, Razumovskaya A. Pineal-regulating tetrapeptide Epithalon improves eye retina condition in retinitis pigmentosa. Neuro Endocrinol Lett. 2002 Aug;23(4):365-8. PMID: 12195242. https://pubmed.ncbi.nlm.nih.gov/12195242/",
                    "Khavinson VKh, Morozov VG. Geroprotektornaia éffektivnost' timalina i épitalamina [Geroprotective effect of thymalin and Epithalamin]. Adv Gerontol. 2002;10:74-84. Russian. PMID: 12577695. https://pubmed.ncbi.nlm.nih.gov/12577695/",
                    "Korkushko OV, Khavinson VKh, Shatilo VB, Antonyuk-Shcheglova IA. Geroprotective effect of Epithalamine (pineal gland peptide preparation) in elderly subjects with accelerated aging. Bull Exp Biol Med. 2006 Sep;142(3):356-9. English, Russian. doi: 10.1007/s10517-006-0365-z. PMID: 17426848. https://pubmed.ncbi.nlm.nih.gov/17426848/"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/09/Epithalon-coa.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/09/Epithalon-lc-1.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/09/Epithalon-ms.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Epithalon (Epitalon) for sale online (25mg). Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Epitalon For Sale (25mg) | Core Peptides",
            "og:description": "Epitalon (Epithalon) for sale online (25mg). Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/epitalon-25mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-05-28T11:02:32+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Epithalon-5MG.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Epitalon For Sale (25mg) | Core Peptides",
            "twitter:description": "Epitalon (Epithalon) for sale online (25mg). Peptides for sale at 99% purity with top customer service. Get research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Epithalon-5MG.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$90.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "90.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-EPITALON-25",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/melanotan-2-10mg/",
                "name": "Melanotan 2 (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2023/03/Melanotan-2-10MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/fragment-176-191/",
                "name": "Fragment 176-191 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Fragment-176-191-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/bpc-157/",
                "name": "BPC-157 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/BPC-157-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/pt-141-10mg-bremelanotide/",
                "name": "PT-141 (Bremelanotide) (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/PT-141-10mg-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/dsip-5mg/",
        "name": "DSIP (5mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2020/04/DSIP-5MG.jpg",
        "display_price": "$41.00",
        "display_specs": [
            "Size: 5mg Contents: DSIP (5mg) Form: Lyophilized powder Purity: >99% SKU: P-DSIP-5",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$38.95"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$36.90"
            }
        ],
        "description": [
            {
                "h2": "DSIP (Delta Sleep-Inducing Peptide)"
            },
            {
                "p": "Delta Sleep-Inducing Peptide, or DSIP, is a naturally-occurring peptide made of nine amino acids, isolated from the central nervous system of experimental models of electrically induced sleep. DSIP is posited to regulate the sleep cycle, as suggested by its name, but may also play a role in regulating various physiological processes. Suggested to induce delta sleep in test models, this neuropeptide also appears to impact electrophysiological activity and possibly regulate the neurotransmitter levels in the brain.(1)"
            },
            {
                "p": "DSIP peptide was first characterized and examined from 1963 to 1977 and has since been widely studied by scientists.(2) Initially regarded only for its potential as a sleep-including factor, DSIP was soon suggested to induce other potential actions, such as mitigating pain, sleep cycle regulation, and mitigating withdrawal.(3)"
            },
            {
                "p": " "
            },
            {
                "h2": "Mechanisms of Action"
            },
            {
                "p": "DSIP is believed to have the potential to modify the structure and quality of sleep by engaging with the central nervous system. It is thought that DSIP may potentially reduce the time it takes to fall asleep and enhance the overall quality of sleep by influencing the activity of various neurotransmitters within the brain. Despite these possibilities, scientific research has yet to definitively identify the primary mechanisms and pathways through which DSIP exerts its actions. However, it is hypothesized that DSIP may target several specific receptors, which are considered crucial in its function. These include:"
            },
            {
                "p": "These findings underline the complex and multifaceted ways in which DSIP might influence sleep and stress management, although more research is needed to understand its mechanisms of action."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C35H48N10O15 Molecular Weight: 848.82 g/mol Other Known Titles: DSIP nonapeptide; emideltide"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "DSIP and Sleep Cycles"
            },
            {
                "p": "A study(9) was conducted on feline models to examine the potential action of DSIP on sleep patterns. The models were divided into two groups; one was a control, and the other was labeled as the DSIP group. The peptide was presented to the cats and was monitored for 8 hours. Results indicated that there appeared to be a significant increase in total sleep and slow wave sleep (SWS) in the DSIP group. The action of DSIP appeared to be immediate as the amount of SWS sleep elevated within the first hour following study initiation. This increase appeared to be maintained for 7 hours and then decreased in the eighth hour. SWS, often called deep sleep, is suggested as one of the core stages within sleep architecture, broadly categorized into non-rapid eye movement (NREM) sleep and rapid eye movement (REM) sleep. The overall structure of sleep is typically cyclic, alternating between NREM and REM stages multiple times. Apparently, SWS falls under the NREM category and scientists detect it by its low-frequency, high-amplitude delta waves evident in electroencephalogram (EEG) recordings. Sleep begins with NREM sleep, subdivided into three stages: N1, N2, and N3. N1 and N2 are lighter stages of sleep, while N3, synonymous with SWS, is the deepest stage of sleep. Following the deep sleep stage, the cycle progresses into REM sleep, where brain activity increases and dreams occur."
            },
            {
                "p": "A clinical study(10) has suggested that the peptide may lead to an immediate increase in sleep pressure and resulted in a 59% increase in sleep within two hours of initiating DSIP experimentation. The scientists also posited that the peptide may have enhanced sleep efficiency, potentially by shortening sleep onset.(10)"
            },
            {
                "h3": "DSIP and Endocrine Regulation"
            },
            {
                "p": "DSIP has been posited to interact with certain hormonal messengers typically released during sleep. Examples may include the luteinizing hormone (LH), which is considered a crucial hormone in the regulation of reproductive hormones such as testosterone. In a study with murine models,(11) DSIP was examined for its potential actions on the endocrine system. Within 30 minutes, it was noted that the levels of LH appeared to be significantly elevated, whereas there was no perceived impact on another regulatory messenger called follicle-stimulating hormone (FSH)."
            },
            {
                "p": "Further studies have suggested that DSIP may lead to increased secretion of growth hormone, positing that the peptide may potentially act on the hypothalamus to regulate hormonal secretion. Utilizing ovariectomized murine models to exclude the actions of gonadal steroids, the research observed an apparent elevation in GH levels caused by DSIP. The potential involvement of a dopaminergic mechanism in this process was inferred from the blocking action of pimozide, a dopamine antagonist, on the DSIP-induced GH increase. Additionally, in vitro studies with pituitary cells suggest a similar increase in GH release upon exposure to DSIP, albeit with a notable decline at higher concentrations. This pattern hints at the complex nature of DSIP's role in GH regulation, potentially linking it to sleep-induced GH release, given the peptide's association with slow-wave sleep patterns and the apparent correlation of such sleep phases with GH secretion.(12)"
            },
            {
                "h3": "DSIP and Stress Response"
            },
            {
                "p": "Researchers have investigated the potential action of DSIP on murine models subjected to experimentally induced stress.(13) The murine models were divided into six groups, where the control group was presented with a placebo and the rest with DSIP. The six groups included (i) control group, (ii) stress group, (iii) group with DSIP one hour before stress experiments, (iv) DSIP 24 hours before stress experiments, (v) DSIP one hour before the last stress experiment and (vi) DSIP 24 hours before the last stress experiment. This research primarily focused on assessing changes in substance P, beta-endorphin, and corticosterone levels, which are critical in understanding the stress response and potential modulatory impacts of DSIP. Initial findings highlighted that DSIP exposure might induce noticeable fluctuations in the levels of these markers, suggesting a possible stress-modulatory role. For instance, there was an initial decrease followed by a dramatic increase in beta-endorphin. This pattern suggests DSIP's potential influence on the opioidergic system, possibly contributing to mechanisms of stress mitigation or adaptation. Regarding corticosterone levels, which directly indicate stress in murine models, a decrease was noted shortly after DSIP exposure. The study posits that DSIP's actions on substance P, beta-endorphin, and corticosterone levels are part of a broader spectrum of biochemical changes, hinting that DSIP might initiate a series of molecular reactions contributing to its stress-modulatory actions.(13)"
            },
            {
                "h3": "DSIP and Longevity"
            },
            {
                "p": "A study(14) was conducted on murine models, equally divided into DSIP and control groups. The researchers suggested that DSIP did not appear to influence food intake, however, it did apparently decrease the weight of the murine models. It appeared to decrease the chromosomal aberrations in the bone marrow by 23% and improve the life span by 24% compared to the control group. Moreover, DSIP also appeared to lead to a 2.5-fold decrease in the occurrence of malignancies."
            },
            {
                "p": "Another study suggests that the apparent protective actions of DSIP may be due to the potential antioxidative properties of the peptide. The study(15) was conducted on murine models, and the researchers posited that DSIP may inhibit the levels of malonic dialdehyde in the models. Malonic dialdehyde is a byproduct of lipid peroxidation, and increased levels of malonic dialdehyde typically induce increased oxidative stress. This suggested that DSIP may prevent lipid peroxidation in the murine models, which may execute antioxidant properties. DSIP may also stimulate the endogenous antioxidant system, influencing various enzymatic levels. The researchers commented that “DSIP exerts stimulating influence upon the superoxid-dismutese, catalase, ceruloplasmin activities as well as the level of nonenzymatic antioxidants--urea and uric acids, because during organism aging the antioxidant defense systems are being suppressed. DSIP increases the volume of tissues and blood endogenous antioxidant defense system mainly by means of enzymatic antioxidant system, especially during later ontogenesis.”(15)"
            },
            {
                "p": "DSIP is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "National Center for Biotechnology Information. \"PubChem Compound Summary for CID 3623358, Emideltide;delta Sleep Inducing Peptide\" PubChem, https://pubchem.ncbi.nlm.nih.gov/compound/3623358",
                    "Graf MV, Kastin AJ. Delta-sleep-inducing peptide (DSIP): an update. Peptides. 1986 Nov-Dec;7(6):1165-87. https://pubmed.ncbi.nlm.nih.gov/3550726/",
                    "Kovalzon VM, Strekalova TV. Delta sleep-inducing peptide (DSIP): a still unresolved riddle. J Neurochem. 2006 Apr;97(2):303-9. https://pubmed.ncbi.nlm.nih.gov/16539679/",
                    "Grigor'ev VV, Ivanova TA, Kustova EA, Petrova LN, Serkova TP, Bachurin SO. Effects of delta sleep-inducing peptide on pre- and postsynaptic glutamate and postsynaptic GABA receptors in neurons of the cortex, hippocampus, and cerebellum in rats. Bull Exp Biol Med. 2006 Aug;142(2):186-8. English, Russian. doi: 10.1007/s10517-006-0323-9. PMID: 17369935",
                    "Sudakov KV, Umriukhin PE, Rayevsky KS. Delta-sleep inducing peptide and neuronal activity after glutamate microiontophoresis: the role of NMDA-receptors. Pathophysiology. 2004 Oct;11(2):81-86. https://pubmed.ncbi.nlm.nih.gov/15364118/",
                    "Nakamura A, Nakashima M, Sakai K, Niwa M, Nozaki M, Shiomi H. Delta-sleep-inducing peptide (DSIP) stimulates the release of immunoreactive Met-enkephalin from rat lower brainstem slices in vitro. Brain Res. 1989 Feb 27;481(1):165-8. doi: 10.1016/0006-8993(89)90498-8. PMID: 2706459.",
                    "Dick P, Grandjean ME, Tissot R. Successful treatment of withdrawal symptoms with delta sleep-inducing peptide, a neuropeptide with potential agonistic activity on opiate receptors. Neuropsychobiology. 1983;10(4):205-8. doi: 10.1159/000118012. PMID: 6328354.",
                    "Graf MV, Schoenenberger GA. Delta sleep-inducing peptide modulates the stimulation of rat pineal N-acetyltransferase activity by involving the alpha 1-adrenergic receptor. J Neurochem. 1987 Apr;48(4):1252-7. doi: 10.1111/j.1471-4159.1987.tb05654.x. PMID: 3029331.",
                    "Susić V, Masirević G, Totić S. The effects of delta-sleep-inducing peptide (DSIP) on wakefulness and sleep patterns in the cat. Brain Res. 1987 Jun 30;414(2):262-70. https://pubmed.ncbi.nlm.nih.gov/3620931/",
                    "Schneider-Helmert D, Gnirss F, Monnier M, Schenker J, Schoenenberger GA. Acute and delayed effects of DSIP (delta sleep-inducing peptide) on human sleep behavior. Int J Clin Pharmacol Ther Toxicol. 1981 Aug;19(8):341-5. https://pubmed.ncbi.nlm.nih.gov/6895513/",
                    "Iyer KS, McCann SM. Delta sleep inducing peptide (DSIP) stimulates the release of LH but not FSH via a hypothalamic site of action in the rat. Brain Res Bull. 1987 Nov;19(5):535-8. doi: 10.1016/0361-9230(87)90069-4. https://pubmed.ncbi.nlm.nih.gov/3121137/",
                    "Iyer KS, McCann SM. Delta sleep-inducing peptide (DSIP) stimulates growth hormone (GH) release in the rat by hypothalamic and pituitary actions. Peptides. 1987 Jan-Feb;8(1):45-8. doi: 10.1016/0196-9781(87)90163-x. PMID: 3575154.",
                    "Sudakov KV, Coghlan JP, Kotov AV, Salieva RM, Polyntsev YuV, Koplik EV. Delta-sleep-inducing peptide sequels in the mechanisms of resistance to emotional stress. Ann N Y Acad Sci. 1995 Dec 29;771:240-51. https://pubmed.ncbi.nlm.nih.gov/8597403/",
                    "Popovich IG, Voitenkov BO, Anisimov VN, Ivanov VT, Mikhaleva II, Zabezhinski MA, Alimova IN, Baturin DA, Zavarzina NY, Rosenfeld SV, Semenchenko AV, Yashin AI. Effect of delta-sleep inducing peptide-containing preparation Deltaran on biomarkers of aging, life span and spontaneous tumor incidence in female SHR mice. Mech Ageing Dev. 2003 Jun;124(6). https://pubmed.ncbi.nlm.nih.gov/12782416/",
                    "Bondarenko TI, Maĭboroda EA, Mikhaleva II, Prudchenko IA. [Mechanism of delta-sleep inducing peptide geroprotective activity]. Adv Gerontol. 2011;24(1):80-92. Russian. https://pubmed.ncbi.nlm.nih.gov/21809625/"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/12/DSIP-COA.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/12/DSIP-LC.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/12/DSIP-MS.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "DSIP for sale online. Peptides for sale at 99% purity with top customer service. Get DSIP research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "DSIP For Sale (5mg) | Core Peptides",
            "og:description": "DSIP for sale online. Peptides for sale at 99% purity with top customer service. Get DSIP research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/dsip-5mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T18:07:01+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/DSIP-5MG.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "DSIP For Sale (5mg) | Core Peptides",
            "twitter:description": "DSIP for sale online. Peptides for sale at 99% purity with top customer service. Get DSIP research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/DSIP-5MG.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$41.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "41.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-DSIP-5",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/mgf-5mg/",
                "name": "MGF (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/MGF-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/melanotan-2-10mg/",
                "name": "Melanotan 2 (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2023/03/Melanotan-2-10MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/peg-mgf-5mg/",
                "name": "PEG-MGF (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/PEG-MGF-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/oxytocin-10mg/",
                "name": "Oxytocin (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Oxytocin-10mg-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/aod-9604-5mg/",
        "name": "AOD 9604 (5mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2020/04/AOD-9604-5MG.jpg",
        "display_price": "$41.00",
        "display_specs": [
            "Size: 5mg Contents: AOD 9604 (5mg) Form: Lyophilized powder Purity: >99% SKU: P-AOD9604-5",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$38.95"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$36.90"
            }
        ],
        "description": [
            {
                "h2": "AOD 9604 Peptide"
            },
            {
                "p": "AOD 9604 peptide is a synthetic analog of growth hormone designed with the intention of mitigating obesity and aiding weight loss. The peptide is a modified fragment of the growth hormone where the last 16 amino acids (176-191) have been reproduced as a specific peptide, called GH Fragment 176-191 or simply AOD 9604. It also has a tyrosine residue to replace the first amino acid at the N-terminus, which researchers consider to help increase the stability of the peptide.(1)"
            },
            {
                "p": "More specifically, AOD 9604 is considered the lipolytic fragment of GH as different parts of the GH molecule appease to have different potentials. For instance, studies suggest that out of its 191 amino acid structure “the N-terminal region exhibits an insulin-potentiating action, while amino acids 108 - 129 of hGH were found to evoke high mitogenic responses.”(2)"
            },
            {
                "h3": "Overview"
            },
            {
                "p": "AOD 9604 peptide was developed in the 1990s in an effort to develop proteins which might exhibit anti-obesity properties similar to Growth Hormone (hGH). Rigorous scientific studies and experiments have since been conducted to determine the potential action of AOD 9604 in lipolysis.(1) Lipolysis is a term to describe the process through which stored fats or triglycerides in fat cells are broken down into glycerol and free fatty acids, which may be used as an energy source by other cells. Enzymes such as lipase appear to play a critical role in this process, helping in the breakdown of these fats. It's possible that AOD9604 may influence the fat cells and lipolytic receptors, particularly given its observed association with changes in weight and fat in murine models. Research study findings indicate that the fragment seems to have the capacity to amplify lipolytic sensitivity following its introduction. Furthermore, the study hypothesizes a potential interaction of AOD9604 with the beta-adrenergic pathway, especially concerning the beta(3)-adrenergic receptors (beta(3)-AR), which are considered to be key lipolytic receptors found in fat cells. While it is not entirely clear, the expression level of beta(3)-AR RNA, the primary lipolytic receptor in fat cells, was observed to increase in the presence of AOD 9604. This could possibly suggest that the peptide might be playing a role in enhancing the sensitivity of these lipolytic receptors, potentially making them more responsive to lipolytic stimuli. However, it is essential to note that while the peptide appears to elevate the expression of beta(3)-AR, it may not act directly through the beta(3)-AR to induce its potential lipolytic action."
            },
            {
                "p": "Scientists and researchers have suggested that the modified portion of the hGH in the AOD 9604 peptide may be responsible for significantly inducing the fat burning process, possibly without stimulating the production of Insulin-like Growth Factor IGF 1, as opposed to the natural growth hormone."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C78H123N23O23S2 Molecular Weight: 1815.12 g/mol Other Known Titles: Tyr-hGH Fragment 177-191"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "AOD 9604 Peptide and Lipolytic Activity"
            },
            {
                "p": "Early studies were carried out on obese mice where the AOD 9604 peptide was periodically introduced for 14 days. Following the experiment, the results reported a reduction in weight and excess fat. These results appeared directly correlated with the increased levels of major lipolytic receptors, beta(3)-AR, found in the fat cells. AOD 9604 peptide appeared to exhibit action similar to hGH wherein both may be capable of increasing repressed levels of lipolytic receptors in obese mice as compared to the lean mice. To confirm whether the lipolytic action of AOD 9604 might merely be associated with the increased lipolytic receptor levels, additional studies were carried out where AOD 9604 was given to mice with knocked out lipolytic receptors. Further analysis suggested that the AOD 9604 peptide enacted the lipolytic action via increased energy expenditure and fat oxidation.(1) Both these findings on chronic and acute action of AOD 9604 suggested that while enhanced beta(3)-AR expression may have played a role in the chronic action of the compound, beta(3)-AR might not be the sole arbiter in this reaction. Oxidation and enhanced energy expenditure appeared to be vital in the proposed action of the peptide."
            },
            {
                "p": "In 2000, a research study was carried out in obese Zucker rats where the AOD 9604 peptide was given daily for 19 consecutive days. Following the study, it was reported that weight appeared to be reduced in all rats by over 50%, in comparison to the rats given a placebo. Further analysis suggested that the adipose tissues of the AOD 9604 peptide animals had increased lipolytic activity and no marked insulin sensitivity interruption in the animals.(3)"
            },
            {
                "h3": "AOD 9604 Peptide and Obesity"
            },
            {
                "p": "In 2004, clinical trials observed the actions of the peptide in 300 obese subjects who were given the peptide for 12 weeks. The rate of weight loss remained consistent throughout the study period. The trial results noted minor improvement exhibited in the subjects’ cholesterol profiles and glucose tolerance levels.(4)"
            },
            {
                "h3": "AOD 9604 Peptide and Cell Regeneration"
            },
            {
                "p": "Additional research was conducted to study the regenerative potential of the peptide. In 2015, 32 white rabbits were divided into four groups of eight, and each group was given a placebo, AOD 9604, hyaluronic acid, or a combination of AOD 9604 and hyaluronic acid for 4 to 7 weeks. After the study, these rabbits were assessed morphologically and histopathologically to determine the degree of cartilage degeneration. It was concluded that rabbits given the combination of AOD 9604 with hyaluronic acid apparently exhibited the least degeneration. Thus, it was suggested by the researchers that AOD 9604 might exhibit potential to enhance cartilage regeneration and cartilage repair in some capacity.(5)"
            },
            {
                "p": "This may be due to the potential role of AOD 9604 in cellular differentiation processes and, potentially, in the synthesis of proteins important for tissue repair. According to an in vitro study, AOD 9604 may possibly enhance the differentiation of adipose mesenchymal stem cells into bone(5). These stem cells, which are typically found within fat tissue, may have the potential to evolve into various cell types. It has been hypothesized that under the influence of AOD 9604, these stem cells may show a predisposition to differentiate into bone cells. Moreover, when the research was conducted on isolated bovine chondrocytes, it appeared that there might be an increased production of proteoglycan and collagen. Chondrocytes are cells believed to be found within cartilage tissue, and they possibly play a role in producing and maintaining the extracellular matrix, which consists of components like collagen and proteoglycans. It is posited that the presence of AOD 9604 could stimulate these chondrocytes to produce more of these vital components. The study also hints at the idea that AOD 9604 might promote the differentiation of myoblasts into C2C12 cells. Myoblasts are thought to be precursor muscle cells, and C2C12 cells are a type of murine model muscle cell line. From what the study suggests, AOD 9604 may assist in the transition of these precursor cells into a more mature form. The research seems to underline the potential role AOD 9604 might have in processes connected to the repair of bone, cartilage, and muscle tissues."
            },
            {
                "h3": "AOD 9604 and Research in Cancer Cells"
            },
            {
                "p": "The peptide may be able to bind (target) tumor-related proteins to enhance tumor drug accumulation and local cytotoxicity.(6) The hGH fragment AOD 9604 may potentially play a pivotal role in cancer cell research, as it has been observed to enhance the anticancer efficacy of doxorubicin, a commonly recognized chemotherapeutic agent. One study utilized chitosan nanoparticles, a biocompatible and biodegradable polymer, as a carrier for doxorubicin and AOD 9604.(6) The research team hypothesized that AOD 9604 possibly enhanced the doxorubicin binding to multiple breast cancer cell protein targets, thereby exhibiting greater anti-proliferative activity against the MCF-7 breast cancer cell line compared to chitosan loaded with doxorubicin alone. This suggests that AOD 9604 may potentially augment the anti-cancer potency of doxorubicin while possibly minimizing unintended actions associated with non-target tissue exposure. In conclusion, multiple clinical studies have suggested that the peptide may significantly induce lipolysis and possibly prevent lipogenesis by mimicking natural hGH."
            },
            {
                "p": "AOD 9604 is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Mark Heffernan, Roger J. Summers, Anne Thorburn, Esra Ogru, Robert Gianello, Woei-Jia Jiang, Frank M. Ng, The Effects of Human GH and Its Lipolytic Fragment (AOD 9604) on Lipid Metabolism Following Chronic Treatment in Obese Mice and β 3-AR Knock-Out Mice, Endocrinology, Volume 142, Issue 12, 1 December 2001, Pages 5182–5189. https://pubmed.ncbi.nlm.nih.gov/11713213/",
                    "Moré, M. I., & Kenley, D. (2014). Safety and metabolism of AOD9604, a novel nutraceutical ingredient for improved metabolic health. Journal of Endocrinology and Metabolism, 4(3), 64-77.",
                    "Frank M. Ng, J Sun et.al, Metabolic Studies of a Synthetic Lipolytic Domain (AOD 9604) of Human Growth Hormone, Hormone Research, February 2000.",
                    "News, Medical and Life Sciences, Obesity drug codenamed AOD 9604 highly successful in trials, 16 December 2004.",
                    "Dong Rak Kwon and GI Young Park, Effect of Intra-articular Injection of AOD9604 with or without Hyaluronic Acid in Rabbit Osteoarthritis Model, Annals of Clinical and Laboratory Science, Volume 45, July-August 2015.",
                    "Habibullah, M. M., Mohan, S., Syed, N. K., Makeen, H. A., Jamal, Q. M. S., Alothaid, H., Bantun, F., Alhazmi, A., Hakamy, A., Kaabi, Y. A., Samlan, G., Lohani, M., Thangavel, N., & Al-Kasim, M. A. (2022). Human Growth Hormone Fragment 176-191 Peptide Enhances the Toxicity of Doxorubicin-Loaded Chitosan Nanoparticles Against MCF-7 Breast Cancer Cells. Drug design, development and therapy, 16, 1963–1974. https://doi.org/10.2147/DDDT.S367586"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/12/AOD-9604-COA-1.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/12/AOD-9604-LC-1.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/12/AOD-9604-MS-1.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "AOD 9604 for sale online (5mg). Peptides for sale at 99% purity with top customer service. Get AOD 9604 research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "AOD 9604 For Sale (5mg) | Core Peptides",
            "og:description": "AOD 9604 for sale online (5mg). Peptides for sale at 99% purity with top customer service. Get AOD 9604 research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/aod-9604-5mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-05-28T11:02:31+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/AOD-9604-5MG.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "AOD 9604 For Sale (5mg) | Core Peptides",
            "twitter:description": "AOD 9604 for sale online (5mg). Peptides for sale at 99% purity with top customer service. Get AOD 9604 research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/AOD-9604-5MG.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$41.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "41.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-AOD9604-5",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/cjc-1295-dac-5mg/",
                "name": "CJC-1295 DAC (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/CJC-1295-DAC-5MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/receptor-grade-igf-1-lr3-1mg/",
                "name": "Receptor Grade IGF-1 LR3 (1mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-1MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/melanotan-1-10mg/",
                "name": "Melanotan 1 (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Melanotan-1-10MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/mgf-5mg/",
                "name": "MGF (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/MGF-5MG-300x300.jpg.webp",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/aicar-50mg/",
        "name": "AICAR (50mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2023/03/AICAR-50mg.jpg",
        "display_price": "$62.00",
        "display_specs": [
            "Size: 50mg Contents: AICAR Form: Lyophilized powder Purity: >99% SKU: P-AICAR",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$58.90"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$55.80"
            }
        ],
        "description": [
            {
                "h2": "AICAR Peptide"
            },
            {
                "p": "AICAR is an analog of adenosine monophosphate (AMP), a nucleotide that is considered to play an important role in cellular energy metabolism. It has been studied for its potential applications in research, particularly in reducing reperfusion injury after tissue ischemia and mitigating metabolic disorders. AICAR has been suggested to exert this potential by apparently activating AMP-activated protein kinase (AMPK), an enzyme that regulates various metabolic processes. AMPK potentially plays a role in restoring energy balance. It might do this by inhibiting anabolic processes: energy-consuming pathways like protein and fatty acid synthesis. Simultaneously, it might activate catabolic processes, such as the breakdown of glucose and fats, which generate ATP, thereby increasing the energy supply. There is also a possibility that AMPK influences various other cellular processes, including autophagy (the process by which cells clean out damaged components), mitochondrial biogenesis (the creation of new mitochondria), and the regulation of inflammation and stress responses. This broad range of actions suggests that AMPK might be involved in regulating several aspects of cellular and organismal function."
            },
            {
                "p": "By potentially activating AMPK, AICAR is posited to possibly increase glucose uptake in skeletal muscle, enhance insulin sensitivity, and improve glucose tolerance. AICAR has also been suggested by researchers to have anti-inflammatory potential and may improve physical performance in certain experimental models."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular formula: C9H15N4O8P Molecular Weight: 338.21 g/mol Other known titles: AICA ribonucleotide"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "AICAR Peptide and Tissue Protection"
            },
            {
                "p": "AICAR may have organ-protective potential, especially against ischemia and reperfusion injury. The nucleotide has been suggested to potentially reduce myocardial infarction size and improve cardiac function in an animal model of myocardial ischemia-reperfusion injury.(1)"
            },
            {
                "p": "One meta-analysis aimed to investigate the potential of AICAR on cardiovascular tissues.(2) The data was collected from 5 randomized, placebo-controlled, double-blind clinical studies. From the results, AICAR was suggested to reduce myocardial tissue infarction size and cardiac cell death and apparently improve the overall outcome of the experiment. The study concluded that AICAR may \"reduce [...] adverse cardiovascular outcomes.\""
            },
            {
                "p": "Researchers posited that the apparent protective potential of AICAR may be due to its action on cellular metabolism. AICAR may potentially alter it to become more resistant to lack of oxygen by apparently upregulating the availability of energy that can be used even in anaerobic conditions. One such process is the apparent increase in the availability of myocardial glucose. To achieve that, AICAR may promote myocardial glycogenolysis (glycogen degradation) by activating AMPK. This was suggested by experiments using isolated hearts from halothane-anesthetized murine models. In these studies, AICAR appeared to increase glycogenolysis in the myocardium of murine models, while its action on glycogen synthesis was reportedly negligible. This observation hints at a potential role for AMPK activation in glycogenolysis. Further, AICAR was noted to potentially increase myocardial levels of 5-aminoimidazole-4-carboxamide 1-beta-d-ribofuranotide (ZMP), which is AICAR's active intracellular form. However, there was no apparent change in the activity of glycogen synthase (GS) and glycogen phosphorylase (GP) in tissue homogenates, nor did AICAR seem to affect the levels of glucose-6-phosphate and adenine nucleotides in freeze-clamped tissues of these murine models. These findings suggest the possibility that ZMP might allosterically activate GP, leading to glycogenolysis in the intact hearts of the murine models, thereby providing glucose that can be used for energy even in less optimal conditions for the cells.(3)"
            },
            {
                "p": "AICAR may have protective action in other tissues as well. One study investigated the potential of AICAR, an AMPK activator, on an experimental murine model of ethanol-induced hepatic steatosis.(4) The study observed that chronic ethanol exposure appeared to result in a histologically and biochemically fatty liver. Upon AICAR presentation, it appeared to attenuate the degree of change in the liver tissues. AICAR was also posited to decrease the hepatic sterol regulatory element-binding protein 1c (SREBP-1c) and reduce fatty acid synthase (FAS) enzyme expression, reducing triglyceride synthesis in murine models’ livers. SREBP-1c is posited to be a protein apparently involved in lipid metabolism, primarily in liver tissues. It is a member of the SREBP family, which appears to be transcription factors that regulate the expression of genes required to synthesize cholesterol, fatty acids, and triglycerides. Therefore, it is possible that a decrease in SREBP-1c might lead to a reduction in fatty acid synthesis. FAS is an enzyme that is considered to play a crucial role in synthesizing fatty acids. It is suggested to play a role in the process of converting acetyl-CoA and malonyl-CoA, small molecules, into palmitate, a long-chain saturated fatty acid. FAS expression also appears to be regulated by SREBP-1c."
            },
            {
                "h3": "AICAR Peptide and Insulin Sensitivity"
            },
            {
                "p": "Studies suggest that AICAR may have the potential to improve the insulin sensitivity of various tissues due to its potential to activate the AMPK inside cells and make them draw in glucose. One experimental model aimed to investigate whether AICAR could potentially enhance glucose transport in equine skeletal muscle.(5) Upon presentation, AICAR appeared to decrease glucose and increase insulin concentration without affecting lactate concentration. AICAR was also observed to potentially increase the ratio of phosphorylated to total AMPK in skeletal muscle and may have upregulated GLUT8 protein expression. The apparent increase in the expression of the GLUT8 protein in the cells could potentially enhance the movement of glucose into cells, thereby possibly improving insulin sensitivity."
            },
            {
                "p": "A study also aimed to determine whether AICAR may stimulate glucose uptake in muscle.(6) AICAR and physical activity were employed to stimulate muscle AMPK activity and glucose uptake. Results expressed the possibility that both AICAR and physical activity may increase glucose uptake in muscle. Still, AICAR may also increase glucose uptake in other tissues, thereby potentially increasing peripheral and overall insulin sensitivity. Researchers also suggested that AICAR might potentially increase the phosphorylation of extracellular signal-regulated kinase 1/2. Phosphorylation is a chemical process where a phosphate group is added to the enzymes ERK1 and ERK2. These enzymes are part of a specific signaling pathway known as the MAP kinase/ERK pathway, posited to regulate various cellular activities like division, differentiation, and response to stress."
            },
            {
                "p": "Another study observed that AICAR may potentially reduce hepatic tissues’ glucose output, lower glucose concentrations, stimulate hepatic tissues’ fatty acid oxidation, and inhibit lipolysis, thereby reducing plasma-free fatty acid availability.(7) Although AMPK phosphorylation in skeletal muscle was not reported to be increased, the researchers reported acetyl-CoA carboxylase phosphorylation to be significantly increased. This enzyme is considered to play a potential role in fatty acid metabolism. It apparently catalyzes acetyl-CoA conversion to malonyl-CoA, a crucial step in fatty acid synthesis. Thus, this inactivation could potentially lead to a decrease in fatty acid synthesis and an apparent increase in fatty acid oxidation to fuel the cells with energy."
            },
            {
                "h3": "AICAR Peptide and Endurance"
            },
            {
                "p": "Researchers posit that AICAR may potentially activate AMPK, glycogen phosphorylase, and fructose-1,6-bisphosphatase.(8) Some studies have suggested these potential actions may contribute to enhanced oxidative metabolism and mitochondrial biogenesis.(9) Increasing the number and function of mitochondria may benefit muscle endurance. For example, one experiment suggested that AICAR may induce metabolic genes and enhance running endurance in sedentary murine models by 44%.(10) The results suggest that peptides may target the AMPK-PPARδ pathway to enhance training adaptation or increase endurance without exercise. PPARδ, or Peroxisome Proliferator-Activated Receptor Delta, is a type of nuclear receptor that possibly plays a role in regulating genes involved in energy metabolism. It is thought that PPARδ may be involved in processes like fat-burning and mitochondrial biogenesis (the creation of new mitochondria, which are the energy-producing structures in cells). The AMPK-PPARδ pathway potentially represents a link between the sensing of energy status by AMPK and the gene regulatory functions of PPARδ. When activated, this pathway might promote adaptations in muscle cells similar to those induced by endurance training. These adaptations could include increased mitochondrial content and a shift in muscle fiber type towards more endurance-oriented fibers, potentially leading to enhanced endurance capacity.(10)"
            },
            {
                "p": "Another experiment in murine models(11) also reported that the presentation of \"an agonist of the AMP-activated protein kinase showed an increase in endurance compared to exercise-trained controls.\" Furthermore, in a murine model for Duchene muscular dystrophy, AICAR was observed by researchers to have the potential to enhance the impact of exercise and improve muscle function, probably by stimulating autophagy.(12) An infusion of AICA-riboside resulted in increment-correlated increases in forearm blood flow but did not appear to impact glucose uptake in skeletal muscle. The increase in blood flow appeared to be mediated by nitric oxide, as an inhibitor of endothelial NO synthase apparently attenuated it. These findings suggest that AICAR may exert impact in improving blood flow into muscle and acting as a NO-booster, which is also an important factor for improving performance during prolonged physical activity.(13)"
            },
            {
                "h3": "AICAR Peptide and Malignant Cell Lines"
            },
            {
                "p": "Research indicates that AICAR may trigger apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) test models. One study proposes that this process might involve the activation of caspase-3, -8, and -9, along with the release of cytochrome C.(14) Additionally, incubating B-CLL cells with AICAR seems to lead to the phosphorylation of AMPK, hinting at AICAR's potential role in activating this protein. The research further explored whether the entry of AICAR into the cell and its conversion to AICA ribotide (ZMP) is necessary for apoptosis. It employed inhibitors like Nitrobenzylthioinosine (NBTI), 5-iodotubercidin, and adenosine. These inhibitors were suggested to potentially reduce AICAR-induced apoptosis and AMPK phosphorylation. However, inhibitors of protein kinase A and mitogen-activated protein kinases did not appear to prevent AICAR-induced apoptosis in B-CLL cells."
            },
            {
                "p": "The study also noted that AICAR did not appear to affect p53 levels or phosphorylation, suggesting a p53-independent apoptosis mechanism in B-CLL cells. A comparison was made between normal B lymphocytes, T cells, and B-CLL cells' sensitivity to AICAR-induced apoptosis. The findings indicated that normal B lymphocytes and B-CLL cells were similarly sensitive to AICAR-induced apoptosis, whereas T cells from B-CLL subjects appeared to show only minor sensitivity. Notably, AMPK phosphorylation did not seem to occur in T cells exposed to AICAR. Furthermore, upon exposure to AICAR, B-CLL cells appeared to have higher intracellular levels of ZMP compared to T cells. This observation suggests that ZMP accumulation may be crucial in activating AMPK and inducing apoptosis in these cells."
            },
            {
                "p": "AICAR peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Cieslik, K. A., Taffet, G. E., Crawford, J. R., Trial, J., Mejia Osuna, P., & Entman, M. L. (2013). AICAR-dependent AMPK activation improves scar formation in the aged heart in a murine model of reperfused myocardial infarction. Journal of molecular and cellular cardiology, 63, 26–36. https://doi.org/10.1016/j.yjmcc.2013.07.005",
                    "Mangano D. T. (1997). Effects of acadesine on myocardial infarction, stroke, and death following surgery. A meta-analysis of the 5 international randomized trials. The Multicenter Study of Perioperative Ischemia (McSPI) Research Group. JAMA, 277(4), 325–332. https://doi.org/10.1001/jama.277.4.325",
                    "Longnus, S. L., Wambolt, R. B., Parsons, H. L., Brownsey, R. W., & Allard, M. F. (2003). 5-Aminoimidazole-4-carboxamide 1-beta -D-ribofuranoside (AICAR) stimulates myocardial glycogenolysis by allosteric mechanisms. American journal of physiology. Regulatory, integrative and comparative physiology, 284(4), R936–R944. https://doi.org/10.1152/ajpregu.00319.2002",
                    "Tomita, K., Tamiya, G., Ando, S., Kitamura, N., Koizumi, H., Kato, S., Horie, Y., Kaneko, T., Azuma, T., Nagata, H., Ishii, H., & Hibi, T. (2005). AICAR, an AMPK activator, has protective effects on alcohol-induced fatty liver in rats. Alcoholism, clinical and experimental research, 29(12 Suppl), 240S–5S. https://doi.org/10.1097/01.alc.0000191126.11479.69",
                    "de Laat, M. A., Robinson, M. A., Gruntmeir, K. J., Liu, Y., Soma, L. R., & Lacombe, V. A. (2015). AICAR administration affects glucose metabolism by upregulating the novel glucose transporter, GLUT8, in equine skeletal muscle. Veterinary journal (London, England : 1997), 205(3), 381–386. https://doi.org/10.1016/j.tvjl.2015.05.018",
                    "Cuthbertson, D. J., Babraj, J. A., Mustard, K. J., Towler, M. C., Green, K. A., Wackerhage, H., Leese, G. P., Baar, K., Thomason-Hughes, M., Sutherland, C., Hardie, D. G., & Rennie, M. J. (2007). 5-aminoimidazole-4-carboxamide 1-beta-D-ribofuranoside acutely stimulates skeletal muscle 2-deoxyglucose uptake in healthy men. Diabetes, 56(8), 2078–2084. https://doi.org/10.2337/db06-1716",
                    "Boon, H., Bosselaar, M., Praet, S. F., Blaak, E. E., Saris, W. H., Wagenmakers, A. J., McGee, S. L., Tack, C. J., Smits, P., Hargreaves, M., & van Loon, L. J. (2008). Intravenous AICAR administration reduces hepatic glucose output and inhibits whole body lipolysis in type 2 diabetic patients. Diabetologia, 51(10), 1893–1900. https://doi.org/10.1007/s00125-008-1108-7",
                    "Višnjić D, Lalić H, Dembitz V, Tomić B, Smoljo T. AICAr, a Widely Used AMPK Activator with Important AMPK-Independent Effects: A Systematic Review. Cells. 2021 May 4;10(5):1095. doi: 10.3390/cells10051095. PMID: 34064363; PMCID: PMC8147799.",
                    "Hardie DG. AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. Genes Dev. 2011 Sep 15;25(18):1895-908. doi: 10.1101/gad.17420111. PMID: 21937710; PMCID: PMC3185962.",
                    "Narkar, V. A., Downes, M., Yu, R. T., Embler, E., Wang, Y. X., Banayo, E., Mihaylova, M. M., Nelson, M. C., Zou, Y., Juguilon, H., Kang, H., Shaw, R. J., & Evans, R. M. (2008). AMPK and PPARdelta agonists are exercise mimetics. Cell, 134(3), 405–415. https://doi.org/10.1016/j.cell.2008.06.051",
                    "Goodyear, L. J. (2008). The exercise pill—too good to be true?. New England Journal of Medicine, 359(17), 1842-1844.",
                    "Bueno Júnior, C. R., Pantaleão, L. C., Voltarelli, V. A., Bozi, L. H., Brum, P. C., & Zatz, M. (2012). Combined effect of AMPK/PPAR agonists and exercise training in mdx mice functional performance. PloS one, 7(9), e45699. https://doi.org/10.1371/journal.pone.0045699",
                    "Bosselaar, M., Boon, H., van Loon, L. J., van den Broek, P. H., Smits, P., & Tack, C. J. (2009). Intra-arterial AICA-riboside administration induces NO-dependent vasodilation in vivo in human skeletal muscle. American journal of physiology. Endocrinology and metabolism, 297(3), E759–E766. https://doi.org/10.1152/ajpendo.00141.2009",
                    "Campàs, C., Lopez, J. M., Santidrián, A. F., Barragán, M., Bellosillo, B., Colomer, D., & Gil, J. (2003). Acadesine activates AMPK and induces apoptosis in B-cell chronic lymphocytic leukemia cells but not in T lymphocytes. Blood, 101(9), 3674–3680. https://doi.org/10.1182/blood-2002-07-2339"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "",
        "high_performance_liquid_chromatography": "",
        "mass_spectrometry": "",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "AICAR peptide for sale online (50mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "AICAR For Sale (50mg) - Core Peptides",
            "og:description": "AICAR peptide for sale online (50mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:url": "https://www.corepeptides.com/peptides/aicar-50mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T16:10:13+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2023/03/AICAR-50mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "AICAR For Sale (50mg) - Core Peptides",
            "twitter:description": "AICAR peptide for sale online (50mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2023/03/AICAR-50mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$62.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "62.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-AICAR",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/receptor-grade-igf-1-lr3-1mg/",
                "name": "Receptor Grade IGF-1 LR3 (1mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-1MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ghk-cu-50mg-copper/",
                "name": "GHK-Cu (Copper) (50mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHK-CU-50mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ll-37-5mg/",
                "name": "LL-37 (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/LL-37-5mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/receptor-grade-igf-1-lr3-100mcg/",
                "name": "Receptor Grade IGF-1 LR3 (100mcg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-100MCG-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/ahk-cu-topical-200mg/",
        "name": "AHK-Cu (200mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2023/04/AHK-Cu-200mg.jpg",
        "display_price": "$203.00",
        "display_specs": [
            "Size: 200mg Contents: AHK-Cu Form: Lyophilized powder Purity: >99% SKU: P-AHK-CU",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$192.85"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$182.70"
            }
        ],
        "description": [
            {
                "h2": "AHK-Cu"
            },
            {
                "p": "AHK-Cu is a peptide composed of amino acids alanine, histidine, and lysine, with a copper ion coordinated by various parts of these three amino acids.(1) This peptide appears to be naturally present in the bloodstream and has been suggested as a potential element in regulating the growth, development, and apoptosis of vascular endothelial cells."
            },
            {
                "p": "AHK-Cu, also known as copper AHK, has been researched for its potential in hair growth and supporting skin tissue integrity. This peptide has been suggested to exhibit its potential primarily on fibroblasts, responsible for maintaining and growing the extracellular matrix (ECM) components surrounding the cells. Fibroblasts also appear to secrete various biological substances, including the Vascular Endothelial Growth Factor (VEGF), which is suggested to promote the formation of new blood vessels."
            },
            {
                "p": "The copper ion in AHK-Cu is suggested to be involved in enzyme activity related to collagen and elastin synthesis. These two proteins are critical components of the extracellular matrix and play a role in maintaining the skin tissues' structural integrity. Copper ions are also suggested to exhibit antioxidant properties."
            },
            {
                "h3": "Chemical Makeup(2)"
            },
            {
                "p": "Molecular Formula: C15H25CuN6O4 Molecular Weight: 416.9 g/mol Other known titles: ALA-HIS-LYS-CU, L-Alanyl-κN-L-histidyl-κN,κN3-L-lysinato(2-)]copper Monohydrochloride"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "AHK-Cu Peptide and Antioxidative Potential"
            },
            {
                "p": "AHK-Cu is posited to have potent antioxidant qualities, primarily due to its distinct amino acid structure. Based on the antioxidative properties of this peptide, studies have suggested its potential in amplifying hair follicle size, which may increase growth. This peptide has been the focus of numerous in-vitro investigations, particularly concerning its role in hair growth. These studies uniformly suggest AHK-Cu's potential to foster hair follicle development. In addition to hair growth, AHK-Cu's scope of application may extend to cell aging, wound healing, and other areas, according to researchers. They posit its potential role in boosting dermal cell multiplication and survival, both of which are essential in collagen production. Collagen is a vital element for maintaining skin cell turnover and function, and the increased cell activity provided by AHK-Cu may facilitate this process.(3)"
            },
            {
                "h3": "AHK-Cu Peptide and Hair Follicle Development"
            },
            {
                "p": "Researchers posit that the tripeptide AHK-Cu may potentially stimulate the proliferation of dermal fibroblasts, a type of cell that produces substances like vascular endothelial growth factor (VEGF), which are considered to be crucial for the growth of blood vessels. AHK-Cu may also reduce the secretion of transforming growth factor-beta1 by dermal fibroblasts."
            },
            {
                "p": "In a recent study,(4) the potential of AHK-Cu on hair growth was investigated. It was suggested that the peptide may promote the elongation of hair follicles and the proliferation of dermal papilla cells (DPCs), which are specialized fibroblasts with a potential to increase the growth and development of hair follicles. Moreover, the authors suggested that the presence of AHK-Cu may have reduced the number of apoptotic dermal papilla cells. Further analysis suggested that the peptide may have increased the ratio of Bcl-2/Bax, and potentially decreased cleaved caspase-3 and PARP levels, two markers of cell death. The Bcl-2/Bax ratio is suggested to play a potential role in the regulation of apoptosis. Bcl-2 is posited as an anti-apoptotic protein that apparently inhibits cell death, while Bax is suggested to be a pro-apoptotic protein that promotes cell death. Thus, a higher Bcl-2/Bax ratio is posted as a predominance of Bcl-2, which may inhibit apoptosis and apparently promotes cell survival. Ultimately, the researchers suggested that AHK-Cu “stimulated the elongation of […] hair follicles […] and the proliferation of DPCs in vitro.” Based on these observations, the researchers commented, “The present study proposed that AHK-Cu promotes the growth of [...] hair follicles, and this stimulatory effect may occur due to stimulation of the proliferation and the preclusion of the apoptosis of DPCs.”(4). Other researchers delving into this trial also noticed that the peptide may have interacted with VEGF and Transforming Growth Factor Beta 1 (TGF-β1). TGF-β1 is researched for its role in cell proliferation, differentiation, and apoptosis. It is posited to be involved in several cellular processes, including the regulation of immune responses and wound healing. By potentially downregulating TGF-β1, AHK-Cu may alter these cellular processes, possibly affecting cell growth and the immune response at a cellular level. On the other hand VEGF is researched for its role in angiogenesis, the formation of new blood vessels from pre-existing vessels. The upregulation of VEGF by AHK-Cu might imply an enhanced potential for angiogenesis, which could influence nutrient and oxygen supply at the cellular level.(5) VEGF specifically is posited to foster the development of blood vessels surrounding hair follicles. This action potentially aids in delivering nutrients and oxygen to the hair follicles, thereby supporting hair growth."
            },
            {
                "h3": "AHK-Cu Peptide and Alopecia Research"
            },
            {
                "p": "The study examined the potential of two formulations containing growth factors and peptides such as vascular endothelial growth factor, basic fibroblast growth factor, insulin-like growth factor-1, keratinocyte growth factor, and copper tripeptide 1 and related peptides such as AHK-Cu, suspended in a sterile vehicle. The experiment investigated the potential cytotoxicity of these factors using in vitro keratinocyte and fibroblast cell assays. The formulations were also investigated for their potential for hair growth and hair follicle viability in cases of secondary alopecia.(1)"
            },
            {
                "p": "The authors suggested that both formulations appeared to produce a positive response regarding hair growth in the animals. The formulations also were posited to be impactful when tested alongside agents that may be associated with alopecia. Researchers Rinky Kapoor et al. state, “Results seem encouraging enough to warrant a trial in [...] secondary alopecia.” (1)"
            },
            {
                "h3": "AHK-Cu Peptide and Skin Tissue Integrity"
            },
            {
                "p": "Preliminary lab studies have suggested that the core molecule of the peptide, AHK, may stimulate the growth of fibroblast cells and the production of collagen. Notably, AHK appears to improve the survival and multiplication of dermal fibroblasts, which are researched for their potential for generating vital skin proteins like collagen. In experiments with normal dermal fibroblasts, AHK was observed to apparently boost both cell growth and viability, alongside enhancing collagen type I production. This conclusion was drawn by measuring collagen type I levels produced by fibroblasts in a cell culture following exposure to varying concentrations of AHK. The studies indicated that AHK's presence may have raised collagen type I production, with a threefold increase compared to the control group. These results imply that AHK could potentially rejuvenate the extracellular matrix and contribute to skin function.(6)"
            },
            {
                "p": "AHK-Cu peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References"
            },
            {
                "references": [
                    "Kapoor R, Shome D, Vadera S, Kumar V, Ram MS. QR678 & QR678 Neo Hair Growth Formulations: A Cellular Toxicity & Animal Efficacy Study. Plast Reconstr Surg Glob Open. 2020 Aug 25;8(8):e2843. doi: 10.1097/GOX.0000000000002843. PMID: 32983753; PMCID: PMC7489598. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489598/",
                    "AHK-Cu, ChemBK. https://www.chembk.com/en/chem/AHK-Cu",
                    "Kecel-Gunduza, S., Kocb, E., Bicaka, B., Kokcub, Y., Ozela, A. E., & Akyuzc, S. (2020). IN SILICO ANALYSIS FOR CHARACTERIZING THE STRUCTURE AND BINDING PROPERTIES OF ALA-HIS-LYS (AHK) TRIPEPTIDE. The Online Journal of Science and Technology-July, 10(3).",
                    "Pyo HK, Yoo HG, Won CH, Lee SH, Kang YJ, Eun HC, Cho KH, Kim KH. The effect of tripeptide-copper complex on human hair growth in vitro. Arch Pharm Res. 2007 Jul;30(7):834-9. doi: 10.1007/BF02978833. PMID: 17703734. https://pubmed.ncbi.nlm.nih.gov/17703734/",
                    "Sadgrove NJ, Simmonds MSJ. Topical and nutricosmetic products for healthy hair and dermal anti-aging using \"dual-acting\" (2 for 1) plant-based peptides, hormones, and cannabinoids. FASEB Bioadv. 2021 Jun 6;3(8):601-610. doi: 10.1096/fba.2021-00022. PMID: 34377956; PMCID: PMC8332470. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8332470/",
                    "Patt, L. M., & Procyte, A. (2009). Neova® DNA Repair Factor Nourishing Lotion Stimulates Collagen and Speeds Natural Repair Process. skin, 1, 2."
                ]
            },
            {
                "p": " "
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "",
        "high_performance_liquid_chromatography": "",
        "mass_spectrometry": "",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "AHK-Cu for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "AHK-Cu For Sale (200mg) - Core Peptides",
            "og:description": "AHK-Cu for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:url": "https://www.corepeptides.com/peptides/ahk-cu-topical-200mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T16:13:11+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2023/04/AHK-Cu-200mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "AHK-Cu For Sale (200mg) - Core Peptides",
            "twitter:description": "AHK-Cu for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2023/04/AHK-Cu-200mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$203.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "203.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-AHK-CU",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/ll-37-5mg/",
                "name": "LL-37 (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/LL-37-5mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/ghk-cu-50mg-copper/",
                "name": "GHK-Cu (Copper) (50mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/GHK-CU-50mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/oxytocin-10mg/",
                "name": "Oxytocin (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Oxytocin-10mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/receptor-grade-igf-1-lr3-1mg/",
                "name": "Receptor Grade IGF-1 LR3 (1mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-1MG-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/adipotide-10mg/",
        "name": "Adipotide (FTPP) (10mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Adipotide-FTPP-10MG.jpg",
        "display_price": "$78.00",
        "display_specs": [
            "Size: 10mg Contents: Adipotide (FTPP) (10mg) Form: Lyophilized powder Purity: >99% SKU: P-ADIPOTID-10",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$74.10"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$70.20"
            }
        ],
        "description": [
            {
                "h2": "Adipotide Peptide (FTPP)"
            },
            {
                "p": "Adipotide Peptide, also known as FTPP (Fat-Targeted Proapoptotic Peptide), fat-targeted proapoptotic peptide, or proapoptotic peptide, has been widely researched and is posited by scientists to be a proapoptotic peptide that may contribute to cell apoptosis. Adipotide may possibly act as a peptide targeting prohibitin, which is why it also bears the name Prohibitin-targeting peptide 1 (Prohibitin-TP01). Current research is still exploring Adipotide’s potential in this area and its potential actions related to its targeting properties.(1) Prohibitins are natural proteins considered by scientists to regulate such functions as cell formation, metabolism, and inflammation."
            },
            {
                "p": "Research teams initially considered Adipotide for its supposed potential to mitigate the action of cancer cells. Still, the peptide indicated it may have research potential for experiments investigating lipolysis and obesity mitigation, leaving the research pioneers “at a loss of words.”(2) It was presumed that Adipotide might prevent blood supply to the cancer cells, resulting in cell death and malignant cell growth inhibition. Upon further research, it was suggested by the scientists that the peptide appeared to exhibit the same mechanism of action but on fat cells instead. This “proof of concept” study was an early-stage experiment suggesting that the peptide may have significant potential. Yet, the compound has to be studied further to understand its full potential and impact on cells."
            },
            {
                "h3": "Overview"
            },
            {
                "p": "Researchers isolated a naturally occurring peptide (sequence CKGGRAKDC) via phage display methodology and combined it with a proapoptotic sequence, forming the now-termed Adipotide compound. Adipotide is homologous to the peptide sequence found in the white adipose tissue. Owing to this development and characteristics, researchers suggest that the peptide may possibly target the prohibitin PHB1 found at the surface of the adipose tissue – possibly attaching and thereby damaging them, potentially causing a blood supply disruption to the adipocytes (fat cells).(1) Prohibitins are considered by scientists to act as a vascular marker of the fatty tissues, and Adipotide may possibly be able to identify these markers and consequently conduct apoptosis on these cells.(3) Further, researchers speculate that Adipotide may interact not only with prohibitin but also another receptor called annexin A2 (ANX2) and thus potentially disrupt their role in supporting blood and fat supply to fat cells in white adipose tissue. Studies suggest that prohibitin and ANX2, when interacting in a complex with a fatty acid transporter called CD36, potentially facilitate the uptake of fatty acids by the endothelium and their subsequent transport into adipocytes. One study suggested that there was a purported white adipose tissue hypotrophy in murine models lacking ANX2, despite apparently normal white adipose tissue vascularization, adipogenesis, and glucose metabolism. This condition was potentially attributed to reduced fatty acid uptake by white adipose tissue endothelium and adipocytes. It was suggested that the efficiency of fatty acid transport relies on the interaction of ANX2 and prohibitin. This interaction was posited to be essential for mediating fatty acid transport from the endothelium into adipocytes. Additionally, it was commented that ANX2 and prohibitin form a complex with CD36, and this interaction is crucial for fatty acid transport. Importantly, the colocalization of prohibitin and CD36 on the adipocyte surface was induced by extracellular fatty acids, suggesting a dynamic regulation of this protein complex in response to fatty acid levels. The study posited that the biochemical interaction between ANX2 and prohibitin potentially regulates CD36-mediated fatty acid transport in white adipose tissue, unveiling a potential pathway that compounds like Adipotide might target.(4) Consequently, Adipotide is posited to potentially burn the fat stored in these fat cells as fuel, according to researchers' speculations.(2)"
            },
            {
                "p": "Based on early preclinical studies on monkeys, it was also suggested that following Adipotide presentation, the monkeys exhibited apparently reduced insulin resistance.(5)"
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C152H252N44O42 Molecular Weight: 2611.41 g/mol Other Known Titles: FTPP"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Adipotide (FTPP) Initial Research"
            },
            {
                "p": "Adipotide's mode of action appears to hinge on its selective affinity for the receptor prohibitin, expressed on the surface of endothelial cells in the vasculature of white adipose tissue. The compound's potential to cause targeted apoptosis is facilitated by its fusion to the d-enantiomer D(KLAKLAK)2 sequence, an amphipathic peptidomimetic posited to disrupt mitochondrial membranes upon internalization into cells. This disruption might lead to cell death, specifically in the targeted vasculature. To evaluate the compound's potential, Adipotide was presented to three different types of primate models daily for four weeks. No deliberate changes were made to their diet or exercise routine. After the study, it was suggested by the researchers that the models apparently lost about 11% of weight and 39% of the fat deposits in their bodies compared to baseline.(5) As suggested by the authors, some of the models also exhibited apparent mild renal dysfunction, as reported across four study groups, A, B, C, and D. Creatinine levels apparently increased in study groups A and B, however, after a washout period, these returned to optimal levels. Further, the authors suggested that there may be an apparent reduction in food intake in the test models, which raises questions about potential actions on appetite or satiety signals, which could be another avenue through which Adipotide may exert its potential. However, the specific mechanisms by which Adipotide might influence these processes, if at all, are still unclear. While Adipotide is suggested to have potential at the cellular level for inducing weight loss by targeting the vasculature of white adipose tissue, its exact mechanisms of action, particularly in relation to appetite regulation and metabolic changes, require further investigation to fully understand its potential implications in the context of obesity."
            },
            {
                "h3": "Adipotide (FTPP) and Malignant Cells"
            },
            {
                "p": "Scientists surveyed a number of blood vessels and tissues (both normal and malignant), and isolated and studied the various peptides and molecules distributed in them. Peptides, proteins, and certain molecular distributions are considered to be specific and differentially expressed in normal and cancer tissues under control conditions. Through various chemical isolation and analytical techniques, researchers posited four native ligand receptors that appeared to be specific to certain types of carcinogenic cells. These receptors may, in turn, be vascular markets, and the researchers suggested that Adipotide exerts some of its potential action via these receptors. Notably, the research suggested four native ligand-receptors within the cells comprising the vasculature, two apparently common across multiple tissues and two potentially specific to certain tissues. The researchers posited common ligand-receptors were integrin α4/annexin A4 and cathepsin B/apolipoprotein E3. These were suggested following identification through protein purification, identification of native ligands from protein arrays, and supervised online database searches.(6)"
            },
            {
                "h3": "Adipotide (FTPP) and Diabetes"
            },
            {
                "p": "In preliminary studies, obese murine models were given Adipotide to explore its potential mechanism on adipose cells. The research team noted it that within 2 to 3 days of the experiment, the murine models appeared to exhibit improved glucose tolerance and decreased levels of triglycerides.(7) More specifically, the study was conducted on obese murine models, and the alterations in glucose tolerance and metabolic variables were apparently observed without a corresponding change in body weight. This observation suggests a mechanism independent of weight loss. In the context of glucose homeostasis, Adipotide apparently improved glucose tolerance as suggested by a reduction in insulin and triglycerides, which was not merely a consequence of reduced food intake, as the changes differed from those in control groups with similar food intake. As noted, the apparent improvement in glucose tolerance was rapid, suggesting a potential direct influence of Adipotide on glucose regulatory mechanisms. Microarray analysis suggested shifts in gene expression within the white adipose tissue of Adipotide-presented murine models. Notably, pathways related to mitochondrial function, oxidative phosphorylation, and amino acid degradation appeared to be altered by the high-fat diet but were seemingly reversed by Adipotide. This suggests a potential role for Adipotide in modulating mitochondrial activity and metabolic processing in white adipose tissue, possibly contributing to improved glucose regulation. The study also explored the potential impact of Adipotide on various metabolic variables. While increased serum lipids were expected due to rapid white adipose tissue reduction, the findings were somewhat different. Triglycerides decreased in Adipotide-presented murine models, and there were distinctive levels of fatty acids and acylcarnitines compared to control groups. These observations hint at potential metabolic alterations not solely related to food intake or body weight changes. Another aspect examined was the serum levels of adipokines like adiponectin and resistin, which are considered to influence glucose regulation. The data did not suggest significant changes in these markers attributable to Adipotide, and the authors posited that the rapid improvement in glucose homeostasis might not be directly linked to these adipokines. Furthermore, Adipotide appeared to cause unique changes in serum acylcarnitines, indicating potential alterations in the mitochondrial metabolism of fatty acids and amino acids. Specifically, there was suggested to be a decrease in short- and medium-chain acylcarnitines and an increase in long-chain species, implying a shift in the metabolic processing of these molecules.(7)"
            },
            {
                "p": "Adipotide peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Thuaud, F., Ribeiro, N., Nebigil, C. G., & Désaubry, L. (2013). Prohibitin ligands in cell death and survival: mode of action and therapeutic potential. Chemistry & biology, 20(3), 316–331. https://doi.org/10.1016/j.chembiol.2013.02.006",
                    "Melissa H., Cancer treatment shows promise for rapid weight loss, Los Angeles Times, 10 Nov 2011. https://www.latimes.com/local/la-xpm-2011-nov-10-la-he-drug-fat-loss-20111110-story.html",
                    "Kolonin, Mikhail G et al. “Reversal of obesity by targeted ablation of adipose tissue.” Nature medicine vol. 10,6 (2004): 625-32. https://pubmed.ncbi.nlm.nih.gov/15133506/",
                    "Salameh A, Daquinag AC, Staquicini DI, An Z, Hajjar KA, Pasqualini R, Arap W, Kolonin MG. Prohibitin/annexin 2 interaction regulates fatty acid transport in adipose tissue. JCI Insight. 2016 Jul 7;1(10):e86351. doi: 10.1172/jci.insight.86351. PMID: 27468426; PMCID: PMC4959783.",
                    "Barnhart, Kirstin F et al. “A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys.” Science translational medicine vol. 3,108 (2011): 108ra112. doi:10.1126/scitranslmed.3002621. https://pubmed.ncbi.nlm.nih.gov/22072637/",
                    "Staquicini, Fernanda I et al. “Vascular ligand-receptor mapping by direct combinatorial selection in cancer patients.” Proceedings of the National Academy of Sciences of the United States of America vol. 108,46 (2011): 18637-42. doi:10.1073/pnas.1114503108. https://pubmed.ncbi.nlm.nih.gov/22049339/",
                    "Kim, Dong-Hoon et al. “Rapid and weight-independent improvement of glucose tolerance induced by a peptide designed to elicit apoptosis in adipose tissue endothelium.” Diabetes vol. 61,9 (2012): 2299-310. doi:10.2337/db11-1579. https://pubmed.ncbi.nlm.nih.gov/22733798/",
                    "Kolonin, Mikhail G et al. “Reversal of obesity by targeted ablation of adipose tissue.” Nature medicine vol. 10,6 (2004): 625-32. doi:10.1038/nm1048. https://pubmed.ncbi.nlm.nih.gov/15133506/"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/09/Adipotide-FTPP-coa.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/09/Adipotide-FTPP-lc.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/09/Adipotide-FTPP-ms.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Adipotide (FTPP) for sale online. Peptides for sale at 99% purity with top customer service. Get Adipotide research study results and information.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Adipotide (FTPP) For Sale (10mg) | Core Peptides",
            "og:description": "Adipotide FTPP for sale online. Peptides for sale at 99% purity with top customer service. Get Adipotide research study results and information.",
            "og:url": "https://www.corepeptides.com/peptides/adipotide-10mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-05-28T11:02:13+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Adipotide-FTPP-10MG.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Adipotide (FTPP) For Sale (10mg) | Core Peptides",
            "twitter:description": "Adipotide FTPP for sale online. Peptides for sale at 99% purity with top customer service. Get Adipotide research study results and information.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Adipotide-FTPP-10MG.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$78.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "78.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-ADIPOTID-10",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/semax-25mg/",
                "name": "Semax (25mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Semax-25MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/bpc-157/",
                "name": "BPC-157 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/BPC-157-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/dsip-5mg/",
                "name": "DSIP (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/DSIP-5MG-300x300.jpg.webp",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/selank-10mg/",
                "name": "Selank (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Selank-10MG-300x300.jpg.webp",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/ace-031-1mg/",
        "name": "ACE-031 (1mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2022/01/ACE-031-1mg.jpg",
        "display_price": "$173.00",
        "display_specs": [
            "Size: 1mg Contents: ACE-031 (1mg) Form: Lyophilized powder Purity: >99% SKU: P-ACE031-1",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$164.35"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$155.70"
            }
        ],
        "description": [
            {
                "h2": "ACE-031 Peptide"
            },
            {
                "p": "ACE-031 peptide, also known as ActRIIB-IgG1 peptide, appears to be a myostatin inhibitor. In terms of structure, it is a fusion compound consisting of the activin receptor type IIB (ACV2RB) and recombinant immunoglobulin IgG1 FC, which is a form of antibody.(1) Research suggests that this soluble peptide may block the action of circulating myostatin to potentially prevent myostatin from apparently inhibiting the native ACV2RB receptors and thus reducing muscle growth. Myostatin, also known as growth and differentiation factor 8 (GDF8), apparently may be blocked by certain substances termed inhibitors. These inhibitors may target the actions of naturally occurring myostatin, a possible negative regulator of muscle growth primarily found in skeletal muscle tissues. Interestingly, myostatin seemingly has no impact on cardiac or smooth muscle tissues. The discovery of myostatin dates back to 1997, when it was reportedly identified due to its potential inhibitory action on muscle growth, as observed in comparative murine studies.(2) Myostatin may inhibit the activation of murine satellite cells, which are partially committed stem cells within muscle tissue. Additionally, overexpression of myostatin has been suggested to lead to muscle mass reduction in experimental models. Myostatin is thought to bind with the ActR2B receptors with a high affinity, potentially initiating a signaling cascade involving Smad2/3, which is crucial for muscle mass regulation. Other ligands, such as other GDFs and activins, might also bind to ActR2B and potentially regulate muscle growth. These ligands, along with activin receptors, are part of the transforming growth factor-beta (TGF-β) superfamily, which is implicated in controlling tissue growth and differentiation. ACE-031 appears to work by binding with any circulating members from the TGF-β superfamily and, most notably, myostatin. Thus, the ACV2RB receptors in muscle cells remain uninhibited, which is posited to result in the activation of muscle hypertrophy and increase in skeletal muscle tissue size. Besides this, the peptide may have a positive potential for metabolism, fat storage, and bone density."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular Formula: C3418H5188N928O1062S38 Molecular Weight: 77,489.82 g/mol Other Known Titles: soluble activin type IIB receptor (ActRIIB-IgG1-Fc)"
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "ACE-031 and Muscle Cell Hypertrophy"
            },
            {
                "p": "In an experimental setting, which was structured as a double-blind, placebo-controlled research study, the potential of ACE-031 on muscle tissue was investigated, and a pharmacokinetics analysis was conducted.(3) Based on the pharmacokinetic analysis report on ACE-031, the half-life (T(½)) was estimated to be between 10 to 15 days. The apparent outcome of this study indicated a potential increase in muscle mass attributed to a single test with ACE-031. This conclusion is drawn from observations of changes in muscle tissue, which were quantified using specific measurement techniques such as dual-energy X-ray absorptiometry (DEXA) and MRI after 29 days following the exposure of the peptide. The results suggested that there was a noticeable increase in muscle mass. Specifically, a 3.3% increase in total body lean mass and a 5.1% increase in quadriceps femoris muscle volume were noted. More specifically, the researchers commented that “Statistically significant increases in mean total body lean mass (3.3%; P = 0.03, by DXA) and thigh muscle volume (5.1%; P = 0.03, by MRI) were observed at day 29.” These percentages reflect changes in muscle tissue, potentially indicating the hypertrophy-stimulating capability of ACE-031. Additionally, there were apparent shifts in serum biomarkers, suggesting possible improvements in bone and fat metabolism. Moreover, the scientists also concluded that “Statistically significant changes in serum biomarkers suggest ACE-031 also improved bone and fat metabolism.”"
            },
            {
                "h3": "ACE-031 and Fat Metabolism"
            },
            {
                "p": "There may be an increased expression of myostatin in obesity models, according to a review of several scientific studies.(4) For instance, in murine models for studying obesity, the levels of myostatin and its receptor ActR2b appeared to be higher than control models. More specifically, in experimental settings, overexpression of myostatin in murine models appears to correlate with decreased muscle mass, decreased myocardial mass, and increased fat mass. This suggests a potential role of myostatin in promoting fat accumulation and reducing muscle mass. Conversely, depletion of myostatin in certain murine models was linked to a reduction in age-related adipose tissue mass increase and a partial reduction in obesity phenotypes. This suggests that reducing myostatin can mitigate some consequences of obesity. The review also highlights that in mice fed a high-calorie diet, the absence of myostatin appears to result in reduced fat accumulation. This was attributed to two mechanisms:"
            },
            {
                "p": "Consequently, the researchers employed ACE-031 in control murine models on a high-fat diet, and the peptide appeared to prevent and reduce obesity.(5)"
            },
            {
                "h3": "ACE-031 and Muscle Contractile Force"
            },
            {
                "p": "Continuous research by scientists has suggested that the potential of the peptide may extend beyond myostatin inhibition.(6) By potentially preventing oxidative stress in muscle tissues, the peptide may improve the capacity of the muscle tissue to generate a force and in turn, preserve energy and stimulate the muscles toward oxidative respiration. These observations were made in murine models and measured using magnetic resonance imaging (MR imaging) and dynamic [31P]-magnetic resonance spectroscopy ([31P]-MRS). More specifically, the exposure of ACE-031 was linked to an apparent increase in muscle volume by 33% without altering the distribution of muscle fiber types. This suggests that the peptide may promote muscle growth. Additionally, there was an observed increase in basal oxygen consumption (by 22%) and energy expenditure (by 23%) in the murine models, indicating a potential rise in metabolic activity. During a standardized fatiguing exercise, murine models exposed to ACE-031 showed an apparent muscle performance enhancement. Both maximum and total absolute contractile forces were higher (40% and 24%, respectively) than the control group. However, it is important to note that specific force-generating capacity and fatigue resistance seemed unaffected. ACE-031 did not seem to modify metabolic fluxes, adenosine triphosphate (ATP) homeostasis, or contractile efficiency during exercise. However, it appeared to reduce the intrinsic mitochondrial capacity for ATP production. This aspect may suggest a shift in how muscle cells generate energy, although the implications of this finding are not fully clear."
            },
            {
                "h3": "ACE-031 and Bone Density"
            },
            {
                "p": "Another study explored the potential impact of ACE-031 on bone tissue in murine models of Duchenne Muscular Dystrophy (DMD), characterized by muscle degeneration and a heightened risk of fractures.(7) The models were divided into groups based on their activity (running or non-running) and additionally into active or placebo groups. The publication suggested that ACE-031 led to an apparent increase in both body and muscle weights in sedentary and exercising murine models. Importantly, femoral micro-CT analysis suggested an increase in bone volume by about 80% and trabecular number by about +70% in the ACE-031 groups. Although running also appeared to improve these bone parameters in the placebo group, it did not appear to enhance trabecular bone structure or volumetric bone mineral density. Additionally, ACE-031 was posited to increase bone mass in vertebral bone tissue, albeit more modestly by about 20-30%. Histological analysis also indicated a potential reduction in osteoclast numbers, and there was data supporting an increased expression of osteoblast marker genes in ACE-031 groups. These findings suggest a potential reduction in bone resorption and an increase in bone formation. Crucially, the researchers commented, \"Increased bone mass in femurs translated into enhanced bone strength in biomechanical testing as the maximum force and stiffness were significantly elevated” in the ACE-031 group."
            },
            {
                "p": "ACE-031 peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Campbell C, McMillan HJ, Mah JK, Tarnopolsky M, Selby K, McClure T, Wilson DM, Sherman ML, Escolar D, Attie KM. Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: Results of a randomized, placebo-controlled clinical trial. Muscle Nerve. 2017 Apr;55(4):458-464. https://pubmed.ncbi.nlm.nih.gov/27462804/",
                    "McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature. 1997 May 1;387(6628):83-90. https://pubmed.ncbi.nlm.nih.gov/9139826/",
                    "Attie KM, Borgstein NG, Yang Y, Condon CH, Wilson DM, Pearsall AE, Kumar R, Willins DA, Seehra JS, Sherman ML. A single ascending-dose study of muscle regulator ACE-031 in healthy volunteers. Muscle Nerve. 2013 Mar;47(3):416-23. https://pubmed.ncbi.nlm.nih.gov/23169607/",
                    "Yang M, Liu C, Jiang N, Liu Y, Luo S, Li C, Zhao H, Han Y, Chen W, Li L, Xiao L, Sun L. Myostatin: a potential therapeutic target for metabolic syndrome. Front Endocrinol (Lausanne). 2023 May 23;14:1181913. doi: 10.3389/fendo.2023.1181913. PMID: 37288303; PMCID: PMC10242177.",
                    "Zhang C, McFarlane C, Lokireddy S, Masuda S, Ge X, Gluckman PD, Sharma M, Kambadur R. Inhibition of myostatin protects against diet-induced obesity by enhancing fatty acid oxidation and promoting a brown adipose phenotype in mice. Diabetologia. 2012 Jan;55(1):183-93. doi: 10.1007/s00125-011-2304-4. Epub 2011 Sep 17. Erratum in: Diabetologia. 2015 Mar;58(3):643. PMID: 21927895.",
                    "Béchir N, Pecchi E, Vilmen C, Le Fur Y, Amthor H, Bernard M, Bendahan D, Giannesini B. ActRIIB blockade increases force-generating capacity and preserves energy supply in exercising mdx mouse muscle in vivo. FASEB J. 2016 Oct;30(10):3551-3562. https://pubmed.ncbi.nlm.nih.gov/27416839/",
                    "Puolakkainen, Tero et al. “Treatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of Duchenne muscular dystrophy.” BMC musculoskeletal disorders vol. 18,1 20. 19 Jan. 2017. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5244551/"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "https://www.corepeptides.com/wp-content/uploads/2024/09/ACE-031-coa.jpg",
        "high_performance_liquid_chromatography": "https://www.corepeptides.com/wp-content/uploads/2024/09/ACE-031-lc.jpg",
        "mass_spectrometry": "https://www.corepeptides.com/wp-content/uploads/2024/09/ACE-031-ms.jpg",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "ACE-031 peptide for sale online (1mg). Research peptides for sale at 99% purity with unmatched service and bulk purchase discounts from Core Peptides.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "ACE-031 For Sale (1mg) - Core Peptides",
            "og:description": "ACE-031 peptide for sale online (1mg). Research peptides for sale at 99+% purity with unmatched service and bulk purchase discounts from Core.",
            "og:url": "https://www.corepeptides.com/peptides/ace-031-1mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-15T16:28:11+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2022/01/ACE-031-1mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "ACE-031 For Sale (1mg) - Core Peptides",
            "twitter:description": "ACE-031 peptide for sale online (1mg). Research peptides for sale at 99+% purity with unmatched service and bulk purchase discounts from Core.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2022/01/ACE-031-1mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$173.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:brand": "Core Peptides",
            "product:price:amount": "173.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-ACE031-1",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/mgf-5mg/",
                "name": "MGF (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/MGF-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/adipotide-10mg/",
                "name": "Adipotide (FTPP) (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Adipotide-FTPP-10MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/oxytocin-10mg/",
                "name": "Oxytocin (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/Oxytocin-10mg-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/bpc-157/",
                "name": "BPC-157 (5mg / 10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/BPC-157-300x300.jpg",
                "price": ""
            }
        ]
    },
    {
        "url": "https://www.corepeptides.com/peptides/acetyl-hexapeptide-3-argireline-topical-200mg/",
        "name": "Acetyl Hexapeptide-3 (Argireline) (200mg)",
        "primary_image": "https://www.corepeptides.com/wp-content/uploads/2023/04/ACETYL-HEXAPEPTIDE-3-200mg.jpg",
        "display_price": "$226.00",
        "display_specs": [
            "Size: 200mg Contents: Acetyl Hexapeptide-3 (Argireline) Form: Lyophilized powder Purity: >99% SKU: P-ACETYL-HEXAPEPTIDE-3",
            "FREE Shipping on $200+ orders"
        ],
        "price_specs": [
            {
                "Quantity": "5 - 8",
                "Discount": "5%",
                "Price": "$214.70"
            },
            {
                "Quantity": "9 +",
                "Discount": "10%",
                "Price": "$203.40"
            }
        ],
        "description": [
            {
                "h2": "Acetyl Hexapeptide-3"
            },
            {
                "p": "Acetyl Hexapeptide-3 is a synthetic peptide commonly researched for its potential action in reducing wrinkle formation in skin tissues. Researchers developed Acetyl Hexapeptide-3 as a competitive SNAP25 (synaptosome-associated protein 25 kDa) inhibitor. SNAP-25 is a component of the SNARE (soluble N-ethylmaleimide sensitive factor attachment protein receptor) complex, which is posited to be a central regulator of synaptic vesicle Ca(2+)-dependent exocytosis - a key process in the release of signaling molecules and cellular communication. This inhibition is thought to occur due to the apparent similarity between the amino acid sequence pattern from the N-terminal end of SNAP-25 and Acetyl Hexapeptide-3. This is hypothesized to prevent the formation of the SNARE complex and inhibit the exocytosis of messengers. By apparently inhibiting exocytosis, Acetyl Hexapeptide-3 may potentially block the release of acetylcholine, a neurotransmitter involved in muscle contractions that mediates the communication between nerve and muscle cells."
            },
            {
                "p": "Conducting research with Acetyl Hexapeptide-3 is considered a milder and less invasive alternative to bacterial toxins because the peptide may have the potential to act directly through the skin tissues and reach any superficially underlying muscle cells.(2) The peptide may also have research applications in other areas related to skin tissue and muscle tissue studies, such as collagen synthesis, muscle spasms, and scarring. Furthermore, palmitoylated peptide versions have been posited to block the function of pain-mediating neurons."
            },
            {
                "h3": "Chemical Makeup"
            },
            {
                "p": "Molecular formula: C34H60N14O12S Molecular weight: 888.99 g/mol Other known titles: Acetyl Hexapeptide-8, Argireline"
            },
            {
                "p": " "
            },
            {
                "h2": "Research and Clinical Studies"
            },
            {
                "h3": "Acetyl Hexapeptide-3 and Wrinkles"
            },
            {
                "p": "Acetyl Hexapeptide-3 was apparently designed to mimic the action of BoNTs while passing through the skin layers. One study suggested that an emulsion containing Hexapeptide led to an apparent reduction in wrinkle depth by up to 30% after 30 days in 10 test subjects.(2)"
            },
            {
                "p": "An additional study investigated the impact of Acetyl Hexapeptide-3 on the skin properties of 24 test subjects and reported similar results.(3) Subjects were randomly assigned to a peptide or placebo group for 60 days. Skin microtopography and transepidermal water loss (TEWL) were estimated at different times throughout the experiment. The authors suggested that Acetyl Hexapeptide-3 had possible anti-wrinkle activity and might decrease TEWL, indicating increased water retention and hydration of the skin tissues. The potential of the peptide does not appear to depend on the type of skin model."
            },
            {
                "p": "Further data has also posed similar findings. For example, another clinical study that involved 52 test subjects was conducted over 29 days to evaluate the potential impact of Acetyl Hexapeptide-3 in wrinkle improvement.(4) After the study, the scientists observed apparently improved skin wrinkle morphology and skin hydration in all groups."
            },
            {
                "p": "In another clinical study, the scientists report that compared to the placebo, \"the total anti-wrinkle efficiency …] was 48.9%, the depth of the wrinkles was notably reduced\" in the Acetyl Hexapeptide-3 group.(5)"
            },
            {
                "p": "Experiments with murine models suggest that Acetyl Hexapeptide-3 may help improve wrinkles and fine lines by interacting with collagen synthesis, although this mechanism is poorly studied. For example, one study in aged murine models which were given the peptide for six weeks exhibited an apparent improvement in the histological structure of the skin tissue, with an increase in type I collagen fibers and a decrease in type III collagen fibers.(6) The study concluded that Acetyl Hexapeptide-3 might rejuvenate aging skin tissues through a potential impact on its histological structure."
            },
            {
                "h3": "Acetyl Hexapeptide-3 and Muscle Spasms"
            },
            {
                "p": "Acetyl Hexapeptide-3 has been studied in the context of involuntary muscle spasms, such as blepharospasms, characterized by involuntary contractions of the eyelid muscles. One study investigated the potential of Acetyl Hexapeptide-3 for blepharospasm in a clinical setting.(7) The study involved 24 test subjects with blepharospasm in a double-blind, placebo-controlled, randomized design. The primary outcome measured was the time until the spasm before the experiment returned, and the spasm grade was assessed via the Jankovic Blepharospasm Rating Scale (JBRS). There was a trend for a longer period until the return of the spasm in the active group compared to the placebo group, with an average of 3.7 months versus 3.0 months. Additionally, the active group tended to have better JBRS scores- or a lower grade of blepharospasm- than those in the placebo group. Interestingly, the researchers also report that \"One-third (4/12) of the [subjects] in the active group had a considerable extension of symptom control after [neurotoxins] (range: 3.3-7.1 months).\""
            },
            {
                "h3": "Acetyl Hexapeptide-3 and Scarring"
            },
            {
                "p": "According to one retrospective study, Acetyl Hexapeptide-3 may support the mitigation of scar tissues, such as the one that may develop following the damage of skin cells.(8) Scientists measured skin tissue quality parameters, took photographs, and performed a clinical assessment before and after the study.(8) This apparent effect on scarring tissues may be due to the aforementioned potential of Acetyl Hexapeptide-3 to minimize the production of collagen type 3 fibers. Collagen type 3 fibers are typical for scar tissues and are identified as having low elasticity and a structure that differentiates from surrounding tissues. Moreover, this was observed as a potential factor that increased the elasticity of regenerating tissues. More specifically, the authors reported that scar tissue elasticity increased \"from 33.5% to 40.5%” in certain areas of the skin tissues."
            },
            {
                "h3": "Acetyl Hexapeptide-3 and Pain Perception"
            },
            {
                "p": "Acetyl Hexapeptide-3 has undergone various in vitro examinations to determine its possible effects on cell and molecular activities linked to neurotransmission and pain sensation. For instance, the palmitoylated version of Acetyl Hexapeptide-3, called DD04107, has been studied for its potential analgesic activity in chronic inflammatory and neuropathic pain models.(9) It was suggested to be potentially impactful in blocking the inflammatory recruitment of ion channels and the release of calcitonin gene-related peptides, resulting in anti-hyperalgesia and anti-allodynia. Further, the study purported that the palmitoylated form of Acetyl Hexapeptide-3 might hinder the release of neuromodulators, which are considered crucial to pain-related signaling. This may potentially be achieved by disrupting SNAP-25 activity and blocking the Ca(2+)-dependent release of these neuromodulators. Consequently, this modified form of Acetyl Hexapeptide-3 might prevent the activation of TRPV1 channels, which are involved in inflammatory processes, further showcasing its potential to alleviate hyperalgesia and allodynia. TRPV1 channels, primarily located on sensory nerve fibers responsible for pain perception, are considered to be triggered by various elements such as heat, inflammatory substances, and chemical irritants. Activation of these channels is considered a key step in pain signal generation and transmission."
            },
            {
                "p": "In another experiment, carrageenan-induced inflammation models were used to simulate acute inflammatory pain, and the palmitoylated Acetyl Hexapeptide-3 has been proposed to exhibit anti-inflammatory effects, through decreased paw swelling (an inflammation indicator) and reduced mechanical sensitivity.(10) Additionally, this peptide's actions have been assessed in chronic inflammatory pain models, like Complete Freund's Adjuvant (CFA)-induced inflammation. CFA-induced inflammation is an experimental method in scientific research to simulate chronic inflammatory conditions in laboratory models, typically murine models. CFA, a complex mixture, contains inactivated and dried mycobacteria, usually Mycobacterium tuberculosis, emulsified in mineral oil. This mixture prompts a robust and persistent inflammatory response. In such models, it has been observed to apparently reduce both thermal hyperalgesia and mechanical allodynia, suggesting its potential in influencing chronic inflammatory pain. The palmitoylated version of Acetyl Hexapeptide-3 is also considered for its potential to alleviate pain linked to peripheral neuropathy caused by various factors. It was reported by the researchers to potentially have a concentration-responsive capability to lessen mechanical hyperalgesia in animal models of such neuropathies."
            },
            {
                "p": " "
            },
            {
                "p": "Acetyl Hexapeptide-3 peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering."
            },
            {
                "h3": "References:"
            },
            {
                "references": [
                    "Grosicki, M., Latacz, G., Szopa, A., Cukier, A., & Kieć-Kononowicz, K. (2014). The study of cellular cytotoxicity of argireline - an anti-aging peptide. Acta biochimica Polonica, 61(1), 29–32.",
                    "Blanes-Mira, C., Clemente, J., Jodas, G., Gil, A., Fernández-Ballester, G., Ponsati, B., Gutierrez, L., Pérez-Payá, E., & Ferrer-Montiel, A. (2002). A synthetic hexapeptide (Argireline) with antiwrinkle activity. International journal of cosmetic science, 24(5), 303–310. https://doi.org/10.1046/j.1467-2494.2002.00153.x",
                    "Raikou, V., Varvaresou, A., Panderi, I., & Papageorgiou, E. (2017). The efficacy study of the combination of tripeptide-10-citrulline and acetyl hexapeptide-3. A prospective, randomized controlled study. Journal of cosmetic dermatology, 16(2), 271–278. https://doi.org/10.1111/jocd.12314",
                    "An, J. H., Lee, H. J., Yoon, M. S., & Kim, D. H. (2019). Anti-Wrinkle Efficacy of Cross-Linked Hyaluronic Acid-Based Microneedle Patch with Acetyl Hexapeptide-8 and Epidermal Growth Factor on Korean Skin. Annals of dermatology, 31(3), 263–271. https://doi.org/10.5021/ad.2019.31.3.263",
                    "Wang, Y., Wang, M., Xiao, X. S., Pan, P., Li, P., & Huo, J. (2013). The anti wrinkle efficacy of synthetic hexapeptide (Argireline) in Chinese Subjects. Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology, Advance online publication.",
                    "Wang, Y., Wang, M., Xiao, X. S., Huo, J., & Zhang, W. D. (2013). The anti-wrinkle efficacy of Argireline. Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology, 15(4), 237–241. https://doi.org/10.3109/14764172.2013.769273",
                    "Lungu, C., Considine, E., Zahir, S., Ponsati, B., Arrastia, S., & Hallett, M. (2013). Pilot study of acetyl hexapeptide-8 in the treatment for blepharospasm in patients receiving botulinum toxin therapy. European journal of neurology, 20(3), 515–518. https://doi.org/10.1111/ene.12009",
                    "Palmieri, B., Noviello, A., Corazzari, V., Garelli, A., & Vadala, M. (2020). Skin scars and wrinkles temporary camouflage in dermatology and oncoesthetics: focus on acetyl hexapeptide-8. La Clinica terapeutica, 171(6), e539–e548. https://doi.org/10.7417/CT.2020.2270",
                    "Ponsati, B., Carreño, C., Curto-Reyes, V., Valenzuela, B., Duart, M. J., Van den Nest, W., Cauli, O., Beltran, B., Fernandez, J., Borsini, F., Caprioli, A., Di Serio, S., Veretchy, M., Baamonde, A., Menendez, L., Barros, F., de la Pena, P., Borges, R., Felipo, V., Planells-Cases, R., … Ferrer-Montiel, A. (2012). An inhibitor of neuronal exocytosis (DD04107) displays long-lasting in vivo activity against chronic inflammatory and neuropathic pain. The Journal of pharmacology and experimental therapeutics, 341(3), 634–645. https://doi.org/10.1124/jpet.111.190678",
                    "Butrón, D., Zamora-Carreras, H., Devesa, I., Treviño, M. A., Abian, O., Velázquez-Campoy, A., Bonache, M. Á., Lagartera, L., Martín-Martínez, M., González-Rodríguez, S., Baamonde, A., Fernández-Carvajal, A., Ferrer-Montiel, A., Jiménez, M. Á., & González-Muñiz, R. (2021). DD04107-Derived neuronal exocytosis inhibitor peptides: Evidences for synaptotagmin-1 as a putative target. Bioorganic chemistry, 115, 105231. https://doi.org/10.1016/j.bioorg.2021.105231"
                ]
            },
            {
                "author_details": [
                    {
                        "h3": "Dr. Marinov"
                    },
                    {
                        "p": "Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research."
                    }
                ]
            }
        ],
        "certificate_of_analysis": "",
        "high_performance_liquid_chromatography": "",
        "mass_spectrometry": "",
        "metadata": {
            "viewport": "width=device-width, initial-scale=1",
            "paperblog:tag": " I confirm the subscription of this blog to the Paperblog service under the username corepeptides ",
            "robots": "index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1",
            "description": "Acetyl Hexapeptide-3 (Argireline) for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:locale": "en_US",
            "og:type": "product",
            "og:title": "Acetyl Hexapeptide-3 (Argireline) For Sale (200mg) | Core Peptides",
            "og:description": "Acetyl Hexapeptide-3 (Argireline) for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "og:url": "https://www.corepeptides.com/peptides/acetyl-hexapeptide-3-argireline-topical-200mg/",
            "og:site_name": "Core Peptides",
            "article:modified_time": "2025-01-30T18:23:05+00:00",
            "og:image": "https://www.corepeptides.com/wp-content/uploads/2023/04/ACETYL-HEXAPEPTIDE-3-200mg.jpg",
            "og:image:width": "800",
            "og:image:height": "800",
            "og:image:type": "image/jpeg",
            "twitter:card": "summary_large_image",
            "twitter:title": "Acetyl Hexapeptide-3 (Argireline) For Sale (200mg) | Core Peptides",
            "twitter:description": "Acetyl Hexapeptide-3 (Argireline) for sale online (200mg). Purchase peptides online at 99+% purity with unmatched customer service and free shipping.",
            "twitter:image": "https://www.corepeptides.com/wp-content/uploads/2023/04/ACETYL-HEXAPEPTIDE-3-200mg.jpg",
            "twitter:label1": "Price",
            "twitter:data1": "$226.00",
            "twitter:label2": "Availability",
            "twitter:data2": "In stock",
            "product:price:amount": "226.00",
            "product:price:currency": "USD",
            "og:availability": "instock",
            "product:availability": "instock",
            "product:retailer_item_id": "P-ACETYL-HEXAPEPTIDE-3",
            "product:condition": "new",
            "generator": "Core Child Theme v.4.2.2",
            "omnisend-site-verification": "671bba7942f3e1630792d287",
            "google-site-verification": "HjULbh8O4ejgTwoKYcHJGiMsoppsGdaioxTAFieEEqQ",
            "msapplication-TileImage": "https://www.corepeptides.com/wp-content/uploads/2023/04/Favicon.png"
        },
        "related_products": [
            {
                "url": "https://www.corepeptides.com/peptides/dsip-5mg/",
                "name": "DSIP (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/DSIP-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/melanotan-2-10mg/",
                "name": "Melanotan 2 (10mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2023/03/Melanotan-2-10MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/peg-mgf-5mg/",
                "name": "PEG-MGF (5mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/PEG-MGF-5MG-300x300.jpg",
                "price": ""
            },
            {
                "url": "https://www.corepeptides.com/peptides/receptor-grade-igf-1-lr3-1mg/",
                "name": "Receptor Grade IGF-1 LR3 (1mg)",
                "image": "https://www.corepeptides.com/wp-content/uploads/2020/04/IGF-1-LR3-Receptor-Grade-1MG-300x300.jpg",
                "price": ""
            }
        ]
    }
]